{"pair_id":"BioInfer.d454.s0.p0","sentence":"No significant changes in glomerular ps vinculin pe, talin, ps beta 1-integrin pe, or total actin expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p1","sentence":"No significant changes in glomerular vinculin, talin, ps beta 1-integrin pe, or total ps actin pe expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p2","sentence":"No significant changes in glomerular vinculin, ps talin pe, ps beta 1-integrin pe, or total actin expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p3","sentence":"No significant changes in glomerular ps vinculin pe, talin, beta 1-integrin, or total ps actin pe expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p4","sentence":"No significant changes in glomerular ps vinculin pe, ps talin pe, beta 1-integrin, or total actin expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d454.s0.p5","sentence":"No significant changes in glomerular vinculin, ps talin pe, beta 1-integrin, or total ps actin pe expression occurred at any time point during disease development.","label":0}
{"pair_id":"BioInfer.d637.s1.p0","sentence":"To our knowledge, ps AF-6 pe is the only integral component in cell-cell junctions discovered thus far that interacts with ps profilin pe and thus could modulate actin modeling proximal to adhesion complexes.","label":1}
{"pair_id":"BioInfer.d637.s1.p1","sentence":"To our knowledge, ps AF-6 pe is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate ps actin pe modeling proximal to adhesion complexes.","label":1}
{"pair_id":"BioInfer.d637.s1.p2","sentence":"To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with ps profilin pe and thus could modulate ps actin pe modeling proximal to adhesion complexes.","label":0}
{"pair_id":"AIMed.d128.s1094.p0","sentence":"The ps hGH pe and ps hPRL pe receptors (hGHR and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"AIMed.d128.s1094.p1","sentence":"The ps hGH pe and hPRL receptors (ps hGHR pe and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":1}
{"pair_id":"AIMed.d128.s1094.p2","sentence":"The ps hGH pe and hPRL receptors (hGHR and ps hPRLR pe, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"AIMed.d128.s1094.p3","sentence":"The hGH and ps hPRL pe receptors (ps hGHR pe and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"AIMed.d128.s1094.p4","sentence":"The hGH and ps hPRL pe receptors (hGHR and ps hPRLR pe, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":1}
{"pair_id":"AIMed.d128.s1094.p5","sentence":"The hGH and hPRL receptors (ps hGHR pe and ps hPRLR pe, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.","label":0}
{"pair_id":"BioInfer.d551.s0.p0","sentence":"Structural studies on the ribbon-to-helix transition in ps profilin pe: ps actin pe crystals.","label":0}
{"pair_id":"BioInfer.d421.s0.p0","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (ps alpha-SMA pe), ps myosin heavy chain pe, and smoothelin, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p1","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (ps alpha-SMA pe), myosin heavy chain, and ps smoothelin pe, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p2","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to ps alpha-smooth muscle actin pe (ps alpha-SMA pe), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p3","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), ps myosin heavy chain pe, and ps smoothelin pe, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p4","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to ps alpha-smooth muscle actin pe (alpha-SMA), ps myosin heavy chain pe, and smoothelin, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d421.s0.p5","sentence":"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to ps alpha-smooth muscle actin pe (alpha-SMA), myosin heavy chain, and ps smoothelin pe, a novel marker for contractile VSMC phenotype.","label":0}
{"pair_id":"BioInfer.d12.s0.p0","sentence":"A core activity associated with the N terminus of the yeast RAD52 protein is revealed by ps RAD51 pe overexpression suppression of C-terminal ps rad52 pe truncation alleles.","label":1}
{"pair_id":"BioInfer.d12.s0.p1","sentence":"A core activity associated with the N terminus of the yeast ps RAD52 pe protein is revealed by RAD51 overexpression suppression of C-terminal ps rad52 pe truncation alleles.","label":0}
{"pair_id":"BioInfer.d12.s0.p2","sentence":"A core activity associated with the N terminus of the yeast ps RAD52 pe protein is revealed by ps RAD51 pe overexpression suppression of C-terminal rad52 truncation alleles.","label":0}
{"pair_id":"BioInfer.d575.s0.p0","sentence":"The ps APC pe binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d575.s0.p1","sentence":"The ps APC pe binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with ps APC pe, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"BioInfer.d575.s0.p2","sentence":"The ps APC pe binding site on ps beta-catenin pe may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.","label":1}
{"pair_id":"BioInfer.d575.s0.p3","sentence":"The ps APC pe binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of ps beta-catenin pe will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"BioInfer.d575.s0.p4","sentence":"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with ps APC pe, although the amino-terminal half independently binds ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d575.s0.p5","sentence":"The APC binding site on ps beta-catenin pe may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d575.s0.p6","sentence":"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of ps beta-catenin pe will independently associate with APC, although the amino-terminal half independently binds ps alpha-catenin pe.","label":1}
{"pair_id":"BioInfer.d575.s0.p7","sentence":"The APC binding site on ps beta-catenin pe may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with ps APC pe, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"BioInfer.d575.s0.p8","sentence":"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of ps beta-catenin pe will independently associate with ps APC pe, although the amino-terminal half independently binds alpha-catenin.","label":1}
{"pair_id":"BioInfer.d575.s0.p9","sentence":"The APC binding site on ps beta-catenin pe may be discontinuous since neither the carboxyl- nor amino-terminal halves of ps beta-catenin pe will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.","label":0}
{"pair_id":"AIMed.d103.s875.p0","sentence":"These results reveal differences not only in subunit composition, but also in the organization of ps dTFIID pe and ps hTFIID pe complexes.","label":0}
{"pair_id":"BioInfer.d296.s3.p0","sentence":"We found that the down-regulation of ps E-cad pe, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for ps beta-catenin pe, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p1","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and ps beta-catenin pe expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for ps beta-catenin pe, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p2","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or ps c-erbB2 pe expression, except for ps beta-catenin pe, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p3","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, ps p53 pe expression, Ki-67 labeling, or c-erbB2 expression, except for ps beta-catenin pe, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p4","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for ps beta-catenin pe, the down-regulation of which was associated with ps c-erbB2 pe down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p5","sentence":"We found that the down-regulation of E-cad, ps alpha-catenin pe, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for ps beta-catenin pe, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p6","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, ps Ki-67 pe labeling, or c-erbB2 expression, except for ps beta-catenin pe, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p7","sentence":"We found that the down-regulation of ps E-cad pe, alpha-catenin, and ps beta-catenin pe expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p8","sentence":"We found that the down-regulation of ps E-cad pe, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or ps c-erbB2 pe expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p9","sentence":"We found that the down-regulation of ps E-cad pe, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, ps p53 pe expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p10","sentence":"We found that the down-regulation of ps E-cad pe, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with ps c-erbB2 pe down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p11","sentence":"We found that the down-regulation of ps E-cad pe, ps alpha-catenin pe, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p12","sentence":"We found that the down-regulation of ps E-cad pe, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, ps Ki-67 pe labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p13","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and ps beta-catenin pe expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or ps c-erbB2 pe expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p14","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and ps beta-catenin pe expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, ps p53 pe expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p15","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and ps beta-catenin pe expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with ps c-erbB2 pe down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p16","sentence":"We found that the down-regulation of E-cad, ps alpha-catenin pe, and ps beta-catenin pe expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p17","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and ps beta-catenin pe expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, ps Ki-67 pe labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p18","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, ps p53 pe expression, Ki-67 labeling, or ps c-erbB2 pe expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p19","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or ps c-erbB2 pe expression, except for beta-catenin, the down-regulation of which was associated with ps c-erbB2 pe down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p20","sentence":"We found that the down-regulation of E-cad, ps alpha-catenin pe, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or ps c-erbB2 pe expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p21","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, ps Ki-67 pe labeling, or ps c-erbB2 pe expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p22","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, ps p53 pe expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with ps c-erbB2 pe down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p23","sentence":"We found that the down-regulation of E-cad, ps alpha-catenin pe, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, ps p53 pe expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":1}
{"pair_id":"BioInfer.d296.s3.p24","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, ps p53 pe expression, ps Ki-67 pe labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p25","sentence":"We found that the down-regulation of E-cad, ps alpha-catenin pe, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with ps c-erbB2 pe down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p26","sentence":"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, ps Ki-67 pe labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with ps c-erbB2 pe down-regulation.","label":0}
{"pair_id":"BioInfer.d296.s3.p27","sentence":"We found that the down-regulation of E-cad, ps alpha-catenin pe, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, ps Ki-67 pe labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.","label":0}
{"pair_id":"AIMed.d35.s292.p0","sentence":"Most familial early-onset Alzheimer's disease cases are caused by mutations in the ps presenilin 1 pe (ps PS1 pe) gene.","label":0}
{"pair_id":"AIMed.d48.s419.p0","sentence":"ps LEC pe induces chemotaxis and adhesion by interacting with ps CCR1 pe and CCR8.","label":1}
{"pair_id":"AIMed.d48.s419.p1","sentence":"ps LEC pe induces chemotaxis and adhesion by interacting with CCR1 and ps CCR8 pe.","label":1}
{"pair_id":"AIMed.d48.s419.p2","sentence":"LEC induces chemotaxis and adhesion by interacting with ps CCR1 pe and ps CCR8 pe.","label":0}
{"pair_id":"BioInfer.d431.s0.p0","sentence":"[Molecular functions of ps cofilin pe which regulates reorganization of ps actin pe cytoskeleton].","label":1}
{"pair_id":"AIMed.d211.s1833.p0","sentence":"Recombinant ps neuregulin-2beta pe induces the tyrosine-phosphorylation of ps ErbB2 pe, ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.","label":1}
{"pair_id":"AIMed.d211.s1833.p1","sentence":"Recombinant ps neuregulin-2beta pe induces the tyrosine-phosphorylation of ErbB2, ps ErbB3 pe and ErbB4 in cell lines expressing all of these ErbB-family receptors.","label":1}
{"pair_id":"AIMed.d211.s1833.p2","sentence":"Recombinant ps neuregulin-2beta pe induces the tyrosine-phosphorylation of ErbB2, ErbB3 and ps ErbB4 pe in cell lines expressing all of these ErbB-family receptors.","label":1}
{"pair_id":"AIMed.d211.s1833.p3","sentence":"Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ps ErbB2 pe, ps ErbB3 pe and ErbB4 in cell lines expressing all of these ErbB-family receptors.","label":0}
{"pair_id":"AIMed.d211.s1833.p4","sentence":"Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ps ErbB2 pe, ErbB3 and ps ErbB4 pe in cell lines expressing all of these ErbB-family receptors.","label":0}
{"pair_id":"AIMed.d211.s1833.p5","sentence":"Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ErbB2, ps ErbB3 pe and ps ErbB4 pe in cell lines expressing all of these ErbB-family receptors.","label":0}
{"pair_id":"BioInfer.d634.s0.p0","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, TRADD, and ps RIP pe and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p1","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, ps TRADD pe, and ps RIP pe and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p2","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, TRADD, and ps RIP pe and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p3","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and ps RIP pe and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p4","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and ps RIP pe and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p5","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and ps RIP pe and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p6","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and ps RIP pe and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p7","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and ps RIP pe and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p8","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and ps RIP pe and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p9","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, ps TRADD pe, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p10","sentence":"The involvement of the death adaptor proteins ps FADD pe\/ps MORT1 pe, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p11","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p12","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p13","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p14","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p15","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p16","sentence":"The involvement of the death adaptor proteins ps FADD pe\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p17","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, ps TRADD pe, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p18","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, ps TRADD pe, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p19","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, ps TRADD pe, and RIP and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p20","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, ps TRADD pe, and RIP and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p21","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, ps TRADD pe, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p22","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, ps TRADD pe, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p23","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, ps TRADD pe, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p24","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p25","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, TRADD, and RIP and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p26","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, TRADD, and RIP and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p27","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p28","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p29","sentence":"The involvement of the death adaptor proteins FADD\/ps MORT1 pe, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p30","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing TRAIL receptors 1 and T (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p31","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p32","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p33","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (ps TRAIL-R1 pe and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p34","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (ps TRAIL-R1 pe and ps TRAIL-R2 pe) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p35","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases peps caspases-8 pe and ps cas pe in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p36","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p37","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p38","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases pe-8 and ps cas pe in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p39","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p40","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (TRAIL-R1 and TRAIL-R2) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p41","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating ps caspases-8 pe and cas in death signaling by the two death-inducing TRAIL receptors 1 and T (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":1}
{"pair_id":"BioInfer.d634.s0.p42","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors peps TRAIL receptors 1 pe and ps T pe (TRAIL-R1 and TRAIL-R2) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p43","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors pe 1 and ps T pe (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":0}
{"pair_id":"BioInfer.d634.s0.p44","sentence":"The involvement of the death adaptor proteins FADD\/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and cas in death signaling by the two death-inducing ps TRAIL receptors 1 pe and T (TRAIL-R1 and ps TRAIL-R2 pe) are controversial.","label":0}
{"pair_id":"BioInfer.d193.s0.p0","sentence":"Evaluation of the binding of Acanthamoeba ps profilin pe to pyrene-labeled ps actin pe by fluorescence enhancement.","label":1}
{"pair_id":"BioInfer.d591.s0.p0","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the ps fibronectin receptor pe, talin, ps vinculin pe and actin.","label":0}
{"pair_id":"BioInfer.d591.s0.p1","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, ps vinculin pe and ps actin pe.","label":0}
{"pair_id":"BioInfer.d591.s0.p2","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, ps talin pe, ps vinculin pe and actin.","label":0}
{"pair_id":"BioInfer.d591.s0.p3","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the ps fibronectin receptor pe, talin, vinculin and ps actin pe.","label":0}
{"pair_id":"BioInfer.d591.s0.p4","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the ps fibronectin receptor pe, ps talin pe, vinculin and actin.","label":0}
{"pair_id":"BioInfer.d591.s0.p5","sentence":"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, ps talin pe, vinculin and ps actin pe.","label":0}
{"pair_id":"BioInfer.d205.s0.p0","sentence":"Expression of ps E-cadherin pe, alpha-catenin and ps beta-catenin pe in normal ovarian surface epithelium and epithelial ovarian cancers.","label":0}
{"pair_id":"BioInfer.d205.s0.p1","sentence":"Expression of ps E-cadherin pe, ps alpha-catenin pe and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.","label":0}
{"pair_id":"BioInfer.d205.s0.p2","sentence":"Expression of E-cadherin, ps alpha-catenin pe and ps beta-catenin pe in normal ovarian surface epithelium and epithelial ovarian cancers.","label":0}
{"pair_id":"AIMed.d109.s918.p0","sentence":"We have determined the X-ray crystal structure of a heterodimer of the bZIP regions of ps c-Fos pe and ps c-Jun pe bound to DNA.","label":1}
{"pair_id":"AIMed.d121.s1023.p0","sentence":"Several hydrophobic amino acids in the ps p53 pe amino-terminal domain are required for transcriptional activation, binding to ps mdm-2 pe and the adenovirus 5 E1B 55-kD protein.","label":1}
{"pair_id":"AIMed.d121.s1023.p1","sentence":"Several hydrophobic amino acids in the ps p53 pe amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 ps E1B pe 55-kD protein.","label":0}
{"pair_id":"AIMed.d121.s1023.p2","sentence":"Several hydrophobic amino acids in the ps p53 pe amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus ps 5 E1B pe 55-kD protein.","label":1}
{"pair_id":"AIMed.d121.s1023.p3","sentence":"Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to ps mdm-2 pe and the adenovirus 5 ps E1B pe 55-kD protein.","label":0}
{"pair_id":"AIMed.d121.s1023.p4","sentence":"Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to ps mdm-2 pe and the adenovirus ps 5 E1B pe 55-kD protein.","label":0}
{"pair_id":"AIMed.d121.s1023.p5","sentence":"Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus ps 5 E1B peps E1B pe 55-kD protein.","label":0}
{"pair_id":"AIMed.d131.s1126.p0","sentence":"Like ps mIL-10R pe, ps hIL-10R pe is structurally related to IFNR.","label":0}
{"pair_id":"AIMed.d131.s1126.p1","sentence":"Like ps mIL-10R pe, hIL-10R is structurally related to ps IFNR pe.","label":0}
{"pair_id":"AIMed.d131.s1126.p2","sentence":"Like mIL-10R, ps hIL-10R pe is structurally related to ps IFNR pe.","label":0}
{"pair_id":"BioInfer.d633.s0.p0","sentence":"The intracellular molecules ps calmodulin pe and ps profilin pe actively regulate actin-based motility and participate in the signaling pathways used to steer growth cones.","label":0}
{"pair_id":"BioInfer.d633.s0.p1","sentence":"The intracellular molecules calmodulin and ps profilin pe actively regulate ps actin pe-based motility and participate in the signaling pathways used to steer growth cones.","label":1}
{"pair_id":"BioInfer.d633.s0.p2","sentence":"The intracellular molecules ps calmodulin pe and profilin actively regulate ps actin pe-based motility and participate in the signaling pathways used to steer growth cones.","label":1}
{"pair_id":"AIMed.d114.s969.p0","sentence":"We have found a COOH-terminal 37-kD fragment of ps beta 1-syntrophin pe sufficient to interact with translated ps dystrophin pe and its homologues, suggesting that the dystrophin binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues.","label":1}
{"pair_id":"AIMed.d114.s969.p1","sentence":"We have found a COOH-terminal 37-kD fragment of ps beta 1-syntrophin pe sufficient to interact with translated dystrophin and its homologues, suggesting that the ps dystrophin pe binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p2","sentence":"We have found a COOH-terminal 37-kD fragment of ps beta 1-syntrophin pe sufficient to interact with translated dystrophin and its homologues, suggesting that the dystrophin binding site on ps beta 1-syntrophin pe occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p3","sentence":"We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated ps dystrophin pe and its homologues, suggesting that the ps dystrophin pe binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p4","sentence":"We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated ps dystrophin pe and its homologues, suggesting that the dystrophin binding site on ps beta 1-syntrophin pe occurs on a region that is conserved among the three syntrophin homologues.","label":0}
{"pair_id":"AIMed.d114.s969.p5","sentence":"We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated dystrophin and its homologues, suggesting that the ps dystrophin pe binding site on ps beta 1-syntrophin pe occurs on a region that is conserved among the three syntrophin homologues.","label":1}
{"pair_id":"BioInfer.d184.s0.p0","sentence":"Effects of ps profilin pe-annexin I association on some properties of both ps profilin pe and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p1","sentence":"Effects of profilin-ps annexin I pe association on some properties of both ps profilin pe and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p2","sentence":"Effects of profilin-annexin I association on some properties of both ps profilin pe and annexin I: modification of the inhibitory activity of ps profilin pe on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p3","sentence":"Effects of profilin-annexin I association on some properties of both ps profilin pe and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of ps annexin I pe and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p4","sentence":"Effects of profilin-annexin I association on some properties of both ps profilin pe and annexin I: modification of the inhibitory activity of profilin on ps actin pe polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p5","sentence":"Effects of profilin-annexin I association on some properties of both ps profilin pe and ps annexin I pe: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p6","sentence":"Effects of ps profilin pe-ps annexin I pe association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p7","sentence":"Effects of ps profilin pe-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of ps profilin pe on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p8","sentence":"Effects of ps profilin pe-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of ps annexin I pe and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p9","sentence":"Effects of ps profilin pe-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on ps actin pe polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p10","sentence":"Effects of ps profilin pe-annexin I association on some properties of both profilin and ps annexin I pe: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p11","sentence":"Effects of profilin-ps annexin I pe association on some properties of both profilin and annexin I: modification of the inhibitory activity of ps profilin pe on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p12","sentence":"Effects of profilin-ps annexin I pe association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of ps annexin I pe and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p13","sentence":"Effects of profilin-ps annexin I pe association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on ps actin pe polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p14","sentence":"Effects of profilin-ps annexin I pe association on some properties of both profilin and ps annexin I pe: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p15","sentence":"Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of ps profilin pe on actin polymerization and inhibition of the self-association of ps annexin I pe and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p16","sentence":"Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of ps profilin pe on ps actin pe polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":1}
{"pair_id":"BioInfer.d184.s0.p17","sentence":"Effects of profilin-annexin I association on some properties of both profilin and ps annexin I pe: modification of the inhibitory activity of ps profilin pe on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p18","sentence":"Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on ps actin pe polymerization and inhibition of the self-association of ps annexin I pe and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p19","sentence":"Effects of profilin-annexin I association on some properties of both profilin and ps annexin I pe: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of ps annexin I pe and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d184.s0.p20","sentence":"Effects of profilin-annexin I association on some properties of both profilin and ps annexin I pe: modification of the inhibitory activity of profilin on ps actin pe polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.","label":0}
{"pair_id":"BioInfer.d229.s0.p0","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of ps actin pe or myosin and of ps myosin heavy chain pe (MHC) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p1","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of ps actin pe or ps myosin pe and of myosin heavy chain (MHC) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p2","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of ps actin pe or myosin and of myosin heavy chain (ps MHC pe) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p3","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of actin or ps myosin pe and of ps myosin heavy chain pe (MHC) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p4","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of ps myosin heavy chain pe (ps MHC pe) isoforms.","label":0}
{"pair_id":"BioInfer.d229.s0.p5","sentence":"Gel electrophoresis was used to measure changes in the relative amounts of actin or ps myosin pe and of myosin heavy chain (ps MHC pe) isoforms.","label":0}
{"pair_id":"AIMed.d222.s1929.p0","sentence":"The precise function of ps c-Cbl pe in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that ps c-Cbl pe is a negative regulator of the epidermal growth factor receptor.","label":0}
{"pair_id":"AIMed.d222.s1929.p1","sentence":"The precise function of ps c-Cbl pe in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the ps epidermal growth factor pe receptor.","label":0}
{"pair_id":"AIMed.d222.s1929.p2","sentence":"The precise function of ps c-Cbl pe in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the ps epidermal growth factor receptor pe.","label":0}
{"pair_id":"AIMed.d222.s1929.p3","sentence":"The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that ps c-Cbl pe is a negative regulator of the ps epidermal growth factor pe receptor.","label":0}
{"pair_id":"AIMed.d222.s1929.p4","sentence":"The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that ps c-Cbl pe is a negative regulator of the ps epidermal growth factor receptor pe.","label":1}
{"pair_id":"AIMed.d222.s1929.p5","sentence":"The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the ps epidermal growth factor peps epidermal growth factor receptor pe.","label":0}
{"pair_id":"AIMed.d2.s19.p0","sentence":"DESIGN: We took advantage of previously collected data during a randomised double-blind, placebo-controlled clinical trial to conduct a secondary analysis of the ps RBP pe\/ps TTR pe ratio and its relationship to infection and VA status.","label":0}
{"pair_id":"BioInfer.d170.s1.p0","sentence":"The truncated ps cofilin pe molecules produced in E. coli were purified and examined for their ps actin pe-binding and PIP2-binding ability.","label":1}
{"pair_id":"AIMed.d39.s336.p0","sentence":"Here we show that ps QM pe\/ps Jun-interacting factor (Jif)-1 pe, a negative regulator of c-Jun, is a candidate to mediate the function of PS1 in the cell.","label":0}
{"pair_id":"AIMed.d39.s336.p1","sentence":"Here we show that ps QM pe\/Jun-interacting factor (Jif)-1, a negative regulator of ps c-Jun pe, is a candidate to mediate the function of PS1 in the cell.","label":1}
{"pair_id":"AIMed.d39.s336.p2","sentence":"Here we show that ps QM pe\/Jun-interacting factor (Jif)-1, a negative regulator of c-Jun, is a candidate to mediate the function of ps PS1 pe in the cell.","label":0}
{"pair_id":"AIMed.d39.s336.p3","sentence":"Here we show that QM\/ps Jun-interacting factor (Jif)-1 pe, a negative regulator of ps c-Jun pe, is a candidate to mediate the function of PS1 in the cell.","label":1}
{"pair_id":"AIMed.d39.s336.p4","sentence":"Here we show that QM\/ps Jun-interacting factor (Jif)-1 pe, a negative regulator of c-Jun, is a candidate to mediate the function of ps PS1 pe in the cell.","label":0}
{"pair_id":"AIMed.d39.s336.p5","sentence":"Here we show that QM\/Jun-interacting factor (Jif)-1, a negative regulator of ps c-Jun pe, is a candidate to mediate the function of ps PS1 pe in the cell.","label":0}
{"pair_id":"BioInfer.d742.s0.p0","sentence":"This novel mutation was predicted to disrupt the binding of ps beta-catenin pe to ps alpha-catenin pe and may be related to the diffuse type morphology.","label":1}
{"pair_id":"BioInfer.d558.s1.p0","sentence":"ps alpha-Sm actin pe inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, ps talin pe, and beta1-integrin.","label":0}
{"pair_id":"BioInfer.d558.s1.p1","sentence":"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, ps talin pe, and ps beta1-integrin pe.","label":0}
{"pair_id":"BioInfer.d558.s1.p2","sentence":"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against ps vinculin pe, ps talin pe, and beta1-integrin.","label":0}
{"pair_id":"BioInfer.d558.s1.p3","sentence":"ps alpha-Sm actin pe inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and ps beta1-integrin pe.","label":0}
{"pair_id":"BioInfer.d558.s1.p4","sentence":"ps alpha-Sm actin pe inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against ps vinculin pe, talin, and beta1-integrin.","label":0}
{"pair_id":"BioInfer.d558.s1.p5","sentence":"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against ps vinculin pe, talin, and ps beta1-integrin pe.","label":0}
{"pair_id":"BioInfer.d695.s0.p0","sentence":"These data suggest that nuclear ps profilin pe can mediate a stimulus-response action on the ps actin pe cytoskeleton which is somehow linked to a phosphoinositide-signaling cascade.","label":1}
{"pair_id":"BioInfer.d805.s0.p0","sentence":"We found normal levels of ps alpha-catenin pe and ps beta-catenin pe in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.","label":0}
{"pair_id":"BioInfer.d805.s0.p1","sentence":"We found normal levels of alpha-catenin and ps beta-catenin pe in BT549 and HS578t cells; however, low levels of ps plakoglobin pe were expressed in these cells compared to those found in weakly invasive MCF-7 cells.","label":0}
{"pair_id":"BioInfer.d805.s0.p2","sentence":"We found normal levels of ps alpha-catenin pe and beta-catenin in BT549 and HS578t cells; however, low levels of ps plakoglobin pe were expressed in these cells compared to those found in weakly invasive MCF-7 cells.","label":0}
{"pair_id":"AIMed.d123.s1047.p0","sentence":"We demonstrate that ps IRS-1 pe forms a specific complex with the cytoplasmic domain of the ps insulin receptor pe when both are expressed as hybrid proteins in yeast cells.","label":1}
{"pair_id":"AIMed.d204.s1757.p0","sentence":"Here, we describe the production of ps recombinant human tissue inhibitor of metalloproteinases-1 pe (ps rTIMP-1 pe) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p1","sentence":"Here, we describe the production of ps recombinant human tissue inhibitor of metalloproteinases-1 pe (rTIMP-1) and wild-type and mutant human ps collagenase type I pe (rMMP-1) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p2","sentence":"Here, we describe the production of ps recombinant human tissue inhibitor of metalloproteinases-1 pe (rTIMP-1) and wild-type and mutant human collagenase type I (ps rMMP-1 pe) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p3","sentence":"Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (ps rTIMP-1 pe) and wild-type and mutant human ps collagenase type I pe (rMMP-1) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p4","sentence":"Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (ps rTIMP-1 pe) and wild-type and mutant human collagenase type I (ps rMMP-1 pe) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d204.s1757.p5","sentence":"Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human ps collagenase type I pe (ps rMMP-1 pe) proteins in SF9 cells by the baculovirus expression system.","label":0}
{"pair_id":"AIMed.d152.s1291.p0","sentence":"ps TRADD pe-ps TRAF2 pe and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.","label":1}
{"pair_id":"AIMed.d152.s1291.p1","sentence":"ps TRADD pe-TRAF2 and ps TRADD pe-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p2","sentence":"ps TRADD pe-TRAF2 and TRADD-ps FADD pe interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p3","sentence":"ps TRADD pe-TRAF2 and TRADD-FADD interactions define two distinct ps TNF receptor 1 pe signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p4","sentence":"TRADD-ps TRAF2 pe and ps TRADD pe-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p5","sentence":"TRADD-ps TRAF2 pe and TRADD-ps FADD pe interactions define two distinct TNF receptor 1 signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p6","sentence":"TRADD-ps TRAF2 pe and TRADD-FADD interactions define two distinct ps TNF receptor 1 pe signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p7","sentence":"TRADD-TRAF2 and ps TRADD pe-ps FADD pe interactions define two distinct TNF receptor 1 signal transduction pathways.","label":1}
{"pair_id":"AIMed.d152.s1291.p8","sentence":"TRADD-TRAF2 and ps TRADD pe-FADD interactions define two distinct ps TNF receptor 1 pe signal transduction pathways.","label":0}
{"pair_id":"AIMed.d152.s1291.p9","sentence":"TRADD-TRAF2 and TRADD-ps FADD pe interactions define two distinct ps TNF receptor 1 pe signal transduction pathways.","label":0}
{"pair_id":"AIMed.d160.s1344.p0","sentence":"ps Vascular endothelial growth factor pe (ps VEGF pe) expression in various cell types is induced by hypoxia and other stimuli.","label":0}
{"pair_id":"BioInfer.d311.s0.p0","sentence":"In addition to their role in mismatch repair (MMR), the ps MSH2 pe and ps MSH3 pe gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.","label":0}
{"pair_id":"BioInfer.d437.s1.p0","sentence":"pH control of ps actin pe polymerization by ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d388.s2.p0","sentence":"The ps actin pe monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on ps actin pe, and promoting barbed-end assembly.","label":0}
{"pair_id":"BioInfer.d388.s2.p1","sentence":"The ps actin pe monomer-binding protein, profilin, influences the dynamics of ps actin pe filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.","label":0}
{"pair_id":"BioInfer.d388.s2.p2","sentence":"The ps actin pe monomer-binding protein, ps profilin pe, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.","label":1}
{"pair_id":"BioInfer.d388.s2.p3","sentence":"The actin monomer-binding protein, profilin, influences the dynamics of ps actin pe filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on ps actin pe, and promoting barbed-end assembly.","label":1}
{"pair_id":"BioInfer.d388.s2.p4","sentence":"The actin monomer-binding protein, ps profilin pe, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on ps actin pe, and promoting barbed-end assembly.","label":1}
{"pair_id":"BioInfer.d388.s2.p5","sentence":"The actin monomer-binding protein, ps profilin pe, influences the dynamics of ps actin pe filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.","label":1}
{"pair_id":"AIMed.d113.s956.p0","sentence":"Using a protein interaction cloning technique, we identified cDNAs that encode a novel ps Bcl-2 peps Bcl-2-binding protein pe, termed BAG-1.","label":0}
{"pair_id":"AIMed.d113.s956.p1","sentence":"Using a protein interaction cloning technique, we identified cDNAs that encode a novel ps Bcl-2 pe-binding protein, termed ps BAG-1 pe.","label":1}
{"pair_id":"AIMed.d113.s956.p2","sentence":"Using a protein interaction cloning technique, we identified cDNAs that encode a novel ps Bcl-2-binding protein pe, termed ps BAG-1 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p0","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p1","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p2","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p3","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p4","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p5","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p6","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p7","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p8","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p9","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p10","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe ps H4 pe.","label":1}
{"pair_id":"BioInfer.d31.s0.p11","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p12","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p13","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p14","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p15","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p16","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p17","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p18","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p19","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p20","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p21","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p22","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p23","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p24","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p25","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p26","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p27","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe ps H3 pe variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p28","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p29","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p30","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p31","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p32","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p33","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p34","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p35","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p36","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p37","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p38","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three ps histone pe H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p39","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p40","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p41","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p42","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p43","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p44","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p45","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p46","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p47","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p48","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p49","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p50","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p51","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p52","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p53","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p54","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p55","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p56","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: ps histone pe H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p57","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p58","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p59","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p60","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p61","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p62","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p63","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p64","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p65","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p66","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p67","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p68","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p69","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p70","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p71","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p72","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p73","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, ps histone pe ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p74","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p75","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p76","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p77","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p78","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p79","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p80","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p81","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p82","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p83","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p84","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p85","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p86","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p87","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p88","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p89","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, ps histone pe H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p90","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p91","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p92","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p93","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p94","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p95","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p96","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p97","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p98","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p99","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p100","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p101","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p102","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p103","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p104","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four ps histone pe H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p105","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p106","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p107","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p108","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p109","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p110","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p111","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p112","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p113","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p114","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p115","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p116","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, ps histone pe ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p117","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p118","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, ps histone pe H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p119","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p120","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p121","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe ps H2B pe, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p122","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p123","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p124","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p125","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p126","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p127","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p128","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p129","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p130","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p131","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, ps histone pe H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p132","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p133","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p134","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p135","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p136","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p137","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p138","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p139","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p140","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, ps histone pe ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p141","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p142","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p143","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, ps histone pe H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p144","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p145","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p146","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p147","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p148","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p149","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p150","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p151","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p152","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p153","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p154","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone ps H3 pe variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p155","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p156","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p157","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p158","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p159","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p160","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p161","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p162","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p163","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p164","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone ps H2B pe, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p165","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p166","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p167","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p168","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p169","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p170","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p171","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p172","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p173","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d31.s0.p174","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p175","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p176","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p177","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p178","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p179","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p180","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized ps histone pe ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":1}
{"pair_id":"BioInfer.d31.s0.p181","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized ps histone pe H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p182","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p183","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p184","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p185","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p186","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p187","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p188","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone ps H2A.1 pe, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p189","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p190","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p191","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p192","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p193","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p194","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone ps H1 pe subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p195","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p196","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p197","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p198","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p199","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone ps H1(0) pe, four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p200","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p201","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p202","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p203","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified ps histones pe were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p204","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone ps H2A.X pe, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p205","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p206","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone H2A.X, histone ps H2A.Z pe, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p207","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone ps H2A.2 pe, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p208","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone H2A.2, histone ps H2A.X pe, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d31.s0.p209","sentence":"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone ps H2A.2 pe, oxidized histone ps H2A.2 pe, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.","label":0}
{"pair_id":"BioInfer.d597.s0.p0","sentence":"The concentration of ps beta-catenin pe was constant during the follicular phase, whereas the content of ps alpha-catenin pe decreased in granulosa cells after treatment with diethylstilboestrol or hCG.","label":0}
{"pair_id":"AIMed.d129.s1101.p0","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of ps hsp90 pe, ps hsp70 pe, and three additional proteins, p54, p50, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p1","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of ps hsp90 pe, hsp70, and three additional proteins, ps p54 pe, p50, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p2","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of ps hsp90 pe, hsp70, and three additional proteins, p54, ps p50 pe, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p3","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of ps hsp90 pe, hsp70, and three additional proteins, p54, p50, and ps p23 pe.","label":0}
{"pair_id":"AIMed.d129.s1101.p4","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, ps hsp70 pe, and three additional proteins, ps p54 pe, p50, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p5","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, ps hsp70 pe, and three additional proteins, p54, ps p50 pe, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p6","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, ps hsp70 pe, and three additional proteins, p54, p50, and ps p23 pe.","label":0}
{"pair_id":"AIMed.d129.s1101.p7","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, ps p54 pe, ps p50 pe, and p23.","label":0}
{"pair_id":"AIMed.d129.s1101.p8","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, ps p54 pe, p50, and ps p23 pe.","label":0}
{"pair_id":"AIMed.d129.s1101.p9","sentence":"Immunoprecipitation of unactivated avian progesterone receptor results in the copurification of hsp90, hsp70, and three additional proteins, p54, ps p50 pe, and ps p23 pe.","label":0}
{"pair_id":"BioInfer.d678.s0.p0","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (ps XRCC1 pe, XRCC3, ps XRCC5 pe, RAD51, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p1","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, ps XRCC5 pe, RAD51, ps RAD52 pe).","label":0}
{"pair_id":"BioInfer.d678.s0.p2","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, ps XRCC3 pe, ps XRCC5 pe, RAD51, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p3","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, ps XRCC5 pe, ps RAD51 pe, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p4","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (ps XRCC1 pe, XRCC3, XRCC5, RAD51, ps RAD52 pe).","label":0}
{"pair_id":"BioInfer.d678.s0.p5","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (ps XRCC1 pe, ps XRCC3 pe, XRCC5, RAD51, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p6","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (ps XRCC1 pe, XRCC3, XRCC5, ps RAD51 pe, RAD52).","label":0}
{"pair_id":"BioInfer.d678.s0.p7","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, ps XRCC3 pe, XRCC5, RAD51, ps RAD52 pe).","label":0}
{"pair_id":"BioInfer.d678.s0.p8","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, ps RAD51 pe, ps RAD52 pe).","label":0}
{"pair_id":"BioInfer.d678.s0.p9","sentence":"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, ps XRCC3 pe, XRCC5, ps RAD51 pe, RAD52).","label":0}
{"pair_id":"BioInfer.d740.s0.p0","sentence":"This is consistent with ps cofilin pe activation being required for ps actin pe reorganization during exocytosis.","label":1}
{"pair_id":"AIMed.d117.s990.p0","sentence":"ps SKR2 pe complexes in which an ps activin beta pe chain occupies each receptor subunit.","label":0}
{"pair_id":"BioInfer.d543.s0.p0","sentence":"ps Single-headed myosin pe, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and ps actin pe.","label":1}
{"pair_id":"BioInfer.d543.s0.p1","sentence":"Single-headed myosin, which consists of a full length ps myosin heavy chain pe and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and ps actin pe.","label":0}
{"pair_id":"BioInfer.d543.s0.p2","sentence":"ps Single-headed myosin pe, which consists of a full length ps myosin heavy chain pe and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.","label":1}
{"pair_id":"AIMed.d36.s301.p0","sentence":"Molecular determinants of the interaction between the C-terminal domain of Alzheimer's ps beta-amyloid peptide pe and ps apolipoprotein E pe alpha-helices.","label":1}
{"pair_id":"AIMed.d148.s1252.p0","sentence":".Originally identified as a 'mitotic cyclin', ps cyclin A pe exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an ps S-phase-promoting factor pe (SPF) as well as a candidate proto-oncogene.","label":0}
{"pair_id":"AIMed.d148.s1252.p1","sentence":".Originally identified as a 'mitotic cyclin', ps cyclin A pe exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an S-phase-promoting factor (ps SPF pe) as well as a candidate proto-oncogene.","label":0}
{"pair_id":"AIMed.d148.s1252.p2","sentence":".Originally identified as a 'mitotic cyclin', cyclin A exhibits properties of growth factor sensitivity, susceptibility to viral subversion and association with a tumor-suppressor protein, properties which are indicative of an ps S-phase-promoting factor pe (ps SPF pe) as well as a candidate proto-oncogene.","label":0}
{"pair_id":"BioInfer.d662.s0.p0","sentence":"The posttranslational metabolism of ps myosin heavy chain pe (ps MHC pe) and actin was regulated in parallel with the total contractile protein pool.","label":0}
{"pair_id":"BioInfer.d662.s0.p1","sentence":"The posttranslational metabolism of ps myosin heavy chain pe (MHC) and ps actin pe was regulated in parallel with the total contractile protein pool.","label":0}
{"pair_id":"BioInfer.d662.s0.p2","sentence":"The posttranslational metabolism of myosin heavy chain (ps MHC pe) and ps actin pe was regulated in parallel with the total contractile protein pool.","label":0}
{"pair_id":"AIMed.d69.s589.p0","sentence":"Activation of ps protein kinase C pe results in rapid, site-specific dephosphorylation of ps c-Jun pe at one or more of these three sites and is coincident with increased AP-1-binding activity.","label":1}
{"pair_id":"AIMed.d69.s589.p1","sentence":"Activation of ps protein kinase C pe results in rapid, site-specific dephosphorylation of c-Jun at one or more of these three sites and is coincident with increased ps AP-1 pe-binding activity.","label":0}
{"pair_id":"AIMed.d69.s589.p2","sentence":"Activation of protein kinase C results in rapid, site-specific dephosphorylation of ps c-Jun pe at one or more of these three sites and is coincident with increased ps AP-1 pe-binding activity.","label":0}
{"pair_id":"BioInfer.d264.s0.p0","sentence":"ps Histone pe H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and ps histone pe H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p1","sentence":"Histone H3 showed at least seven sites of acetylation, histone ps H2B.1 pe had six sites and ps histone pe H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p2","sentence":"Histone H3 showed at least seven sites of acetylation, ps histone pe H2B.1 had six sites and ps histone pe H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p3","sentence":"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and ps histone pe ps H4 pe had five sites.","label":1}
{"pair_id":"BioInfer.d264.s0.p4","sentence":"Histone ps H3 pe showed at least seven sites of acetylation, histone H2B.1 had six sites and ps histone pe H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p5","sentence":"ps Histone pe H3 showed at least seven sites of acetylation, histone ps H2B.1 pe had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p6","sentence":"ps Histone pe H3 showed at least seven sites of acetylation, ps histone pe H2B.1 had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p7","sentence":"ps Histone pe H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone ps H4 pe had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p8","sentence":"ps Histone pe ps H3 pe showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.","label":1}
{"pair_id":"BioInfer.d264.s0.p9","sentence":"Histone H3 showed at least seven sites of acetylation, ps histone pe ps H2B.1 pe had six sites and histone H4 had five sites.","label":1}
{"pair_id":"BioInfer.d264.s0.p10","sentence":"Histone H3 showed at least seven sites of acetylation, histone ps H2B.1 pe had six sites and histone ps H4 pe had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p11","sentence":"Histone ps H3 pe showed at least seven sites of acetylation, histone ps H2B.1 pe had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p12","sentence":"Histone H3 showed at least seven sites of acetylation, ps histone pe H2B.1 had six sites and histone ps H4 pe had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p13","sentence":"Histone ps H3 pe showed at least seven sites of acetylation, ps histone pe H2B.1 had six sites and histone H4 had five sites.","label":0}
{"pair_id":"BioInfer.d264.s0.p14","sentence":"Histone ps H3 pe showed at least seven sites of acetylation, histone H2B.1 had six sites and histone ps H4 pe had five sites.","label":0}
{"pair_id":"AIMed.d176.s1494.p0","sentence":"From these results, it appears that ps p60 pe is a key mediator in the chaperoned assembly and functional maturation of ps PR pe complexes.","label":0}
{"pair_id":"BioInfer.d8.s1.p0","sentence":"In addition to its presence in cell-cell adhesion sites, we have found ps beta-catenin pe, but not ps alpha-catenin pe, in the Z-discs of heart and skeletal striated muscles.","label":1}
{"pair_id":"AIMed.d115.s974.p0","sentence":"Further, ps RAP74 pe's central charged cluster domain is required for binding to ps SRF pe's activation domain.","label":0}
{"pair_id":"BioInfer.d282.s0.p0","sentence":"Human ps platelet P-235 pe, a talin-like ps actin binding protein pe, binds selectively to mixed lipid bilayers.","label":1}
{"pair_id":"BioInfer.d282.s0.p1","sentence":"Human platelet P-235, a ps talin pe-like ps actin binding protein pe, binds selectively to mixed lipid bilayers.","label":0}
{"pair_id":"BioInfer.d282.s0.p2","sentence":"Human ps platelet P-235 pe, a ps talin pe-like actin binding protein, binds selectively to mixed lipid bilayers.","label":1}
{"pair_id":"BioInfer.d33.s0.p0","sentence":"A highly significant correlation was observed between the loss of expression of ps E-cadherin pe, ps alpha-catenin pe and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p1","sentence":"A highly significant correlation was observed between the loss of expression of E-cadherin, ps alpha-catenin pe and gamma-catenin, but not ps beta-catenin pe, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p2","sentence":"A highly significant correlation was observed between the loss of expression of E-cadherin, ps alpha-catenin pe and ps gamma-catenin pe, but not beta-catenin, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p3","sentence":"A highly significant correlation was observed between the loss of expression of ps E-cadherin pe, alpha-catenin and gamma-catenin, but not ps beta-catenin pe, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p4","sentence":"A highly significant correlation was observed between the loss of expression of ps E-cadherin pe, alpha-catenin and ps gamma-catenin pe, but not beta-catenin, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d33.s0.p5","sentence":"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and ps gamma-catenin pe, but not ps beta-catenin pe, with increased TNM stage (p <0.05).","label":1}
{"pair_id":"BioInfer.d461.s0.p0","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p1","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, ps TRADD pe, binds to the p55 TNF receptor but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p2","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to ps p55-R pe; another, TRADD, binds to the p55 TNF receptor but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p3","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p4","sentence":"One, MORT1 (also called FADD), binds to Fas\/ps APO1 pe but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p5","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p6","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 ps TNF receptor pe but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p7","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/ps APO1 pe; and the third, ps RIP pe, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p8","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to ps Fas pe\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p9","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the ps p55 pe TNF receptor but not to Fas\/ps APO1 pe; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p10","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/APO1 but not to p55-R; another, ps TRADD pe, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p11","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/APO1 but not to ps p55-R pe; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p12","sentence":"One, ps MORT1 pe (also called ps FADD pe), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p13","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/ps APO1 pe but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p14","sentence":"One, ps MORT1 pe (also called FADD), binds to ps Fas pe\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p15","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 ps TNF receptor pe but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p16","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p17","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p18","sentence":"One, ps MORT1 pe (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the ps p55 pe TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p19","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to ps p55-R pe; another, ps TRADD pe, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p20","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/APO1 but not to p55-R; another, ps TRADD pe, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p21","sentence":"One, MORT1 (also called FADD), binds to Fas\/ps APO1 pe but not to p55-R; another, ps TRADD pe, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p22","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/APO1 but not to p55-R; another, ps TRADD pe, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p23","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, ps TRADD pe, binds to the p55 ps TNF receptor pe but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p24","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, ps TRADD pe, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p25","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, ps TRADD pe, binds to the p55 TNF receptor but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p26","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, ps TRADD pe, binds to the ps p55 pe TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p27","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/APO1 but not to ps p55-R pe; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p28","sentence":"One, MORT1 (also called FADD), binds to Fas\/ps APO1 pe but not to ps p55-R pe; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p29","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/APO1 but not to ps p55-R pe; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p30","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to ps p55-R pe; another, TRADD, binds to the p55 ps TNF receptor pe but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p31","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to ps p55-R pe; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p32","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to ps p55-R pe; another, TRADD, binds to the p55 TNF receptor but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p33","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to ps p55-R pe; another, TRADD, binds to the ps p55 pe TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p34","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/ps APO1 pe but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p35","sentence":"One, MORT1 (also called ps FADD pe), binds to ps Fas pe\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p36","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 ps TNF receptor pe but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p37","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p38","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p39","sentence":"One, MORT1 (also called ps FADD pe), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the ps p55 pe TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p40","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/ps APO1 pe but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p41","sentence":"One, MORT1 (also called FADD), binds to Fas\/ps APO1 pe but not to p55-R; another, TRADD, binds to the p55 ps TNF receptor pe but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p42","sentence":"One, MORT1 (also called FADD), binds to Fas\/ps APO1 pe but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p43","sentence":"One, MORT1 (also called FADD), binds to Fas\/ps APO1 pe but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p44","sentence":"One, MORT1 (also called FADD), binds to Fas\/ps APO1 pe but not to p55-R; another, TRADD, binds to the ps p55 pe TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p45","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/APO1 but not to p55-R; another, TRADD, binds to the p55 ps TNF receptor pe but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p46","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p47","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p48","sentence":"One, MORT1 (also called FADD), binds to ps Fas pe\/APO1 but not to p55-R; another, TRADD, binds to the ps p55 pe TNF receptor but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p49","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 ps TNF receptor pe but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p50","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 ps TNF receptor pe but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p51","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the ps p55 pe ps TNF receptor pe but not to Fas\/APO1; and the third, RIP, binds weakly to both receptors.","label":1}
{"pair_id":"BioInfer.d461.s0.p52","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to ps Fas pe\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p53","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the ps p55 pe TNF receptor but not to Fas\/APO1; and the third, ps RIP pe, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d461.s0.p54","sentence":"One, MORT1 (also called FADD), binds to Fas\/APO1 but not to p55-R; another, TRADD, binds to the ps p55 pe TNF receptor but not to ps Fas pe\/APO1; and the third, RIP, binds weakly to both receptors.","label":0}
{"pair_id":"BioInfer.d141.s0.p0","sentence":"Chemical modification of the cysteine residue 374 of actin, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of ps profilin pe on ps actin pe polymerization.","label":1}
{"pair_id":"BioInfer.d141.s0.p1","sentence":"Chemical modification of the cysteine residue 374 of ps actin pe, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of ps profilin pe on actin polymerization.","label":1}
{"pair_id":"BioInfer.d141.s0.p2","sentence":"Chemical modification of the cysteine residue 374 of ps actin pe, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of profilin on ps actin pe polymerization.","label":1}
{"pair_id":"AIMed.d143.s1207.p0","sentence":"The similarities in biofunctions and differences in ligand binding proteins between ps IL-11 pe and ps IL-6 pe prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.","label":0}
{"pair_id":"AIMed.d143.s1207.p1","sentence":"The similarities in biofunctions and differences in ligand binding proteins between ps IL-11 pe and IL-6 prompted us to investigate whether ps IL-11 pe shares common signal transduction mechanisms with IL-6.","label":0}
{"pair_id":"AIMed.d143.s1207.p2","sentence":"The similarities in biofunctions and differences in ligand binding proteins between ps IL-11 pe and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with ps IL-6 pe.","label":0}
{"pair_id":"AIMed.d143.s1207.p3","sentence":"The similarities in biofunctions and differences in ligand binding proteins between IL-11 and ps IL-6 pe prompted us to investigate whether ps IL-11 pe shares common signal transduction mechanisms with IL-6.","label":0}
{"pair_id":"AIMed.d143.s1207.p4","sentence":"The similarities in biofunctions and differences in ligand binding proteins between IL-11 and ps IL-6 pe prompted us to investigate whether IL-11 shares common signal transduction mechanisms with ps IL-6 pe.","label":0}
{"pair_id":"AIMed.d143.s1207.p5","sentence":"The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether ps IL-11 pe shares common signal transduction mechanisms with ps IL-6 pe.","label":0}
{"pair_id":"BioInfer.d597.s1.p0","sentence":"ps alpha- pe and ps beta-alpha-  peps alpha-  pe were present in most ovarian cells at all stages of folliculogenesis.","label":0}
{"pair_id":"BioInfer.d343.s0.p0","sentence":"In higher plants, a large number of isoforms for the ps actin pe monomer-binding protein profilin have been identified, whereas other organisms express only few ps profilins pe.","label":0}
{"pair_id":"BioInfer.d343.s0.p1","sentence":"In higher plants, a large number of isoforms for the ps actin pe monomer-binding protein ps profilin pe have been identified, whereas other organisms express only few profilins.","label":1}
{"pair_id":"BioInfer.d343.s0.p2","sentence":"In higher plants, a large number of isoforms for the actin monomer-binding protein ps profilin pe have been identified, whereas other organisms express only few ps profilins pe.","label":0}
{"pair_id":"AIMed.d190.s1610.p0","sentence":"Discrete protein interactions with the ps Grb2 pe\/ps c-Cbl pe complex in SCF- and TPO-mediated myeloid cell proliferation.","label":1}
{"pair_id":"AIMed.d190.s1610.p1","sentence":"Discrete protein interactions with the ps Grb2 pe\/c-Cbl complex in ps SCF pe- and TPO-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p2","sentence":"Discrete protein interactions with the ps Grb2 pe\/c-Cbl complex in SCF- and ps TPO pe-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p3","sentence":"Discrete protein interactions with the Grb2\/ps c-Cbl pe complex in ps SCF pe- and TPO-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p4","sentence":"Discrete protein interactions with the Grb2\/ps c-Cbl pe complex in SCF- and ps TPO pe-mediated myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1610.p5","sentence":"Discrete protein interactions with the Grb2\/c-Cbl complex in ps SCF pe- and ps TPO pe-mediated myeloid cell proliferation.","label":0}
{"pair_id":"BioInfer.d756.s0.p0","sentence":"Thus, poly-L-proline binding, ps actin pe binding, and ps actin pe nucleotide exchange are each independent requirements for profilin function in fission yeast.","label":0}
{"pair_id":"BioInfer.d756.s0.p1","sentence":"Thus, poly-L-proline binding, ps actin pe binding, and actin nucleotide exchange are each independent requirements for ps profilin pe function in fission yeast.","label":1}
{"pair_id":"BioInfer.d756.s0.p2","sentence":"Thus, poly-L-proline binding, actin binding, and ps actin pe nucleotide exchange are each independent requirements for ps profilin pe function in fission yeast.","label":1}
{"pair_id":"AIMed.d58.s517.p0","sentence":"These results suggest that ps GRB2 pe\/ps sem-5 pe plays a crucial role in a highly conserved mechanism for growth factor control of ras signaling.","label":0}
{"pair_id":"BioInfer.d379.s2.p0","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either ps MSH2 pe and MSH6 or ps MSH2 pe and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p1","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and ps MSH6 pe or ps MSH2 pe and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p2","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or ps MSH2 pe and ps MSH3 pe.","label":0}
{"pair_id":"BioInfer.d379.s2.p3","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires ps MSH2 pe and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or ps MSH2 pe and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p4","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and ps MSH6 pe, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or ps MSH2 pe and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p5","sentence":"The results indicate that S. cerevisiae has two pathways of ps MSH2 pe-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or ps MSH2 pe and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p6","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either ps MSH2 pe and ps MSH6 pe or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p7","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either ps MSH2 pe and MSH6 or MSH2 and ps MSH3 pe.","label":0}
{"pair_id":"BioInfer.d379.s2.p8","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires ps MSH2 pe and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either ps MSH2 pe and MSH6 or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p9","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and ps MSH6 pe, and a second that recognizes insertion\/deletion mispairs and requires a combination of either ps MSH2 pe and MSH6 or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p10","sentence":"The results indicate that S. cerevisiae has two pathways of ps MSH2 pe-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either ps MSH2 pe and MSH6 or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p11","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and ps MSH6 pe or MSH2 and ps MSH3 pe.","label":0}
{"pair_id":"BioInfer.d379.s2.p12","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires ps MSH2 pe and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and ps MSH6 pe or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p13","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and ps MSH6 pe, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and ps MSH6 pe or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p14","sentence":"The results indicate that S. cerevisiae has two pathways of ps MSH2 pe-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and ps MSH6 pe or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p15","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires ps MSH2 pe and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and ps MSH3 pe.","label":0}
{"pair_id":"BioInfer.d379.s2.p16","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and ps MSH6 pe, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and ps MSH3 pe.","label":0}
{"pair_id":"BioInfer.d379.s2.p17","sentence":"The results indicate that S. cerevisiae has two pathways of ps MSH2 pe-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and ps MSH3 pe.","label":1}
{"pair_id":"BioInfer.d379.s2.p18","sentence":"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires ps MSH2 pe and ps MSH6 pe, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.","label":0}
{"pair_id":"BioInfer.d379.s2.p19","sentence":"The results indicate that S. cerevisiae has two pathways of ps MSH2 pe-dependent mismatch repair: one that recognized single-base mispairs and requires ps MSH2 pe and MSH6, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d379.s2.p20","sentence":"The results indicate that S. cerevisiae has two pathways of ps MSH2 pe-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and ps MSH6 pe, and a second that recognizes insertion\/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.","label":1}
{"pair_id":"BioInfer.d213.s2.p0","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of ps actin pe that bound profilin, a protein that interacts with phosphoinositides and ps actin pe-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":0}
{"pair_id":"BioInfer.d213.s2.p1","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of ps actin pe that bound ps profilin pe, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":1}
{"pair_id":"BioInfer.d213.s2.p2","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of ps actin pe that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit ps DNase I pe.","label":1}
{"pair_id":"BioInfer.d213.s2.p3","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of ps actin pe that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled ps actin pe (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":0}
{"pair_id":"BioInfer.d213.s2.p4","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound ps profilin pe, a protein that interacts with phosphoinositides and ps actin pe-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":1}
{"pair_id":"BioInfer.d213.s2.p5","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and ps actin pe-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit ps DNase I pe.","label":0}
{"pair_id":"BioInfer.d213.s2.p6","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and ps actin pe-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled ps actin pe (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":0}
{"pair_id":"BioInfer.d213.s2.p7","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound ps profilin pe, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit ps DNase I pe.","label":0}
{"pair_id":"BioInfer.d213.s2.p8","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound ps profilin pe, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled ps actin pe (Kd > 30 microM), yet retained the ability to inhibit DNase I.","label":1}
{"pair_id":"BioInfer.d213.s2.p9","sentence":"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled ps actin pe (Kd > 30 microM), yet retained the ability to inhibit ps DNase I pe.","label":0}
{"pair_id":"AIMed.d199.s1710.p0","sentence":"In summary, ps FGFR3 pe signaling pathway utilizes two ps GRB2 pe-containing complexes; Shc.","label":0}
{"pair_id":"AIMed.d199.s1710.p1","sentence":"In summary, ps FGFR3 pe signaling pathway utilizes two GRB2-containing complexes; ps Shc pe.","label":0}
{"pair_id":"AIMed.d199.s1710.p2","sentence":"In summary, FGFR3 signaling pathway utilizes two ps GRB2 pe-containing complexes; ps Shc pe.","label":0}
{"pair_id":"AIMed.d219.s1904.p0","sentence":"However, whether 14-3-3 proteins interact directly with the ps Raf-CRD pe and how this interaction may mediate ps Raf-1 pe function has not been determined.","label":0}
{"pair_id":"AIMed.d125.s1069.p0","sentence":"In contrast to LexA\/ps Bcl-2 pe fusion proteins, expression of a LexA\/ps Bax pe protein was lethal to yeast.","label":0}
{"pair_id":"BioInfer.d751.s0.p0","sentence":"Thus, actin was found in association with ps fimbrin pe in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in ps actin pe, did not reveal fimbrin.","label":0}
{"pair_id":"BioInfer.d751.s0.p1","sentence":"Thus, ps actin pe was found in association with ps fimbrin pe in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.","label":1}
{"pair_id":"BioInfer.d751.s0.p2","sentence":"Thus, actin was found in association with ps fimbrin pe in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal ps fimbrin pe.","label":0}
{"pair_id":"BioInfer.d751.s0.p3","sentence":"Thus, ps actin pe was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in ps actin pe, did not reveal fimbrin.","label":0}
{"pair_id":"BioInfer.d751.s0.p4","sentence":"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in ps actin pe, did not reveal ps fimbrin pe.","label":0}
{"pair_id":"BioInfer.d751.s0.p5","sentence":"Thus, ps actin pe was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal ps fimbrin pe.","label":0}
{"pair_id":"BioInfer.d529.s0.p0","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (ps alpha-SMA pe), desmin and smooth muscle myosin heavy chain isoforms: SM1, ps SM2 pe and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p1","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and ps smooth muscle myosin heavy chain pe isoforms: SM1, ps SM2 pe and SMemb.","label":1}
{"pair_id":"BioInfer.d529.s0.p2","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to ps alpha-smooth muscle actin pe (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, ps SM2 pe and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p3","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: ps SM1 pe, ps SM2 pe and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p4","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), ps desmin pe and smooth muscle myosin heavy chain isoforms: SM1, ps SM2 pe and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p5","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, ps SM2 pe and ps SMemb pe.","label":0}
{"pair_id":"BioInfer.d529.s0.p6","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (ps alpha-SMA pe), desmin and ps smooth muscle myosin heavy chain pe isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p7","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to ps alpha-smooth muscle actin pe (ps alpha-SMA pe), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p8","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (ps alpha-SMA pe), desmin and smooth muscle myosin heavy chain isoforms: ps SM1 pe, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p9","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (ps alpha-SMA pe), ps desmin pe and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p10","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (ps alpha-SMA pe), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and ps SMemb pe.","label":0}
{"pair_id":"BioInfer.d529.s0.p11","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to ps alpha-smooth muscle actin pe (alpha-SMA), desmin and ps smooth muscle myosin heavy chain pe isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p12","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and ps smooth muscle myosin heavy chain pe isoforms: ps SM1 pe, SM2 and SMemb.","label":1}
{"pair_id":"BioInfer.d529.s0.p13","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), ps desmin pe and ps smooth muscle myosin heavy chain pe isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p14","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and ps smooth muscle myosin heavy chain pe isoforms: SM1, SM2 and ps SMemb pe.","label":1}
{"pair_id":"BioInfer.d529.s0.p15","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to ps alpha-smooth muscle actin pe (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: ps SM1 pe, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p16","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to ps alpha-smooth muscle actin pe (alpha-SMA), ps desmin pe and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p17","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to ps alpha-smooth muscle actin pe (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and ps SMemb pe.","label":0}
{"pair_id":"BioInfer.d529.s0.p18","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), ps desmin pe and smooth muscle myosin heavy chain isoforms: ps SM1 pe, SM2 and SMemb.","label":0}
{"pair_id":"BioInfer.d529.s0.p19","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: ps SM1 pe, SM2 and ps SMemb pe.","label":0}
{"pair_id":"BioInfer.d529.s0.p20","sentence":"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), ps desmin pe and smooth muscle myosin heavy chain isoforms: SM1, SM2 and ps SMemb pe.","label":0}
{"pair_id":"AIMed.d131.s1121.p0","sentence":"The predicted amino acid sequence of ps hIL-10R pe is 60% identical and 73% similar to mouse ps IL-10R pe (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p1","sentence":"The predicted amino acid sequence of ps hIL-10R pe is 60% identical and 73% similar to mouse IL-10R (ps mIL-10R pe). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p2","sentence":"The predicted amino acid sequence of ps hIL-10R pe is 60% identical and 73% similar to mouse IL-10R (mIL-10R). ps rIL-10R pe expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p3","sentence":"The predicted amino acid sequence of ps hIL-10R pe is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an ps IL-3 pe-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p4","sentence":"The predicted amino acid sequence of ps hIL-10R pe is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds ps hIL-10 pe with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p5","sentence":"The predicted amino acid sequence of ps hIL-10R pe is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to ps hIL-10 pe.","label":0}
{"pair_id":"AIMed.d131.s1121.p6","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse ps IL-10R pe (ps mIL-10R pe). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p7","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse ps IL-10R pe (mIL-10R). ps rIL-10R pe expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p8","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse ps IL-10R pe (mIL-10R). rIL-10R expressed in an ps IL-3 pe-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p9","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse ps IL-10R pe (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds ps hIL-10 pe with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p10","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse ps IL-10R pe (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to ps hIL-10 pe.","label":0}
{"pair_id":"AIMed.d131.s1121.p11","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (ps mIL-10R pe). ps rIL-10R pe expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p12","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (ps mIL-10R pe). rIL-10R expressed in an ps IL-3 pe-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p13","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (ps mIL-10R pe). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds ps hIL-10 pe with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p14","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (ps mIL-10R pe). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to ps hIL-10 pe.","label":0}
{"pair_id":"AIMed.d131.s1121.p15","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). ps rIL-10R pe expressed in an ps IL-3 pe-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p16","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). ps rIL-10R pe expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds ps hIL-10 pe with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":1}
{"pair_id":"AIMed.d131.s1121.p17","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). ps rIL-10R pe expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to ps hIL-10 pe.","label":0}
{"pair_id":"AIMed.d131.s1121.p18","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an ps IL-3 pe-dependent mouse pro-B cell line (Ba\/F3) binds ps hIL-10 pe with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.","label":0}
{"pair_id":"AIMed.d131.s1121.p19","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an ps IL-3 pe-dependent mouse pro-B cell line (Ba\/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to ps hIL-10 pe.","label":0}
{"pair_id":"AIMed.d131.s1121.p20","sentence":"The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba\/F3) binds ps hIL-10 pe with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to ps hIL-10 pe.","label":0}
{"pair_id":"BioInfer.d645.s0.p0","sentence":"The monomeric ps actin-binding protein pe, profilin, is a key regulator of ps actin pe-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.","label":0}
{"pair_id":"BioInfer.d645.s0.p1","sentence":"The monomeric ps actin-binding protein pe, ps profilin pe, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.","label":1}
{"pair_id":"BioInfer.d645.s0.p2","sentence":"The monomeric actin-binding protein, ps profilin pe, is a key regulator of ps actin pe-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.","label":1}
{"pair_id":"AIMed.d161.s1357.p0","sentence":"Using ps SHPTP2 pe as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that ps SHPTP2 pe interacts with another signaling protein, Grb7.","label":0}
{"pair_id":"AIMed.d161.s1357.p1","sentence":"Using ps SHPTP2 pe as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that SHPTP2 interacts with another signaling protein, ps Grb7 pe.","label":0}
{"pair_id":"AIMed.d161.s1357.p2","sentence":"Using SHPTP2 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that ps SHPTP2 pe interacts with another signaling protein, ps Grb7 pe.","label":1}
{"pair_id":"BioInfer.d332.s0.p0","sentence":"Increasing the ionic strength within a relatively narrow range significantly decreased ability of ps talin pe to bind to ps actin pe, regardless of pH.","label":1}
{"pair_id":"BioInfer.d352.s0.p0","sentence":"In resting leukocytes, ps beta2 integrins pe are constitutively linked to the ps actin pe cytoskeleton via the protein talin.","label":1}
{"pair_id":"BioInfer.d352.s0.p1","sentence":"In resting leukocytes, beta2 integrins are constitutively linked to the ps actin pe cytoskeleton via the protein ps talin pe.","label":1}
{"pair_id":"BioInfer.d352.s0.p2","sentence":"In resting leukocytes, ps beta2 integrins pe are constitutively linked to the actin cytoskeleton via the protein ps talin pe.","label":1}
{"pair_id":"AIMed.d218.s1891.p0","sentence":"The ps erythropoietin pe-like domain of ps TPO pe (TPO1-153) has been fused to the gIII coat protein of M13 bacteriophage.","label":0}
{"pair_id":"AIMed.d218.s1891.p1","sentence":"The ps erythropoietin pe-like domain of TPO (TPO1-153) has been fused to the ps gIII pe coat protein of M13 bacteriophage.","label":0}
{"pair_id":"AIMed.d218.s1891.p2","sentence":"The erythropoietin-like domain of ps TPO pe (TPO1-153) has been fused to the ps gIII pe coat protein of M13 bacteriophage.","label":0}
{"pair_id":"BioInfer.d319.s0.p0","sentence":"In a model system, the interacting proteins recruiting ps TFIIIC pe to DNA were PRP21 and ps PRP9 pe or PRP21 and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p1","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and ps PRP9 pe or ps PRP21 pe and PRP11.","label":0}
{"pair_id":"BioInfer.d319.s0.p2","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and ps PRP9 pe or PRP21 and ps PRP11 pe.","label":0}
{"pair_id":"BioInfer.d319.s0.p3","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were ps PRP21 pe and ps PRP9 pe or PRP21 and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p4","sentence":"In a model system, the interacting proteins recruiting ps TFIIIC pe to DNA were PRP21 and PRP9 or ps PRP21 pe and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p5","sentence":"In a model system, the interacting proteins recruiting ps TFIIIC pe to DNA were PRP21 and PRP9 or PRP21 and ps PRP11 pe.","label":1}
{"pair_id":"BioInfer.d319.s0.p6","sentence":"In a model system, the interacting proteins recruiting ps TFIIIC pe to DNA were ps PRP21 pe and PRP9 or PRP21 and PRP11.","label":1}
{"pair_id":"BioInfer.d319.s0.p7","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or ps PRP21 pe and ps PRP11 pe.","label":1}
{"pair_id":"BioInfer.d319.s0.p8","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were ps PRP21 pe and PRP9 or ps PRP21 pe and PRP11.","label":0}
{"pair_id":"BioInfer.d319.s0.p9","sentence":"In a model system, the interacting proteins recruiting TFIIIC to DNA were ps PRP21 pe and PRP9 or PRP21 and ps PRP11 pe.","label":0}
{"pair_id":"BioInfer.d150.s0.p0","sentence":"CONCLUSIONS: The expression of alpha-catenin, ps beta-catenin pe, and gamma-catenin is related to histological type and differentiation in NSCLC, although ps catenins pe have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p1","sentence":"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and ps gamma-catenin pe is related to histological type and differentiation in NSCLC, although ps catenins pe have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p2","sentence":"CONCLUSIONS: The expression of ps alpha-catenin pe, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although ps catenins pe have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p3","sentence":"CONCLUSIONS: The expression of alpha-catenin, ps beta-catenin pe, and ps gamma-catenin pe is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p4","sentence":"CONCLUSIONS: The expression of ps alpha-catenin pe, ps beta-catenin pe, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.","label":0}
{"pair_id":"BioInfer.d150.s0.p5","sentence":"CONCLUSIONS: The expression of ps alpha-catenin pe, beta-catenin, and ps gamma-catenin pe is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.","label":0}
{"pair_id":"AIMed.d120.s1016.p0","sentence":"However, the function of ps HSP27 pe and the identity of proteins that interact with ps HSP27 pe remain unknown.","label":0}
{"pair_id":"AIMed.d168.s1413.p0","sentence":"The ps erythropoietin peps erythropoietin receptor pe (EPOR) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.","label":0}
{"pair_id":"AIMed.d168.s1413.p1","sentence":"The ps erythropoietin pe receptor (ps EPOR pe) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.","label":1}
{"pair_id":"AIMed.d168.s1413.p2","sentence":"The ps erythropoietin receptor pe (ps EPOR pe) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.","label":0}
{"pair_id":"AIMed.d160.s1343.p0","sentence":"Identification of vascular endothelial growth factor determinants for binding ps KDR pe and ps FLT-1 pe receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.","label":0}
{"pair_id":"AIMed.d160.s1343.p1","sentence":"Identification of vascular endothelial growth factor determinants for binding ps KDR pe and FLT-1 receptors. Generation of receptor-selective ps VEGF pe variants by site-directed mutagenesis.","label":0}
{"pair_id":"AIMed.d160.s1343.p2","sentence":"Identification of vascular endothelial growth factor determinants for binding KDR and ps FLT-1 pe receptors. Generation of receptor-selective ps VEGF pe variants by site-directed mutagenesis.","label":0}
{"pair_id":"BioInfer.d5.s0.p0","sentence":"Acanthamoeba ps actin pe and ps profilin pe can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.","label":1}
{"pair_id":"BioInfer.d5.s0.p1","sentence":"Acanthamoeba ps actin pe and profilin can be cross-linked between glutamic acid 364 of ps actin pe and lysine 115 of profilin.","label":0}
{"pair_id":"BioInfer.d5.s0.p2","sentence":"Acanthamoeba ps actin pe and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of ps profilin pe.","label":0}
{"pair_id":"BioInfer.d5.s0.p3","sentence":"Acanthamoeba actin and ps profilin pe can be cross-linked between glutamic acid 364 of ps actin pe and lysine 115 of profilin.","label":0}
{"pair_id":"BioInfer.d5.s0.p4","sentence":"Acanthamoeba actin and ps profilin pe can be cross-linked between glutamic acid 364 of actin and lysine 115 of ps profilin pe.","label":0}
{"pair_id":"BioInfer.d5.s0.p5","sentence":"Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of ps actin pe and lysine 115 of ps profilin pe.","label":1}
{"pair_id":"BioInfer.d715.s0.p0","sentence":"These results suggest that ps TNF-alpha pe can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, ps TRADD pe, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p1","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, ps TRADD pe, FADD, and ps FLICE pe, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p2","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, ps TRADD pe, ps FADD pe, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p3","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, ps TRADD pe, FADD, and FLICE, and ps TNF pe-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p4","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through ps TNFR1 pe-linked apoptotic factors, ps TRADD pe, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p5","sentence":"These results suggest that ps TNF-alpha pe can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and ps FLICE pe, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p6","sentence":"These results suggest that ps TNF-alpha pe can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, ps FADD pe, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p7","sentence":"These results suggest that ps TNF-alpha pe can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and ps TNF pe-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p8","sentence":"These results suggest that ps TNF-alpha pe can cause apoptosis in pancreatic beta cells through ps TNFR1 pe-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p9","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, ps FADD pe, and ps FLICE pe, and TNF-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p10","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and ps FLICE pe, and ps TNF pe-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p11","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through ps TNFR1 pe-linked apoptotic factors, TRADD, FADD, and ps FLICE pe, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p12","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, ps FADD pe, and FLICE, and ps TNF pe-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"BioInfer.d715.s0.p13","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through ps TNFR1 pe-linked apoptotic factors, TRADD, ps FADD pe, and FLICE, and TNF-induced ceramide production may be involved in the pathways.","label":1}
{"pair_id":"BioInfer.d715.s0.p14","sentence":"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through ps TNFR1 pe-linked apoptotic factors, TRADD, FADD, and FLICE, and ps TNF pe-induced ceramide production may be involved in the pathways.","label":0}
{"pair_id":"AIMed.d76.s638.p0","sentence":"ps CD5 pe is a T-cell-specific antigen which binds to the B-cell antigen ps CD72 pe and acts as a coreceptor in the stimulation of T-cell growth.","label":1}
{"pair_id":"AIMed.d14.s117.p0","sentence":"Concentrations of ps glial fibrillary acidic protein pe (ps GFAp pe) and light subunit neurofilament protein (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p1","sentence":"Concentrations of ps glial fibrillary acidic protein pe (GFAp) and ps light subunit neurofilament protein pe (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p2","sentence":"Concentrations of ps glial fibrillary acidic protein pe (GFAp) and light subunit neurofilament protein (ps NFL pe) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p3","sentence":"Concentrations of glial fibrillary acidic protein (ps GFAp pe) and ps light subunit neurofilament protein pe (NFL) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p4","sentence":"Concentrations of glial fibrillary acidic protein (ps GFAp pe) and light subunit neurofilament protein (ps NFL pe) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d14.s117.p5","sentence":"Concentrations of glial fibrillary acidic protein (GFAp) and ps light subunit neurofilament protein pe (ps NFL pe) in cerebrospinal fluid (CSF) were measured in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.","label":0}
{"pair_id":"AIMed.d80.s683.p0","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p1","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p2","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and ps Fas pe-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p3","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p4","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p5","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p6","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p7","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p8","sentence":"Using the cytoplasmic domain of ps Fas pe in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p9","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds ps Fas pe and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":1}
{"pair_id":"AIMed.d80.s683.p10","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and ps Fas pe-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":1}
{"pair_id":"AIMed.d80.s683.p11","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and Fas-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":1}
{"pair_id":"AIMed.d80.s683.p12","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and Fas-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p13","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p14","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p15","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p16","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, ps FADD pe, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p17","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and ps Fas pe-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p18","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and Fas-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p19","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and Fas-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p20","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p21","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p22","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p23","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds ps Fas pe and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p24","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and ps Fas pe-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p25","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and ps Fas pe-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p26","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and ps Fas pe-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p27","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and ps Fas pe-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p28","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and ps Fas pe-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p29","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and ps Fas pe-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p30","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-ps FD5 pe, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p31","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p32","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p33","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p34","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-ps FD5 pe, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p35","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p36","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p37","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p38","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of ps Fas pe possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p39","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-ps LPR pe and Fas-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p40","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p41","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants ps Fas pe-LPR and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p42","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and ps Fas pe-FD8.","label":0}
{"pair_id":"AIMed.d80.s683.p43","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-ps LPR pe and Fas-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d80.s683.p44","sentence":"Using the cytoplasmic domain of Fas in the yeast two-hybrid system, we have identified a novel interacting protein, FADD, which binds Fas and Fas-FD5, a mutant of Fas possessing enhanced killing activity, but not the functionally inactive mutants Fas-LPR and ps Fas pe-ps FD8 pe.","label":0}
{"pair_id":"AIMed.d91.s782.p0","sentence":"Moreover, a partial recombinant ps TFIID pe complex containing ps hTAFII32 pe was capable of mediating in vitro transcriptional activation by the VP16 activation domain.","label":0}
{"pair_id":"AIMed.d91.s782.p1","sentence":"Moreover, a partial recombinant ps TFIID pe complex containing hTAFII32 was capable of mediating in vitro transcriptional activation by the ps VP16 pe activation domain.","label":0}
{"pair_id":"AIMed.d91.s782.p2","sentence":"Moreover, a partial recombinant TFIID complex containing ps hTAFII32 pe was capable of mediating in vitro transcriptional activation by the ps VP16 pe activation domain.","label":0}
{"pair_id":"AIMed.d103.s867.p0","sentence":"Cloning and characterization of ps hTAFII18 pe, ps hTAFII20 pe and hTAFII28: three subunits of the human transcription factor TFIID.","label":1}
{"pair_id":"AIMed.d103.s867.p1","sentence":"Cloning and characterization of ps hTAFII18 pe, hTAFII20 and ps hTAFII28 pe: three subunits of the human transcription factor TFIID.","label":1}
{"pair_id":"AIMed.d103.s867.p2","sentence":"Cloning and characterization of ps hTAFII18 pe, hTAFII20 and hTAFII28: three subunits of the human transcription factor ps TFIID pe.","label":0}
{"pair_id":"AIMed.d103.s867.p3","sentence":"Cloning and characterization of hTAFII18, ps hTAFII20 pe and ps hTAFII28 pe: three subunits of the human transcription factor TFIID.","label":1}
{"pair_id":"AIMed.d103.s867.p4","sentence":"Cloning and characterization of hTAFII18, ps hTAFII20 pe and hTAFII28: three subunits of the human transcription factor ps TFIID pe.","label":0}
{"pair_id":"AIMed.d103.s867.p5","sentence":"Cloning and characterization of hTAFII18, hTAFII20 and ps hTAFII28 pe: three subunits of the human transcription factor ps TFIID pe.","label":0}
{"pair_id":"AIMed.d205.s1766.p0","sentence":"Thymocyte activation induces the association of ps phosphatidylinositol 3-kinase pe and ps pp120 pe with CD5.","label":0}
{"pair_id":"AIMed.d205.s1766.p1","sentence":"Thymocyte activation induces the association of ps phosphatidylinositol 3-kinase pe and pp120 with ps CD5 pe.","label":1}
{"pair_id":"AIMed.d205.s1766.p2","sentence":"Thymocyte activation induces the association of phosphatidylinositol 3-kinase and ps pp120 pe with ps CD5 pe.","label":1}
{"pair_id":"AIMed.d204.s1761.p0","sentence":"In addition to co-immunoprecipitation analysis, we have established a rapid and sensitive ELISA assay using immobilized ps rTIMP pe to determine the structural requirements of ps MMP-1 pe to form complexes with its inhibitor.","label":0}
{"pair_id":"BioInfer.d724.s0.p0","sentence":"The structure of an ps actin pe-crosslinking domain from human ps fimbrin pe.","label":1}
{"pair_id":"BioInfer.d279.s2.p0","sentence":"Stimulus-dependent disorganization of ps actin pe filaments induced by overexpression of ps cofilin pe in C2 myoblasts.","label":1}
{"pair_id":"AIMed.d217.s1881.p0","sentence":"When human soluble ps FasL pe (sFasL, containing the extracellular portion) was expressed in human embryo kidney 293 cells, the three N-linked glycans of each ps FasL pe monomer were found to be essential for efficient secretion.","label":0}
{"pair_id":"BioInfer.d700.s0.p0","sentence":"These increases were specific; DNA, total protein, lactic dehydrogenase, ps profilin pe, and ps actin depolymerizing factor pe levels were unchanged in the overexpressing cells.","label":0}
{"pair_id":"BioInfer.d700.s0.p1","sentence":"These increases were specific; DNA, total protein, ps lactic dehydrogenase pe, ps profilin pe, and actin depolymerizing factor levels were unchanged in the overexpressing cells.","label":0}
{"pair_id":"BioInfer.d700.s0.p2","sentence":"These increases were specific; DNA, total protein, ps lactic dehydrogenase pe, profilin, and ps actin depolymerizing factor pe levels were unchanged in the overexpressing cells.","label":0}
{"pair_id":"BioInfer.d306.s0.p0","sentence":"In a blot overlay experiment, purified 125I-labeled recombinant ps profilin pe bound not only to plant ps actin pe, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.","label":1}
{"pair_id":"BioInfer.d306.s0.p1","sentence":"In a blot overlay experiment, purified 125I-labeled recombinant ps profilin pe bound not only to plant actin, but also to mammalian ps actin pe, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.","label":1}
{"pair_id":"BioInfer.d306.s0.p2","sentence":"In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant ps actin pe, but also to mammalian ps actin pe, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.","label":0}
{"pair_id":"AIMed.d32.s270.p0","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the ps EBP pe bound to an ps EPO pe-mimetic peptide (EMP1), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p1","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the ps EBP pe bound to an ps EPO-mimetic peptide pe (EMP1), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p2","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the ps EBP pe bound to an EPO-mimetic peptide (ps EMP1 pe), suggesting that Phe93 is also important for EMP1 binding.","label":1}
{"pair_id":"AIMed.d32.s270.p3","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the ps EBP pe bound to an EPO-mimetic peptide (EMP1), suggesting that Phe93 is also important for ps EMP1 pe binding.","label":1}
{"pair_id":"AIMed.d32.s270.p4","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an ps EPO peps EPO-mimetic peptide pe (EMP1), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p5","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an ps EPO pe-mimetic peptide (ps EMP1 pe), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p6","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an ps EPO pe-mimetic peptide (EMP1), suggesting that Phe93 is also important for ps EMP1 pe binding.","label":0}
{"pair_id":"AIMed.d32.s270.p7","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an ps EPO-mimetic peptide pe (ps EMP1 pe), suggesting that Phe93 is also important for EMP1 binding.","label":0}
{"pair_id":"AIMed.d32.s270.p8","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an ps EPO-mimetic peptide pe (EMP1), suggesting that Phe93 is also important for ps EMP1 pe binding.","label":0}
{"pair_id":"AIMed.d32.s270.p9","sentence":"Remarkably, Phe93 forms extensive contacts with a peptide ligand in the crystal structure of the EBP bound to an EPO-mimetic peptide (ps EMP1 pe), suggesting that Phe93 is also important for ps EMP1 pe binding.","label":0}
{"pair_id":"AIMed.d171.s1443.p0","sentence":"ps p27Kip1 pe binds the complex as an extended structure interacting with both ps cyclin A pe and Cdk2.","label":1}
{"pair_id":"AIMed.d171.s1443.p1","sentence":"ps p27Kip1 pe binds the complex as an extended structure interacting with both cyclin A and ps Cdk2 pe.","label":1}
{"pair_id":"AIMed.d171.s1443.p2","sentence":"p27Kip1 binds the complex as an extended structure interacting with both ps cyclin A pe and ps Cdk2 pe.","label":0}
{"pair_id":"AIMed.d22.s184.p0","sentence":"In the end we refer to the relations between circulating ps RAS pe of renal origin and the extrarenal ps RAS pe specific to tissue underlying the fact that the two RAS components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.","label":0}
{"pair_id":"AIMed.d22.s184.p1","sentence":"In the end we refer to the relations between circulating ps RAS pe of renal origin and the extrarenal RAS specific to tissue underlying the fact that the two ps RAS pe components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.","label":0}
{"pair_id":"AIMed.d22.s184.p2","sentence":"In the end we refer to the relations between circulating RAS of renal origin and the extrarenal ps RAS pe specific to tissue underlying the fact that the two ps RAS pe components cooperate and constitute a unitary hormonal system, regulating the major functions of the organism and maintaining the main homeostatic equilibria.","label":0}
{"pair_id":"AIMed.d102.s863.p0","sentence":"These cells contain a temperature-sensitive mutation in the ps TATA-binding protein peps TATA-binding protein-associated factor pe TAFII250, first identified as the cell cycle regulatory protein CCG1.","label":0}
{"pair_id":"AIMed.d102.s863.p1","sentence":"These cells contain a temperature-sensitive mutation in the ps TATA-binding protein pe-associated factor ps TAFII250 pe, first identified as the cell cycle regulatory protein CCG1.","label":0}
{"pair_id":"AIMed.d102.s863.p2","sentence":"These cells contain a temperature-sensitive mutation in the ps TATA-binding protein pe-associated factor TAFII250, first identified as the cell cycle regulatory protein ps CCG1 pe.","label":0}
{"pair_id":"AIMed.d102.s863.p3","sentence":"These cells contain a temperature-sensitive mutation in the ps TATA-binding protein-associated factor pe ps TAFII250 pe, first identified as the cell cycle regulatory protein CCG1.","label":0}
{"pair_id":"AIMed.d102.s863.p4","sentence":"These cells contain a temperature-sensitive mutation in the ps TATA-binding protein-associated factor pe TAFII250, first identified as the cell cycle regulatory protein ps CCG1 pe.","label":0}
{"pair_id":"AIMed.d102.s863.p5","sentence":"These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor ps TAFII250 pe, first identified as the cell cycle regulatory protein ps CCG1 pe.","label":0}
{"pair_id":"BioInfer.d411.s0.p0","sentence":"Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, ps RAD51 pe and ps RAD54 pe, have been isolated.","label":0}
{"pair_id":"BioInfer.d99.s0.p0","sentence":"Biochemical analyses revealed a strong induction of ps VEGF-receptor-2 pe (flk-1\/KDR) tyrosine-autophosphorylation by ps VEGF pe which was maximal after 5 minutes and was followed by receptor downregulation.","label":1}
{"pair_id":"BioInfer.d99.s0.p1","sentence":"Biochemical analyses revealed a strong induction of ps VEGF-receptor-2 pe (flk-1\/ps KDR pe) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.","label":0}
{"pair_id":"BioInfer.d99.s0.p2","sentence":"Biochemical analyses revealed a strong induction of ps VEGF-receptor-2 pe (ps flk-1 pe\/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.","label":0}
{"pair_id":"BioInfer.d99.s0.p3","sentence":"Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1\/ps KDR pe) tyrosine-autophosphorylation by ps VEGF pe which was maximal after 5 minutes and was followed by receptor downregulation.","label":1}
{"pair_id":"BioInfer.d99.s0.p4","sentence":"Biochemical analyses revealed a strong induction of VEGF-receptor-2 (ps flk-1 pe\/KDR) tyrosine-autophosphorylation by ps VEGF pe which was maximal after 5 minutes and was followed by receptor downregulation.","label":1}
{"pair_id":"BioInfer.d99.s0.p5","sentence":"Biochemical analyses revealed a strong induction of VEGF-receptor-2 (ps flk-1 pe\/ps KDR pe) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.","label":0}
{"pair_id":"BioInfer.d637.s0.p0","sentence":"The junctional multidomain protein ps AF-6 pe is a binding partner of the ps Rap1A pe GTPase and associates with the actin cytoskeletal regulator profilin.","label":1}
{"pair_id":"BioInfer.d637.s0.p1","sentence":"The junctional multidomain protein ps AF-6 pe is a binding partner of the Rap1A GTPase and associates with the ps actin pe cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p2","sentence":"The junctional multidomain protein ps AF-6 pe is a binding partner of the Rap1A ps GTPase pe and associates with the actin cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p3","sentence":"The junctional multidomain protein ps AF-6 pe is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator ps profilin pe.","label":1}
{"pair_id":"BioInfer.d637.s0.p4","sentence":"The junctional multidomain protein AF-6 is a binding partner of the ps Rap1A pe GTPase and associates with the ps actin pe cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p5","sentence":"The junctional multidomain protein AF-6 is a binding partner of the ps Rap1A pe ps GTPase pe and associates with the actin cytoskeletal regulator profilin.","label":1}
{"pair_id":"BioInfer.d637.s0.p6","sentence":"The junctional multidomain protein AF-6 is a binding partner of the ps Rap1A pe GTPase and associates with the actin cytoskeletal regulator ps profilin pe.","label":0}
{"pair_id":"BioInfer.d637.s0.p7","sentence":"The junctional multidomain protein AF-6 is a binding partner of the Rap1A ps GTPase pe and associates with the ps actin pe cytoskeletal regulator profilin.","label":0}
{"pair_id":"BioInfer.d637.s0.p8","sentence":"The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the ps actin pe cytoskeletal regulator ps profilin pe.","label":1}
{"pair_id":"BioInfer.d637.s0.p9","sentence":"The junctional multidomain protein AF-6 is a binding partner of the Rap1A ps GTPase pe and associates with the actin cytoskeletal regulator ps profilin pe.","label":0}
{"pair_id":"AIMed.d202.s1740.p0","sentence":"Each of these molecules binds to the ps type I IL-1 receptor peps IL-1 pe receptor (IL1R).","label":0}
{"pair_id":"AIMed.d202.s1740.p1","sentence":"Each of these molecules binds to the type I ps IL-1 pe receptor (ps IL1R pe).","label":0}
{"pair_id":"AIMed.d202.s1740.p2","sentence":"Each of these molecules binds to the ps type I IL-1 receptor pe (ps IL1R pe).","label":0}
{"pair_id":"BioInfer.d242.s0.p0","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins ps TRADD pe and ps FADD pe.","label":0}
{"pair_id":"BioInfer.d242.s0.p1","sentence":"Here we describe the ps TNF pe-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins ps TRADD pe and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p2","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the ps p55 pe TNF receptor-associated proteins ps TRADD pe and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p3","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 ps TNF receptor pe-associated proteins ps TRADD pe and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p4","sentence":"Here we describe the TNF-dependent activation of ps acid SMase pe (A-SMase) through the p55 TNF receptor-associated proteins ps TRADD pe and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p5","sentence":"Here we describe the TNF-dependent activation of acid SMase (ps A-SMase pe) through the p55 TNF receptor-associated proteins ps TRADD pe and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p6","sentence":"Here we describe the ps TNF pe-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and ps FADD pe.","label":0}
{"pair_id":"BioInfer.d242.s0.p7","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the ps p55 pe TNF receptor-associated proteins TRADD and ps FADD pe.","label":1}
{"pair_id":"BioInfer.d242.s0.p8","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 ps TNF receptor pe-associated proteins TRADD and ps FADD pe.","label":0}
{"pair_id":"BioInfer.d242.s0.p9","sentence":"Here we describe the TNF-dependent activation of ps acid SMase pe (A-SMase) through the p55 TNF receptor-associated proteins TRADD and ps FADD pe.","label":1}
{"pair_id":"BioInfer.d242.s0.p10","sentence":"Here we describe the TNF-dependent activation of acid SMase (ps A-SMase pe) through the p55 TNF receptor-associated proteins TRADD and ps FADD pe.","label":1}
{"pair_id":"BioInfer.d242.s0.p11","sentence":"Here we describe the ps TNF pe-dependent activation of acid SMase (A-SMase) through the ps p55 pe TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p12","sentence":"Here we describe the ps TNF pe-dependent activation of acid SMase (A-SMase) through the p55 ps TNF receptor pe-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p13","sentence":"Here we describe the ps TNF pe-dependent activation of ps acid SMase pe (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p14","sentence":"Here we describe the ps TNF pe-dependent activation of acid SMase (ps A-SMase pe) through the p55 TNF receptor-associated proteins TRADD and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p15","sentence":"Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the ps p55 pe ps TNF receptor pe-associated proteins TRADD and FADD.","label":1}
{"pair_id":"BioInfer.d242.s0.p16","sentence":"Here we describe the TNF-dependent activation of ps acid SMase pe (A-SMase) through the ps p55 pe TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p17","sentence":"Here we describe the TNF-dependent activation of acid SMase (ps A-SMase pe) through the ps p55 pe TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p18","sentence":"Here we describe the TNF-dependent activation of ps acid SMase pe (A-SMase) through the p55 ps TNF receptor pe-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p19","sentence":"Here we describe the TNF-dependent activation of acid SMase (ps A-SMase pe) through the p55 ps TNF receptor pe-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d242.s0.p20","sentence":"Here we describe the TNF-dependent activation of ps acid SMase pe (ps A-SMase pe) through the p55 TNF receptor-associated proteins TRADD and FADD.","label":0}
{"pair_id":"BioInfer.d762.s0.p0","sentence":"To check its applicability, well characterized, commercially available antibodies (against E-cadherin, ps alpha-catenin pe, and ps beta-catenin pe) were used on sections of human small intestine.","label":0}
{"pair_id":"BioInfer.d762.s0.p1","sentence":"To check its applicability, well characterized, commercially available antibodies (against ps E-cadherin pe, ps alpha-catenin pe, and beta-catenin) were used on sections of human small intestine.","label":0}
{"pair_id":"BioInfer.d762.s0.p2","sentence":"To check its applicability, well characterized, commercially available antibodies (against ps E-cadherin pe, alpha-catenin, and ps beta-catenin pe) were used on sections of human small intestine.","label":0}
{"pair_id":"AIMed.d39.s334.p0","sentence":"ps Presenilin 1 pe suppresses the function of ps c-Jun pe homodimers via interaction with QM\/Jif-1.","label":0}
{"pair_id":"AIMed.d39.s334.p1","sentence":"ps Presenilin 1 pe suppresses the function of c-Jun homodimers via interaction with ps QM pe\/Jif-1.","label":1}
{"pair_id":"AIMed.d39.s334.p2","sentence":"ps Presenilin 1 pe suppresses the function of c-Jun homodimers via interaction with QM\/ps Jif-1 pe.","label":1}
{"pair_id":"AIMed.d39.s334.p3","sentence":"Presenilin 1 suppresses the function of ps c-Jun pe homodimers via interaction with ps QM pe\/Jif-1.","label":0}
{"pair_id":"AIMed.d39.s334.p4","sentence":"Presenilin 1 suppresses the function of ps c-Jun pe homodimers via interaction with QM\/ps Jif-1 pe.","label":0}
{"pair_id":"AIMed.d39.s334.p5","sentence":"Presenilin 1 suppresses the function of c-Jun homodimers via interaction with ps QM pe\/ps Jif-1 pe.","label":0}
{"pair_id":"BioInfer.d670.s1.p0","sentence":"These results suggest that ps MSH2 pe and ps MSH3 pe can function differentially to control homeologous exchanges.","label":0}
{"pair_id":"AIMed.d163.s1376.p0","sentence":"Thus, ps SNX1 pe is likely to play a role in sorting ps EGFR pe to lysosomes.","label":0}
{"pair_id":"BioInfer.d370.s0.p0","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d370.s0.p1","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d370.s0.p2","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: ps vascular endothelial pe (VE)-ps vascular pe, alpha-catenin, beta-catenin, and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d370.s0.p3","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to ps tumor necrosis factor pe-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, alpha-catenin, beta-catenin, and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d370.s0.p4","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p5","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: ps vascular endothelial pe (VE)-ps vascular pe, alpha-catenin, ps beta-catenin pe, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p6","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to ps tumor necrosis factor pe-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, alpha-catenin, ps beta-catenin pe, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p7","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: ps vascular endothelial pe (VE)-ps vascular pe, ps alpha-catenin pe, beta-catenin, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p8","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to ps tumor necrosis factor pe-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-vascular, ps alpha-catenin pe, beta-catenin, and plakoglobin.","label":0}
{"pair_id":"BioInfer.d370.s0.p9","sentence":"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to ps tumor necrosis factor pe-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: ps vascular endothelial pe (VE)-ps vascular pe, alpha-catenin, beta-catenin, and plakoglobin.","label":0}
{"pair_id":"AIMed.d199.s1712.p0","sentence":"ps Sos pe and ps 80K-H pe.pp66.","label":0}
{"pair_id":"AIMed.d199.s1712.p1","sentence":"ps Sos pe and 80K-H.ps pp66 pe.","label":0}
{"pair_id":"AIMed.d199.s1712.p2","sentence":"Sos and ps 80K-H pe.ps pp66 pe.","label":1}
{"pair_id":"AIMed.d90.s767.p0","sentence":"Using radiolabeled ps PU.1 pe protein as a probe, we screened a B cell cDNA expression library and isolated a number of clones encoding ps PU.1 pe interacting proteins.","label":0}
{"pair_id":"AIMed.d14.s119.p0","sentence":"Abnormal levels of ps GFAp pe and ps NFL pe were significantly associated with increasing CSF cell number and protein concentration, and with the absence of lymph nodes or the absence of trypanosomes in lymph node aspirate.","label":0}
{"pair_id":"AIMed.d199.s1695.p0","sentence":"Stimulation of ps fibroblast growth factor receptor 3 pe (ps FGFR3 pe) results in a variety of functional effects, including regulation of epithelial cell growth and differentiation.","label":0}
{"pair_id":"AIMed.d219.s1908.p0","sentence":"Thus, 14-3-3 interaction with the ps Raf-CRD pe may serve in negative regulation of ps Raf-1 pe function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.","label":0}
{"pair_id":"AIMed.d219.s1908.p1","sentence":"Thus, 14-3-3 interaction with the ps Raf-CRD pe may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of ps Raf-1 pe to promote subsequent events necessary for full activation of Raf-1.","label":0}
{"pair_id":"AIMed.d219.s1908.p2","sentence":"Thus, 14-3-3 interaction with the ps Raf-CRD pe may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of ps Raf-1 pe.","label":0}
{"pair_id":"AIMed.d219.s1908.p3","sentence":"Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of ps Raf-1 pe function by facilitating dissociation of 14-3-3 from the NH2 terminus of ps Raf-1 pe to promote subsequent events necessary for full activation of Raf-1.","label":0}
{"pair_id":"AIMed.d219.s1908.p4","sentence":"Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of ps Raf-1 pe function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of ps Raf-1 pe.","label":0}
{"pair_id":"AIMed.d219.s1908.p5","sentence":"Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of ps Raf-1 pe to promote subsequent events necessary for full activation of ps Raf-1 pe.","label":0}
{"pair_id":"BioInfer.d315.s0.p0","sentence":"In addition, we have demonstrated that increased gene dosage of either SIR1 or ps SIR4 pe, two other factors required for silencing, suppresses the silencing defect of the ps rap1 pe mutants.","label":1}
{"pair_id":"BioInfer.d315.s0.p1","sentence":"In addition, we have demonstrated that increased gene dosage of either ps SIR1 pe or ps SIR4 pe, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.","label":0}
{"pair_id":"BioInfer.d315.s0.p2","sentence":"In addition, we have demonstrated that increased gene dosage of either ps SIR1 pe or SIR4, two other factors required for silencing, suppresses the silencing defect of the ps rap1 pe mutants.","label":1}
{"pair_id":"BioInfer.d375.s1.p0","sentence":"Quantitative analysis of the effect of Acanthamoeba ps profilin pe on ps actin pe filament nucleation and elongation.","label":1}
{"pair_id":"AIMed.d70.s597.p0","sentence":"A bacterially expressed 318-amino acid fragment, ps Ht 31 pe (418-736), containing the amphipathic helix region, was able to bind ps RII pe alpha.","label":0}
{"pair_id":"AIMed.d70.s597.p1","sentence":"A bacterially expressed 318-amino acid fragment, ps Ht 31 pe (418-736), containing the amphipathic helix region, was able to bind ps RII alpha pe.","label":1}
{"pair_id":"AIMed.d70.s597.p2","sentence":"A bacterially expressed 318-amino acid fragment, Ht 31 (418-736), containing the amphipathic helix region, was able to bind ps RII peps RII alpha pe.","label":0}
{"pair_id":"AIMed.d108.s912.p0","sentence":"Here, a direct interaction between the activation domain of ps p53 pe and two subunits of the ps TFIID pe complex, TAFII40 and TAFII60, is reported.","label":0}
{"pair_id":"AIMed.d108.s912.p1","sentence":"Here, a direct interaction between the activation domain of ps p53 pe and two subunits of the TFIID complex, ps TAFII40 pe and TAFII60, is reported.","label":1}
{"pair_id":"AIMed.d108.s912.p2","sentence":"Here, a direct interaction between the activation domain of ps p53 pe and two subunits of the TFIID complex, TAFII40 and ps TAFII60 pe, is reported.","label":1}
{"pair_id":"AIMed.d108.s912.p3","sentence":"Here, a direct interaction between the activation domain of p53 and two subunits of the ps TFIID pe complex, ps TAFII40 pe and TAFII60, is reported.","label":0}
{"pair_id":"AIMed.d108.s912.p4","sentence":"Here, a direct interaction between the activation domain of p53 and two subunits of the ps TFIID pe complex, TAFII40 and ps TAFII60 pe, is reported.","label":0}
{"pair_id":"AIMed.d108.s912.p5","sentence":"Here, a direct interaction between the activation domain of p53 and two subunits of the TFIID complex, ps TAFII40 pe and ps TAFII60 pe, is reported.","label":0}
{"pair_id":"BioInfer.d35.s0.p0","sentence":"ps Aip1p pe interacts with cofilin to disassemble ps actin pe filaments.","label":1}
{"pair_id":"BioInfer.d35.s0.p1","sentence":"ps Aip1p pe interacts with ps cofilin pe to disassemble actin filaments.","label":1}
{"pair_id":"BioInfer.d35.s0.p2","sentence":"Aip1p interacts with ps cofilin pe to disassemble ps actin pe filaments.","label":1}
{"pair_id":"AIMed.d214.s1857.p0","sentence":"Proto-oncoprotein ps Vav pe interacts with ps c-Cbl pe in activated thymocytes and peripheral T cells.","label":1}
{"pair_id":"BioInfer.d795.s0.p0","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as ps verprolin pe\/ps cofilin pe-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p1","sentence":"WASp contains a binding motif for the Rho GTPase ps CDC42Hs pe as well as ps verprolin pe\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p2","sentence":"ps WASp pe contains a binding motif for the Rho GTPase CDC42Hs as well as ps verprolin pe\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p3","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as ps verprolin pe\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by ps CDC42Hs pe-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p4","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as ps verprolin pe\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-ps WASp pe has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p5","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as ps verprolin pe\/cofilin-like ps actin pe-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p6","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as ps verprolin pe\/cofilin-like actin-regulatory domains, but no specific ps actin pe structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p7","sentence":"WASp contains a binding motif for the ps Rho GTPase pe CDC42Hs as well as ps verprolin pe\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p8","sentence":"WASp contains a binding motif for the Rho GTPase ps CDC42Hs pe as well as verprolin\/ps cofilin pe-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p9","sentence":"ps WASp pe contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/ps cofilin pe-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p10","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/ps cofilin pe-like actin-regulatory domains, but no specific actin structure regulated by ps CDC42Hs pe-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p11","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/ps cofilin pe-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-ps WASp pe has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p12","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/ps cofilin pe-like ps actin pe-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p13","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/ps cofilin pe-like actin-regulatory domains, but no specific ps actin pe structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p14","sentence":"WASp contains a binding motif for the ps Rho GTPase pe CDC42Hs as well as verprolin\/ps cofilin pe-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p15","sentence":"ps WASp pe contains a binding motif for the Rho GTPase ps CDC42Hs pe as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p16","sentence":"WASp contains a binding motif for the Rho GTPase ps CDC42Hs pe as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by ps CDC42Hs pe-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p17","sentence":"WASp contains a binding motif for the Rho GTPase ps CDC42Hs pe as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-ps WASp pe has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p18","sentence":"WASp contains a binding motif for the Rho GTPase ps CDC42Hs pe as well as verprolin\/cofilin-like ps actin pe-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p19","sentence":"WASp contains a binding motif for the Rho GTPase ps CDC42Hs pe as well as verprolin\/cofilin-like actin-regulatory domains, but no specific ps actin pe structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p20","sentence":"WASp contains a binding motif for the ps Rho GTPase pe ps CDC42Hs pe as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p21","sentence":"ps WASp pe contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by ps CDC42Hs pe-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p22","sentence":"ps WASp pe contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-ps WASp pe has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p23","sentence":"ps WASp pe contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like ps actin pe-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p24","sentence":"ps WASp pe contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific ps actin pe structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p25","sentence":"ps WASp pe contains a binding motif for the ps Rho GTPase pe CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p26","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by ps CDC42Hs pe-ps WASp pe has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p27","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like ps actin pe-regulatory domains, but no specific actin structure regulated by ps CDC42Hs pe-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p28","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific ps actin pe structure regulated by ps CDC42Hs pe-WASp has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p29","sentence":"WASp contains a binding motif for the ps Rho GTPase pe CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by ps CDC42Hs pe-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p30","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like ps actin pe-regulatory domains, but no specific actin structure regulated by CDC42Hs-ps WASp pe has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p31","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific ps actin pe structure regulated by CDC42Hs-ps WASp pe has been identified.","label":1}
{"pair_id":"BioInfer.d795.s0.p32","sentence":"WASp contains a binding motif for the ps Rho GTPase pe CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-ps WASp pe has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p33","sentence":"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin\/cofilin-like ps actin pe-regulatory domains, but no specific ps actin pe structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p34","sentence":"WASp contains a binding motif for the ps Rho GTPase pe CDC42Hs as well as verprolin\/cofilin-like ps actin pe-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"BioInfer.d795.s0.p35","sentence":"WASp contains a binding motif for the ps Rho GTPase pe CDC42Hs as well as verprolin\/cofilin-like actin-regulatory domains, but no specific ps actin pe structure regulated by CDC42Hs-WASp has been identified.","label":0}
{"pair_id":"AIMed.d82.s697.p0","sentence":"Previously, a mammalian protein that directly associates with ps FKBP12 pe-rapamycin has been identified and its encoding gene has been cloned from both human (designated ps FRAP pe) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].","label":1}
{"pair_id":"AIMed.d82.s697.p1","sentence":"Previously, a mammalian protein that directly associates with ps FKBP12 pe-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated ps RAFT pe) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].","label":0}
{"pair_id":"AIMed.d82.s697.p2","sentence":"Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated ps FRAP pe) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated ps RAFT pe) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].","label":0}
{"pair_id":"BioInfer.d262.s0.p0","sentence":"HGF\/ps SF pe treatment of LoVo reduced the amount of ps alpha-catenin pe complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p1","sentence":"HGF\/ps SF pe treatment of LoVo reduced the amount of alpha-catenin complexed with ps E-cadherin pe more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p2","sentence":"ps HGF pe\/ps SF pe treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p3","sentence":"HGF\/ps SF pe treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of ps beta-catenin pe, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p4","sentence":"HGF\/SF treatment of LoVo reduced the amount of ps alpha-catenin pe complexed with ps E-cadherin pe more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":1}
{"pair_id":"BioInfer.d262.s0.p5","sentence":"ps HGF pe\/SF treatment of LoVo reduced the amount of ps alpha-catenin pe complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p6","sentence":"HGF\/SF treatment of LoVo reduced the amount of ps alpha-catenin pe complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of ps beta-catenin pe, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p7","sentence":"ps HGF pe\/SF treatment of LoVo reduced the amount of alpha-catenin complexed with ps E-cadherin pe more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p8","sentence":"HGF\/SF treatment of LoVo reduced the amount of alpha-catenin complexed with ps E-cadherin pe more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of ps beta-catenin pe, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"BioInfer.d262.s0.p9","sentence":"ps HGF pe\/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of ps beta-catenin pe, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.","label":0}
{"pair_id":"AIMed.d54.s478.p0","sentence":"ps PDGF-CC pe exhibits greater mitogenic potency than ps PDGF-AA pe and comparable or greater mitogenic activity than PDGF-AB and PDGF-BB on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p1","sentence":"ps PDGF-CC pe exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than ps PDGF-AB pe and PDGF-BB on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p2","sentence":"ps PDGF-CC pe exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than PDGF-AB and ps PDGF-BB pe on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p3","sentence":"PDGF-CC exhibits greater mitogenic potency than ps PDGF-AA pe and comparable or greater mitogenic activity than ps PDGF-AB pe and PDGF-BB on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p4","sentence":"PDGF-CC exhibits greater mitogenic potency than ps PDGF-AA pe and comparable or greater mitogenic activity than PDGF-AB and ps PDGF-BB pe on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d54.s478.p5","sentence":"PDGF-CC exhibits greater mitogenic potency than PDGF-AA and comparable or greater mitogenic activity than ps PDGF-AB pe and ps PDGF-BB pe on several mesenchymal cell types.","label":0}
{"pair_id":"AIMed.d127.s1085.p0","sentence":"ps Interleukin-2 pe (ps IL-2 pe) signaling requires the dimerization of the IL-2 receptor beta.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p1","sentence":"ps Interleukin-2 pe (IL-2) signaling requires the dimerization of the ps IL-2 pe receptor beta.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p2","sentence":"ps Interleukin-2 pe (IL-2) signaling requires the dimerization of the ps IL-2 receptor beta pe.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p3","sentence":"ps Interleukin-2 pe (IL-2) signaling requires the dimerization of the IL-2 receptor beta.(ps IL-2R beta pe) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p4","sentence":"Interleukin-2 (ps IL-2 pe) signaling requires the dimerization of the ps IL-2 pe receptor beta.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p5","sentence":"Interleukin-2 (ps IL-2 pe) signaling requires the dimerization of the ps IL-2 receptor beta pe.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p6","sentence":"Interleukin-2 (ps IL-2 pe) signaling requires the dimerization of the IL-2 receptor beta.(ps IL-2R beta pe) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p7","sentence":"Interleukin-2 (IL-2) signaling requires the dimerization of the ps IL-2 peps IL-2 receptor beta pe.(IL-2R beta) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p8","sentence":"Interleukin-2 (IL-2) signaling requires the dimerization of the ps IL-2 pe receptor beta.(ps IL-2R beta pe) and common gamma (gamma c) chains.","label":0}
{"pair_id":"AIMed.d127.s1085.p9","sentence":"Interleukin-2 (IL-2) signaling requires the dimerization of the ps IL-2 receptor beta pe.(ps IL-2R beta pe) and common gamma (gamma c) chains.","label":0}
{"pair_id":"BioInfer.d60.s1.p0","sentence":"In this study, cell cycle-dependent expression of human and rodent ps RAD51 pe and ps RAD52 pe proteins was monitored using two approaches.","label":0}
{"pair_id":"BioInfer.d278.s1.p0","sentence":"This suggests that dephosphorylation of cofilin and destrin\/ps ADF pe by ps TSH pe could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p1","sentence":"This suggests that dephosphorylation of cofilin and destrin\/ps ADF pe by TSH could be implicated in the disruption of ps actin pe-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p2","sentence":"This suggests that dephosphorylation of cofilin and ps destrin pe\/ps ADF pe by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":0}
{"pair_id":"BioInfer.d278.s1.p3","sentence":"This suggests that dephosphorylation of ps cofilin pe and destrin\/ps ADF pe by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":0}
{"pair_id":"BioInfer.d278.s1.p4","sentence":"This suggests that dephosphorylation of cofilin and destrin\/ADF by ps TSH pe could be implicated in the disruption of ps actin pe-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p5","sentence":"This suggests that dephosphorylation of cofilin and ps destrin pe\/ADF by ps TSH pe could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p6","sentence":"This suggests that dephosphorylation of ps cofilin pe and destrin\/ADF by ps TSH pe could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p7","sentence":"This suggests that dephosphorylation of cofilin and ps destrin pe\/ADF by TSH could be implicated in the disruption of ps actin pe-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p8","sentence":"This suggests that dephosphorylation of ps cofilin pe and destrin\/ADF by TSH could be implicated in the disruption of ps actin pe-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":1}
{"pair_id":"BioInfer.d278.s1.p9","sentence":"This suggests that dephosphorylation of ps cofilin pe and ps destrin pe\/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.","label":0}
{"pair_id":"AIMed.d216.s1873.p0","sentence":"The three-dimensional structure of the complex between human ps H-Ras pe bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human ps GTPase-activating protein pe p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d216.s1873.p1","sentence":"The three-dimensional structure of the complex between human ps H-Ras pe bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein ps p120GAP pe (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":1}
{"pair_id":"AIMed.d216.s1873.p2","sentence":"The three-dimensional structure of the complex between human ps H-Ras pe bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (ps GAP-334 pe) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":1}
{"pair_id":"AIMed.d216.s1873.p3","sentence":"The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human ps GTPase-activating protein pe ps p120GAP pe (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d216.s1873.p4","sentence":"The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human ps GTPase-activating protein pe p120GAP (ps GAP-334 pe) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d216.s1873.p5","sentence":"The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein ps p120GAP pe (ps GAP-334 pe) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.","label":0}
{"pair_id":"AIMed.d43.s376.p0","sentence":"In this study, a minimum set of residues in the human ps TrkC pe second immunoglobulin-like domain, which does not bind ps nerve growth factor pe (NGF), were substituted with those from human TrkA.","label":0}
{"pair_id":"AIMed.d43.s376.p1","sentence":"In this study, a minimum set of residues in the human ps TrkC pe second immunoglobulin-like domain, which does not bind nerve growth factor (ps NGF pe), were substituted with those from human TrkA.","label":0}
{"pair_id":"AIMed.d43.s376.p2","sentence":"In this study, a minimum set of residues in the human ps TrkC pe second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human ps TrkA pe.","label":0}
{"pair_id":"AIMed.d43.s376.p3","sentence":"In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind ps nerve growth factor pe (ps NGF pe), were substituted with those from human TrkA.","label":0}
{"pair_id":"AIMed.d43.s376.p4","sentence":"In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind ps nerve growth factor pe (NGF), were substituted with those from human ps TrkA pe.","label":0}
{"pair_id":"AIMed.d43.s376.p5","sentence":"In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (ps NGF pe), were substituted with those from human ps TrkA pe.","label":0}
{"pair_id":"AIMed.d39.s337.p0","sentence":"We screened for proteins that bind to ps PS1 pe from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the ps QM pe\/Jif-1 gene.","label":1}
{"pair_id":"AIMed.d39.s337.p1","sentence":"We screened for proteins that bind to ps PS1 pe from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the QM\/ps Jif-1 pe gene.","label":1}
{"pair_id":"AIMed.d39.s337.p2","sentence":"We screened for proteins that bind to PS1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the ps QM pe\/ps Jif-1 pe gene.","label":0}
{"pair_id":"BioInfer.d481.s0.p0","sentence":"Particle aggregates associated with this array of ps actin pe microfilaments also labeled with antibodies to vinculin, ps talin pe and beta 1-integrin.","label":0}
{"pair_id":"BioInfer.d481.s0.p1","sentence":"Particle aggregates associated with this array of ps actin pe microfilaments also labeled with antibodies to ps vinculin pe, talin and beta 1-integrin.","label":0}
{"pair_id":"BioInfer.d481.s0.p2","sentence":"Particle aggregates associated with this array of ps actin pe microfilaments also labeled with antibodies to vinculin, talin and ps beta 1-integrin pe.","label":0}
{"pair_id":"BioInfer.d481.s0.p3","sentence":"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to ps vinculin pe, ps talin pe and beta 1-integrin.","label":0}
{"pair_id":"BioInfer.d481.s0.p4","sentence":"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, ps talin pe and ps beta 1-integrin pe.","label":0}
{"pair_id":"BioInfer.d481.s0.p5","sentence":"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to ps vinculin pe, talin and ps beta 1-integrin pe.","label":0}
{"pair_id":"AIMed.d132.s1129.p0","sentence":"The gamma chain of the ps interleukin-2 pe (ps IL-2 pe) receptor is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p1","sentence":"The gamma chain of the ps interleukin-2 peps interleukin-2 (IL-2) receptor pe is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p2","sentence":"The gamma chain of the ps interleukin-2 pe (IL-2) receptor is shared with the functional ps IL-4 pe receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p3","sentence":"The gamma chain of the ps interleukin-2 pe (IL-2) receptor is shared with the functional ps IL-4 receptor pe and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p4","sentence":"The gamma chain of the ps interleukin-2 (IL-2) receptor peps IL-2 pe) receptor is shared with the functional IL-4 receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p5","sentence":"The gamma chain of the interleukin-2 (ps IL-2 pe) receptor is shared with the functional ps IL-4 pe receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p6","sentence":"The gamma chain of the interleukin-2 (ps IL-2 pe) receptor is shared with the functional ps IL-4 receptor pe and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p7","sentence":"The gamma chain of the ps interleukin-2 (IL-2) receptor pe is shared with the functional ps IL-4 pe receptor and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p8","sentence":"The gamma chain of the ps interleukin-2 (IL-2) receptor pe is shared with the functional ps IL-4 receptor pe and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"AIMed.d132.s1129.p9","sentence":"The gamma chain of the interleukin-2 (IL-2) receptor is shared with the functional ps IL-4 peps IL-4 receptor pe and is causatively related to X-linked severe combined immunodeficiency (XSCID), which is ascribed to a profound T cell defect.","label":0}
{"pair_id":"BioInfer.d268.s0.p0","sentence":"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that ps verprolin pe establishes and maintains its location independent of the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d268.s0.p1","sentence":"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter ps verprolin pe's location, indicating that ps verprolin pe establishes and maintains its location independent of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p2","sentence":"However, disassembly of the ps actin pe cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that ps verprolin pe establishes and maintains its location independent of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p3","sentence":"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter ps verprolin pe's location, indicating that verprolin establishes and maintains its location independent of the ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p4","sentence":"However, disassembly of the ps actin pe cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d268.s0.p5","sentence":"However, disassembly of the ps actin pe cytoskeleton using Latrunculin-A does not alter ps verprolin pe's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d416.s0.p0","sentence":"Mechanism of inhibition of ps proliferating cell nuclear antigen pe-dependent DNA synthesis by the cyclin-dependent kinase inhibitor ps p21 pe.","label":0}
{"pair_id":"BioInfer.d416.s0.p1","sentence":"Mechanism of inhibition of ps proliferating cell nuclear antigen pe-dependent DNA synthesis by the ps cyclin-dependent kinase inhibitor pe p21.","label":0}
{"pair_id":"BioInfer.d416.s0.p2","sentence":"Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the ps cyclin-dependent kinase inhibitor pe ps p21 pe.","label":1}
{"pair_id":"AIMed.d209.s1810.p0","sentence":"When expressed in mammalian cells, the ps RAS pe binding domain of ps RIN1 pe can act as a dominant negative signal transduction blocker.","label":1}
{"pair_id":"AIMed.d60.s528.p0","sentence":"The ps v-Raf pe proteins purified from cells infected with EC12 or 22W viruses activated ps MAP kinase pe kinase from skeletal muscle in vitro.","label":0}
{"pair_id":"AIMed.d60.s528.p1","sentence":"The ps v-Raf pe proteins purified from cells infected with EC12 or 22W viruses activated ps MAP kinase kinase pe from skeletal muscle in vitro.","label":1}
{"pair_id":"AIMed.d60.s528.p2","sentence":"The v-Raf proteins purified from cells infected with EC12 or 22W viruses activated ps MAP kinase peps MAP kinase kinase pe from skeletal muscle in vitro.","label":0}
{"pair_id":"BioInfer.d21.s0.p0","sentence":"Actophorin and ps profilin pe have opposite effects on the rate of exchange of nucleotide bound to ps actin pe monomers.","label":0}
{"pair_id":"BioInfer.d21.s0.p1","sentence":"ps Actophorin pe and profilin have opposite effects on the rate of exchange of nucleotide bound to ps actin pe monomers.","label":0}
{"pair_id":"BioInfer.d21.s0.p2","sentence":"ps Actophorin pe and ps profilin pe have opposite effects on the rate of exchange of nucleotide bound to actin monomers.","label":0}
{"pair_id":"BioInfer.d812.s0.p0","sentence":"We have examined the level of ps cyclin E pe, a G1 cyclin, and ps p27kip pe, a cyclin-dependent kinase inhibitor, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d812.s0.p1","sentence":"We have examined the level of cyclin E, a ps G1 cyclin pe, and ps p27kip pe, a cyclin-dependent kinase inhibitor, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d812.s0.p2","sentence":"We have examined the level of cyclin E, a G1 cyclin, and ps p27kip pe, a ps cyclin-dependent kinase inhibitor pe, in BALB\/c 3T3 cells.","label":1}
{"pair_id":"BioInfer.d812.s0.p3","sentence":"We have examined the level of ps cyclin E pe, a ps G1 cyclin pe, and p27kip, a cyclin-dependent kinase inhibitor, in BALB\/c 3T3 cells.","label":1}
{"pair_id":"BioInfer.d812.s0.p4","sentence":"We have examined the level of ps cyclin E pe, a G1 cyclin, and p27kip, a ps cyclin-dependent kinase inhibitor pe, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d812.s0.p5","sentence":"We have examined the level of cyclin E, a ps G1 cyclin pe, and p27kip, a ps cyclin-dependent kinase inhibitor pe, in BALB\/c 3T3 cells.","label":0}
{"pair_id":"BioInfer.d257.s0.p0","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric ps helicase-primase pe complex that is composed of the products of the UL5, ps UL52 pe, and UL8 genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p1","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the ps UL5 pe, ps UL52 pe, and UL8 genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p2","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, ps UL52 pe, and ps UL8 pe genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p3","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric ps helicase-primase pe complex that is composed of the products of the ps UL5 pe, UL52, and UL8 genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p4","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric ps helicase-primase pe complex that is composed of the products of the UL5, UL52, and ps UL8 pe genes.","label":1}
{"pair_id":"BioInfer.d257.s0.p5","sentence":"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the ps UL5 pe, UL52, and ps UL8 pe genes.","label":1}
{"pair_id":"BioInfer.d144.s1.p0","sentence":"Expression of the A8R and ps A23R pe genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for ps VITF-3 pe in specifically regulating intermediate transcription in vivo.","label":0}
{"pair_id":"BioInfer.d144.s1.p1","sentence":"Expression of the ps A8R pe and ps A23R pe genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.","label":0}
{"pair_id":"BioInfer.d144.s1.p2","sentence":"Expression of the ps A8R pe and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for ps VITF-3 pe in specifically regulating intermediate transcription in vivo.","label":0}
{"pair_id":"AIMed.d129.s1110.p0","sentence":"Bacterially overexpressed human ps p23 pe was used to raise several monoclonal antibodies to ps p23 pe.","label":0}
{"pair_id":"AIMed.d103.s874.p0","sentence":"As observed with the homologous Drosophila proteins, ps hTAFII20 pe interacts directly with ps TBP pe; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.","label":1}
{"pair_id":"AIMed.d103.s874.p1","sentence":"As observed with the homologous Drosophila proteins, ps hTAFII20 pe interacts directly with TBP; however, additional interactions between ps hTAFII20 pe and hTAFII28 or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p2","sentence":"As observed with the homologous Drosophila proteins, ps hTAFII20 pe interacts directly with TBP; however, additional interactions between hTAFII20 and ps hTAFII28 pe or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p3","sentence":"As observed with the homologous Drosophila proteins, ps hTAFII20 pe interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or ps hTAFII30 pe were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p4","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with ps TBP pe; however, additional interactions between ps hTAFII20 pe and hTAFII28 or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p5","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with ps TBP pe; however, additional interactions between hTAFII20 and ps hTAFII28 pe or hTAFII30 were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p6","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with ps TBP pe; however, additional interactions between hTAFII20 and hTAFII28 or ps hTAFII30 pe were detected.","label":0}
{"pair_id":"AIMed.d103.s874.p7","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between ps hTAFII20 pe and ps hTAFII28 pe or hTAFII30 were detected.","label":1}
{"pair_id":"AIMed.d103.s874.p8","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between ps hTAFII20 pe and hTAFII28 or ps hTAFII30 pe were detected.","label":1}
{"pair_id":"AIMed.d103.s874.p9","sentence":"As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and ps hTAFII28 pe or ps hTAFII30 pe were detected.","label":0}
{"pair_id":"BioInfer.d496.s1.p0","sentence":"Since functional characteristics for ps profilin II pe are lacking, we assayed the ps actin pe, the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.","label":1}
{"pair_id":"BioInfer.d391.s1.p0","sentence":"These results indicate that the assembly of cytoskeletal and ps sarcomeric cytosk pe is regulated differently by ps profilin pe in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.","label":1}
{"pair_id":"BioInfer.d391.s1.p1","sentence":"These results indicate that the assembly of ps cytoskeletal pe and sarcomeric ps cytosk pe is regulated differently by ps profilin pe in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.","label":1}
{"pair_id":"BioInfer.d391.s1.p2","sentence":"These results indicate that the assembly of ps cytoskeletal pe and ps sarcomeric cytosk peps cytosk pe is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.","label":0}
{"pair_id":"AIMed.d196.s1673.p0","sentence":"Thus ps HOX11 pe is a cellular oncogene that targets ps PP2A pe and PP1, both of which are targets for oncogenic viruses and chemical tumour promoters.","label":1}
{"pair_id":"AIMed.d196.s1673.p1","sentence":"Thus ps HOX11 pe is a cellular oncogene that targets PP2A and ps PP1 pe, both of which are targets for oncogenic viruses and chemical tumour promoters.","label":1}
{"pair_id":"AIMed.d196.s1673.p2","sentence":"Thus HOX11 is a cellular oncogene that targets ps PP2A pe and ps PP1 pe, both of which are targets for oncogenic viruses and chemical tumour promoters.","label":0}
{"pair_id":"AIMed.d125.s1070.p0","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing ps Bcl-2 pe, ps Bcl-X-L pe, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p1","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing ps Bcl-2 pe, Bcl-X-L, or ps Mcl-1 pe but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p2","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing ps Bcl-2 pe, Bcl-X-L, or Mcl-1 but not those containing ps Bcl-X-S pe (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p3","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing ps Bcl-2 pe, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of ps Bcl-X pe that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p4","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, ps Bcl-X-L pe, or ps Mcl-1 pe but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p5","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, ps Bcl-X-L pe, or Mcl-1 but not those containing ps Bcl-X-S pe (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p6","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, ps Bcl-X-L pe, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of ps Bcl-X pe that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p7","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or ps Mcl-1 pe but not those containing ps Bcl-X-S pe (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p8","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or ps Mcl-1 pe but not those containing Bcl-X-S (an alternatively spliced form of ps Bcl-X pe that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d125.s1070.p9","sentence":"This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing ps Bcl-X-S pe (an alternatively spliced form of ps Bcl-X pe that lacks a well-conserved 63-amino acid region).","label":0}
{"pair_id":"AIMed.d154.s1314.p0","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like ps beta 1-syntrophin pe, both beta 2- and ps alpha 1-syntrophin pe interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/dystrophin related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p1","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like ps beta 1-syntrophin pe, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of ps dystrophin pe, utrophin\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p2","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like ps beta 1-syntrophin pe, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, ps utrophin pe\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p3","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like ps beta 1-syntrophin pe, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/ps dystrophin pe related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p4","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like ps beta 1-syntrophin pe, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/ps dystrophin related protein pe, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p5","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like ps beta 1-syntrophin pe, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/dystrophin related protein, and the ps Torpedo 87K protein pe.","label":1}
{"pair_id":"AIMed.d154.s1314.p6","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and ps alpha 1-syntrophin pe interact with peptides encoding the syntrophin-binding region of ps dystrophin pe, utrophin\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p7","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and ps alpha 1-syntrophin pe interact with peptides encoding the syntrophin-binding region of dystrophin, ps utrophin pe\/dystrophin related protein, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p8","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and ps alpha 1-syntrophin pe interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/ps dystrophin pe related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p9","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and ps alpha 1-syntrophin pe interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/ps dystrophin related protein pe, and the Torpedo 87K protein.","label":1}
{"pair_id":"AIMed.d154.s1314.p10","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and ps alpha 1-syntrophin pe interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/dystrophin related protein, and the ps Torpedo 87K protein pe.","label":1}
{"pair_id":"AIMed.d154.s1314.p11","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of ps dystrophin pe, ps utrophin pe\/dystrophin related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p12","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of ps dystrophin pe, utrophin\/ps dystrophin pe related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p13","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of ps dystrophin pe, utrophin\/ps dystrophin related protein pe, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p14","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of ps dystrophin pe, utrophin\/dystrophin related protein, and the ps Torpedo 87K protein pe.","label":0}
{"pair_id":"AIMed.d154.s1314.p15","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, ps utrophin pe\/ps dystrophin pe related protein, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p16","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, ps utrophin pe\/ps dystrophin related protein pe, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p17","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, ps utrophin pe\/dystrophin related protein, and the ps Torpedo 87K protein pe.","label":0}
{"pair_id":"AIMed.d154.s1314.p18","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/ps dystrophin peps dystrophin related protein pe, and the Torpedo 87K protein.","label":0}
{"pair_id":"AIMed.d154.s1314.p19","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/ps dystrophin pe related protein, and the ps Torpedo 87K protein pe.","label":0}
{"pair_id":"AIMed.d154.s1314.p20","sentence":"Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin\/ps dystrophin related protein pe, and the ps Torpedo 87K protein pe.","label":0}
{"pair_id":"AIMed.d54.s475.p0","sentence":"ps PDGF-C pe is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of ps neuropilin-1 pe, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and PDGF A-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p1","sentence":"ps PDGF-C pe is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular ps endothelial growth factor pe (25%) and PDGF A-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p2","sentence":"ps PDGF-C pe is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and ps PDGF A pe-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p3","sentence":"PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of ps neuropilin-1 pe, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular ps endothelial growth factor pe (25%) and PDGF A-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p4","sentence":"PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of ps neuropilin-1 pe, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular endothelial growth factor (25%) and ps PDGF A pe-chain (23%).","label":0}
{"pair_id":"AIMed.d54.s475.p5","sentence":"PDGF-C is a multidomain protein with the N-terminal region homologous to the extracellular CUB domain of neuropilin-1, and the C-terminal region consists of a growth factor domain (GFD) with homology to vascular ps endothelial growth factor pe (25%) and ps PDGF A pe-chain (23%).","label":0}
{"pair_id":"AIMed.d85.s717.p0","sentence":"ps Wiskott-Aldrich syndrome protein pe physically associates with ps Nck pe through Src homology 3 domains.","label":1}
{"pair_id":"AIMed.d30.s252.p0","sentence":"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that ps delta-catenin pe interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of ps PS1 pe, but not with that of PS-2.","label":1}
{"pair_id":"AIMed.d30.s252.p1","sentence":"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that ps delta-catenin pe interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PS1, but not with that of ps PS-2 pe.","label":0}
{"pair_id":"AIMed.d30.s252.p2","sentence":"Yeast two-hybrid assay, GST binding assay and immunoprecipitation demonstrated that delta-catenin interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of ps PS1 pe, but not with that of ps PS-2 pe.","label":0}
{"pair_id":"AIMed.d193.s1642.p0","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ps ITF-2 pe transcription factor, ps ITF-2b pe, that interacts with the transcriptional inhibitor Id3\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1642.p1","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ps ITF-2 pe transcription factor, ITF-2b, that interacts with the transcriptional inhibitor ps Id3 pe\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1642.p2","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ps ITF-2 pe transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3\/ps HLH462 pe.","label":0}
{"pair_id":"AIMed.d193.s1642.p3","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ps ITF-2b pe, that interacts with the transcriptional inhibitor ps Id3 pe\/HLH462.","label":1}
{"pair_id":"AIMed.d193.s1642.p4","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ps ITF-2b pe, that interacts with the transcriptional inhibitor Id3\/ps HLH462 pe.","label":1}
{"pair_id":"AIMed.d193.s1642.p5","sentence":"We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ITF-2b, that interacts with the transcriptional inhibitor ps Id3 pe\/ps HLH462 pe.","label":0}
{"pair_id":"BioInfer.d179.s0.p0","sentence":"Double mutants containing N-terminal domain deletions of both ps histone pe H3 and histone ps H4 pe were inviable.","label":0}
{"pair_id":"BioInfer.d179.s0.p1","sentence":"Double mutants containing N-terminal domain deletions of both ps histone pe H3 and ps histone pe H4 were inviable.","label":0}
{"pair_id":"BioInfer.d179.s0.p2","sentence":"Double mutants containing N-terminal domain deletions of both ps histone pe ps H3 pe and histone H4 were inviable.","label":1}
{"pair_id":"BioInfer.d179.s0.p3","sentence":"Double mutants containing N-terminal domain deletions of both histone H3 and ps histone pe ps H4 pe were inviable.","label":1}
{"pair_id":"BioInfer.d179.s0.p4","sentence":"Double mutants containing N-terminal domain deletions of both histone ps H3 pe and histone ps H4 pe were inviable.","label":0}
{"pair_id":"BioInfer.d179.s0.p5","sentence":"Double mutants containing N-terminal domain deletions of both histone ps H3 pe and ps histone pe H4 were inviable.","label":0}
{"pair_id":"BioInfer.d297.s0.p0","sentence":"Immunoprecipitation of ps alpha-catenin pe was increased in response to both doses of CdCl2, while the immunoprecipitation of ps beta-catenin pe was little changed by either cadmium dose.","label":0}
{"pair_id":"BioInfer.d183.s2.p0","sentence":"While parallel ps actin pe bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous ps actin pe network of these cells is denser than in control cells.","label":0}
{"pair_id":"BioInfer.d183.s2.p1","sentence":"While parallel actin bundles crossing the cells are virtually absent in cells overexpressing ps profilin pe, the submembranous ps actin pe network of these cells is denser than in control cells.","label":0}
{"pair_id":"BioInfer.d183.s2.p2","sentence":"While parallel ps actin pe bundles crossing the cells are virtually absent in cells overexpressing ps profilin pe, the submembranous actin network of these cells is denser than in control cells.","label":0}
{"pair_id":"BioInfer.d590.s0.p0","sentence":"The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the ps actin pe- or ATP-binding capacities of two size-limited recombinant ps myosin heavy chain pe fragments.","label":1}
{"pair_id":"BioInfer.d590.s0.p1","sentence":"The ps cardiac myosin heavy chain pe Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the ps actin pe- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.","label":1}
{"pair_id":"BioInfer.d590.s0.p2","sentence":"The ps cardiac myosin heavy chain pe Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant ps myosin heavy chain pe fragments.","label":1}
{"pair_id":"BioInfer.d435.s0.p0","sentence":"Moreover, talin, but not ps vinculin pe or tubulin, appears to co-localize with ps actin pe microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":1}
{"pair_id":"BioInfer.d435.s0.p1","sentence":"Moreover, talin, but not vinculin or ps tubulin pe, appears to co-localize with ps actin pe microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":1}
{"pair_id":"BioInfer.d435.s0.p2","sentence":"Moreover, ps talin pe, but not vinculin or tubulin, appears to co-localize with ps actin pe microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":1}
{"pair_id":"BioInfer.d435.s0.p3","sentence":"Moreover, talin, but not vinculin or tubulin, appears to co-localize with ps actin pe microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following ps CD31 pe cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p4","sentence":"Moreover, talin, but not ps vinculin pe or ps tubulin pe, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p5","sentence":"Moreover, ps talin pe, but not ps vinculin pe or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p6","sentence":"Moreover, talin, but not ps vinculin pe or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following ps CD31 pe cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p7","sentence":"Moreover, ps talin pe, but not vinculin or ps tubulin pe, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p8","sentence":"Moreover, talin, but not vinculin or ps tubulin pe, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following ps CD31 pe cross-linking.","label":0}
{"pair_id":"BioInfer.d435.s0.p9","sentence":"Moreover, ps talin pe, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following ps CD31 pe cross-linking.","label":0}
{"pair_id":"BioInfer.d665.s0.p0","sentence":"The presence, in varying quantities, of ps myosin heavy chain pe and ps actin pe isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.","label":0}
{"pair_id":"AIMed.d211.s1829.p0","sentence":"Through their interaction with the ErbB family of receptors (ps ErbB2 pe, ps ErbB3 pe and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.","label":0}
{"pair_id":"AIMed.d211.s1829.p1","sentence":"Through their interaction with the ErbB family of receptors (ps ErbB2 pe, ErbB3 and ps ErbB4 pe), neuregulins help to regulate cell growth and differentiation in many tissues.","label":0}
{"pair_id":"AIMed.d211.s1829.p2","sentence":"Through their interaction with the ErbB family of receptors (ErbB2, ps ErbB3 pe and ps ErbB4 pe), neuregulins help to regulate cell growth and differentiation in many tissues.","label":0}
{"pair_id":"AIMed.d135.s1147.p0","sentence":"Tumor necrosis factor (TNF) and ps lymphotoxin-alpha pe (ps LT-alpha pe) are members of a family of secreted and cell surface cytokines that participate in the regulation of immune and inflammatory responses.","label":0}
{"pair_id":"AIMed.d190.s1613.p0","sentence":"By using the growth factor dependent M-07e cell line, we found that both ps c-Mpl pe and ps c-Kit pe ligands, namely: SCF and TPO, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p1","sentence":"By using the growth factor dependent M-07e cell line, we found that both ps c-Mpl pe and c-Kit ligands, namely: ps SCF pe and TPO, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p2","sentence":"By using the growth factor dependent M-07e cell line, we found that both ps c-Mpl pe and c-Kit ligands, namely: SCF and ps TPO pe, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p3","sentence":"By using the growth factor dependent M-07e cell line, we found that both ps c-Mpl pe and c-Kit ligands, namely: SCF and TPO, induce ps c-Cbl pe tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p4","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and ps c-Kit pe ligands, namely: ps SCF pe and TPO, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p5","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and ps c-Kit pe ligands, namely: SCF and ps TPO pe, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p6","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and ps c-Kit pe ligands, namely: SCF and TPO, induce ps c-Cbl pe tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p7","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: ps SCF pe and ps TPO pe, induce c-Cbl tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d190.s1613.p8","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: ps SCF pe and TPO, induce ps c-Cbl pe tyrosine phosphorylation.","label":1}
{"pair_id":"AIMed.d190.s1613.p9","sentence":"By using the growth factor dependent M-07e cell line, we found that both c-Mpl and c-Kit ligands, namely: SCF and ps TPO pe, induce ps c-Cbl pe tyrosine phosphorylation.","label":1}
{"pair_id":"BioInfer.d288.s3.p0","sentence":"We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian ps actin binding protein pe ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d490.s0.p0","sentence":"Polyacrylamide gels of platelets heated at 45 degrees C for 90 minutes showed an increase in ps talin pe incorporation into heated platelet cytoskeletons but no increase in filamentous ps actin pe.","label":0}
{"pair_id":"AIMed.d144.s1217.p0","sentence":"The ps retinoblastoma protein pe (ps p110RB pe) interacts with many cellular proteins in complexes potentially important for its growth-suppressing function.","label":0}
{"pair_id":"BioInfer.d609.s0.p0","sentence":"The effects of two adhesion substrates (serum and ps laminin pe) and time in culture on the expression of genes encoding ps myosin heavy chain pe (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":1}
{"pair_id":"BioInfer.d609.s0.p1","sentence":"The effects of two adhesion substrates (serum and ps laminin pe) and time in culture on the expression of genes encoding myosin heavy chain (ps MHC pe) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":1}
{"pair_id":"BioInfer.d609.s0.p2","sentence":"The effects of two adhesion substrates (serum and ps laminin pe) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and ps alpha-skeletal actin pe were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":1}
{"pair_id":"BioInfer.d609.s0.p3","sentence":"The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding ps myosin heavy chain pe (ps MHC pe) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":0}
{"pair_id":"BioInfer.d609.s0.p4","sentence":"The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding ps myosin heavy chain pe (MHC) isoforms and ps alpha-skeletal actin pe were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":0}
{"pair_id":"BioInfer.d609.s0.p5","sentence":"The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (ps MHC pe) isoforms and ps alpha-skeletal actin pe were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.","label":0}
{"pair_id":"BioInfer.d625.s0.p0","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the ps cyclin dependent kinase inhibitor pe ps p27kip1 pe.","label":1}
{"pair_id":"BioInfer.d625.s0.p1","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of ps p53 pe and decreased expression of the ps cyclin dependent kinase inhibitor pe p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p2","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor ps p16ink4a pe and of p53 and decreased expression of the ps cyclin dependent kinase inhibitor pe p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p3","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the ps cyclin dependent kinase inhibitor pe p16ink4a and of p53 and decreased expression of the ps cyclin dependent kinase inhibitor pe p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p4","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of ps cyclin D1 pe, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the ps cyclin dependent kinase inhibitor pe p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p5","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of ps p53 pe and decreased expression of the cyclin dependent kinase inhibitor ps p27kip1 pe.","label":0}
{"pair_id":"BioInfer.d625.s0.p6","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor ps p16ink4a pe and of p53 and decreased expression of the cyclin dependent kinase inhibitor ps p27kip1 pe.","label":0}
{"pair_id":"BioInfer.d625.s0.p7","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the ps cyclin dependent kinase inhibitor pe p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor ps p27kip1 pe.","label":0}
{"pair_id":"BioInfer.d625.s0.p8","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of ps cyclin D1 pe, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor ps p27kip1 pe.","label":0}
{"pair_id":"BioInfer.d625.s0.p9","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor ps p16ink4a pe and of ps p53 pe and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p10","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the ps cyclin dependent kinase inhibitor pe p16ink4a and of ps p53 pe and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p11","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of ps cyclin D1 pe, the cyclin dependent kinase inhibitor p16ink4a and of ps p53 pe and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p12","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the ps cyclin dependent kinase inhibitor pe ps p16ink4a pe and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":1}
{"pair_id":"BioInfer.d625.s0.p13","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of ps cyclin D1 pe, the cyclin dependent kinase inhibitor ps p16ink4a pe and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d625.s0.p14","sentence":"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of ps cyclin D1 pe, the ps cyclin dependent kinase inhibitor pe p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.","label":0}
{"pair_id":"BioInfer.d444.s0.p0","sentence":"Mutations in RVS161 and ps RVS167 pe, the two yeast ps amphiphysin pe homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d444.s0.p1","sentence":"Mutations in RVS161 and ps RVS167 pe, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized ps actin pe cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d444.s0.p2","sentence":"Mutations in ps RVS161 pe and ps RVS167 pe, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.","label":0}
{"pair_id":"BioInfer.d444.s0.p3","sentence":"Mutations in RVS161 and RVS167, the two yeast ps amphiphysin pe homologs, cause very similar growth phenotypes, a depolarized ps actin pe cytoskeleton, and a defect in the internalization step of endocytosis.","label":0}
{"pair_id":"BioInfer.d444.s0.p4","sentence":"Mutations in ps RVS161 pe and RVS167, the two yeast ps amphiphysin pe homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d444.s0.p5","sentence":"Mutations in ps RVS161 pe and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized ps actin pe cytoskeleton, and a defect in the internalization step of endocytosis.","label":1}
{"pair_id":"BioInfer.d635.s0.p0","sentence":"Their abilities to store lipids and express ps desmin pe intermediate filaments, alpha-smooth muscle actin, and ps smooth muscle myosin heavy chain pe in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.","label":1}
{"pair_id":"BioInfer.d635.s0.p1","sentence":"Their abilities to store lipids and express desmin intermediate filaments, ps alpha-smooth muscle actin pe, and ps smooth muscle myosin heavy chain pe in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.","label":1}
{"pair_id":"BioInfer.d635.s0.p2","sentence":"Their abilities to store lipids and express ps desmin pe intermediate filaments, ps alpha-smooth muscle actin pe, and smooth muscle myosin heavy chain in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.","label":1}
{"pair_id":"BioInfer.d1.s2.p0","sentence":"Interaction of plant ps profilin pe with mammalian ps actin pe.","label":1}
{"pair_id":"BioInfer.d189.s0.p0","sentence":"Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing ps actin pe and ps talin pe.","label":1}
{"pair_id":"BioInfer.d538.s0.p0","sentence":"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the ps actin pe crystal structure previously defined as the ps fimbrin pe (Sac6p)-binding site.","label":1}
{"pair_id":"BioInfer.d538.s0.p1","sentence":"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the ps actin pe crystal structure previously defined as the fimbrin (ps Sac6p pe)-binding site.","label":1}
{"pair_id":"BioInfer.d538.s0.p2","sentence":"Significantly, those ps actin pe mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the ps actin pe crystal structure previously defined as the fimbrin (Sac6p)-binding site.","label":0}
{"pair_id":"BioInfer.d538.s0.p3","sentence":"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the ps fimbrin pe (ps Sac6p pe)-binding site.","label":0}
{"pair_id":"BioInfer.d538.s0.p4","sentence":"Significantly, those ps actin pe mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the ps fimbrin pe (Sac6p)-binding site.","label":0}
{"pair_id":"BioInfer.d538.s0.p5","sentence":"Significantly, those ps actin pe mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (ps Sac6p pe)-binding site.","label":0}
{"pair_id":"BioInfer.d697.s0.p0","sentence":"These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of ps RAD51 pe and ps RAD52 pe.","label":0}
{"pair_id":"AIMed.d143.s1208.p0","sentence":"We have examined early signals triggered by ps IL-11 pe or ps IL-6 pe in a multifactor-dependent human erythroleukemic cell line, TF-1.","label":0}
{"pair_id":"BioInfer.d450.s1.p0","sentence":"The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and ps profilin II pe to inhibit ps actin pe nucleation and restores the extent of filament formation.","label":1}
{"pair_id":"BioInfer.d450.s1.p1","sentence":"The resulting profilin II-peptide complex overcomes the combined capacity of ps thymosin beta4 pe and profilin II to inhibit ps actin pe nucleation and restores the extent of filament formation.","label":1}
{"pair_id":"BioInfer.d450.s1.p2","sentence":"The resulting ps profilin II pe-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit ps actin pe nucleation and restores the extent of filament formation.","label":1}
{"pair_id":"BioInfer.d450.s1.p3","sentence":"The resulting profilin II-peptide complex overcomes the combined capacity of ps thymosin beta4 pe and ps profilin II pe to inhibit actin nucleation and restores the extent of filament formation.","label":0}
{"pair_id":"BioInfer.d450.s1.p4","sentence":"The resulting ps profilin II pe-peptide complex overcomes the combined capacity of thymosin beta4 and ps profilin II pe to inhibit actin nucleation and restores the extent of filament formation.","label":0}
{"pair_id":"BioInfer.d450.s1.p5","sentence":"The resulting ps profilin II pe-peptide complex overcomes the combined capacity of ps thymosin beta4 pe and profilin II to inhibit actin nucleation and restores the extent of filament formation.","label":0}
{"pair_id":"AIMed.d10.s81.p0","sentence":"ps BMP-4 pe and ps BMP-6 pe involvement in the osteogenic properties of the HeLa cell line.","label":0}
{"pair_id":"BioInfer.d327.s0.p0","sentence":"In contrast, the ps RAD51 pe and ps RAD52 pe genes are essential for homothallic mating-type switching.","label":0}
{"pair_id":"BioInfer.d28.s1.p0","sentence":"Cells were fixed and stained with antibodies to ps vascular endothelial pe (VE) ps vascular pe, alpha-catenin, ps beta-catenin pe, or plakoglobin.","label":0}
{"pair_id":"BioInfer.d28.s1.p1","sentence":"Cells were fixed and stained with antibodies to ps vascular endothelial pe (VE) ps vascular pe, ps alpha-catenin pe, beta-catenin, or plakoglobin.","label":0}
{"pair_id":"BioInfer.d28.s1.p2","sentence":"Cells were fixed and stained with antibodies to ps vascular endothelial pe (VE) ps vascular pe, alpha-catenin, beta-catenin, or ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d28.s1.p3","sentence":"Cells were fixed and stained with antibodies to vascular endothelial (VE) vascular, ps alpha-catenin pe, ps beta-catenin pe, or plakoglobin.","label":0}
{"pair_id":"BioInfer.d28.s1.p4","sentence":"Cells were fixed and stained with antibodies to vascular endothelial (VE) vascular, alpha-catenin, ps beta-catenin pe, or ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d28.s1.p5","sentence":"Cells were fixed and stained with antibodies to vascular endothelial (VE) vascular, ps alpha-catenin pe, beta-catenin, or ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d430.s0.p0","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human ps plakoglobin pe and the Drosophila gene product ps armadillo pe.","label":0}
{"pair_id":"BioInfer.d430.s0.p1","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to ps vinculin pe and the beta-catenin is homologous to human ps plakoglobin pe and the Drosophila gene product armadillo.","label":0}
{"pair_id":"BioInfer.d430.s0.p2","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the ps beta-catenin pe is homologous to human ps plakoglobin pe and the Drosophila gene product armadillo.","label":1}
{"pair_id":"BioInfer.d430.s0.p3","sentence":"Molecular cloning and primary structure analysis demonstrated that ps alpha-catenin pe is homologous to vinculin and the beta-catenin is homologous to human ps plakoglobin pe and the Drosophila gene product armadillo.","label":0}
{"pair_id":"BioInfer.d430.s0.p4","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to ps vinculin pe and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product ps armadillo pe.","label":0}
{"pair_id":"BioInfer.d430.s0.p5","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the ps beta-catenin pe is homologous to human plakoglobin and the Drosophila gene product ps armadillo pe.","label":1}
{"pair_id":"BioInfer.d430.s0.p6","sentence":"Molecular cloning and primary structure analysis demonstrated that ps alpha-catenin pe is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product ps armadillo pe.","label":0}
{"pair_id":"BioInfer.d430.s0.p7","sentence":"Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to ps vinculin pe and the ps beta-catenin pe is homologous to human plakoglobin and the Drosophila gene product armadillo.","label":0}
{"pair_id":"BioInfer.d430.s0.p8","sentence":"Molecular cloning and primary structure analysis demonstrated that ps alpha-catenin pe is homologous to ps vinculin pe and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.","label":1}
{"pair_id":"BioInfer.d430.s0.p9","sentence":"Molecular cloning and primary structure analysis demonstrated that ps alpha-catenin pe is homologous to vinculin and the ps beta-catenin pe is homologous to human plakoglobin and the Drosophila gene product armadillo.","label":0}
{"pair_id":"AIMed.d199.s1706.p0","sentence":"In addition to this unique pathway, ps FGFR3 pe also links to ps GRB2 pe.","label":0}
{"pair_id":"AIMed.d153.s1298.p0","sentence":"Characterization of ps adenosine deaminase pe binding to human ps CD26 pe on T cells and its biologic role in immune response.","label":1}
{"pair_id":"BioInfer.d62.s2.p0","sentence":"The herpes simplex virus type 1 (HSV-1) ps helicase-primase pe, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded ps UL5 pe, UL8, and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p1","sentence":"The herpes simplex virus type 1 (HSV-1) ps helicase-primase pe, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, ps UL8 pe, and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p2","sentence":"The herpes simplex virus type 1 (HSV-1) ps helicase-primase pe, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and ps UL52 pe proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p3","sentence":"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded ps UL5 pe, ps UL8 pe, and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p4","sentence":"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded ps UL5 pe, UL8, and ps UL52 pe proteins.","label":1}
{"pair_id":"BioInfer.d62.s2.p5","sentence":"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, ps UL8 pe, and ps UL52 pe proteins.","label":1}
{"pair_id":"AIMed.d121.s1025.p0","sentence":"The acidic amino terminus of the ps p53 pe protein has been shown to contain this trans-activation activity as well as the domains for ps mdm-2 pe and adenovirus 5 E1B 55-kD protein binding.","label":1}
{"pair_id":"AIMed.d121.s1025.p1","sentence":"The acidic amino terminus of the ps p53 pe protein has been shown to contain this trans-activation activity as well as the domains for mdm-2 and adenovirus 5 ps E1B pe 55-kD protein binding.","label":0}
{"pair_id":"AIMed.d121.s1025.p2","sentence":"The acidic amino terminus of the ps p53 pe protein has been shown to contain this trans-activation activity as well as the domains for mdm-2 and adenovirus ps 5 E1B pe 55-kD protein binding.","label":1}
{"pair_id":"AIMed.d121.s1025.p3","sentence":"The acidic amino terminus of the p53 protein has been shown to contain this trans-activation activity as well as the domains for ps mdm-2 pe and adenovirus 5 ps E1B pe 55-kD protein binding.","label":0}
{"pair_id":"AIMed.d121.s1025.p4","sentence":"The acidic amino terminus of the p53 protein has been shown to contain this trans-activation activity as well as the domains for ps mdm-2 pe and adenovirus ps 5 E1B pe 55-kD protein binding.","label":0}
{"pair_id":"AIMed.d121.s1025.p5","sentence":"The acidic amino terminus of the p53 protein has been shown to contain this trans-activation activity as well as the domains for mdm-2 and adenovirus ps 5 E1B peps E1B pe 55-kD protein binding.","label":0}
{"pair_id":"BioInfer.d150.s1.p0","sentence":"Reduced expression of ps alpha-catenin pe, beta-catenin, and ps gamma-catenin pe is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.","label":0}
{"pair_id":"BioInfer.d150.s1.p1","sentence":"Reduced expression of alpha-catenin, ps beta-catenin pe, and ps gamma-catenin pe is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.","label":0}
{"pair_id":"BioInfer.d150.s1.p2","sentence":"Reduced expression of ps alpha-catenin pe, ps beta-catenin pe, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.","label":0}
{"pair_id":"BioInfer.d77.s1.p0","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of ps profilin pe for barbed ends of actin filaments and its high affinity for ps actin pe monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p1","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds ps Arp2 pe\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for ps actin pe monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p2","sentence":"By analytical ultracentrifugation, rhodamine-labeled ps profilin pe binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for ps actin pe monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p3","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of ps actin pe filaments and its high affinity for ps actin pe monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p4","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds ps Arp pe2\/ps A pe complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for ps actin pe monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p5","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds ps Arp2 pe\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of ps profilin pe for barbed ends of actin filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p6","sentence":"By analytical ultracentrifugation, rhodamine-labeled ps profilin pe binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of ps profilin pe for barbed ends of actin filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p7","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of ps profilin pe for barbed ends of ps actin pe filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p8","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds ps Arp pe2\/ps A pe complex with a Kd of 7 microM, an affinity intermediate between the low affinity of ps profilin pe for barbed ends of actin filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p9","sentence":"By analytical ultracentrifugation, rhodamine-labeled ps profilin pe binds ps Arp2 pe\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p10","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds ps Arp2 pe\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of ps actin pe filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p11","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds ps Arp2 peps Arp pe2\/ps A pe complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p12","sentence":"By analytical ultracentrifugation, rhodamine-labeled ps profilin pe binds Arp2\/A complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of ps actin pe filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"BioInfer.d77.s1.p13","sentence":"By analytical ultracentrifugation, rhodamine-labeled ps profilin pe binds ps Arp pe2\/ps A pe complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.","label":1}
{"pair_id":"BioInfer.d77.s1.p14","sentence":"By analytical ultracentrifugation, rhodamine-labeled profilin binds ps Arp pe2\/ps A pe complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of ps actin pe filaments and its high affinity for actin monomers.","label":0}
{"pair_id":"AIMed.d196.s1669.p0","sentence":"We observed that the protein ps HOX11 pe interacted with protein ps serine-threonine phosphatase 2A pe catalytic subunit (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p1","sentence":"We observed that the protein ps HOX11 pe interacted with protein ps serine-threonine phosphatase 2A catalytic subunit pe (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p2","sentence":"We observed that the protein ps HOX11 pe interacted with protein serine-threonine phosphatase 2A catalytic subunit (ps PP2AC pe), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p3","sentence":"We observed that the protein ps HOX11 pe interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as ps protein phosphatase 1 pe (PP1C) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p4","sentence":"We observed that the protein ps HOX11 pe interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as protein phosphatase 1 (ps PP1C pe) in mammalian cells.","label":1}
{"pair_id":"AIMed.d196.s1669.p5","sentence":"We observed that the protein HOX11 interacted with protein ps serine-threonine phosphatase 2A peps serine-threonine phosphatase 2A catalytic subunit pe (PP2AC), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p6","sentence":"We observed that the protein HOX11 interacted with protein ps serine-threonine phosphatase 2A pe catalytic subunit (ps PP2AC pe), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p7","sentence":"We observed that the protein HOX11 interacted with protein ps serine-threonine phosphatase 2A pe catalytic subunit (PP2AC), as well as ps protein phosphatase 1 pe (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p8","sentence":"We observed that the protein HOX11 interacted with protein ps serine-threonine phosphatase 2A pe catalytic subunit (PP2AC), as well as protein phosphatase 1 (ps PP1C pe) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p9","sentence":"We observed that the protein HOX11 interacted with protein ps serine-threonine phosphatase 2A catalytic subunit pe (ps PP2AC pe), as well as protein phosphatase 1 (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p10","sentence":"We observed that the protein HOX11 interacted with protein ps serine-threonine phosphatase 2A catalytic subunit pe (PP2AC), as well as ps protein phosphatase 1 pe (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p11","sentence":"We observed that the protein HOX11 interacted with protein ps serine-threonine phosphatase 2A catalytic subunit pe (PP2AC), as well as protein phosphatase 1 (ps PP1C pe) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p12","sentence":"We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (ps PP2AC pe), as well as ps protein phosphatase 1 pe (PP1C) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p13","sentence":"We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (ps PP2AC pe), as well as protein phosphatase 1 (ps PP1C pe) in mammalian cells.","label":0}
{"pair_id":"AIMed.d196.s1669.p14","sentence":"We observed that the protein HOX11 interacted with protein serine-threonine phosphatase 2A catalytic subunit (PP2AC), as well as ps protein phosphatase 1 pe (ps PP1C pe) in mammalian cells.","label":0}
{"pair_id":"AIMed.d220.s1910.p0","sentence":"The extracellular domain of the human ps neurotrophin TRKB receptor peps TRKB pe receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF).","label":0}
{"pair_id":"AIMed.d220.s1910.p1","sentence":"The extracellular domain of the human neurotrophin ps TRKB pe receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for ps brain-derived neurotrophic factor pe (BDNF).","label":0}
{"pair_id":"AIMed.d220.s1910.p2","sentence":"The extracellular domain of the human neurotrophin ps TRKB pe receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (ps BDNF pe).","label":0}
{"pair_id":"AIMed.d220.s1910.p3","sentence":"The extracellular domain of the human ps neurotrophin TRKB receptor pe expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for ps brain-derived neurotrophic factor pe (BDNF).","label":1}
{"pair_id":"AIMed.d220.s1910.p4","sentence":"The extracellular domain of the human ps neurotrophin TRKB receptor pe expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (ps BDNF pe).","label":1}
{"pair_id":"AIMed.d220.s1910.p5","sentence":"The extracellular domain of the human neurotrophin TRKB receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for ps brain-derived neurotrophic factor pe (ps BDNF pe).","label":0}
{"pair_id":"AIMed.d53.s469.p0","sentence":"Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human ps interleukin-6 pe (ps IL-6 pe) that activates human gp130.","label":0}
{"pair_id":"AIMed.d53.s469.p1","sentence":"Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human ps interleukin-6 pe (IL-6) that activates human ps gp130 pe.","label":1}
{"pair_id":"AIMed.d53.s469.p2","sentence":"Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 (ps IL-6 pe) that activates human ps gp130 pe.","label":1}
{"pair_id":"BioInfer.d505.s0.p0","sentence":"Pyrenyliodoacetamide labeling of cysteine 374 of ps muscle actin pe reduces the affinity for ps profilin pe 10-fold.","label":1}
{"pair_id":"AIMed.d33.s282.p0","sentence":"Analysis of sedimentation equilibria and also of the fluorescence enhancement of suramin when bound to protein provided evidence for two suramin-binding sites on each ps C9 pe and three on each ps C8 pe in the oligomers.","label":0}
{"pair_id":"AIMed.d9.s73.p0","sentence":"We investigated the mechanism of calcium-stimulated ps gastrin pe release from gastrinoma cells in vitro with a particular focus on the ps calcium-sensing receptor pe (CaR).","label":0}
{"pair_id":"AIMed.d9.s73.p1","sentence":"We investigated the mechanism of calcium-stimulated ps gastrin pe release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor (ps CaR pe).","label":0}
{"pair_id":"AIMed.d9.s73.p2","sentence":"We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the ps calcium-sensing receptor pe (ps CaR pe).","label":0}
{"pair_id":"AIMed.d94.s797.p0","sentence":"We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor, designated ps CC chemokine receptor 3 pe (ps CC CKR3 pe).","label":0}
{"pair_id":"AIMed.d214.s1862.p0","sentence":"ps Vav pe\/ps c-Cbl pe interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which c-Cbl is hyperphosphorylated on tyrosine residues.","label":1}
{"pair_id":"AIMed.d214.s1862.p1","sentence":"ps Vav pe\/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor ps CTLA-4 pe, in which c-Cbl is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p2","sentence":"ps Vav pe\/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which ps c-Cbl pe is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p3","sentence":"Vav\/ps c-Cbl pe interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor ps CTLA-4 pe, in which c-Cbl is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p4","sentence":"Vav\/ps c-Cbl pe interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which ps c-Cbl pe is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"AIMed.d214.s1862.p5","sentence":"Vav\/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor ps CTLA-4 pe, in which ps c-Cbl pe is hyperphosphorylated on tyrosine residues.","label":0}
{"pair_id":"BioInfer.d230.s0.p0","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, ps actin binding protein pe (ABP), talin, and ps myosin heavy chain pe.","label":0}
{"pair_id":"BioInfer.d230.s0.p1","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, ps actin binding protein pe (ABP), ps talin pe, and myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d230.s0.p2","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, ps actin binding protein pe (ps ABP pe), talin, and myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d230.s0.p3","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), ps talin pe, and ps myosin heavy chain pe.","label":0}
{"pair_id":"BioInfer.d230.s0.p4","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ps ABP pe), talin, and ps myosin heavy chain pe.","label":0}
{"pair_id":"BioInfer.d230.s0.p5","sentence":"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ps ABP pe), ps talin pe, and myosin heavy chain.","label":0}
{"pair_id":"AIMed.d108.s909.p0","sentence":"ps p53 pe transcriptional activation mediated by coactivators ps TAFII40 pe and TAFII60.","label":1}
{"pair_id":"AIMed.d108.s909.p1","sentence":"ps p53 pe transcriptional activation mediated by coactivators TAFII40 and ps TAFII60 pe.","label":1}
{"pair_id":"AIMed.d108.s909.p2","sentence":"p53 transcriptional activation mediated by coactivators ps TAFII40 pe and ps TAFII60 pe.","label":0}
{"pair_id":"AIMed.d91.s780.p0","sentence":"We find that ps hTAFII32 pe is the human homologue of Drosophila ps TAFII40 pe.","label":0}
{"pair_id":"BioInfer.d618.s0.p0","sentence":"The herpes simplex virus ps helicase-primase pe complex, a heterotrimer of the ps UL5 pe, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p1","sentence":"The herpes simplex virus helicase-primase complex, a heterotrimer of the ps UL5 pe, ps UL8 pe, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p2","sentence":"The herpes simplex virus helicase-primase complex, a heterotrimer of the ps UL5 pe, UL8, and ps UL52 pe proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p3","sentence":"The herpes simplex virus ps helicase-primase pe complex, a heterotrimer of the UL5, ps UL8 pe, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p4","sentence":"The herpes simplex virus ps helicase-primase pe complex, a heterotrimer of the UL5, UL8, and ps UL52 pe proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d618.s0.p5","sentence":"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, ps UL8 pe, and ps UL52 pe proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).","label":1}
{"pair_id":"BioInfer.d457.s0.p0","sentence":"Of the five major structural proteins of MV, only ps nucleocapsid pe (ps N pe) ps nucleoc pe and phosphoprotein (P protein) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p1","sentence":"Of the five major structural proteins of MV, only ps nucleocapsid pe (N) ps nucleoc pe and ps phosphoprotein pe (P protein) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p2","sentence":"Of the five major structural proteins of MV, only ps nucleocapsid pe (N) ps nucleoc pe and phosphoprotein (ps P protein pe) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p3","sentence":"Of the five major structural proteins of MV, only nucleocapsid (ps N pe) nucleoc and ps phosphoprotein pe (P protein) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p4","sentence":"Of the five major structural proteins of MV, only nucleocapsid (ps N pe) nucleoc and phosphoprotein (ps P protein pe) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"BioInfer.d457.s0.p5","sentence":"Of the five major structural proteins of MV, only nucleocapsid (N) nucleoc and ps phosphoprotein pe (ps P protein pe) were consistently detected in diseased brain areas.","label":0}
{"pair_id":"AIMed.d174.s1468.p0","sentence":"Monomeric (ps IL-6M pe) and dimeric (ps IL-6D pe) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p1","sentence":"Monomeric (ps IL-6M pe) and dimeric (IL-6D) forms of Escherichia coli-derived human ps IL-6 pe and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p2","sentence":"Monomeric (ps IL-6M pe) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 pe receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p3","sentence":"Monomeric (ps IL-6M pe) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 receptor pe (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p4","sentence":"Monomeric (ps IL-6M pe) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (ps sIL-6R pe) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p5","sentence":"Monomeric (ps IL-6M pe) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and ps gp130 pe have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p6","sentence":"Monomeric (ps IL-6M pe) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of ps IL-6 pe dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p7","sentence":"Monomeric (IL-6M) and dimeric (ps IL-6D pe) forms of Escherichia coli-derived human ps IL-6 pe and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p8","sentence":"Monomeric (IL-6M) and dimeric (ps IL-6D pe) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 pe receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p9","sentence":"Monomeric (IL-6M) and dimeric (ps IL-6D pe) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 receptor pe (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p10","sentence":"Monomeric (IL-6M) and dimeric (ps IL-6D pe) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (ps sIL-6R pe) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p11","sentence":"Monomeric (IL-6M) and dimeric (ps IL-6D pe) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and ps gp130 pe have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p12","sentence":"Monomeric (IL-6M) and dimeric (ps IL-6D pe) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of ps IL-6 pe dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p13","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human ps IL-6 pe and the extracellular (\"soluble\") portions of the ps IL-6 pe receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p14","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human ps IL-6 pe and the extracellular (\"soluble\") portions of the ps IL-6 receptor pe (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p15","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human ps IL-6 pe and the extracellular (\"soluble\") portions of the IL-6 receptor (ps sIL-6R pe) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p16","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human ps IL-6 pe and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and ps gp130 pe have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p17","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human ps IL-6 pe and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of ps IL-6 pe dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p18","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 peps IL-6 receptor pe (sIL-6R) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p19","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 pe receptor (ps sIL-6R pe) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":1}
{"pair_id":"AIMed.d174.s1468.p20","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 pe receptor (sIL-6R) and ps gp130 pe have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p21","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 pe receptor (sIL-6R) and gp130 have been purified in order to investigate the effect of ps IL-6 pe dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p22","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 receptor pe (ps sIL-6R pe) and gp130 have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p23","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 receptor pe (sIL-6R) and ps gp130 pe have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p24","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the ps IL-6 receptor pe (sIL-6R) and gp130 have been purified in order to investigate the effect of ps IL-6 pe dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p25","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (ps sIL-6R pe) and ps gp130 pe have been purified in order to investigate the effect of IL-6 dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p26","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (ps sIL-6R pe) and gp130 have been purified in order to investigate the effect of ps IL-6 pe dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1468.p27","sentence":"Monomeric (IL-6M) and dimeric (IL-6D) forms of Escherichia coli-derived human IL-6 and the extracellular (\"soluble\") portions of the IL-6 receptor (sIL-6R) and ps gp130 pe have been purified in order to investigate the effect of ps IL-6 pe dimerization on binding to the receptor complex.","label":0}
{"pair_id":"AIMed.d49.s431.p0","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p1","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor pe receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p2","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor receptor pe (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p3","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (ps KGFR pe), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p4","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas ps FGF-2 pe binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p5","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to ps FGFR1 pe, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p6","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, ps FGFR2 pe, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p7","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and ps FGFR4 pe but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p8","sentence":"ps FGF-7 pe recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s431.p9","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or ps keratinocyte growth factor pe receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p10","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or ps keratinocyte growth factor receptor pe (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p11","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or keratinocyte growth factor receptor (ps KGFR pe), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p12","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or keratinocyte growth factor receptor (KGFR), whereas ps FGF-2 pe binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p13","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to ps FGFR1 pe, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p14","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, ps FGFR2 pe, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p15","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and ps FGFR4 pe but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p16","sentence":"FGF-7 recognizes one FGFR isoform known as the ps FGFR2 IIIb pe isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s431.p17","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor peps keratinocyte growth factor receptor pe (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p18","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor pe receptor (ps KGFR pe), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p19","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor pe receptor (KGFR), whereas ps FGF-2 pe binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p20","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor pe receptor (KGFR), whereas FGF-2 binds well to ps FGFR1 pe, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p21","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor pe receptor (KGFR), whereas FGF-2 binds well to FGFR1, ps FGFR2 pe, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p22","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor pe receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and ps FGFR4 pe but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p23","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor pe receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s431.p24","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor receptor pe (ps KGFR pe), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p25","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor receptor pe (KGFR), whereas ps FGF-2 pe binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p26","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor receptor pe (KGFR), whereas FGF-2 binds well to ps FGFR1 pe, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p27","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor receptor pe (KGFR), whereas FGF-2 binds well to FGFR1, ps FGFR2 pe, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p28","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor receptor pe (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and ps FGFR4 pe but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p29","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or ps keratinocyte growth factor receptor pe (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s431.p30","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (ps KGFR pe), whereas ps FGF-2 pe binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p31","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (ps KGFR pe), whereas FGF-2 binds well to ps FGFR1 pe, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p32","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (ps KGFR pe), whereas FGF-2 binds well to FGFR1, ps FGFR2 pe, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p33","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (ps KGFR pe), whereas FGF-2 binds well to FGFR1, FGFR2, and ps FGFR4 pe but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p34","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (ps KGFR pe), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s431.p35","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas ps FGF-2 pe binds well to ps FGFR1 pe, FGFR2, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p36","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas ps FGF-2 pe binds well to FGFR1, ps FGFR2 pe, and FGFR4 but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p37","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas ps FGF-2 pe binds well to FGFR1, FGFR2, and ps FGFR4 pe but interacts poorly with KGFR.","label":1}
{"pair_id":"AIMed.d49.s431.p38","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas ps FGF-2 pe binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with ps KGFR pe.","label":1}
{"pair_id":"AIMed.d49.s431.p39","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to ps FGFR1 pe, ps FGFR2 pe, and FGFR4 but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p40","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to ps FGFR1 pe, FGFR2, and ps FGFR4 pe but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p41","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to ps FGFR1 pe, FGFR2, and FGFR4 but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s431.p42","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, ps FGFR2 pe, and ps FGFR4 pe but interacts poorly with KGFR.","label":0}
{"pair_id":"AIMed.d49.s431.p43","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, ps FGFR2 pe, and FGFR4 but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s431.p44","sentence":"FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and ps FGFR4 pe but interacts poorly with ps KGFR pe.","label":0}
{"pair_id":"BioInfer.d245.s1.p0","sentence":"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or ps plakoglobin pe, which both can assemble ps alpha-catenin pe into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p1","sentence":"It is well established that the cytoplasmic domain of E-cadherin binds either ps beta-catenin pe or ps plakoglobin pe, which both can assemble alpha-catenin into the complex.","label":0}
{"pair_id":"BioInfer.d245.s1.p2","sentence":"It is well established that the cytoplasmic domain of ps E-cadherin pe binds either beta-catenin or ps plakoglobin pe, which both can assemble alpha-catenin into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p3","sentence":"It is well established that the cytoplasmic domain of E-cadherin binds either ps beta-catenin pe or plakoglobin, which both can assemble ps alpha-catenin pe into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p4","sentence":"It is well established that the cytoplasmic domain of ps E-cadherin pe binds either beta-catenin or plakoglobin, which both can assemble ps alpha-catenin pe into the complex.","label":1}
{"pair_id":"BioInfer.d245.s1.p5","sentence":"It is well established that the cytoplasmic domain of ps E-cadherin pe binds either ps beta-catenin pe or plakoglobin, which both can assemble alpha-catenin into the complex.","label":1}
{"pair_id":"BioInfer.d735.s0.p0","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or ps RIP pe suggesting that it is distinct from ps FADD pe's functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p1","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, ps Fas pe, TRADD or ps RIP pe suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p2","sentence":"This activity is independent of ps FADD-DN pe's ability to bind to three known interacting proteins, Fas, TRADD or ps RIP pe suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p3","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or ps RIP pe suggesting that it is distinct from FADD's functions at activated ps death receptors pe.","label":0}
{"pair_id":"BioInfer.d735.s0.p4","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, ps TRADD pe or ps RIP pe suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p5","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, ps Fas pe, TRADD or RIP suggesting that it is distinct from ps FADD pe's functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p6","sentence":"This activity is independent of ps FADD-DN pe's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from ps FADD pe's functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p7","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from ps FADD pe's functions at activated ps death receptors pe.","label":1}
{"pair_id":"BioInfer.d735.s0.p8","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, ps TRADD pe or RIP suggesting that it is distinct from ps FADD pe's functions at activated death receptors.","label":0}
{"pair_id":"BioInfer.d735.s0.p9","sentence":"This activity is independent of ps FADD-DN pe's ability to bind to three known interacting proteins, ps Fas pe, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p10","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, ps Fas pe, TRADD or RIP suggesting that it is distinct from FADD's functions at activated ps death receptors pe.","label":0}
{"pair_id":"BioInfer.d735.s0.p11","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, ps Fas pe, ps TRADD pe or RIP suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p12","sentence":"This activity is independent of ps FADD-DN pe's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated ps death receptors pe.","label":0}
{"pair_id":"BioInfer.d735.s0.p13","sentence":"This activity is independent of ps FADD-DN pe's ability to bind to three known interacting proteins, Fas, ps TRADD pe or RIP suggesting that it is distinct from FADD's functions at activated death receptors.","label":1}
{"pair_id":"BioInfer.d735.s0.p14","sentence":"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, ps TRADD pe or RIP suggesting that it is distinct from FADD's functions at activated ps death receptors pe.","label":0}
{"pair_id":"AIMed.d151.s1287.p0","sentence":"Immunoprecipitation studies confirm that the four ps PTF pe subunits originally found to copurify during conventional chromatography indeed form a tightly associated complex; they further show that the ps PTF pe so defined, including the gamma and delta subunits specifically, is essential for transcription of both class II and class III snRNA genes.","label":0}
{"pair_id":"BioInfer.d248.s0.p0","sentence":"Here we report that ps p120 pe associates with a complex containing ps E-cadherin pe, alpha-catenin, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p1","sentence":"Here we report that p120 associates with a complex containing ps E-cadherin pe, ps alpha-catenin pe, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p2","sentence":"Here we report that p120 associates with a complex containing ps E-cadherin pe, alpha-catenin, beta-catenin, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d248.s0.p3","sentence":"Here we report that p120 associates with a complex containing ps E-cadherin pe, alpha-catenin, ps beta-catenin pe, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p4","sentence":"Here we report that ps p120 pe associates with a complex containing E-cadherin, ps alpha-catenin pe, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p5","sentence":"Here we report that ps p120 pe associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d248.s0.p6","sentence":"Here we report that ps p120 pe associates with a complex containing E-cadherin, alpha-catenin, ps beta-catenin pe, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p7","sentence":"Here we report that p120 associates with a complex containing E-cadherin, ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d248.s0.p8","sentence":"Here we report that p120 associates with a complex containing E-cadherin, ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d248.s0.p9","sentence":"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe.","label":1}
{"pair_id":"AIMed.d167.s1405.p0","sentence":"A truncated version of the integral membrane glycoprotein ps Glut 1 pe (ps GT155 pe) was synthesized in a rabbit reticulocyte translation system in the presence of canine pancreatic microsomes.","label":0}
{"pair_id":"AIMed.d199.s1707.p0","sentence":"ps Sos pe complex via the adapter protein ps Shc pe.","label":0}
{"pair_id":"AIMed.d204.s1764.p0","sentence":"This demonstrates that the C-terminal hemopexin domain of ps MMP-1 pe, in contrast to the corresponding regions of ps gelatinase A pe and gelatinase B, does not interact with TIMP-1.","label":0}
{"pair_id":"AIMed.d204.s1764.p1","sentence":"This demonstrates that the C-terminal hemopexin domain of ps MMP-1 pe, in contrast to the corresponding regions of gelatinase A and ps gelatinase B pe, does not interact with TIMP-1.","label":0}
{"pair_id":"AIMed.d204.s1764.p2","sentence":"This demonstrates that the C-terminal hemopexin domain of ps MMP-1 pe, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with ps TIMP-1 pe.","label":0}
{"pair_id":"AIMed.d204.s1764.p3","sentence":"This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of ps gelatinase A pe and ps gelatinase B pe, does not interact with TIMP-1.","label":0}
{"pair_id":"AIMed.d204.s1764.p4","sentence":"This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of ps gelatinase A pe and gelatinase B, does not interact with ps TIMP-1 pe.","label":1}
{"pair_id":"AIMed.d204.s1764.p5","sentence":"This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and ps gelatinase B pe, does not interact with ps TIMP-1 pe.","label":1}
{"pair_id":"AIMed.d110.s928.p0","sentence":"The ps TAFII55 pe-interacting region of ps Sp1 pe was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila TAFII110.","label":1}
{"pair_id":"AIMed.d110.s928.p1","sentence":"The ps TAFII55 pe-interacting region of Sp1 was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila ps TAFII110 pe.","label":0}
{"pair_id":"AIMed.d110.s928.p2","sentence":"The TAFII55-interacting region of ps Sp1 pe was localized to its DNA-binding domain, which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila ps TAFII110 pe.","label":1}
{"pair_id":"AIMed.d56.s495.p0","sentence":"A cDNA clone, designated ps TRAP pe (ps TNF-related activation protein pe) was isolated from a collection of T cell activation genes.","label":0}
{"pair_id":"AIMed.d77.s657.p0","sentence":"We have identified an 18-amino acid residue stretch in the ps K5 pe head that is conserved only among type II epidermal keratins and that appears to play some role in ps DPI pe tail binding.","label":1}
{"pair_id":"AIMed.d199.s1697.p0","sentence":"Expression of ps FGFR3 peps FGFR3 IIIc pe in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p1","sentence":"Expression of ps FGFR3 pe IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including ps FGF-1 pe, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p2","sentence":"Expression of ps FGFR3 pe IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while ps FGFR3 pe IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p3","sentence":"Expression of ps FGFR3 pe IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while ps FGFR3 IIIb pe-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p4","sentence":"Expression of ps FGFR3 pe IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to ps FGF-1 pe.","label":0}
{"pair_id":"AIMed.d199.s1697.p5","sentence":"Expression of ps FGFR3 IIIc pe in stably transfected L6 cells conferred growth responses to several members of the FGF family including ps FGF-1 pe, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p6","sentence":"Expression of ps FGFR3 IIIc pe in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while ps FGFR3 pe IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p7","sentence":"Expression of ps FGFR3 IIIc pe in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while ps FGFR3 IIIb pe-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p8","sentence":"Expression of ps FGFR3 IIIc pe in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to ps FGF-1 pe.","label":0}
{"pair_id":"AIMed.d199.s1697.p9","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including ps FGF-1 pe, -2, -4, and -6, while ps FGFR3 pe IIIb-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p10","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including ps FGF-1 pe, -2, -4, and -6, while ps FGFR3 IIIb pe-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p11","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including ps FGF-1 pe, -2, -4, and -6, while FGFR3 IIIb-expressing cells responded only to ps FGF-1 pe.","label":0}
{"pair_id":"AIMed.d199.s1697.p12","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while ps FGFR3 peps FGFR3 IIIb pe-expressing cells responded only to FGF-1.","label":0}
{"pair_id":"AIMed.d199.s1697.p13","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while ps FGFR3 pe IIIb-expressing cells responded only to ps FGF-1 pe.","label":0}
{"pair_id":"AIMed.d199.s1697.p14","sentence":"Expression of FGFR3 IIIc in stably transfected L6 cells conferred growth responses to several members of the FGF family including FGF-1, -2, -4, and -6, while ps FGFR3 IIIb pe-expressing cells responded only to ps FGF-1 pe.","label":0}
{"pair_id":"AIMed.d137.s1164.p0","sentence":"Co-transfection of human ps TBP pe and ps Oct2 pe expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter.","label":0}
{"pair_id":"AIMed.d42.s367.p0","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p1","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p2","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p3","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p4","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p5","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p6","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p7","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p8","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p9","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p10","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (ps BR-II pe\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p11","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p12","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p13","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p14","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p15","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p16","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p17","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p18","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p19","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p20","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/ps BR-Ia pe and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p21","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p22","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p23","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p24","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p25","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p26","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p27","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p28","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p29","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and ps BR-II pe\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p30","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p31","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p32","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p33","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p34","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p35","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p36","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p37","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/ps BR-Ib pe) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p38","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p39","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p40","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p41","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p42","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p43","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p44","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (ps BR-II pe\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p45","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p46","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p47","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p48","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p49","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p50","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/ps BR-II pe, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p51","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p52","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p53","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p54","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p55","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, ps BR-Ia pe\/ BR-Ia, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p56","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p57","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p58","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p59","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ ps BR-Ia pe, BR-Ib\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p60","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ ps BR-Ib pe, and also BR-Ia\/ BR-Ib) oligomers in the absence of ligand.","label":1}
{"pair_id":"AIMed.d42.s367.p61","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p62","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, ps BR-Ib pe\/ BR-Ib, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p63","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also ps BR-Ia pe\/ BR-Ib) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p64","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ ps BR-Ib pe, and also BR-Ia\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":0}
{"pair_id":"AIMed.d42.s367.p65","sentence":"Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors, we provide evidence in live cells for preexisting heteromeric (BR-II\/BR-Ia and BR-II\/BR-Ib) and homomeric (BR-II\/BR-II, BR-Ia\/ BR-Ia, BR-Ib\/ BR-Ib, and also ps BR-Ia pe\/ ps BR-Ib pe) oligomers in the absence of ligand.","label":1}
{"pair_id":"BioInfer.d39.s0.p0","sentence":"Although binding patterns of different sera were not identical, almost all sera caused ps IgG pe binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and ps actin-binding protein pe).","label":1}
{"pair_id":"BioInfer.d39.s0.p1","sentence":"Although binding patterns of different sera were not identical, almost all sera caused ps IgG pe binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as ps talin pe and actin-binding protein).","label":1}
{"pair_id":"BioInfer.d39.s0.p2","sentence":"Although binding patterns of different sera were not identical, almost all sera caused ps IgG pe binding to platelet components of 87-90 kD, 140 kD (identified as ps vinculin pe) and 220-240 kD (tentatively identified as talin and actin-binding protein).","label":1}
{"pair_id":"BioInfer.d39.s0.p3","sentence":"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as ps talin pe and ps actin-binding protein pe).","label":0}
{"pair_id":"BioInfer.d39.s0.p4","sentence":"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as ps vinculin pe) and 220-240 kD (tentatively identified as talin and ps actin-binding protein pe).","label":0}
{"pair_id":"BioInfer.d39.s0.p5","sentence":"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as ps vinculin pe) and 220-240 kD (tentatively identified as ps talin pe and actin-binding protein).","label":0}
{"pair_id":"AIMed.d63.s544.p0","sentence":"Coassociation of ps CD26 pe (ps dipeptidyl peptidase IV pe) with CD45 on the surface of human T lymphocytes.","label":0}
{"pair_id":"AIMed.d63.s544.p1","sentence":"Coassociation of ps CD26 pe (dipeptidyl peptidase IV) with ps CD45 pe on the surface of human T lymphocytes.","label":1}
{"pair_id":"AIMed.d63.s544.p2","sentence":"Coassociation of CD26 (ps dipeptidyl peptidase IV pe) with ps CD45 pe on the surface of human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d165.s0.p0","sentence":"Deletion and overexpression studies demonstrate that ps SIR2 pe, but not SIR1, ps SIR3 pe or SIR4, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p1","sentence":"Deletion and overexpression studies demonstrate that ps SIR2 pe, but not ps SIR1 pe, SIR3 or SIR4, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p2","sentence":"Deletion and overexpression studies demonstrate that ps SIR2 pe, but not SIR1, SIR3 or ps SIR4 pe, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p3","sentence":"Deletion and overexpression studies demonstrate that SIR2, but not ps SIR1 pe, ps SIR3 pe or SIR4, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p4","sentence":"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, ps SIR3 pe or ps SIR4 pe, is required for this rDNA position effect.","label":0}
{"pair_id":"BioInfer.d165.s0.p5","sentence":"Deletion and overexpression studies demonstrate that SIR2, but not ps SIR1 pe, SIR3 or ps SIR4 pe, is required for this rDNA position effect.","label":0}
{"pair_id":"AIMed.d195.s1662.p0","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p1","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p2","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p3","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p4","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p5","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p6","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p7","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p8","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of ps actin pe, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p9","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p10","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p11","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p12","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p13","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p14","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p15","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p16","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. ps alpha-Actinin-2 pe, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p17","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p18","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p19","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p20","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p21","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p22","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p23","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/ps dystrophin pe family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p24","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p25","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p26","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p27","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p28","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p29","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of ps actin pe-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p30","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p31","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p32","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p33","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p34","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule ps PSD-95 pe. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p35","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p36","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p37","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":1}
{"pair_id":"AIMed.d195.s1662.p38","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. ps alpha-Actinin-2 pe binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":1}
{"pair_id":"AIMed.d195.s1662.p39","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p40","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p41","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both ps NR1 pe and NR2B subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p42","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and PSD-95 from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p43","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and ps NR2B pe subunits of the NMDA receptor, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"AIMed.d195.s1662.p44","sentence":"The activity of NMDA (N-methyl-D-aspartate) receptors is mechanosensitive and dependent on the integrity of actin, suggesting a functionally important interaction between NMDA receptors and the postsynaptic cytoskeleton. alpha-Actinin-2, a member of the spectrin\/dystrophin family of actin-binding proteins, is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PSD-95. alpha-Actinin-2 binds by its central rod domain to the cytoplasmic tail of both NR1 and NR2B subunits of the ps NMDA receptor pe, and can be immunoprecipitated with NMDA receptors and ps PSD-95 pe from rat brain.","label":0}
{"pair_id":"BioInfer.d706.s0.p0","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the ps cell adhesion proteins pe alpha-catenin, ps beta-catenin pe\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p1","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins ps alpha-catenin pe, ps beta-catenin pe\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p2","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, ps beta-catenin pe\/Armadillo, and ps classical cadherin pe, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p3","sentence":"The sequences of the predicted HMP-1, ps HMP-2 pe, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, ps beta-catenin pe\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p4","sentence":"The sequences of the predicted HMP-1, HMP-2, and ps HMR-1 pe proteins are related to the cell adhesion proteins alpha-catenin, ps beta-catenin pe\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p5","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, ps beta-catenin pe\/ps Armadillo pe, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p6","sentence":"The sequences of the predicted ps HMP-1 pe, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, ps beta-catenin pe\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p7","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the ps cell adhesion proteins pe ps alpha-catenin pe, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p8","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the ps cell adhesion proteins pe alpha-catenin, beta-catenin\/Armadillo, and ps classical cadherin pe, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p9","sentence":"The sequences of the predicted HMP-1, ps HMP-2 pe, and HMR-1 proteins are related to the ps cell adhesion proteins pe alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p10","sentence":"The sequences of the predicted HMP-1, HMP-2, and ps HMR-1 pe proteins are related to the ps cell adhesion proteins pe alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p11","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the ps cell adhesion proteins pe alpha-catenin, beta-catenin\/ps Armadillo pe, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p12","sentence":"The sequences of the predicted ps HMP-1 pe, HMP-2, and HMR-1 proteins are related to the ps cell adhesion proteins pe alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p13","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins ps alpha-catenin pe, beta-catenin\/Armadillo, and ps classical cadherin pe, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p14","sentence":"The sequences of the predicted HMP-1, ps HMP-2 pe, and HMR-1 proteins are related to the cell adhesion proteins ps alpha-catenin pe, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p15","sentence":"The sequences of the predicted HMP-1, HMP-2, and ps HMR-1 pe proteins are related to the cell adhesion proteins ps alpha-catenin pe, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p16","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins ps alpha-catenin pe, beta-catenin\/ps Armadillo pe, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p17","sentence":"The sequences of the predicted ps HMP-1 pe, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins ps alpha-catenin pe, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p18","sentence":"The sequences of the predicted HMP-1, ps HMP-2 pe, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and ps classical cadherin pe, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p19","sentence":"The sequences of the predicted HMP-1, HMP-2, and ps HMR-1 pe proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and ps classical cadherin pe, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p20","sentence":"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/ps Armadillo pe, and ps classical cadherin pe, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p21","sentence":"The sequences of the predicted ps HMP-1 pe, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and ps classical cadherin pe, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p22","sentence":"The sequences of the predicted HMP-1, ps HMP-2 pe, and ps HMR-1 pe proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p23","sentence":"The sequences of the predicted HMP-1, ps HMP-2 pe, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/ps Armadillo pe, and classical cadherin, respectively.","label":1}
{"pair_id":"BioInfer.d706.s0.p24","sentence":"The sequences of the predicted ps HMP-1 pe, ps HMP-2 pe, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p25","sentence":"The sequences of the predicted HMP-1, HMP-2, and ps HMR-1 pe proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/ps Armadillo pe, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p26","sentence":"The sequences of the predicted ps HMP-1 pe, HMP-2, and ps HMR-1 pe proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/Armadillo, and classical cadherin, respectively.","label":0}
{"pair_id":"BioInfer.d706.s0.p27","sentence":"The sequences of the predicted ps HMP-1 pe, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin\/ps Armadillo pe, and classical cadherin, respectively.","label":0}
{"pair_id":"AIMed.d47.s412.p0","sentence":"Bone morphogenetic proteins (BMPs) belong to the large ps transforming growth factor-beta pe (ps TGF-beta pe) superfamily of multifunctional cytokines.","label":0}
{"pair_id":"AIMed.d118.s1002.p0","sentence":"Furthermore, ps p21 pe blocks the ability of ps PCNA pe to activate DNA polymerase delta, the principal replicative DNA polymerase.","label":1}
{"pair_id":"AIMed.d118.s1002.p1","sentence":"Furthermore, ps p21 pe blocks the ability of PCNA to activate ps DNA polymerase delta pe, the principal replicative DNA polymerase.","label":0}
{"pair_id":"AIMed.d118.s1002.p2","sentence":"Furthermore, p21 blocks the ability of ps PCNA pe to activate ps DNA polymerase delta pe, the principal replicative DNA polymerase.","label":1}
{"pair_id":"AIMed.d215.s1868.p0","sentence":"Specific cleavage of ps laminin-5 pe (ps Ln-5 pe) by matrix metalloprotease-2 (MMP2) was shown to induce migration of breast epithelial cells.","label":0}
{"pair_id":"AIMed.d215.s1868.p1","sentence":"Specific cleavage of ps laminin-5 pe (Ln-5) by ps matrix metalloprotease-2 pe (MMP2) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p2","sentence":"Specific cleavage of ps laminin-5 pe (Ln-5) by matrix metalloprotease-2 (ps MMP2 pe) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p3","sentence":"Specific cleavage of laminin-5 (ps Ln-5 pe) by ps matrix metalloprotease-2 pe (MMP2) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p4","sentence":"Specific cleavage of laminin-5 (ps Ln-5 pe) by matrix metalloprotease-2 (ps MMP2 pe) was shown to induce migration of breast epithelial cells.","label":1}
{"pair_id":"AIMed.d215.s1868.p5","sentence":"Specific cleavage of laminin-5 (Ln-5) by ps matrix metalloprotease-2 pe (ps MMP2 pe) was shown to induce migration of breast epithelial cells.","label":0}
{"pair_id":"BioInfer.d562.s0.p0","sentence":"The ps actin pe bundle formation induced by overexpression of ps cofilin pe is accompanied with an increase in cell motility of Dictyostelium cells. 4.","label":1}
{"pair_id":"BioInfer.d115.s0.p0","sentence":"ps SNF11 pe, a new component of the yeast ps SNF pe-SWI complex that interacts with a conserved region of SNF2.","label":1}
{"pair_id":"BioInfer.d115.s0.p1","sentence":"ps SNF11 pe, a new component of the yeast SNF-SWI complex that interacts with a conserved region of ps SNF2 pe.","label":1}
{"pair_id":"BioInfer.d115.s0.p2","sentence":"ps SNF11 pe, a new component of the yeast SNF-ps SWI pe complex that interacts with a conserved region of SNF2.","label":1}
{"pair_id":"BioInfer.d115.s0.p3","sentence":"SNF11, a new component of the yeast ps SNF pe-SWI complex that interacts with a conserved region of ps SNF2 pe.","label":0}
{"pair_id":"BioInfer.d115.s0.p4","sentence":"SNF11, a new component of the yeast ps SNF pe-ps SWI pe complex that interacts with a conserved region of SNF2.","label":1}
{"pair_id":"BioInfer.d115.s0.p5","sentence":"SNF11, a new component of the yeast SNF-ps SWI pe complex that interacts with a conserved region of ps SNF2 pe.","label":0}
{"pair_id":"AIMed.d213.s1851.p0","sentence":"We show that the physical interaction between ps YY1 pe and ps p300 pe, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.","label":1}
{"pair_id":"AIMed.d213.s1851.p1","sentence":"We show that the physical interaction between ps YY1 pe and p300, a coactivator for ps CREB pe, is not sufficient for repression of CREB-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1851.p2","sentence":"We show that the physical interaction between ps YY1 pe and p300, a coactivator for CREB, is not sufficient for repression of ps CREB pe-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1851.p3","sentence":"We show that the physical interaction between YY1 and ps p300 pe, a coactivator for ps CREB pe, is not sufficient for repression of CREB-mediated transcription.","label":1}
{"pair_id":"AIMed.d213.s1851.p4","sentence":"We show that the physical interaction between YY1 and ps p300 pe, a coactivator for CREB, is not sufficient for repression of ps CREB pe-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1851.p5","sentence":"We show that the physical interaction between YY1 and p300, a coactivator for ps CREB pe, is not sufficient for repression of ps CREB pe-mediated transcription.","label":0}
{"pair_id":"BioInfer.d187.s0.p0","sentence":"Effects of single amino acid substitutions in the ps actin pe-binding site on the biological activity of bovine ps profilin I pe.","label":1}
{"pair_id":"BioInfer.d453.s0.p0","sentence":"No evidence for the surface expression of the phosphoprotein (ps P pe), matrix (M) or nucleocapsid (ps N pe) matrix p was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p1","sentence":"No evidence for the surface expression of the phosphoprotein (ps P pe), matrix (M) or ps nucleocapsid pe (N) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p2","sentence":"No evidence for the surface expression of the ps phosphoprotein pe (ps P pe), matrix (M) or nucleocapsid (N) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p3","sentence":"No evidence for the surface expression of the phosphoprotein (ps P pe), matrix (ps M pe) or nucleocapsid (N) matrix p was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p4","sentence":"No evidence for the surface expression of the phosphoprotein (ps P pe), ps matrix pe (M) or nucleocapsid (N) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p5","sentence":"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or ps nucleocapsid pe (ps N pe) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p6","sentence":"No evidence for the surface expression of the ps phosphoprotein pe (P), matrix (M) or nucleocapsid (ps N pe) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p7","sentence":"No evidence for the surface expression of the phosphoprotein (P), matrix (ps M pe) or nucleocapsid (ps N pe) matrix p was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p8","sentence":"No evidence for the surface expression of the phosphoprotein (P), ps matrix pe (M) or nucleocapsid (ps N pe) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p9","sentence":"No evidence for the surface expression of the ps phosphoprotein pe (P), matrix (M) or ps nucleocapsid pe (N) ps matrix p peps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p10","sentence":"No evidence for the surface expression of the phosphoprotein (P), matrix (ps M pe) or ps nucleocapsid pe (N) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p11","sentence":"No evidence for the surface expression of the phosphoprotein (P), ps matrix pe (M) or ps nucleocapsid pe (N) ps matrix p peps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p12","sentence":"No evidence for the surface expression of the ps phosphoprotein pe (P), matrix (ps M pe) or nucleocapsid (N) ps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p13","sentence":"No evidence for the surface expression of the ps phosphoprotein pe (P), ps matrix pe (M) or nucleocapsid (N) ps matrix p peps matrix p pe was found.","label":0}
{"pair_id":"BioInfer.d453.s0.p14","sentence":"No evidence for the surface expression of the phosphoprotein (P), ps matrix pe (ps M pe) or nucleocapsid (N) ps matrix p pe was found.","label":0}
{"pair_id":"AIMed.d202.s1744.p0","sentence":"The crystal structure shows that ps s-IL1R pe consists of three immunoglobulin-like domains which wrap around ps IL-1beta pe in a manner distinct from the structures of previously described cytokine-receptor complexes.","label":1}
{"pair_id":"AIMed.d87.s735.p0","sentence":"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of ps IR pe and ps IGF-1R pe and p85 or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).","label":0}
{"pair_id":"AIMed.d87.s735.p1","sentence":"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of ps IR pe and IGF-1R and ps p85 pe or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).","label":0}
{"pair_id":"AIMed.d87.s735.p2","sentence":"The experiments were performed with the cytoplasmic beta domain (wild type or mutated) of IR and ps IGF-1R pe and ps p85 pe or its subdomains (N + C-SH2, N-SH2, C-SH2, SH3 + N-SH2).","label":0}
{"pair_id":"BioInfer.d727.s0.p0","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, ps TRADD pe, FADD and ps RAIDD pe - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p1","sentence":"The tumor necrosis factor receptor 1 (ps TNFR1 pe) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, ps TRADD pe, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p2","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the ps Fas pe receptor recruit complexes formed by the interactions between RIP kinase, ps TRADD pe, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p3","sentence":"The ps tumor necrosis factor receptor 1 pe (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, ps TRADD pe, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p4","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between ps RIP kinase pe, ps TRADD pe, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p5","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, ps TRADD pe, ps FADD pe and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p6","sentence":"The tumor necrosis factor receptor 1 (ps TNFR1 pe) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and ps RAIDD pe - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p7","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the ps Fas pe receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and ps RAIDD pe - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p8","sentence":"The ps tumor necrosis factor receptor 1 pe (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and ps RAIDD pe - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p9","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between ps RIP kinase pe, TRADD, FADD and ps RAIDD pe - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p10","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, ps FADD pe and ps RAIDD pe - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p11","sentence":"The tumor necrosis factor receptor 1 (ps TNFR1 pe) and the ps Fas pe receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":0}
{"pair_id":"BioInfer.d727.s0.p12","sentence":"The ps tumor necrosis factor receptor 1 pe (ps TNFR1 pe) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":0}
{"pair_id":"BioInfer.d727.s0.p13","sentence":"The tumor necrosis factor receptor 1 (ps TNFR1 pe) and the Fas receptor recruit complexes formed by the interactions between ps RIP kinase pe, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p14","sentence":"The tumor necrosis factor receptor 1 (ps TNFR1 pe) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, ps FADD pe and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p15","sentence":"The ps tumor necrosis factor receptor 1 pe (TNFR1) and the ps Fas pe receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":0}
{"pair_id":"BioInfer.d727.s0.p16","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the ps Fas pe receptor recruit complexes formed by the interactions between ps RIP kinase pe, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p17","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the ps Fas pe receptor recruit complexes formed by the interactions between RIP kinase, TRADD, ps FADD pe and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p18","sentence":"The ps tumor necrosis factor receptor 1 pe (TNFR1) and the Fas receptor recruit complexes formed by the interactions between ps RIP kinase pe, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p19","sentence":"The ps tumor necrosis factor receptor 1 pe (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, ps FADD pe and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"BioInfer.d727.s0.p20","sentence":"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between ps RIP kinase pe, TRADD, ps FADD pe and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].","label":1}
{"pair_id":"AIMed.d26.s217.p0","sentence":"Flow cytometric analysis demonstrated high levels of ps perforin pe and ps granulysin pe expression by CD3(-) CD16(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p1","sentence":"Flow cytometric analysis demonstrated high levels of ps perforin pe and granulysin expression by ps CD3 pe(-) CD16(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p2","sentence":"Flow cytometric analysis demonstrated high levels of ps perforin pe and granulysin expression by CD3(-) ps CD16 pe(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p3","sentence":"Flow cytometric analysis demonstrated high levels of perforin and ps granulysin pe expression by ps CD3 pe(-) CD16(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p4","sentence":"Flow cytometric analysis demonstrated high levels of perforin and ps granulysin pe expression by CD3(-) ps CD16 pe(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d26.s217.p5","sentence":"Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by ps CD3 pe(-) ps CD16 pe(+) cells in healthy controls.","label":0}
{"pair_id":"AIMed.d116.s980.p0","sentence":"Here we report that (1) there is an accumulation of ps Rb pe protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of ps Rb pe to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p1","sentence":"Here we report that (1) there is an accumulation of ps Rb pe protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional ps Rb pe pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p2","sentence":"Here we report that (1) there is an accumulation of ps Rb pe protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) ps Rb pe specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p3","sentence":"Here we report that (1) there is an accumulation of ps Rb pe protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor ps UBF pe (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p4","sentence":"Here we report that (1) there is an accumulation of ps Rb pe protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (ps upstream binding factor pe) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p5","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of ps Rb pe to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional ps Rb pe pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p6","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of ps Rb pe to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) ps Rb pe specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p7","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of ps Rb pe to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor ps UBF pe (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p8","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of ps Rb pe to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (ps upstream binding factor pe) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p9","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional ps Rb pe pocket; and (4) ps Rb pe specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p10","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional ps Rb pe pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor ps UBF pe (upstream binding factor) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p11","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional ps Rb pe pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (ps upstream binding factor pe) in vitro.","label":0}
{"pair_id":"AIMed.d116.s980.p12","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) ps Rb pe specifically inhibits the activity of the RNA polymerase I transcription factor ps UBF pe (upstream binding factor) in vitro.","label":1}
{"pair_id":"AIMed.d116.s980.p13","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) ps Rb pe specifically inhibits the activity of the RNA polymerase I transcription factor UBF (ps upstream binding factor pe) in vitro.","label":1}
{"pair_id":"AIMed.d116.s980.p14","sentence":"Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor ps UBF pe (ps upstream binding factor pe) in vitro.","label":0}
{"pair_id":"BioInfer.d394.s0.p0","sentence":"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from ps profilin pe or promoting the cross-linking of ps actin pe or its anchorage to the plasma membrane.","label":0}
{"pair_id":"BioInfer.d394.s0.p1","sentence":"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G ps actin pe from ps profilin pe or promoting the cross-linking of actin or its anchorage to the plasma membrane.","label":1}
{"pair_id":"BioInfer.d394.s0.p2","sentence":"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G ps actin pe from profilin or promoting the cross-linking of ps actin pe or its anchorage to the plasma membrane.","label":0}
{"pair_id":"AIMed.d198.s1690.p0","sentence":"Site-specific mutants were expressed in Escherichia coli as soluble ps EBP pe and analyzed for ps EPO pe binding in several different assay formats.","label":0}
{"pair_id":"BioInfer.d135.s1.p0","sentence":"For example, ps profilin pe with a deletion of the eight C-terminal residues has many of the physical properties of a molten globule, yet remarkably still binds to ps actin pe.","label":1}
{"pair_id":"BioInfer.d185.s0.p0","sentence":"Effects of macrophage profilin on ps actin pe in the presence and absence of ps acumentin pe and gelsolin.","label":0}
{"pair_id":"BioInfer.d185.s0.p1","sentence":"Effects of macrophage profilin on ps actin pe in the presence and absence of acumentin and ps gelsolin pe.","label":0}
{"pair_id":"BioInfer.d185.s0.p2","sentence":"Effects of ps macrophage profilin pe on ps actin pe in the presence and absence of acumentin and gelsolin.","label":1}
{"pair_id":"BioInfer.d185.s0.p3","sentence":"Effects of macrophage profilin on actin in the presence and absence of ps acumentin pe and ps gelsolin pe.","label":0}
{"pair_id":"BioInfer.d185.s0.p4","sentence":"Effects of ps macrophage profilin pe on actin in the presence and absence of ps acumentin pe and gelsolin.","label":0}
{"pair_id":"BioInfer.d185.s0.p5","sentence":"Effects of ps macrophage profilin pe on actin in the presence and absence of acumentin and ps gelsolin pe.","label":0}
{"pair_id":"BioInfer.d599.s0.p0","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p1","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p2","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p3","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p4","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and ps H2B pe show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p5","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p6","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p7","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p8","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p9","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p10","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p11","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p12","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p13","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p14","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; ps histones pe ps H2A pe and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p15","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; ps histones pe H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p16","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p17","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p18","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p19","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p20","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p21","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p22","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p23","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p24","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p25","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p26","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p27","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p28","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p29","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p30","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian ps histone pe H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p31","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p32","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p33","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p34","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p35","sentence":"The core ps histones pe from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p36","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p37","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p38","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p39","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p40","sentence":"The core ps histones pe from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p41","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p42","sentence":"The core ps histones pe from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p43","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p44","sentence":"The core ps histones pe from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p45","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p46","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p47","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p48","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p49","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p50","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p51","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p52","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p53","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p54","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p55","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p56","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p57","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of ps histone pe ps H3 pe; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p58","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p59","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p60","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p61","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p62","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p63","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p64","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p65","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p66","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p67","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p68","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p69","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; ps histone pe H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p70","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p71","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p72","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p73","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p74","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p75","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p76","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p77","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p78","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p79","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p80","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and ps H2B pe show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p81","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p82","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p83","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p84","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p85","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p86","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p87","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p88","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p89","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p90","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); ps histone pe H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p91","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p92","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p93","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p94","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p95","sentence":"The core histones from Physarum, ps histones pe ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p96","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p97","sentence":"The core histones from Physarum, ps histones pe H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":1}
{"pair_id":"BioInfer.d599.s0.p98","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p99","sentence":"The core histones from Physarum, ps histones pe H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p100","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p101","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p102","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p103","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p104","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p105","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p106","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p107","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone ps H4 pe shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p108","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p109","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p110","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p111","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p112","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p113","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p114","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and ps H4 pe, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p115","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p116","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p117","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p118","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p119","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p120","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone ps H3 pe has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p121","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p122","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p123","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p124","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p125","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone ps H4 pe (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p126","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p127","sentence":"The core histones from Physarum, histones ps H2A pe, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p128","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p129","sentence":"The core histones from Physarum, histones ps H2A pe, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p130","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p131","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p132","sentence":"The core histones from Physarum, histones H2A, H2B, ps H3 pe, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p133","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p134","sentence":"The core histones from Physarum, histones H2A, ps H2B pe, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones H2A and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d599.s0.p135","sentence":"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone ps H3 pe; histones ps H2A pe and H2B show less heterogeneity.","label":0}
{"pair_id":"BioInfer.d567.s0.p0","sentence":"The ps CREB pe binding domain of ps CBP pe is sufficient to contact to c-Jun in vitro.","label":1}
{"pair_id":"BioInfer.d567.s0.p1","sentence":"The CREB binding domain of ps CBP pe is sufficient to contact to ps c-Jun pe in vitro.","label":1}
{"pair_id":"BioInfer.d567.s0.p2","sentence":"The ps CREB pe binding domain of CBP is sufficient to contact to ps c-Jun pe in vitro.","label":0}
{"pair_id":"AIMed.d46.s404.p0","sentence":"ps BMP-2 pe is a homodimeric cysteine knot protein that, as a member of the ps transforming growth factor-beta pe (TGF-beta) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.","label":0}
{"pair_id":"AIMed.d46.s404.p1","sentence":"ps BMP-2 pe is a homodimeric cysteine knot protein that, as a member of the transforming growth factor-beta (ps TGF-beta pe) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.","label":0}
{"pair_id":"AIMed.d46.s404.p2","sentence":"BMP-2 is a homodimeric cysteine knot protein that, as a member of the ps transforming growth factor-beta pe (ps TGF-beta pe) superfamily, signals by oligomerizing type I and type II receptor serine-kinases in the cell membrane.","label":0}
{"pair_id":"AIMed.d138.s1169.p0","sentence":"ps SF3a pe interacts with ps U2 snRNP pe in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":1}
{"pair_id":"AIMed.d138.s1169.p1","sentence":"ps SF3a pe interacts with U2 snRNP in the presence of ps SF3b pe to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p2","sentence":"ps SF3a pe interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S ps U2 snRNP pe, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p3","sentence":"ps SF3a pe interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for ps SF3a pe and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p4","sentence":"ps SF3a pe interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and ps SF3b pe in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p5","sentence":"ps SF3a pe interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of ps U2 snRNP pe into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p6","sentence":"SF3a interacts with ps U2 snRNP pe in the presence of ps SF3b pe to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p7","sentence":"SF3a interacts with ps U2 snRNP pe in the presence of SF3b to generate a structure similar to 17S ps U2 snRNP pe, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p8","sentence":"SF3a interacts with ps U2 snRNP pe in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for ps SF3a pe and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p9","sentence":"SF3a interacts with ps U2 snRNP pe in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and ps SF3b pe in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p10","sentence":"SF3a interacts with ps U2 snRNP pe in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of ps U2 snRNP pe into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p11","sentence":"SF3a interacts with U2 snRNP in the presence of ps SF3b pe to generate a structure similar to 17S ps U2 snRNP pe, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p12","sentence":"SF3a interacts with U2 snRNP in the presence of ps SF3b pe to generate a structure similar to 17S U2 snRNP, which suggests a function for ps SF3a pe and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p13","sentence":"SF3a interacts with U2 snRNP in the presence of ps SF3b pe to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and ps SF3b pe in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p14","sentence":"SF3a interacts with U2 snRNP in the presence of ps SF3b pe to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of ps U2 snRNP pe into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p15","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S ps U2 snRNP pe, which suggests a function for ps SF3a pe and SF3b in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p16","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S ps U2 snRNP pe, which suggests a function for SF3a and ps SF3b pe in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p17","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S ps U2 snRNP pe, which suggests a function for SF3a and SF3b in the incorporation of ps U2 snRNP pe into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p18","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for ps SF3a pe and ps SF3b pe in the incorporation of U2 snRNP into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p19","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for ps SF3a pe and SF3b in the incorporation of ps U2 snRNP pe into the spliceosome.","label":0}
{"pair_id":"AIMed.d138.s1169.p20","sentence":"SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and ps SF3b pe in the incorporation of ps U2 snRNP pe into the spliceosome.","label":0}
{"pair_id":"BioInfer.d336.s1.p0","sentence":"ps Myosin heavy chain A pe staining was dimmer and its colocalization with filamentous ps actin pe bundles in growth cones was less striking than that of myosin heavy chain B.","label":1}
{"pair_id":"BioInfer.d336.s1.p1","sentence":"Myosin heavy chain A staining was dimmer and its colocalization with filamentous ps actin pe bundles in growth cones was less striking than that of ps myosin heavy chain B pe.","label":1}
{"pair_id":"BioInfer.d336.s1.p2","sentence":"ps Myosin heavy chain A pe staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of ps myosin heavy chain B pe.","label":0}
{"pair_id":"BioInfer.d187.s1.p0","sentence":"However, these mutants displayed a lower affinity for ps actin pe than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for ps actin pe.","label":0}
{"pair_id":"BioInfer.d187.s1.p1","sentence":"However, these mutants displayed a lower affinity for ps actin pe than wild-type ps profilin pe, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.","label":1}
{"pair_id":"BioInfer.d187.s1.p2","sentence":"However, these mutants displayed a lower affinity for ps actin pe than wild-type profilin, suggesting that additional putative bonds created this way cannot increase ps profilin pe's affinity for actin.","label":0}
{"pair_id":"BioInfer.d187.s1.p3","sentence":"However, these mutants displayed a lower affinity for actin than wild-type ps profilin pe, suggesting that additional putative bonds created this way cannot increase profilin's affinity for ps actin pe.","label":0}
{"pair_id":"BioInfer.d187.s1.p4","sentence":"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase ps profilin pe's affinity for ps actin pe.","label":1}
{"pair_id":"BioInfer.d187.s1.p5","sentence":"However, these mutants displayed a lower affinity for actin than wild-type ps profilin pe, suggesting that additional putative bonds created this way cannot increase ps profilin pe's affinity for actin.","label":0}
{"pair_id":"BioInfer.d774.s0.p0","sentence":"Transfection of ps alpha-catenin pe-deficient colon carcinoma cells recruited E-cadherin and ps beta-catenin pe to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p1","sentence":"Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and ps beta-catenin pe to cell-cell contacts and functional ps cadherin pe-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p2","sentence":"Transfection of alpha-catenin-deficient colon carcinoma cells recruited ps E-cadherin pe and ps beta-catenin pe to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p3","sentence":"Transfection of ps alpha-catenin pe-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional ps cadherin pe-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p4","sentence":"Transfection of ps alpha-catenin pe-deficient colon carcinoma cells recruited ps E-cadherin pe and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d774.s0.p5","sentence":"Transfection of alpha-catenin-deficient colon carcinoma cells recruited ps E-cadherin pe and beta-catenin to cell-cell contacts and functional ps cadherin pe-mediated cell-cell adhesion was restored in this way.","label":0}
{"pair_id":"BioInfer.d27.s0.p0","sentence":"ADP-ribosylation of ps actin pe at Arg 177 by Clostridium perfringens ps iota toxin pe increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.","label":1}
{"pair_id":"BioInfer.d27.s0.p1","sentence":"ADP-ribosylation of ps actin pe at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the ps profilin pe-induced stimulation of nucleotide exchange.","label":0}
{"pair_id":"BioInfer.d27.s0.p2","sentence":"ADP-ribosylation of actin at Arg 177 by Clostridium perfringens ps iota toxin pe increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the ps profilin pe-induced stimulation of nucleotide exchange.","label":1}
{"pair_id":"AIMed.d139.s1173.p0","sentence":"The self-association site appears to be formed by interactions between helices 1 and 2 of ps beta spectrin pe repeat 17 of one dimer with helix 3 of ps alpha spectrin pe repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.","label":1}
{"pair_id":"BioInfer.d392.s0.p0","sentence":"Isolation of human ps delta-catenin pe and its binding specificity with ps presenilin 1 pe.","label":1}
{"pair_id":"BioInfer.d250.s0.p0","sentence":"Here we show that ps cdc12p pe is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe ps fus1 pe, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p1","sentence":"Here we show that ps cdc12p pe is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other ps actin pe-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p2","sentence":"Here we show that ps cdc12p pe is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae ps BNI1 pe, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p3","sentence":"Here we show that ps cdc12p pe is a member of a family of proteins including Drosophila ps diaphanous pe, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p4","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe ps fus1 pe, which are involved in cytokinesis or other ps actin pe-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p5","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae ps BNI1 pe, and S. pombe ps fus1 pe, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p6","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila ps diaphanous pe, Saccharomyces cerevisiae BNI1, and S. pombe ps fus1 pe, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p7","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae ps BNI1 pe, and S. pombe fus1, which are involved in cytokinesis or other ps actin pe-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p8","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila ps diaphanous pe, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other ps actin pe-mediated processes.","label":0}
{"pair_id":"BioInfer.d250.s0.p9","sentence":"Here we show that cdc12p is a member of a family of proteins including Drosophila ps diaphanous pe, Saccharomyces cerevisiae ps BNI1 pe, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.","label":0}
{"pair_id":"BioInfer.d14.s0.p0","sentence":"Actin-binding proteins such as profilin and ps gelsolin pe bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric ps actin pe.","label":0}
{"pair_id":"BioInfer.d14.s0.p1","sentence":"ps Actin-binding proteins pe such as profilin and ps gelsolin pe bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.","label":1}
{"pair_id":"BioInfer.d14.s0.p2","sentence":"Actin-binding proteins such as ps profilin pe and ps gelsolin pe bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.","label":0}
{"pair_id":"BioInfer.d14.s0.p3","sentence":"ps Actin-binding proteins pe such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric ps actin pe.","label":1}
{"pair_id":"BioInfer.d14.s0.p4","sentence":"Actin-binding proteins such as ps profilin pe and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric ps actin pe.","label":0}
{"pair_id":"BioInfer.d14.s0.p5","sentence":"ps Actin-binding proteins pe such as ps profilin pe and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.","label":1}
{"pair_id":"BioInfer.d648.s0.p0","sentence":"The multifunctional protein ps profilin pe is one of the most abundant proteins in the cytoplasm and is thought to regulate ps actin pe assembly and the phosphoinositide signaling pathway.","label":1}
{"pair_id":"BioInfer.d752.s0.p0","sentence":"Thus, ps beta-catenin pe, E-cadherin, and ps alpha-catenin pe have similar prognostic values.","label":0}
{"pair_id":"BioInfer.d752.s0.p1","sentence":"Thus, beta-catenin, ps E-cadherin pe, and ps alpha-catenin pe have similar prognostic values.","label":0}
{"pair_id":"BioInfer.d752.s0.p2","sentence":"Thus, ps beta-catenin pe, ps E-cadherin pe, and alpha-catenin have similar prognostic values.","label":0}
{"pair_id":"BioInfer.d401.s0.p0","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p1","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p2","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p3","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p4","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p5","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p6","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p7","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p8","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p9","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p10","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the ps srs2 pe rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p11","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p12","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p13","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p14","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p15","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p16","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p17","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p18","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p19","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p20","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 ps rad54 pe and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p21","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p22","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p23","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p24","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p25","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p26","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p27","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p28","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p29","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, ps RAD24 pe, and MEC3, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p30","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p31","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p32","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p33","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p34","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p35","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p36","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p37","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions ps RAD9 pe, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p38","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p39","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p40","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p41","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p42","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p43","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p44","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and ps MEC3 pe, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p45","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p46","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p47","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p48","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p49","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p50","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, ps RAD17 pe, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p51","sentence":"Lethality of the ps srs2Delta pe ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p52","sentence":"Lethality of the ps srs2Delta pe rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p53","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p54","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p55","sentence":"Lethality of the ps srs2Delta pe rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p56","sentence":"Lethality of the srs2Delta ps rad54Delta pe and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p57","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p58","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p59","sentence":"Lethality of the srs2Delta ps rad54Delta pe and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p60","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p61","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p62","sentence":"Lethality of the srs2Delta rad54Delta and ps srs2Delta pe rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p63","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and ps srs2 pe rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p64","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta ps rdh54Delta pe double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"BioInfer.d401.s0.p65","sentence":"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and ps srs2 pe ps rdh54 pe mutant combinations lead to an intermediate that is sensed by these checkpoint functions.","label":0}
{"pair_id":"AIMed.d216.s1872.p0","sentence":"The ps Ras pe-ps RasGAP pe complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.","label":1}
{"pair_id":"AIMed.d216.s1872.p1","sentence":"The ps Ras pe-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic ps Ras pe mutants.","label":0}
{"pair_id":"AIMed.d216.s1872.p2","sentence":"The Ras-ps RasGAP pe complex: structural basis for GTPase activation and its loss in oncogenic ps Ras pe mutants.","label":0}
{"pair_id":"AIMed.d148.s1258.p0","sentence":"In synchronized human osteosarcoma cells, ps cyclin D1 pe is induced in early G1 and becomes associated with ps p9Ckshs1 pe, a Cdk-binding subunit.","label":1}
{"pair_id":"BioInfer.d702.s0.p0","sentence":"These phenotypes are similar to those of the mutant of ps PFY1 pe, which encodes profilin, an ps actin-binding protein pe.","label":0}
{"pair_id":"BioInfer.d702.s0.p1","sentence":"These phenotypes are similar to those of the mutant of ps PFY1 pe, which encodes ps profilin pe, an actin-binding protein.","label":1}
{"pair_id":"BioInfer.d702.s0.p2","sentence":"These phenotypes are similar to those of the mutant of PFY1, which encodes ps profilin pe, an ps actin-binding protein pe.","label":1}
{"pair_id":"AIMed.d50.s441.p0","sentence":"Type I interferons bind to two cell surface receptors, ps ifnar1 pe and ps ifnar2 pe, as the first step in the activation of several signal transduction pathways that elicit an anti-viral state and an anti-proliferative response.","label":0}
{"pair_id":"AIMed.d109.s921.p0","sentence":"Comparison of the two crystallographically distinct protein-DNA complexes show that the coiled-coil is flexibly joined to the basic regions and that the ps Fos pe-ps Jun pe heterodimer does not recognize the asymmetric 5'-TGAGTCA-3' recognition element in a unique orientation.","label":1}
{"pair_id":"AIMed.d105.s885.p0","sentence":"The helical cytokine ps interleukin (IL) 6 pe and its specific binding subunit ps IL-6R alpha pe form a 1:1 complex which, by promoting homodimerization of the signalling subunit gp130 on the surface of target cells, triggers intracellular responses.","label":1}
{"pair_id":"AIMed.d105.s885.p1","sentence":"The helical cytokine ps interleukin (IL) 6 pe and its specific binding subunit IL-6R alpha form a 1:1 complex which, by promoting homodimerization of the signalling subunit ps gp130 pe on the surface of target cells, triggers intracellular responses.","label":0}
{"pair_id":"AIMed.d105.s885.p2","sentence":"The helical cytokine interleukin (IL) 6 and its specific binding subunit ps IL-6R alpha pe form a 1:1 complex which, by promoting homodimerization of the signalling subunit ps gp130 pe on the surface of target cells, triggers intracellular responses.","label":0}
{"pair_id":"BioInfer.d246.s1.p0","sentence":"Our results define a mechanism for the regulation of ps cofilin pe and hence of ps actin pe dynamics in vivo.","label":0}
{"pair_id":"BioInfer.d267.s0.p0","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (ps XPD pe), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of ps XPC pe.","label":0}
{"pair_id":"BioInfer.d267.s0.p1","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the ps HHR23B pe\/p58 and HHR23A subunits of ps XPC pe.","label":1}
{"pair_id":"BioInfer.d267.s0.p2","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B\/ps p58 pe and HHR23A subunits of ps XPC pe.","label":1}
{"pair_id":"BioInfer.d267.s0.p3","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B\/p58 and ps HHR23A pe subunits of ps XPC pe.","label":1}
{"pair_id":"BioInfer.d267.s0.p4","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ps ERCC1 pe, ERCC2 (XPD), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of ps XPC pe.","label":0}
{"pair_id":"BioInfer.d267.s0.p5","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ps ERCC2 pe (XPD), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of ps XPC pe.","label":0}
{"pair_id":"BioInfer.d267.s0.p6","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse ps RAD51 pe, and the HHR23B\/p58 and HHR23A subunits of ps XPC pe.","label":0}
{"pair_id":"BioInfer.d267.s0.p7","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (ps XPD pe), mouse RAD51, and the ps HHR23B pe\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p8","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (ps XPD pe), mouse RAD51, and the HHR23B\/ps p58 pe and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p9","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (ps XPD pe), mouse RAD51, and the HHR23B\/p58 and ps HHR23A pe subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p10","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ps ERCC1 pe, ERCC2 (ps XPD pe), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p11","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ps ERCC2 pe (ps XPD pe), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p12","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (ps XPD pe), mouse ps RAD51 pe, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p13","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the ps HHR23B pe\/ps p58 pe and HHR23A subunits of XPC.","label":1}
{"pair_id":"BioInfer.d267.s0.p14","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the ps HHR23B pe\/p58 and ps HHR23A pe subunits of XPC.","label":1}
{"pair_id":"BioInfer.d267.s0.p15","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ps ERCC1 pe, ERCC2 (XPD), mouse RAD51, and the ps HHR23B pe\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p16","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ps ERCC2 pe (XPD), mouse RAD51, and the ps HHR23B pe\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p17","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse ps RAD51 pe, and the ps HHR23B pe\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p18","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B\/ps p58 pe and ps HHR23A pe subunits of XPC.","label":1}
{"pair_id":"BioInfer.d267.s0.p19","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ps ERCC1 pe, ERCC2 (XPD), mouse RAD51, and the HHR23B\/ps p58 pe and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p20","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ps ERCC2 pe (XPD), mouse RAD51, and the HHR23B\/ps p58 pe and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p21","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse ps RAD51 pe, and the HHR23B\/ps p58 pe and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p22","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ps ERCC1 pe, ERCC2 (XPD), mouse RAD51, and the HHR23B\/p58 and ps HHR23A pe subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p23","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ps ERCC2 pe (XPD), mouse RAD51, and the HHR23B\/p58 and ps HHR23A pe subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p24","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse ps RAD51 pe, and the HHR23B\/p58 and ps HHR23A pe subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p25","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ps ERCC1 pe, ps ERCC2 pe (XPD), mouse RAD51, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p26","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ps ERCC1 pe, ERCC2 (XPD), mouse ps RAD51 pe, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"BioInfer.d267.s0.p27","sentence":"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ps ERCC2 pe (XPD), mouse ps RAD51 pe, and the HHR23B\/p58 and HHR23A subunits of XPC.","label":0}
{"pair_id":"AIMed.d168.s1422.p0","sentence":"These data indicate that Phe93 is a critical ps EPO pe binding determinant of the ps EPOR pe.","label":1}
{"pair_id":"AIMed.d85.s722.p0","sentence":"In vitro translation studies identified the 66-kDa protein as the protein product of ps WASP pe, and subcellular fractionation experiments showed that ps p66WASP pe is mainly present in the cytosol fraction, although significant amounts are also present in membrane and nuclear fractions.","label":0}
{"pair_id":"AIMed.d204.s1765.p0","sentence":"In summary, we have shown that the integrity of the catalytic domain of ps MMP-1 pe and its ability to bind Zn2+ is absolutely required for complex formation with ps TIMP-1 pe, which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.","label":1}
{"pair_id":"AIMed.d204.s1765.p1","sentence":"In summary, we have shown that the integrity of the catalytic domain of ps MMP-1 pe and its ability to bind Zn2+ is absolutely required for complex formation with TIMP-1, which further underlines the importance of this region for proper regulation of enzymatic activity of ps MMP-1 pe.","label":0}
{"pair_id":"AIMed.d204.s1765.p2","sentence":"In summary, we have shown that the integrity of the catalytic domain of MMP-1 and its ability to bind Zn2+ is absolutely required for complex formation with ps TIMP-1 pe, which further underlines the importance of this region for proper regulation of enzymatic activity of ps MMP-1 pe.","label":0}
{"pair_id":"AIMed.d172.s1448.p0","sentence":"ps Flt1 pe and ps Flk1 pe have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (VEGF).","label":0}
{"pair_id":"AIMed.d172.s1448.p1","sentence":"ps Flt1 pe and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by ps vascular endothelial growth factor pe (VEGF).","label":1}
{"pair_id":"AIMed.d172.s1448.p2","sentence":"ps Flt1 pe and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (ps VEGF pe).","label":1}
{"pair_id":"AIMed.d172.s1448.p3","sentence":"Flt1 and ps Flk1 pe have been shown to play key roles in vascular development; these two receptors bind and are activated by ps vascular endothelial growth factor pe (VEGF).","label":1}
{"pair_id":"AIMed.d172.s1448.p4","sentence":"Flt1 and ps Flk1 pe have been shown to play key roles in vascular development; these two receptors bind and are activated by vascular endothelial growth factor (ps VEGF pe).","label":1}
{"pair_id":"AIMed.d172.s1448.p5","sentence":"Flt1 and Flk1 have been shown to play key roles in vascular development; these two receptors bind and are activated by ps vascular endothelial growth factor pe (ps VEGF pe).","label":0}
{"pair_id":"BioInfer.d832.s0.p0","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of ps histone pe ps H3 pe and only inefficiently competed with DNA for binding of histone H1.","label":1}
{"pair_id":"BioInfer.d832.s0.p1","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of ps histone pe H3 and only inefficiently competed with DNA for binding of ps histone pe H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p2","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of ps histone pe H4, it equally competed with DNA for binding of ps histone pe H3 and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p3","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone ps H4 pe, it equally competed with DNA for binding of ps histone pe H3 and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p4","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of ps histone pe H3 and only inefficiently competed with DNA for binding of histone ps H1 pe.","label":0}
{"pair_id":"BioInfer.d832.s0.p5","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone ps H3 pe and only inefficiently competed with DNA for binding of ps histone pe H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p6","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of ps histone pe H4, it equally competed with DNA for binding of histone ps H3 pe and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p7","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone ps H4 pe, it equally competed with DNA for binding of histone ps H3 pe and only inefficiently competed with DNA for binding of histone H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p8","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone ps H3 pe and only inefficiently competed with DNA for binding of histone ps H1 pe.","label":0}
{"pair_id":"BioInfer.d832.s0.p9","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of ps histone pe H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of ps histone pe H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p10","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone ps H4 pe, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of ps histone pe H1.","label":0}
{"pair_id":"BioInfer.d832.s0.p11","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of ps histone pe ps H1 pe.","label":1}
{"pair_id":"BioInfer.d832.s0.p12","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of ps histone pe ps H4 pe, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.","label":1}
{"pair_id":"BioInfer.d832.s0.p13","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of ps histone pe H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone ps H1 pe.","label":0}
{"pair_id":"BioInfer.d832.s0.p14","sentence":"While poly(ADP-ribose) effectively competed with DNA for binding of histone ps H4 pe, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone ps H1 pe.","label":0}
{"pair_id":"AIMed.d141.s1188.p0","sentence":"The ps p21 pe Cdk-interacting protein ps Cip1 pe is a potent inhibitor of G1 cyclin-dependent kinases.","label":0}
{"pair_id":"AIMed.d150.s1277.p0","sentence":"ps Elf-1 pe binds exclusively to the underphosphorylated form of ps Rb pe and fails to bind to Rb mutants derived from patients with retinoblastoma.","label":0}
{"pair_id":"AIMed.d150.s1277.p1","sentence":"ps Elf-1 pe binds exclusively to the underphosphorylated form of Rb and fails to bind to ps Rb pe mutants derived from patients with retinoblastoma.","label":0}
{"pair_id":"AIMed.d150.s1277.p2","sentence":"Elf-1 binds exclusively to the underphosphorylated form of ps Rb pe and fails to bind to ps Rb pe mutants derived from patients with retinoblastoma.","label":0}
{"pair_id":"BioInfer.d301.s0.p0","sentence":"Immunoreactive ps E-cadherin pe, alpha-catenin, ps beta-catenin pe, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p1","sentence":"Immunoreactive ps E-cadherin pe, ps alpha-catenin pe, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p2","sentence":"Immunoreactive ps E-cadherin pe, alpha-catenin, beta-catenin, and ps gamma-catenin pe proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p3","sentence":"Immunoreactive E-cadherin, ps alpha-catenin pe, ps beta-catenin pe, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p4","sentence":"Immunoreactive E-cadherin, alpha-catenin, ps beta-catenin pe, and ps gamma-catenin pe proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d301.s0.p5","sentence":"Immunoreactive E-cadherin, ps alpha-catenin pe, beta-catenin, and ps gamma-catenin pe proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.","label":0}
{"pair_id":"BioInfer.d399.s1.p0","sentence":"The results suggest some cooperativity with respect to ps cofilin pe binding to filamentous ps actin pe which may be pH dependent.","label":1}
{"pair_id":"AIMed.d158.s1335.p0","sentence":"We also show that ps RIP pe is a serine-threonine kinase that is recruited by ps TRADD pe to TNFR1 in a TNF-dependent process.","label":0}
{"pair_id":"AIMed.d158.s1335.p1","sentence":"We also show that ps RIP pe is a serine-threonine kinase that is recruited by TRADD to ps TNFR1 pe in a TNF-dependent process.","label":0}
{"pair_id":"AIMed.d158.s1335.p2","sentence":"We also show that RIP is a serine-threonine kinase that is recruited by ps TRADD pe to ps TNFR1 pe in a TNF-dependent process.","label":0}
{"pair_id":"BioInfer.d624.s0.p0","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, ps RAD51 pe, RAD52, and ps RAD5 pe genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p1","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, ps RAD52 pe, and ps RAD5 pe genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p2","sentence":"The high recombination levels seen in rad5 and ps rad18 pe mutants is dependent on the RAD1, RAD51, RAD52, and ps RAD5 pe genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p3","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the ps RAD1 pe, RAD51, RAD52, and ps RAD5 pe genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p4","sentence":"The high recombination levels seen in ps rad5 pe and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and ps RAD5 pe genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p5","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, ps RAD51 pe, ps RAD52 pe, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p6","sentence":"The high recombination levels seen in rad5 and ps rad18 pe mutants is dependent on the RAD1, ps RAD51 pe, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p7","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the ps RAD1 pe, ps RAD51 pe, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p8","sentence":"The high recombination levels seen in ps rad5 pe and rad18 mutants is dependent on the RAD1, ps RAD51 pe, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p9","sentence":"The high recombination levels seen in rad5 and ps rad18 pe mutants is dependent on the RAD1, RAD51, ps RAD52 pe, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p10","sentence":"The high recombination levels seen in rad5 and rad18 mutants is dependent on the ps RAD1 pe, RAD51, ps RAD52 pe, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p11","sentence":"The high recombination levels seen in ps rad5 pe and rad18 mutants is dependent on the RAD1, RAD51, ps RAD52 pe, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p12","sentence":"The high recombination levels seen in rad5 and ps rad18 pe mutants is dependent on the ps RAD1 pe, RAD51, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p13","sentence":"The high recombination levels seen in ps rad5 pe and ps rad18 pe mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d624.s0.p14","sentence":"The high recombination levels seen in ps rad5 pe and rad18 mutants is dependent on the ps RAD1 pe, RAD51, RAD52, and RAD5 genes.","label":0}
{"pair_id":"BioInfer.d385.s0.p0","sentence":"Introduction of high concentrations of ps profilin pe (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of ps actin pe tail elongation and bacterial migration.","label":1}
{"pair_id":"AIMed.d168.s1412.p0","sentence":"Identification of a critical ligand binding determinant of the human ps erythropoietin peps erythropoietin receptor pe. Evidence for common ligand binding motifs in the cytokine receptor family.","label":0}
{"pair_id":"BioInfer.d140.s0.p0","sentence":"Characterization of the interactions of ps alpha-catenin pe with ps alpha-actinin pe and beta-catenin\/plakoglobin.","label":1}
{"pair_id":"BioInfer.d140.s0.p1","sentence":"Characterization of the interactions of alpha-catenin with ps alpha-actinin pe and beta-catenin\/ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d140.s0.p2","sentence":"Characterization of the interactions of alpha-catenin with ps alpha-actinin pe and ps beta-catenin pe\/plakoglobin.","label":0}
{"pair_id":"BioInfer.d140.s0.p3","sentence":"Characterization of the interactions of ps alpha-catenin pe with alpha-actinin and beta-catenin\/ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d140.s0.p4","sentence":"Characterization of the interactions of ps alpha-catenin pe with alpha-actinin and ps beta-catenin pe\/plakoglobin.","label":1}
{"pair_id":"BioInfer.d140.s0.p5","sentence":"Characterization of the interactions of alpha-catenin with alpha-actinin and ps beta-catenin pe\/ps plakoglobin pe.","label":1}
{"pair_id":"AIMed.d90.s769.p0","sentence":"We have characterized the physical and functional interactions between ps PU.1 pe and ps NF-IL6 beta pe, a leucine zipper transcription factor implicated in inflammatory responses.","label":1}
{"pair_id":"AIMed.d202.s1737.p0","sentence":"Crystal structure of the ps type-I interleukin-1 receptor peps interleukin-1 pe receptor complexed with interleukin-1beta.","label":0}
{"pair_id":"AIMed.d202.s1737.p1","sentence":"Crystal structure of the type-I ps interleukin-1 pe receptor complexed with ps interleukin-1beta pe.","label":0}
{"pair_id":"AIMed.d202.s1737.p2","sentence":"Crystal structure of the ps type-I interleukin-1 receptor pe complexed with ps interleukin-1beta pe.","label":1}
{"pair_id":"BioInfer.d378.s0.p0","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, ps basic calponin pe and the smooth muscle myosin heavy-chain isoforms of SM1 and ps SM2 pe) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p1","sentence":"In this study, the expressions of smooth muscle-specific proteins (ps desmin pe, alpha-smooth muscle actin, ps basic calponin pe and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p2","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, ps basic calponin pe and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-ps polymerase pe chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p3","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, ps basic calponin pe and the ps smooth muscle myosin heavy-chain pe isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p4","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, ps alpha-smooth muscle actin pe, ps basic calponin pe and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p5","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, ps basic calponin pe and the smooth muscle myosin heavy-chain isoforms of ps SM1 pe and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p6","sentence":"In this study, the expressions of smooth muscle-specific proteins (ps desmin pe, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and ps SM2 pe) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p7","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and ps SM2 pe) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-ps polymerase pe chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p8","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the ps smooth muscle myosin heavy-chain pe isoforms of SM1 and ps SM2 pe) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":1}
{"pair_id":"BioInfer.d378.s0.p9","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, ps alpha-smooth muscle actin pe, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and ps SM2 pe) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p10","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of ps SM1 pe and ps SM2 pe) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p11","sentence":"In this study, the expressions of smooth muscle-specific proteins (ps desmin pe, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-ps polymerase pe chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p12","sentence":"In this study, the expressions of smooth muscle-specific proteins (ps desmin pe, alpha-smooth muscle actin, basic calponin and the ps smooth muscle myosin heavy-chain pe isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p13","sentence":"In this study, the expressions of smooth muscle-specific proteins (ps desmin pe, ps alpha-smooth muscle actin pe, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p14","sentence":"In this study, the expressions of smooth muscle-specific proteins (ps desmin pe, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of ps SM1 pe and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p15","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the ps smooth muscle myosin heavy-chain pe isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-ps polymerase pe chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p16","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, ps alpha-smooth muscle actin pe, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-ps polymerase pe chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p17","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of ps SM1 pe and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-ps polymerase pe chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p18","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, ps alpha-smooth muscle actin pe, basic calponin and the ps smooth muscle myosin heavy-chain pe isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d378.s0.p19","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the ps smooth muscle myosin heavy-chain pe isoforms of ps SM1 pe and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":1}
{"pair_id":"BioInfer.d378.s0.p20","sentence":"In this study, the expressions of smooth muscle-specific proteins (desmin, ps alpha-smooth muscle actin pe, basic calponin and the smooth muscle myosin heavy-chain isoforms of ps SM1 pe and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and\/or by reverse transcription-polymerase chain reaction (RT-PCR).","label":0}
{"pair_id":"BioInfer.d266.s0.p0","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 ps cyclin-dependent kinase inhibitor pe (ps CKI pe).","label":0}
{"pair_id":"BioInfer.d266.s0.p1","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with ps Myc pe allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 ps cyclin-dependent kinase inhibitor pe (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p2","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of ps Ras pe with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 ps cyclin-dependent kinase inhibitor pe (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p3","sentence":"However, although expression of Ras alone will not induce G1 ps CDK pe activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 ps cyclin-dependent kinase inhibitor pe (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p4","sentence":"However, although expression of ps Ras pe alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 ps cyclin-dependent kinase inhibitor pe (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p5","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the ps p27 pe ps cyclin-dependent kinase inhibitor pe (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p6","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of ps cyclin E-dependent kinase pe activity and the induction of S phase, coincident with the loss of the p27 ps cyclin-dependent kinase inhibitor pe (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p7","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with ps Myc pe allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (ps CKI pe).","label":0}
{"pair_id":"BioInfer.d266.s0.p8","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of ps Ras pe with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (ps CKI pe).","label":0}
{"pair_id":"BioInfer.d266.s0.p9","sentence":"However, although expression of Ras alone will not induce G1 ps CDK pe activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (ps CKI pe).","label":0}
{"pair_id":"BioInfer.d266.s0.p10","sentence":"However, although expression of ps Ras pe alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (ps CKI pe).","label":0}
{"pair_id":"BioInfer.d266.s0.p11","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the ps p27 pe cyclin-dependent kinase inhibitor (ps CKI pe).","label":1}
{"pair_id":"BioInfer.d266.s0.p12","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of ps cyclin E-dependent kinase pe activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (ps CKI pe).","label":0}
{"pair_id":"BioInfer.d266.s0.p13","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of ps Ras pe with ps Myc pe allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p14","sentence":"However, although expression of Ras alone will not induce G1 ps CDK pe activity or S phase, coexpression of Ras with ps Myc pe allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p15","sentence":"However, although expression of ps Ras pe alone will not induce G1 CDK activity or S phase, coexpression of Ras with ps Myc pe allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p16","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with ps Myc pe allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the ps p27 pe cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p17","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with ps Myc pe allows the generation of ps cyclin E-dependent kinase pe activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p18","sentence":"However, although expression of Ras alone will not induce G1 ps CDK pe activity or S phase, coexpression of ps Ras pe with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p19","sentence":"However, although expression of ps Ras pe alone will not induce G1 CDK activity or S phase, coexpression of ps Ras pe with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p20","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of ps Ras pe with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the ps p27 pe cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p21","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of ps Ras pe with Myc allows the generation of ps cyclin E-dependent kinase pe activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p22","sentence":"However, although expression of ps Ras pe alone will not induce G1 ps CDK pe activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d266.s0.p23","sentence":"However, although expression of Ras alone will not induce G1 ps CDK pe activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the ps p27 pe cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p24","sentence":"However, although expression of Ras alone will not induce G1 ps CDK pe activity or S phase, coexpression of Ras with Myc allows the generation of ps cyclin E-dependent kinase pe activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p25","sentence":"However, although expression of ps Ras pe alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the ps p27 pe cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p26","sentence":"However, although expression of ps Ras pe alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of ps cyclin E-dependent kinase pe activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).","label":0}
{"pair_id":"BioInfer.d266.s0.p27","sentence":"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of ps cyclin E-dependent kinase pe activity and the induction of S phase, coincident with the loss of the ps p27 pe cyclin-dependent kinase inhibitor (CKI).","label":1}
{"pair_id":"BioInfer.d395.s0.p0","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of ps L pe, 120 molecules of phosphoprotein P, and 60 molecules each of ps actin pe and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p1","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of ps L pe, 120 molecules of ps phosphoprotein pe P, and 60 molecules each of actin and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p2","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of ps L pe, 120 molecules of phosphoprotein ps P pe, and 60 molecules each of actin and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p3","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of ps L pe, 120 molecules of phosphoprotein P, and 60 molecules each of actin and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d395.s0.p4","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of ps phosphoprotein pe P, and 60 molecules each of ps actin pe and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p5","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein ps P pe, and 60 molecules each of ps actin pe and profilin.","label":0}
{"pair_id":"BioInfer.d395.s0.p6","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of ps actin pe and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d395.s0.p7","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of ps phosphoprotein pe ps P pe, and 60 molecules each of actin and profilin.","label":1}
{"pair_id":"BioInfer.d395.s0.p8","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of ps phosphoprotein pe P, and 60 molecules each of actin and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d395.s0.p9","sentence":"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein ps P pe, and 60 molecules each of actin and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d581.s0.p0","sentence":"The ps adenosine deaminase pe-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(ps CD26 pe) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p1","sentence":"The ps adenosine deaminase pe-binding region is distinct from major anti-ps CD26 pe mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p2","sentence":"The ps adenosine deaminase pe-binding region is distinct from major anti-CD26 mAb epitopes on the human ps dipeptidyl peptidase IV pe(CD26) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p3","sentence":"The adenosine deaminase-binding region is distinct from major anti-ps CD26 pe mAb epitopes on the human dipeptidyl peptidase IV(ps CD26 pe) molecule.","label":1}
{"pair_id":"BioInfer.d581.s0.p4","sentence":"The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human ps dipeptidyl peptidase IV pe(ps CD26 pe) molecule.","label":0}
{"pair_id":"BioInfer.d581.s0.p5","sentence":"The adenosine deaminase-binding region is distinct from major anti-ps CD26 pe mAb epitopes on the human ps dipeptidyl peptidase IV pe(CD26) molecule.","label":1}
{"pair_id":"AIMed.d146.s1237.p0","sentence":"ps IL-7 pe-driven proliferation is mediated via high affinity ps IL-7R pe, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p1","sentence":"ps IL-7 pe-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the ps p90 pe IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p2","sentence":"ps IL-7 pe-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 ps IL-7R pe, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p3","sentence":"ps IL-7 pe-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the ps p76 pe IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p4","sentence":"ps IL-7 pe-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 ps IL-7R pe bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p5","sentence":"ps IL-7 pe-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound ps IL-7 pe with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p6","sentence":"IL-7-driven proliferation is mediated via high affinity ps IL-7R pe, and accordingly, Scatchard analysis revealed that, like the ps p90 pe IL-7R, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p7","sentence":"IL-7-driven proliferation is mediated via high affinity ps IL-7R pe, and accordingly, Scatchard analysis revealed that, like the p90 ps IL-7R pe, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p8","sentence":"IL-7-driven proliferation is mediated via high affinity ps IL-7R pe, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the ps p76 pe IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p9","sentence":"IL-7-driven proliferation is mediated via high affinity ps IL-7R pe, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 ps IL-7R pe bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p10","sentence":"IL-7-driven proliferation is mediated via high affinity ps IL-7R pe, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 IL-7R bound ps IL-7 pe with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p11","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the ps p90 pe ps IL-7R pe, the p76 IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p12","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the ps p90 pe IL-7R, the ps p76 pe IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p13","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the ps p90 pe IL-7R, the p76 ps IL-7R pe bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p14","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the ps p90 pe IL-7R, the p76 IL-7R bound ps IL-7 pe with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p15","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 ps IL-7R pe, the ps p76 pe IL-7R bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p16","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 ps IL-7R pe, the p76 ps IL-7R pe bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p17","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 ps IL-7R pe, the p76 IL-7R bound ps IL-7 pe with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p18","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the ps p76 pe ps IL-7R pe bound IL-7 with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p19","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the ps p76 pe IL-7R bound ps IL-7 pe with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"AIMed.d146.s1237.p20","sentence":"IL-7-driven proliferation is mediated via high affinity IL-7R, and accordingly, Scatchard analysis revealed that, like the p90 IL-7R, the p76 ps IL-7R pe bound ps IL-7 pe with dual (high; Kd 38 pM and low; Kd 360 pM) affinity.","label":0}
{"pair_id":"BioInfer.d659.s0.p0","sentence":"The polycystic kidney disease 1 gene product mediates ps protein kinase C alpha pe-dependent and ps c-Jun N-terminal kinase pe-dependent activation of the transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d659.s0.p1","sentence":"The ps polycystic kidney disease 1 pe gene product mediates ps protein kinase C alpha pe-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d659.s0.p2","sentence":"The polycystic kidney disease 1 gene product mediates ps protein kinase C alpha pe-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor ps AP-1 pe.","label":1}
{"pair_id":"BioInfer.d659.s0.p3","sentence":"The ps polycystic kidney disease 1 pe gene product mediates protein kinase C alpha-dependent and ps c-Jun N-terminal kinase pe-dependent activation of the transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d659.s0.p4","sentence":"The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and ps c-Jun N-terminal kinase pe-dependent activation of the transcription factor ps AP-1 pe.","label":1}
{"pair_id":"BioInfer.d659.s0.p5","sentence":"The ps polycystic kidney disease 1 pe gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor ps AP-1 pe.","label":1}
{"pair_id":"BioInfer.d113.s1.p0","sentence":"The results suggest that tyrosine phosphorylation of ps beta-catenin pe is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of ps alpha-catenin pe from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s1.p1","sentence":"The results suggest that tyrosine phosphorylation of beta-catenin is achieved by ps EGFR pe upon tryptic digestion of cells and concurrent with but independent of dissociation of ps alpha-catenin pe from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s1.p2","sentence":"The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of ps alpha-catenin pe from ps E-cadherin pe.","label":1}
{"pair_id":"BioInfer.d113.s1.p3","sentence":"The results suggest that tyrosine phosphorylation of ps beta-catenin pe is achieved by ps EGFR pe upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s1.p4","sentence":"The results suggest that tyrosine phosphorylation of ps beta-catenin pe is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from ps E-cadherin pe.","label":1}
{"pair_id":"BioInfer.d113.s1.p5","sentence":"The results suggest that tyrosine phosphorylation of beta-catenin is achieved by ps EGFR pe upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from ps E-cadherin pe.","label":0}
{"pair_id":"AIMed.d18.s156.p0","sentence":"ps Endothelin-1 pe and sP- and ps sE-selectin pe levels were not related to function of lymphocytes (by MDM data) as seen in both tests; it is probable that another cell-cell communication mechanism had been switched on.","label":0}
{"pair_id":"BioInfer.d33.s3.p0","sentence":"RESULTS: E-cadherin, ps alpha-catenin pe, beta-catenin and ps gamma-catenin pe were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p1","sentence":"RESULTS: ps E-cadherin pe, ps alpha-catenin pe, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p2","sentence":"RESULTS: E-cadherin, ps alpha-catenin pe, ps beta-catenin pe and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p3","sentence":"RESULTS: ps E-cadherin pe, alpha-catenin, beta-catenin and ps gamma-catenin pe were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p4","sentence":"RESULTS: E-cadherin, alpha-catenin, ps beta-catenin pe and ps gamma-catenin pe were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d33.s3.p5","sentence":"RESULTS: ps E-cadherin pe, alpha-catenin, ps beta-catenin pe and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.","label":0}
{"pair_id":"BioInfer.d35.s2.p0","sentence":"A two-hybrid-based approach using ps cofilin pe and ps actin pe mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p1","sentence":"A two-hybrid-based approach using cofilin and ps actin pe mutants identified residues necessary for the interaction of ps actin pe, cofilin, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p2","sentence":"A two-hybrid-based approach using cofilin and ps actin pe mutants identified residues necessary for the interaction of actin, ps cofilin pe, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p3","sentence":"A two-hybrid-based approach using cofilin and ps actin pe mutants identified residues necessary for the interaction of actin, cofilin, and ps Aip1p pe in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p4","sentence":"A two-hybrid-based approach using ps cofilin pe and actin mutants identified residues necessary for the interaction of ps actin pe, cofilin, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p5","sentence":"A two-hybrid-based approach using ps cofilin pe and actin mutants identified residues necessary for the interaction of actin, ps cofilin pe, and Aip1p in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p6","sentence":"A two-hybrid-based approach using ps cofilin pe and actin mutants identified residues necessary for the interaction of actin, cofilin, and ps Aip1p pe in an apparent ternary complex.","label":0}
{"pair_id":"BioInfer.d35.s2.p7","sentence":"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of ps actin pe, ps cofilin pe, and Aip1p in an apparent ternary complex.","label":1}
{"pair_id":"BioInfer.d35.s2.p8","sentence":"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of ps actin pe, cofilin, and ps Aip1p pe in an apparent ternary complex.","label":1}
{"pair_id":"BioInfer.d35.s2.p9","sentence":"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, ps cofilin pe, and ps Aip1p pe in an apparent ternary complex.","label":1}
{"pair_id":"BioInfer.d512.s0.p0","sentence":"Reduced E-cadherin, ps alpha-catenin pe, beta-catenin and ps plakoglobin pe expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p1","sentence":"Reduced E-cadherin, alpha-catenin, ps beta-catenin pe and ps plakoglobin pe expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p2","sentence":"Reduced ps E-cadherin pe, alpha-catenin, beta-catenin and ps plakoglobin pe expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p3","sentence":"Reduced E-cadherin, ps alpha-catenin pe, ps beta-catenin pe and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p4","sentence":"Reduced ps E-cadherin pe, ps alpha-catenin pe, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"BioInfer.d512.s0.p5","sentence":"Reduced ps E-cadherin pe, alpha-catenin, ps beta-catenin pe and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).","label":0}
{"pair_id":"AIMed.d209.s1809.p0","sentence":"The same domain of ps RIN1 pe that binds ps RAS pe also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other RAS effectors.","label":1}
{"pair_id":"AIMed.d209.s1809.p1","sentence":"The same domain of ps RIN1 pe that binds RAS also interacts with 14-3-3 proteins, extending the similarity between ps RIN1 pe and other RAS effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p2","sentence":"The same domain of ps RIN1 pe that binds RAS also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other ps RAS pe effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p3","sentence":"The same domain of RIN1 that binds ps RAS pe also interacts with 14-3-3 proteins, extending the similarity between ps RIN1 pe and other RAS effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p4","sentence":"The same domain of RIN1 that binds ps RAS pe also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other ps RAS pe effectors.","label":0}
{"pair_id":"AIMed.d209.s1809.p5","sentence":"The same domain of RIN1 that binds RAS also interacts with 14-3-3 proteins, extending the similarity between ps RIN1 pe and other ps RAS pe effectors.","label":0}
{"pair_id":"BioInfer.d670.s0.p0","sentence":"The products of the yeast mismatch repair genes ps MSH2 pe and ps MSH3 pe participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.","label":0}
{"pair_id":"AIMed.d117.s991.p0","sentence":"ps Inhibin pe also binds to ps ActRII pe through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.","label":1}
{"pair_id":"AIMed.d117.s991.p1","sentence":"ps Inhibin pe also binds to ActRII through its beta subunit, competes with the binding of activin to ps ActRII pe, but fails to form the ActRII.","label":0}
{"pair_id":"AIMed.d117.s991.p2","sentence":"ps Inhibin pe also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ps ActRII pe.","label":0}
{"pair_id":"AIMed.d117.s991.p3","sentence":"Inhibin also binds to ps ActRII pe through its beta subunit, competes with the binding of activin to ps ActRII pe, but fails to form the ActRII.","label":0}
{"pair_id":"AIMed.d117.s991.p4","sentence":"Inhibin also binds to ps ActRII pe through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ps ActRII pe.","label":0}
{"pair_id":"AIMed.d117.s991.p5","sentence":"Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ps ActRII pe, but fails to form the ps ActRII pe.","label":0}
{"pair_id":"AIMed.d131.s1124.p0","sentence":"In a number of human T cell clones, expression of ps hIL-10R pe mRNA is down-regulated after activation of the cells with anti-ps CD3 pe Ab and phorbol ester.","label":0}
{"pair_id":"AIMed.d146.s1234.p0","sentence":"In this study the origin and function of the ps p90 pe and ps p76 pe molecules have been investigated.","label":0}
{"pair_id":"BioInfer.d6.s2.p0","sentence":"We speculate that nonfilamentous ps actin pe and ps profilin pe, both of which form shear-sensitive structures, can be modeled as flocculant materials.","label":0}
{"pair_id":"AIMed.d153.s1300.p0","sentence":"In the present study, we examined both the binding of ps ADA pe and ps CD26 pe and the functional consequences of this interaction.","label":1}
{"pair_id":"AIMed.d103.s873.p0","sentence":"The binding of ps hTAFII28 pe and ps hTAFII30 pe requires distinct domains of hTAFII18.","label":0}
{"pair_id":"AIMed.d103.s873.p1","sentence":"The binding of ps hTAFII28 pe and hTAFII30 requires distinct domains of ps hTAFII18 pe.","label":1}
{"pair_id":"AIMed.d103.s873.p2","sentence":"The binding of hTAFII28 and ps hTAFII30 pe requires distinct domains of ps hTAFII18 pe.","label":1}
{"pair_id":"AIMed.d115.s972.p0","sentence":"Here we show that the general transcription factor ps TFIIF pe is also a target for a transcriptional activator, namely ps serum response factor pe (SRF), which binds to the c-fos promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p1","sentence":"Here we show that the general transcription factor ps TFIIF pe is also a target for a transcriptional activator, namely serum response factor (ps SRF pe), which binds to the c-fos promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p2","sentence":"Here we show that the general transcription factor ps TFIIF pe is also a target for a transcriptional activator, namely serum response factor (SRF), which binds to the ps c-fos pe promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p3","sentence":"Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely ps serum response factor pe (ps SRF pe), which binds to the c-fos promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p4","sentence":"Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely ps serum response factor pe (SRF), which binds to the ps c-fos pe promoter.","label":0}
{"pair_id":"AIMed.d115.s972.p5","sentence":"Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely serum response factor (ps SRF pe), which binds to the ps c-fos pe promoter.","label":0}
{"pair_id":"BioInfer.d500.s0.p0","sentence":"Proteolytic activity was not detected with casein, ps actin pe, or ps myosin heavy-chain pe substrates.","label":0}
{"pair_id":"BioInfer.d500.s0.p1","sentence":"Proteolytic activity was not detected with ps casein pe, ps actin pe, or myosin heavy-chain substrates.","label":0}
{"pair_id":"BioInfer.d500.s0.p2","sentence":"Proteolytic activity was not detected with ps casein pe, actin, or ps myosin heavy-chain pe substrates.","label":0}
{"pair_id":"AIMed.d147.s1248.p0","sentence":"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, ps RBP1 pe and ps RBP2 pe, cloned originally by their interaction with pRB.","label":0}
{"pair_id":"AIMed.d147.s1248.p1","sentence":"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, ps RBP1 pe and RBP2, cloned originally by their interaction with ps pRB pe.","label":1}
{"pair_id":"AIMed.d147.s1248.p2","sentence":"We have now isolated cDNA clones that contain the full-length coding sequence of two other proteins, RBP1 and ps RBP2 pe, cloned originally by their interaction with ps pRB pe.","label":1}
{"pair_id":"BioInfer.d433.s1.p0","sentence":"These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody ps TD77 pe, raising the possibility that it binds to a novel functionally important ligand-binding site in the ps talin pe molecule.","label":1}
{"pair_id":"BioInfer.d433.s1.p1","sentence":"These results show that the C-terminal ps actin pe-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the ps talin pe molecule.","label":1}
{"pair_id":"BioInfer.d433.s1.p2","sentence":"These results show that the C-terminal ps actin pe-binding site is distinct from the region recognized by the anti-functional antibody ps TD77 pe, raising the possibility that it binds to a novel functionally important ligand-binding site in the talin molecule.","label":0}
{"pair_id":"BioInfer.d488.s0.p0","sentence":"Photochemical cleavage of ps myosin heavy chain pe and the effect on the interaction with ps actin pe.","label":1}
{"pair_id":"AIMed.d58.s516.p0","sentence":"While injection of ps GRB2 pe or ps H-ras pe proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with H-ras protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p1","sentence":"While injection of ps GRB2 pe or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of ps GRB2 pe together with H-ras protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p2","sentence":"While injection of ps GRB2 pe or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with ps H-ras pe protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p3","sentence":"While injection of GRB2 or ps H-ras pe proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of ps GRB2 pe together with H-ras protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p4","sentence":"While injection of GRB2 or ps H-ras pe proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with ps H-ras pe protein stimulated DNA synthesis.","label":0}
{"pair_id":"AIMed.d58.s516.p5","sentence":"While injection of GRB2 or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of ps GRB2 pe together with ps H-ras pe protein stimulated DNA synthesis.","label":0}
{"pair_id":"BioInfer.d143.s2.p0","sentence":"We propose a model in which ps profilin pe alters cellular concentrations of ps actin pe polymers in response to fluctuations in cytosolic calcium concentration.","label":1}
{"pair_id":"AIMed.d26.s219.p0","sentence":"The tumor-free patients expressed ps granulysin pe at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of ps granulysin pe compared to healthy controls ( P<0.0001).","label":0}
{"pair_id":"AIMed.d35.s299.p0","sentence":"Cell surface ps PS1 pe formed complexes in vivo with actin-binding protein ps filamin pe (ABP-280), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.","label":1}
{"pair_id":"AIMed.d35.s299.p1","sentence":"Cell surface ps PS1 pe formed complexes in vivo with actin-binding protein filamin (ps ABP-280 pe), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.","label":1}
{"pair_id":"AIMed.d35.s299.p2","sentence":"Cell surface PS1 formed complexes in vivo with actin-binding protein ps filamin pe (ps ABP-280 pe), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.","label":0}
{"pair_id":"AIMed.d148.s1251.p0","sentence":"Two potentially oncogenic cyclins, ps cyclin A pe and ps cyclin D1 pe, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein","label":0}
{"pair_id":"AIMed.d148.s1251.p1","sentence":"Two potentially oncogenic cyclins, ps cyclin A pe and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the ps Rb pe protein","label":1}
{"pair_id":"AIMed.d148.s1251.p2","sentence":"Two potentially oncogenic cyclins, cyclin A and ps cyclin D1 pe, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the ps Rb pe protein","label":1}
{"pair_id":"BioInfer.d212.s0.p0","sentence":"First, the C-terminal ps verprolin pe-ps cofilin pe-acidic domain was shown to be essential for the regulation of actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d212.s0.p1","sentence":"First, the C-terminal verprolin-ps cofilin pe-acidic domain was shown to be essential for the regulation of ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d212.s0.p2","sentence":"First, the C-terminal ps verprolin pe-cofilin-acidic domain was shown to be essential for the regulation of ps actin pe cytoskeleton.","label":0}
{"pair_id":"AIMed.d153.s1299.p0","sentence":"ps CD26 pe, a T cell activation Ag, also known as ps dipeptidyl peptidase IV pe,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"AIMed.d153.s1299.p1","sentence":"ps CD26 pe, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with ps adenosine deaminase pe (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p2","sentence":"ps CD26 pe, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (ps ADA pe) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p3","sentence":"CD26, a T cell activation Ag, also known as ps dipeptidyl peptidase IV pe,is directly associated with ps adenosine deaminase pe (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p4","sentence":"CD26, a T cell activation Ag, also known as ps dipeptidyl peptidase IV pe,is directly associated with adenosine deaminase (ps ADA pe) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"AIMed.d153.s1299.p5","sentence":"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with ps adenosine deaminase pe (ps ADA pe) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"BioInfer.d339.s0.p0","sentence":"Inhibition of ps actin pe polymerization in KCl was stronger than that of the parental ps profilin pe, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).","label":1}
{"pair_id":"BioInfer.d339.s0.p1","sentence":"Inhibition of actin polymerization in KCl was stronger than that of the parental ps profilin pe, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine ps profilin pe).","label":0}
{"pair_id":"BioInfer.d339.s0.p2","sentence":"Inhibition of actin polymerization in KCl was stronger than that of the parental ps profilin pe, and the Kd value of its interaction with rabbit ps skeletal muscle actin pe, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).","label":0}
{"pair_id":"BioInfer.d339.s0.p3","sentence":"Inhibition of ps actin pe polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine ps profilin pe).","label":0}
{"pair_id":"BioInfer.d339.s0.p4","sentence":"Inhibition of ps actin pe polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit ps skeletal muscle actin pe, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).","label":0}
{"pair_id":"BioInfer.d339.s0.p5","sentence":"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit ps skeletal muscle actin pe, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine ps profilin pe).","label":1}
{"pair_id":"AIMed.d114.s961.p0","sentence":"ps Syntrophin pe binds to an alternatively spliced exon of ps dystrophin pe.","label":0}
{"pair_id":"AIMed.d168.s1416.p0","sentence":"Substitution of phenylalanine at position 93 (Phe93) with alanine (F93A mutation) resulted in a drastic reduction in ps EPO pe binding in the ps EBP pe.","label":1}
{"pair_id":"BioInfer.d647.s0.p0","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of histone H3: with the purified acetylase, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p1","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe ps H4 pe versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p2","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p3","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of histone ps H3 pe: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p4","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of histone H3: with the purified ps acetylase pe, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p5","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":0}
{"pair_id":"BioInfer.d647.s0.p6","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of ps histone pe H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p7","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of histone H3: with the purified acetylase, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p8","sentence":"The most striking difference was in the relative preference for acetylation of histone ps H4 pe versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p9","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of histone H3: with the purified acetylase, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p10","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p11","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone ps H3 pe: with the purified acetylase, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p12","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified ps acetylase pe, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p13","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":0}
{"pair_id":"BioInfer.d647.s0.p14","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of ps histone pe H3: with the purified acetylase, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p15","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, ps histone pe ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p16","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, ps histone pe H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p17","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p18","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of histone ps H3 pe: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p19","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of histone H3: with the purified ps acetylase pe, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p20","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":0}
{"pair_id":"BioInfer.d647.s0.p21","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of ps histone pe H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p22","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of histone H3: with the purified acetylase, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p23","sentence":"The most striking difference was in the relative preference for acetylation of ps histone pe H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p24","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone ps H3 pe: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p25","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified ps acetylase pe, histone H4 in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p26","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":1}
{"pair_id":"BioInfer.d647.s0.p27","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of ps histone pe H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p28","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p29","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe ps H3 pe, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p30","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone ps H3 pe: with the purified ps acetylase pe, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p31","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone ps H3 pe: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":0}
{"pair_id":"BioInfer.d647.s0.p32","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of ps histone pe ps H3 pe: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p33","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone ps H3 pe: with the purified acetylase, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p34","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone ps H3 pe: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p35","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified ps acetylase pe, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":0}
{"pair_id":"BioInfer.d647.s0.p36","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of ps histone pe H3: with the purified ps acetylase pe, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p37","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified ps acetylase pe, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":1}
{"pair_id":"BioInfer.d647.s0.p38","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified ps acetylase pe, histone H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p39","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of ps histone pe H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":0}
{"pair_id":"BioInfer.d647.s0.p40","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":1}
{"pair_id":"BioInfer.d647.s0.p41","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous ps acetylase(s) pe.","label":0}
{"pair_id":"BioInfer.d647.s0.p42","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of ps histone pe H3: with the purified acetylase, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p43","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of ps histone pe H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"BioInfer.d647.s0.p44","sentence":"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone ps H4 pe in nucleosomes was acetylated to a much greater extent than was ps histone pe H3, whereas the reverse preference was found with the endogenous acetylase(s).","label":0}
{"pair_id":"AIMed.d213.s1846.p0","sentence":"In addition, previous work indicated that ps p300 pe and ps CBP pe might be involved in YY1-mediated repression.","label":0}
{"pair_id":"AIMed.d213.s1846.p1","sentence":"In addition, previous work indicated that ps p300 pe and CBP might be involved in ps YY1 pe-mediated repression.","label":0}
{"pair_id":"AIMed.d213.s1846.p2","sentence":"In addition, previous work indicated that p300 and ps CBP pe might be involved in ps YY1 pe-mediated repression.","label":0}
{"pair_id":"BioInfer.d14.s2.p0","sentence":"This effect is specific to ps profilin pe and gelsolin because other cytoskeletal proteins such as tau or actin do not affect ps PI 3-kinase pe activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p1","sentence":"This effect is specific to ps profilin pe and gelsolin because other cytoskeletal proteins such as ps tau pe or actin do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p2","sentence":"This effect is specific to ps profilin pe and gelsolin because other cytoskeletal proteins such as tau or ps actin pe do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p3","sentence":"This effect is specific to ps profilin pe and ps gelsolin pe because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p4","sentence":"This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as ps tau pe or actin do not affect ps PI 3-kinase pe activity.","label":1}
{"pair_id":"BioInfer.d14.s2.p5","sentence":"This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or ps actin pe do not affect ps PI 3-kinase pe activity.","label":1}
{"pair_id":"BioInfer.d14.s2.p6","sentence":"This effect is specific to profilin and ps gelsolin pe because other cytoskeletal proteins such as tau or actin do not affect ps PI 3-kinase pe activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p7","sentence":"This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as ps tau pe or ps actin pe do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p8","sentence":"This effect is specific to profilin and ps gelsolin pe because other cytoskeletal proteins such as ps tau pe or actin do not affect PI 3-kinase activity.","label":0}
{"pair_id":"BioInfer.d14.s2.p9","sentence":"This effect is specific to profilin and ps gelsolin pe because other cytoskeletal proteins such as tau or ps actin pe do not affect PI 3-kinase activity.","label":0}
{"pair_id":"AIMed.d32.s273.p0","sentence":"Our results indicate that Phe93 and Phe205 are important for both ps EPO pe and ps EMP1 pe binding, Met150 is not important for EPO binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p1","sentence":"Our results indicate that Phe93 and Phe205 are important for both ps EPO pe and EMP1 binding, Met150 is not important for ps EPO pe binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p2","sentence":"Our results indicate that Phe93 and Phe205 are important for both ps EPO pe and EMP1 binding, Met150 is not important for EPO binding but is critical for ps EMP1 pe binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p3","sentence":"Our results indicate that Phe93 and Phe205 are important for both EPO and ps EMP1 pe binding, Met150 is not important for ps EPO pe binding but is critical for EMP1 binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p4","sentence":"Our results indicate that Phe93 and Phe205 are important for both EPO and ps EMP1 pe binding, Met150 is not important for EPO binding but is critical for ps EMP1 pe binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"AIMed.d32.s273.p5","sentence":"Our results indicate that Phe93 and Phe205 are important for both EPO and EMP1 binding, Met150 is not important for ps EPO pe binding but is critical for ps EMP1 pe binding, and Thr151 is not important for binding either ligand.","label":0}
{"pair_id":"BioInfer.d334.s0.p0","sentence":"In extracts from mouse brain, ps profilin I pe and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and ps actin pe assembly.","label":0}
{"pair_id":"BioInfer.d334.s0.p1","sentence":"In extracts from mouse brain, profilin I and ps profilin II pe can form complexes with regulators of endocytosis, synaptic vesicle recycling and ps actin pe assembly.","label":0}
{"pair_id":"BioInfer.d334.s0.p2","sentence":"In extracts from mouse brain, ps profilin I pe and ps profilin II pe can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.","label":0}
{"pair_id":"AIMed.d154.s1313.p0","sentence":"Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations: ps beta 2-syntrophin pe to chromosome 16q22-23 and ps alpha 1-syntrophin pe to chromosome 20q11.2.","label":0}
{"pair_id":"BioInfer.d322.s0.p0","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the ps cyclin-dependent kinase inhibitor pe p21(ps WAF1 pe\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":1}
{"pair_id":"BioInfer.d322.s0.p1","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the ps cyclin-dependent kinase inhibitor pe p21(WAF1\/CIP1) and rescued by the addition of ps proliferating cell nuclear antigen pe, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p2","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the ps cyclin-dependent kinase inhibitor pe p21(WAF1\/ps CIP1 pe) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":1}
{"pair_id":"BioInfer.d322.s0.p3","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the ps cyclin-dependent kinase inhibitor pe ps p21 pe(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":1}
{"pair_id":"BioInfer.d322.s0.p4","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the ps cyclin-dependent kinase inhibitor pe p21(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of ps DNA polymerase pe (Pol) ps DNA p pe in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p5","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the ps cyclin-dependent kinase inhibitor pe p21(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (ps Pol pe) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p6","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(ps WAF1 pe\/CIP1) and rescued by the addition of ps proliferating cell nuclear antigen pe, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p7","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(ps WAF1 pe\/ps CIP1 pe) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p8","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor ps p21 pe(ps WAF1 pe\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p9","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(ps WAF1 pe\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of ps DNA polymerase pe (Pol) ps DNA p pe in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p10","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(ps WAF1 pe\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (ps Pol pe) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p11","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/ps CIP1 pe) and rescued by the addition of ps proliferating cell nuclear antigen pe, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p12","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor ps p21 pe(WAF1\/CIP1) and rescued by the addition of ps proliferating cell nuclear antigen pe, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p13","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/CIP1) and rescued by the addition of ps proliferating cell nuclear antigen pe, arguing for the involvement of ps DNA polymerase pe (Pol) ps DNA p pe in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p14","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/CIP1) and rescued by the addition of ps proliferating cell nuclear antigen pe, arguing for the involvement of DNA polymerase (ps Pol pe) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p15","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor ps p21 pe(WAF1\/ps CIP1 pe) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p16","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/ps CIP1 pe) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of ps DNA polymerase pe (Pol) ps DNA p pe in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p17","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/ps CIP1 pe) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (ps Pol pe) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p18","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor ps p21 pe(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of ps DNA polymerase pe (Pol) ps DNA p pe in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p19","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor ps p21 pe(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (ps Pol pe) DNA p in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d322.s0.p20","sentence":"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1\/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of ps DNA polymerase pe (ps Pol pe) ps DNA p pe in the conversion reaction.","label":0}
{"pair_id":"BioInfer.d465.s0.p0","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and ps UL52 pe), the origin-binding protein (ps UL9 pe), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p1","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and ps UL52 pe), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ps ICP8 pe) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p2","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the ps helicase-primase pe components (UL5, UL8, and ps UL52 pe), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p3","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and ps UL52 pe), the origin-binding protein (UL9), and the viral ps single-stranded DNA-binding protein pe (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p4","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (ps UL5 pe, UL8, and ps UL52 pe), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p5","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, ps UL8 pe, and ps UL52 pe), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p6","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and ps UL52 pe), the ps origin-binding protein pe (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p7","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (ps UL9 pe), and the viral single-stranded DNA-binding protein (ps ICP8 pe) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p8","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the ps helicase-primase pe components (UL5, UL8, and UL52), the origin-binding protein (ps UL9 pe), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p9","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (ps UL9 pe), and the viral ps single-stranded DNA-binding protein pe (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p10","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (ps UL5 pe, UL8, and UL52), the origin-binding protein (ps UL9 pe), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p11","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, ps UL8 pe, and UL52), the origin-binding protein (ps UL9 pe), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p12","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the ps origin-binding protein pe (ps UL9 pe), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p13","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the ps helicase-primase pe components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ps ICP8 pe) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p14","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral ps single-stranded DNA-binding protein pe (ps ICP8 pe) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p15","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (ps UL5 pe, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ps ICP8 pe) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p16","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, ps UL8 pe, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ps ICP8 pe) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p17","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the ps origin-binding protein pe (UL9), and the viral single-stranded DNA-binding protein (ps ICP8 pe) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p18","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the ps helicase-primase pe components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral ps single-stranded DNA-binding protein pe (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p19","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the ps helicase-primase pe components (ps UL5 pe, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p20","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the ps helicase-primase pe components (UL5, ps UL8 pe, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p21","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the ps helicase-primase pe components (UL5, UL8, and UL52), the ps origin-binding protein pe (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":0}
{"pair_id":"BioInfer.d465.s0.p22","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (ps UL5 pe, UL8, and UL52), the origin-binding protein (UL9), and the viral ps single-stranded DNA-binding protein pe (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p23","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, ps UL8 pe, and UL52), the origin-binding protein (UL9), and the viral ps single-stranded DNA-binding protein pe (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p24","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the ps origin-binding protein pe (UL9), and the viral ps single-stranded DNA-binding protein pe (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p25","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (ps UL5 pe, ps UL8 pe, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p26","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (ps UL5 pe, UL8, and UL52), the ps origin-binding protein pe (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d465.s0.p27","sentence":"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, ps UL8 pe, and UL52), the ps origin-binding protein pe (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.","label":1}
{"pair_id":"BioInfer.d283.s0.p0","sentence":"Human platelets contain ps profilin pe, a potential regulator of ps actin pe polymerisability.","label":1}
{"pair_id":"BioInfer.d530.s0.p0","sentence":"Sequence analysis of the genes encoding the ps nucleocapsid protein pe and phosphoprotein (P) of phocid distemper virus, and editing of the ps P pe gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p1","sentence":"Sequence analysis of the genes encoding the ps nucleocapsid protein pe and ps phosphoprotein pe (P) of phocid distemper virus, and editing of the P gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p2","sentence":"Sequence analysis of the genes encoding the ps nucleocapsid protein pe and phosphoprotein (ps P pe) of phocid distemper virus, and editing of the P gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p3","sentence":"Sequence analysis of the genes encoding the nucleocapsid protein and ps phosphoprotein pe (P) of phocid distemper virus, and editing of the ps P pe gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p4","sentence":"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (ps P pe) of phocid distemper virus, and editing of the ps P pe gene transcript.","label":0}
{"pair_id":"BioInfer.d530.s0.p5","sentence":"Sequence analysis of the genes encoding the nucleocapsid protein and ps phosphoprotein pe (ps P pe) of phocid distemper virus, and editing of the P gene transcript.","label":0}
{"pair_id":"AIMed.d99.s838.p0","sentence":"The cloned ps CSB pe gene encodes a member of a protein family that includes the yeast ps Snf2 pe protein, a component of the transcriptional regulator Swi\/Snf.","label":0}
{"pair_id":"AIMed.d99.s838.p1","sentence":"The cloned ps CSB pe gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator ps Swi pe\/Snf.","label":0}
{"pair_id":"AIMed.d99.s838.p2","sentence":"The cloned ps CSB pe gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi\/ps Snf pe.","label":0}
{"pair_id":"AIMed.d99.s838.p3","sentence":"The cloned CSB gene encodes a member of a protein family that includes the yeast ps Snf2 pe protein, a component of the transcriptional regulator ps Swi pe\/Snf.","label":0}
{"pair_id":"AIMed.d99.s838.p4","sentence":"The cloned CSB gene encodes a member of a protein family that includes the yeast ps Snf2 pe protein, a component of the transcriptional regulator Swi\/ps Snf pe.","label":0}
{"pair_id":"AIMed.d99.s838.p5","sentence":"The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator ps Swi pe\/ps Snf pe.","label":0}
{"pair_id":"AIMed.d47.s415.p0","sentence":"Here we report the crystal structure of human dimeric ps BMP-2 pe in complex with two high affinity ps BMP receptor IA pe extracellular domains(BRIAec).","label":0}
{"pair_id":"AIMed.d47.s415.p1","sentence":"Here we report the crystal structure of human dimeric ps BMP-2 pe in complex with two high affinity ps BMP receptor IA extracellular domain pes(BRIAec).","label":1}
{"pair_id":"AIMed.d47.s415.p2","sentence":"Here we report the crystal structure of human dimeric ps BMP-2 pe in complex with two high affinity BMP receptor IA extracellular domains(ps BRIAec pe).","label":1}
{"pair_id":"AIMed.d47.s415.p3","sentence":"Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity ps BMP receptor IA peps BMP receptor IA extracellular domain pes(BRIAec).","label":0}
{"pair_id":"AIMed.d47.s415.p4","sentence":"Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity ps BMP receptor IA pe extracellular domains(ps BRIAec pe).","label":0}
{"pair_id":"AIMed.d47.s415.p5","sentence":"Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity ps BMP receptor IA extracellular domain pes(ps BRIAec pe).","label":0}
{"pair_id":"AIMed.d60.s530.p0","sentence":"These findings suggest that one function of ps c-Raf-1 pe in mitogenic signaling is to phosphorylate and activate ps MAP kinase pe kinase.","label":0}
{"pair_id":"AIMed.d60.s530.p1","sentence":"These findings suggest that one function of ps c-Raf-1 pe in mitogenic signaling is to phosphorylate and activate ps MAP kinase kinase pe.","label":1}
{"pair_id":"AIMed.d60.s530.p2","sentence":"These findings suggest that one function of c-Raf-1 in mitogenic signaling is to phosphorylate and activate ps MAP kinase peps MAP kinase kinase pe.","label":0}
{"pair_id":"BioInfer.d294.s0.p0","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (ps c pe\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p1","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p2","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p3","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p4","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p5","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p6","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p7","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p8","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p9","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p10","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p11","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p12","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p13","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (ps CKs pe) (c\/cy, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p14","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/cy, ps c pe\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":1}
{"pair_id":"BioInfer.d294.s0.p15","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/ps cy pe, ps c pe\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p16","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p17","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p18","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p19","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p20","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p21","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p22","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p23","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p24","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p25","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p26","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p27","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p28","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (ps CKs pe) (ps c pe\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p29","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (ps c pe\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p30","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (ps c pe\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":1}
{"pair_id":"BioInfer.d294.s0.p31","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p32","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p33","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p34","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p35","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p36","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p37","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p38","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p39","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p40","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p41","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p42","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p43","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p44","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), ps S-100 pe protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p45","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p46","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p47","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p48","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p49","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p50","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p51","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p52","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p53","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p54","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p55","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p56","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p57","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and ps glial fibrillary acid protein pe was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p58","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p59","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p60","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p61","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p62","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p63","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p64","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p65","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p66","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p67","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p68","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p69","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (ps EMA pe), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p70","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p71","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p72","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p73","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p74","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p75","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p76","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p77","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p78","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p79","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p80","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), ps epithelial membrane antigen pe (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p81","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p82","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p83","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p84","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p85","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p86","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p87","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p88","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p89","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p90","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, ps type IV collagen pe, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p91","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p92","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p93","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p94","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p95","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p96","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p97","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p98","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p99","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, ps vimentin pe CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p100","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p101","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p102","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p103","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p104","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p105","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p106","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p107","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, ps smooth muscle myosin heavy chain pe, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p108","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p109","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p110","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p111","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p112","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p113","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p114","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, ps smooth muscle actin pe, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p115","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p116","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p117","sentence":"Immunohistochemistry for a variety of cytokeratins (CKs) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p118","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p119","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p120","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin ps CD34 pe, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p121","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p122","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p123","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (ps CKs pe) (c\/cy, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p124","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p125","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and ps cy pe), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p126","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p127","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (ps CKs pe) (c\/cy, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p128","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p129","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, ps c pe, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p130","sentence":"Immunohistochemistry for a variety of cytokeratins (ps CKs pe) (c\/cy, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p131","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p132","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (CKs) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, ps calponin pe, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p133","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (ps CKs pe) (c\/cy, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p134","sentence":"Immunohistochemistry for a variety of ps cytokeratins pe (ps CKs pe) (c\/ps cy pe, c\/cy, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d294.s0.p135","sentence":"Immunohistochemistry for a variety of ps cytokeratins peps cytokeratins pe (CKs) (c\/ps cy pe, c\/ps cy pe, c, and cy), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.","label":0}
{"pair_id":"BioInfer.d162.s0.p0","sentence":"Data is presented to suggest that the G1 ps cyclin D1 pe and the cyclin-dependent kinase inhibitor ps p27KIP1 pe may be involved in subversion of the G1\/S traverse by signaling pathways activated by HER-2 function.","label":0}
{"pair_id":"BioInfer.d162.s0.p1","sentence":"Data is presented to suggest that the G1 ps cyclin D1 pe and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1\/S traverse by signaling pathways activated by ps HER-2 pe function.","label":1}
{"pair_id":"BioInfer.d162.s0.p2","sentence":"Data is presented to suggest that the G1 ps cyclin D1 pe and the ps cyclin-dependent kinase inhibitor pe p27KIP1 may be involved in subversion of the G1\/S traverse by signaling pathways activated by HER-2 function.","label":0}
{"pair_id":"BioInfer.d162.s0.p3","sentence":"Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor ps p27KIP1 pe may be involved in subversion of the G1\/S traverse by signaling pathways activated by ps HER-2 pe function.","label":1}
{"pair_id":"BioInfer.d162.s0.p4","sentence":"Data is presented to suggest that the G1 cyclin D1 and the ps cyclin-dependent kinase inhibitor pe ps p27KIP1 pe may be involved in subversion of the G1\/S traverse by signaling pathways activated by HER-2 function.","label":1}
{"pair_id":"BioInfer.d162.s0.p5","sentence":"Data is presented to suggest that the G1 cyclin D1 and the ps cyclin-dependent kinase inhibitor pe p27KIP1 may be involved in subversion of the G1\/S traverse by signaling pathways activated by ps HER-2 pe function.","label":0}
{"pair_id":"BioInfer.d731.s0.p0","sentence":"The vaccinia virus ps E3L pe gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated ps protein kinase pe, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p1","sentence":"The vaccinia virus ps E3L pe gene product, ps pE3 pe, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p2","sentence":"The vaccinia virus ps E3L pe gene product, pE3, is a dsRNA binding protein that prevents activation of the ps interferon pe-induced, dsRNA-activated protein kinase, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p3","sentence":"The vaccinia virus ps E3L pe gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, ps PKR pe.","label":1}
{"pair_id":"BioInfer.d731.s0.p4","sentence":"The vaccinia virus E3L gene product, ps pE3 pe, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated ps protein kinase pe, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p5","sentence":"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the ps interferon pe-induced, dsRNA-activated ps protein kinase pe, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p6","sentence":"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated ps protein kinase pe, ps PKR pe.","label":1}
{"pair_id":"BioInfer.d731.s0.p7","sentence":"The vaccinia virus E3L gene product, ps pE3 pe, is a dsRNA binding protein that prevents activation of the ps interferon pe-induced, dsRNA-activated protein kinase, PKR.","label":0}
{"pair_id":"BioInfer.d731.s0.p8","sentence":"The vaccinia virus E3L gene product, ps pE3 pe, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, ps PKR pe.","label":1}
{"pair_id":"BioInfer.d731.s0.p9","sentence":"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the ps interferon pe-induced, dsRNA-activated protein kinase, ps PKR pe.","label":1}
{"pair_id":"AIMed.d57.s509.p0","sentence":"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted ps pp60src pe multiprotein complex contains ps hsp70 pe, which is a major candidate for providing the protein unfoldase activity required for hsp90 association.","label":1}
{"pair_id":"AIMed.d57.s509.p1","sentence":"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted ps pp60src pe multiprotein complex contains hsp70, which is a major candidate for providing the protein unfoldase activity required for ps hsp90 pe association.","label":0}
{"pair_id":"AIMed.d57.s509.p2","sentence":"As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted pp60src multiprotein complex contains ps hsp70 pe, which is a major candidate for providing the protein unfoldase activity required for ps hsp90 pe association.","label":0}
{"pair_id":"AIMed.d41.s357.p0","sentence":"The structures of ps TfR pe alone and complexed with ps HFE pe differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between TfR chains.","label":1}
{"pair_id":"AIMed.d41.s357.p1","sentence":"The structures of ps TfR pe alone and complexed with HFE differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between ps TfR pe chains.","label":0}
{"pair_id":"AIMed.d41.s357.p2","sentence":"The structures of TfR alone and complexed with ps HFE pe differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between ps TfR pe chains.","label":0}
{"pair_id":"BioInfer.d49.s4.p0","sentence":"When barbed ends are capped, ps profilin pe simply sequesters globular ps actin pe.","label":1}
{"pair_id":"AIMed.d135.s1148.p0","sentence":"The cell surface form of ps LT-alpha pe is assembled during biosynthesis as a heteromeric complex with ps lymphotoxin-beta pe (LT-beta), a type II transmembrane protein that is another member of the TNF ligand family.","label":1}
{"pair_id":"AIMed.d135.s1148.p1","sentence":"The cell surface form of ps LT-alpha pe is assembled during biosynthesis as a heteromeric complex with lymphotoxin-beta (ps LT-beta pe), a type II transmembrane protein that is another member of the TNF ligand family.","label":1}
{"pair_id":"AIMed.d135.s1148.p2","sentence":"The cell surface form of LT-alpha is assembled during biosynthesis as a heteromeric complex with ps lymphotoxin-beta pe (ps LT-beta pe), a type II transmembrane protein that is another member of the TNF ligand family.","label":0}
{"pair_id":"AIMed.d39.s335.p0","sentence":"ps Presenilin 1 pe (ps PS1 pe) is the causative gene for an autosomal dominant familial Alzheimer's disease (AD) mapped to chromosome 14.","label":0}
{"pair_id":"AIMed.d112.s948.p0","sentence":"This ps Syk pe-ps Lyn pe interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":1}
{"pair_id":"AIMed.d112.s948.p1","sentence":"This ps Syk pe-Lyn interaction may be dependent on the stage of B-cell differentiation, since ps Syk pe-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p2","sentence":"This ps Syk pe-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-ps Lyn pe associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p3","sentence":"This ps Syk pe-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and ps Syk pe from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p4","sentence":"This ps Syk pe-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with ps Lyn pe in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p5","sentence":"This Syk-ps Lyn pe interaction may be dependent on the stage of B-cell differentiation, since ps Syk pe-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p6","sentence":"This Syk-ps Lyn pe interaction may be dependent on the stage of B-cell differentiation, since Syk-ps Lyn pe associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p7","sentence":"This Syk-ps Lyn pe interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and ps Syk pe from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p8","sentence":"This Syk-ps Lyn pe interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with ps Lyn pe in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p9","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since ps Syk pe-ps Lyn pe associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.","label":1}
{"pair_id":"AIMed.d112.s948.p10","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since ps Syk pe-Lyn associations were not detected in pre-B and myeloma cell lines and ps Syk pe from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p11","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since ps Syk pe-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with ps Lyn pe in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p12","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-ps Lyn pe associations were not detected in pre-B and myeloma cell lines and ps Syk pe from an immature B-cell line did not reassociate with Lyn in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p13","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-ps Lyn pe associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with ps Lyn pe in vitro.","label":0}
{"pair_id":"AIMed.d112.s948.p14","sentence":"This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and ps Syk pe from an immature B-cell line did not reassociate with ps Lyn pe in vitro.","label":0}
{"pair_id":"AIMed.d97.s821.p0","sentence":"In transfected COS-1 cells, ps osteogenic protein (OP)-1 pe\/ps BMP-7 pe, and less efficiently BMP-4, bound to BMPR-II.","label":0}
{"pair_id":"AIMed.d97.s821.p1","sentence":"In transfected COS-1 cells, ps osteogenic protein (OP)-1 pe\/BMP-7, and less efficiently ps BMP-4 pe, bound to BMPR-II.","label":0}
{"pair_id":"AIMed.d97.s821.p2","sentence":"In transfected COS-1 cells, ps osteogenic protein (OP)-1 pe\/BMP-7, and less efficiently BMP-4, bound to ps BMPR-II pe.","label":1}
{"pair_id":"AIMed.d97.s821.p3","sentence":"In transfected COS-1 cells, osteogenic protein (OP)-1\/ps BMP-7 pe, and less efficiently ps BMP-4 pe, bound to BMPR-II.","label":0}
{"pair_id":"AIMed.d97.s821.p4","sentence":"In transfected COS-1 cells, osteogenic protein (OP)-1\/ps BMP-7 pe, and less efficiently BMP-4, bound to ps BMPR-II pe.","label":1}
{"pair_id":"AIMed.d97.s821.p5","sentence":"In transfected COS-1 cells, osteogenic protein (OP)-1\/BMP-7, and less efficiently ps BMP-4 pe, bound to ps BMPR-II pe.","label":1}
{"pair_id":"AIMed.d207.s1796.p0","sentence":"Our data indicate that, in differentiating myocytes, one mechanism through which ps MyoD pe induces permanent cell cycle arrest involves ps p21 pe upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.","label":0}
{"pair_id":"AIMed.d207.s1796.p1","sentence":"Our data indicate that, in differentiating myocytes, one mechanism through which ps MyoD pe induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing ps E2F pe complexes formation.","label":0}
{"pair_id":"AIMed.d207.s1796.p2","sentence":"Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves ps p21 pe upregulation and suppression of the proliferation-associated cdks-containing ps E2F pe complexes formation.","label":0}
{"pair_id":"BioInfer.d122.s1.p0","sentence":"Our results provide support for both physical and functional interactions between three subunits, TIF34, ps PRT1 pe and ps p33 pe, in the eIF3 complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p1","sentence":"Our results provide support for both physical and functional interactions between three subunits, TIF34, ps PRT1 pe and p33, in the ps eIF3 pe complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p2","sentence":"Our results provide support for both physical and functional interactions between three subunits, ps TIF34 pe, ps PRT1 pe and p33, in the eIF3 complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p3","sentence":"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and ps p33 pe, in the ps eIF3 pe complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p4","sentence":"Our results provide support for both physical and functional interactions between three subunits, ps TIF34 pe, PRT1 and ps p33 pe, in the eIF3 complex.","label":1}
{"pair_id":"BioInfer.d122.s1.p5","sentence":"Our results provide support for both physical and functional interactions between three subunits, ps TIF34 pe, PRT1 and p33, in the ps eIF3 pe complex.","label":1}
{"pair_id":"AIMed.d164.s1382.p0","sentence":"In vitro protein-RNA interaction studies with pre-mRNAs containing either a constitutive or regulated splicing enhancer revealed that ps U2AF35 pe directly mediates interactions between ps U2AF65 pe and proteins bound to the enhancers.","label":0}
{"pair_id":"AIMed.d162.s1367.p0","sentence":"We found that the human ps TR subtype beta 1 pe (ps h-TR beta 1 pe) physically interacted with p53 via its DNA binding domain.","label":0}
{"pair_id":"AIMed.d162.s1367.p1","sentence":"We found that the human ps TR subtype beta 1 pe (h-TR beta 1) physically interacted with ps p53 pe via its DNA binding domain.","label":1}
{"pair_id":"AIMed.d162.s1367.p2","sentence":"We found that the human TR subtype beta 1 (ps h-TR beta 1 pe) physically interacted with ps p53 pe via its DNA binding domain.","label":1}
{"pair_id":"AIMed.d137.s1161.p0","sentence":"We show that the POU homeodomain of ps Oct2 pe and the evolutionarily conserved C-terminal core domain of ps TBP pe are both required and sufficient for the interaction.","label":1}
{"pair_id":"AIMed.d110.s926.p0","sentence":"The cloning of a complementary DNA encoding a human ps TFIID pe TAF, ps TAFII55 pe, that has no known homolog in Drosophila TFIID is now described.","label":0}
{"pair_id":"AIMed.d110.s926.p1","sentence":"The cloning of a complementary DNA encoding a human ps TFIID pe TAF, TAFII55, that has no known homolog in Drosophila ps TFIID pe is now described.","label":0}
{"pair_id":"AIMed.d110.s926.p2","sentence":"The cloning of a complementary DNA encoding a human TFIID TAF, ps TAFII55 pe, that has no known homolog in Drosophila ps TFIID pe is now described.","label":0}
{"pair_id":"BioInfer.d549.s0.p0","sentence":"Spontaneous and mitomycin C-induced SCE levels were significantly reduced for chicken DT40 B cells lacking the key HR genes ps RAD51 pe and ps RAD54 pe but not for nonhomologous DNA end-joining (NHEJ)-defective KU70(-\/-) cells.","label":0}
{"pair_id":"BioInfer.d728.s0.p0","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ps ATPase pe than does ps beta myosin pe, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p1","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, ps alpha Myosin pe exhibits higher actin-activated ps ATPase pe than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p2","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ps ATPase pe than does beta myosin, and hearts expressing ps alpha myosin pe exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p3","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ps ATPase pe than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing ps beta myosin pe.","label":0}
{"pair_id":"BioInfer.d728.s0.p4","sentence":"The two ps cardiac myosin heavy chain pe isoforms, ps cardi pe and card, differ functionally, alpha Myosin exhibits higher actin-activated ps ATPase pe than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p5","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher ps actin pe-activated ps ATPase pe than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p6","sentence":"The two ps cardiac myosin heavy chain pe isoforms, cardi and ps card pe, differ functionally, alpha Myosin exhibits higher actin-activated ps ATPase pe than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p7","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, ps alpha Myosin pe exhibits higher actin-activated ATPase than does ps beta myosin pe, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p8","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does ps beta myosin pe, and hearts expressing ps alpha myosin pe exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p9","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does ps beta myosin pe, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing ps beta myosin pe.","label":0}
{"pair_id":"BioInfer.d728.s0.p10","sentence":"The two ps cardiac myosin heavy chain pe isoforms, ps cardi pe and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does ps beta myosin pe, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p11","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher ps actin pe-activated ATPase than does ps beta myosin pe, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p12","sentence":"The two ps cardiac myosin heavy chain pe isoforms, cardi and ps card pe, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does ps beta myosin pe, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p13","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, ps alpha Myosin pe exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing ps alpha myosin pe exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p14","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, ps alpha Myosin pe exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing ps beta myosin pe.","label":0}
{"pair_id":"BioInfer.d728.s0.p15","sentence":"The two ps cardiac myosin heavy chain pe isoforms, ps cardi pe and card, differ functionally, ps alpha Myosin pe exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p16","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, ps alpha Myosin pe exhibits higher ps actin pe-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p17","sentence":"The two ps cardiac myosin heavy chain pe isoforms, cardi and ps card pe, differ functionally, ps alpha Myosin pe exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p18","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing ps alpha myosin pe exhibit increased contractility relative to hearts expressing ps beta myosin pe.","label":0}
{"pair_id":"BioInfer.d728.s0.p19","sentence":"The two ps cardiac myosin heavy chain pe isoforms, ps cardi pe and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing ps alpha myosin pe exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p20","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher ps actin pe-activated ATPase than does beta myosin, and hearts expressing ps alpha myosin pe exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p21","sentence":"The two ps cardiac myosin heavy chain pe isoforms, cardi and ps card pe, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing ps alpha myosin pe exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p22","sentence":"The two ps cardiac myosin heavy chain pe isoforms, ps cardi pe and card, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing ps beta myosin pe.","label":0}
{"pair_id":"BioInfer.d728.s0.p23","sentence":"The two cardiac myosin heavy chain isoforms, cardi and card, differ functionally, alpha Myosin exhibits higher ps actin pe-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing ps beta myosin pe.","label":0}
{"pair_id":"BioInfer.d728.s0.p24","sentence":"The two ps cardiac myosin heavy chain pe isoforms, cardi and ps card pe, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing ps beta myosin pe.","label":0}
{"pair_id":"BioInfer.d728.s0.p25","sentence":"The two ps cardiac myosin heavy chain pe isoforms, ps cardi pe and card, differ functionally, alpha Myosin exhibits higher ps actin pe-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d728.s0.p26","sentence":"The two ps cardiac myosin heavy chain peps cardiac myosin heavy chain pe isoforms, ps cardi pe and ps card pe, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":1}
{"pair_id":"BioInfer.d728.s0.p27","sentence":"The two ps cardiac myosin heavy chain pe isoforms, cardi and ps card pe, differ functionally, alpha Myosin exhibits higher ps actin pe-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.","label":0}
{"pair_id":"BioInfer.d246.s2.p0","sentence":"Phosphorylation by LIM-kinase 1 inactivates ps cofilin pe, leading to accumulation of ps actin pe filaments.","label":1}
{"pair_id":"BioInfer.d246.s2.p1","sentence":"Phosphorylation by ps LIM-kinase 1 pe inactivates cofilin, leading to accumulation of ps actin pe filaments.","label":1}
{"pair_id":"BioInfer.d246.s2.p2","sentence":"Phosphorylation by ps LIM-kinase 1 pe inactivates ps cofilin pe, leading to accumulation of actin filaments.","label":1}
{"pair_id":"AIMed.d143.s1210.p0","sentence":"These findings imply that ps IL-11 pe and ps IL-6 pe share similar early signaling events with the possibility of using the same signal transducer, gp130.","label":0}
{"pair_id":"AIMed.d143.s1210.p1","sentence":"These findings imply that ps IL-11 pe and IL-6 share similar early signaling events with the possibility of using the same signal transducer, ps gp130 pe.","label":0}
{"pair_id":"AIMed.d143.s1210.p2","sentence":"These findings imply that IL-11 and ps IL-6 pe share similar early signaling events with the possibility of using the same signal transducer, ps gp130 pe.","label":0}
{"pair_id":"AIMed.d8.s63.p0","sentence":"These cell lines showed mutations in ps K-ras pe and ps p53 pe at frequencies of 91% and 95%, respectively.","label":0}
{"pair_id":"BioInfer.d202.s0.p0","sentence":"Expression of ps alpha-catenin pe was generally weak and did not correlate with the expression of either beta-catenin or ps E-cadherin pe.","label":1}
{"pair_id":"BioInfer.d202.s0.p1","sentence":"Expression of alpha-catenin was generally weak and did not correlate with the expression of either ps beta-catenin pe or ps E-cadherin pe.","label":0}
{"pair_id":"BioInfer.d202.s0.p2","sentence":"Expression of ps alpha-catenin pe was generally weak and did not correlate with the expression of either ps beta-catenin pe or E-cadherin.","label":1}
{"pair_id":"AIMed.d83.s707.p0","sentence":"Superposition of the ps CNTF pe and growth hormone structures showed that the location of these epitopes on ps CNTF pe is analogous to the location of the first and second receptor epitopes on the surface of growth hormone.","label":0}
{"pair_id":"BioInfer.d1.s3.p0","sentence":"In viscometric assays, the birch protein was seen to modulate ps actin pe filament formation analogous to animal ps profilin pe.","label":1}
{"pair_id":"BioInfer.d224.s0.p0","sentence":"Furthermore, this inactivating effect of ps calmodulin pe can be prevented by coexpressing a region of the cytoskeletal protein ps alpha-actinin2 pe known to interact with the CO region of NR1.","label":1}
{"pair_id":"BioInfer.d224.s0.p1","sentence":"Furthermore, this inactivating effect of ps calmodulin pe can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of ps NR1 pe.","label":0}
{"pair_id":"BioInfer.d224.s0.p2","sentence":"Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein ps alpha-actinin2 pe known to interact with the CO region of ps NR1 pe.","label":1}
{"pair_id":"AIMed.d89.s761.p0","sentence":"Immunoprecipitation experiments employing a polyclonal anti-ps calreticulin pe antibody provided further evidence that the 60-kDa protein isolated in this study was ps calreticulin pe.","label":0}
{"pair_id":"AIMed.d104.s881.p0","sentence":"Here we demonstrate that DP is also a family of polypeptides with at least two members (ps hDP-1 pe and ps hDP-2 pe).","label":0}
{"pair_id":"BioInfer.d36.s0.p0","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the ps protein kinase pe activity and stress fiber formation by ps LIMK2 pe.","label":1}
{"pair_id":"BioInfer.d36.s0.p1","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for ps cofilin pe phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the ps protein kinase pe activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p2","sentence":"A ps LIMK2 pe mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the ps protein kinase pe activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p3","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and ps actin pe cytoskeletal changes, whereas replacement by glutamate enhanced the ps protein kinase pe activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p4","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished ps LIMK2 pe activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the ps protein kinase pe activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p5","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for ps cofilin pe phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by ps LIMK2 pe.","label":0}
{"pair_id":"BioInfer.d36.s0.p6","sentence":"A ps LIMK2 pe mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by ps LIMK2 pe.","label":0}
{"pair_id":"BioInfer.d36.s0.p7","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and ps actin pe cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by ps LIMK2 pe.","label":0}
{"pair_id":"BioInfer.d36.s0.p8","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished ps LIMK2 pe activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by ps LIMK2 pe.","label":0}
{"pair_id":"BioInfer.d36.s0.p9","sentence":"A ps LIMK2 pe mutant with replacement of threonine 505 by valine abolished LIMK2 activities for ps cofilin pe phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"BioInfer.d36.s0.p10","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for ps cofilin pe phosphorylation and ps actin pe cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p11","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished ps LIMK2 pe activities for ps cofilin pe phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"BioInfer.d36.s0.p12","sentence":"A ps LIMK2 pe mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and ps actin pe cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"BioInfer.d36.s0.p13","sentence":"A ps LIMK2 pe mutant with replacement of threonine 505 by valine abolished ps LIMK2 pe activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":0}
{"pair_id":"BioInfer.d36.s0.p14","sentence":"A LIMK2 mutant with replacement of threonine 505 by valine abolished ps LIMK2 pe activities for cofilin phosphorylation and ps actin pe cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.","label":1}
{"pair_id":"AIMed.d169.s1424.p0","sentence":"Cloning and characterization of a specific ps interleukin (IL)-13 pe binding protein structurally related to the ps IL-5 pe receptor alpha chain.","label":0}
{"pair_id":"AIMed.d169.s1424.p1","sentence":"Cloning and characterization of a specific ps interleukin (IL)-13 pe binding protein structurally related to the ps IL-5 receptor pe alpha chain.","label":0}
{"pair_id":"AIMed.d169.s1424.p2","sentence":"Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the ps IL-5 peps IL-5 receptor pe alpha chain.","label":0}
{"pair_id":"AIMed.d112.s952.p0","sentence":"Sequential immunoprecipitation identified the 72-kDa protein associated with ps PLC gamma 1 pe as ps Syk pe.","label":1}
{"pair_id":"AIMed.d146.s1240.p0","sentence":"These antibodies also immunoprecipitated the cloned ps IL-7R pe as a 90-kDa species from both 125-I-surface-labeled resting and activated T cells, but were unable to precipitate the 76-kDa ps IL-7R pe.","label":0}
{"pair_id":"BioInfer.d70.s0.p0","sentence":"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by ps thrombin pe (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and ps myosin heavy chain pe associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p1","sentence":"ps Aprotinin pe inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and ps myosin heavy chain pe associated with cytoskeletons.","label":1}
{"pair_id":"BioInfer.d70.s0.p2","sentence":"Aprotinin inhibited platelet aggregation induced by ps thrombin pe (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and ps myosin heavy chain pe associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p3","sentence":"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of ps actin pe and ps myosin heavy chain pe associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p4","sentence":"ps Aprotinin pe inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by ps thrombin pe (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.","label":1}
{"pair_id":"BioInfer.d70.s0.p5","sentence":"Aprotinin inhibited platelet aggregation induced by ps thrombin pe (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by ps thrombin pe (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p6","sentence":"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by ps thrombin pe (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of ps actin pe and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p7","sentence":"ps Aprotinin pe inhibited platelet aggregation induced by ps thrombin pe (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d70.s0.p8","sentence":"ps Aprotinin pe inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of ps actin pe and myosin heavy chain associated with cytoskeletons.","label":1}
{"pair_id":"BioInfer.d70.s0.p9","sentence":"Aprotinin inhibited platelet aggregation induced by ps thrombin pe (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of ps actin pe and myosin heavy chain associated with cytoskeletons.","label":0}
{"pair_id":"BioInfer.d783.s0.p0","sentence":"Unlike ps fimbrin pe, ps L-plastin pe's actin-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.","label":0}
{"pair_id":"BioInfer.d783.s0.p1","sentence":"Unlike fimbrin, ps L-plastin pe's ps actin pe-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.","label":1}
{"pair_id":"BioInfer.d783.s0.p2","sentence":"Unlike ps fimbrin pe, L-plastin's ps actin pe-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.","label":1}
{"pair_id":"AIMed.d128.s1092.p0","sentence":"The human pituitary hormones, ps growth hormone pe (ps hGH pe) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p1","sentence":"The human pituitary hormones, ps growth hormone pe (hGH) and ps prolactin pe (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p2","sentence":"The human pituitary hormones, ps growth hormone pe (hGH) and prolactin (ps hPRL pe), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p3","sentence":"The human pituitary hormones, growth hormone (ps hGH pe) and ps prolactin pe (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p4","sentence":"The human pituitary hormones, growth hormone (ps hGH pe) and prolactin (ps hPRL pe), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"AIMed.d128.s1092.p5","sentence":"The human pituitary hormones, growth hormone (hGH) and ps prolactin pe (ps hPRL pe), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.","label":0}
{"pair_id":"BioInfer.d561.s0.p0","sentence":"The ps actin-binding protein pe ps profilin pe was isolated from Tetrahymena thermophila by affinity chromatography, and the peptide sequence was determined for part of the protein.","label":1}
{"pair_id":"AIMed.d48.s420.p0","sentence":"ps Liver-expressed chemokine pe (ps LEC pe) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p1","sentence":"ps Liver-expressed chemokine pe (LEC) is an unusually large CC chemokine, which is also known as ps LMC pe, HCC-4, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p2","sentence":"ps Liver-expressed chemokine pe (LEC) is an unusually large CC chemokine, which is also known as LMC, ps HCC-4 pe, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p3","sentence":"ps Liver-expressed chemokine pe (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, ps NCC-4 pe, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p4","sentence":"ps Liver-expressed chemokine pe (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and ps CCL16 pe.","label":0}
{"pair_id":"AIMed.d48.s420.p5","sentence":"Liver-expressed chemokine (ps LEC pe) is an unusually large CC chemokine, which is also known as ps LMC pe, HCC-4, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p6","sentence":"Liver-expressed chemokine (ps LEC pe) is an unusually large CC chemokine, which is also known as LMC, ps HCC-4 pe, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p7","sentence":"Liver-expressed chemokine (ps LEC pe) is an unusually large CC chemokine, which is also known as LMC, HCC-4, ps NCC-4 pe, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p8","sentence":"Liver-expressed chemokine (ps LEC pe) is an unusually large CC chemokine, which is also known as LMC, HCC-4, NCC-4, and ps CCL16 pe.","label":0}
{"pair_id":"AIMed.d48.s420.p9","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as ps LMC pe, ps HCC-4 pe, NCC-4, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p10","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as ps LMC pe, HCC-4, ps NCC-4 pe, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p11","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as ps LMC pe, HCC-4, NCC-4, and ps CCL16 pe.","label":0}
{"pair_id":"AIMed.d48.s420.p12","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, ps HCC-4 pe, ps NCC-4 pe, and CCL16.","label":0}
{"pair_id":"AIMed.d48.s420.p13","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, ps HCC-4 pe, NCC-4, and ps CCL16 pe.","label":0}
{"pair_id":"AIMed.d48.s420.p14","sentence":"Liver-expressed chemokine (LEC) is an unusually large CC chemokine, which is also known as LMC, HCC-4, ps NCC-4 pe, and ps CCL16 pe.","label":0}
{"pair_id":"AIMed.d199.s1696.p0","sentence":"In order to characterize the signaling pathway through which ps FGFR3 pe regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 pe IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p1","sentence":"In order to characterize the signaling pathway through which ps FGFR3 pe regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 IIIb pe and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p2","sentence":"In order to characterize the signaling pathway through which ps FGFR3 pe regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and ps FGFR3 pe IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p3","sentence":"In order to characterize the signaling pathway through which ps FGFR3 pe regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and ps FGFR3 IIIc pe, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p4","sentence":"In order to characterize the signaling pathway through which ps FGFR3 pe regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the ps FGFR3 pe gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p5","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 peps FGFR3 IIIb pe and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p6","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 pe IIIb and ps FGFR3 pe IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p7","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 pe IIIb and ps FGFR3 IIIc pe, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p8","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 pe IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the ps FGFR3 pe gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p9","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 IIIb pe and ps FGFR3 pe IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p10","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 IIIb pe and ps FGFR3 IIIc pe, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p11","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, ps FGFR3 IIIb pe and FGFR3 IIIc, that result from alternative splicing of exon III of the ps FGFR3 pe gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p12","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and ps FGFR3 peps FGFR3 IIIc pe, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p13","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and ps FGFR3 pe IIIc, that result from alternative splicing of exon III of the ps FGFR3 pe gene encoding the ligand binding domain.","label":0}
{"pair_id":"AIMed.d199.s1696.p14","sentence":"In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and ps FGFR3 IIIc pe, that result from alternative splicing of exon III of the ps FGFR3 pe gene encoding the ligand binding domain.","label":0}
{"pair_id":"BioInfer.d449.s1.p0","sentence":"ps alpha-Skeletal actin pe and ps fast myosin heavy chain pe mRNAs were detected precociously, before the young myotube stage.","label":0}
{"pair_id":"AIMed.d172.s1451.p0","sentence":"This protein, designated ps VEGF peps VEGF-related protein pe (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p1","sentence":"This protein, designated ps VEGF pe-related protein (ps VRP pe), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p2","sentence":"This protein, designated ps VEGF pe-related protein (VRP), specifically binds to the extracellular domain of ps Flt4 pe, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p3","sentence":"This protein, designated ps VEGF pe-related protein (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of ps Flt4 pe expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p4","sentence":"This protein, designated ps VEGF-related protein pe (ps VRP pe), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p5","sentence":"This protein, designated ps VEGF-related protein pe (VRP), specifically binds to the extracellular domain of ps Flt4 pe, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":1}
{"pair_id":"AIMed.d172.s1451.p6","sentence":"This protein, designated ps VEGF-related protein pe (VRP), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of ps Flt4 pe expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p7","sentence":"This protein, designated VEGF-related protein (ps VRP pe), specifically binds to the extracellular domain of ps Flt4 pe, stimulates the tyrosine phosphorylation of Flt4 expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":1}
{"pair_id":"AIMed.d172.s1451.p8","sentence":"This protein, designated VEGF-related protein (ps VRP pe), specifically binds to the extracellular domain of Flt4, stimulates the tyrosine phosphorylation of ps Flt4 pe expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"AIMed.d172.s1451.p9","sentence":"This protein, designated VEGF-related protein (VRP), specifically binds to the extracellular domain of ps Flt4 pe, stimulates the tyrosine phosphorylation of ps Flt4 pe expressed in mammalian cells, and promotes the mitogenesis of human lung endothelial cells.","label":0}
{"pair_id":"BioInfer.d563.s0.p0","sentence":"The ps actin pe cytoskeleton-associated protein ps talin pe binds to integrins, vinculin, and actin.","label":1}
{"pair_id":"BioInfer.d563.s0.p1","sentence":"The ps actin pe cytoskeleton-associated protein talin binds to ps integrins pe, vinculin, and actin.","label":0}
{"pair_id":"BioInfer.d563.s0.p2","sentence":"The ps actin pe cytoskeleton-associated protein talin binds to integrins, ps vinculin pe, and actin.","label":0}
{"pair_id":"BioInfer.d563.s0.p3","sentence":"The ps actin pe cytoskeleton-associated protein talin binds to integrins, vinculin, and ps actin pe.","label":0}
{"pair_id":"BioInfer.d563.s0.p4","sentence":"The actin cytoskeleton-associated protein ps talin pe binds to ps integrins pe, vinculin, and actin.","label":1}
{"pair_id":"BioInfer.d563.s0.p5","sentence":"The actin cytoskeleton-associated protein ps talin pe binds to integrins, ps vinculin pe, and actin.","label":1}
{"pair_id":"BioInfer.d563.s0.p6","sentence":"The actin cytoskeleton-associated protein ps talin pe binds to integrins, vinculin, and ps actin pe.","label":1}
{"pair_id":"BioInfer.d563.s0.p7","sentence":"The actin cytoskeleton-associated protein talin binds to ps integrins pe, ps vinculin pe, and actin.","label":0}
{"pair_id":"BioInfer.d563.s0.p8","sentence":"The actin cytoskeleton-associated protein talin binds to ps integrins pe, vinculin, and ps actin pe.","label":0}
{"pair_id":"BioInfer.d563.s0.p9","sentence":"The actin cytoskeleton-associated protein talin binds to integrins, ps vinculin pe, and ps actin pe.","label":0}
{"pair_id":"BioInfer.d629.s0.p0","sentence":"The interaction between the human respiratory syncytial virus phosphoprotein (P) and ps nucleocapsid pe (ps N pe) ps phospho pe has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":0}
{"pair_id":"BioInfer.d629.s0.p1","sentence":"The interaction between the human respiratory syncytial virus phosphoprotein (ps P pe) and ps nucleocapsid pe (N) ps phospho pe has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p2","sentence":"The interaction between the human respiratory syncytial virus ps phosphoprotein pe (P) and ps nucleocapsid pe (N) ps phospho peps phospho pe has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p3","sentence":"The interaction between the human respiratory syncytial virus phosphoprotein (ps P pe) and nucleocapsid (ps N pe) phospho has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p4","sentence":"The interaction between the human respiratory syncytial virus ps phosphoprotein pe (P) and nucleocapsid (ps N pe) ps phospho pe has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":1}
{"pair_id":"BioInfer.d629.s0.p5","sentence":"The interaction between the human respiratory syncytial virus ps phosphoprotein pe (ps P pe) and nucleocapsid (N) ps phospho pe has been investigated using the two hybrid system in yeast and in tissue culture cells.","label":0}
{"pair_id":"AIMed.d91.s781.p0","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila ps TAFII40 pe, ps hTAFII32 pe interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p1","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila ps TAFII40 pe, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator ps viral protein 16 pe (VP16) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p2","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila ps TAFII40 pe, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (ps VP16 pe) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p3","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila ps TAFII40 pe, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor ps TFIIB pe.","label":0}
{"pair_id":"AIMed.d91.s781.p4","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, ps hTAFII32 pe interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator ps viral protein 16 pe (VP16) as well as with the general transcription factor TFIIB.","label":1}
{"pair_id":"AIMed.d91.s781.p5","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, ps hTAFII32 pe interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (ps VP16 pe) as well as with the general transcription factor TFIIB.","label":1}
{"pair_id":"AIMed.d91.s781.p6","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, ps hTAFII32 pe interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (VP16) as well as with the general transcription factor ps TFIIB pe.","label":1}
{"pair_id":"AIMed.d91.s781.p7","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator ps viral protein 16 pe (ps VP16 pe) as well as with the general transcription factor TFIIB.","label":0}
{"pair_id":"AIMed.d91.s781.p8","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator ps viral protein 16 pe (VP16) as well as with the general transcription factor ps TFIIB pe.","label":0}
{"pair_id":"AIMed.d91.s781.p9","sentence":"In vitro protein-protein interaction assays reveal that as observed with Drosophila TAFII40, hTAFII32 interacts with the C-terminal 39-amino acid activation domain of the acidic transactivator viral protein 16 (ps VP16 pe) as well as with the general transcription factor ps TFIIB pe.","label":0}
{"pair_id":"BioInfer.d803.s0.p0","sentence":"We find that ps profilin pe and ps cofilin pe regulate actin-filament formation throughout the cell cortex.","label":0}
{"pair_id":"BioInfer.d803.s0.p1","sentence":"We find that profilin and ps cofilin pe regulate ps actin pe-filament formation throughout the cell cortex.","label":1}
{"pair_id":"BioInfer.d803.s0.p2","sentence":"We find that ps profilin pe and cofilin regulate ps actin pe-filament formation throughout the cell cortex.","label":1}
{"pair_id":"AIMed.d151.s1284.p0","sentence":"The ps proximal sequence element (PSE)-binding transcription factor pe (ps PTF pe) specifically recognizes the PSEs of both RNA polymerase II- and RNA polymerase III-transcribed small nuclear RNA (snRNA) genes.","label":0}
{"pair_id":"BioInfer.d89.s0.p0","sentence":"BACKGROUND: Although ps profilin pe is believed to be an essential regulator of the ps actin pe cytoskeleton in most cells, its precise role in mammalian cells remains unknown.","label":1}
{"pair_id":"BioInfer.d797.s0.p0","sentence":"We believe that this complex may mediate the cortical functions of ps profilin pe at ps actin pe patches in S. pombe.","label":1}
{"pair_id":"AIMed.d125.s1067.p0","sentence":"ps Bcl-X-L pe displayed the same pattern of combinatorial interactions with ps Bcl-2 pe family proteins as Bcl-2.","label":0}
{"pair_id":"AIMed.d125.s1067.p1","sentence":"ps Bcl-X-L pe displayed the same pattern of combinatorial interactions with Bcl-2 family proteins as ps Bcl-2 pe.","label":0}
{"pair_id":"AIMed.d125.s1067.p2","sentence":"Bcl-X-L displayed the same pattern of combinatorial interactions with ps Bcl-2 pe family proteins as ps Bcl-2 pe.","label":0}
{"pair_id":"AIMed.d185.s1569.p0","sentence":"ps Stat3 pe recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the ps interleukin-10 pe receptor intracellular domain.","label":0}
{"pair_id":"AIMed.d185.s1569.p1","sentence":"ps Stat3 pe recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the ps interleukin-10 receptor pe intracellular domain.","label":1}
{"pair_id":"AIMed.d185.s1569.p2","sentence":"Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the ps interleukin-10 peps interleukin-10 receptor pe intracellular domain.","label":0}
{"pair_id":"AIMed.d180.s1534.p0","sentence":"ps PKC pe phosphorylates ps GAP-43 pe on serine 41.","label":1}
{"pair_id":"AIMed.d2.s23.p0","sentence":"MAIN OUTCOME MEASURES: ps RBP pe\/ps TTR pe molar ratio after 7 days hospitalisation.","label":0}
{"pair_id":"BioInfer.d375.s3.p0","sentence":"This model includes two different Kd's--one for ps profilin pe bound to actin monomers and one for ps profilin pe bound to an actin molecule at the barbed end of a filament.","label":0}
{"pair_id":"BioInfer.d375.s3.p1","sentence":"This model includes two different Kd's--one for ps profilin pe bound to ps actin pe monomers and one for profilin bound to an actin molecule at the barbed end of a filament.","label":1}
{"pair_id":"BioInfer.d375.s3.p2","sentence":"This model includes two different Kd's--one for ps profilin pe bound to actin monomers and one for profilin bound to an ps actin pe molecule at the barbed end of a filament.","label":0}
{"pair_id":"BioInfer.d375.s3.p3","sentence":"This model includes two different Kd's--one for profilin bound to ps actin pe monomers and one for ps profilin pe bound to an actin molecule at the barbed end of a filament.","label":0}
{"pair_id":"BioInfer.d375.s3.p4","sentence":"This model includes two different Kd's--one for profilin bound to actin monomers and one for ps profilin pe bound to an ps actin pe molecule at the barbed end of a filament.","label":1}
{"pair_id":"BioInfer.d375.s3.p5","sentence":"This model includes two different Kd's--one for profilin bound to ps actin pe monomers and one for profilin bound to an ps actin pe molecule at the barbed end of a filament.","label":0}
{"pair_id":"AIMed.d167.s1406.p0","sentence":"Following immunoprecipitation with an anticalnexin antiserum, a cross-linker-independent association was observed between ps GT155 pe and ps calnexin pe.","label":1}
{"pair_id":"BioInfer.d606.s0.p0","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral ps E1A pe-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and ps K03H1.10 pe (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p1","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral ps E1A pe-associated cellular protein ps p300 pe (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p2","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral ps E1A pe-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, ps R10E11.1 pe and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p3","sentence":"The domains in CBP that are involved in ps CREB pe binding and transcriptional activation are highly related to the adenoviral ps E1A pe-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p4","sentence":"The domains in ps CBP pe that are involved in CREB binding and transcriptional activation are highly related to the adenoviral ps E1A pe-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p5","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein ps p300 pe (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and ps K03H1.10 pe (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p6","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, ps R10E11.1 pe and ps K03H1.10 pe (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p7","sentence":"The domains in CBP that are involved in ps CREB pe binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and ps K03H1.10 pe (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p8","sentence":"The domains in ps CBP pe that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and ps K03H1.10 pe (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p9","sentence":"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein ps p300 pe (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, ps R10E11.1 pe and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p10","sentence":"The domains in CBP that are involved in ps CREB pe binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein ps p300 pe (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p11","sentence":"The domains in ps CBP pe that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein ps p300 pe (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p12","sentence":"The domains in CBP that are involved in ps CREB pe binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, ps R10E11.1 pe and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":0}
{"pair_id":"BioInfer.d606.s0.p13","sentence":"The domains in ps CBP pe that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, ps R10E11.1 pe and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"BioInfer.d606.s0.p14","sentence":"The domains in ps CBP pe that are involved in ps CREB pe binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.","label":1}
{"pair_id":"AIMed.d153.s1303.p0","sentence":"In keeping with this observation, we showed that human ps CD26 pe-transfected murine pre-B cell lines lacking human ps ADA pe acquired ADA from an extracellular source.","label":0}
{"pair_id":"AIMed.d153.s1303.p1","sentence":"In keeping with this observation, we showed that human ps CD26 pe-transfected murine pre-B cell lines lacking human ADA acquired ps ADA pe from an extracellular source.","label":0}
{"pair_id":"AIMed.d153.s1303.p2","sentence":"In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ps ADA pe acquired ps ADA pe from an extracellular source.","label":0}
{"pair_id":"BioInfer.d354.s0.p0","sentence":"ps Insulin-like growth factor-I pe, ps actin pe, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.","label":0}
{"pair_id":"BioInfer.d354.s0.p1","sentence":"Insulin-like growth factor-I, ps actin pe, and ps myosin heavy chain pe messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.","label":0}
{"pair_id":"BioInfer.d354.s0.p2","sentence":"ps Insulin-like growth factor-I pe, actin, and ps myosin heavy chain pe messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.","label":0}
{"pair_id":"AIMed.d92.s784.p0","sentence":"A potential interaction of ps p75 pe and ps trkA pe NGF receptors revealed by affinity crosslinking and immunoprecipitation.","label":0}
{"pair_id":"AIMed.d92.s784.p1","sentence":"A potential interaction of ps p75 pe and trkA ps NGF pe receptors revealed by affinity crosslinking and immunoprecipitation.","label":0}
{"pair_id":"AIMed.d92.s784.p2","sentence":"A potential interaction of p75 and ps trkA pe ps NGF pe receptors revealed by affinity crosslinking and immunoprecipitation.","label":0}
{"pair_id":"BioInfer.d517.s0.p0","sentence":"Removal of one nonhomologous DNA end during gene conversion by a ps RAD1 pe- and ps MSH2 pe-independent pathway.","label":0}
{"pair_id":"AIMed.d168.s1419.p0","sentence":"Furthermore, the F93A mutation in full-length ps EPOR pe expressed in COS cells abolished detectable ps EPO pe binding.","label":1}
{"pair_id":"BioInfer.d287.s1.p0","sentence":"We attribute the detection of ps actin pe and ps profilin pe to the applied cryomethods which yield a much better preservation of ultrastructure and antigenicity of delicate cytoskeletal constituents than conventional fixation techniques.","label":0}
{"pair_id":"BioInfer.d97.s1.p0","sentence":"ps Platelet talin pe binds to ps actin pe in vitro and hence is an actin binding protein.","label":1}
{"pair_id":"BioInfer.d97.s1.p1","sentence":"ps Platelet talin pe binds to actin in vitro and hence is an ps actin binding protein pe.","label":1}
{"pair_id":"BioInfer.d97.s1.p2","sentence":"Platelet talin binds to ps actin pe in vitro and hence is an ps actin binding protein pe.","label":0}
{"pair_id":"AIMed.d143.s1204.p0","sentence":"Involvement of ps IL-6 pe signal transducer ps gp130 pe in IL-11-mediated signal transduction.","label":0}
{"pair_id":"AIMed.d143.s1204.p1","sentence":"Involvement of ps IL-6 pe signal transducer gp130 in ps IL-11 pe-mediated signal transduction.","label":0}
{"pair_id":"AIMed.d143.s1204.p2","sentence":"Involvement of IL-6 signal transducer ps gp130 pe in ps IL-11 pe-mediated signal transduction.","label":0}
{"pair_id":"AIMed.d52.s464.p0","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p1","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p2","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or ps FGF10 pe and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p3","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of ps FGFR2 pe (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p4","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (ps FGFR2b pe) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p5","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by ps FGF2 pe, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p6","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, ps FGF6 pe, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p7","sentence":"We show that the S252W mutation allows the mesenchymal splice form of ps FGFR2 pe (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and ps FGF9 pe.","label":0}
{"pair_id":"AIMed.d52.s464.p8","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p9","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands FGF7 or ps FGF10 pe and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p10","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of ps FGFR2 pe (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p11","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (ps FGFR2b pe) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p12","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by ps FGF2 pe, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p13","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, ps FGF6 pe, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p14","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (ps FGFR2c pe) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and ps FGF9 pe.","label":0}
{"pair_id":"AIMed.d52.s464.p15","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or ps FGF10 pe and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p16","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or FGF10 and the epithelial splice form of ps FGFR2 pe (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p17","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or FGF10 and the epithelial splice form of FGFR2 (ps FGFR2b pe) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p18","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by ps FGF2 pe, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p19","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, ps FGF6 pe, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p20","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands ps FGF7 pe or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and ps FGF9 pe.","label":0}
{"pair_id":"AIMed.d52.s464.p21","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or ps FGF10 pe and the epithelial splice form of ps FGFR2 pe (FGFR2b) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p22","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or ps FGF10 pe and the epithelial splice form of FGFR2 (ps FGFR2b pe) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p23","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or ps FGF10 pe and the epithelial splice form of FGFR2 (FGFR2b) to be activated by ps FGF2 pe, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p24","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or ps FGF10 pe and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, ps FGF6 pe, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p25","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or ps FGF10 pe and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, FGF6, and ps FGF9 pe.","label":0}
{"pair_id":"AIMed.d52.s464.p26","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of ps FGFR2 pe (ps FGFR2b pe) to be activated by FGF2, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p27","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of ps FGFR2 pe (FGFR2b) to be activated by ps FGF2 pe, FGF6, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p28","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of ps FGFR2 pe (FGFR2b) to be activated by FGF2, ps FGF6 pe, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p29","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of ps FGFR2 pe (FGFR2b) to be activated by FGF2, FGF6, and ps FGF9 pe.","label":0}
{"pair_id":"AIMed.d52.s464.p30","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (ps FGFR2b pe) to be activated by ps FGF2 pe, FGF6, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p31","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (ps FGFR2b pe) to be activated by FGF2, ps FGF6 pe, and FGF9.","label":1}
{"pair_id":"AIMed.d52.s464.p32","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (ps FGFR2b pe) to be activated by FGF2, FGF6, and ps FGF9 pe.","label":1}
{"pair_id":"AIMed.d52.s464.p33","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by ps FGF2 pe, ps FGF6 pe, and FGF9.","label":0}
{"pair_id":"AIMed.d52.s464.p34","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by ps FGF2 pe, FGF6, and ps FGF9 pe.","label":0}
{"pair_id":"AIMed.d52.s464.p35","sentence":"We show that the S252W mutation allows the mesenchymal splice form of FGFR2 (FGFR2c) to bind and to be activated by the mesenchymally expressed ligands FGF7 or FGF10 and the epithelial splice form of FGFR2 (FGFR2b) to be activated by FGF2, ps FGF6 pe, and ps FGF9 pe.","label":0}
{"pair_id":"BioInfer.d76.s0.p0","sentence":"Armadillo (ps Arm pe) repeat 10 to the COOH terminus of beta-catenin is involved in binding to ps CBP pe, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p1","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to ps CBP pe, whereas ps beta-catenin pe interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p2","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to ps CBP pe, whereas beta-catenin interacts directly with the ps CREB pe-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p3","sentence":"ps Armadillo pe (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to ps CBP pe, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p4","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to ps CBP pe, whereas beta-catenin interacts directly with the CREB-binding domain of ps CBP pe.","label":0}
{"pair_id":"BioInfer.d76.s0.p5","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of ps beta-catenin pe is involved in binding to ps CBP pe, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p6","sentence":"Armadillo (ps Arm pe) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas ps beta-catenin pe interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p7","sentence":"Armadillo (ps Arm pe) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the ps CREB pe-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p8","sentence":"ps Armadillo pe (ps Arm pe) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p9","sentence":"Armadillo (ps Arm pe) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of ps CBP pe.","label":0}
{"pair_id":"BioInfer.d76.s0.p10","sentence":"Armadillo (ps Arm pe) repeat 10 to the COOH terminus of ps beta-catenin pe is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p11","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas ps beta-catenin pe interacts directly with the ps CREB pe-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p12","sentence":"ps Armadillo pe (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas ps beta-catenin pe interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p13","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas ps beta-catenin pe interacts directly with the CREB-binding domain of ps CBP pe.","label":1}
{"pair_id":"BioInfer.d76.s0.p14","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of ps beta-catenin pe is involved in binding to CBP, whereas ps beta-catenin pe interacts directly with the CREB-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p15","sentence":"ps Armadillo pe (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the ps CREB pe-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p16","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the ps CREB pe-binding domain of ps CBP pe.","label":1}
{"pair_id":"BioInfer.d76.s0.p17","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of ps beta-catenin pe is involved in binding to CBP, whereas beta-catenin interacts directly with the ps CREB pe-binding domain of CBP.","label":0}
{"pair_id":"BioInfer.d76.s0.p18","sentence":"ps Armadillo pe (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of ps CBP pe.","label":0}
{"pair_id":"BioInfer.d76.s0.p19","sentence":"ps Armadillo pe (Arm) repeat 10 to the COOH terminus of ps beta-catenin pe is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.","label":1}
{"pair_id":"BioInfer.d76.s0.p20","sentence":"Armadillo (Arm) repeat 10 to the COOH terminus of ps beta-catenin pe is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of ps CBP pe.","label":0}
{"pair_id":"AIMed.d92.s787.p0","sentence":"Here we have utilized affinity crosslinking agents with 125I-NGF to detect an association of ps trkA pe and ps p75 pe receptors in embryonic spinal cord and brain tissues enriched in the two receptors.","label":0}
{"pair_id":"AIMed.d100.s850.p0","sentence":"Recombinant ps hTAFII250 pe binds directly to ps TBP pe both in vitro and in yeast, and participates in the formation of the TFIID complex.","label":1}
{"pair_id":"AIMed.d100.s850.p1","sentence":"Recombinant ps hTAFII250 pe binds directly to TBP both in vitro and in yeast, and participates in the formation of the ps TFIID pe complex.","label":0}
{"pair_id":"AIMed.d100.s850.p2","sentence":"Recombinant hTAFII250 binds directly to ps TBP pe both in vitro and in yeast, and participates in the formation of the ps TFIID pe complex.","label":0}
{"pair_id":"AIMed.d95.s803.p0","sentence":"The crystal structure of the human ps cyclinA pe-ps cyclin-dependent kinase2 pe (CDK2)-ATP complex has been determined at 2.3 A resolution.","label":1}
{"pair_id":"AIMed.d95.s803.p1","sentence":"The crystal structure of the human ps cyclinA pe-cyclin-dependent kinase2 (ps CDK2 pe)-ATP complex has been determined at 2.3 A resolution.","label":1}
{"pair_id":"AIMed.d95.s803.p2","sentence":"The crystal structure of the human cyclinA-ps cyclin-dependent kinase2 pe (ps CDK2 pe)-ATP complex has been determined at 2.3 A resolution.","label":0}
{"pair_id":"BioInfer.d817.s0.p0","sentence":"We previously showed that ps actin pe is transported in an unassembled form with its associated proteins actin depolymerizing factor, ps cofilin pe, and profilin.","label":1}
{"pair_id":"BioInfer.d817.s0.p1","sentence":"We previously showed that ps actin pe is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and ps profilin pe.","label":1}
{"pair_id":"BioInfer.d817.s0.p2","sentence":"We previously showed that ps actin pe is transported in an unassembled form with its associated proteins ps actin depolymerizing factor pe, cofilin, and profilin.","label":1}
{"pair_id":"BioInfer.d817.s0.p3","sentence":"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, ps cofilin pe, and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d817.s0.p4","sentence":"We previously showed that actin is transported in an unassembled form with its associated proteins ps actin depolymerizing factor pe, ps cofilin pe, and profilin.","label":0}
{"pair_id":"BioInfer.d817.s0.p5","sentence":"We previously showed that actin is transported in an unassembled form with its associated proteins ps actin depolymerizing factor pe, cofilin, and ps profilin pe.","label":0}
{"pair_id":"AIMed.d184.s1564.p0","sentence":"The apparent affinity of the interaction between ps gp120 pe and ps CCR-5 pe was dramatically lower in the absence of soluble CD4.","label":1}
{"pair_id":"AIMed.d184.s1564.p1","sentence":"The apparent affinity of the interaction between ps gp120 pe and CCR-5 was dramatically lower in the absence of soluble ps CD4 pe.","label":0}
{"pair_id":"AIMed.d184.s1564.p2","sentence":"The apparent affinity of the interaction between gp120 and ps CCR-5 pe was dramatically lower in the absence of soluble ps CD4 pe.","label":0}
{"pair_id":"AIMed.d218.s1893.p0","sentence":"Phage enzyme-linked immunosorbent assay was used to determine affinities for binding to both the ps TPO pe receptor and five anti-ps TPO1 pe-153 monoclonal antibodies.","label":0}
{"pair_id":"AIMed.d39.s339.p0","sentence":"Immunoelectronmicroscopic analysis showed that ps QM pe\/ps Jif-1 pe and PS1 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.","label":0}
{"pair_id":"AIMed.d39.s339.p1","sentence":"Immunoelectronmicroscopic analysis showed that ps QM pe\/Jif-1 and ps PS1 pe are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.","label":0}
{"pair_id":"AIMed.d39.s339.p2","sentence":"Immunoelectronmicroscopic analysis showed that QM\/ps Jif-1 pe and ps PS1 pe are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.","label":0}
{"pair_id":"BioInfer.d822.s0.p0","sentence":"We speculate that ps fimbrin pe may help maintain the parallel growth of ps actin pe filaments within the stereocilia.","label":1}
{"pair_id":"AIMed.d29.s249.p0","sentence":"This study demonstrates that ps IL-8 pe recognizes and activates ps CXCR1 pe, CXCR2, and the Duffy antigen by distinct mechanisms.","label":1}
{"pair_id":"AIMed.d29.s249.p1","sentence":"This study demonstrates that ps IL-8 pe recognizes and activates CXCR1, ps CXCR2 pe, and the Duffy antigen by distinct mechanisms.","label":1}
{"pair_id":"AIMed.d29.s249.p2","sentence":"This study demonstrates that ps IL-8 pe recognizes and activates CXCR1, CXCR2, and the ps Duffy antigen pe by distinct mechanisms.","label":1}
{"pair_id":"AIMed.d29.s249.p3","sentence":"This study demonstrates that IL-8 recognizes and activates ps CXCR1 pe, ps CXCR2 pe, and the Duffy antigen by distinct mechanisms.","label":0}
{"pair_id":"AIMed.d29.s249.p4","sentence":"This study demonstrates that IL-8 recognizes and activates ps CXCR1 pe, CXCR2, and the ps Duffy antigen pe by distinct mechanisms.","label":0}
{"pair_id":"AIMed.d29.s249.p5","sentence":"This study demonstrates that IL-8 recognizes and activates CXCR1, ps CXCR2 pe, and the ps Duffy antigen pe by distinct mechanisms.","label":0}
{"pair_id":"AIMed.d160.s1350.p0","sentence":"Endothelial cell mitogenesis was abolished in mutants lacking ps KDR pe affinity; however, ps FLT-1 pe deficient mutants induced normal proliferation.","label":0}
{"pair_id":"BioInfer.d405.s0.p0","sentence":"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an ps actin-depolymerizing factor pe, and regulates ps actin pe cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p1","sentence":"LIM-kinase 1 (LIMK1) phosphorylates ps cofilin pe, an actin-depolymerizing factor, and regulates ps actin pe cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p2","sentence":"LIM-kinase 1 (ps LIMK1 pe) phosphorylates cofilin, an actin-depolymerizing factor, and regulates ps actin pe cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p3","sentence":"ps LIM-kinase 1 pe (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates ps actin pe cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p4","sentence":"LIM-kinase 1 (LIMK1) phosphorylates ps cofilin pe, an ps actin-depolymerizing factor pe, and regulates actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p5","sentence":"LIM-kinase 1 (ps LIMK1 pe) phosphorylates cofilin, an ps actin-depolymerizing factor pe, and regulates actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p6","sentence":"ps LIM-kinase 1 pe (LIMK1) phosphorylates cofilin, an ps actin-depolymerizing factor pe, and regulates actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d405.s0.p7","sentence":"LIM-kinase 1 (ps LIMK1 pe) phosphorylates ps cofilin pe, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p8","sentence":"ps LIM-kinase 1 pe (LIMK1) phosphorylates ps cofilin pe, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d405.s0.p9","sentence":"ps LIM-kinase 1 pe (ps LIMK1 pe) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d471.s2.p0","sentence":"Selective monoclonal antibodies confirm that most of the ps profilin pe is bound to ps actin pe: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.","label":1}
{"pair_id":"AIMed.d70.s600.p0","sentence":"Mutation of Ala-522 to proline, which is located outside the predicted amphipathic helix region, had no effect on ps RII peps RII alpha pe binding.","label":0}
{"pair_id":"BioInfer.d447.s1.p0","sentence":"Recombinant ps HSH49 pe protein has a general RNA-binding activity that does not require ps CUS1 pe.","label":1}
{"pair_id":"AIMed.d150.s1273.p0","sentence":"Regulation of the ps Ets pe-related transcription factor ps Elf-1 pe by binding to the retinoblastoma protein.","label":0}
{"pair_id":"AIMed.d150.s1273.p1","sentence":"Regulation of the ps Ets pe-related transcription factor Elf-1 by binding to the ps retinoblastoma pe protein.","label":0}
{"pair_id":"AIMed.d150.s1273.p2","sentence":"Regulation of the Ets-related transcription factor ps Elf-1 pe by binding to the ps retinoblastoma pe protein.","label":1}
{"pair_id":"BioInfer.d602.s0.p0","sentence":"The C-terminal region of ORC3 was, however, necessary to bring ps ORC4 pe and ps ORC5 pe into the core complex.","label":1}
{"pair_id":"BioInfer.d602.s0.p1","sentence":"The C-terminal region of ps ORC3 pe was, however, necessary to bring ps ORC4 pe and ORC5 into the core complex.","label":1}
{"pair_id":"BioInfer.d602.s0.p2","sentence":"The C-terminal region of ps ORC3 pe was, however, necessary to bring ORC4 and ps ORC5 pe into the core complex.","label":1}
{"pair_id":"AIMed.d224.s1949.p0","sentence":"We demonstrate that ps HLA-E pe surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to ps HLA-E pe.","label":0}
{"pair_id":"AIMed.d80.s686.p0","sentence":"Overexpression of ps FADD pe in MCF7 and BJAB cells induces apoptosis, which, like ps Fas pe-induced apoptosis, is blocked by CrmA, a specific inhibitor of the interleukin-1 beta-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p1","sentence":"Overexpression of ps FADD pe in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by ps CrmA pe, a specific inhibitor of the interleukin-1 beta-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p2","sentence":"Overexpression of ps FADD pe in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the ps interleukin-1 beta pe-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p3","sentence":"Overexpression of ps FADD pe in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the ps interleukin-1 beta-converting enzyme pe.","label":0}
{"pair_id":"AIMed.d80.s686.p4","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like ps Fas pe-induced apoptosis, is blocked by ps CrmA pe, a specific inhibitor of the interleukin-1 beta-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p5","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like ps Fas pe-induced apoptosis, is blocked by CrmA, a specific inhibitor of the ps interleukin-1 beta pe-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p6","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like ps Fas pe-induced apoptosis, is blocked by CrmA, a specific inhibitor of the ps interleukin-1 beta-converting enzyme pe.","label":0}
{"pair_id":"AIMed.d80.s686.p7","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by ps CrmA pe, a specific inhibitor of the ps interleukin-1 beta pe-converting enzyme.","label":0}
{"pair_id":"AIMed.d80.s686.p8","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by ps CrmA pe, a specific inhibitor of the ps interleukin-1 beta-converting enzyme pe.","label":1}
{"pair_id":"AIMed.d80.s686.p9","sentence":"Overexpression of FADD in MCF7 and BJAB cells induces apoptosis, which, like Fas-induced apoptosis, is blocked by CrmA, a specific inhibitor of the ps interleukin-1 beta peps interleukin-1 beta-converting enzyme pe.","label":0}
{"pair_id":"BioInfer.d620.s0.p0","sentence":"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, ps UL8 pe, and ps UL52 pe genes.","label":0}
{"pair_id":"BioInfer.d620.s0.p1","sentence":"The herpes simplex virus type-1 ps DNA helicase-primase pe is a heterotrimer encoded by the UL5, ps UL8 pe, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d620.s0.p2","sentence":"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the ps UL5 pe, ps UL8 pe, and UL52 genes.","label":0}
{"pair_id":"BioInfer.d620.s0.p3","sentence":"The herpes simplex virus type-1 ps DNA helicase-primase pe is a heterotrimer encoded by the UL5, UL8, and ps UL52 pe genes.","label":1}
{"pair_id":"BioInfer.d620.s0.p4","sentence":"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the ps UL5 pe, UL8, and ps UL52 pe genes.","label":0}
{"pair_id":"BioInfer.d620.s0.p5","sentence":"The herpes simplex virus type-1 ps DNA helicase-primase pe is a heterotrimer encoded by the ps UL5 pe, UL8, and UL52 genes.","label":1}
{"pair_id":"AIMed.d157.s1330.p0","sentence":"The subcellular distributions of ps PKC pe and ps AKAP79 pe were similar in neurons.","label":0}
{"pair_id":"AIMed.d30.s253.p0","sentence":"These results suggest that ps PS1 pe and ps PS2 pe partly differ in function.","label":0}
{"pair_id":"BioInfer.d216.s0.p0","sentence":"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that ps E-APC pe also requires ps actin pe filaments to associate with adhesive cell membranes in the ovary.","label":1}
{"pair_id":"BioInfer.d216.s0.p1","sentence":"From an analysis of ps profilin pe mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires ps actin pe filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p2","sentence":"From an analysis of profilin mutants, whose ps actin pe cytoskeleton is disrupted, we found that E-APC also requires ps actin pe filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p3","sentence":"From an analysis of ps profilin pe mutants, whose actin cytoskeleton is disrupted, we found that ps E-APC pe also requires actin filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p4","sentence":"From an analysis of profilin mutants, whose ps actin pe cytoskeleton is disrupted, we found that ps E-APC pe also requires actin filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"BioInfer.d216.s0.p5","sentence":"From an analysis of ps profilin pe mutants, whose ps actin pe cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.","label":0}
{"pair_id":"AIMed.d164.s1383.p0","sentence":"Thus, ps U2AF35 pe functions as a bridge between ps U2AF65 pe and the enhancer complex to recruit U2AF65 to the adjacent intron.","label":0}
{"pair_id":"AIMed.d164.s1383.p1","sentence":"Thus, ps U2AF35 pe functions as a bridge between U2AF65 and the enhancer complex to recruit ps U2AF65 pe to the adjacent intron.","label":0}
{"pair_id":"AIMed.d164.s1383.p2","sentence":"Thus, U2AF35 functions as a bridge between ps U2AF65 pe and the enhancer complex to recruit ps U2AF65 pe to the adjacent intron.","label":0}
{"pair_id":"BioInfer.d448.s0.p0","sentence":"ps Myo2p pe shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and ps actin pe.","label":1}
{"pair_id":"BioInfer.d448.s0.p1","sentence":"Myo2p shows homology to the head domains and the coiledcoil tail of the conventional ps type II myosin heavy chain pe and carries putative binding sites for ATP and ps actin pe.","label":0}
{"pair_id":"BioInfer.d448.s0.p2","sentence":"ps Myo2p pe shows homology to the head domains and the coiledcoil tail of the conventional ps type II myosin heavy chain pe and carries putative binding sites for ATP and actin.","label":1}
{"pair_id":"BioInfer.d139.s0.p0","sentence":"Characterization of the action of porcine ps brain profilin pe on ps actin pe polymerization.","label":1}
{"pair_id":"AIMed.d41.s355.p0","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of ps HFE pe and ps TfR pe shows two HFE molecules which grasp each side of a twofold symmetric TfR dimer.","label":1}
{"pair_id":"AIMed.d41.s355.p1","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of ps HFE pe and TfR shows two ps HFE pe molecules which grasp each side of a twofold symmetric TfR dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p2","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of ps HFE pe and TfR shows two HFE molecules which grasp each side of a twofold symmetric ps TfR pe dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p3","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of HFE and ps TfR pe shows two ps HFE pe molecules which grasp each side of a twofold symmetric TfR dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p4","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of HFE and ps TfR pe shows two HFE molecules which grasp each side of a twofold symmetric ps TfR pe dimer.","label":0}
{"pair_id":"AIMed.d41.s355.p5","sentence":"The 2.8 A crystal structure of a complex between the extracellular portions of HFE and TfR shows two ps HFE pe molecules which grasp each side of a twofold symmetric ps TfR pe dimer.","label":1}
{"pair_id":"BioInfer.d103.s0.p0","sentence":"Bistratene A causes phosphorylation of ps talin pe and redistribution of ps actin pe microfilaments in fibroblasts: possible role for PKC-delta.","label":0}
{"pair_id":"BioInfer.d103.s0.p1","sentence":"Bistratene A causes phosphorylation of talin and redistribution of ps actin pe microfilaments in fibroblasts: possible role for ps PKC-delta pe.","label":1}
{"pair_id":"BioInfer.d103.s0.p2","sentence":"Bistratene A causes phosphorylation of ps talin pe and redistribution of actin microfilaments in fibroblasts: possible role for ps PKC-delta pe.","label":1}
{"pair_id":"AIMed.d94.s798.p0","sentence":"ps CC CKR3 pe is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor ps CC CKR1 pe (also known as the MIP-1 alpha\/RANTES receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p1","sentence":"ps CC CKR3 pe is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the ps MIP-1 alpha pe\/RANTES receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p2","sentence":"ps CC CKR3 pe is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha\/ps RANTES pe receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p3","sentence":"CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor ps CC CKR1 pe (also known as the ps MIP-1 alpha pe\/RANTES receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p4","sentence":"CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor ps CC CKR1 pe (also known as the MIP-1 alpha\/ps RANTES pe receptor).","label":0}
{"pair_id":"AIMed.d94.s798.p5","sentence":"CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the ps MIP-1 alpha pe\/ps RANTES pe receptor).","label":0}
{"pair_id":"AIMed.d10.s84.p0","sentence":"We postulate that the mechanism of bone induction is based on the secretion of bone morphogenetic proteins ps BMP-4 pe and ps BMP-6 pe by the grafted HeLa cells.","label":0}
{"pair_id":"AIMed.d144.s1216.p0","sentence":"The ps retinoblastoma protein pe associates with the ps protein phosphatase type 1 pe catalytic subunit.","label":1}
{"pair_id":"BioInfer.d270.s0.p0","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including ps actin pe (twofold to threefold), vimentin (2.5-fold to sevenfold), ps tropomyosin pe (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p1","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including ps actin pe (twofold to threefold), ps vimentin pe (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p2","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including ps actin pe (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and ps myosin heavy chain pe, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p3","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), ps vimentin pe (2.5-fold to sevenfold), ps tropomyosin pe (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p4","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), ps tropomyosin pe (threefold to sixfold), and ps myosin heavy chain pe, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d270.s0.p5","sentence":"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), ps vimentin pe (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and ps myosin heavy chain pe, far exceeding overall increases in cellular protein content (20-40%).","label":0}
{"pair_id":"BioInfer.d663.s0.p0","sentence":"The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the ps cyclin-dependent kinase inhibitor pe p27(ps Kip1 pe).","label":1}
{"pair_id":"BioInfer.d663.s0.p1","sentence":"The potentiating effect of insulin appears to involve increases in the expression of ps cyclin E pe and decreases in the expression of the ps cyclin-dependent kinase inhibitor pe p27(Kip1).","label":0}
{"pair_id":"BioInfer.d663.s0.p2","sentence":"The potentiating effect of ps insulin pe appears to involve increases in the expression of cyclin E and decreases in the expression of the ps cyclin-dependent kinase inhibitor pe p27(Kip1).","label":0}
{"pair_id":"BioInfer.d663.s0.p3","sentence":"The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the ps cyclin-dependent kinase inhibitor pe ps p27 pe(Kip1).","label":1}
{"pair_id":"BioInfer.d663.s0.p4","sentence":"The potentiating effect of insulin appears to involve increases in the expression of ps cyclin E pe and decreases in the expression of the cyclin-dependent kinase inhibitor p27(ps Kip1 pe).","label":0}
{"pair_id":"BioInfer.d663.s0.p5","sentence":"The potentiating effect of ps insulin pe appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(ps Kip1 pe).","label":1}
{"pair_id":"BioInfer.d663.s0.p6","sentence":"The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor ps p27 pe(ps Kip1 pe).","label":0}
{"pair_id":"BioInfer.d663.s0.p7","sentence":"The potentiating effect of ps insulin pe appears to involve increases in the expression of ps cyclin E pe and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).","label":1}
{"pair_id":"BioInfer.d663.s0.p8","sentence":"The potentiating effect of insulin appears to involve increases in the expression of ps cyclin E pe and decreases in the expression of the cyclin-dependent kinase inhibitor ps p27 pe(Kip1).","label":0}
{"pair_id":"BioInfer.d663.s0.p9","sentence":"The potentiating effect of ps insulin pe appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor ps p27 pe(Kip1).","label":1}
{"pair_id":"AIMed.d220.s1911.p0","sentence":"Two distinct ligand binding domains of ps TRKB pe were isolated from proteolytic digests of the receptor by affinity separation on immobilized ps BDNF pe.","label":0}
{"pair_id":"AIMed.d112.s950.p0","sentence":"Crosslinking of cell surface IgM led to rapid activation of both tyrosine and serine\/threonine protein kinase activities that resulted in phosphorylation in vitro of proteins coprecipitating with ps Syk pe--in particular, a serine\/threonine phosphorylated protein 120 kDa in size (ps pp120 pe).","label":0}
{"pair_id":"AIMed.d59.s523.p0","sentence":"The results show that ps myogenin pe heterodimerizes with ps E12 pe and E47 in vivo, but it does not homodimerize to a measurable extent.","label":1}
{"pair_id":"AIMed.d59.s523.p1","sentence":"The results show that ps myogenin pe heterodimerizes with E12 and ps E47 pe in vivo, but it does not homodimerize to a measurable extent.","label":1}
{"pair_id":"AIMed.d59.s523.p2","sentence":"The results show that myogenin heterodimerizes with ps E12 pe and ps E47 pe in vivo, but it does not homodimerize to a measurable extent.","label":0}
{"pair_id":"BioInfer.d167.s0.p0","sentence":"Deletion of ps SIR4 pe enhanced ps mURA3 pe and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p1","sentence":"Deletion of SIR4 enhanced ps mURA3 pe and MET15 silencing, but deletion of SIR1 or ps SIR3 pe did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p2","sentence":"Deletion of SIR4 enhanced ps mURA3 pe and MET15 silencing, but deletion of ps SIR1 pe or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p3","sentence":"Deletion of SIR4 enhanced ps mURA3 pe and ps MET15 pe silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p4","sentence":"Deletion of ps SIR4 pe enhanced mURA3 and MET15 silencing, but deletion of SIR1 or ps SIR3 pe did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p5","sentence":"Deletion of ps SIR4 pe enhanced mURA3 and MET15 silencing, but deletion of ps SIR1 pe or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p6","sentence":"Deletion of ps SIR4 pe enhanced mURA3 and ps MET15 pe silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p7","sentence":"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of ps SIR1 pe or ps SIR3 pe did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":0}
{"pair_id":"BioInfer.d167.s0.p8","sentence":"Deletion of SIR4 enhanced mURA3 and ps MET15 pe silencing, but deletion of SIR1 or ps SIR3 pe did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"BioInfer.d167.s0.p9","sentence":"Deletion of SIR4 enhanced mURA3 and ps MET15 pe silencing, but deletion of ps SIR1 pe or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.","label":1}
{"pair_id":"AIMed.d160.s1347.p0","sentence":"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding ps KDR pe\/ps Flk-1 pe, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with FLT-1 binding.","label":0}
{"pair_id":"AIMed.d160.s1347.p1","sentence":"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding ps KDR pe\/Flk-1, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with ps FLT-1 pe binding.","label":0}
{"pair_id":"AIMed.d160.s1347.p2","sentence":"Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding KDR\/ps Flk-1 pe, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with ps FLT-1 pe binding.","label":0}
{"pair_id":"BioInfer.d584.s0.p0","sentence":"The ps myosin heavy chain pe (ps MHC pe) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.","label":0}
{"pair_id":"BioInfer.d584.s0.p1","sentence":"The ps myosin heavy chain pe (MHC) contains the ps actin pe- and ATP-binding sites and represents the molecular motor of muscle contraction.","label":1}
{"pair_id":"BioInfer.d584.s0.p2","sentence":"The myosin heavy chain (ps MHC pe) contains the ps actin pe- and ATP-binding sites and represents the molecular motor of muscle contraction.","label":1}
{"pair_id":"BioInfer.d97.s0.p0","sentence":"Binding of ps talin pe to ps actin pe occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.","label":1}
{"pair_id":"AIMed.d187.s1589.p0","sentence":"ps Transthyretin pe (ps TTR pe), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation.","label":0}
{"pair_id":"AIMed.d187.s1589.p1","sentence":"ps Transthyretin pe (TTR), a second major CSF protein, formed SDS-stable complexes with ps A beta pe and significantly decreased the rate of A beta fibril formation.","label":1}
{"pair_id":"AIMed.d187.s1589.p2","sentence":"ps Transthyretin pe (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of ps A beta pe fibril formation.","label":0}
{"pair_id":"AIMed.d187.s1589.p3","sentence":"Transthyretin (ps TTR pe), a second major CSF protein, formed SDS-stable complexes with ps A beta pe and significantly decreased the rate of A beta fibril formation.","label":1}
{"pair_id":"AIMed.d187.s1589.p4","sentence":"Transthyretin (ps TTR pe), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of ps A beta pe fibril formation.","label":0}
{"pair_id":"AIMed.d187.s1589.p5","sentence":"Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with ps A beta pe and significantly decreased the rate of ps A beta pe fibril formation.","label":0}
{"pair_id":"BioInfer.d397.s1.p0","sentence":"Regulation of ps myosin heavy chain pe and ps actin pe isogenes expression during cardiac growth.","label":0}
{"pair_id":"BioInfer.d33.s1.p0","sentence":"Loss of normal surface ps E-cadherin pe, alpha-catenin, ps beta-catenin pe and gamma-catenin expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p1","sentence":"Loss of normal surface E-cadherin, alpha-catenin, ps beta-catenin pe and ps gamma-catenin pe expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p2","sentence":"Loss of normal surface E-cadherin, ps alpha-catenin pe, ps beta-catenin pe and gamma-catenin expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p3","sentence":"Loss of normal surface ps E-cadherin pe, alpha-catenin, beta-catenin and ps gamma-catenin pe expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p4","sentence":"Loss of normal surface ps E-cadherin pe, ps alpha-catenin pe, beta-catenin and gamma-catenin expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d33.s1.p5","sentence":"Loss of normal surface E-cadherin, ps alpha-catenin pe, beta-catenin and ps gamma-catenin pe expression was found in 52\/68 (76.4%) tumors, 57\/68 (83.8%) tumors, 54\/68 (79.4%) tumors and 54\/68 (79.4%) tumors (p <0.001).","label":0}
{"pair_id":"BioInfer.d143.s1.p0","sentence":"The ps actin pe-sequestering activity of both maize ps profilin pe classes was found to be dependent on the concentration of free calcium.","label":1}
{"pair_id":"BioInfer.d574.s0.p0","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (ps F pe), phosphoprotein (P), H, nucleocapsid (N) and matrix (ps M pe) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p1","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, ps nucleocapsid pe (N) and matrix (ps M pe) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p2","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (ps P pe), H, nucleocapsid (N) and matrix (ps M pe) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p3","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (ps N pe) and matrix (ps M pe) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p4","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), ps H pe, nucleocapsid (N) and matrix (ps M pe) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p5","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (ps M pe) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p6","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and ps matrix pe (ps M pe) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p7","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), ps phosphoprotein pe (P), H, nucleocapsid (N) and matrix (ps M pe) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p8","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (ps F pe), phosphoprotein (P), H, ps nucleocapsid pe (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p9","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (ps F pe), phosphoprotein (ps P pe), H, nucleocapsid (N) and matrix (M) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p10","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (ps F pe), phosphoprotein (P), H, nucleocapsid (ps N pe) and matrix (M) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p11","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (ps F pe), phosphoprotein (P), ps H pe, nucleocapsid (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p12","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (ps F pe), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p13","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (ps F pe), phosphoprotein (P), H, nucleocapsid (N) and ps matrix pe (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p14","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (ps F pe), ps phosphoprotein pe (P), H, nucleocapsid (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p15","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (ps P pe), H, ps nucleocapsid pe (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p16","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, ps nucleocapsid pe (ps N pe) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p17","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), ps H pe, ps nucleocapsid pe (N) and matrix (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p18","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (F), phosphoprotein (P), H, ps nucleocapsid pe (N) and matrix (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p19","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, ps nucleocapsid pe (N) and ps matrix pe (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p20","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), ps phosphoprotein pe (P), H, ps nucleocapsid pe (N) and matrix (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p21","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (ps P pe), H, nucleocapsid (ps N pe) and matrix (M) phosphop.","label":0}
{"pair_id":"BioInfer.d574.s0.p22","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (ps P pe), ps H pe, nucleocapsid (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p23","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (F), phosphoprotein (ps P pe), H, nucleocapsid (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p24","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (ps P pe), H, nucleocapsid (N) and ps matrix pe (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p25","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), ps phosphoprotein pe (ps P pe), H, nucleocapsid (N) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p26","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), ps H pe, nucleocapsid (ps N pe) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p27","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (F), phosphoprotein (P), H, nucleocapsid (ps N pe) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p28","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (ps N pe) and ps matrix pe (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p29","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), ps phosphoprotein pe (P), H, nucleocapsid (ps N pe) and matrix (M) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p30","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (F), phosphoprotein (P), ps H pe, nucleocapsid (N) and matrix (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p31","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), ps H pe, nucleocapsid (N) and ps matrix pe (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p32","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), ps phosphoprotein pe (P), ps H pe, nucleocapsid (N) and matrix (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p33","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (F), phosphoprotein (P), H, nucleocapsid (N) and ps matrix pe (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p34","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the ps fusion pe (F), ps phosphoprotein pe (P), H, nucleocapsid (N) and matrix (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d574.s0.p35","sentence":"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), ps phosphoprotein pe (P), H, nucleocapsid (N) and ps matrix pe (M) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"AIMed.d48.s426.p0","sentence":"A neutralizing polyclonal antibody to ps LEC pe was developed to demonstrate that the unusually high concentration of ps LEC pe required to induce chemotaxis was a property of LEC and not as a result of an irrelevant protein contamination.","label":0}
{"pair_id":"AIMed.d48.s426.p1","sentence":"A neutralizing polyclonal antibody to ps LEC pe was developed to demonstrate that the unusually high concentration of LEC required to induce chemotaxis was a property of ps LEC pe and not as a result of an irrelevant protein contamination.","label":0}
{"pair_id":"AIMed.d48.s426.p2","sentence":"A neutralizing polyclonal antibody to LEC was developed to demonstrate that the unusually high concentration of ps LEC pe required to induce chemotaxis was a property of ps LEC pe and not as a result of an irrelevant protein contamination.","label":0}
{"pair_id":"BioInfer.d479.s0.p0","sentence":"ps p21 pe (p21WAF1\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (ps PCNA pe).","label":1}
{"pair_id":"BioInfer.d479.s0.p1","sentence":"ps p21 pe (p21WAF1\/ps Cip1 pe), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":0}
{"pair_id":"BioInfer.d479.s0.p2","sentence":"ps p21 pe (ps p21WAF1 pe\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":0}
{"pair_id":"BioInfer.d479.s0.p3","sentence":"ps p21 pe (p21WAF1\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the ps proliferating cell nuclear antigen pe (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p4","sentence":"ps p21 pe (p21WAF1\/Cip1), a ps cyclin-dependent kinase inhibitor pe, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p5","sentence":"p21 (p21WAF1\/ps Cip1 pe), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (ps PCNA pe).","label":1}
{"pair_id":"BioInfer.d479.s0.p6","sentence":"p21 (ps p21WAF1 pe\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (ps PCNA pe).","label":1}
{"pair_id":"BioInfer.d479.s0.p7","sentence":"p21 (p21WAF1\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the ps proliferating cell nuclear antigen pe (ps PCNA pe).","label":0}
{"pair_id":"BioInfer.d479.s0.p8","sentence":"p21 (p21WAF1\/Cip1), a ps cyclin-dependent kinase inhibitor pe, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (ps PCNA pe).","label":0}
{"pair_id":"BioInfer.d479.s0.p9","sentence":"p21 (ps p21WAF1 pe\/ps Cip1 pe), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":0}
{"pair_id":"BioInfer.d479.s0.p10","sentence":"p21 (p21WAF1\/ps Cip1 pe), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the ps proliferating cell nuclear antigen pe (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p11","sentence":"p21 (p21WAF1\/ps Cip1 pe), a ps cyclin-dependent kinase inhibitor pe, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p12","sentence":"p21 (ps p21WAF1 pe\/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the ps proliferating cell nuclear antigen pe (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p13","sentence":"p21 (ps p21WAF1 pe\/Cip1), a ps cyclin-dependent kinase inhibitor pe, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).","label":1}
{"pair_id":"BioInfer.d479.s0.p14","sentence":"p21 (p21WAF1\/Cip1), a ps cyclin-dependent kinase inhibitor pe, induces G1 arrest and can inhibit the activity of the ps proliferating cell nuclear antigen pe (PCNA).","label":0}
{"pair_id":"BioInfer.d113.s2.p0","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (ps EGFR pe) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from ps E-cadherin pe.","label":0}
{"pair_id":"BioInfer.d113.s2.p1","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of ps beta-catenin pe with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from ps E-cadherin pe.","label":0}
{"pair_id":"BioInfer.d113.s2.p2","sentence":"Tyrosine phosphorylation of ps beta-catenin pe was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from ps E-cadherin pe.","label":0}
{"pair_id":"BioInfer.d113.s2.p3","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with ps EGF receptor pe (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from ps E-cadherin pe.","label":0}
{"pair_id":"BioInfer.d113.s2.p4","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of ps alpha-catenin pe from ps E-cadherin pe.","label":1}
{"pair_id":"BioInfer.d113.s2.p5","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of ps beta-catenin pe with EGF receptor (ps EGFR pe) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p6","sentence":"Tyrosine phosphorylation of ps beta-catenin pe was concomitantly induced with association of beta-catenin with EGF receptor (ps EGFR pe) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p7","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with ps EGF receptor pe (ps EGFR pe) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p8","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (ps EGFR pe) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of ps alpha-catenin pe from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p9","sentence":"Tyrosine phosphorylation of ps beta-catenin pe was concomitantly induced with association of ps beta-catenin pe with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p10","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of ps beta-catenin pe with ps EGF receptor pe (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p11","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of ps beta-catenin pe with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of ps alpha-catenin pe from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p12","sentence":"Tyrosine phosphorylation of ps beta-catenin pe was concomitantly induced with association of beta-catenin with ps EGF receptor pe (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.","label":1}
{"pair_id":"BioInfer.d113.s2.p13","sentence":"Tyrosine phosphorylation of ps beta-catenin pe was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of ps alpha-catenin pe from E-cadherin.","label":0}
{"pair_id":"BioInfer.d113.s2.p14","sentence":"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with ps EGF receptor pe (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of ps alpha-catenin pe from E-cadherin.","label":0}
{"pair_id":"AIMed.d131.s1120.p0","sentence":"cDNA clones encoding a human ps IL-10R pe (ps hIL-10R pe) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds hIL-10 specifically.","label":0}
{"pair_id":"AIMed.d131.s1120.p1","sentence":"cDNA clones encoding a human ps IL-10R pe (hIL-10R) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds ps hIL-10 pe specifically.","label":1}
{"pair_id":"AIMed.d131.s1120.p2","sentence":"cDNA clones encoding a human IL-10R (ps hIL-10R pe) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds ps hIL-10 pe specifically.","label":1}
{"pair_id":"BioInfer.d66.s0.p0","sentence":"Another ps cyclin-dependent kinase inhibitor pe, p27KIP1, and cyclin D increased slightly, whereas ps proliferating cell nuclear antigen pe and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p1","sentence":"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas ps proliferating cell nuclear antigen pe and ps p130 pe remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p2","sentence":"Another cyclin-dependent kinase inhibitor, ps p27KIP1 pe, and cyclin D increased slightly, whereas ps proliferating cell nuclear antigen pe and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p3","sentence":"Another cyclin-dependent kinase inhibitor, p27KIP1, and ps cyclin D pe increased slightly, whereas ps proliferating cell nuclear antigen pe and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p4","sentence":"Another ps cyclin-dependent kinase inhibitor pe, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and ps p130 pe remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p5","sentence":"Another ps cyclin-dependent kinase inhibitor pe, ps p27KIP1 pe, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.","label":1}
{"pair_id":"BioInfer.d66.s0.p6","sentence":"Another ps cyclin-dependent kinase inhibitor pe, p27KIP1, and ps cyclin D pe increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p7","sentence":"Another cyclin-dependent kinase inhibitor, ps p27KIP1 pe, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and ps p130 pe remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p8","sentence":"Another cyclin-dependent kinase inhibitor, p27KIP1, and ps cyclin D pe increased slightly, whereas proliferating cell nuclear antigen and ps p130 pe remained unchanged.","label":0}
{"pair_id":"BioInfer.d66.s0.p9","sentence":"Another cyclin-dependent kinase inhibitor, ps p27KIP1 pe, and ps cyclin D pe increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.","label":0}
{"pair_id":"BioInfer.d814.s0.p0","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the ps Rho pe family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the ps actin pe cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p1","sentence":"We have shown that the FH proteins Bni1p and ps Bnr1p pe are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the ps actin pe cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p2","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family ps small GTP-binding proteins pe and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the ps actin pe cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p3","sentence":"We have shown that the FH proteins ps Bni1p pe and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the ps actin pe cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p4","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, ps profilin pe, at their proline-rich FH1 domains to regulate reorganization of the ps actin pe cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p5","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an ps actin-binding protein pe, profilin, at their proline-rich FH1 domains to regulate reorganization of the ps actin pe cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p6","sentence":"We have shown that the ps FH proteins pe Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the ps actin pe cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p7","sentence":"We have shown that the FH proteins Bni1p and ps Bnr1p pe are potential targets of the ps Rho pe family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p8","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the ps Rho pe family ps small GTP-binding proteins pe and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p9","sentence":"We have shown that the FH proteins ps Bni1p pe and Bnr1p are potential targets of the ps Rho pe family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p10","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the ps Rho pe family small GTP-binding proteins and bind to an actin-binding protein, ps profilin pe, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p11","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the ps Rho pe family small GTP-binding proteins and bind to an ps actin-binding protein pe, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p12","sentence":"We have shown that the ps FH proteins pe Bni1p and Bnr1p are potential targets of the ps Rho pe family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p13","sentence":"We have shown that the FH proteins Bni1p and ps Bnr1p pe are potential targets of the Rho family ps small GTP-binding proteins pe and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p14","sentence":"We have shown that the FH proteins ps Bni1p pe and ps Bnr1p pe are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p15","sentence":"We have shown that the FH proteins Bni1p and ps Bnr1p pe are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, ps profilin pe, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p16","sentence":"We have shown that the FH proteins Bni1p and ps Bnr1p pe are potential targets of the Rho family small GTP-binding proteins and bind to an ps actin-binding protein pe, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p17","sentence":"We have shown that the ps FH proteins pe Bni1p and ps Bnr1p pe are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p18","sentence":"We have shown that the FH proteins ps Bni1p pe and Bnr1p are potential targets of the Rho family ps small GTP-binding proteins pe and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p19","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family ps small GTP-binding proteins pe and bind to an actin-binding protein, ps profilin pe, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p20","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family ps small GTP-binding proteins pe and bind to an ps actin-binding protein pe, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p21","sentence":"We have shown that the ps FH proteins pe Bni1p and Bnr1p are potential targets of the Rho family ps small GTP-binding proteins pe and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p22","sentence":"We have shown that the FH proteins ps Bni1p pe and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, ps profilin pe, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p23","sentence":"We have shown that the FH proteins ps Bni1p pe and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an ps actin-binding protein pe, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p24","sentence":"We have shown that the ps FH proteins pe ps Bni1p pe and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p25","sentence":"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an ps actin-binding protein pe, ps profilin pe, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d814.s0.p26","sentence":"We have shown that the ps FH proteins pe Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, ps profilin pe, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d814.s0.p27","sentence":"We have shown that the ps FH proteins pe Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an ps actin-binding protein pe, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"AIMed.d211.s1831.p0","sentence":"The encoded product of the ps neuregulin-2 pe gene has a motif structure similar to that of neuregulins and an alternative splicing site in the ps epidermal growth factor pe(EGF)-like domain gives rise to two isoforms (alpha and beta).","label":0}
{"pair_id":"AIMed.d211.s1831.p1","sentence":"The encoded product of the ps neuregulin-2 pe gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor(ps EGF pe)-like domain gives rise to two isoforms (alpha and beta).","label":0}
{"pair_id":"AIMed.d211.s1831.p2","sentence":"The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the ps epidermal growth factor pe(ps EGF pe)-like domain gives rise to two isoforms (alpha and beta).","label":0}
{"pair_id":"BioInfer.d651.s0.p0","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p1","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p2","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p3","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p4","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p5","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p6","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, ps high molecular weight caldesmon pe, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p7","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, ps calponin pe, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p8","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p9","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, ps smooth muscle myosin heavy chain pe, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p10","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p11","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p12","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p13","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p14","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p15","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p16","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p17","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p18","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and ps S-100 pe protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p19","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p20","sentence":"The neoplastic cells were positive for ps vimentin pe, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p21","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p22","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p23","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p24","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p25","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p26","sentence":"The neoplastic cells were positive for ps vimentin pe, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p27","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p28","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for ps desmin pe, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p29","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and ps CD34 pe, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p30","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p31","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p32","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p33","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, ps alpha-smooth muscle actin pe and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p34","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p35","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p36","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p37","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for desmin, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p38","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p39","sentence":"The neoplastic cells were positive for vimentin, ps Factor-XIIIa pe, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p40","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for ps desmin pe, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p41","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p42","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p43","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p44","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for ps desmin pe, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p45","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p46","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p47","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p48","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and ps CD34 pe, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p49","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, ps calponin pe, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p50","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p51","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, ps high molecular weight caldesmon pe, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p52","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, laminin and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p53","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, ps calponin pe, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"BioInfer.d651.s0.p54","sentence":"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, ps collagen type IV pe, ps laminin pe and S-100 protein.","label":0}
{"pair_id":"AIMed.d139.s1171.p0","sentence":"ps Spectrin cagliari pe. an Ala-->Gly substitution in helix 1 of ps beta spectrin pe repeat 17 that severely disrupts the structure and self-association of the erythrocyte spectrin heterodimer.","label":0}
{"pair_id":"BioInfer.d769.s1.p0","sentence":"Various immunological assays suggest that four of these proteins (UL5, ps UL8 pe, UL9, and ps UL52 pe) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p1","sentence":"Various immunological assays suggest that four of these proteins (UL5, UL8, ps UL9 pe, and ps UL52 pe) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p2","sentence":"Various immunological assays suggest that four of these proteins (ps UL5 pe, UL8, UL9, and ps UL52 pe) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p3","sentence":"Various immunological assays suggest that four of these proteins (UL5, ps UL8 pe, ps UL9 pe, and UL52) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p4","sentence":"Various immunological assays suggest that four of these proteins (ps UL5 pe, ps UL8 pe, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d769.s1.p5","sentence":"Various immunological assays suggest that four of these proteins (ps UL5 pe, UL8, ps UL9 pe, and UL52) are made in infected cells in very low abundance relative to the other three.","label":0}
{"pair_id":"BioInfer.d827.s0.p0","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in ps MSH2 pe or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of ps MSH3 pe, MSH6, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p1","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in ps MSH2 pe or ps MLH1 pe to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p2","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in ps MSH2 pe or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, ps BAX pe, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p3","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in ps MSH2 pe or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, ps MSH6 pe, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p4","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in ps MSH2 pe or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and ps TGFbeta RII pe.","label":0}
{"pair_id":"BioInfer.d827.s0.p5","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or ps MLH1 pe to assess the involvement of mononucleotide repeats contained in the coding regions of ps MSH3 pe, MSH6, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p6","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of ps MSH3 pe, MSH6, ps BAX pe, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p7","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of ps MSH3 pe, ps MSH6 pe, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p8","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of ps MSH3 pe, MSH6, BAX, and ps TGFbeta RII pe.","label":0}
{"pair_id":"BioInfer.d827.s0.p9","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or ps MLH1 pe to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, ps BAX pe, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p10","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or ps MLH1 pe to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, ps MSH6 pe, BAX, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p11","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or ps MLH1 pe to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and ps TGFbeta RII pe.","label":0}
{"pair_id":"BioInfer.d827.s0.p12","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, ps MSH6 pe, ps BAX pe, and TGFbeta RII.","label":0}
{"pair_id":"BioInfer.d827.s0.p13","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, ps BAX pe, and ps TGFbeta RII pe.","label":0}
{"pair_id":"BioInfer.d827.s0.p14","sentence":"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, ps MSH6 pe, BAX, and ps TGFbeta RII pe.","label":0}
{"pair_id":"BioInfer.d49.s0.p0","sentence":"A model is proposed for the function of ps profilin pe in ps actin pe-based motility.","label":1}
{"pair_id":"AIMed.d12.s96.p0","sentence":"Soluble ps interleukin 2 peps interleukin 2 receptor pe and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.","label":0}
{"pair_id":"AIMed.d12.s96.p1","sentence":"Soluble ps interleukin 2 pe receptor and ps interleukin 1alpha pe in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.","label":0}
{"pair_id":"AIMed.d12.s96.p2","sentence":"Soluble ps interleukin 2 receptor pe and ps interleukin 1alpha pe in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.","label":0}
{"pair_id":"AIMed.d101.s855.p0","sentence":"The ability of ps c-Fos pe and ps c-Jun pe proteins to interact directly with the TATA box-binding protein (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":0}
{"pair_id":"AIMed.d101.s855.p1","sentence":"The ability of ps c-Fos pe and c-Jun proteins to interact directly with the ps TATA box-binding protein pe (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p2","sentence":"The ability of ps c-Fos pe and c-Jun proteins to interact directly with the TATA box-binding protein (ps TBP pe), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p3","sentence":"The ability of c-Fos and ps c-Jun pe proteins to interact directly with the ps TATA box-binding protein pe (TBP), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p4","sentence":"The ability of c-Fos and ps c-Jun pe proteins to interact directly with the TATA box-binding protein (ps TBP pe), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":1}
{"pair_id":"AIMed.d101.s855.p5","sentence":"The ability of c-Fos and c-Jun proteins to interact directly with the ps TATA box-binding protein pe (ps TBP pe), the general transcription factor required for initiating the assembly of transcription complexes, was investigated.","label":0}
{"pair_id":"AIMed.d219.s1905.p0","sentence":"In the present study, we demonstrate that ps 14-3-3 zeta pe binds directly to the isolated ps Raf-CRD pe.","label":1}
{"pair_id":"BioInfer.d169.s2.p0","sentence":"Recombinant plant (birch) ps profilin pe was analyzed for its ability to promote actin polymerization from the actin:ps thymosin pe beta4 and ps thymo pe complex.","label":0}
{"pair_id":"BioInfer.d169.s2.p1","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:ps thymosin peps thymosin beta4 pe and ps thymo pe complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p2","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote ps actin pe polymerization from the actin:ps thymosin pe beta4 and ps thymo pe complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p3","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the ps actin pe:ps thymosin pe beta4 and ps thymo pe complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p4","sentence":"Recombinant plant (birch) ps profilin pe was analyzed for its ability to promote actin polymerization from the actin:ps thymosin beta4 pe and thymo complex.","label":0}
{"pair_id":"BioInfer.d169.s2.p5","sentence":"Recombinant plant (birch) ps profilin pe was analyzed for its ability to promote ps actin pe polymerization from the actin:thymosin beta4 and thymo complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p6","sentence":"Recombinant plant (birch) ps profilin pe was analyzed for its ability to promote actin polymerization from the ps actin pe:thymosin beta4 and thymo complex.","label":0}
{"pair_id":"BioInfer.d169.s2.p7","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote ps actin pe polymerization from the actin:ps thymosin beta4 pe and thymo complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p8","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the ps actin pe:ps thymosin beta4 pe and thymo complex.","label":1}
{"pair_id":"BioInfer.d169.s2.p9","sentence":"Recombinant plant (birch) profilin was analyzed for its ability to promote ps actin pe polymerization from the ps actin pe:thymosin beta4 and thymo complex.","label":1}
{"pair_id":"AIMed.d119.s1010.p0","sentence":"We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the ps phosphoCREB pe:ps CBP pe interaction and report here that CBP can activate transcription through a region in its carboxy terminus.","label":1}
{"pair_id":"AIMed.d119.s1010.p1","sentence":"We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the ps phosphoCREB pe:CBP interaction and report here that ps CBP pe can activate transcription through a region in its carboxy terminus.","label":0}
{"pair_id":"AIMed.d119.s1010.p2","sentence":"We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the phosphoCREB:ps CBP pe interaction and report here that ps CBP pe can activate transcription through a region in its carboxy terminus.","label":0}
{"pair_id":"AIMed.d25.s206.p0","sentence":"ps TNFalpha pe, ps alpha1AT pe, and complement factors C3 and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p1","sentence":"ps TNFalpha pe, alpha1AT, and complement factors ps C3 pe and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p2","sentence":"ps TNFalpha pe, alpha1AT, and complement factors C3 and ps C4 pe concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p3","sentence":"TNFalpha, ps alpha1AT pe, and complement factors ps C3 pe and C4 concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p4","sentence":"TNFalpha, ps alpha1AT pe, and complement factors C3 and ps C4 pe concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"AIMed.d25.s206.p5","sentence":"TNFalpha, alpha1AT, and complement factors ps C3 pe and ps C4 pe concentrations were measured simultaneously in blood and serous effusion using commercially available methods.","label":0}
{"pair_id":"BioInfer.d505.s2.p0","sentence":"Three methods, fluorescence anisotropy of rhodamine-labeled ps profilin pe, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba ps actin pe monomers with bound Mg-ATP.","label":0}
{"pair_id":"BioInfer.d505.s2.p1","sentence":"Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba ps profilins pe binding amoeba ps actin pe monomers with bound Mg-ATP.","label":1}
{"pair_id":"BioInfer.d505.s2.p2","sentence":"Three methods, fluorescence anisotropy of rhodamine-labeled ps profilin pe, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba ps profilins pe binding amoeba actin monomers with bound Mg-ATP.","label":0}
{"pair_id":"BioInfer.d605.s0.p0","sentence":"The domain consists of a mixed alpha-helical\/beta-sheet fold that resembles a circular permutation of the ps actin pe\/poly-proline binding protein, profilin, and the ps GAF\/PAS pe family of regulatory modules.","label":0}
{"pair_id":"BioInfer.d605.s0.p1","sentence":"The domain consists of a mixed alpha-helical\/beta-sheet fold that resembles a circular permutation of the ps actin pe\/poly-proline binding protein, ps profilin pe, and the GAF\/PAS family of regulatory modules.","label":1}
{"pair_id":"BioInfer.d605.s0.p2","sentence":"The domain consists of a mixed alpha-helical\/beta-sheet fold that resembles a circular permutation of the actin\/poly-proline binding protein, ps profilin pe, and the ps GAF\/PAS pe family of regulatory modules.","label":0}
{"pair_id":"BioInfer.d623.s0.p0","sentence":"The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia ps profilin pe expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia ps profilin pe binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p1","sentence":"The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for ps actin pe or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia ps profilin pe binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p2","sentence":"The higher affinity of vaccinia ps profilin pe for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia ps profilin pe binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p3","sentence":"The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for ps actin pe or poly(L-proline) and the concentration of vaccinia ps profilin pe expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p4","sentence":"The higher affinity of vaccinia ps profilin pe for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia ps profilin pe expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.","label":0}
{"pair_id":"BioInfer.d623.s0.p5","sentence":"The higher affinity of vaccinia ps profilin pe for polyphosphoinositides (Kd = 0.2-8.5 microM) than for ps actin pe or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.","label":1}
{"pair_id":"AIMed.d172.s1452.p0","sentence":"ps VRP pe fails to bind appreciably to the extracellular domain of ps Flt1 pe or Flk1.","label":0}
{"pair_id":"AIMed.d172.s1452.p1","sentence":"ps VRP pe fails to bind appreciably to the extracellular domain of Flt1 or ps Flk1 pe.","label":0}
{"pair_id":"AIMed.d172.s1452.p2","sentence":"VRP fails to bind appreciably to the extracellular domain of ps Flt1 pe or ps Flk1 pe.","label":0}
{"pair_id":"BioInfer.d173.s0.p0","sentence":"Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of ps myosin heavy chain pe and ps actin pe.","label":0}
{"pair_id":"BioInfer.d173.s0.p1","sentence":"Digestion of isolated myofibrils with ps alkaline proteinase pe resulted in the degradation of ps myosin heavy chain pe and actin.","label":1}
{"pair_id":"BioInfer.d173.s0.p2","sentence":"Digestion of isolated myofibrils with ps alkaline proteinase pe resulted in the degradation of myosin heavy chain and ps actin pe.","label":1}
{"pair_id":"AIMed.d197.s1681.p0","sentence":"Following this hypothesis, we altered in ps hIL-6 pe and ps hIL-6R pe residues predicted to reside in the contact region and to interact with each other.","label":1}
{"pair_id":"AIMed.d115.s970.p0","sentence":"Interaction with ps RAP74 pe subunit of ps TFIIF pe is required for transcriptional activation by serum response factor.","label":0}
{"pair_id":"AIMed.d115.s970.p1","sentence":"Interaction with ps RAP74 pe subunit of TFIIF is required for transcriptional activation by ps serum response factor pe.","label":1}
{"pair_id":"AIMed.d115.s970.p2","sentence":"Interaction with RAP74 subunit of ps TFIIF pe is required for transcriptional activation by ps serum response factor pe.","label":0}
{"pair_id":"BioInfer.d7.s2.p0","sentence":"Addition of ps profilin pe to polymerized ps actin pe causes it to depolymerize until a new steady-state, dependent on profilin concentration, is achieved.","label":1}
{"pair_id":"BioInfer.d7.s2.p1","sentence":"Addition of ps profilin pe to polymerized actin causes it to depolymerize until a new steady-state, dependent on ps profilin pe concentration, is achieved.","label":0}
{"pair_id":"BioInfer.d7.s2.p2","sentence":"Addition of profilin to polymerized ps actin pe causes it to depolymerize until a new steady-state, dependent on ps profilin pe concentration, is achieved.","label":0}
{"pair_id":"AIMed.d37.s310.p0","sentence":"ps CCR5 pe binds multiple CC-chemokines: ps MCP-3 pe acts as a natural antagonist.","label":0}
{"pair_id":"AIMed.d197.s1678.p0","sentence":"We studied the human ps IL-6 pe (ps hIL-6 pe)\/hIL-6R binding interface by a combination of molecular modelling and site-directed mutagenesis.","label":0}
{"pair_id":"AIMed.d197.s1678.p1","sentence":"We studied the human ps IL-6 pe (hIL-6)\/ps hIL-6R pe binding interface by a combination of molecular modelling and site-directed mutagenesis.","label":1}
{"pair_id":"AIMed.d197.s1678.p2","sentence":"We studied the human IL-6 (ps hIL-6 pe)\/ps hIL-6R pe binding interface by a combination of molecular modelling and site-directed mutagenesis.","label":1}
{"pair_id":"BioInfer.d96.s0.p0","sentence":"Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified ps myosin heavy chain pe and ps actin pe ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).","label":0}
{"pair_id":"BioInfer.d91.s0.p0","sentence":"BACKGROUND: ps p27 pe(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the ps cyclin E pe\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p1","sentence":"BACKGROUND: ps p27 pe(ps Kip1 pe), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/cyclin-dependent kinase 2 complex.","label":0}
{"pair_id":"BioInfer.d91.s0.p2","sentence":"BACKGROUND: ps p27 pe(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/ps cyclin-dependent kinase 2 pe complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p3","sentence":"BACKGROUND: ps p27 pe(Kip1), a ps cyclin-dependent kinase inhibitor pe, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p4","sentence":"BACKGROUND: p27(ps Kip1 pe), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the ps cyclin E pe\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p5","sentence":"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the ps cyclin E pe\/ps cyclin-dependent kinase 2 pe complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p6","sentence":"BACKGROUND: p27(Kip1), a ps cyclin-dependent kinase inhibitor pe, negatively regulates the G1 phase progression of the cell cycle by binding to the ps cyclin E pe\/cyclin-dependent kinase 2 complex.","label":0}
{"pair_id":"BioInfer.d91.s0.p7","sentence":"BACKGROUND: p27(ps Kip1 pe), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/ps cyclin-dependent kinase 2 pe complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p8","sentence":"BACKGROUND: p27(ps Kip1 pe), a ps cyclin-dependent kinase inhibitor pe, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/cyclin-dependent kinase 2 complex.","label":1}
{"pair_id":"BioInfer.d91.s0.p9","sentence":"BACKGROUND: p27(Kip1), a ps cyclin-dependent kinase inhibitor pe, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E\/ps cyclin-dependent kinase 2 pe complex.","label":0}
{"pair_id":"BioInfer.d108.s0.p0","sentence":"ps Neuropilin 1 pe (ps NP-1 pe) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p1","sentence":"Neuropilin 1 (ps NP-1 pe) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (ps VEGFR-2 pe).","label":1}
{"pair_id":"BioInfer.d108.s0.p2","sentence":"Neuropilin 1 (ps NP-1 pe) is a receptor for ps vascular endothelial growth factor pe (VEGF) ps vas pe (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p3","sentence":"Neuropilin 1 (ps NP-1 pe) is a receptor for vascular endothelial growth factor (VEGF) vas (ps VEGF165 pe) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p4","sentence":"Neuropilin 1 (ps NP-1 pe) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances ps VEGF165 pe function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p5","sentence":"Neuropilin 1 (ps NP-1 pe) is a receptor for vascular endothelial growth factor (ps VEGF pe) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p6","sentence":"Neuropilin 1 (ps NP-1 pe) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through ps tyrosine kinase pe VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p7","sentence":"Neuropilin 1 (ps NP-1 pe) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase ps VEGF receptor 2 pe (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p8","sentence":"ps Neuropilin 1 pe (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (ps VEGFR-2 pe).","label":1}
{"pair_id":"BioInfer.d108.s0.p9","sentence":"ps Neuropilin 1 pe (NP-1) is a receptor for ps vascular endothelial growth factor pe (VEGF) ps vas pe (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p10","sentence":"ps Neuropilin 1 pe (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (ps VEGF165 pe) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p11","sentence":"ps Neuropilin 1 pe (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances ps VEGF165 pe function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p12","sentence":"ps Neuropilin 1 pe (NP-1) is a receptor for vascular endothelial growth factor (ps VEGF pe) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p13","sentence":"ps Neuropilin 1 pe (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through ps tyrosine kinase pe VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p14","sentence":"ps Neuropilin 1 pe (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase ps VEGF receptor 2 pe (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p15","sentence":"Neuropilin 1 (NP-1) is a receptor for ps vascular endothelial growth factor pe (VEGF) ps vas pe (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (ps VEGFR-2 pe).","label":0}
{"pair_id":"BioInfer.d108.s0.p16","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (ps VEGF165 pe) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (ps VEGFR-2 pe).","label":0}
{"pair_id":"BioInfer.d108.s0.p17","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances ps VEGF165 pe function through tyrosine kinase VEGF receptor 2 (ps VEGFR-2 pe).","label":1}
{"pair_id":"BioInfer.d108.s0.p18","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (ps VEGF pe) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (ps VEGFR-2 pe).","label":0}
{"pair_id":"BioInfer.d108.s0.p19","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through ps tyrosine kinase pe VEGF receptor 2 (ps VEGFR-2 pe).","label":1}
{"pair_id":"BioInfer.d108.s0.p20","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase ps VEGF receptor 2 pe (ps VEGFR-2 pe).","label":0}
{"pair_id":"BioInfer.d108.s0.p21","sentence":"Neuropilin 1 (NP-1) is a receptor for ps vascular endothelial growth factor pe (VEGF) ps vas pe (ps VEGF165 pe) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p22","sentence":"Neuropilin 1 (NP-1) is a receptor for ps vascular endothelial growth factor pe (VEGF) ps vas pe (VEGF165) and acts as a coreceptor that enhances ps VEGF165 pe function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p23","sentence":"Neuropilin 1 (NP-1) is a receptor for ps vascular endothelial growth factor pe (ps VEGF pe) ps vas pe (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p24","sentence":"Neuropilin 1 (NP-1) is a receptor for ps vascular endothelial growth factor pe (VEGF) ps vas pe (VEGF165) and acts as a coreceptor that enhances VEGF165 function through ps tyrosine kinase pe VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p25","sentence":"Neuropilin 1 (NP-1) is a receptor for ps vascular endothelial growth factor pe (VEGF) ps vas pe (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase ps VEGF receptor 2 pe (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p26","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (ps VEGF165 pe) and acts as a coreceptor that enhances ps VEGF165 pe function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p27","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (ps VEGF pe) vas (ps VEGF165 pe) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p28","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (ps VEGF165 pe) and acts as a coreceptor that enhances VEGF165 function through ps tyrosine kinase pe VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p29","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (ps VEGF165 pe) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase ps VEGF receptor 2 pe (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p30","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (ps VEGF pe) vas (VEGF165) and acts as a coreceptor that enhances ps VEGF165 pe function through tyrosine kinase VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p31","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances ps VEGF165 pe function through ps tyrosine kinase pe VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p32","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances ps VEGF165 pe function through tyrosine kinase ps VEGF receptor 2 pe (VEGFR-2).","label":1}
{"pair_id":"BioInfer.d108.s0.p33","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (ps VEGF pe) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through ps tyrosine kinase pe VEGF receptor 2 (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p34","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (ps VEGF pe) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase ps VEGF receptor 2 pe (VEGFR-2).","label":0}
{"pair_id":"BioInfer.d108.s0.p35","sentence":"Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) vas (VEGF165) and acts as a coreceptor that enhances VEGF165 function through ps tyrosine kinase pe ps VEGF receptor 2 pe (VEGFR-2).","label":1}
{"pair_id":"AIMed.d215.s1869.p0","sentence":"ps MMP2 pe cleaved the ps Ln-5 pe gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.","label":1}
{"pair_id":"AIMed.d215.s1869.p1","sentence":"ps MMP2 pe cleaved the ps Ln-5 gamma2 pe subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p2","sentence":"ps MMP2 pe cleaved the Ln-5 gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on ps Ln-5 pe that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p3","sentence":"MMP2 cleaved the ps Ln-5 peps Ln-5 gamma2 pe subunit at residue 587, exposing a putative cryptic promigratory site on Ln-5 that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p4","sentence":"MMP2 cleaved the ps Ln-5 pe gamma2 subunit at residue 587, exposing a putative cryptic promigratory site on ps Ln-5 pe that triggers cell motility.","label":0}
{"pair_id":"AIMed.d215.s1869.p5","sentence":"MMP2 cleaved the ps Ln-5 gamma2 pe subunit at residue 587, exposing a putative cryptic promigratory site on ps Ln-5 pe that triggers cell motility.","label":0}
{"pair_id":"AIMed.d54.s473.p0","sentence":"ps Platelet-derived growth factor C pe (ps PDGF-C pe), a novel growth factor that binds to PDGF alpha and beta receptor.","label":0}
{"pair_id":"AIMed.d54.s473.p1","sentence":"ps Platelet-derived growth factor C pe (PDGF-C), a novel growth factor that binds to ps PDGF alpha pe and beta receptor.","label":1}
{"pair_id":"AIMed.d54.s473.p2","sentence":"Platelet-derived growth factor C (ps PDGF-C pe), a novel growth factor that binds to ps PDGF alpha pe and beta receptor.","label":1}
{"pair_id":"BioInfer.d78.s2.p0","sentence":"In most cases, ps ADF pe and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while ps cofilin pe was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p1","sentence":"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ps ADF pe appeared to predominate in mononucleated cells, while ps cofilin pe was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p2","sentence":"In most cases, ADF and cofilin colocalized in the same nuclear ps actin pe rods, but ADF appeared to predominate in mononucleated cells, while ps cofilin pe was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p3","sentence":"In most cases, ADF and ps cofilin pe colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while ps cofilin pe was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p4","sentence":"In most cases, ps ADF pe and cofilin colocalized in the same nuclear actin rods, but ps ADF pe appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p5","sentence":"In most cases, ps ADF pe and cofilin colocalized in the same nuclear ps actin pe rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":1}
{"pair_id":"BioInfer.d78.s2.p6","sentence":"In most cases, ps ADF pe and ps cofilin pe colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":1}
{"pair_id":"BioInfer.d78.s2.p7","sentence":"In most cases, ADF and cofilin colocalized in the same nuclear ps actin pe rods, but ps ADF pe appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p8","sentence":"In most cases, ADF and ps cofilin pe colocalized in the same nuclear actin rods, but ps ADF pe appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":0}
{"pair_id":"BioInfer.d78.s2.p9","sentence":"In most cases, ADF and ps cofilin pe colocalized in the same nuclear ps actin pe rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.","label":1}
{"pair_id":"AIMed.d54.s477.p0","sentence":"Competition binding and immunoprecipitation studies on cells bearing both ps PDGF alpha pe and beta receptors reveal a high affinity binding of recombinant GFD (ps PDGF-CC pe) to PDGF receptor-alpha homodimers and PDGF receptor-alpha\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d54.s477.p1","sentence":"Competition binding and immunoprecipitation studies on cells bearing both ps PDGF alpha pe and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to ps PDGF receptor-alpha pe homodimers and PDGF receptor-alpha\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d54.s477.p2","sentence":"Competition binding and immunoprecipitation studies on cells bearing both ps PDGF alpha pe and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to PDGF receptor-alpha homodimers and ps PDGF receptor-alpha pe\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d54.s477.p3","sentence":"Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (ps PDGF-CC pe) to ps PDGF receptor-alpha pe homodimers and PDGF receptor-alpha\/beta heterodimers.","label":1}
{"pair_id":"AIMed.d54.s477.p4","sentence":"Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (ps PDGF-CC pe) to PDGF receptor-alpha homodimers and ps PDGF receptor-alpha pe\/beta heterodimers.","label":1}
{"pair_id":"AIMed.d54.s477.p5","sentence":"Competition binding and immunoprecipitation studies on cells bearing both PDGF alpha and beta receptors reveal a high affinity binding of recombinant GFD (PDGF-CC) to ps PDGF receptor-alpha pe homodimers and ps PDGF receptor-alpha pe\/beta heterodimers.","label":0}
{"pair_id":"AIMed.d80.s682.p0","sentence":"ps FADD pe, a novel death domain-containing protein, interacts with the death domain of ps Fas pe and initiates apoptosis.","label":1}
{"pair_id":"BioInfer.d245.s2.p0","sentence":"Recently we have identified an ps alpha-catenin pe binding site in ps beta-catenin pe and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.","label":1}
{"pair_id":"BioInfer.d245.s2.p1","sentence":"Recently we have identified an ps alpha-catenin pe binding site in beta-catenin and ps plakoglobin pe and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.","label":1}
{"pair_id":"BioInfer.d245.s2.p2","sentence":"Recently we have identified an alpha-catenin binding site in ps beta-catenin pe and ps plakoglobin pe and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.","label":0}
{"pair_id":"BioInfer.d233.s0.p0","sentence":"Germline mutations in several members of these families, MSH2, ps MSH6 pe, MLH1, and PMS2, but not ps MSH3 pe, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p1","sentence":"Germline mutations in several members of these families, MSH2, MSH6, ps MLH1 pe, and PMS2, but not ps MSH3 pe, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p2","sentence":"Germline mutations in several members of these families, ps MSH2 pe, MSH6, MLH1, and PMS2, but not ps MSH3 pe, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p3","sentence":"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and ps PMS2 pe, but not ps MSH3 pe, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p4","sentence":"Germline mutations in several members of these families, MSH2, ps MSH6 pe, ps MLH1 pe, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p5","sentence":"Germline mutations in several members of these families, ps MSH2 pe, ps MSH6 pe, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p6","sentence":"Germline mutations in several members of these families, MSH2, ps MSH6 pe, MLH1, and ps PMS2 pe, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p7","sentence":"Germline mutations in several members of these families, ps MSH2 pe, MSH6, ps MLH1 pe, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p8","sentence":"Germline mutations in several members of these families, MSH2, MSH6, ps MLH1 pe, and ps PMS2 pe, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d233.s0.p9","sentence":"Germline mutations in several members of these families, ps MSH2 pe, MSH6, MLH1, and ps PMS2 pe, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.","label":0}
{"pair_id":"BioInfer.d88.s0.p0","sentence":"At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins ps villin pe and ps fimbrin pe that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.","label":0}
{"pair_id":"BioInfer.d88.s0.p1","sentence":"At the light microscope level, brush cells can be identified by antibodies against the ps actin pe filament crosslinking proteins ps villin pe and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.","label":1}
{"pair_id":"BioInfer.d88.s0.p2","sentence":"At the light microscope level, brush cells can be identified by antibodies against the ps actin pe filament crosslinking proteins villin and ps fimbrin pe that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.","label":1}
{"pair_id":"BioInfer.d222.s0.p0","sentence":"Furthermore, a simultaneous expression of profilin, ps actin pe and ps extracellular matrix proteins pe was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.","label":1}
{"pair_id":"BioInfer.d222.s0.p1","sentence":"Furthermore, a simultaneous expression of ps profilin pe, actin and ps extracellular matrix proteins pe was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.","label":1}
{"pair_id":"BioInfer.d222.s0.p2","sentence":"Furthermore, a simultaneous expression of ps profilin pe, ps actin pe and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.","label":1}
{"pair_id":"AIMed.d183.s1555.p0","sentence":"In the baculovirus coexpression system, ps Raf-1 pe was activated by ps JAK2 pe in the presence of p21ras.","label":1}
{"pair_id":"AIMed.d183.s1555.p1","sentence":"In the baculovirus coexpression system, ps Raf-1 pe was activated by JAK2 in the presence of ps p21ras pe.","label":0}
{"pair_id":"AIMed.d183.s1555.p2","sentence":"In the baculovirus coexpression system, Raf-1 was activated by ps JAK2 pe in the presence of ps p21ras pe.","label":0}
{"pair_id":"AIMed.d153.s1305.p0","sentence":"On the other hand, cells expressing ps ADA pe and ps CD26 pe on the surface were much more resistant to the inhibitory effect of adenosine.","label":0}
{"pair_id":"AIMed.d50.s447.p0","sentence":"Relating the anti-viral and anti-proliferative activity of the various interferon mutants with their affinity toward ps ifnar2 pe results in linear function over the whole range of affinities investigated, suggesting that ps ifnar2 pe binding is the rate-determining step in cellular activation.","label":0}
{"pair_id":"AIMed.d109.s917.p0","sentence":"The ps Fos pe and ps Jun pe families of eukaryotic transcription factors heterodimerize to form complexes capable of binding 5'-TGAGTCA-3' DNA elements.","label":1}
{"pair_id":"BioInfer.d148.s0.p0","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, ps TRAIL pe, TRADD, RIP, and ps caspase-8 pe, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p1","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and ps caspase-8 pe, and an up to twofold increase for FADD and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p2","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, ps RIP pe, and ps caspase-8 pe, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p3","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, ps TNF-R1 pe, TRAIL, TRADD, RIP, and ps caspase-8 pe, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p4","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and ps caspase-8 pe, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p5","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, ps TRADD pe, RIP, and ps caspase-8 pe, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p6","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, TNF-R1, TRAIL, TRADD, RIP, and ps caspase-8 pe, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p7","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and ps caspase-8 pe, and an up to twofold increase for FADD and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p8","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and ps caspase-8 pe, and an up to twofold increase for ps FADD pe and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p9","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, ps TRAIL pe, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p10","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, ps TRAIL pe, TRADD, ps RIP pe, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p11","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, ps TNF-R1 pe, ps TRAIL pe, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p12","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, TNF-R1, ps TRAIL pe, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p13","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, ps TRAIL pe, ps TRADD pe, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p14","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, TNF-R1, ps TRAIL pe, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p15","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, ps TRAIL pe, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p16","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, ps TRAIL pe, TRADD, RIP, and caspase-8, and an up to twofold increase for ps FADD pe and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p17","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, ps RIP pe, and caspase-8, and an up to twofold increase for FADD and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p18","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, ps TNF-R1 pe, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p19","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p20","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, ps TRADD pe, RIP, and caspase-8, and an up to twofold increase for FADD and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p21","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p22","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and ps FAP pe, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p23","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for ps FADD pe and ps FAP pe, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p24","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, ps TNF-R1 pe, TRAIL, TRADD, ps RIP pe, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p25","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, TNF-R1, TRAIL, TRADD, ps RIP pe, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p26","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, ps TRADD pe, ps RIP pe, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p27","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, TNF-R1, TRAIL, TRADD, ps RIP pe, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p28","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, ps RIP pe, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p29","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, ps RIP pe, and caspase-8, and an up to twofold increase for ps FADD pe and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p30","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, ps TNF-R1 pe, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p31","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, ps TNF-R1 pe, TRAIL, ps TRADD pe, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p32","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, ps TNF-R1 pe, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p33","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, ps TNF-R1 pe, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p34","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, ps TNF-R1 pe, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for ps FADD pe and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p35","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, TNF-R1, TRAIL, ps TRADD pe, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p36","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, ps Fas ligand pe, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p37","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p38","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for ps Fas pe, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for ps FADD pe and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p39","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, TNF-R1, TRAIL, ps TRADD pe, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p40","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, ps TRADD pe, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p41","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, ps TRADD pe, RIP, and caspase-8, and an up to twofold increase for ps FADD pe and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p42","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d148.s0.p43","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, ps Fas ligand pe, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for ps FADD pe and FAP, but there was little change for FAF.","label":0}
{"pair_id":"BioInfer.d148.s0.p44","sentence":"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for ps FADD pe and FAP, but there was little change for ps FAF pe.","label":0}
{"pair_id":"BioInfer.d171.s2.p0","sentence":"We investigate allelic losses in microsatellites of the RAD51, RAD52, ps RAD54 pe, ps BRCA1 pe and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p1","sentence":"We investigate allelic losses in microsatellites of the ps RAD51 pe, RAD52, RAD54, ps BRCA1 pe and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p2","sentence":"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, ps BRCA1 pe and ps BRCA2 pe regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p3","sentence":"We investigate allelic losses in microsatellites of the RAD51, ps RAD52 pe, RAD54, ps BRCA1 pe and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p4","sentence":"We investigate allelic losses in microsatellites of the ps RAD51 pe, RAD52, ps RAD54 pe, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p5","sentence":"We investigate allelic losses in microsatellites of the RAD51, RAD52, ps RAD54 pe, BRCA1 and ps BRCA2 pe regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p6","sentence":"We investigate allelic losses in microsatellites of the RAD51, ps RAD52 pe, ps RAD54 pe, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p7","sentence":"We investigate allelic losses in microsatellites of the ps RAD51 pe, RAD52, RAD54, BRCA1 and ps BRCA2 pe regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p8","sentence":"We investigate allelic losses in microsatellites of the ps RAD51 pe, ps RAD52 pe, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d171.s2.p9","sentence":"We investigate allelic losses in microsatellites of the RAD51, ps RAD52 pe, RAD54, BRCA1 and ps BRCA2 pe regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.","label":0}
{"pair_id":"BioInfer.d526.s0.p0","sentence":"Saccharomyces cerevisiae ps PAC2 pe functions with ps CIN1 pe, C and C in a pathway leading to normal microtubule stability.","label":1}
{"pair_id":"BioInfer.d526.s0.p1","sentence":"Saccharomyces cerevisiae ps PAC2 pe functions with ps CIN pe1, C and ps C pe in a pathway leading to normal microtubule stability.","label":1}
{"pair_id":"BioInfer.d526.s0.p2","sentence":"Saccharomyces cerevisiae ps PAC2 pe functions with ps CIN pe1, ps C pe and C in a pathway leading to normal microtubule stability.","label":1}
{"pair_id":"BioInfer.d526.s0.p3","sentence":"Saccharomyces cerevisiae PAC2 functions with ps CIN1 peps CIN pe1, C and ps C pe in a pathway leading to normal microtubule stability.","label":0}
{"pair_id":"BioInfer.d526.s0.p4","sentence":"Saccharomyces cerevisiae PAC2 functions with ps CIN1 peps CIN pe1, ps C pe and C in a pathway leading to normal microtubule stability.","label":0}
{"pair_id":"BioInfer.d526.s0.p5","sentence":"Saccharomyces cerevisiae PAC2 functions with ps CIN peps CIN pe1, ps C pe and ps C pe in a pathway leading to normal microtubule stability.","label":0}
{"pair_id":"AIMed.d219.s1901.p0","sentence":"We recently reported that ps Ras pe interaction with the ps Raf-1 pe cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p1","sentence":"We recently reported that ps Ras pe interaction with the ps Raf-1 cysteine-rich domain pe (Raf-CRD, residues 139-184) may be required for Raf-1 activation.","label":1}
{"pair_id":"AIMed.d219.s1901.p2","sentence":"We recently reported that ps Ras pe interaction with the Raf-1 cysteine-rich domain (ps Raf-CRD pe, residues 139-184) may be required for Raf-1 activation.","label":1}
{"pair_id":"AIMed.d219.s1901.p3","sentence":"We recently reported that ps Ras pe interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for ps Raf-1 pe activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p4","sentence":"We recently reported that Ras interaction with the ps Raf-1 peps Raf-1 cysteine-rich domain pe (Raf-CRD, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p5","sentence":"We recently reported that Ras interaction with the ps Raf-1 pe cysteine-rich domain (ps Raf-CRD pe, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p6","sentence":"We recently reported that Ras interaction with the ps Raf-1 pe cysteine-rich domain (Raf-CRD, residues 139-184) may be required for ps Raf-1 pe activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p7","sentence":"We recently reported that Ras interaction with the ps Raf-1 cysteine-rich domain pe (ps Raf-CRD pe, residues 139-184) may be required for Raf-1 activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p8","sentence":"We recently reported that Ras interaction with the ps Raf-1 cysteine-rich domain pe (Raf-CRD, residues 139-184) may be required for ps Raf-1 pe activation.","label":0}
{"pair_id":"AIMed.d219.s1901.p9","sentence":"We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (ps Raf-CRD pe, residues 139-184) may be required for ps Raf-1 pe activation.","label":0}
{"pair_id":"BioInfer.d267.s1.p0","sentence":"NLS-less S.cerevisiae proteins include both RAD51 and ps RAD52 pe that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and ps HRR25 pe molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p1","sentence":"NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the ps RAD23 pe and ps HRR25 pe molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p2","sentence":"NLS-less S.cerevisiae proteins include both ps RAD51 pe and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and ps HRR25 pe molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p3","sentence":"NLS-less S.cerevisiae proteins include both RAD51 and ps RAD52 pe that function in the recombination and in the repair of double-strand breaks as well as the ps RAD23 pe and HRR25 molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p4","sentence":"NLS-less S.cerevisiae proteins include both ps RAD51 pe and ps RAD52 pe that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.","label":0}
{"pair_id":"BioInfer.d267.s1.p5","sentence":"NLS-less S.cerevisiae proteins include both ps RAD51 pe and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the ps RAD23 pe and HRR25 molecules.","label":0}
{"pair_id":"AIMed.d112.s945.p0","sentence":"The 72-kDa spleen tyrosine kinase (ps Syk pe) and Src-family kinase ps p53 pe\/56Lyn (Lyn) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p1","sentence":"The 72-kDa spleen tyrosine kinase (ps Syk pe) and Src-family kinase p53\/ps 56Lyn pe (Lyn) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p2","sentence":"The 72-kDa spleen tyrosine kinase (ps Syk pe) and Src-family kinase p53\/56Lyn (ps Lyn pe) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p3","sentence":"The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase ps p53 pe\/ps 56Lyn pe (Lyn) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p4","sentence":"The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase ps p53 pe\/56Lyn (ps Lyn pe) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"AIMed.d112.s945.p5","sentence":"The 72-kDa spleen tyrosine kinase (Syk) and Src-family kinase p53\/ps 56Lyn pe (ps Lyn pe) contribute to signaling via the B-cell antigen receptor complex.","label":0}
{"pair_id":"BioInfer.d736.s1.p0","sentence":"21 ps actin pe mutations were analyzed in budding yeast, and specific regions of ps actin pe subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p1","sentence":"21 actin mutations were analyzed in budding yeast, and specific regions of ps actin pe subdomain 1 were implicated in the interaction with fimbrin, an ps actin pe filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p2","sentence":"21 actin mutations were analyzed in budding yeast, and specific regions of ps actin pe subdomain 1 were implicated in the interaction with ps fimbrin pe, an actin filament-bundling protein.","label":1}
{"pair_id":"BioInfer.d736.s1.p3","sentence":"21 ps actin pe mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an ps actin pe filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p4","sentence":"21 ps actin pe mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with ps fimbrin pe, an actin filament-bundling protein.","label":0}
{"pair_id":"BioInfer.d736.s1.p5","sentence":"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with ps fimbrin pe, an ps actin pe filament-bundling protein.","label":1}
{"pair_id":"BioInfer.d102.s2.p0","sentence":"The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by ps profilin pe-specific antibodies that react with different epitopes of birch ps profilin pe.","label":1}
{"pair_id":"BioInfer.d102.s2.p1","sentence":"The binding of 125I-labeled recombinant birch pollen profilin to plant and animal ps actins pe can be blocked by ps profilin pe-specific antibodies that react with different epitopes of birch profilin.","label":1}
{"pair_id":"BioInfer.d102.s2.p2","sentence":"The binding of 125I-labeled recombinant birch pollen ps profilin pe to plant and animal actins can be blocked by ps profilin pe-specific antibodies that react with different epitopes of birch profilin.","label":1}
{"pair_id":"BioInfer.d102.s2.p3","sentence":"The binding of 125I-labeled recombinant birch pollen profilin to plant and animal ps actins pe can be blocked by profilin-specific antibodies that react with different epitopes of birch ps profilin pe.","label":0}
{"pair_id":"BioInfer.d102.s2.p4","sentence":"The binding of 125I-labeled recombinant birch pollen ps profilin pe to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch ps profilin pe.","label":0}
{"pair_id":"BioInfer.d102.s2.p5","sentence":"The binding of 125I-labeled recombinant birch pollen ps profilin pe to plant and animal ps actins pe can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.","label":1}
{"pair_id":"AIMed.d169.s1427.p0","sentence":"Two proteins have been described as constituents of the ps IL-4 pe receptor, a approximately 140-kDa glycoprotein (ps IL-4R pe) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p1","sentence":"Two proteins have been described as constituents of the ps IL-4 pe receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the ps IL-2 pe receptor, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p2","sentence":"Two proteins have been described as constituents of the ps IL-4 pe receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the ps IL-2 receptor pe, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p3","sentence":"Two proteins have been described as constituents of the ps IL-4 pe receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds ps IL-13 pe.","label":0}
{"pair_id":"AIMed.d169.s1427.p4","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (ps IL-4R pe) and the gamma chain (gammac) of the ps IL-2 pe receptor, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p5","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (ps IL-4R pe) and the gamma chain (gammac) of the ps IL-2 receptor pe, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p6","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (ps IL-4R pe) and the gamma chain (gammac) of the IL-2 receptor, but neither of these proteins binds ps IL-13 pe.","label":0}
{"pair_id":"AIMed.d169.s1427.p7","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the ps IL-2 peps IL-2 receptor pe, but neither of these proteins binds IL-13.","label":0}
{"pair_id":"AIMed.d169.s1427.p8","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the ps IL-2 pe receptor, but neither of these proteins binds ps IL-13 pe.","label":0}
{"pair_id":"AIMed.d169.s1427.p9","sentence":"Two proteins have been described as constituents of the IL-4 receptor, a approximately 140-kDa glycoprotein (IL-4R) and the gamma chain (gammac) of the ps IL-2 receptor pe, but neither of these proteins binds ps IL-13 pe.","label":0}
{"pair_id":"BioInfer.d583.s1.p0","sentence":"This review describes three structures of ps actin pe complexed with different monomer-binding proteins, namely with ps DNase I pe, gelsolin segment 1, and profilin.","label":1}
{"pair_id":"BioInfer.d583.s1.p1","sentence":"This review describes three structures of ps actin pe complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and ps profilin pe.","label":1}
{"pair_id":"BioInfer.d583.s1.p2","sentence":"This review describes three structures of ps actin pe complexed with different monomer-binding proteins, namely with DNase I, ps gelsolin pe segment 1, and profilin.","label":1}
{"pair_id":"BioInfer.d583.s1.p3","sentence":"This review describes three structures of actin complexed with different monomer-binding proteins, namely with ps DNase I pe, gelsolin segment 1, and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d583.s1.p4","sentence":"This review describes three structures of actin complexed with different monomer-binding proteins, namely with ps DNase I pe, ps gelsolin pe segment 1, and profilin.","label":0}
{"pair_id":"BioInfer.d583.s1.p5","sentence":"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, ps gelsolin pe segment 1, and ps profilin pe.","label":0}
{"pair_id":"AIMed.d176.s1487.p0","sentence":"This observation supports a model in which ps p60 pe functions at an intermediate stage of ps PR pe assembly to facilitate formation of subsequent PR complexes lacking p60.","label":0}
{"pair_id":"AIMed.d176.s1487.p1","sentence":"This observation supports a model in which ps p60 pe functions at an intermediate stage of PR assembly to facilitate formation of subsequent ps PR pe complexes lacking p60.","label":0}
{"pair_id":"AIMed.d176.s1487.p2","sentence":"This observation supports a model in which ps p60 pe functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking ps p60 pe.","label":0}
{"pair_id":"AIMed.d176.s1487.p3","sentence":"This observation supports a model in which p60 functions at an intermediate stage of ps PR pe assembly to facilitate formation of subsequent ps PR pe complexes lacking p60.","label":0}
{"pair_id":"AIMed.d176.s1487.p4","sentence":"This observation supports a model in which p60 functions at an intermediate stage of ps PR pe assembly to facilitate formation of subsequent PR complexes lacking ps p60 pe.","label":0}
{"pair_id":"AIMed.d176.s1487.p5","sentence":"This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent ps PR pe complexes lacking ps p60 pe.","label":0}
{"pair_id":"BioInfer.d757.s0.p0","sentence":"Thus, the ps actin pe-binding dodecapeptide sequence of ps cofilin pe may constitute a multifunctional domain in cofilin.","label":1}
{"pair_id":"BioInfer.d757.s0.p1","sentence":"Thus, the ps actin pe-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d757.s0.p2","sentence":"Thus, the actin-binding dodecapeptide sequence of ps cofilin pe may constitute a multifunctional domain in ps cofilin pe.","label":0}
{"pair_id":"AIMed.d182.s1549.p0","sentence":"The interface relies on the steric complementarity between the ps MDM2 pe cleft and the hydrophobic face of the ps p53 pe alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p1","sentence":"The interface relies on the steric complementarity between the ps MDM2 pe cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of ps p53 pe amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p2","sentence":"The interface relies on the steric complementarity between the ps MDM2 pe cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the ps MDM2 pe cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p3","sentence":"The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the ps p53 pe alpha helix and, in particular, on a triad of ps p53 pe amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p4","sentence":"The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the ps p53 pe alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the ps MDM2 pe cleft.","label":0}
{"pair_id":"AIMed.d182.s1549.p5","sentence":"The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of ps p53 pe amino acids-Phe19, Trp23, and Leu26-which insert deep into the ps MDM2 pe cleft.","label":1}
{"pair_id":"AIMed.d153.s1302.p0","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that ps CD26 pe and ps ADA pe co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p1","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that ps CD26 pe and ADA co-localized on the cell surface, but not inside cells, suggesting that ps CD26 pe did not transport ADA to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p2","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that ps CD26 pe and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ps ADA pe to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p3","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ps ADA pe co-localized on the cell surface, but not inside cells, suggesting that ps CD26 pe did not transport ADA to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p4","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ps ADA pe co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ps ADA pe to the surface.","label":0}
{"pair_id":"AIMed.d153.s1302.p5","sentence":"Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that ps CD26 pe did not transport ps ADA pe to the surface.","label":0}
{"pair_id":"AIMed.d146.s1230.p0","sentence":"Characterization of a novel high affinity human ps IL-7 peps IL-7 receptor pe. Expression on T cells and association with IL-7 driven proliferation.","label":0}
{"pair_id":"AIMed.d146.s1230.p1","sentence":"Characterization of a novel high affinity human ps IL-7 pe receptor. Expression on T cells and association with ps IL-7 pe driven proliferation.","label":0}
{"pair_id":"AIMed.d146.s1230.p2","sentence":"Characterization of a novel high affinity human ps IL-7 receptor pe. Expression on T cells and association with ps IL-7 pe driven proliferation.","label":0}
{"pair_id":"AIMed.d195.s1663.p0","sentence":"Intriguingly, ps NR1 pe-ps alpha-actinin pe binding is directly antagonized by Ca2+\/calmodulin.","label":0}
{"pair_id":"AIMed.d195.s1663.p1","sentence":"Intriguingly, ps NR1 pe-alpha-actinin binding is directly antagonized by Ca2+\/ps calmodulin pe.","label":0}
{"pair_id":"AIMed.d195.s1663.p2","sentence":"Intriguingly, NR1-ps alpha-actinin pe binding is directly antagonized by Ca2+\/ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d51.s0.p0","sentence":"ps MSH2 pe plays a fundamental role in mispair recognition whereas MSH3 and ps MSH6 pe appear to modify the specificity of this recognition.","label":0}
{"pair_id":"BioInfer.d51.s0.p1","sentence":"ps MSH2 pe plays a fundamental role in mispair recognition whereas ps MSH3 pe and MSH6 appear to modify the specificity of this recognition.","label":0}
{"pair_id":"BioInfer.d51.s0.p2","sentence":"MSH2 plays a fundamental role in mispair recognition whereas ps MSH3 pe and ps MSH6 pe appear to modify the specificity of this recognition.","label":0}
{"pair_id":"AIMed.d126.s1074.p0","sentence":"Using immunoprecipitation techniques, we have determined the rates at which ps rhodanese pe and ps glutamine synthetase pe (GS) are released from groEL in a form committed to refold to active enzyme.","label":0}
{"pair_id":"AIMed.d126.s1074.p1","sentence":"Using immunoprecipitation techniques, we have determined the rates at which ps rhodanese pe and glutamine synthetase (ps GS pe) are released from groEL in a form committed to refold to active enzyme.","label":0}
{"pair_id":"AIMed.d126.s1074.p2","sentence":"Using immunoprecipitation techniques, we have determined the rates at which ps rhodanese pe and glutamine synthetase (GS) are released from ps groEL pe in a form committed to refold to active enzyme.","label":1}
{"pair_id":"AIMed.d126.s1074.p3","sentence":"Using immunoprecipitation techniques, we have determined the rates at which rhodanese and ps glutamine synthetase pe (ps GS pe) are released from groEL in a form committed to refold to active enzyme.","label":0}
{"pair_id":"AIMed.d126.s1074.p4","sentence":"Using immunoprecipitation techniques, we have determined the rates at which rhodanese and ps glutamine synthetase pe (GS) are released from ps groEL pe in a form committed to refold to active enzyme.","label":1}
{"pair_id":"AIMed.d126.s1074.p5","sentence":"Using immunoprecipitation techniques, we have determined the rates at which rhodanese and glutamine synthetase (ps GS pe) are released from ps groEL pe in a form committed to refold to active enzyme.","label":1}
{"pair_id":"BioInfer.d240.s0.p0","sentence":"Here we demonstrate that ps type XIII collagen pe is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components ps talin pe and vinculin.","label":1}
{"pair_id":"BioInfer.d240.s0.p1","sentence":"Here we demonstrate that ps type XIII collagen pe is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and ps vinculin pe.","label":1}
{"pair_id":"BioInfer.d240.s0.p2","sentence":"Here we demonstrate that ps type XIII collagen pe is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of ps actin pe stress fibers, co-localizing with the known focal adhesion components talin and vinculin.","label":1}
{"pair_id":"BioInfer.d240.s0.p3","sentence":"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components ps talin pe and ps vinculin pe.","label":0}
{"pair_id":"BioInfer.d240.s0.p4","sentence":"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of ps actin pe stress fibers, co-localizing with the known focal adhesion components ps talin pe and vinculin.","label":0}
{"pair_id":"BioInfer.d240.s0.p5","sentence":"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of ps actin pe stress fibers, co-localizing with the known focal adhesion components talin and ps vinculin pe.","label":0}
{"pair_id":"BioInfer.d692.s0.p0","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and ps rhp54+ pe genes are homologous to RAD51, RAD52 and ps RAD54 pe respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d692.s0.p1","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and ps rhp54+ pe genes are homologous to ps RAD51 pe, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p2","sentence":"The Schizosaccharomyces pombe rhp51+, ps rad22+ pe and ps rhp54+ pe genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p3","sentence":"The Schizosaccharomyces pombe ps rhp51+ pe, rad22+ and ps rhp54+ pe genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p4","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and ps rhp54+ pe genes are homologous to RAD51, ps RAD52 pe and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p5","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to ps RAD51 pe, RAD52 and ps RAD54 pe respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p6","sentence":"The Schizosaccharomyces pombe rhp51+, ps rad22+ pe and rhp54+ genes are homologous to RAD51, RAD52 and ps RAD54 pe respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p7","sentence":"The Schizosaccharomyces pombe ps rhp51+ pe, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and ps RAD54 pe respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p8","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, ps RAD52 pe and ps RAD54 pe respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p9","sentence":"The Schizosaccharomyces pombe rhp51+, ps rad22+ pe and rhp54+ genes are homologous to ps RAD51 pe, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p10","sentence":"The Schizosaccharomyces pombe ps rhp51+ pe, rad22+ and rhp54+ genes are homologous to ps RAD51 pe, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d692.s0.p11","sentence":"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to ps RAD51 pe, ps RAD52 pe and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p12","sentence":"The Schizosaccharomyces pombe ps rhp51+ pe, ps rad22+ pe and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d692.s0.p13","sentence":"The Schizosaccharomyces pombe rhp51+, ps rad22+ pe and rhp54+ genes are homologous to RAD51, ps RAD52 pe and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":1}
{"pair_id":"BioInfer.d692.s0.p14","sentence":"The Schizosaccharomyces pombe ps rhp51+ pe, rad22+ and rhp54+ genes are homologous to RAD51, ps RAD52 pe and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d255.s0.p0","sentence":"ps alpha-SNAP pe binds to predicted alpha-helical coiled-coil regions of ps syntaxin pe and SNAP-25, shown previously to be engaged in their direct interaction.","label":1}
{"pair_id":"BioInfer.d255.s0.p1","sentence":"alpha-SNAP binds to predicted alpha-helical coiled-coil regions of ps syntaxin pe and ps SNAP-25 pe, shown previously to be engaged in their direct interaction.","label":1}
{"pair_id":"BioInfer.d255.s0.p2","sentence":"ps alpha-SNAP pe binds to predicted alpha-helical coiled-coil regions of syntaxin and ps SNAP-25 pe, shown previously to be engaged in their direct interaction.","label":1}
{"pair_id":"AIMed.d120.s1017.p0","sentence":"To identify specific ps HSP27 pe-protein interactions, a recombinant fusion protein affinity reagent was constructed and used to identify proteins associating with ps HSP27 pe from human platelet lysates and erythroleukemia cells.","label":0}
{"pair_id":"BioInfer.d119.s1.p0","sentence":"The ps K114E profilin pe exhibited a profound decrease in its ability to interact with ps actin pe, whereas binding to poly-(L)-proline was essentially unchanged.","label":1}
{"pair_id":"AIMed.d175.s1481.p0","sentence":"A physical interaction between ps CDC37 pe and ps CDK4 pe suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on CDK4.","label":1}
{"pair_id":"AIMed.d175.s1481.p1","sentence":"A physical interaction between ps CDC37 pe and CDK4 suggests that ps CDC37 pe may regulate the mammalian cell cycle through a direct effect on CDK4.","label":0}
{"pair_id":"AIMed.d175.s1481.p2","sentence":"A physical interaction between ps CDC37 pe and CDK4 suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on ps CDK4 pe.","label":0}
{"pair_id":"AIMed.d175.s1481.p3","sentence":"A physical interaction between CDC37 and ps CDK4 pe suggests that ps CDC37 pe may regulate the mammalian cell cycle through a direct effect on CDK4.","label":0}
{"pair_id":"AIMed.d175.s1481.p4","sentence":"A physical interaction between CDC37 and ps CDK4 pe suggests that CDC37 may regulate the mammalian cell cycle through a direct effect on ps CDK4 pe.","label":0}
{"pair_id":"AIMed.d175.s1481.p5","sentence":"A physical interaction between CDC37 and CDK4 suggests that ps CDC37 pe may regulate the mammalian cell cycle through a direct effect on ps CDK4 pe.","label":1}
{"pair_id":"BioInfer.d348.s1.p0","sentence":"The exogeneous ps cofilin pe, but not ps ADF pe, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.","label":0}
{"pair_id":"BioInfer.d348.s1.p1","sentence":"The exogeneous ps cofilin pe, but not ADF, caused quick disassembly of ps actin pe filaments and accumulated in furrow region of dividing cells.","label":1}
{"pair_id":"BioInfer.d348.s1.p2","sentence":"The exogeneous cofilin, but not ps ADF pe, caused quick disassembly of ps actin pe filaments and accumulated in furrow region of dividing cells.","label":1}
{"pair_id":"AIMed.d42.s364.p0","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (ps BR-Ia pe and ps BR-Ib pe) and the BMP type II receptor (BR-II).","label":0}
{"pair_id":"AIMed.d42.s364.p1","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (ps BR-Ia pe and BR-Ib) and the ps BMP type II receptor pe (BR-II).","label":0}
{"pair_id":"AIMed.d42.s364.p2","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (ps BR-Ia pe and BR-Ib) and the BMP type II receptor (ps BR-II pe).","label":0}
{"pair_id":"AIMed.d42.s364.p3","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and ps BR-Ib pe) and the ps BMP type II receptor pe (BR-II).","label":0}
{"pair_id":"AIMed.d42.s364.p4","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and ps BR-Ib pe) and the BMP type II receptor (ps BR-II pe).","label":0}
{"pair_id":"AIMed.d42.s364.p5","sentence":"Using several complementary approaches, we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors (BR-Ia and BR-Ib) and the ps BMP type II receptor pe (ps BR-II pe).","label":0}
{"pair_id":"BioInfer.d234.s0.p0","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in ps Tax pe critical for binding CBP\/ps p300 pe to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p1","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding ps CBP pe\/ps p300 pe to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p2","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/ps p300 pe to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for ps CREB pe binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p3","sentence":"ps Glutathione S-transferase pe pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/ps p300 pe to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p4","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/ps p300 pe to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and ps Tax pe subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p5","sentence":"Glutathione S-transferase pull-down performed with ps Tax pe deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/ps p300 pe to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p6","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in ps Tax pe critical for binding ps CBP pe\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p7","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in ps Tax pe critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for ps CREB pe binding and Tax subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p8","sentence":"ps Glutathione S-transferase pe pull-down performed with Tax deletion mutants and peptide competition have localized the site in ps Tax pe critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p9","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in ps Tax pe critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and ps Tax pe subunit dimerization.","label":1}
{"pair_id":"BioInfer.d234.s0.p10","sentence":"Glutathione S-transferase pull-down performed with ps Tax pe deletion mutants and peptide competition have localized the site in ps Tax pe critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p11","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding ps CBP pe\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for ps CREB pe binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p12","sentence":"ps Glutathione S-transferase pe pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding ps CBP pe\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p13","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding ps CBP pe\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and ps Tax pe subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p14","sentence":"Glutathione S-transferase pull-down performed with ps Tax pe deletion mutants and peptide competition have localized the site in Tax critical for binding ps CBP pe\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p15","sentence":"ps Glutathione S-transferase pe pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for ps CREB pe binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p16","sentence":"Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for ps CREB pe binding and ps Tax pe subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p17","sentence":"Glutathione S-transferase pull-down performed with ps Tax pe deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for ps CREB pe binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p18","sentence":"ps Glutathione S-transferase pe pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and ps Tax pe subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p19","sentence":"ps Glutathione S-transferase pe pull-down performed with ps Tax pe deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.","label":0}
{"pair_id":"BioInfer.d234.s0.p20","sentence":"Glutathione S-transferase pull-down performed with ps Tax pe deletion mutants and peptide competition have localized the site in Tax critical for binding CBP\/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and ps Tax pe subunit dimerization.","label":0}
{"pair_id":"BioInfer.d246.s3.p0","sentence":"Regulation of ps actin pe dynamics through phosphorylation of ps cofilin pe by LIM-kinase.","label":1}
{"pair_id":"BioInfer.d246.s3.p1","sentence":"Regulation of ps actin pe dynamics through phosphorylation of cofilin by ps LIM-kinase pe.","label":1}
{"pair_id":"BioInfer.d246.s3.p2","sentence":"Regulation of actin dynamics through phosphorylation of ps cofilin pe by ps LIM-kinase pe.","label":1}
{"pair_id":"BioInfer.d296.s1.p0","sentence":"In CC, membranous expression of ps E-cad pe, alpha-catenin, and ps beta-catenin pe was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.","label":0}
{"pair_id":"BioInfer.d296.s1.p1","sentence":"In CC, membranous expression of ps E-cad pe, ps alpha-catenin pe, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.","label":0}
{"pair_id":"BioInfer.d296.s1.p2","sentence":"In CC, membranous expression of E-cad, ps alpha-catenin pe, and ps beta-catenin pe was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.","label":0}
{"pair_id":"BioInfer.d321.s0.p0","sentence":"In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of ps E-cadherin pe (19 of 86, 22%), but less than that of ps alpha-catenin pe (47 of 86, 55%).","label":0}
{"pair_id":"BioInfer.d321.s0.p1","sentence":"In cancerous tissues, the frequency of reduced expression of ps beta-catenin pe (28 of 86, 33%) was similar to that of ps E-cadherin pe (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).","label":0}
{"pair_id":"BioInfer.d321.s0.p2","sentence":"In cancerous tissues, the frequency of reduced expression of ps beta-catenin pe (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of ps alpha-catenin pe (47 of 86, 55%).","label":0}
{"pair_id":"AIMed.d96.s808.p0","sentence":"It binds homophilically, i.e., ps PTPmu pe on the surface of one cell binds to ps PTPmu pe on an apposing cell, and the binding site lies within the immunoglobulin domain.","label":1}
{"pair_id":"AIMed.d205.s1773.p0","sentence":"Cellular ps p85 pe as well as the recombinant Src homology 2 (SH2) domains of ps p85 pe bound a tyrosine-phosphorylated peptide encompassing Y463 with approximately threefold greater affinity than a doubly tyrosine-phosphorylated Y429-Y441 peptide.","label":0}
{"pair_id":"AIMed.d119.s1005.p0","sentence":"Nuclear protein ps CBP pe is a coactivator for the transcription factor ps CREB pe.","label":1}
{"pair_id":"AIMed.d94.s800.p0","sentence":"However, ps MIP-1 beta pe was also an agonist for ps CC CKR3 pe but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not CC CKR3.","label":1}
{"pair_id":"AIMed.d94.s800.p1","sentence":"However, ps MIP-1 beta pe was also an agonist for CC CKR3 but not ps CC CKR1 pe; MCP-3 was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p2","sentence":"However, ps MIP-1 beta pe was also an agonist for CC CKR3 but not CC CKR1; ps MCP-3 pe was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p3","sentence":"However, ps MIP-1 beta pe was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for ps CC CKR1 pe but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p4","sentence":"However, ps MIP-1 beta pe was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not ps CC CKR3 pe.","label":0}
{"pair_id":"AIMed.d94.s800.p5","sentence":"However, MIP-1 beta was also an agonist for ps CC CKR3 pe but not ps CC CKR1 pe; MCP-3 was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p6","sentence":"However, MIP-1 beta was also an agonist for ps CC CKR3 pe but not CC CKR1; ps MCP-3 pe was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p7","sentence":"However, MIP-1 beta was also an agonist for ps CC CKR3 pe but not CC CKR1; MCP-3 was an agonist for ps CC CKR1 pe but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p8","sentence":"However, MIP-1 beta was also an agonist for ps CC CKR3 pe but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not ps CC CKR3 pe.","label":0}
{"pair_id":"AIMed.d94.s800.p9","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not ps CC CKR1 pe; ps MCP-3 pe was an agonist for CC CKR1 but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p10","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not ps CC CKR1 pe; MCP-3 was an agonist for ps CC CKR1 pe but not CC CKR3.","label":0}
{"pair_id":"AIMed.d94.s800.p11","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not ps CC CKR1 pe; MCP-3 was an agonist for CC CKR1 but not ps CC CKR3 pe.","label":0}
{"pair_id":"AIMed.d94.s800.p12","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; ps MCP-3 pe was an agonist for ps CC CKR1 pe but not CC CKR3.","label":1}
{"pair_id":"AIMed.d94.s800.p13","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; ps MCP-3 pe was an agonist for CC CKR1 but not ps CC CKR3 pe.","label":0}
{"pair_id":"AIMed.d94.s800.p14","sentence":"However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for ps CC CKR1 pe but not ps CC CKR3 pe.","label":0}
{"pair_id":"BioInfer.d480.s0.p0","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p1","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p2","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop pe of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p3","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p4","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p5","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the ps H pe, F, ps NP pe and P ps F protei peps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p6","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, ps NP pe and ps P F protei peps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p7","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop pe of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p8","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, ps F pe, ps NP pe and P ps F protei peps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p9","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p10","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) phosphop of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p11","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p12","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) phosphop of MV and the H, F, ps NP pe and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p13","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p14","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p15","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p16","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p17","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p18","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p19","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p20","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p21","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p22","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p23","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p24","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (ps F pe), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p25","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p26","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p27","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p28","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p29","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p30","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p31","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p32","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p33","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p34","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p35","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), ps fusion pe (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p36","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p37","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p38","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop pe of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p39","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop pe of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p40","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and ps matrix pe (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p41","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop pe of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p42","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p43","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and ps matrix pe (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p44","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and ps matrix pe (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p45","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and ps matrix pe (ps M pe) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p46","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p47","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p48","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p49","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p50","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p51","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p52","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p53","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p54","sentence":"Panels of six to 31 MAbs against the ps haemagglutinin pe (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p55","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p56","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p57","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop peps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p58","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p59","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p60","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (ps P pe) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p61","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (ps NP pe), phosphoprotein (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p62","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), ps nucleocapsid protein pe (NP), phosphoprotein (P) and matrix (ps M pe) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p63","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the ps H pe, F, NP and ps P F protei peps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p64","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop pe of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p65","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the ps H pe, ps F pe, NP and P ps F protei peps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p66","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p67","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) phosphop of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p68","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) phosphop of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p69","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) phosphop of MV and the ps H pe, F, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p70","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p71","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, ps F pe, NP and ps P F protei peps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p72","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p73","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) phosphop of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p74","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p75","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) phosphop of MV and the H, F, NP and ps P F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p76","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop pe of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p77","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p78","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (ps P pe) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p79","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), ps phosphoprotein pe (P) and matrix (M) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p80","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), ps phosphoprotein pe (P) and matrix (ps M pe) ps phosphop pe of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p81","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) phosphop of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p82","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) phosphop of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p83","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) phosphop of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p84","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) phosphop of MV and the H, ps F pe, NP and P ps F protei pe of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p85","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p86","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p87","sentence":"Panels of six to 31 MAbs against the haemagglutinin (ps H pe), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (ps M pe) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p88","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (ps P pe) and matrix (M) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p89","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (ps P pe) and matrix (ps M pe) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"BioInfer.d480.s0.p90","sentence":"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (ps NP pe), phosphoprotein (P) and matrix (ps M pe) phosphop of MV and the H, F, NP and P F protei of CDV were employed.","label":0}
{"pair_id":"AIMed.d202.s1742.p0","sentence":"Here we report the three-dimensional structure of ps IL-1beta pe bound to the extracellular domain of ps IL1R pe (s-IL1R) at 2.5 A resolution.","label":1}
{"pair_id":"AIMed.d202.s1742.p1","sentence":"Here we report the three-dimensional structure of ps IL-1beta pe bound to the extracellular domain of IL1R (ps s-IL1R pe) at 2.5 A resolution.","label":1}
{"pair_id":"AIMed.d202.s1742.p2","sentence":"Here we report the three-dimensional structure of IL-1beta bound to the extracellular domain of ps IL1R pe (ps s-IL1R pe) at 2.5 A resolution.","label":0}
{"pair_id":"BioInfer.d247.s3.p0","sentence":"This mutant ps profilin I pe suppresses actin polymerization in microspike formation induced by ps N-WASP pe, the essential factor in microspike formation.","label":1}
{"pair_id":"BioInfer.d247.s3.p1","sentence":"This mutant ps profilin I pe suppresses ps actin pe polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.","label":1}
{"pair_id":"BioInfer.d247.s3.p2","sentence":"This mutant profilin I suppresses ps actin pe polymerization in microspike formation induced by ps N-WASP pe, the essential factor in microspike formation.","label":1}
{"pair_id":"BioInfer.d312.s0.p0","sentence":"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net ps actin pe protein synthesis and a 3.3-fold increase in net ps myosin heavy chain pe synthesis.","label":0}
{"pair_id":"BioInfer.d312.s0.p1","sentence":"In addition to the ps TNF-alpha pe-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net ps myosin heavy chain pe synthesis.","label":0}
{"pair_id":"BioInfer.d312.s0.p2","sentence":"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with ps TNF-alpha pe led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net ps myosin heavy chain pe synthesis.","label":1}
{"pair_id":"BioInfer.d312.s0.p3","sentence":"In addition to the ps TNF-alpha pe-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net ps actin pe protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.","label":0}
{"pair_id":"BioInfer.d312.s0.p4","sentence":"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with ps TNF-alpha pe led to a 2.4-fold increase in net ps actin pe protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.","label":1}
{"pair_id":"BioInfer.d312.s0.p5","sentence":"In addition to the ps TNF-alpha pe-induced increase in the general protein synthesis, stimulation with ps TNF-alpha pe led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.","label":0}
{"pair_id":"AIMed.d60.s529.p0","sentence":"Furthermore, a bacterially expressed ps v-Raf pe fusion protein (glutathione S-transferase-p3722W) also activated ps MAP kinase pe kinase in vitro.","label":0}
{"pair_id":"AIMed.d60.s529.p1","sentence":"Furthermore, a bacterially expressed ps v-Raf pe fusion protein (glutathione S-transferase-p3722W) also activated ps MAP kinase kinase pe in vitro.","label":0}
{"pair_id":"AIMed.d60.s529.p2","sentence":"Furthermore, a bacterially expressed v-Raf fusion protein (glutathione S-transferase-p3722W) also activated ps MAP kinase peps MAP kinase kinase pe in vitro.","label":0}
{"pair_id":"AIMed.d165.s1388.p0","sentence":"At least two of the subunits of ps TFIIH pe (ps XPB pe and XPD proteins) are implicated in the disease xeroderma pigmentosum (XP).","label":0}
{"pair_id":"AIMed.d165.s1388.p1","sentence":"At least two of the subunits of ps TFIIH pe (XPB and ps XPD pe proteins) are implicated in the disease xeroderma pigmentosum (XP).","label":0}
{"pair_id":"AIMed.d165.s1388.p2","sentence":"At least two of the subunits of TFIIH (ps XPB pe and ps XPD pe proteins) are implicated in the disease xeroderma pigmentosum (XP).","label":0}
{"pair_id":"BioInfer.d638.s0.p0","sentence":"The long repeats, which are interdigitated between the PRRs, increased the frequency with which ps actin pe-based motility occurred by a mechanism independent of the PRRs, VASP, and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d638.s0.p1","sentence":"The long repeats, which are interdigitated between the PRRs, increased the frequency with which ps actin pe-based motility occurred by a mechanism independent of the PRRs, ps VASP pe, and profilin.","label":0}
{"pair_id":"BioInfer.d638.s0.p2","sentence":"The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, ps VASP pe, and ps profilin pe.","label":0}
{"pair_id":"AIMed.d190.s1617.p0","sentence":"In vitro and in vivo experiments support the hypothesis that ps Grb2 pe mediates the association of ps c-Kit pe with c-Cbl.","label":0}
{"pair_id":"AIMed.d190.s1617.p1","sentence":"In vitro and in vivo experiments support the hypothesis that ps Grb2 pe mediates the association of c-Kit with ps c-Cbl pe.","label":0}
{"pair_id":"AIMed.d190.s1617.p2","sentence":"In vitro and in vivo experiments support the hypothesis that Grb2 mediates the association of ps c-Kit pe with ps c-Cbl pe.","label":1}
{"pair_id":"BioInfer.d147.s0.p0","sentence":"ps Cofilin pe was identified by peptide sequencing, and ps cofilin pe recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.","label":0}
{"pair_id":"BioInfer.d147.s0.p1","sentence":"ps Cofilin pe was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing ps actin pe filament turnover.","label":1}
{"pair_id":"BioInfer.d147.s0.p2","sentence":"Cofilin was identified by peptide sequencing, and ps cofilin pe recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing ps actin pe filament turnover.","label":0}
{"pair_id":"BioInfer.d355.s1.p0","sentence":"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into ps myosin heavy chain pe and ps actin pe during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p1","sentence":"To determine the effect of ps insulin-like growth factor I pe (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and ps actin pe during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p2","sentence":"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and ps actin pe during intravenous infusions (4 h) of either saline or ps IGF-I pe (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p3","sentence":"To determine the effect of insulin-like growth factor I (ps IGF-I pe) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and ps actin pe during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p4","sentence":"To determine the effect of ps insulin-like growth factor I pe (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into ps myosin heavy chain pe and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p5","sentence":"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into ps myosin heavy chain pe and actin during intravenous infusions (4 h) of either saline or ps IGF-I pe (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p6","sentence":"To determine the effect of insulin-like growth factor I (ps IGF-I pe) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into ps myosin heavy chain pe and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p7","sentence":"To determine the effect of ps insulin-like growth factor I pe (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or ps IGF-I pe (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p8","sentence":"To determine the effect of ps insulin-like growth factor I pe (ps IGF-I pe) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d355.s1.p9","sentence":"To determine the effect of insulin-like growth factor I (ps IGF-I pe) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or ps IGF-I pe (1 microgram. kg-1. min-1) in awake rats.","label":0}
{"pair_id":"BioInfer.d604.s0.p0","sentence":"The deduced peptide sequence contained a nuclear localization signal and a putative ps actin pe-binding sequence as reported in ps NM-type cofilin pe.","label":1}
{"pair_id":"BioInfer.d7.s1.p0","sentence":"Acanthamoeba ps profilin pe strongly inhibits in a concentration-dependent fashion the rate and extent of Acanthamoeba ps actin pe polymerization in 50 mM KCl.","label":1}
{"pair_id":"BioInfer.d469.s0.p0","sentence":"Other mammalian actin-binding proteins such as profilin and ps CapG pe but also ps fragmin pe from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p1","sentence":"Other mammalian actin-binding proteins such as profilin and ps CapG pe but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated ps pp60 pe(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p2","sentence":"Other mammalian actin-binding proteins such as profilin and ps CapG pe but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(ps c-src pe) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p3","sentence":"Other mammalian ps actin-binding proteins pe such as profilin and ps CapG pe but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p4","sentence":"Other mammalian actin-binding proteins such as ps profilin pe and ps CapG pe but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p5","sentence":"Other mammalian actin-binding proteins such as profilin and CapG but also ps fragmin pe from Physarum polycephalum are similar targets for PIP2-stimulated ps pp60 pe(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p6","sentence":"Other mammalian actin-binding proteins such as profilin and CapG but also ps fragmin pe from Physarum polycephalum are similar targets for PIP2-stimulated pp60(ps c-src pe) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p7","sentence":"Other mammalian ps actin-binding proteins pe such as profilin and CapG but also ps fragmin pe from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p8","sentence":"Other mammalian actin-binding proteins such as ps profilin pe and CapG but also ps fragmin pe from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p9","sentence":"Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated ps pp60 pe(ps c-src pe) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p10","sentence":"Other mammalian ps actin-binding proteins pe such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated ps pp60 pe(c-src) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p11","sentence":"Other mammalian actin-binding proteins such as ps profilin pe and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated ps pp60 pe(c-src) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p12","sentence":"Other mammalian ps actin-binding proteins pe such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(ps c-src pe) phosphorylation.","label":0}
{"pair_id":"BioInfer.d469.s0.p13","sentence":"Other mammalian actin-binding proteins such as ps profilin pe and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(ps c-src pe) phosphorylation.","label":1}
{"pair_id":"BioInfer.d469.s0.p14","sentence":"Other mammalian ps actin-binding proteins pe such as ps profilin pe and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.","label":1}
{"pair_id":"AIMed.d176.s1489.p0","sentence":"ps P60 pe can bind either ps hsp70 pe or hsp90 independently and in an ATP-independent manner.","label":1}
{"pair_id":"AIMed.d176.s1489.p1","sentence":"ps P60 pe can bind either hsp70 or ps hsp90 pe independently and in an ATP-independent manner.","label":1}
{"pair_id":"AIMed.d176.s1489.p2","sentence":"P60 can bind either ps hsp70 pe or ps hsp90 pe independently and in an ATP-independent manner.","label":0}
{"pair_id":"BioInfer.d768.s0.p0","sentence":"Together these results indicate that ps TGFbeta pe regulates ps clusterin pe gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p1","sentence":"Together these results indicate that ps TGFbeta pe regulates clusterin gene expression through an AP-1 site and its cognate transcription factor ps AP-1 pe, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p2","sentence":"Together these results indicate that ps TGFbeta pe regulates clusterin gene expression through an ps AP-1 pe site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p3","sentence":"Together these results indicate that ps TGFbeta pe regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of ps protein kinase C pe.","label":1}
{"pair_id":"BioInfer.d768.s0.p4","sentence":"Together these results indicate that TGFbeta regulates ps clusterin pe gene expression through an AP-1 site and its cognate transcription factor ps AP-1 pe, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p5","sentence":"Together these results indicate that TGFbeta regulates ps clusterin pe gene expression through an ps AP-1 pe site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p6","sentence":"Together these results indicate that TGFbeta regulates ps clusterin pe gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of ps protein kinase C pe.","label":0}
{"pair_id":"BioInfer.d768.s0.p7","sentence":"Together these results indicate that TGFbeta regulates clusterin gene expression through an ps AP-1 pe site and its cognate transcription factor ps AP-1 pe, and requires the involvement of protein kinase C.","label":1}
{"pair_id":"BioInfer.d768.s0.p8","sentence":"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor ps AP-1 pe, and requires the involvement of ps protein kinase C pe.","label":0}
{"pair_id":"BioInfer.d768.s0.p9","sentence":"Together these results indicate that TGFbeta regulates clusterin gene expression through an ps AP-1 pe site and its cognate transcription factor AP-1, and requires the involvement of ps protein kinase C pe.","label":0}
{"pair_id":"BioInfer.d641.s0.p0","sentence":"The majority of the aromatic residues in ps profilin pe are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with ps actin pe.","label":1}
{"pair_id":"BioInfer.d296.s0.p0","sentence":"Immunolocalization of ps E-cadherin pe (E-cad), alpha-catenin, ps beta-catenin pe, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p1","sentence":"Immunolocalization of E-cadherin (ps E-cad pe), alpha-catenin, ps beta-catenin pe, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p2","sentence":"Immunolocalization of E-cadherin (E-cad), ps alpha-catenin pe, ps beta-catenin pe, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p3","sentence":"Immunolocalization of E-cadherin (E-cad), alpha-catenin, ps beta-catenin pe, and ps CD44 pe has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p4","sentence":"Immunolocalization of ps E-cadherin pe (ps E-cad pe), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p5","sentence":"Immunolocalization of ps E-cadherin pe (E-cad), ps alpha-catenin pe, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p6","sentence":"Immunolocalization of ps E-cadherin pe (E-cad), alpha-catenin, beta-catenin, and ps CD44 pe has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p7","sentence":"Immunolocalization of E-cadherin (ps E-cad pe), ps alpha-catenin pe, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p8","sentence":"Immunolocalization of E-cadherin (ps E-cad pe), alpha-catenin, beta-catenin, and ps CD44 pe has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d296.s0.p9","sentence":"Immunolocalization of E-cadherin (E-cad), ps alpha-catenin pe, beta-catenin, and ps CD44 pe has rarely been investigated in human cholangiocarcinoma (CC).","label":0}
{"pair_id":"BioInfer.d332.s1.p0","sentence":"Interaction of ps talin pe with ps actin pe: sensitive modulation of filament crosslinking activity.","label":1}
{"pair_id":"BioInfer.d82.s0.p0","sentence":"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the ps cofilin\/ADF pe family of ps actin pe-severing proteins.","label":1}
{"pair_id":"BioInfer.d82.s0.p1","sentence":"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the ps twinstar pe locus, a gene that encodes a Drosophila member of the cofilin\/ADF family of ps actin pe-severing proteins.","label":0}
{"pair_id":"BioInfer.d82.s0.p2","sentence":"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the ps twinstar pe locus, a gene that encodes a Drosophila member of the ps cofilin\/ADF pe family of actin-severing proteins.","label":1}
{"pair_id":"AIMed.d126.s1078.p0","sentence":"At 25 degrees C, the rate profiles indicate the release and commitment to folding of ps GS pe to its native state occurs far earlier (t1\/2 < 1 min) than for ps rhodanese pe (t1\/2 = 5 min).","label":0}
{"pair_id":"BioInfer.d502.s1.p0","sentence":"The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a ps talin pe mediated mechanism for the attachment of ps actin pe filaments to the cell surfaces in the cleavage furrow.","label":1}
{"pair_id":"BioInfer.d502.s1.p1","sentence":"The presence of ps filamin pe in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of ps actin pe filaments to the cell surfaces in the cleavage furrow.","label":0}
{"pair_id":"BioInfer.d502.s1.p2","sentence":"The presence of ps filamin pe in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a ps talin pe mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.","label":0}
{"pair_id":"BioInfer.d554.s0.p0","sentence":"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of ps profilin pe to suppress ps cap- pe cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p1","sentence":"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress ps cap- pe cells is dependent upon a property other than, or in addition to, its ability to bind ps actin pe.","label":0}
{"pair_id":"BioInfer.d554.s0.p2","sentence":"Study of mutated yeast ps profilins pe and profilins from Acanthamoeba suggests that the ability of profilin to suppress ps cap- pe cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p3","sentence":"Study of mutated yeast profilins and ps profilins pe from Acanthamoeba suggests that the ability of profilin to suppress ps cap- pe cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p4","sentence":"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of ps profilin pe to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind ps actin pe.","label":1}
{"pair_id":"BioInfer.d554.s0.p5","sentence":"Study of mutated yeast ps profilins pe and profilins from Acanthamoeba suggests that the ability of ps profilin pe to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p6","sentence":"Study of mutated yeast profilins and ps profilins pe from Acanthamoeba suggests that the ability of ps profilin pe to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d554.s0.p7","sentence":"Study of mutated yeast ps profilins pe and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind ps actin pe.","label":0}
{"pair_id":"BioInfer.d554.s0.p8","sentence":"Study of mutated yeast profilins and ps profilins pe from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind ps actin pe.","label":0}
{"pair_id":"BioInfer.d554.s0.p9","sentence":"Study of mutated yeast ps profilins pe and ps profilins pe from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.","label":0}
{"pair_id":"BioInfer.d552.s0.p0","sentence":"Studies on cultured cells have suggested that both ps alpha-catenin pe and plakoglobin are important for the adhesive function of ps cadherins pe.","label":1}
{"pair_id":"BioInfer.d552.s0.p1","sentence":"Studies on cultured cells have suggested that both alpha-catenin and ps plakoglobin pe are important for the adhesive function of ps cadherins pe.","label":1}
{"pair_id":"BioInfer.d552.s0.p2","sentence":"Studies on cultured cells have suggested that both ps alpha-catenin pe and ps plakoglobin pe are important for the adhesive function of cadherins.","label":0}
{"pair_id":"BioInfer.d464.s0.p0","sentence":"Only the unphosphorylated form of cofilin is an active form that binds ps actin pe, whereas the regulatory mechanisms of ps cofilin pe have not been elucidated.","label":0}
{"pair_id":"BioInfer.d464.s0.p1","sentence":"Only the unphosphorylated form of ps cofilin pe is an active form that binds actin, whereas the regulatory mechanisms of ps cofilin pe have not been elucidated.","label":0}
{"pair_id":"BioInfer.d464.s0.p2","sentence":"Only the unphosphorylated form of ps cofilin pe is an active form that binds ps actin pe, whereas the regulatory mechanisms of cofilin have not been elucidated.","label":1}
{"pair_id":"AIMed.d69.s592.p0","sentence":"We propose that ps c-Jun pe is present in resting cells in a latent, phosphorylated form that can be activated by site-specific dephosphorylation in response to ps protein kinase C pe activation.","label":1}
{"pair_id":"BioInfer.d644.s0.p0","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, ps villin pe (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and ps calmodulin pe (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p1","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, ps villin pe (95,000 daltons), ps fimbrin pe (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p2","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, ps villin pe (95,000 daltons), fimbrin (68,000 daltons), ps actin pe (43,000 daltons), and calmodulin (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p3","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), ps fimbrin pe (68,000 daltons), actin (43,000 daltons), and ps calmodulin pe (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p4","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), ps actin pe (43,000 daltons), and ps calmodulin pe (17,000 daltons).","label":1}
{"pair_id":"BioInfer.d644.s0.p5","sentence":"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), ps fimbrin pe (68,000 daltons), ps actin pe (43,000 daltons), and calmodulin (17,000 daltons).","label":1}
{"pair_id":"AIMed.d59.s524.p0","sentence":"Peptide growth factors, as well as the immediate early gene products ps c-Jun pe, ps v-Fos pe, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.","label":0}
{"pair_id":"AIMed.d59.s524.p1","sentence":"Peptide growth factors, as well as the immediate early gene products ps c-Jun pe, v-Fos, and ps c-Myc pe, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.","label":0}
{"pair_id":"AIMed.d59.s524.p2","sentence":"Peptide growth factors, as well as the immediate early gene products ps c-Jun pe, v-Fos, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with ps E2A pe products.","label":0}
{"pair_id":"AIMed.d59.s524.p3","sentence":"Peptide growth factors, as well as the immediate early gene products c-Jun, ps v-Fos pe, and ps c-Myc pe, inhibit the activity of myogenin through a mechanism independent of its association with E2A products.","label":0}
{"pair_id":"AIMed.d59.s524.p4","sentence":"Peptide growth factors, as well as the immediate early gene products c-Jun, ps v-Fos pe, and c-Myc, inhibit the activity of myogenin through a mechanism independent of its association with ps E2A pe products.","label":0}
{"pair_id":"AIMed.d59.s524.p5","sentence":"Peptide growth factors, as well as the immediate early gene products c-Jun, v-Fos, and ps c-Myc pe, inhibit the activity of myogenin through a mechanism independent of its association with ps E2A pe products.","label":0}
{"pair_id":"AIMed.d152.s1293.p0","sentence":"ps TRADD pe is a ps TNFR1 pe-associated signal transducer that is involved in activating both pathways.","label":0}
{"pair_id":"BioInfer.d83.s0.p0","sentence":"As previous studies indicated that the ps RVS161 pe and ps RVS167 pe gene products of Saccharomyces cerevisiae seem to be involved in the same cellular function, we considered the possibility of a complex between the proteins encoded by these two genes.","label":1}
{"pair_id":"AIMed.d112.s946.p0","sentence":"Here we show that ps Syk pe and ps Lyn pe from human B lymphocytes can interact directly.","label":1}
{"pair_id":"BioInfer.d187.s2.p0","sentence":"These results emphasize the highly conserved biological function of ps profilins pe with low sequence homology, and correlate specifically their ps actin pe-binding capacity with cell motility and proliferation.","label":1}
{"pair_id":"AIMed.d115.s973.p0","sentence":"Using a yeast interaction assay, we find that ps SRF pe binds the ps RAP74 pe subunit of TFIIF and that SRF's transcriptional activation domain is the region involved in this binding.","label":1}
{"pair_id":"AIMed.d115.s973.p1","sentence":"Using a yeast interaction assay, we find that ps SRF pe binds the RAP74 subunit of ps TFIIF pe and that SRF's transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p2","sentence":"Using a yeast interaction assay, we find that ps SRF pe binds the RAP74 subunit of TFIIF and that ps SRF pe's transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p3","sentence":"Using a yeast interaction assay, we find that SRF binds the ps RAP74 pe subunit of ps TFIIF pe and that SRF's transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p4","sentence":"Using a yeast interaction assay, we find that SRF binds the ps RAP74 pe subunit of TFIIF and that ps SRF pe's transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d115.s973.p5","sentence":"Using a yeast interaction assay, we find that SRF binds the RAP74 subunit of ps TFIIF pe and that ps SRF pe's transcriptional activation domain is the region involved in this binding.","label":0}
{"pair_id":"AIMed.d127.s1084.p0","sentence":"Interaction of ps IL-2R beta pe and gamma c chains with ps Jak1 pe and Jak3: implications for XSCID and XCID.","label":1}
{"pair_id":"AIMed.d127.s1084.p1","sentence":"Interaction of ps IL-2R beta pe and gamma c chains with Jak1 and ps Jak3 pe: implications for XSCID and XCID.","label":1}
{"pair_id":"AIMed.d127.s1084.p2","sentence":"Interaction of IL-2R beta and gamma c chains with ps Jak1 pe and ps Jak3 pe: implications for XSCID and XCID.","label":0}
{"pair_id":"BioInfer.d2.s0.p0","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for ps alpha-catenin pe, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for ps gamma-catenin pe.","label":0}
{"pair_id":"BioInfer.d2.s0.p1","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for ps E-cadherin pe, in 35 (66.0%) for ps alpha-catenin pe, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d2.s0.p2","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for ps alpha-catenin pe, in 20 (37.7%) for ps beta-catenin pe, and in 37 (69.8%) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d2.s0.p3","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for ps E-cadherin pe, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for ps gamma-catenin pe.","label":0}
{"pair_id":"BioInfer.d2.s0.p4","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for ps beta-catenin pe, and in 37 (69.8%) for ps gamma-catenin pe.","label":0}
{"pair_id":"BioInfer.d2.s0.p5","sentence":"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for ps E-cadherin pe, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for ps beta-catenin pe, and in 37 (69.8%) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d237.s4.p0","sentence":"These results suggest that ps RAD52 pe may modulate the catalytic activities of ps RAD51 pe protein such as homologous pairing and strand exchange through a direct physical interaction.","label":1}
{"pair_id":"BioInfer.d16.s0.p0","sentence":"ps Actin-depolymerizing factor pe (ps ADF pe) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p1","sentence":"Actin-depolymerizing factor (ps ADF pe) and ps cofilin pe define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p2","sentence":"Actin-depolymerizing factor (ps ADF pe) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous ps actin pe in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p3","sentence":"Actin-depolymerizing factor (ps ADF pe) and cofilin define a family of ps actin-binding proteins pe essential for the rapid turnover of filamentous actin in vivo.","label":1}
{"pair_id":"BioInfer.d16.s0.p4","sentence":"ps Actin-depolymerizing factor pe (ADF) and ps cofilin pe define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p5","sentence":"ps Actin-depolymerizing factor pe (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous ps actin pe in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p6","sentence":"ps Actin-depolymerizing factor pe (ADF) and cofilin define a family of ps actin-binding proteins pe essential for the rapid turnover of filamentous actin in vivo.","label":1}
{"pair_id":"BioInfer.d16.s0.p7","sentence":"Actin-depolymerizing factor (ADF) and ps cofilin pe define a family of actin-binding proteins essential for the rapid turnover of filamentous ps actin pe in vivo.","label":0}
{"pair_id":"BioInfer.d16.s0.p8","sentence":"Actin-depolymerizing factor (ADF) and ps cofilin pe define a family of ps actin-binding proteins pe essential for the rapid turnover of filamentous actin in vivo.","label":1}
{"pair_id":"BioInfer.d16.s0.p9","sentence":"Actin-depolymerizing factor (ADF) and cofilin define a family of ps actin-binding proteins pe essential for the rapid turnover of filamentous ps actin pe in vivo.","label":1}
{"pair_id":"BioInfer.d166.s1.p0","sentence":"ps rad59 pe mutations completely abolished the ability to generate type II survivors, while ps rad50 pe mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.","label":0}
{"pair_id":"AIMed.d64.s550.p0","sentence":"Transient expression in COS-1 cells and immunoprecipitation using an antiserum raised against a C-terminal peptide, gave rise to two components, representing mature (130 kDa) and precursor (115 kDa) forms of the ps phFGFR pe encoded polypeptide, which was denoted ps hFGFR-1 pe.","label":0}
{"pair_id":"BioInfer.d577.s0.p0","sentence":"The Arp2\/A complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the ps actin pe monomer-binding protein ps profilin pe, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p1","sentence":"The Arp2\/A complex with full-length ps Scar pe, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the ps actin pe monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p2","sentence":"The ps Arp pe2\/ps A pe complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the ps actin pe monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p3","sentence":"The Arp2\/A complex with full-length Scar, ps Scar pe containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the ps actin pe monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p4","sentence":"The Arp2\/A complex with full-length Scar, Scar containing P, W, and A domains, or ps Scar pe containing W and A domains overcomes inhibition of nucleation by the ps actin pe monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p5","sentence":"The ps Arp2 pe\/A complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the ps actin pe monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p6","sentence":"The Arp2\/A complex with full-length ps Scar pe, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein ps profilin pe, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p7","sentence":"The ps Arp pe2\/ps A pe complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein ps profilin pe, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p8","sentence":"The Arp2\/A complex with full-length Scar, ps Scar pe containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein ps profilin pe, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p9","sentence":"The Arp2\/A complex with full-length Scar, Scar containing P, W, and A domains, or ps Scar pe containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein ps profilin pe, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p10","sentence":"The ps Arp2 pe\/A complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein ps profilin pe, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p11","sentence":"The ps Arp pe2\/ps A pe complex with full-length ps Scar pe, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p12","sentence":"The Arp2\/A complex with full-length ps Scar pe, ps Scar pe containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p13","sentence":"The Arp2\/A complex with full-length ps Scar pe, Scar containing P, W, and A domains, or ps Scar pe containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p14","sentence":"The ps Arp2 pe\/A complex with full-length ps Scar pe, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p15","sentence":"The ps Arp pe2\/ps A pe complex with full-length Scar, ps Scar pe containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p16","sentence":"The ps Arp pe2\/ps A pe complex with full-length Scar, Scar containing P, W, and A domains, or ps Scar pe containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p17","sentence":"The ps Arp peps Arp2 pe\/ps A pe complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":1}
{"pair_id":"BioInfer.d577.s0.p18","sentence":"The Arp2\/A complex with full-length Scar, ps Scar pe containing P, W, and A domains, or ps Scar pe containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p19","sentence":"The ps Arp2 pe\/A complex with full-length Scar, ps Scar pe containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d577.s0.p20","sentence":"The ps Arp2 pe\/A complex with full-length Scar, Scar containing P, W, and A domains, or ps Scar pe containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.","label":0}
{"pair_id":"BioInfer.d802.s0.p0","sentence":"We examined whether levels of ps alpha-smooth-muscle actin pe or ps proliferating cell nuclear antigen pe correlated with myosin heavy-chain levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.","label":0}
{"pair_id":"BioInfer.d802.s0.p1","sentence":"We examined whether levels of alpha-smooth-muscle actin or ps proliferating cell nuclear antigen pe correlated with ps myosin heavy-chain pe levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.","label":1}
{"pair_id":"BioInfer.d802.s0.p2","sentence":"We examined whether levels of ps alpha-smooth-muscle actin pe or proliferating cell nuclear antigen correlated with ps myosin heavy-chain pe levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.","label":1}
{"pair_id":"AIMed.d144.s1219.p0","sentence":"One clone encodes a novel ps type 1 protein phosphatase pe catalytic subunit (ps PP-1 alpha 2 pe), which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert.","label":0}
{"pair_id":"AIMed.d144.s1219.p1","sentence":"One clone encodes a novel ps type 1 protein phosphatase pe catalytic subunit (PP-1 alpha 2), which differs from the originally defined ps PP-1 alpha pe by an amino-terminal 11-amino-acid insert.","label":0}
{"pair_id":"AIMed.d144.s1219.p2","sentence":"One clone encodes a novel type 1 protein phosphatase catalytic subunit (ps PP-1 alpha 2 pe), which differs from the originally defined ps PP-1 alpha pe by an amino-terminal 11-amino-acid insert.","label":0}
{"pair_id":"BioInfer.d441.s0.p0","sentence":"Motile areas of leech neurites are rich in microfilaments and two actin-binding proteins: ps gelsolin pe and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d441.s0.p1","sentence":"Motile areas of leech neurites are rich in microfilaments and two ps actin-binding proteins pe: ps gelsolin pe and profilin.","label":1}
{"pair_id":"BioInfer.d441.s0.p2","sentence":"Motile areas of leech neurites are rich in microfilaments and two ps actin-binding proteins pe: gelsolin and ps profilin pe.","label":1}
{"pair_id":"AIMed.d174.s1473.p0","sentence":"These data imply that ps IL-6 pe-induced dimerization of ps sIL-6R pe is not the driving force in promoting formation of the hexameric (IL-6 IL-6R gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p1","sentence":"These data imply that ps IL-6 pe-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (ps IL-6 pe IL-6R gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p2","sentence":"These data imply that ps IL-6 pe-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 ps IL-6R pe gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p3","sentence":"These data imply that ps IL-6 pe-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 IL-6R ps gp130 pe)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p4","sentence":"These data imply that IL-6-induced dimerization of ps sIL-6R pe is not the driving force in promoting formation of the hexameric (ps IL-6 pe IL-6R gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p5","sentence":"These data imply that IL-6-induced dimerization of ps sIL-6R pe is not the driving force in promoting formation of the hexameric (IL-6 ps IL-6R pe gp130)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p6","sentence":"These data imply that IL-6-induced dimerization of ps sIL-6R pe is not the driving force in promoting formation of the hexameric (IL-6 IL-6R ps gp130 pe)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p7","sentence":"These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (ps IL-6 pe ps IL-6R pe gp130)2 complex.","label":1}
{"pair_id":"AIMed.d174.s1473.p8","sentence":"These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (ps IL-6 pe IL-6R ps gp130 pe)2 complex.","label":0}
{"pair_id":"AIMed.d174.s1473.p9","sentence":"These data imply that IL-6-induced dimerization of sIL-6R is not the driving force in promoting formation of the hexameric (IL-6 ps IL-6R pe ps gp130 pe)2 complex.","label":0}
{"pair_id":"AIMed.d152.s1296.p0","sentence":"Conversely, a ps FADD pe mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor of TNF-induced apoptosis, but does not inhibit ps NF-kappa B pe activation.","label":0}
{"pair_id":"BioInfer.d365.s0.p0","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to ps P-cadherin pe, alpha-catenin, or with pan-desmocollin and ps pan-desmoglein pe antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p1","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with ps pan-desmocollin pe and ps pan-desmoglein pe antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p2","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and ps gamma-catenin pe, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and ps pan-desmoglein pe antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p3","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to ps E-cadherin pe, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and ps pan-desmoglein pe antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p4","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, ps alpha-catenin pe, or with pan-desmocollin and ps pan-desmoglein pe antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p5","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, ps beta-catenin pe, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and ps pan-desmoglein pe antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p6","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to ps P-cadherin pe, alpha-catenin, or with ps pan-desmocollin pe and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p7","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and ps gamma-catenin pe, but not with antibodies to ps P-cadherin pe, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p8","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to ps E-cadherin pe, beta-catenin, and gamma-catenin, but not with antibodies to ps P-cadherin pe, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p9","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to ps P-cadherin pe, ps alpha-catenin pe, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p10","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, ps beta-catenin pe, and gamma-catenin, but not with antibodies to ps P-cadherin pe, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p11","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and ps gamma-catenin pe, but not with antibodies to P-cadherin, alpha-catenin, or with ps pan-desmocollin pe and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p12","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to ps E-cadherin pe, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with ps pan-desmocollin pe and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p13","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, ps alpha-catenin pe, or with ps pan-desmocollin pe and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p14","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, ps beta-catenin pe, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with ps pan-desmocollin pe and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p15","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to ps E-cadherin pe, beta-catenin, and ps gamma-catenin pe, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p16","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and ps gamma-catenin pe, but not with antibodies to P-cadherin, ps alpha-catenin pe, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p17","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, ps beta-catenin pe, and ps gamma-catenin pe, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p18","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to ps E-cadherin pe, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, ps alpha-catenin pe, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p19","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to ps E-cadherin pe, ps beta-catenin pe, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"BioInfer.d365.s0.p20","sentence":"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, ps beta-catenin pe, and gamma-catenin, but not with antibodies to P-cadherin, ps alpha-catenin pe, or with pan-desmocollin and pan-desmoglein antibodies.","label":0}
{"pair_id":"AIMed.d122.s1036.p0","sentence":"In previous studies (Scott, J. D., Stofko, R. E., McDonald, J. R., Comer, J. D., Vitalis, E. A., and Mangili J. (1990) J. Biol. Chem. 265, 21561-21566) we have shown that dimerization of ps RII alpha pe was required for interaction with the cytoskeletal component ps microtubule-associated protein 2 pe.","label":1}
{"pair_id":"AIMed.d57.s506.p0","sentence":"In addition, ps hsp90 pe in the lysate complexes with wild-type ps pp60v-src pe, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.","label":1}
{"pair_id":"AIMed.d57.s506.p1","sentence":"In addition, ps hsp90 pe in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, ps pp60c-src pe, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.","label":1}
{"pair_id":"AIMed.d57.s506.p2","sentence":"In addition, ps hsp90 pe in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with ps hsp90 pe.","label":0}
{"pair_id":"AIMed.d57.s506.p3","sentence":"In addition, hsp90 in the lysate complexes with wild-type ps pp60v-src pe, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, ps pp60c-src pe, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90.","label":0}
{"pair_id":"AIMed.d57.s506.p4","sentence":"In addition, hsp90 in the lysate complexes with wild-type ps pp60v-src pe, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with ps hsp90 pe.","label":0}
{"pair_id":"AIMed.d57.s506.p5","sentence":"In addition, hsp90 in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, ps pp60c-src pe, which has never been recovered in cytosol in the form of a native multiprotein complex with ps hsp90 pe.","label":0}
{"pair_id":"AIMed.d199.s1709.p0","sentence":"ps Sos pe complex following ps Sos pe phosphorylation.","label":0}
{"pair_id":"BioInfer.d631.s0.p0","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (ps N pe) and ps large polymerase pe (L) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p1","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with ps nucleocapsid pe (N) and ps large polymerase pe (L) ps nucleoca peps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p2","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) ps phosphoprotein pe (P) with nucleocapsid (N) and ps large polymerase pe (L) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p3","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (ps P pe) with nucleocapsid (N) and ps large polymerase pe (L) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p4","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and ps large polymerase pe (L) ps nucleoca pe was investigated using an intracellular BRSV-ps CAT pe minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p5","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and ps large polymerase pe (ps L pe) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p6","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with ps nucleocapsid pe (ps N pe) and large polymerase (L) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p7","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) ps phosphoprotein pe (P) with nucleocapsid (ps N pe) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p8","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (ps P pe) with nucleocapsid (ps N pe) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p9","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (ps N pe) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-ps CAT pe minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p10","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (ps N pe) and large polymerase (ps L pe) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p11","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) ps phosphoprotein pe (P) with ps nucleocapsid pe (N) and large polymerase (L) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p12","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (ps P pe) with ps nucleocapsid pe (N) and large polymerase (L) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p13","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with ps nucleocapsid pe (N) and large polymerase (L) ps nucleoca pe was investigated using an intracellular BRSV-ps CAT pe minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p14","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with ps nucleocapsid pe (N) and large polymerase (ps L pe) ps nucleoca pe was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p15","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) ps phosphoprotein pe (ps P pe) with nucleocapsid (N) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p16","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) ps phosphoprotein pe (P) with nucleocapsid (N) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-ps CAT pe minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p17","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) ps phosphoprotein pe (P) with nucleocapsid (N) and large polymerase (ps L pe) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p18","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (ps P pe) with nucleocapsid (N) and large polymerase (L) nucleoca was investigated using an intracellular BRSV-ps CAT pe minigenome replication system.","label":0}
{"pair_id":"BioInfer.d631.s0.p19","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (ps P pe) with nucleocapsid (N) and large polymerase (ps L pe) nucleoca was investigated using an intracellular BRSV-CAT minigenome replication system.","label":1}
{"pair_id":"BioInfer.d631.s0.p20","sentence":"The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (ps L pe) nucleoca was investigated using an intracellular BRSV-ps CAT pe minigenome replication system.","label":0}
{"pair_id":"AIMed.d61.s534.p0","sentence":"Cross-linking of 125I-ps TNF-alpha pe and 125I-ps TNF-beta pe to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p1","sentence":"Cross-linking of 125I-ps TNF-alpha pe and 125I-TNF-beta to 293\/ps TNF-R2 pe cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p2","sentence":"Cross-linking of 125I-ps TNF-alpha pe and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for ps TNF-alpha pe and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p3","sentence":"Cross-linking of 125I-ps TNF-alpha pe and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for ps TNF-beta pe, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p4","sentence":"Cross-linking of 125I-ps TNF-alpha pe and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three ps TNF-R2 pe molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p5","sentence":"Cross-linking of 125I-TNF-alpha and 125I-ps TNF-beta pe to 293\/ps TNF-R2 pe cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p6","sentence":"Cross-linking of 125I-TNF-alpha and 125I-ps TNF-beta pe to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for ps TNF-alpha pe and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p7","sentence":"Cross-linking of 125I-TNF-alpha and 125I-ps TNF-beta pe to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for ps TNF-beta pe, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p8","sentence":"Cross-linking of 125I-TNF-alpha and 125I-ps TNF-beta pe to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three ps TNF-R2 pe molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p9","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/ps TNF-R2 pe cells yielded predominant complexes with apparent molecular weights of 211,000 for ps TNF-alpha pe and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p10","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/ps TNF-R2 pe cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for ps TNF-beta pe, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p11","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/ps TNF-R2 pe cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three ps TNF-R2 pe molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p12","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for ps TNF-alpha pe and 205,000 and 244,000 for ps TNF-beta pe, suggesting these complexes contain two or three TNF-R2 molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p13","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for ps TNF-alpha pe and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three ps TNF-R2 pe molecules.","label":0}
{"pair_id":"AIMed.d61.s534.p14","sentence":"Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293\/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for ps TNF-beta pe, suggesting these complexes contain two or three ps TNF-R2 pe molecules.","label":0}
{"pair_id":"BioInfer.d470.s0.p0","sentence":"ps p53 pe-mediated cell injury exhibited proteolysis of the ps caspase pe protein substrate lamin B without appreciable breakdown of TnI.","label":0}
{"pair_id":"BioInfer.d470.s0.p1","sentence":"ps p53 pe-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of ps TnI pe.","label":0}
{"pair_id":"BioInfer.d470.s0.p2","sentence":"ps p53 pe-mediated cell injury exhibited proteolysis of the caspase protein substrate ps lamin B pe without appreciable breakdown of TnI.","label":0}
{"pair_id":"BioInfer.d470.s0.p3","sentence":"p53-mediated cell injury exhibited proteolysis of the ps caspase pe protein substrate lamin B without appreciable breakdown of ps TnI pe.","label":0}
{"pair_id":"BioInfer.d470.s0.p4","sentence":"p53-mediated cell injury exhibited proteolysis of the ps caspase pe protein substrate ps lamin B pe without appreciable breakdown of TnI.","label":0}
{"pair_id":"BioInfer.d470.s0.p5","sentence":"p53-mediated cell injury exhibited proteolysis of the caspase protein substrate ps lamin B pe without appreciable breakdown of ps TnI pe.","label":0}
{"pair_id":"AIMed.d165.s1384.p0","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex ps TFIIH pe, the nucleotide excision repair protein ps XPG pe, and Cockayne syndrome group B (CSB) protein.","label":0}
{"pair_id":"AIMed.d165.s1384.p1","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex ps TFIIH pe, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (ps CSB pe) protein.","label":0}
{"pair_id":"AIMed.d165.s1384.p2","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex ps TFIIH pe, the nucleotide excision repair protein XPG, and ps Cockayne syndrome group B (CSB) protein pe.","label":0}
{"pair_id":"AIMed.d165.s1384.p3","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein ps XPG pe, and Cockayne syndrome group B (ps CSB pe) protein.","label":1}
{"pair_id":"AIMed.d165.s1384.p4","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein ps XPG pe, and ps Cockayne syndrome group B (CSB) protein pe.","label":0}
{"pair_id":"AIMed.d165.s1384.p5","sentence":"Interactions involving the human RNA polymerase II transcription\/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and ps Cockayne syndrome group B (CSB) protein peps CSB pe) protein.","label":0}
{"pair_id":"BioInfer.d658.s0.p0","sentence":"The phosphoprotein was identified as ps cofilin pe, an ps actin-binding protein pe, and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).","label":1}
{"pair_id":"BioInfer.d148.s1.p0","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, ps TRAIL pe, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p1","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, ps TRAIL pe, FADD, TRADD, RIP, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p2","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, ps TRAIL pe, FADD, TRADD, RIP, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p3","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, ps TRAIL pe, FADD, ps TRADD pe, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p4","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, ps TRAIL pe, FADD, TRADD, ps RIP pe, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p5","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, ps TRAIL pe, FADD, TRADD, RIP, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p6","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, ps TRAIL pe, ps FADD pe, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p7","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, ps TRAIL pe, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p8","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, ps TRAIL pe, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p9","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, ps TRAIL pe, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p10","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p11","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p12","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, ps TRADD pe, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p13","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, ps RIP pe, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p14","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p15","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, ps FADD pe, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p16","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p17","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p18","sentence":"To detect the expression of apoptosis-related molecules, ps ribonuclease pe protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p19","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, ps FAF pe, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p20","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, ps TRADD pe, RIP, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p21","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, ps RIP pe, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p22","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, ps FAF pe, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p23","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, ps FADD pe, TRADD, RIP, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p24","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, TRAIL, FADD, TRADD, RIP, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p25","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, TRAIL, FADD, TRADD, RIP, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p26","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, ps FAF pe, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p27","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, ps TRADD pe, RIP, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p28","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, ps RIP pe, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p29","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, ps FAP pe, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p30","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, ps FADD pe, TRADD, RIP, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p31","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p32","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, TRAIL, FADD, TRADD, RIP, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p33","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, ps FAP pe, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p34","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, ps TRADD pe, ps RIP pe, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p35","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, ps TRADD pe, RIP, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p36","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, ps FADD pe, ps TRADD pe, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p37","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, TRAIL, FADD, ps TRADD pe, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p38","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, TRAIL, FADD, ps TRADD pe, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p39","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, TRAIL, FADD, ps TRADD pe, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p40","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, ps RIP pe, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p41","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, ps FADD pe, TRADD, ps RIP pe, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p42","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, TRAIL, FADD, TRADD, ps RIP pe, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p43","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, TRAIL, FADD, TRADD, ps RIP pe, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p44","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, ps RIP pe, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p45","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, ps FADD pe, TRADD, RIP, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p46","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p47","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, TRAIL, FADD, TRADD, RIP, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p48","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and ps caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d148.s1.p49","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, TNFR-1, TRAIL, ps FADD pe, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p50","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, ps TNFR-1 pe, TRAIL, ps FADD pe, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p51","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, TNFR-1, TRAIL, ps FADD pe, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p52","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, ps Fas ligand pe, ps TNFR-1 pe, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p53","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, ps Fas ligand pe, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"BioInfer.d148.s1.p54","sentence":"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for ps Fas pe, Fas ligand, ps TNFR-1 pe, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.","label":0}
{"pair_id":"AIMed.d76.s649.p0","sentence":"ps CD5 pe interaction wps ith pe p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p1","sentence":"ps CD5 pe interaction with ps p56lck pe represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":1}
{"pair_id":"AIMed.d76.s649.p2","sentence":"ps CD5 pe interaction with p56lck represents a novel variant of a receptor-kinasps e compl peex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p3","sentence":"CD5 interaction wps ith pe ps p56lck pe represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p4","sentence":"CD5 interaction wps ith pe p56lck represents a novel variant of a receptor-kinasps e compl peex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d76.s649.p5","sentence":"CD5 interaction with ps p56lck pe represents a novel variant of a receptor-kinasps e compl peex in which receptor can also serve as substrate. ( ABSTRACT TRUNCATED AT 250 WORDS )","label":0}
{"pair_id":"AIMed.d61.s537.p0","sentence":"ps TNF-alpha pe treatment of 293\/ps TNF-R2 pe cells did not significantly affect the degree or pattern of phosphorylation.","label":0}
{"pair_id":"AIMed.d217.s1879.p0","sentence":"Characterization of ps Fas pe (ps Apo-1 pe, CD95)-Fas ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p1","sentence":"Characterization of ps Fas pe (Apo-1, ps CD95 pe)-Fas ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p2","sentence":"Characterization of ps Fas pe (Apo-1, CD95)-ps Fas pe ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p3","sentence":"Characterization of ps Fas pe (Apo-1, CD95)-ps Fas ligand pe interaction.","label":1}
{"pair_id":"AIMed.d217.s1879.p4","sentence":"Characterization of Fas (ps Apo-1 pe, ps CD95 pe)-Fas ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p5","sentence":"Characterization of Fas (ps Apo-1 pe, CD95)-ps Fas pe ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p6","sentence":"Characterization of Fas (ps Apo-1 pe, CD95)-ps Fas ligand pe interaction.","label":1}
{"pair_id":"AIMed.d217.s1879.p7","sentence":"Characterization of Fas (Apo-1, ps CD95 pe)-ps Fas pe ligand interaction.","label":0}
{"pair_id":"AIMed.d217.s1879.p8","sentence":"Characterization of Fas (Apo-1, ps CD95 pe)-ps Fas ligand pe interaction.","label":1}
{"pair_id":"AIMed.d217.s1879.p9","sentence":"Characterization of Fas (Apo-1, CD95)-ps Fas peps Fas ligand pe interaction.","label":0}
{"pair_id":"AIMed.d217.s1880.p0","sentence":"The death-inducing receptor ps Fas pe is activated when cross-linked by the type II membrane protein ps Fas pe ligand (FasL).","label":0}
{"pair_id":"AIMed.d217.s1880.p1","sentence":"The death-inducing receptor ps Fas pe is activated when cross-linked by the type II membrane protein ps Fas ligand pe (FasL).","label":1}
{"pair_id":"AIMed.d217.s1880.p2","sentence":"The death-inducing receptor ps Fas pe is activated when cross-linked by the type II membrane protein Fas ligand (ps FasL pe).","label":1}
{"pair_id":"AIMed.d217.s1880.p3","sentence":"The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein ps Fas peps Fas ligand pe (FasL).","label":0}
{"pair_id":"AIMed.d217.s1880.p4","sentence":"The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein ps Fas pe ligand (ps FasL pe).","label":1}
{"pair_id":"AIMed.d217.s1880.p5","sentence":"The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein ps Fas ligand pe (ps FasL pe).","label":0}
{"pair_id":"BioInfer.d137.s0.p0","sentence":"Characterization of gelsolin truncates that inhibit ps actin pe depolymerization by severing activity of gelsolin and ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d137.s0.p1","sentence":"Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of ps gelsolin pe and ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d137.s0.p2","sentence":"Characterization of ps gelsolin pe truncates that inhibit actin depolymerization by severing activity of gelsolin and ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d137.s0.p3","sentence":"Characterization of gelsolin truncates that inhibit ps actin pe depolymerization by severing activity of ps gelsolin pe and cofilin.","label":1}
{"pair_id":"BioInfer.d137.s0.p4","sentence":"Characterization of ps gelsolin pe truncates that inhibit ps actin pe depolymerization by severing activity of gelsolin and cofilin.","label":1}
{"pair_id":"BioInfer.d137.s0.p5","sentence":"Characterization of ps gelsolin pe truncates that inhibit actin depolymerization by severing activity of ps gelsolin pe and cofilin.","label":1}
{"pair_id":"BioInfer.d84.s1.p0","sentence":"In contrast, ps alpha actin pe and ps myosin heavy chain pe mRNA accumulation was not enhanced in hybrid embryos.","label":0}
{"pair_id":"BioInfer.d463.s0.p0","sentence":"One such protein is the yeast ps actin-binding protein pe ps Sac6p pe, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).","label":1}
{"pair_id":"BioInfer.d463.s0.p1","sentence":"One such protein is the yeast ps actin-binding protein pe Sac6p, which is homologous to vertebrate ps fimbrin pe (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).","label":0}
{"pair_id":"BioInfer.d463.s0.p2","sentence":"One such protein is the yeast actin-binding protein ps Sac6p pe, which is homologous to vertebrate ps fimbrin pe (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).","label":1}
{"pair_id":"BioInfer.d334.s1.p0","sentence":"In mouse brain profilin I and ps profilin II pe associate with regulators of the endocytic pathway and ps actin pe assembly.","label":0}
{"pair_id":"BioInfer.d334.s1.p1","sentence":"In mouse brain ps profilin I pe and ps profilin II pe associate with regulators of the endocytic pathway and actin assembly.","label":0}
{"pair_id":"BioInfer.d334.s1.p2","sentence":"In mouse brain ps profilin I pe and profilin II associate with regulators of the endocytic pathway and ps actin pe assembly.","label":0}
{"pair_id":"AIMed.d160.s1352.p0","sentence":"Furthermore, this mutational analysis implicates ps KDR pe, but not ps FLT-1 pe, in VEGF induction of endothelial cell proliferation.","label":0}
{"pair_id":"AIMed.d160.s1352.p1","sentence":"Furthermore, this mutational analysis implicates ps KDR pe, but not FLT-1, in ps VEGF pe induction of endothelial cell proliferation.","label":0}
{"pair_id":"AIMed.d160.s1352.p2","sentence":"Furthermore, this mutational analysis implicates KDR, but not ps FLT-1 pe, in ps VEGF pe induction of endothelial cell proliferation.","label":0}
{"pair_id":"AIMed.d68.s580.p0","sentence":"Microinjection of anti-ps cdc25A pe antibodies into HeLa cells causes their arrest in mitosis. ps cdc25A pe and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p1","sentence":"Microinjection of anti-ps cdc25A pe antibodies into HeLa cells causes their arrest in mitosis. cdc25A and ps cdc25B pe display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p2","sentence":"Microinjection of anti-ps cdc25A pe antibodies into HeLa cells causes their arrest in mitosis. cdc25A and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either ps cyclin B1 pe or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p3","sentence":"Microinjection of anti-cdc25A antibodies into HeLa cells causes their arrest in mitosis. ps cdc25A pe and ps cdc25B pe display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either cyclin B1 or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p4","sentence":"Microinjection of anti-cdc25A antibodies into HeLa cells causes their arrest in mitosis. ps cdc25A pe and cdc25B display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either ps cyclin B1 pe or B2 but not A or D1.","label":0}
{"pair_id":"AIMed.d68.s580.p5","sentence":"Microinjection of anti-cdc25A antibodies into HeLa cells causes their arrest in mitosis. cdc25A and ps cdc25B pe display endogenous tyrosine phosphatase activity that is stimulated several-fold, in the absence of cdc2, by stoichiometric addition of either ps cyclin B1 pe or B2 but not A or D1.","label":0}
{"pair_id":"BioInfer.d547.s0.p0","sentence":"Specific interaction between the nucleocapsid protein (N) and the ps phosphoprotein pe (ps P pe) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":0}
{"pair_id":"BioInfer.d547.s0.p1","sentence":"Specific interaction between the ps nucleocapsid protein pe (N) and the phosphoprotein (ps P pe) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p2","sentence":"Specific interaction between the nucleocapsid protein (ps N pe) and the phosphoprotein (ps P pe) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p3","sentence":"Specific interaction between the ps nucleocapsid protein pe (N) and the ps phosphoprotein pe (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p4","sentence":"Specific interaction between the nucleocapsid protein (ps N pe) and the ps phosphoprotein pe (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":1}
{"pair_id":"BioInfer.d547.s0.p5","sentence":"Specific interaction between the ps nucleocapsid protein pe (ps N pe) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.","label":0}
{"pair_id":"BioInfer.d170.s0.p0","sentence":"Detection of a sequence involved in ps actin pe-binding and phosphoinositide-binding in the N-terminal side of ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d275.s0.p0","sentence":"However, smooth muscle contents of ps actin pe (26.0 +\/- 1.8 vs. 19.1 +\/- 2.2 micrograms\/mg wet wt) and ps myosin heavy chain pe (5.5 +\/- 0.4 vs. 2.0 +\/- 0.3 microgram\/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.","label":0}
{"pair_id":"AIMed.d219.s1899.p0","sentence":"ps 14-3-3 zeta pe negatively regulates ps raf-1 pe activity by interactions with the Raf-1 cysteine-rich domain.","label":1}
{"pair_id":"AIMed.d219.s1899.p1","sentence":"ps 14-3-3 zeta pe negatively regulates raf-1 activity by interactions with the ps Raf-1 pe cysteine-rich domain.","label":1}
{"pair_id":"AIMed.d219.s1899.p2","sentence":"14-3-3 zeta negatively regulates ps raf-1 pe activity by interactions with the ps Raf-1 pe cysteine-rich domain.","label":0}
{"pair_id":"AIMed.d216.s1878.p0","sentence":"Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of ps GAP-334 pe and glutamine-61 of ps Ras pe, and even its mutation to alanine would disturb the arrangements of residues in the transition state.","label":0}
{"pair_id":"BioInfer.d55.s0.p0","sentence":"Analysis of ps profilin pe: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of ps profilin pe molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p1","sentence":"Analysis of ps profilin pe: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked ps actin pe ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p2","sentence":"Analysis of ps profilin pe: ps actin pe crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p3","sentence":"Analysis of ps profilin pe: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring ps actin pe subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p4","sentence":"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked ps actin pe ribbons held in place by columns of ps profilin pe molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p5","sentence":"Analysis of profilin: ps actin pe crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of ps profilin pe molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p6","sentence":"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of ps profilin pe molecules, wedged in between neighboring ps actin pe subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p7","sentence":"Analysis of profilin: ps actin pe crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked ps actin pe ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p8","sentence":"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked ps actin pe ribbons held in place by columns of profilin molecules, wedged in between neighboring ps actin pe subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d55.s0.p9","sentence":"Analysis of profilin: ps actin pe crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring ps actin pe subunits and running perpendicular to the ribbons.","label":0}
{"pair_id":"BioInfer.d359.s0.p0","sentence":"Interaction between nucleocapsid protein (ps NP pe) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two ps NP pe binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p1","sentence":"Interaction between nucleocapsid protein (ps NP pe) and phosphoprotein (ps P pe) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p2","sentence":"Interaction between nucleocapsid protein (ps NP pe) and ps phosphoprotein pe (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p3","sentence":"Interaction between ps nucleocapsid protein pe (ps NP pe) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p4","sentence":"Interaction between nucleocapsid protein (ps NP pe) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on ps P pe is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p5","sentence":"Interaction between nucleocapsid protein (NP) and phosphoprotein (ps P pe) of human parainfluenza virus type 2: one of the two ps NP pe binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p6","sentence":"Interaction between nucleocapsid protein (NP) and ps phosphoprotein pe (P) of human parainfluenza virus type 2: one of the two ps NP pe binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p7","sentence":"Interaction between ps nucleocapsid protein pe (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two ps NP pe binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p8","sentence":"Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two ps NP pe binding sites on ps P pe is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p9","sentence":"Interaction between nucleocapsid protein (NP) and ps phosphoprotein pe (ps P pe) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p10","sentence":"Interaction between ps nucleocapsid protein pe (NP) and phosphoprotein (ps P pe) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p11","sentence":"Interaction between nucleocapsid protein (NP) and phosphoprotein (ps P pe) of human parainfluenza virus type 2: one of the two NP binding sites on ps P pe is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p12","sentence":"Interaction between ps nucleocapsid protein pe (NP) and ps phosphoprotein pe (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.","label":1}
{"pair_id":"BioInfer.d359.s0.p13","sentence":"Interaction between nucleocapsid protein (NP) and ps phosphoprotein pe (P) of human parainfluenza virus type 2: one of the two NP binding sites on ps P pe is essential for granule formation.","label":0}
{"pair_id":"BioInfer.d359.s0.p14","sentence":"Interaction between ps nucleocapsid protein pe (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on ps P pe is essential for granule formation.","label":0}
{"pair_id":"AIMed.d91.s776.p0","sentence":"Molecular cloning and expression of the 32-kDa subunit of human ps TFIID pe reveals interactions with ps VP16 pe and TFIIB that mediate transcriptional activation.","label":0}
{"pair_id":"AIMed.d91.s776.p1","sentence":"Molecular cloning and expression of the 32-kDa subunit of human ps TFIID pe reveals interactions with VP16 and ps TFIIB pe that mediate transcriptional activation.","label":0}
{"pair_id":"AIMed.d91.s776.p2","sentence":"Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with ps VP16 pe and ps TFIIB pe that mediate transcriptional activation.","label":0}
{"pair_id":"AIMed.d15.s126.p0","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely ps interleukin (IL)-8 pe, ps interferon-gamma pe and IL-2 versus IL-10.","label":0}
{"pair_id":"AIMed.d15.s126.p1","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely ps interleukin (IL)-8 pe, interferon-gamma and ps IL-2 pe versus IL-10.","label":0}
{"pair_id":"AIMed.d15.s126.p2","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely ps interleukin (IL)-8 pe, interferon-gamma and IL-2 versus ps IL-10 pe.","label":0}
{"pair_id":"AIMed.d15.s126.p3","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, ps interferon-gamma pe and ps IL-2 pe versus IL-10.","label":0}
{"pair_id":"AIMed.d15.s126.p4","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, ps interferon-gamma pe and IL-2 versus ps IL-10 pe.","label":0}
{"pair_id":"AIMed.d15.s126.p5","sentence":"We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and ps IL-2 pe versus ps IL-10 pe.","label":0}
{"pair_id":"AIMed.d195.s1660.p0","sentence":"Competitive binding of ps alpha-actinin pe and ps calmodulin pe to the NMDA receptor.","label":0}
{"pair_id":"AIMed.d195.s1660.p1","sentence":"Competitive binding of ps alpha-actinin pe and calmodulin to the ps NMDA receptor pe.","label":1}
{"pair_id":"AIMed.d195.s1660.p2","sentence":"Competitive binding of alpha-actinin and ps calmodulin pe to the ps NMDA receptor pe.","label":1}
{"pair_id":"BioInfer.d214.s0.p0","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, ps actin depolymerizing factor pe, and ps profilin pe were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p1","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble ps actin pe, cofilin, ps actin depolymerizing factor pe, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p2","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, ps cofilin pe, ps actin depolymerizing factor pe, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p3","sentence":"Fluorographic analysis showed that the specific activity of soluble ps actin pe was two to three times that of its particulate form and that soluble actin, cofilin, ps actin depolymerizing factor pe, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p4","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble ps actin pe, cofilin, actin depolymerizing factor, and ps profilin pe were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p5","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, ps cofilin pe, actin depolymerizing factor, and ps profilin pe were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p6","sentence":"Fluorographic analysis showed that the specific activity of soluble ps actin pe was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and ps profilin pe were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p7","sentence":"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble ps actin pe, ps cofilin pe, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p8","sentence":"Fluorographic analysis showed that the specific activity of soluble ps actin pe was two to three times that of its particulate form and that soluble ps actin pe, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"BioInfer.d214.s0.p9","sentence":"Fluorographic analysis showed that the specific activity of soluble ps actin pe was two to three times that of its particulate form and that soluble actin, ps cofilin pe, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.","label":0}
{"pair_id":"AIMed.d164.s1381.p0","sentence":"Nuclear extracts deficient in ps U2AF35 pe were inactive; however, both constitutive and enhancer-dependent splicing could be restored by the addition of purified recombinant ps U2AF35 pe.","label":0}
{"pair_id":"AIMed.d0.s7.p0","sentence":"In patients with a complete response to ps IFN-alpha pe, the levels of ps IFN-gamma pe were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p1","sentence":"In patients with a complete response to ps IFN-alpha pe, the levels of IFN-gamma were higher at 24 weeks following ps IFN-alpha pe treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p2","sentence":"In patients with a complete response to ps IFN-alpha pe, the levels of IFN-gamma were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of ps IL-4 pe decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p3","sentence":"In patients with a complete response to IFN-alpha, the levels of ps IFN-gamma pe were higher at 24 weeks following ps IFN-alpha pe treatment than that of pre-treatment (P = 0.04), and the levels of IL-4 decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p4","sentence":"In patients with a complete response to IFN-alpha, the levels of ps IFN-gamma pe were higher at 24 weeks following IFN-alpha treatment than that of pre-treatment (P = 0.04), and the levels of ps IL-4 pe decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"AIMed.d0.s7.p5","sentence":"In patients with a complete response to IFN-alpha, the levels of IFN-gamma were higher at 24 weeks following ps IFN-alpha pe treatment than that of pre-treatment (P = 0.04), and the levels of ps IL-4 pe decreased markedly at 12 and 24 weeks (P = 0.02, 0.03, respectively). mRNA expression positively correlated with the level of Th1\/Th2 type cytokines in the supernatant.","label":0}
{"pair_id":"BioInfer.d492.s0.p0","sentence":"Previously, we have shown that in the absence of ps RAD52 pe, repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking ps RAD51 pe, gene conversion is absent but cells can repair the DSB by BIR.","label":0}
{"pair_id":"AIMed.d113.s955.p0","sentence":"Cloning and functional analysis of ps BAG-1 pe: a novel ps Bcl-2 pe-binding protein with anti-cell death activity.","label":1}
{"pair_id":"AIMed.d113.s955.p1","sentence":"Cloning and functional analysis of ps BAG-1 pe: a novel ps Bcl-2-binding protein pe with anti-cell death activity.","label":0}
{"pair_id":"AIMed.d113.s955.p2","sentence":"Cloning and functional analysis of BAG-1: a novel ps Bcl-2 peps Bcl-2-binding protein pe with anti-cell death activity.","label":0}
{"pair_id":"BioInfer.d139.s1.p0","sentence":"Moreover, addition of ps profilin pe to steady-state ps actin pe filaments causes slow depolymerization.","label":1}
{"pair_id":"BioInfer.d761.s0.p0","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and ps alpha-smooth muscle actin pe (alpha-SM actin) in ps IgA pe nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p1","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of ps nonmuscle-type myosin heavy chain pe, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in ps IgA pe nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p2","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (ps alpha-SM actin pe) in ps IgA pe nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p3","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, ps SMemb pe, and alpha-smooth muscle actin (alpha-SM actin) in ps IgA pe nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p4","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of ps nonmuscle-type myosin heavy chain pe, SMemb, and ps alpha-smooth muscle actin pe (alpha-SM actin) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p5","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and ps alpha-smooth muscle actin pe (ps alpha-SM actin pe) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p6","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, ps SMemb pe, and ps alpha-smooth muscle actin pe (alpha-SM actin) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p7","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of ps nonmuscle-type myosin heavy chain pe, SMemb, and alpha-smooth muscle actin (ps alpha-SM actin pe) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p8","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of ps nonmuscle-type myosin heavy chain pe, ps SMemb pe, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d761.s0.p9","sentence":"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, ps SMemb pe, and alpha-smooth muscle actin (ps alpha-SM actin pe) in IgA nephropathy.","label":0}
{"pair_id":"BioInfer.d799.s0.p0","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (ps UL5 pe, UL8, ps UL9 pe and UL52) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p1","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (ps UL5 pe, ps UL8 pe, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p2","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (ps UL5 pe, UL8, UL9 and ps UL52 pe) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p3","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, ps UL8 pe, ps UL9 pe and UL52) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p4","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, ps UL9 pe and ps UL52 pe) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"BioInfer.d799.s0.p5","sentence":"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, ps UL8 pe, UL9 and ps UL52 pe) in the absence of any of the other proteins required for viral DNA synthesis.","label":0}
{"pair_id":"AIMed.d182.s1546.p0","sentence":"The ps MDM2 pe oncoprotein is a cellular inhibitor of the ps p53 pe tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.","label":1}
{"pair_id":"AIMed.d182.s1546.p1","sentence":"The ps MDM2 pe oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of ps p53 pe and downregulate its ability to activate transcription.","label":1}
{"pair_id":"AIMed.d182.s1546.p2","sentence":"The MDM2 oncoprotein is a cellular inhibitor of the ps p53 pe tumor suppressor in that it can bind the transactivation domain of ps p53 pe and downregulate its ability to activate transcription.","label":0}
{"pair_id":"AIMed.d82.s699.p0","sentence":"Using an in vitro transcription\/translation assay method coupled with proteolysis studies, we have identified an 11-kDa ps FKBP12 pe-rapamycin-binding domain within ps FRAP pe.","label":1}
{"pair_id":"AIMed.d166.s1401.p0","sentence":"Abolition of the ps gp130 pe binding site in ps hLIF pe created antagonists of LIF action.","label":1}
{"pair_id":"AIMed.d166.s1401.p1","sentence":"Abolition of the ps gp130 pe binding site in hLIF created antagonists of ps LIF pe action.","label":0}
{"pair_id":"AIMed.d166.s1401.p2","sentence":"Abolition of the gp130 binding site in ps hLIF pe created antagonists of ps LIF pe action.","label":0}
{"pair_id":"BioInfer.d408.s0.p0","sentence":"Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of ps profilin pe, which in turn can supply ps actin pe monomers to growing filament ends.","label":1}
{"pair_id":"BioInfer.d408.s0.p1","sentence":"Localization of ps VASP pe to the leading edge of a migrating cell can lead to local accumulation of ps profilin pe, which in turn can supply actin monomers to growing filament ends.","label":1}
{"pair_id":"BioInfer.d408.s0.p2","sentence":"Localization of ps VASP pe to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply ps actin pe monomers to growing filament ends.","label":0}
{"pair_id":"AIMed.d125.s1066.p0","sentence":"ps Bcl-2 pe also interacted with ps Bcl-X-L pe and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S.","label":1}
{"pair_id":"AIMed.d125.s1066.p1","sentence":"ps Bcl-2 pe also interacted with Bcl-X-L and ps Mcl-1 pe and with the dominant inhibitors Bax and Bcl-X-S.","label":1}
{"pair_id":"AIMed.d125.s1066.p2","sentence":"ps Bcl-2 pe also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors ps Bax pe and Bcl-X-S.","label":1}
{"pair_id":"AIMed.d125.s1066.p3","sentence":"ps Bcl-2 pe also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and ps Bcl-X-S pe.","label":1}
{"pair_id":"AIMed.d125.s1066.p4","sentence":"Bcl-2 also interacted with ps Bcl-X-L pe and ps Mcl-1 pe and with the dominant inhibitors Bax and Bcl-X-S.","label":0}
{"pair_id":"AIMed.d125.s1066.p5","sentence":"Bcl-2 also interacted with ps Bcl-X-L pe and Mcl-1 and with the dominant inhibitors ps Bax pe and Bcl-X-S.","label":0}
{"pair_id":"AIMed.d125.s1066.p6","sentence":"Bcl-2 also interacted with ps Bcl-X-L pe and Mcl-1 and with the dominant inhibitors Bax and ps Bcl-X-S pe.","label":0}
{"pair_id":"AIMed.d125.s1066.p7","sentence":"Bcl-2 also interacted with Bcl-X-L and ps Mcl-1 pe and with the dominant inhibitors ps Bax pe and Bcl-X-S.","label":0}
{"pair_id":"AIMed.d125.s1066.p8","sentence":"Bcl-2 also interacted with Bcl-X-L and ps Mcl-1 pe and with the dominant inhibitors Bax and ps Bcl-X-S pe.","label":0}
{"pair_id":"AIMed.d125.s1066.p9","sentence":"Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors ps Bax pe and ps Bcl-X-S pe.","label":0}
{"pair_id":"BioInfer.d172.s0.p0","sentence":"Developmental changes in ps actin pe and ps myosin heavy chain pe isoform expression in smooth muscle.","label":0}
{"pair_id":"AIMed.d121.s1028.p0","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human ps p53 pe are both required for trans-activation activity, binding to the adenovirus ps E1B pe 55-kD protein and the human mdm-2-p53 protein in vitro.","label":1}
{"pair_id":"AIMed.d121.s1028.p1","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human ps p53 pe are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human ps mdm-2 pe-p53 protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p2","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human ps p53 pe are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human mdm-2-ps p53 pe protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p3","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human p53 are both required for trans-activation activity, binding to the adenovirus ps E1B pe 55-kD protein and the human ps mdm-2 pe-p53 protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p4","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human p53 are both required for trans-activation activity, binding to the adenovirus ps E1B pe 55-kD protein and the human mdm-2-ps p53 pe protein in vitro.","label":0}
{"pair_id":"AIMed.d121.s1028.p5","sentence":"Rather, the hydrophobic amino acid residues Leu-22 and Trp-23 of human p53 are both required for trans-activation activity, binding to the adenovirus E1B 55-kD protein and the human ps mdm-2 pe-ps p53 pe protein in vitro.","label":1}
{"pair_id":"BioInfer.d583.s0.p0","sentence":"The binding surfaces for segment 1 and ps profilin pe are different, although they peripherally overlap on ps actin pe.","label":1}
{"pair_id":"BioInfer.d682.s0.p0","sentence":"The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, ps actin pe-nucleotide exchange rate and the Kd for rabbit ps skeletal actin pe.","label":0}
{"pair_id":"BioInfer.d682.s0.p1","sentence":"The recombinant material is similar to authentic ps profilin pe from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit ps skeletal actin pe.","label":1}
{"pair_id":"BioInfer.d682.s0.p2","sentence":"The recombinant material is similar to authentic ps profilin pe from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, ps actin pe-nucleotide exchange rate and the Kd for rabbit skeletal actin.","label":0}
{"pair_id":"BioInfer.d69.s0.p0","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) nucleoc and ps phosphoprotein pe (ps P pe) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p1","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral ps nucleocapsid pe (N) ps nucleoc pe and ps phosphoprotein pe (P) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p2","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (ps N pe) nucleoc and ps phosphoprotein pe (P) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p3","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral ps nucleocapsid pe (N) ps nucleoc pe and phosphoprotein (ps P pe) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p4","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (ps N pe) nucleoc and phosphoprotein (ps P pe) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d69.s0.p5","sentence":"A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral ps nucleocapsid pe (ps N pe) ps nucleoc pe and phosphoprotein (P) in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d360.s1.p0","sentence":"The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of ps Munc-18-2 pe to associate with ps syntaxin 3 pe in vitro.","label":1}
{"pair_id":"BioInfer.d308.s0.p0","sentence":"In Acanthamoeba, the two isoforms of ps profilin pe may have specialized functions on the basis of their identical (approximately 10 microM) affinities for ps actin pe monomers and different affinities for PIP2.","label":1}
{"pair_id":"BioInfer.d676.s0.p0","sentence":"The proximity of the semi-conserved ps actin pe-binding site and the binding pocket characteristic of plant ps profilins pe suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.","label":0}
{"pair_id":"BioInfer.d676.s0.p1","sentence":"The proximity of the semi-conserved ps actin pe-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant ps profilins pe thought to be responsible for type I allergies.","label":0}
{"pair_id":"BioInfer.d676.s0.p2","sentence":"The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant ps profilins pe suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant ps profilins pe thought to be responsible for type I allergies.","label":0}
{"pair_id":"BioInfer.d732.s0.p0","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) ps phosphoprotein pe (P) and ps nucleocapsid protein pe (N).","label":1}
{"pair_id":"BioInfer.d732.s0.p1","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (ps P pe) and ps nucleocapsid protein pe (N).","label":1}
{"pair_id":"BioInfer.d732.s0.p2","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and ps nucleocapsid protein pe (ps N pe).","label":0}
{"pair_id":"BioInfer.d732.s0.p3","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) ps phosphoprotein pe (ps P pe) and nucleocapsid protein (N).","label":0}
{"pair_id":"BioInfer.d732.s0.p4","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) ps phosphoprotein pe (P) and nucleocapsid protein (ps N pe).","label":1}
{"pair_id":"BioInfer.d732.s0.p5","sentence":"The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (ps P pe) and nucleocapsid protein (ps N pe).","label":1}
{"pair_id":"AIMed.d9.s80.p0","sentence":"Our results demonstrated that ps CaR pe was expressed in human gastrinoma cells and could be involved in the mechanism of calcium-evoked ps gastrin pe release.","label":0}
{"pair_id":"BioInfer.d49.s1.p0","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of ps profilin pe promote extensive ps actin pe assembly off of the pool of actin-T beta 4 complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p1","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of ps profilin pe promote extensive actin assembly off of the pool of ps actin pe-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p2","sentence":"As a consequence, in the presence of ps thymosin beta 4 pe (T beta 4), low amounts of ps profilin pe promote extensive actin assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p3","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of ps profilin pe promote extensive actin assembly off of the pool of actin-ps T beta 4 pe complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p4","sentence":"As a consequence, in the presence of thymosin beta 4 (ps T beta 4 pe), low amounts of ps profilin pe promote extensive actin assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p5","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive ps actin pe assembly off of the pool of ps actin pe-T beta 4 complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p6","sentence":"As a consequence, in the presence of ps thymosin beta 4 pe (T beta 4), low amounts of profilin promote extensive ps actin pe assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p7","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive ps actin pe assembly off of the pool of actin-ps T beta 4 pe complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p8","sentence":"As a consequence, in the presence of thymosin beta 4 (ps T beta 4 pe), low amounts of profilin promote extensive ps actin pe assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p9","sentence":"As a consequence, in the presence of ps thymosin beta 4 pe (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of ps actin pe-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p10","sentence":"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of ps actin pe-ps T beta 4 pe complex.","label":1}
{"pair_id":"BioInfer.d49.s1.p11","sentence":"As a consequence, in the presence of thymosin beta 4 (ps T beta 4 pe), low amounts of profilin promote extensive actin assembly off of the pool of ps actin pe-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p12","sentence":"As a consequence, in the presence of ps thymosin beta 4 pe (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-ps T beta 4 pe complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p13","sentence":"As a consequence, in the presence of ps thymosin beta 4 pe (ps T beta 4 pe), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.","label":0}
{"pair_id":"BioInfer.d49.s1.p14","sentence":"As a consequence, in the presence of thymosin beta 4 (ps T beta 4 pe), low amounts of profilin promote extensive actin assembly off of the pool of actin-ps T beta 4 pe complex.","label":0}
{"pair_id":"AIMed.d139.s1177.p0","sentence":"Following linkage studies which were most consistent with a ps beta spectrin pe gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of ps beta spectrin pe repeat 17.","label":0}
{"pair_id":"BioInfer.d367.s0.p0","sentence":"In the cytoplasm, HBx was shown to stimulate the ps Ras pe-Raf-mitogen-activated protein kinase (ps MAP kinase pe) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p1","sentence":"In the cytoplasm, ps HBx pe was shown to stimulate the ps Ras pe-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p2","sentence":"In the cytoplasm, HBx was shown to stimulate the ps Ras pe-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor ps AP-1 pe.","label":1}
{"pair_id":"BioInfer.d367.s0.p3","sentence":"In the cytoplasm, HBx was shown to stimulate the ps Ras pe-Raf-ps mitogen-activated protein kinase pe (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p4","sentence":"In the cytoplasm, HBx was shown to stimulate the ps Ras pe-ps Raf pe-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p5","sentence":"In the cytoplasm, ps HBx pe was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (ps MAP kinase pe) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p6","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (ps MAP kinase pe) cascade, which is essential for activation of transcription factor ps AP-1 pe.","label":1}
{"pair_id":"BioInfer.d367.s0.p7","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-ps mitogen-activated protein kinase pe (ps MAP kinase pe) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p8","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-ps Raf pe-mitogen-activated protein kinase (ps MAP kinase pe) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d367.s0.p9","sentence":"In the cytoplasm, ps HBx pe was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor ps AP-1 pe.","label":0}
{"pair_id":"BioInfer.d367.s0.p10","sentence":"In the cytoplasm, ps HBx pe was shown to stimulate the Ras-Raf-ps mitogen-activated protein kinase pe (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p11","sentence":"In the cytoplasm, ps HBx pe was shown to stimulate the Ras-ps Raf pe-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":0}
{"pair_id":"BioInfer.d367.s0.p12","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-ps mitogen-activated protein kinase pe (MAP kinase) cascade, which is essential for activation of transcription factor ps AP-1 pe.","label":1}
{"pair_id":"BioInfer.d367.s0.p13","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-ps Raf pe-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor ps AP-1 pe.","label":1}
{"pair_id":"BioInfer.d367.s0.p14","sentence":"In the cytoplasm, HBx was shown to stimulate the Ras-ps Raf pe-ps mitogen-activated protein kinase pe (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.","label":1}
{"pair_id":"BioInfer.d669.s0.p0","sentence":"The product of ps UL38 pe has been shown to be essential for capsid assembly, but no role has previously been assigned to the product of ps UL18 pe.","label":0}
{"pair_id":"AIMed.d44.s379.p0","sentence":"Characterization of the ps CD30L pe binding domain on the human ps CD30 pe molecule using anti-CD30 antibodies.","label":1}
{"pair_id":"AIMed.d44.s379.p1","sentence":"Characterization of the ps CD30L pe binding domain on the human CD30 molecule using anti-ps CD30 pe antibodies.","label":0}
{"pair_id":"AIMed.d44.s379.p2","sentence":"Characterization of the CD30L binding domain on the human ps CD30 pe molecule using anti-ps CD30 pe antibodies.","label":0}
{"pair_id":"BioInfer.d657.s0.p0","sentence":"p27 binds to and inhibits complexes formed by ps cyclin E pe-cdk2, ps cyclin A pe-cdk2, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p1","sentence":"p27 binds to and inhibits complexes formed by ps cyclin E pe-cdk2, cyclin A-cdk2, and ps cyclin D pe-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p2","sentence":"p27 binds to and inhibits complexes formed by ps cyclin E pe-cdk2, cyclin A-ps cdk2 pe, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p3","sentence":"p27 binds to and inhibits complexes formed by ps cyclin E pe-cdk2, cyclin A-cdk2, and cyclin D-ps cdk4 pe.","label":0}
{"pair_id":"BioInfer.d657.s0.p4","sentence":"p27 binds to and inhibits complexes formed by ps cyclin E pe-ps cdk2 pe, cyclin A-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p5","sentence":"ps p27 pe binds to and inhibits complexes formed by ps cyclin E pe-cdk2, cyclin A-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p6","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, ps cyclin A pe-cdk2, and ps cyclin D pe-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p7","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, ps cyclin A pe-ps cdk2 pe, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p8","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, ps cyclin A pe-cdk2, and cyclin D-ps cdk4 pe.","label":0}
{"pair_id":"BioInfer.d657.s0.p9","sentence":"p27 binds to and inhibits complexes formed by cyclin E-ps cdk2 pe, ps cyclin A pe-cdk2, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p10","sentence":"ps p27 pe binds to and inhibits complexes formed by cyclin E-cdk2, ps cyclin A pe-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p11","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-ps cdk2 pe, and ps cyclin D pe-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p12","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and ps cyclin D pe-ps cdk4 pe.","label":1}
{"pair_id":"BioInfer.d657.s0.p13","sentence":"p27 binds to and inhibits complexes formed by cyclin E-ps cdk2 pe, cyclin A-cdk2, and ps cyclin D pe-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p14","sentence":"ps p27 pe binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and ps cyclin D pe-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p15","sentence":"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-ps cdk2 pe, and cyclin D-ps cdk4 pe.","label":0}
{"pair_id":"BioInfer.d657.s0.p16","sentence":"p27 binds to and inhibits complexes formed by cyclin E-ps cdk2 pe, cyclin A-ps cdk2 pe, and cyclin D-cdk4.","label":0}
{"pair_id":"BioInfer.d657.s0.p17","sentence":"ps p27 pe binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-ps cdk2 pe, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d657.s0.p18","sentence":"p27 binds to and inhibits complexes formed by cyclin E-ps cdk2 pe, cyclin A-cdk2, and cyclin D-ps cdk4 pe.","label":0}
{"pair_id":"BioInfer.d657.s0.p19","sentence":"ps p27 pe binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-ps cdk4 pe.","label":1}
{"pair_id":"BioInfer.d657.s0.p20","sentence":"ps p27 pe binds to and inhibits complexes formed by cyclin E-ps cdk2 pe, cyclin A-cdk2, and cyclin D-cdk4.","label":1}
{"pair_id":"BioInfer.d8.s0.p0","sentence":"Accordingly, ps beta-catenin pe is also found in these structures, again in the absence of ps alpha-catenin pe.","label":0}
{"pair_id":"AIMed.d176.s1492.p0","sentence":"The ps hsp90 pe-ps p60 pe-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.","label":1}
{"pair_id":"AIMed.d176.s1492.p1","sentence":"The ps hsp90 pe-p60-ps hsp70 pe multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p2","sentence":"The ps hsp90 pe-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the ps hsp90 pe-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p3","sentence":"The hsp90-ps p60 pe-ps hsp70 pe multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p4","sentence":"The hsp90-ps p60 pe-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the ps hsp90 pe-binding drug geldanamycin.","label":0}
{"pair_id":"AIMed.d176.s1492.p5","sentence":"The hsp90-p60-ps hsp70 pe multichaperone complex is highly dynamic and does not appear to be affected by the ps hsp90 pe-binding drug geldanamycin.","label":0}
{"pair_id":"BioInfer.d163.s1.p0","sentence":"Selective repression of ps actin pe and ps myosin heavy chain pe expression during the programmed death of insect skeletal muscle.","label":0}
{"pair_id":"BioInfer.d447.s0.p0","sentence":"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of ps HSH49 pe are not required for interaction with ps CUS1 pe.","label":1}
{"pair_id":"BioInfer.d447.s0.p1","sentence":"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to ps CUS1 pe in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with ps CUS1 pe.","label":0}
{"pair_id":"BioInfer.d447.s0.p2","sentence":"Mutations that alter putative RNA-binding residues of either ps HSH49 pe RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with ps CUS1 pe.","label":0}
{"pair_id":"BioInfer.d447.s0.p3","sentence":"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to ps CUS1 pe in vitro, suggesting that the predicted RNA-binding surfaces of ps HSH49 pe are not required for interaction with CUS1.","label":0}
{"pair_id":"BioInfer.d447.s0.p4","sentence":"Mutations that alter putative RNA-binding residues of either ps HSH49 pe RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of ps HSH49 pe are not required for interaction with CUS1.","label":0}
{"pair_id":"BioInfer.d447.s0.p5","sentence":"Mutations that alter putative RNA-binding residues of either ps HSH49 pe RRM are lethal in vivo, but do not prevent binding to ps CUS1 pe in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.","label":1}
{"pair_id":"AIMed.d115.s976.p0","sentence":"The correlation of ps SRF pe-ps RAP74 pe binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.","label":1}
{"pair_id":"AIMed.d115.s976.p1","sentence":"The correlation of ps SRF pe-RAP74 binding with transcriptional activation suggests that ps RAP74 pe is a critical target for SRF-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p2","sentence":"The correlation of ps SRF pe-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for ps SRF pe-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p3","sentence":"The correlation of SRF-ps RAP74 pe binding with transcriptional activation suggests that ps RAP74 pe is a critical target for SRF-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p4","sentence":"The correlation of SRF-ps RAP74 pe binding with transcriptional activation suggests that RAP74 is a critical target for ps SRF pe-activated transcription.","label":0}
{"pair_id":"AIMed.d115.s976.p5","sentence":"The correlation of SRF-RAP74 binding with transcriptional activation suggests that ps RAP74 pe is a critical target for ps SRF pe-activated transcription.","label":1}
{"pair_id":"AIMed.d123.s1043.p0","sentence":"Characterization of an interaction between ps insulin receptor substrate 1 pe and the ps insulin receptor pe by using the two-hybrid system.","label":1}
{"pair_id":"BioInfer.d335.s1.p0","sentence":"These results suggest that ps cofilin pe may be involved in dynamic reorganization of membranous ps actin pe cytoskeletons.","label":1}
{"pair_id":"AIMed.d43.s375.p0","sentence":"Although the individual amino acids in ps TrkA pe involved in binding to ps nerve growth factor pe (NGF) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":1}
{"pair_id":"AIMed.d43.s375.p1","sentence":"Although the individual amino acids in ps TrkA pe involved in binding to nerve growth factor (ps NGF pe) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":1}
{"pair_id":"AIMed.d43.s375.p2","sentence":"Although the individual amino acids in ps TrkA pe involved in binding to nerve growth factor (NGF) and those in ps TrkC pe involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p3","sentence":"Although the individual amino acids in ps TrkA pe involved in binding to nerve growth factor (NGF) and those in TrkC involved in binding to ps neurotrophin-3 pe have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p4","sentence":"Although the individual amino acids in TrkA involved in binding to ps nerve growth factor pe (ps NGF pe) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p5","sentence":"Although the individual amino acids in TrkA involved in binding to ps nerve growth factor pe (NGF) and those in ps TrkC pe involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p6","sentence":"Although the individual amino acids in TrkA involved in binding to ps nerve growth factor pe (NGF) and those in TrkC involved in binding to ps neurotrophin-3 pe have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p7","sentence":"Although the individual amino acids in TrkA involved in binding to nerve growth factor (ps NGF pe) and those in ps TrkC pe involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p8","sentence":"Although the individual amino acids in TrkA involved in binding to nerve growth factor (ps NGF pe) and those in TrkC involved in binding to ps neurotrophin-3 pe have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":0}
{"pair_id":"AIMed.d43.s375.p9","sentence":"Although the individual amino acids in TrkA involved in binding to nerve growth factor (NGF) and those in ps TrkC pe involved in binding to ps neurotrophin-3 pe have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.","label":1}
{"pair_id":"BioInfer.d710.s0.p0","sentence":"These results show that ps cofilin pe\/ps ADF pe is an important regulator of actin-based cell motility during Drosophila development.","label":0}
{"pair_id":"BioInfer.d710.s0.p1","sentence":"These results show that ps cofilin pe\/ADF is an important regulator of ps actin pe-based cell motility during Drosophila development.","label":1}
{"pair_id":"BioInfer.d710.s0.p2","sentence":"These results show that cofilin\/ps ADF pe is an important regulator of ps actin pe-based cell motility during Drosophila development.","label":1}
{"pair_id":"AIMed.d179.s1523.p0","sentence":"The ps gastrin pe-induced phosphorylation of ps IRS-1 pe was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.","label":1}
{"pair_id":"AIMed.d169.s1432.p0","sentence":"COS-7 cells co-transfected with the cloned ps IL-13R pe cDNA and ps IL-4R pe cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.","label":0}
{"pair_id":"AIMed.d169.s1432.p1","sentence":"COS-7 cells co-transfected with the cloned ps IL-13R pe cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both ps IL-4 pe and IL-13.","label":0}
{"pair_id":"AIMed.d169.s1432.p2","sentence":"COS-7 cells co-transfected with the cloned ps IL-13R pe cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and ps IL-13 pe.","label":0}
{"pair_id":"AIMed.d169.s1432.p3","sentence":"COS-7 cells co-transfected with the cloned IL-13R cDNA and ps IL-4R pe cDNA resulted in the reconstitution of a small number of receptors that recognized both ps IL-4 pe and IL-13.","label":0}
{"pair_id":"AIMed.d169.s1432.p4","sentence":"COS-7 cells co-transfected with the cloned IL-13R cDNA and ps IL-4R pe cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and ps IL-13 pe.","label":0}
{"pair_id":"AIMed.d169.s1432.p5","sentence":"COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both ps IL-4 pe and ps IL-13 pe.","label":0}
{"pair_id":"BioInfer.d25.s0.p0","sentence":"Adherens junction proteins (N-cadherin, ps E-cadherin pe, alpha-catenin, beta-catenin, ps plakoglobin pe, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p1","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, ps alpha-catenin pe, beta-catenin, ps plakoglobin pe, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p2","sentence":"Adherens junction proteins (ps N-cadherin pe, E-cadherin, alpha-catenin, beta-catenin, ps plakoglobin pe, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p3","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, ps plakoglobin pe, and actin) and the proliferation marker ps Ki-67 pe were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p4","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, ps plakoglobin pe, and ps actin pe) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p5","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, ps beta-catenin pe, ps plakoglobin pe, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p6","sentence":"Adherens junction proteins (N-cadherin, ps E-cadherin pe, ps alpha-catenin pe, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p7","sentence":"Adherens junction proteins (ps N-cadherin pe, ps E-cadherin pe, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p8","sentence":"Adherens junction proteins (N-cadherin, ps E-cadherin pe, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker ps Ki-67 pe were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p9","sentence":"Adherens junction proteins (N-cadherin, ps E-cadherin pe, alpha-catenin, beta-catenin, plakoglobin, and ps actin pe) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p10","sentence":"Adherens junction proteins (N-cadherin, ps E-cadherin pe, alpha-catenin, ps beta-catenin pe, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p11","sentence":"Adherens junction proteins (ps N-cadherin pe, E-cadherin, ps alpha-catenin pe, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p12","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, ps alpha-catenin pe, beta-catenin, plakoglobin, and actin) and the proliferation marker ps Ki-67 pe were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p13","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, ps alpha-catenin pe, beta-catenin, plakoglobin, and ps actin pe) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p14","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, ps alpha-catenin pe, ps beta-catenin pe, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p15","sentence":"Adherens junction proteins (ps N-cadherin pe, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker ps Ki-67 pe were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p16","sentence":"Adherens junction proteins (ps N-cadherin pe, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and ps actin pe) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p17","sentence":"Adherens junction proteins (ps N-cadherin pe, E-cadherin, alpha-catenin, ps beta-catenin pe, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p18","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and ps actin pe) and the proliferation marker ps Ki-67 pe were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p19","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, ps beta-catenin pe, plakoglobin, and actin) and the proliferation marker ps Ki-67 pe were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"BioInfer.d25.s0.p20","sentence":"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, ps beta-catenin pe, plakoglobin, and ps actin pe) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.","label":0}
{"pair_id":"AIMed.d152.s1295.p0","sentence":"A ps TRAF2 pe mutant lacking its N-terminal RING finger domain is a dominant-negative inhibitor of TNF-mediated ps NF-kappa B pe activation, but does not affect TNF-induced apoptosis.","label":0}
{"pair_id":"BioInfer.d149.s0.p0","sentence":"Complete gene sequences for the nucleocapsid protein (ps N pe) and phosphoprotein (P\/ps V pe) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p1","sentence":"Complete gene sequences for the nucleocapsid protein (ps N pe) and phosphoprotein (P\/V) have been determined and recombinant N and ps V pe proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p2","sentence":"Complete gene sequences for the nucleocapsid protein (ps N pe) and phosphoprotein (ps P pe\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p3","sentence":"Complete gene sequences for the nucleocapsid protein (ps N pe) and phosphoprotein (P\/V) have been determined and recombinant ps N pe and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p4","sentence":"Complete gene sequences for the nucleocapsid protein (ps N pe) and ps phosphoprotein pe (P\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p5","sentence":"Complete gene sequences for the ps nucleocapsid protein pe (ps N pe) and phosphoprotein (P\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p6","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P\/ps V pe) have been determined and recombinant N and ps V pe proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p7","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (ps P pe\/ps V pe) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p8","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P\/ps V pe) have been determined and recombinant ps N pe and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p9","sentence":"Complete gene sequences for the nucleocapsid protein (N) and ps phosphoprotein pe (P\/ps V pe) have been determined and recombinant N and V proteins produced in baculovirus.","label":1}
{"pair_id":"BioInfer.d149.s0.p10","sentence":"Complete gene sequences for the ps nucleocapsid protein pe (N) and phosphoprotein (P\/ps V pe) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p11","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (ps P pe\/V) have been determined and recombinant N and ps V pe proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p12","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P\/V) have been determined and recombinant ps N pe and ps V pe proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p13","sentence":"Complete gene sequences for the nucleocapsid protein (N) and ps phosphoprotein pe (P\/V) have been determined and recombinant N and ps V pe proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p14","sentence":"Complete gene sequences for the ps nucleocapsid protein pe (N) and phosphoprotein (P\/V) have been determined and recombinant N and ps V pe proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p15","sentence":"Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (ps P pe\/V) have been determined and recombinant ps N pe and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p16","sentence":"Complete gene sequences for the nucleocapsid protein (N) and ps phosphoprotein pe (ps P pe\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":1}
{"pair_id":"BioInfer.d149.s0.p17","sentence":"Complete gene sequences for the ps nucleocapsid protein pe (N) and phosphoprotein (ps P pe\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p18","sentence":"Complete gene sequences for the nucleocapsid protein (N) and ps phosphoprotein pe (P\/V) have been determined and recombinant ps N pe and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p19","sentence":"Complete gene sequences for the ps nucleocapsid protein pe (N) and phosphoprotein (P\/V) have been determined and recombinant ps N pe and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d149.s0.p20","sentence":"Complete gene sequences for the ps nucleocapsid protein pe (N) and ps phosphoprotein pe (P\/V) have been determined and recombinant N and V proteins produced in baculovirus.","label":0}
{"pair_id":"BioInfer.d429.s0.p0","sentence":"Molecular analysis of the ps cadherin pe-catenin complex elucidated the central role of ps beta-catenin pe in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p1","sentence":"Molecular analysis of the cadherin-ps catenin pe complex elucidated the central role of ps beta-catenin pe in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p2","sentence":"Molecular analysis of the cadherin-catenin complex elucidated the central role of ps beta-catenin pe in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to ps alpha-catenin pe.","label":1}
{"pair_id":"BioInfer.d429.s0.p3","sentence":"Molecular analysis of the cadherin-catenin complex elucidated the central role of ps beta-catenin pe in this adhesion complex, as it binds to the cytoplasmic domain of ps E-cadherin pe and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p4","sentence":"Molecular analysis of the ps cadherin pe-ps catenin pe complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d429.s0.p5","sentence":"Molecular analysis of the ps cadherin pe-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d429.s0.p6","sentence":"Molecular analysis of the ps cadherin pe-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of ps E-cadherin pe and to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d429.s0.p7","sentence":"Molecular analysis of the cadherin-ps catenin pe complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d429.s0.p8","sentence":"Molecular analysis of the cadherin-ps catenin pe complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of ps E-cadherin pe and to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d429.s0.p9","sentence":"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of ps E-cadherin pe and to ps alpha-catenin pe.","label":0}
{"pair_id":"AIMed.d147.s1244.p0","sentence":"Characterization of the ps retinoblastoma pe binding proteins ps RBP1 pe and RBP2.","label":1}
{"pair_id":"AIMed.d147.s1244.p1","sentence":"Characterization of the ps retinoblastoma pe binding proteins RBP1 and ps RBP2 pe.","label":1}
{"pair_id":"AIMed.d147.s1244.p2","sentence":"Characterization of the retinoblastoma binding proteins ps RBP1 pe and ps RBP2 pe.","label":0}
{"pair_id":"AIMed.d118.s1003.p0","sentence":"This regulation results from a direct interaction between ps p21 pe and ps PCNA pe.","label":1}
{"pair_id":"AIMed.d97.s820.p0","sentence":"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (ps BMPR-II pe), which is distantly related to ps DAF-4 pe, a BMP type II receptor from Caenorhabditis elegans.","label":0}
{"pair_id":"AIMed.d97.s820.p1","sentence":"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (ps BMPR-II pe), which is distantly related to DAF-4, a ps BMP type II receptor pe from Caenorhabditis elegans.","label":0}
{"pair_id":"AIMed.d97.s820.p2","sentence":"Here we report the cDNA cloning and characterization of a human type II receptor for BMPs (BMPR-II), which is distantly related to ps DAF-4 pe, a ps BMP type II receptor pe from Caenorhabditis elegans.","label":0}
{"pair_id":"BioInfer.d442.s0.p0","sentence":"Mutants of ps cdc3 pe and cdc8, which encode profilin and ps tropomyosin pe respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p1","sentence":"Mutants of cdc3 and cdc8, which encode ps profilin pe and ps tropomyosin pe respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p2","sentence":"Mutants of cdc3 and ps cdc8 pe, which encode profilin and ps tropomyosin pe respectively, display disorganized actin patches in all cells.","label":1}
{"pair_id":"BioInfer.d442.s0.p3","sentence":"Mutants of cdc3 and cdc8, which encode profilin and ps tropomyosin pe respectively, display disorganized ps actin pe patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p4","sentence":"Mutants of ps cdc3 pe and cdc8, which encode ps profilin pe and tropomyosin respectively, display disorganized actin patches in all cells.","label":1}
{"pair_id":"BioInfer.d442.s0.p5","sentence":"Mutants of ps cdc3 pe and ps cdc8 pe, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p6","sentence":"Mutants of ps cdc3 pe and cdc8, which encode profilin and tropomyosin respectively, display disorganized ps actin pe patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p7","sentence":"Mutants of cdc3 and ps cdc8 pe, which encode ps profilin pe and tropomyosin respectively, display disorganized actin patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p8","sentence":"Mutants of cdc3 and cdc8, which encode ps profilin pe and tropomyosin respectively, display disorganized ps actin pe patches in all cells.","label":0}
{"pair_id":"BioInfer.d442.s0.p9","sentence":"Mutants of cdc3 and ps cdc8 pe, which encode profilin and tropomyosin respectively, display disorganized ps actin pe patches in all cells.","label":0}
{"pair_id":"AIMed.d42.s368.p0","sentence":"ps BMP-2 pe binding significantly increased hetero- and homo-oligomerization (except for the ps BR-II pe homo-oligomer, which binds ligand poorly in the absence of BR-I).","label":1}
{"pair_id":"AIMed.d42.s368.p1","sentence":"ps BMP-2 pe binding significantly increased hetero- and homo-oligomerization (except for the BR-II homo-oligomer, which binds ligand poorly in the absence of ps BR-I pe).","label":0}
{"pair_id":"AIMed.d42.s368.p2","sentence":"BMP-2 binding significantly increased hetero- and homo-oligomerization (except for the ps BR-II pe homo-oligomer, which binds ligand poorly in the absence of ps BR-I pe).","label":1}
{"pair_id":"BioInfer.d374.s0.p0","sentence":"In this case, efficient repair does not require ps RAD1 pe and ps MSH2 pe, consistent with our previous observations.","label":0}
{"pair_id":"BioInfer.d1.s1.p0","sentence":"Birch ps profilin pe increased the critical concentration required for muscle and ps brain actin pe polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.","label":1}
{"pair_id":"BioInfer.d1.s1.p1","sentence":"Birch profilin increased the critical concentration required for ps muscle pe and ps brain actin peps actin pe polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.","label":0}
{"pair_id":"BioInfer.d1.s1.p2","sentence":"Birch profilin increased the critical concentration required for muscle and ps brain actin pe polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal ps actin pe.","label":0}
{"pair_id":"BioInfer.d1.s1.p3","sentence":"Birch ps profilin pe increased the critical concentration required for ps muscle pe and brain ps actin pe polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.","label":1}
{"pair_id":"BioInfer.d1.s1.p4","sentence":"Birch ps profilin pe increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal ps actin pe.","label":1}
{"pair_id":"BioInfer.d1.s1.p5","sentence":"Birch profilin increased the critical concentration required for ps muscle pe and brain ps actin pe polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal ps actin pe.","label":0}
{"pair_id":"BioInfer.d502.s0.p0","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for ps actin pe, myosin, ps filamin pe, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p1","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, ps filamin pe, and ps talin pe in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p2","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, ps myosin pe, ps filamin pe, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p3","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for ps actin pe, myosin, filamin, and ps talin pe in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p4","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for ps actin pe, ps myosin pe, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"BioInfer.d502.s0.p5","sentence":"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, ps myosin pe, filamin, and ps talin pe in order to follow the assembly of the contractile proteins into the cleavage furrows.","label":0}
{"pair_id":"AIMed.d148.s1259.p0","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that ps cyclin D1 pe is associated with both ps p34cdc2 pe and p33cdk2, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.","label":1}
{"pair_id":"AIMed.d148.s1259.p1","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that ps cyclin D1 pe is associated with both p34cdc2 and ps p33cdk2 pe, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.","label":1}
{"pair_id":"AIMed.d148.s1259.p2","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that ps cyclin D1 pe is associated with both p34cdc2 and p33cdk2, and that ps cyclin D1 pe immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d148.s1259.p3","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both ps p34cdc2 pe and ps p33cdk2 pe, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d148.s1259.p4","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both ps p34cdc2 pe and p33cdk2, and that ps cyclin D1 pe immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d148.s1259.p5","sentence":"Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both p34cdc2 and ps p33cdk2 pe, and that ps cyclin D1 pe immune complexes exhibit appreciable histone H1 kinase activity.","label":0}
{"pair_id":"AIMed.d196.s1665.p0","sentence":"ps HOX11 pe interacts with protein phosphatases ps PP2A pe and PP1 and disrupts a G2\/M cell-cycle checkpoint.","label":1}
{"pair_id":"AIMed.d196.s1665.p1","sentence":"ps HOX11 pe interacts with protein phosphatases PP2A and ps PP1 pe and disrupts a G2\/M cell-cycle checkpoint.","label":1}
{"pair_id":"AIMed.d196.s1665.p2","sentence":"HOX11 interacts with protein phosphatases ps PP2A pe and ps PP1 pe and disrupts a G2\/M cell-cycle checkpoint.","label":0}
{"pair_id":"AIMed.d71.s606.p0","sentence":"We present evidence that ps mitogen-activated protein-serine (MAP) kinases pe (ps pp54 pe and pp42\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.","label":0}
{"pair_id":"AIMed.d71.s606.p1","sentence":"We present evidence that ps mitogen-activated protein-serine (MAP) kinases pe (pp54 and ps pp42 pe\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.","label":0}
{"pair_id":"AIMed.d71.s606.p2","sentence":"We present evidence that ps mitogen-activated protein-serine (MAP) kinases pe (pp54 and pp42\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of ps c-jun pe.","label":0}
{"pair_id":"AIMed.d71.s606.p3","sentence":"We present evidence that mitogen-activated protein-serine (MAP) kinases (ps pp54 pe and ps pp42 pe\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.","label":0}
{"pair_id":"AIMed.d71.s606.p4","sentence":"We present evidence that mitogen-activated protein-serine (MAP) kinases (ps pp54 pe and pp42\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of ps c-jun pe.","label":1}
{"pair_id":"AIMed.d71.s606.p5","sentence":"We present evidence that mitogen-activated protein-serine (MAP) kinases (pp54 and ps pp42 pe\/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of ps c-jun pe.","label":1}
{"pair_id":"BioInfer.d52.s1.p0","sentence":"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the ps syntaxin pe interaction is not the sole determinant of ps Sec1 pe protein membrane attachment.","label":1}
{"pair_id":"BioInfer.d52.s1.p1","sentence":"Even the Munc18-2 mutants that do not detectably bind ps syntaxin 3 pe were membrane associated in Caco-2 cells, suggesting that the ps syntaxin pe interaction is not the sole determinant of Sec1 protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p2","sentence":"Even the ps Munc18-2 pe mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the ps syntaxin pe interaction is not the sole determinant of Sec1 protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p3","sentence":"Even the Munc18-2 mutants that do not detectably bind ps syntaxin 3 pe were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of ps Sec1 pe protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p4","sentence":"Even the ps Munc18-2 pe mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of ps Sec1 pe protein membrane attachment.","label":0}
{"pair_id":"BioInfer.d52.s1.p5","sentence":"Even the ps Munc18-2 pe mutants that do not detectably bind ps syntaxin 3 pe were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.","label":1}
{"pair_id":"AIMed.d176.s1485.p0","sentence":"One of these proteins, ps p60 pe, appears transiently during assembly and is not a component of functionally mature ps PR pe complexes.","label":0}
{"pair_id":"AIMed.d192.s1637.p0","sentence":"ps ICE pe was also shown to cleave the precursor of ps interferon-gamma pe inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p1","sentence":"ps ICE pe was also shown to cleave the precursor of ps interferon-gamma inducing factor pe (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":1}
{"pair_id":"AIMed.d192.s1637.p2","sentence":"ps ICE pe was also shown to cleave the precursor of interferon-gamma inducing factor (ps IGIF pe) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":1}
{"pair_id":"AIMed.d192.s1637.p3","sentence":"ps ICE pe was also shown to cleave the precursor of interferon-gamma inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating ps IGIF pe and facilitating its export.","label":1}
{"pair_id":"AIMed.d192.s1637.p4","sentence":"ICE was also shown to cleave the precursor of ps interferon-gamma peps interferon-gamma inducing factor pe (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p5","sentence":"ICE was also shown to cleave the precursor of ps interferon-gamma pe inducing factor (ps IGIF pe) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p6","sentence":"ICE was also shown to cleave the precursor of ps interferon-gamma pe inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating ps IGIF pe and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p7","sentence":"ICE was also shown to cleave the precursor of ps interferon-gamma inducing factor pe (ps IGIF pe) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p8","sentence":"ICE was also shown to cleave the precursor of ps interferon-gamma inducing factor pe (IGIF) at the authentic processing site with high efficiency, thereby activating ps IGIF pe and facilitating its export.","label":0}
{"pair_id":"AIMed.d192.s1637.p9","sentence":"ICE was also shown to cleave the precursor of interferon-gamma inducing factor (ps IGIF pe) at the authentic processing site with high efficiency, thereby activating ps IGIF pe and facilitating its export.","label":0}
{"pair_id":"AIMed.d167.s1407.p0","sentence":"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of ps GT155 pe and a protein of approximately 60 kDa designated ps CAP-60 pe (calnexin-associated protein of 60 kDa).","label":1}
{"pair_id":"AIMed.d167.s1407.p1","sentence":"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of ps GT155 pe and a protein of approximately 60 kDa designated CAP-60 (ps calnexin-associated protein pe of 60 kDa).","label":1}
{"pair_id":"AIMed.d167.s1407.p2","sentence":"In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of GT155 and a protein of approximately 60 kDa designated ps CAP-60 pe (ps calnexin-associated protein pe of 60 kDa).","label":0}
{"pair_id":"AIMed.d79.s676.p0","sentence":"It contains an ps Rb pe-binding motif that shares an antigenic epitope with the C terminus of ps E1A pe.","label":0}
{"pair_id":"AIMed.d152.s1297.p0","sentence":"Thus, these two ps TNFR1 pe-ps TRADD pe signaling cascades appear to bifurcate at TRADD.","label":0}
{"pair_id":"AIMed.d152.s1297.p1","sentence":"Thus, these two ps TNFR1 pe-TRADD signaling cascades appear to bifurcate at ps TRADD pe.","label":0}
{"pair_id":"AIMed.d152.s1297.p2","sentence":"Thus, these two TNFR1-ps TRADD pe signaling cascades appear to bifurcate at ps TRADD pe.","label":0}
{"pair_id":"BioInfer.d289.s0.p0","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-ps TGF-beta1 pe showed that beta-catenin, ps plakoglobin pe, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p1","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-ps TGF-beta1 pe showed that ps beta-catenin pe, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p2","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-ps TGF-beta1 pe showed that beta-catenin, plakoglobin, alpha-catenin, and ps cadherin-5 pe were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p3","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-ps TGF-beta1 pe showed that beta-catenin, plakoglobin, ps alpha-catenin pe, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":0}
{"pair_id":"BioInfer.d289.s0.p4","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that ps beta-catenin pe, ps plakoglobin pe, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p5","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, ps plakoglobin pe, alpha-catenin, and ps cadherin-5 pe were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p6","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, ps plakoglobin pe, ps alpha-catenin pe, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p7","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that ps beta-catenin pe, plakoglobin, alpha-catenin, and ps cadherin-5 pe were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p8","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that ps beta-catenin pe, plakoglobin, ps alpha-catenin pe, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"BioInfer.d289.s0.p9","sentence":"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, ps alpha-catenin pe, and ps cadherin-5 pe were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.","label":1}
{"pair_id":"AIMed.d190.s1616.p0","sentence":"By contrast stimulation with ps TPO pe leads to the formation of a ps Grb2 pe complex containing JAK2.","label":0}
{"pair_id":"AIMed.d190.s1616.p1","sentence":"By contrast stimulation with ps TPO pe leads to the formation of a Grb2 complex containing ps JAK2 pe.","label":0}
{"pair_id":"AIMed.d190.s1616.p2","sentence":"By contrast stimulation with TPO leads to the formation of a ps Grb2 pe complex containing ps JAK2 pe.","label":1}
{"pair_id":"AIMed.d202.s1738.p0","sentence":"ps Interleukin-1 pe (ps IL-1 pe) is an important mediator of inflammatory disease.","label":0}
{"pair_id":"BioInfer.d34.s0.p0","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of ps E-cadherin pe (E-cad), alpha-catenin (alpha-cat) and ps beta-catenin pe (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p1","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of ps E-cadherin pe (E-cad), ps alpha-catenin pe (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p2","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of ps E-cadherin pe (E-cad), alpha-catenin (alpha-cat) and beta-catenin (ps beta-cat pe) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p3","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of ps E-cadherin pe (E-cad), alpha-catenin (ps alpha-cat pe) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p4","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of ps E-cadherin pe (ps E-cad pe), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p5","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), ps alpha-catenin pe (alpha-cat) and ps beta-catenin pe (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p6","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and ps beta-catenin pe (ps beta-cat pe) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p7","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (ps alpha-cat pe) and ps beta-catenin pe (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p8","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (ps E-cad pe), alpha-catenin (alpha-cat) and ps beta-catenin pe (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p9","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), ps alpha-catenin pe (alpha-cat) and beta-catenin (ps beta-cat pe) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p10","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), ps alpha-catenin pe (ps alpha-cat pe) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p11","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (ps E-cad pe), ps alpha-catenin pe (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p12","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (ps alpha-cat pe) and beta-catenin (ps beta-cat pe) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p13","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (ps E-cad pe), alpha-catenin (alpha-cat) and beta-catenin (ps beta-cat pe) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d34.s0.p14","sentence":"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (ps E-cad pe), alpha-catenin (ps alpha-cat pe) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.","label":0}
{"pair_id":"BioInfer.d284.s0.p0","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in ps beta-catenin pe, alpha-catenin, and p120(ps Cas pe) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p1","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and ps p120 pe(ps Cas pe) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p2","sentence":"Hypertonicity provoked ps Fyn pe-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(ps Cas pe) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p3","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, ps alpha-catenin pe, and p120(ps Cas pe) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p4","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(ps Cas pe) and caused the dissociation of ps beta-catenin pe from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p5","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in ps beta-catenin pe, alpha-catenin, and ps p120 pe(Cas) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p6","sentence":"Hypertonicity provoked ps Fyn pe-dependent tyrosine phosphorylation in ps beta-catenin pe, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p7","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in ps beta-catenin pe, ps alpha-catenin pe, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p8","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in ps beta-catenin pe, alpha-catenin, and p120(Cas) and caused the dissociation of ps beta-catenin pe from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p9","sentence":"Hypertonicity provoked ps Fyn pe-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and ps p120 pe(Cas) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p10","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, ps alpha-catenin pe, and ps p120 pe(Cas) and caused the dissociation of beta-catenin from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p11","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and ps p120 pe(Cas) and caused the dissociation of ps beta-catenin pe from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p12","sentence":"Hypertonicity provoked ps Fyn pe-dependent tyrosine phosphorylation in beta-catenin, ps alpha-catenin pe, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.","label":1}
{"pair_id":"BioInfer.d284.s0.p13","sentence":"Hypertonicity provoked ps Fyn pe-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of ps beta-catenin pe from the contacts.","label":0}
{"pair_id":"BioInfer.d284.s0.p14","sentence":"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, ps alpha-catenin pe, and p120(Cas) and caused the dissociation of ps beta-catenin pe from the contacts.","label":0}
{"pair_id":"AIMed.d37.s315.p0","sentence":"We found that in addition to ps MIP-1beta pe, ps MIP-1alpha pe, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p1","sentence":"We found that in addition to ps MIP-1beta pe, MIP-1alpha, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p2","sentence":"We found that in addition to ps MIP-1beta pe, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p3","sentence":"We found that in addition to ps MIP-1beta pe, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: ps MCP-2 pe, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p4","sentence":"We found that in addition to ps MIP-1beta pe, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, ps MCP-3 pe, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p5","sentence":"We found that in addition to ps MIP-1beta pe, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, ps MCP-4 pe, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p6","sentence":"We found that in addition to ps MIP-1beta pe, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, ps MCP-1 pe, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p7","sentence":"We found that in addition to ps MIP-1beta pe, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p8","sentence":"We found that in addition to MIP-1beta, ps MIP-1alpha pe, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p9","sentence":"We found that in addition to MIP-1beta, ps MIP-1alpha pe, and RANTES, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p10","sentence":"We found that in addition to MIP-1beta, ps MIP-1alpha pe, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: ps MCP-2 pe, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p11","sentence":"We found that in addition to MIP-1beta, ps MIP-1alpha pe, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, ps MCP-3 pe, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p12","sentence":"We found that in addition to MIP-1beta, ps MIP-1alpha pe, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, ps MCP-4 pe, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p13","sentence":"We found that in addition to MIP-1beta, ps MIP-1alpha pe, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, ps MCP-1 pe, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p14","sentence":"We found that in addition to MIP-1beta, ps MIP-1alpha pe, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p15","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p16","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: ps MCP-2 pe, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p17","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, ps MCP-3 pe, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p18","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, ps MCP-4 pe, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p19","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, ps MCP-1 pe, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p20","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and ps RANTES pe, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p21","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: ps MCP-2 pe, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p22","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: MCP-2, ps MCP-3 pe, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p23","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: MCP-2, MCP-3, ps MCP-4 pe, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p24","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: MCP-2, MCP-3, MCP-4, ps MCP-1 pe, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p25","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-ps MIP-1beta pe binding: MCP-2, MCP-3, MCP-4, MCP-1, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":1}
{"pair_id":"AIMed.d37.s315.p26","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: ps MCP-2 pe, ps MCP-3 pe, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p27","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: ps MCP-2 pe, MCP-3, ps MCP-4 pe, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p28","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: ps MCP-2 pe, MCP-3, MCP-4, ps MCP-1 pe, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p29","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: ps MCP-2 pe, MCP-3, MCP-4, MCP-1, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p30","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, ps MCP-3 pe, ps MCP-4 pe, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p31","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, ps MCP-3 pe, MCP-4, ps MCP-1 pe, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p32","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, ps MCP-3 pe, MCP-4, MCP-1, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p33","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, ps MCP-4 pe, ps MCP-1 pe, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p34","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, ps MCP-4 pe, MCP-1, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"AIMed.d37.s315.p35","sentence":"We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, ps MCP-1 pe, and ps eotaxin pe binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol\/L, respectively.","label":0}
{"pair_id":"BioInfer.d443.s0.p0","sentence":"Mutations in BUD3, ps BUD4 pe, and ps AXL1 pe cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).","label":0}
{"pair_id":"BioInfer.d443.s0.p1","sentence":"Mutations in ps BUD3 pe, ps BUD4 pe, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).","label":0}
{"pair_id":"BioInfer.d443.s0.p2","sentence":"Mutations in ps BUD3 pe, BUD4, and ps AXL1 pe cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).","label":0}
{"pair_id":"BioInfer.d835.s0.p0","sentence":"YACs containing ps color vision red pigment pe gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or ps RAD52 pe loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p1","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, ps RAD6 pe, RAD51, or ps RAD52 pe loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p2","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, ps RAD51 pe, or ps RAD52 pe loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p3","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the ps RAD1 pe, RAD6, RAD51, or ps RAD52 pe loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p4","sentence":"YACs containing ps color vision red pigment pe gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, ps RAD6 pe, RAD51, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p5","sentence":"YACs containing ps color vision red pigment pe gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, ps RAD51 pe, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p6","sentence":"YACs containing ps color vision red pigment pe gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the ps RAD1 pe, RAD6, RAD51, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p7","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, ps RAD6 pe, ps RAD51 pe, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p8","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the ps RAD1 pe, ps RAD6 pe, RAD51, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d835.s0.p9","sentence":"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the ps RAD1 pe, RAD6, ps RAD51 pe, or RAD52 loci.","label":0}
{"pair_id":"BioInfer.d613.s0.p0","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p1","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p2","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p3","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":0}
{"pair_id":"BioInfer.d613.s0.p4","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p5","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p6","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p7","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p8","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p9","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p10","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p11","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of ps IL-2 pe production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p12","sentence":"The findings suggest that ps M1 pe ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p13","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p14","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":0}
{"pair_id":"BioInfer.d613.s0.p15","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p16","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p17","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p18","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p19","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p20","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p21","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p22","sentence":"The findings suggest that ps M1 pe muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p23","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p24","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":0}
{"pair_id":"BioInfer.d613.s0.p25","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p26","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p27","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p28","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p29","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p30","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p31","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p32","sentence":"The findings suggest that M1 ps muscarinic receptors pe are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p33","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":1}
{"pair_id":"BioInfer.d613.s0.p34","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p35","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p36","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p37","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p38","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p39","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p40","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p41","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and ps c-Jun N-terminal kinase pe, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p42","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of ps IL-2 pe production.","label":1}
{"pair_id":"BioInfer.d613.s0.p43","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":0}
{"pair_id":"BioInfer.d613.s0.p44","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":0}
{"pair_id":"BioInfer.d613.s0.p45","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":1}
{"pair_id":"BioInfer.d613.s0.p46","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":1}
{"pair_id":"BioInfer.d613.s0.p47","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":1}
{"pair_id":"BioInfer.d613.s0.p48","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":1}
{"pair_id":"BioInfer.d613.s0.p49","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of ps IL-2 pe production.","label":1}
{"pair_id":"BioInfer.d613.s0.p50","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p51","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p52","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p53","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p54","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p55","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p56","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the ps muscarinic receptor pe-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p57","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p58","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p59","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p60","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p61","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p62","sentence":"The findings suggest that M1 muscarinic receptors are involved in ps muscarinic receptor pe-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p63","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p64","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p65","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p66","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":1}
{"pair_id":"BioInfer.d613.s0.p67","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 ps MAPK pe, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p68","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p69","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p70","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p71","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/ps extracellular signal regulated protein kinase pe and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p72","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p73","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p74","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (ps MAPK pe)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p75","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via mitogen-activated protein kinase (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p76","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor ps AP-1 pe and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"BioInfer.d613.s0.p77","sentence":"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via ps mitogen-activated protein kinase pe (MAPK)\/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via ps p38 pe MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.","label":0}
{"pair_id":"AIMed.d63.s547.p0","sentence":"These findings strongly suggest that ps CD26 pe may be closely associated with the ps CD45 pe protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p1","sentence":"These findings strongly suggest that ps CD26 pe may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of ps CD26 pe with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p2","sentence":"These findings strongly suggest that ps CD26 pe may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with ps CD45 pe results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p3","sentence":"These findings strongly suggest that CD26 may be closely associated with the ps CD45 pe protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of ps CD26 pe with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p4","sentence":"These findings strongly suggest that CD26 may be closely associated with the ps CD45 pe protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with ps CD45 pe results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":0}
{"pair_id":"AIMed.d63.s547.p5","sentence":"These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of ps CD26 pe with ps CD45 pe results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.","label":1}
{"pair_id":"AIMed.d16.s141.p0","sentence":"CONCLUSION: The triple transduction of ps TH pe, ps AADC pe and GCH genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.","label":0}
{"pair_id":"AIMed.d16.s141.p1","sentence":"CONCLUSION: The triple transduction of ps TH pe, AADC and ps GCH pe genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.","label":0}
{"pair_id":"AIMed.d16.s141.p2","sentence":"CONCLUSION: The triple transduction of TH, ps AADC pe and ps GCH pe genes with separate AAV vectors is effective, which might be important to gene therapy for Parkinson's disease.","label":0}
{"pair_id":"BioInfer.d330.s0.p0","sentence":"In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (N-WASP) unable to interact with ps profilin pe, the ps actin pe tail formation of intracellular Shigella was inhibited.","label":0}
{"pair_id":"BioInfer.d330.s0.p1","sentence":"In COS-7 cells overexpressing a ps N-WASP pe mutant lacking the proline-rich domain (ps N-WASP pe) unable to interact with profilin, the ps actin pe tail formation of intracellular Shigella was inhibited.","label":0}
{"pair_id":"BioInfer.d330.s0.p2","sentence":"In COS-7 cells overexpressing a ps N-WASP pe mutant lacking the proline-rich domain (ps N-WASP pe) unable to interact with ps profilin pe, the actin tail formation of intracellular Shigella was inhibited.","label":1}
{"pair_id":"AIMed.d26.s216.p0","sentence":"The aim of the present study was to elucidate whether intracellular expression of ps granulysin pe and ps perforin pe by NK cells might be associated with progression of cancer.","label":0}
{"pair_id":"AIMed.d160.s1348.p0","sentence":"A ps VEGF pe model based on ps PDGFb pe indicated these positively and negatively charged regions are distal in the monomer but are spatially close in the dimer.","label":0}
{"pair_id":"BioInfer.d180.s0.p0","sentence":"ps DR3 pe signal transduction is mediated by a complex of intracellular signaling molecules including ps TRADD pe, TRAF2, FADD, and FLICE.","label":0}
{"pair_id":"BioInfer.d180.s0.p1","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including ps TRADD pe, TRAF2, FADD, and ps FLICE pe.","label":1}
{"pair_id":"BioInfer.d180.s0.p2","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including ps TRADD pe, TRAF2, ps FADD pe, and FLICE.","label":1}
{"pair_id":"BioInfer.d180.s0.p3","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including ps TRADD pe, ps TRAF2 pe, FADD, and FLICE.","label":1}
{"pair_id":"BioInfer.d180.s0.p4","sentence":"ps DR3 pe signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and ps FLICE pe.","label":0}
{"pair_id":"BioInfer.d180.s0.p5","sentence":"ps DR3 pe signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, ps FADD pe, and FLICE.","label":0}
{"pair_id":"BioInfer.d180.s0.p6","sentence":"ps DR3 pe signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, ps TRAF2 pe, FADD, and FLICE.","label":0}
{"pair_id":"BioInfer.d180.s0.p7","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, ps FADD pe, and ps FLICE pe.","label":1}
{"pair_id":"BioInfer.d180.s0.p8","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, ps TRAF2 pe, FADD, and ps FLICE pe.","label":1}
{"pair_id":"BioInfer.d180.s0.p9","sentence":"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, ps TRAF2 pe, ps FADD pe, and FLICE.","label":1}
{"pair_id":"BioInfer.d638.s1.p0","sentence":"The tandem repeat domain in the Listeria monocytogenes ps ActA pe protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and ps profilin pe.","label":1}
{"pair_id":"BioInfer.d638.s1.p1","sentence":"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of ps actin pe-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d638.s1.p2","sentence":"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of ps vasodilator-stimulated phosphoprotein pe and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d638.s1.p3","sentence":"The tandem repeat domain in the Listeria monocytogenes ps ActA pe protein controls the rate of ps actin pe-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.","label":1}
{"pair_id":"BioInfer.d638.s1.p4","sentence":"The tandem repeat domain in the Listeria monocytogenes ps ActA pe protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of ps vasodilator-stimulated phosphoprotein pe and profilin.","label":1}
{"pair_id":"BioInfer.d638.s1.p5","sentence":"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of ps actin pe-based motility, the percentage of moving bacteria, and the localization of ps vasodilator-stimulated phosphoprotein pe and profilin.","label":0}
{"pair_id":"BioInfer.d201.s0.p0","sentence":"Expression of ps actin pe and ps myosin heavy chain pe genes in skeletal, cardiac and uterine muscles of young and old rats.","label":0}
{"pair_id":"AIMed.d115.s971.p0","sentence":"A few general transcription factors, in particular ps TFIID pe and ps TFIIB pe, have been found to bind transcriptional activators.","label":0}
{"pair_id":"AIMed.d127.s1088.p0","sentence":"ps Jak1 pe and ps Jak3 pe associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p1","sentence":"ps Jak1 pe and Jak3 associated with ps IL-2R beta pe and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":1}
{"pair_id":"AIMed.d127.s1088.p2","sentence":"ps Jak1 pe and Jak3 associated with IL-2R beta and gamma c, respectively; ps IL-2 pe induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p3","sentence":"ps Jak1 pe and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced ps Jak3 pe-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p4","sentence":"ps Jak1 pe and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-ps IL-2R beta pe and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p5","sentence":"ps Jak1 pe and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased ps Jak3 pe-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p6","sentence":"Jak1 and ps Jak3 pe associated with ps IL-2R beta pe and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":1}
{"pair_id":"AIMed.d127.s1088.p7","sentence":"Jak1 and ps Jak3 pe associated with IL-2R beta and gamma c, respectively; ps IL-2 pe induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p8","sentence":"Jak1 and ps Jak3 pe associated with IL-2R beta and gamma c, respectively; IL-2 induced ps Jak3 pe-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p9","sentence":"Jak1 and ps Jak3 pe associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-ps IL-2R beta pe and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p10","sentence":"Jak1 and ps Jak3 pe associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased ps Jak3 pe-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p11","sentence":"Jak1 and Jak3 associated with ps IL-2R beta pe and gamma c, respectively; ps IL-2 pe induced Jak3-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p12","sentence":"Jak1 and Jak3 associated with ps IL-2R beta pe and gamma c, respectively; IL-2 induced ps Jak3 pe-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p13","sentence":"Jak1 and Jak3 associated with ps IL-2R beta pe and gamma c, respectively; IL-2 induced Jak3-ps IL-2R beta pe and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p14","sentence":"Jak1 and Jak3 associated with ps IL-2R beta pe and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased ps Jak3 pe-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p15","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; ps IL-2 pe induced ps Jak3 pe-IL-2R beta and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p16","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; ps IL-2 pe induced Jak3-ps IL-2R beta pe and increased Jak3-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p17","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; ps IL-2 pe induced Jak3-IL-2R beta and increased ps Jak3 pe-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p18","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced ps Jak3 pe-ps IL-2R beta pe and increased Jak3-gamma c associations.","label":1}
{"pair_id":"AIMed.d127.s1088.p19","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced ps Jak3 pe-IL-2R beta and increased ps Jak3 pe-gamma c associations.","label":0}
{"pair_id":"AIMed.d127.s1088.p20","sentence":"Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-ps IL-2R beta pe and increased ps Jak3 pe-gamma c associations.","label":0}
{"pair_id":"AIMed.d160.s1345.p0","sentence":"ps VEGF pe mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, ps kinase insert domain-containing receptor pe (KDR)\/fetal liver kinase 1 (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p1","sentence":"ps VEGF pe mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (ps KDR pe)\/fetal liver kinase 1 (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p2","sentence":"ps VEGF pe mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/ps fetal liver kinase 1 pe (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p3","sentence":"ps VEGF pe mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/fetal liver kinase 1 (ps Flk-1 pe) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p4","sentence":"ps VEGF pe mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/fetal liver kinase 1 (Flk-1) and ps FLT-1 pe.","label":0}
{"pair_id":"AIMed.d160.s1345.p5","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, ps kinase insert domain-containing receptor pe (ps KDR pe)\/fetal liver kinase 1 (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p6","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, ps kinase insert domain-containing receptor pe (KDR)\/ps fetal liver kinase 1 pe (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p7","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, ps kinase insert domain-containing receptor pe (KDR)\/fetal liver kinase 1 (ps Flk-1 pe) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p8","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, ps kinase insert domain-containing receptor pe (KDR)\/fetal liver kinase 1 (Flk-1) and ps FLT-1 pe.","label":0}
{"pair_id":"AIMed.d160.s1345.p9","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (ps KDR pe)\/ps fetal liver kinase 1 pe (Flk-1) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p10","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (ps KDR pe)\/fetal liver kinase 1 (ps Flk-1 pe) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p11","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (ps KDR pe)\/fetal liver kinase 1 (Flk-1) and ps FLT-1 pe.","label":0}
{"pair_id":"AIMed.d160.s1345.p12","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/ps fetal liver kinase 1 pe (ps Flk-1 pe) and FLT-1.","label":0}
{"pair_id":"AIMed.d160.s1345.p13","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/ps fetal liver kinase 1 pe (Flk-1) and ps FLT-1 pe.","label":0}
{"pair_id":"AIMed.d160.s1345.p14","sentence":"VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)\/fetal liver kinase 1 (ps Flk-1 pe) and ps FLT-1 pe.","label":0}
{"pair_id":"BioInfer.d188.s0.p0","sentence":"Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or ps myosin heavy chain peps myosin heavy chain pe (ps myosi pe+ps myos pe) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p1","sentence":"Electrical stimulation of cardiocyte contraction did not enhance ps alpha-cardiac actin pe or ps myosin heavy chain pe (myosi+ps myos pe) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p2","sentence":"Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or ps myosin heavy chain pe (myosi+ps myos pe) mRNA transcript levels relative to ps 28S rRNA pe during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p3","sentence":"Electrical stimulation of cardiocyte contraction did not enhance ps alpha-cardiac actin pe or ps myosin heavy chain pe (ps myosi pe+myos) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p4","sentence":"Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or ps myosin heavy chain pe (ps myosi pe+myos) mRNA transcript levels relative to ps 28S rRNA pe during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d188.s0.p5","sentence":"Electrical stimulation of cardiocyte contraction did not enhance ps alpha-cardiac actin pe or myosin heavy chain (myosi+myos) mRNA transcript levels relative to ps 28S rRNA pe during the period of rapid growth that occurred over the first 48 hours.","label":0}
{"pair_id":"BioInfer.d718.s0.p0","sentence":"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, ps cofilin pe, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d718.s0.p1","sentence":"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive ps actin pe-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d718.s0.p2","sentence":"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive ps actin pe-depolymerizing protein, ps cofilin pe, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.","label":1}
{"pair_id":"BioInfer.d140.s2.p0","sentence":"beta-catenin or ps plakoglobin pe is associated directly with the ps cadherin pe; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p1","sentence":"ps beta-catenin pe or plakoglobin is associated directly with the ps cadherin pe; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p2","sentence":"beta-catenin or plakoglobin is associated directly with the ps cadherin pe; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the ps cadherin pe\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p3","sentence":"beta-catenin or plakoglobin is associated directly with the ps cadherin pe; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/ps catenin pe complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p4","sentence":"beta-catenin or plakoglobin is associated directly with the ps cadherin pe; ps alpha-catenin pe binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p5","sentence":"beta-catenin or plakoglobin is associated directly with the ps cadherin pe; alpha-catenin binds to beta-catenin\/ps plakoglobin pe and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p6","sentence":"beta-catenin or plakoglobin is associated directly with the ps cadherin pe; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p7","sentence":"beta-catenin or plakoglobin is associated directly with the ps cadherin pe; alpha-catenin binds to ps beta-catenin pe\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p8","sentence":"ps beta-catenin pe or ps plakoglobin pe is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p9","sentence":"beta-catenin or ps plakoglobin pe is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the ps cadherin pe\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p10","sentence":"beta-catenin or ps plakoglobin pe is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/ps catenin pe complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p11","sentence":"beta-catenin or ps plakoglobin pe is associated directly with the cadherin; ps alpha-catenin pe binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p12","sentence":"beta-catenin or ps plakoglobin pe is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/ps plakoglobin pe and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p13","sentence":"beta-catenin or ps plakoglobin pe is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p14","sentence":"beta-catenin or ps plakoglobin pe is associated directly with the cadherin; alpha-catenin binds to ps beta-catenin pe\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p15","sentence":"ps beta-catenin pe or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the ps cadherin pe\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p16","sentence":"ps beta-catenin pe or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/ps catenin pe complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p17","sentence":"ps beta-catenin pe or plakoglobin is associated directly with the cadherin; ps alpha-catenin pe binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p18","sentence":"ps beta-catenin pe or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/ps plakoglobin pe and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p19","sentence":"ps beta-catenin pe or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p20","sentence":"ps beta-catenin pe or plakoglobin is associated directly with the cadherin; alpha-catenin binds to ps beta-catenin pe\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p21","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the ps cadherin pe\/ps catenin pe complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p22","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; ps alpha-catenin pe binds to beta-catenin\/plakoglobin and serves to link the ps cadherin pe\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p23","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/ps plakoglobin pe and serves to link the ps cadherin pe\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p24","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the ps cadherin pe\/catenin complex to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p25","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to ps beta-catenin pe\/plakoglobin and serves to link the ps cadherin pe\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p26","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; ps alpha-catenin pe binds to beta-catenin\/plakoglobin and serves to link the cadherin\/ps catenin pe complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p27","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/ps plakoglobin pe and serves to link the cadherin\/ps catenin pe complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p28","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/plakoglobin and serves to link the cadherin\/ps catenin pe complex to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p29","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to ps beta-catenin pe\/plakoglobin and serves to link the cadherin\/ps catenin pe complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p30","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; ps alpha-catenin pe binds to beta-catenin\/ps plakoglobin pe and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p31","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; ps alpha-catenin pe binds to beta-catenin\/plakoglobin and serves to link the cadherin\/catenin complex to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p32","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; ps alpha-catenin pe binds to ps beta-catenin pe\/plakoglobin and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d140.s2.p33","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin\/ps plakoglobin pe and serves to link the cadherin\/catenin complex to the ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p34","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to ps beta-catenin pe\/ps plakoglobin pe and serves to link the cadherin\/catenin complex to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d140.s2.p35","sentence":"beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to ps beta-catenin pe\/plakoglobin and serves to link the cadherin\/catenin complex to the ps actin pe cytoskeleton.","label":0}
{"pair_id":"BioInfer.d35.s1.p0","sentence":"Aip1p localizes to cortical ps actin pe patches in yeast cells, and this localization is disrupted by specific ps actin pe and cofilin mutations.","label":1}
{"pair_id":"BioInfer.d35.s1.p1","sentence":"ps Aip1p pe localizes to cortical ps actin pe patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.","label":1}
{"pair_id":"BioInfer.d35.s1.p2","sentence":"Aip1p localizes to cortical ps actin pe patches in yeast cells, and this localization is disrupted by specific actin and ps cofilin pe mutations.","label":1}
{"pair_id":"BioInfer.d35.s1.p3","sentence":"ps Aip1p pe localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific ps actin pe and cofilin mutations.","label":0}
{"pair_id":"BioInfer.d35.s1.p4","sentence":"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific ps actin pe and ps cofilin pe mutations.","label":0}
{"pair_id":"BioInfer.d35.s1.p5","sentence":"ps Aip1p pe localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and ps cofilin pe mutations.","label":0}
{"pair_id":"AIMed.d153.s1301.p0","sentence":"We found that ps ADA pe was associated with ps CD26 pe on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":1}
{"pair_id":"AIMed.d153.s1301.p1","sentence":"We found that ps ADA pe was associated with CD26 on T cell lines lacking either ps ADA pe or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p2","sentence":"We found that ps ADA pe was associated with CD26 on T cell lines lacking either ADA or ps dipeptidyl peptidase IV pe enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p3","sentence":"We found that ps ADA pe was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between ps dipeptidyl peptidase IV pe and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p4","sentence":"We found that ps ADA pe was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ps ADA pe did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p5","sentence":"We found that ADA was associated with ps CD26 pe on T cell lines lacking either ps ADA pe or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p6","sentence":"We found that ADA was associated with ps CD26 pe on T cell lines lacking either ADA or ps dipeptidyl peptidase IV pe enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p7","sentence":"We found that ADA was associated with ps CD26 pe on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between ps dipeptidyl peptidase IV pe and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p8","sentence":"We found that ADA was associated with ps CD26 pe on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ps ADA pe did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p9","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ps ADA pe or ps dipeptidyl peptidase IV pe enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p10","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ps ADA pe or dipeptidyl peptidase IV enzymatic activity, indicating that the association between ps dipeptidyl peptidase IV pe and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p11","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ps ADA pe or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ps ADA pe did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p12","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ADA or ps dipeptidyl peptidase IV pe enzymatic activity, indicating that the association between ps dipeptidyl peptidase IV pe and ADA did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p13","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ADA or ps dipeptidyl peptidase IV pe enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ps ADA pe did not require enzymatic activity.","label":0}
{"pair_id":"AIMed.d153.s1301.p14","sentence":"We found that ADA was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between ps dipeptidyl peptidase IV pe and ps ADA pe did not require enzymatic activity.","label":1}
{"pair_id":"AIMed.d53.s472.p0","sentence":"The cross-reactivity of ps gp130 pe is apparently due to a chemical plasticity evident in the amphipathic ps gp130 pe cytokine-binding sites.","label":0}
{"pair_id":"AIMed.d187.s1592.p0","sentence":"Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the ps TTR pe monomer that interact with ps A beta pe.","label":1}
{"pair_id":"BioInfer.d716.s0.p0","sentence":"The serine phosphatases PP1 and PP2A associate with and activate the ps actin-binding protein pe ps cofilin pe in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p1","sentence":"The serine phosphatases ps PP1 pe and PP2A associate with and activate the ps actin-binding protein pe cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p2","sentence":"The serine phosphatases PP1 and ps PP2A pe associate with and activate the ps actin-binding protein pe cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p3","sentence":"The ps serine phosphatases pe PP1 and PP2A associate with and activate the ps actin-binding protein pe cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p4","sentence":"The serine phosphatases ps PP1 pe and PP2A associate with and activate the actin-binding protein ps cofilin pe in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p5","sentence":"The serine phosphatases PP1 and ps PP2A pe associate with and activate the actin-binding protein ps cofilin pe in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p6","sentence":"The ps serine phosphatases pe PP1 and PP2A associate with and activate the actin-binding protein ps cofilin pe in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p7","sentence":"The serine phosphatases ps PP1 pe and ps PP2A pe associate with and activate the actin-binding protein cofilin in human T lymphocytes.","label":0}
{"pair_id":"BioInfer.d716.s0.p8","sentence":"The ps serine phosphatases pe ps PP1 pe and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.","label":1}
{"pair_id":"BioInfer.d716.s0.p9","sentence":"The ps serine phosphatases pe PP1 and ps PP2A pe associate with and activate the actin-binding protein cofilin in human T lymphocytes.","label":1}
{"pair_id":"AIMed.d224.s1953.p0","sentence":"The correlation between ps HLA-E pe and MHC class I surface expression might be relevant to the function of ps HLA-E pe.","label":0}
{"pair_id":"AIMed.d87.s733.p0","sentence":"Interaction of ps p85 pe subunit of ps PI 3-kinase pe with insulin and IGF-1 receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p1","sentence":"Interaction of ps p85 pe subunit of PI 3-kinase with ps insulin pe and IGF-1 receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p2","sentence":"Interaction of ps p85 pe subunit of PI 3-kinase with insulin and ps IGF-1 pe receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p3","sentence":"Interaction of p85 subunit of ps PI 3-kinase pe with ps insulin pe and IGF-1 receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p4","sentence":"Interaction of p85 subunit of ps PI 3-kinase pe with insulin and ps IGF-1 pe receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d87.s733.p5","sentence":"Interaction of p85 subunit of PI 3-kinase with ps insulin pe and ps IGF-1 pe receptors analysed by using the two-hybrid system.","label":0}
{"pair_id":"AIMed.d120.s1021.p0","sentence":"ps FXIII pe also was shown to coprecipitate with ps HSP27 pe in immunoprecipitation studies and to colocalize with HSP27 in immunofluorescence studies of intact glass-activated platelets.","label":1}
{"pair_id":"AIMed.d120.s1021.p1","sentence":"ps FXIII pe also was shown to coprecipitate with HSP27 in immunoprecipitation studies and to colocalize with ps HSP27 pe in immunofluorescence studies of intact glass-activated platelets.","label":0}
{"pair_id":"AIMed.d120.s1021.p2","sentence":"FXIII also was shown to coprecipitate with ps HSP27 pe in immunoprecipitation studies and to colocalize with ps HSP27 pe in immunofluorescence studies of intact glass-activated platelets.","label":0}
{"pair_id":"AIMed.d126.s1082.p0","sentence":"If current models of chaperonin mechanism are correct, ps rhodanese pe undergoes more rebinding and release cycles than does ps GS pe.","label":0}
{"pair_id":"AIMed.d118.s1000.p0","sentence":"ps p21 pe controls CDK activity, thereby affecting cell-cycle control, whereas ps PCNA pe functions in both DNA replication and repair.","label":0}
{"pair_id":"AIMed.d37.s319.p0","sentence":"ps MCP-3 pe could compete efficiently for ps gp120 pe binding but was, however, found to be a weak inhibitor of HIV infection, probably as a consequence of its inability to downregulate the receptor.","label":1}
{"pair_id":"AIMed.d117.s984.p0","sentence":"The beta:ps beta activin pe homodimer and alpha:ps beta inhibin pe heterodimer are mutual antagonists which share a common beta subunit.","label":0}
{"pair_id":"AIMed.d126.s1080.p0","sentence":"In contrast, the renaturation rate for ps rhodanese pe with the groE chaperonins mirrored the committed renaturation rates following ps groEL pe depletion.","label":0}
{"pair_id":"BioInfer.d314.s0.p0","sentence":"In addition, we demonstrate that ps cofilin pe and its ps actin pe binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.","label":1}
{"pair_id":"BioInfer.d314.s0.p1","sentence":"In addition, we demonstrate that cofilin and its ps actin pe binding peptide compete with gelsolin segments 2-3 for binding to ps actin pe filaments.","label":0}
{"pair_id":"BioInfer.d314.s0.p2","sentence":"In addition, we demonstrate that cofilin and its ps actin pe binding peptide compete with ps gelsolin pe segments 2-3 for binding to actin filaments.","label":0}
{"pair_id":"BioInfer.d314.s0.p3","sentence":"In addition, we demonstrate that ps cofilin pe and its actin binding peptide compete with gelsolin segments 2-3 for binding to ps actin pe filaments.","label":1}
{"pair_id":"BioInfer.d314.s0.p4","sentence":"In addition, we demonstrate that ps cofilin pe and its actin binding peptide compete with ps gelsolin pe segments 2-3 for binding to actin filaments.","label":0}
{"pair_id":"BioInfer.d314.s0.p5","sentence":"In addition, we demonstrate that cofilin and its actin binding peptide compete with ps gelsolin pe segments 2-3 for binding to ps actin pe filaments.","label":1}
{"pair_id":"AIMed.d69.s586.p0","sentence":"Activation of ps protein kinase C pe decreases phosphorylation of ps c-Jun pe at sites that negatively regulate its DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d673.s0.p0","sentence":"The protein ps profilin pe binds to both ps actin pe and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.","label":1}
{"pair_id":"BioInfer.d673.s0.p1","sentence":"The protein profilin binds to both ps actin pe and the head groups of poly)phosphoinositide)s and may regulate both ps actin pe assembly and the phosphoinositide signaling pathway.","label":0}
{"pair_id":"BioInfer.d673.s0.p2","sentence":"The protein ps profilin pe binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both ps actin pe assembly and the phosphoinositide signaling pathway.","label":1}
{"pair_id":"AIMed.d65.s555.p0","sentence":"The ps Fos pe\/ps Jun pe and ATF\/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p1","sentence":"The ps Fos pe\/Jun and ps ATF pe\/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p2","sentence":"The ps Fos pe\/Jun and ATF\/ps CREB pe families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p3","sentence":"The Fos\/ps Jun pe and ps ATF pe\/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p4","sentence":"The Fos\/ps Jun pe and ATF\/ps CREB pe families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d65.s555.p5","sentence":"The Fos\/Jun and ps ATF pe\/ps CREB pe families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.","label":0}
{"pair_id":"AIMed.d30.s250.p0","sentence":"Isolation of human ps delta-catenin pe and its binding specificity with ps presenilin 1 pe.","label":1}
{"pair_id":"BioInfer.d519.s1.p0","sentence":"Results from epistasis analyses indicate that ps MSH2 pe functions in mismatch repair in conjunction with MSH3 or ps MSH6 pe and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d519.s1.p1","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or ps MSH6 pe and that MSH3 and ps MSH6 pe constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p2","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with ps MSH3 pe or ps MSH6 pe and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p3","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or ps MSH6 pe and that MSH3 and MSH6 constitute alternate pathways of ps MSH2 pe-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p4","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or ps MSH6 pe and that ps MSH3 pe and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p5","sentence":"Results from epistasis analyses indicate that ps MSH2 pe functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and ps MSH6 pe constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p6","sentence":"Results from epistasis analyses indicate that ps MSH2 pe functions in mismatch repair in conjunction with ps MSH3 pe or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d519.s1.p7","sentence":"Results from epistasis analyses indicate that ps MSH2 pe functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of ps MSH2 pe-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p8","sentence":"Results from epistasis analyses indicate that ps MSH2 pe functions in mismatch repair in conjunction with MSH3 or MSH6 and that ps MSH3 pe and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p9","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with ps MSH3 pe or MSH6 and that MSH3 and ps MSH6 pe constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p10","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and ps MSH6 pe constitute alternate pathways of ps MSH2 pe-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d519.s1.p11","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that ps MSH3 pe and ps MSH6 pe constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p12","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with ps MSH3 pe or MSH6 and that MSH3 and MSH6 constitute alternate pathways of ps MSH2 pe-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p13","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with ps MSH3 pe or MSH6 and that ps MSH3 pe and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d519.s1.p14","sentence":"Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that ps MSH3 pe and MSH6 constitute alternate pathways of ps MSH2 pe-dependent mismatch repair.","label":1}
{"pair_id":"BioInfer.d288.s1.p0","sentence":"In this study, we demonstrate using viscosity, sedimentation, and ps actin pe assembly rate assays that yeast ps cofilin pe (16 kD) possesses all of these properties.","label":0}
{"pair_id":"BioInfer.d41.s0.p0","sentence":"Although ps profilin pe released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of ps actin pe released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p1","sentence":"Although ps profilin pe released actin at the appropriate time to stimulate ps actin pe assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p2","sentence":"Although ps profilin pe released ps actin pe at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p3","sentence":"Although ps profilin pe released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized ps actin pe content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p4","sentence":"Although ps profilin pe released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of ps profilin pe in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p5","sentence":"Although ps profilin pe released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized ps actin pe associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p6","sentence":"Although ps profilin pe released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from ps profilin pe too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p7","sentence":"Although profilin released actin at the appropriate time to stimulate ps actin pe assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of ps actin pe released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p8","sentence":"Although profilin released ps actin pe at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of ps actin pe released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p9","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized ps actin pe content in unstimulated PMN and the quantity of ps actin pe released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p10","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of ps profilin pe in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of ps actin pe released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p11","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of ps actin pe released from profilin too small to account for the large shifts from unpolymerized to polymerized ps actin pe associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p12","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of ps actin pe released from ps profilin pe too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p13","sentence":"Although profilin released ps actin pe at the appropriate time to stimulate ps actin pe assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p14","sentence":"Although profilin released actin at the appropriate time to stimulate ps actin pe assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized ps actin pe content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p15","sentence":"Although profilin released actin at the appropriate time to stimulate ps actin pe assembly during exposure to chemoattractants, the concentration of ps profilin pe in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p16","sentence":"Although profilin released actin at the appropriate time to stimulate ps actin pe assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized ps actin pe associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p17","sentence":"Although profilin released actin at the appropriate time to stimulate ps actin pe assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from ps profilin pe too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p18","sentence":"Although profilin released ps actin pe at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized ps actin pe content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p19","sentence":"Although profilin released ps actin pe at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of ps profilin pe in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p20","sentence":"Although profilin released ps actin pe at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized ps actin pe associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p21","sentence":"Although profilin released ps actin pe at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from ps profilin pe too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p22","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of ps profilin pe in PMN was insufficient to explain the high unpolymerized ps actin pe content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":1}
{"pair_id":"BioInfer.d41.s0.p23","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized ps actin pe content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized ps actin pe associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p24","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized ps actin pe content in unstimulated PMN and the quantity of actin released from ps profilin pe too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p25","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of ps profilin pe in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized ps actin pe associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p26","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of ps profilin pe in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from ps profilin pe too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d41.s0.p27","sentence":"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from ps profilin pe too small to account for the large shifts from unpolymerized to polymerized ps actin pe associated with maximal chemoattractant stimulation.","label":0}
{"pair_id":"BioInfer.d711.s0.p0","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with ps actin-binding proteins pe such as gelsolin and ps profilin pe.","label":1}
{"pair_id":"BioInfer.d711.s0.p1","sentence":"These results suggest that activation of PKC precedes the activation of ps PI pe and PIP ps kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d711.s0.p2","sentence":"These results suggest that activation of ps PKC pe precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d711.s0.p3","sentence":"These results suggest that activation of PKC precedes the activation of PI and ps PIP kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d711.s0.p4","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of ps actin pe in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d711.s0.p5","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as ps gelsolin pe and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d711.s0.p6","sentence":"These results suggest that activation of PKC precedes the activation of ps PI pe and PIP ps kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with ps actin-binding proteins pe such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p7","sentence":"These results suggest that activation of ps PKC pe precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with ps actin-binding proteins pe such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p8","sentence":"These results suggest that activation of PKC precedes the activation of PI and ps PIP kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with ps actin-binding proteins pe such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p9","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of ps actin pe in RBL cells, possibly through the interaction of the polyphosphoinositides with ps actin-binding proteins pe such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p10","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with ps actin-binding proteins pe such as ps gelsolin pe and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p11","sentence":"These results suggest that activation of ps PKC pe precedes the activation of ps PI pe and PIP ps kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p12","sentence":"These results suggest that activation of PKC precedes the activation of ps PI pe and ps PIP kinases peps kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p13","sentence":"These results suggest that activation of PKC precedes the activation of ps PI pe and PIP ps kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of ps actin pe in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p14","sentence":"These results suggest that activation of PKC precedes the activation of ps PI pe and PIP ps kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as ps gelsolin pe and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p15","sentence":"These results suggest that activation of ps PKC pe precedes the activation of PI and ps PIP kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p16","sentence":"These results suggest that activation of ps PKC pe precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of ps actin pe in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p17","sentence":"These results suggest that activation of ps PKC pe precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as ps gelsolin pe and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p18","sentence":"These results suggest that activation of PKC precedes the activation of PI and ps PIP kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of ps actin pe in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.","label":1}
{"pair_id":"BioInfer.d711.s0.p19","sentence":"These results suggest that activation of PKC precedes the activation of PI and ps PIP kinases pe and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as ps gelsolin pe and profilin.","label":0}
{"pair_id":"BioInfer.d711.s0.p20","sentence":"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of ps actin pe in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as ps gelsolin pe and profilin.","label":0}
{"pair_id":"AIMed.d32.s269.p0","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (ps EPO pe) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p1","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin peps erythropoietin (EPO) receptor pe (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p2","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (EPO) receptor (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p3","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (EPO) receptor (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p4","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p5","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p6","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO pe-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p7","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p8","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin pe (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p9","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor peps EPO pe) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p10","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (ps EPO pe) receptor (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p11","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (ps EPO pe) receptor (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p12","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (ps EPO pe) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p13","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (ps EPO pe) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p14","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (ps EPO pe) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO pe-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p15","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (ps EPO pe) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p16","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (ps EPO pe) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p17","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor pe (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p18","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor pe (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p19","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor pe (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p20","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor pe (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p21","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor pe (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO pe-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p22","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor pe (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p23","sentence":"We have shown previously that Phe93 in the extracellular domain of the ps erythropoietin (EPO) receptor pe (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p24","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (ps EPOR pe) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p25","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p26","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p27","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO pe-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p28","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p29","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (ps EPOR pe) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p30","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p31","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p32","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO pe-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p33","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p34","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding ps EPO pe.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p35","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (EPO-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p36","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO pe-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p37","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p38","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in ps EPO pe binding to the Escherichia coli-expressed extracellular domain of the EPOR (EPO-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":1}
{"pair_id":"AIMed.d32.s269.p39","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (ps EPO pe-binding protein or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p40","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (ps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p41","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the ps EPOR pe (EPO-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p42","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO peps EPO-binding protein pe or EBP) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p43","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO pe-binding protein or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d32.s269.p44","sentence":"We have shown previously that Phe93 in the extracellular domain of the erythropoietin (EPO) receptor (EPOR) is crucial for binding EPO.Substitution of Phe93 with alanine resulted in a dramatic decrease in EPO binding to the Escherichia coli-expressed extracellular domain of the EPOR (ps EPO-binding protein pe or ps EBP pe) and no detectable binding to full-length mutant receptor expressed in COS cells.","label":0}
{"pair_id":"AIMed.d81.s689.p0","sentence":"Ligation of the extracellular domain of the cell surface receptor ps Fas pe\/ps APO-1 pe (CD95) elicits a characteristic programmed death response in susceptible cells.","label":0}
{"pair_id":"AIMed.d81.s689.p1","sentence":"Ligation of the extracellular domain of the cell surface receptor ps Fas pe\/APO-1 (ps CD95 pe) elicits a characteristic programmed death response in susceptible cells.","label":0}
{"pair_id":"AIMed.d81.s689.p2","sentence":"Ligation of the extracellular domain of the cell surface receptor Fas\/ps APO-1 pe (ps CD95 pe) elicits a characteristic programmed death response in susceptible cells.","label":0}
{"pair_id":"BioInfer.d557.s0.p0","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the ps skeletal muscle actin pe, or the ps myosin heavy chain pe genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p1","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, ps Myf5 pe, the skeletal muscle actin, or the ps myosin heavy chain pe genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p2","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, ps MRF4 pe, Myf5, the skeletal muscle actin, or the ps myosin heavy chain pe genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p3","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous ps MyoD1 pe, MRF4, Myf5, the skeletal muscle actin, or the ps myosin heavy chain pe genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p4","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and ps myosin light chain 2 pe gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the ps myosin heavy chain pe genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p5","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous ps myogenin pe and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the ps myosin heavy chain pe genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p6","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, ps Myf5 pe, the ps skeletal muscle actin pe, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p7","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, ps MRF4 pe, Myf5, the ps skeletal muscle actin pe, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p8","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous ps MyoD1 pe, MRF4, Myf5, the ps skeletal muscle actin pe, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p9","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and ps myosin light chain 2 pe gene but not the endogenous MyoD1, MRF4, Myf5, the ps skeletal muscle actin pe, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p10","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous ps myogenin pe and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the ps skeletal muscle actin pe, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p11","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, ps MRF4 pe, ps Myf5 pe, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p12","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous ps MyoD1 pe, MRF4, ps Myf5 pe, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p13","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and ps myosin light chain 2 pe gene but not the endogenous MyoD1, MRF4, ps Myf5 pe, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p14","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous ps myogenin pe and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, ps Myf5 pe, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p15","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous ps MyoD1 pe, ps MRF4 pe, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p16","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and ps myosin light chain 2 pe gene but not the endogenous MyoD1, ps MRF4 pe, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p17","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous ps myogenin pe and myosin light chain 2 gene but not the endogenous MyoD1, ps MRF4 pe, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p18","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and ps myosin light chain 2 pe gene but not the endogenous ps MyoD1 pe, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p19","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous ps myogenin pe and myosin light chain 2 gene but not the endogenous ps MyoD1 pe, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d557.s0.p20","sentence":"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous ps myogenin pe and ps myosin light chain 2 pe gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.","label":0}
{"pair_id":"BioInfer.d621.s0.p0","sentence":"The Herpes simplex virus type 1 ps primosome pe consists of three subunits that are the products of the ps UL5 pe, UL8, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p1","sentence":"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the ps UL5 pe, ps UL8 pe, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p2","sentence":"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the ps UL5 pe, UL8, and ps UL52 pe genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p3","sentence":"The Herpes simplex virus type 1 ps primosome pe consists of three subunits that are the products of the UL5, ps UL8 pe, and UL52 genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p4","sentence":"The Herpes simplex virus type 1 ps primosome pe consists of three subunits that are the products of the UL5, UL8, and ps UL52 pe genes.","label":1}
{"pair_id":"BioInfer.d621.s0.p5","sentence":"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, ps UL8 pe, and ps UL52 pe genes.","label":1}
{"pair_id":"BioInfer.d199.s0.p0","sentence":"Exposure of the cells to tumor promoter did, however, result in a loss of ps actin pe and ps talin pe-rich cell surface elaborations that resemble focal contact precursor structures.","label":0}
{"pair_id":"AIMed.d180.s1533.p0","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between ps GAP-43 pe and the ps calcium effector protein pe, calmodulin (CaM).","label":0}
{"pair_id":"AIMed.d180.s1533.p1","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between ps GAP-43 pe and the calcium effector protein, ps calmodulin pe (CaM).","label":1}
{"pair_id":"AIMed.d180.s1533.p2","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between ps GAP-43 pe and the calcium effector protein, calmodulin (ps CaM pe).","label":1}
{"pair_id":"AIMed.d180.s1533.p3","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the ps calcium effector protein pe, ps calmodulin pe (CaM).","label":0}
{"pair_id":"AIMed.d180.s1533.p4","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the ps calcium effector protein pe, calmodulin (ps CaM pe).","label":0}
{"pair_id":"AIMed.d180.s1533.p5","sentence":"In the yeast-based cloning system, the only strong interaction that was detected between GAP-43 and the calcium effector protein, ps calmodulin pe (ps CaM pe).","label":0}
{"pair_id":"AIMed.d187.s1586.p0","sentence":"Aggregated ps amyloid beta-protein pe (ps A beta pe) is a key component of the amyloid depositions found in the brains of patients with Alzheimer's disease.","label":0}
{"pair_id":"AIMed.d179.s1519.p0","sentence":"ps Gastrin pe stimulates tyrosine phosphorylation of ps insulin pe receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p1","sentence":"ps Gastrin pe stimulates tyrosine phosphorylation of ps insulin receptor pe substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p2","sentence":"ps Gastrin pe stimulates tyrosine phosphorylation of ps insulin receptor substrate 1 pe and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":1}
{"pair_id":"AIMed.d179.s1519.p3","sentence":"ps Gastrin pe stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with ps Grb2 pe and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p4","sentence":"ps Gastrin pe stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the ps phosphatidylinositol 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1519.p5","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin peps insulin receptor pe substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p6","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin peps insulin receptor substrate 1 pe and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p7","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin pe receptor substrate 1 and its association with ps Grb2 pe and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p8","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin pe receptor substrate 1 and its association with Grb2 and the ps phosphatidylinositol 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1519.p9","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin receptor peps insulin receptor substrate 1 pe and its association with Grb2 and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p10","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin receptor pe substrate 1 and its association with ps Grb2 pe and the phosphatidylinositol 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1519.p11","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin receptor pe substrate 1 and its association with Grb2 and the ps phosphatidylinositol 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1519.p12","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin receptor substrate 1 pe and its association with ps Grb2 pe and the phosphatidylinositol 3-kinase.","label":1}
{"pair_id":"AIMed.d179.s1519.p13","sentence":"Gastrin stimulates tyrosine phosphorylation of ps insulin receptor substrate 1 pe and its association with Grb2 and the ps phosphatidylinositol 3-kinase pe.","label":1}
{"pair_id":"AIMed.d179.s1519.p14","sentence":"Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with ps Grb2 pe and the ps phosphatidylinositol 3-kinase pe.","label":0}
{"pair_id":"BioInfer.d757.s1.p0","sentence":"We have previously shown that the synthetic dodecapeptide corresponding to Trp104-Met115 of ps cofilin pe is a potent inhibitor of ps actin pe polymerization (Yonezawa, N., Nishida, E., Iida, K., Kumagai, H., Yahara, I., and Sakai, H. (1991) J. Biol. Chem. 266, 10485-10489).","label":1}
{"pair_id":"BioInfer.d124.s1.p0","sentence":"ps alpha-catenin pe links ps beta-catenin pe to the actin-based cytoskeleton.","label":1}
{"pair_id":"BioInfer.d124.s1.p1","sentence":"ps alpha-catenin pe links beta-catenin to the ps actin pe-based cytoskeleton.","label":1}
{"pair_id":"BioInfer.d124.s1.p2","sentence":"alpha-catenin links ps beta-catenin pe to the ps actin pe-based cytoskeleton.","label":1}
{"pair_id":"AIMed.d61.s539.p0","sentence":"Shedding of the extracellular domain of ps TNF-R2 pe was induced by 4 beta-phorbol 12-myristate 13-acetate but not by ps TNF-alpha pe or TNF-beta.","label":0}
{"pair_id":"AIMed.d61.s539.p1","sentence":"Shedding of the extracellular domain of ps TNF-R2 pe was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or ps TNF-beta pe.","label":0}
{"pair_id":"AIMed.d61.s539.p2","sentence":"Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by ps TNF-alpha pe or ps TNF-beta pe.","label":0}
{"pair_id":"AIMed.d70.s599.p0","sentence":"Specifically, substitution of proline for Ala-498 significantly diminished ps RII peps RII alpha pe binding, and similar mutation of Ile-502 or Ile-507 abolished interaction.","label":0}
{"pair_id":"BioInfer.d434.s0.p0","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p1","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p2","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of ps VE-cadherin pe, alpha-catenin, beta-catenin, and ps plakoglobin pe during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p3","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p4","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of ps VE-cadherin pe, ps alpha-catenin pe, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d434.s0.p5","sentence":"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of ps VE-cadherin pe, alpha-catenin, ps beta-catenin pe, and plakoglobin during transendothelial migration under physiological flow conditions.","label":0}
{"pair_id":"BioInfer.d388.s1.p0","sentence":"ps act1-157 pe, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of ps pfy1-4 pe, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p1","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of ps pfy1-4 pe, a ps profilin pe mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p2","sentence":"act1-157, an ps actin pe mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of ps pfy1-4 pe, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p3","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in ps actin pe organization, cell growth, and fluid-phase endocytosis of ps pfy1-4 pe, a profilin mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p4","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of ps pfy1-4 pe, a profilin mutant defective in ps actin pe binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p5","sentence":"ps act1-157 pe, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a ps profilin pe mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p6","sentence":"ps act1-157 pe, an ps actin pe mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p7","sentence":"ps act1-157 pe, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in ps actin pe organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p8","sentence":"ps act1-157 pe, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in ps actin pe binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p9","sentence":"act1-157, an ps actin pe mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a ps profilin pe mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p10","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in ps actin pe organization, cell growth, and fluid-phase endocytosis of pfy1-4, a ps profilin pe mutant defective in actin binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p11","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a ps profilin pe mutant defective in ps actin pe binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p12","sentence":"act1-157, an ps actin pe mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in ps actin pe organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.","label":1}
{"pair_id":"BioInfer.d388.s1.p13","sentence":"act1-157, an ps actin pe mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in ps actin pe binding.","label":0}
{"pair_id":"BioInfer.d388.s1.p14","sentence":"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in ps actin pe organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in ps actin pe binding.","label":0}
{"pair_id":"BioInfer.d81.s0.p0","sentence":"As expected from immunofluorescence experiments, Abp1p, ps cofilin pe, and ps actin pe colocalized in immuno-EM to the dense patchlike structures but not to the cables.","label":1}
{"pair_id":"BioInfer.d81.s0.p1","sentence":"As expected from immunofluorescence experiments, ps Abp1p pe, ps cofilin pe, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.","label":1}
{"pair_id":"BioInfer.d81.s0.p2","sentence":"As expected from immunofluorescence experiments, ps Abp1p pe, cofilin, and ps actin pe colocalized in immuno-EM to the dense patchlike structures but not to the cables.","label":1}
{"pair_id":"BioInfer.d20.s0.p0","sentence":"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein ps CREB-binding-protein pe, CBP, which bridges the CRE\/ps CREB pe complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"BioInfer.d20.s0.p1","sentence":"Active, Ser133-phosphorylated ps CREB pe effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein ps CREB-binding-protein pe, CBP, which bridges the CRE\/CREB complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"BioInfer.d20.s0.p2","sentence":"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein ps CREB-binding-protein pe, ps CBP pe, which bridges the CRE\/CREB complex to components of the basal transcriptional apparatus.","label":0}
{"pair_id":"BioInfer.d20.s0.p3","sentence":"Active, Ser133-phosphorylated ps CREB pe effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE\/ps CREB pe complex to components of the basal transcriptional apparatus.","label":0}
{"pair_id":"BioInfer.d20.s0.p4","sentence":"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, ps CBP pe, which bridges the CRE\/ps CREB pe complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"BioInfer.d20.s0.p5","sentence":"Active, Ser133-phosphorylated ps CREB pe effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, ps CBP pe, which bridges the CRE\/CREB complex to components of the basal transcriptional apparatus.","label":1}
{"pair_id":"AIMed.d100.s849.p0","sentence":"The ps hTAFII250 pe gene is identical to a gene, ps CCG1 pe, (ref 7,8), implicated in cell-cycle progression.","label":0}
{"pair_id":"AIMed.d87.s737.p0","sentence":"Interaction of ps p85 pe and N+C-SH2 with ps IR beta pe (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":1}
{"pair_id":"AIMed.d87.s737.p1","sentence":"Interaction of ps p85 pe and N+C-SH2 with IR beta (ps delta C-43 pe) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p2","sentence":"Interaction of ps p85 pe and N+C-SH2 with IR beta (delta C-43) or ps IGF-1R pe beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p3","sentence":"Interaction of ps p85 pe and N+C-SH2 with IR beta (delta C-43) or ps IGF-1R beta pe(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":1}
{"pair_id":"AIMed.d87.s737.p4","sentence":"Interaction of ps p85 pe and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta(ps delta C-43 pe) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p5","sentence":"Interaction of p85 and N+C-SH2 with ps IR beta pe (ps delta C-43 pe) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p6","sentence":"Interaction of p85 and N+C-SH2 with ps IR beta pe (delta C-43) or ps IGF-1R pe beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p7","sentence":"Interaction of p85 and N+C-SH2 with ps IR beta pe (delta C-43) or ps IGF-1R beta pe(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p8","sentence":"Interaction of p85 and N+C-SH2 with ps IR beta pe (delta C-43) or IGF-1R beta(ps delta C-43 pe) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p9","sentence":"Interaction of p85 and N+C-SH2 with IR beta (ps delta C-43 pe) or ps IGF-1R pe beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p10","sentence":"Interaction of p85 and N+C-SH2 with IR beta (ps delta C-43 pe) or ps IGF-1R beta pe(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p11","sentence":"Interaction of p85 and N+C-SH2 with IR beta (ps delta C-43 pe) or IGF-1R beta(ps delta C-43 pe) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p12","sentence":"Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or ps IGF-1R peps IGF-1R beta pe(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p13","sentence":"Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or ps IGF-1R pe beta(ps delta C-43 pe) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d87.s737.p14","sentence":"Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or ps IGF-1R beta pe(ps delta C-43 pe) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.","label":0}
{"pair_id":"AIMed.d187.s1588.p0","sentence":"The analysis of complexes of ps A beta pe with CSF proteins in a KBr gradient revealed an association of ps A beta pe only with free proteins and not with lipoprotein particles.","label":0}
{"pair_id":"BioInfer.d227.s0.p0","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, ps alpha-actinin pe and ps vinculin pe that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p1","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, ps plakoglobin pe, p120, ps alpha-actinin pe and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p2","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, ps p120 pe, ps alpha-actinin pe and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p3","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, ps alpha-catenin pe, beta-catenin, plakoglobin, p120, ps alpha-actinin pe and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p4","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, ps beta-catenin pe, plakoglobin, p120, ps alpha-actinin pe and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p5","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of ps N-cadherin pe, alpha-catenin, beta-catenin, plakoglobin, p120, ps alpha-actinin pe and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p6","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, ps plakoglobin pe, p120, alpha-actinin and ps vinculin pe that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p7","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, ps p120 pe, alpha-actinin and ps vinculin pe that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p8","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, ps alpha-catenin pe, beta-catenin, plakoglobin, p120, alpha-actinin and ps vinculin pe that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p9","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, ps beta-catenin pe, plakoglobin, p120, alpha-actinin and ps vinculin pe that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p10","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of ps N-cadherin pe, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and ps vinculin pe that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p11","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, ps plakoglobin pe, ps p120 pe, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p12","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, ps alpha-catenin pe, beta-catenin, ps plakoglobin pe, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p13","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, ps beta-catenin pe, ps plakoglobin pe, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p14","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of ps N-cadherin pe, alpha-catenin, beta-catenin, ps plakoglobin pe, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p15","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, ps alpha-catenin pe, beta-catenin, plakoglobin, ps p120 pe, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p16","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, ps beta-catenin pe, plakoglobin, ps p120 pe, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p17","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of ps N-cadherin pe, alpha-catenin, beta-catenin, plakoglobin, ps p120 pe, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p18","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, ps alpha-catenin pe, ps beta-catenin pe, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p19","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of ps N-cadherin pe, ps alpha-catenin pe, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"BioInfer.d227.s0.p20","sentence":"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of ps N-cadherin pe, alpha-catenin, ps beta-catenin pe, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.","label":0}
{"pair_id":"AIMed.d164.s1379.p0","sentence":"ps U2AF65 pe binds specifically to 3' splice sites, but previous studies failed to demonstrate a function for ps U2AF35 pe.","label":0}
{"pair_id":"AIMed.d124.s1055.p0","sentence":"The protein ps Raf-1 pe, a key mediator of mitogenesis and differentiation, associates with ps p21ras pe (refs 1-3).","label":1}
{"pair_id":"BioInfer.d169.s3.p0","sentence":"These data indicated a negative co-operativity between the ps profilin pe and ps DNase I pe binding sites on actin.","label":1}
{"pair_id":"BioInfer.d169.s3.p1","sentence":"These data indicated a negative co-operativity between the profilin and ps DNase I pe binding sites on ps actin pe.","label":1}
{"pair_id":"BioInfer.d169.s3.p2","sentence":"These data indicated a negative co-operativity between the ps profilin pe and DNase I binding sites on ps actin pe.","label":1}
{"pair_id":"AIMed.d204.s1760.p0","sentence":"Deletion of the complete active-site [des-(161-228)-ps MMP-1 pe] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of ps MMP-1 pe proteins which are unable to digest collagen type I or beta-casein.","label":0}
{"pair_id":"AIMed.d204.s1760.p1","sentence":"Deletion of the complete active-site [des-(161-228)-ps MMP-1 pe] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest ps collagen type I pe or beta-casein.","label":0}
{"pair_id":"AIMed.d204.s1760.p2","sentence":"Deletion of the complete active-site [des-(161-228)-ps MMP-1 pe] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or ps beta-casein pe.","label":0}
{"pair_id":"AIMed.d204.s1760.p3","sentence":"Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of ps MMP-1 pe proteins which are unable to digest ps collagen type I pe or beta-casein.","label":0}
{"pair_id":"AIMed.d204.s1760.p4","sentence":"Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of ps MMP-1 pe proteins which are unable to digest collagen type I or ps beta-casein pe.","label":0}
{"pair_id":"AIMed.d204.s1760.p5","sentence":"Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest ps collagen type I pe or ps beta-casein pe.","label":0}
{"pair_id":"BioInfer.d41.s1.p0","sentence":"Determination of the total profilin and ps actin pe concentrations in PMN revealed that the molar ratio of profilin to ps actin pe was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p1","sentence":"Determination of the total ps profilin pe and ps actin pe concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p2","sentence":"Determination of the total profilin and ps actin pe concentrations in PMN revealed that the molar ratio of ps profilin pe to actin was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p3","sentence":"Determination of the total ps profilin pe and actin concentrations in PMN revealed that the molar ratio of profilin to ps actin pe was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p4","sentence":"Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of ps profilin pe to ps actin pe was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d41.s1.p5","sentence":"Determination of the total ps profilin pe and actin concentrations in PMN revealed that the molar ratio of ps profilin pe to actin was 1 to 5.2.","label":0}
{"pair_id":"BioInfer.d159.s0.p0","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (ps L pe), phosphoprotein (P), and nucleocapsid protein (ps NP pe), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p1","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (ps L pe), phosphoprotein (P), and ps nucleocapsid protein pe (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p2","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the ps large protein pe (ps L pe), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p3","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (ps L pe), phosphoprotein (ps P pe), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p4","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (ps L pe), ps phosphoprotein pe (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p5","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and ps nucleocapsid protein pe (ps NP pe), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p6","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the ps large protein pe (L), phosphoprotein (P), and nucleocapsid protein (ps NP pe), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p7","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (ps P pe), and nucleocapsid protein (ps NP pe), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p8","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), ps phosphoprotein pe (P), and nucleocapsid protein (ps NP pe), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p9","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the ps large protein pe (L), phosphoprotein (P), and ps nucleocapsid protein pe (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p10","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (ps P pe), and ps nucleocapsid protein pe (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p11","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), ps phosphoprotein pe (P), and ps nucleocapsid protein pe (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p12","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the ps large protein pe (L), phosphoprotein (ps P pe), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p13","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the ps large protein pe (L), ps phosphoprotein pe (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d159.s0.p14","sentence":"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), ps phosphoprotein pe (ps P pe), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.","label":0}
{"pair_id":"BioInfer.d329.s0.p0","sentence":"In contrast to the model of actin binding proposed for ps fimbrin pe, the utrophin actin-binding domain appears to associate with ps actin pe in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p1","sentence":"In contrast to the model of actin binding proposed for fimbrin, the utrophin ps actin pe-binding domain appears to associate with ps actin pe in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p2","sentence":"In contrast to the model of actin binding proposed for fimbrin, the ps utrophin pe actin-binding domain appears to associate with ps actin pe in an extended conformation.","label":1}
{"pair_id":"BioInfer.d329.s0.p3","sentence":"In contrast to the model of ps actin pe binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with ps actin pe in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p4","sentence":"In contrast to the model of actin binding proposed for ps fimbrin pe, the utrophin ps actin pe-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p5","sentence":"In contrast to the model of actin binding proposed for ps fimbrin pe, the ps utrophin pe actin-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p6","sentence":"In contrast to the model of ps actin pe binding proposed for ps fimbrin pe, the utrophin actin-binding domain appears to associate with actin in an extended conformation.","label":1}
{"pair_id":"BioInfer.d329.s0.p7","sentence":"In contrast to the model of actin binding proposed for fimbrin, the ps utrophin pe ps actin pe-binding domain appears to associate with actin in an extended conformation.","label":1}
{"pair_id":"BioInfer.d329.s0.p8","sentence":"In contrast to the model of ps actin pe binding proposed for fimbrin, the utrophin ps actin pe-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d329.s0.p9","sentence":"In contrast to the model of ps actin pe binding proposed for fimbrin, the ps utrophin pe actin-binding domain appears to associate with actin in an extended conformation.","label":0}
{"pair_id":"BioInfer.d151.s1.p0","sentence":"Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical ps actin pe patches where ps cofilin pe was also co-localized.","label":1}
{"pair_id":"BioInfer.d151.s1.p1","sentence":"Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that ps Aip1 pe was distributed in cortical ps actin pe patches where cofilin was also co-localized.","label":1}
{"pair_id":"BioInfer.d151.s1.p2","sentence":"Immunofluorescence staining of a wild-type strain using anti-ps Aip1 pe antibodies revealed that Aip1 was distributed in cortical ps actin pe patches where cofilin was also co-localized.","label":0}
{"pair_id":"BioInfer.d151.s1.p3","sentence":"Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that ps Aip1 pe was distributed in cortical actin patches where ps cofilin pe was also co-localized.","label":0}
{"pair_id":"BioInfer.d151.s1.p4","sentence":"Immunofluorescence staining of a wild-type strain using anti-ps Aip1 pe antibodies revealed that Aip1 was distributed in cortical actin patches where ps cofilin pe was also co-localized.","label":0}
{"pair_id":"BioInfer.d151.s1.p5","sentence":"Immunofluorescence staining of a wild-type strain using anti-ps Aip1 pe antibodies revealed that ps Aip1 pe was distributed in cortical actin patches where cofilin was also co-localized.","label":0}
{"pair_id":"AIMed.d214.s1861.p0","sentence":"Here we show that ps Vav pe and ps c-Cbl pe form inducible molecular complexes in TCR-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.","label":1}
{"pair_id":"AIMed.d214.s1861.p1","sentence":"Here we show that ps Vav pe and c-Cbl form inducible molecular complexes in ps TCR pe-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.","label":0}
{"pair_id":"AIMed.d214.s1861.p2","sentence":"Here we show that Vav and ps c-Cbl pe form inducible molecular complexes in ps TCR pe-activated murine thymocytes and peripheral T cells as well as pervanadate-treated T cells.","label":0}
{"pair_id":"AIMed.d25.s210.p0","sentence":"Their order of selection was ps alpha1AT pe effusion, ps C4 pe serum, TNFalpha-effusion, and C3 effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p1","sentence":"Their order of selection was ps alpha1AT pe effusion, C4 serum, ps TNFalpha pe-effusion, and C3 effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p2","sentence":"Their order of selection was ps alpha1AT pe effusion, C4 serum, TNFalpha-effusion, and ps C3 pe effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p3","sentence":"Their order of selection was alpha1AT effusion, ps C4 pe serum, ps TNFalpha pe-effusion, and C3 effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p4","sentence":"Their order of selection was alpha1AT effusion, ps C4 pe serum, TNFalpha-effusion, and ps C3 pe effusion.","label":0}
{"pair_id":"AIMed.d25.s210.p5","sentence":"Their order of selection was alpha1AT effusion, C4 serum, ps TNFalpha pe-effusion, and ps C3 pe effusion.","label":0}
{"pair_id":"BioInfer.d87.s1.p0","sentence":"However, the recombinant fusion protein containing wild-type ps beta-catenin pe precipitated ps alpha-catenin pe from these cells.","label":0}
{"pair_id":"AIMed.d114.s966.p0","sentence":"We demonstrate that the 53 amino acids encoded on exon 74 of ps dystrophin pe, an alternatively spliced exon, are necessary and sufficient for interaction with translated ps beta 1-syntrophin pe in our assay.","label":1}
{"pair_id":"BioInfer.d130.s0.p0","sentence":"ps CD26 pe is a T cell activation antigen known to bind ps adenosine deaminase pe and have dipeptidyl peptidase IV activity.","label":1}
{"pair_id":"BioInfer.d130.s0.p1","sentence":"ps CD26 pe is a T cell activation antigen known to bind adenosine deaminase and have ps dipeptidyl peptidase IV pe activity.","label":1}
{"pair_id":"BioInfer.d130.s0.p2","sentence":"CD26 is a T cell activation antigen known to bind ps adenosine deaminase pe and have ps dipeptidyl peptidase IV pe activity.","label":0}
{"pair_id":"BioInfer.d243.s0.p0","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p1","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p2","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p3","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p4","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p5","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p6","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p7","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p8","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p9","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p10","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p11","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p12","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p13","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p14","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, ps BUD8 pe and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p15","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p16","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p17","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p18","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p19","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p20","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p21","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p22","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p23","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p24","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p25","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p26","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p27","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p28","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, ps TEC1 pe, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p29","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p30","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p31","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p32","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p33","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p34","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p35","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p36","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p37","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p38","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p39","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p40","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p41","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, ps CDC39 pe, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p42","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p43","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p44","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p45","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p46","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p47","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p48","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p49","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p50","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p51","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p52","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p53","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, ps NAB1 pe, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p54","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p55","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p56","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p57","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p58","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p59","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p60","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p61","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p62","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p63","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p64","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, ps STE12 pe, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p65","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p66","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p67","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p68","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p69","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p70","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p71","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p72","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p73","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p74","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, ps CDC55 pe, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p75","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p76","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p77","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p78","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p79","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p80","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p81","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p82","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p83","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, ps WHI3 pe, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p84","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p85","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p86","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p87","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p88","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p89","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p90","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, ps TPM1 pe, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p91","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, ps TPM1 pe, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p92","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p93","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p94","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p95","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p96","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p97","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p98","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, ps DBR1 pe, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p99","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p100","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p101","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p102","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p103","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, ps BNI1 pe, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p104","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, ps BNI1 pe, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p105","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p106","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p107","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p108","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p109","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, ps DFG10 pe, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p110","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p111","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p112","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p113","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and ps DFG16 pe, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p114","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p115","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, DFG5, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p116","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, ps DFG5 pe, ps DFG9 pe, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p117","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, ps SPA2 pe, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p118","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, ps SPA2 pe, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d243.s0.p119","sentence":"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, ps SRV2 pe, TPM1, SPA2, BNI1, ps DFG5 pe, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.","label":0}
{"pair_id":"BioInfer.d588.s0.p0","sentence":"The C374S mutation had the most pronounced effect; it reduced the polymerizability of the ps actin pe, abolished its binding to ps profilin pe, and filaments containing this mutation moved at reduced rates in the in vitro 'motility assay'.","label":1}
{"pair_id":"BioInfer.d636.s0.p0","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: ps actin pe, villin, fimbrin and ps brush border myosin-I pe.","label":1}
{"pair_id":"BioInfer.d636.s0.p1","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: ps actin pe, ps villin pe, fimbrin and brush border myosin-I.","label":1}
{"pair_id":"BioInfer.d636.s0.p2","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: ps actin pe, villin, ps fimbrin pe and brush border myosin-I.","label":1}
{"pair_id":"BioInfer.d636.s0.p3","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, ps villin pe, fimbrin and ps brush border myosin-I pe.","label":1}
{"pair_id":"BioInfer.d636.s0.p4","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, ps fimbrin pe and ps brush border myosin-I pe.","label":1}
{"pair_id":"BioInfer.d636.s0.p5","sentence":"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, ps villin pe, ps fimbrin pe and brush border myosin-I.","label":1}
{"pair_id":"AIMed.d29.s246.p0","sentence":"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A\/F21D, H18A\/F21S, and H18D\/F21D, reduced up to 431-fold the binding affinity to ps CXCR1 pe, ps CXCR2 pe, and the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s246.p1","sentence":"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A\/F21D, H18A\/F21S, and H18D\/F21D, reduced up to 431-fold the binding affinity to ps CXCR1 pe, CXCR2, and the ps Duffy antigen pe.","label":0}
{"pair_id":"AIMed.d29.s246.p2","sentence":"Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A\/F21D, H18A\/F21S, and H18D\/F21D, reduced up to 431-fold the binding affinity to CXCR1, ps CXCR2 pe, and the ps Duffy antigen pe.","label":0}
{"pair_id":"BioInfer.d409.s0.p0","sentence":"Location of ps profilin pe at presynaptic sites in the cerebellar cortex; implication for the regulation of the ps actin pe-polymerization state during axonal elongation and synaptogenesis.","label":0}
{"pair_id":"AIMed.d39.s343.p0","sentence":"Collectively, the novel function of ps PS1 pe via ps QM pe\/Jif-1 influences c-jun-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p1","sentence":"Collectively, the novel function of ps PS1 pe via QM\/ps Jif-1 pe influences c-jun-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p2","sentence":"Collectively, the novel function of ps PS1 pe via QM\/Jif-1 influences ps c-jun pe-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p3","sentence":"Collectively, the novel function of PS1 via ps QM pe\/ps Jif-1 pe influences c-jun-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p4","sentence":"Collectively, the novel function of PS1 via ps QM pe\/Jif-1 influences ps c-jun pe-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d39.s343.p5","sentence":"Collectively, the novel function of PS1 via QM\/ps Jif-1 pe influences ps c-jun pe-mediated transcription and apoptosis.","label":0}
{"pair_id":"AIMed.d44.s385.p0","sentence":"Cluster Group B antibodies, including M67 and Ki-1, do not affect ps CD30L pe binding to ps CD30 pe.","label":1}
{"pair_id":"AIMed.d214.s1858.p0","sentence":"The molecular adapter ps c-Cbl pe is rapidly tyrosine phosphorylated following stimulation through the ps TCR pe and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p1","sentence":"The molecular adapter ps c-Cbl pe is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with ps Src pe homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p2","sentence":"The molecular adapter ps c-Cbl pe is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as ps Grb2 pe, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":1}
{"pair_id":"AIMed.d214.s1858.p3","sentence":"The molecular adapter ps c-Cbl pe is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, ps Crk pe, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":1}
{"pair_id":"AIMed.d214.s1858.p4","sentence":"The molecular adapter ps c-Cbl pe is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and ps Crk-L pe, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":1}
{"pair_id":"AIMed.d214.s1858.p5","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the ps TCR pe and associates with ps Src pe homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p6","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the ps TCR pe and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as ps Grb2 pe, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p7","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the ps TCR pe and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, ps Crk pe, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p8","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the ps TCR pe and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and ps Crk-L pe, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p9","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with ps Src pe homology domain-2 (SH2)\/SH3 domain-containing adapters such as ps Grb2 pe, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p10","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with ps Src pe homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, ps Crk pe, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p11","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with ps Src pe homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, Crk, and ps Crk-L pe, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p12","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as ps Grb2 pe, ps Crk pe, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p13","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as ps Grb2 pe, Crk, and ps Crk-L pe, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d214.s1858.p14","sentence":"The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)\/SH3 domain-containing adapters such as Grb2, ps Crk pe, and ps Crk-L pe, which interact with guanine nucleotide exchange factors specific for the Ras family.","label":0}
{"pair_id":"AIMed.d161.s1359.p0","sentence":"We demonstrate that ps Grb7 pe binds to ps SHPTP2 pe in vitro under conditions where the latter is tyrosine-phosphorylated.","label":1}
{"pair_id":"BioInfer.d107.s0.p0","sentence":"Neuropilin-1 mediates ps collapsin-1 pe\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and ps vascular endothelial growth factor-165 pe.","label":0}
{"pair_id":"BioInfer.d107.s0.p1","sentence":"Neuropilin-1 mediates ps collapsin-1 pe\/ps semaphorin III pe inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d107.s0.p2","sentence":"ps Neuropilin-1 pe mediates ps collapsin-1 pe\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.","label":1}
{"pair_id":"BioInfer.d107.s0.p3","sentence":"Neuropilin-1 mediates ps collapsin-1 pe\/semaphorin III inhibition of endothelial cell motility: functional competition of ps collapsin-1 pe and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d107.s0.p4","sentence":"Neuropilin-1 mediates collapsin-1\/ps semaphorin III pe inhibition of endothelial cell motility: functional competition of collapsin-1 and ps vascular endothelial growth factor-165 pe.","label":0}
{"pair_id":"BioInfer.d107.s0.p5","sentence":"ps Neuropilin-1 pe mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and ps vascular endothelial growth factor-165 pe.","label":0}
{"pair_id":"BioInfer.d107.s0.p6","sentence":"Neuropilin-1 mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of ps collapsin-1 pe and ps vascular endothelial growth factor-165 pe.","label":1}
{"pair_id":"BioInfer.d107.s0.p7","sentence":"ps Neuropilin-1 pe mediates collapsin-1\/ps semaphorin III pe inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.","label":1}
{"pair_id":"BioInfer.d107.s0.p8","sentence":"Neuropilin-1 mediates collapsin-1\/ps semaphorin III pe inhibition of endothelial cell motility: functional competition of ps collapsin-1 pe and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d107.s0.p9","sentence":"ps Neuropilin-1 pe mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of ps collapsin-1 pe and vascular endothelial growth factor-165.","label":0}
{"pair_id":"BioInfer.d388.s0.p0","sentence":"In vivo importance of ps actin pe nucleotide exchange catalyzed by ps profilin pe.","label":1}
{"pair_id":"AIMed.d162.s1370.p0","sentence":"In contrast, mutant ps p53 pe either had no effect or activated the transcriptional activity of ps h-TR beta 1 pe depending on the type of hormone response elements.","label":0}
{"pair_id":"BioInfer.d763.s0.p0","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and ps CD44 pe, with additional reverse transcription-ps polymerase pe chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p1","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, ps alpha-catenin pe, beta-catenin, and ps CD44 pe, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p2","sentence":"To clarify the relation between alteration of expression of ps cell adhesion molecules pe and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and ps CD44 pe, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p3","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for ps E-cadherin pe, alpha-catenin, beta-catenin, and ps CD44 pe, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p4","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, ps beta-catenin pe, and ps CD44 pe, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p5","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, ps alpha-catenin pe, beta-catenin, and CD44, with additional reverse transcription-ps polymerase pe chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p6","sentence":"To clarify the relation between alteration of expression of ps cell adhesion molecules pe and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-ps polymerase pe chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p7","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for ps E-cadherin pe, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-ps polymerase pe chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p8","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, ps beta-catenin pe, and CD44, with additional reverse transcription-ps polymerase pe chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p9","sentence":"To clarify the relation between alteration of expression of ps cell adhesion molecules pe and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, ps alpha-catenin pe, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p10","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for ps E-cadherin pe, ps alpha-catenin pe, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p11","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, ps alpha-catenin pe, ps beta-catenin pe, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p12","sentence":"To clarify the relation between alteration of expression of ps cell adhesion molecules pe and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for ps E-cadherin pe, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p13","sentence":"To clarify the relation between alteration of expression of ps cell adhesion molecules pe and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, ps beta-catenin pe, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"BioInfer.d763.s0.p14","sentence":"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for ps E-cadherin pe, alpha-catenin, ps beta-catenin pe, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR\/SBH) assays.","label":0}
{"pair_id":"AIMed.d158.s1333.p0","sentence":"The death domain of ps tumor necrosis factor (TNF) receptor-1 pe (ps TNFR1 pe) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD.","label":0}
{"pair_id":"AIMed.d158.s1333.p1","sentence":"The death domain of ps tumor necrosis factor (TNF) receptor-1 pe (TNFR1) triggers distinct signaling pathways leading to apoptosis and ps NF-kappa B pe activation through its interaction with the death domain protein TRADD.","label":0}
{"pair_id":"AIMed.d158.s1333.p2","sentence":"The death domain of ps tumor necrosis factor (TNF) receptor-1 pe (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein ps TRADD pe.","label":1}
{"pair_id":"AIMed.d158.s1333.p3","sentence":"The death domain of tumor necrosis factor (TNF) receptor-1 (ps TNFR1 pe) triggers distinct signaling pathways leading to apoptosis and ps NF-kappa B pe activation through its interaction with the death domain protein TRADD.","label":0}
{"pair_id":"AIMed.d158.s1333.p4","sentence":"The death domain of tumor necrosis factor (TNF) receptor-1 (ps TNFR1 pe) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein ps TRADD pe.","label":1}
{"pair_id":"AIMed.d158.s1333.p5","sentence":"The death domain of tumor necrosis factor (TNF) receptor-1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and ps NF-kappa B pe activation through its interaction with the death domain protein ps TRADD pe.","label":0}
{"pair_id":"AIMed.d137.s1156.p0","sentence":"We had previously shown that the ubiquitous ps Oct1 pe and the lymphoid-specific ps Oct2 pe transcription factors stimulate transcription at the level of stable preinitiation complex formation.","label":0}
{"pair_id":"AIMed.d104.s878.p0","sentence":"This transcriptional activity is inhibited by association with the ps retinoblastoma tumor suppressor protein pe (ps pRB pe) or its relatives p107 and p103.","label":0}
{"pair_id":"AIMed.d104.s878.p1","sentence":"This transcriptional activity is inhibited by association with the ps retinoblastoma tumor suppressor protein pe (pRB) or its relatives ps p107 pe and p103.","label":0}
{"pair_id":"AIMed.d104.s878.p2","sentence":"This transcriptional activity is inhibited by association with the ps retinoblastoma tumor suppressor protein pe (pRB) or its relatives p107 and ps p103 pe.","label":0}
{"pair_id":"AIMed.d104.s878.p3","sentence":"This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (ps pRB pe) or its relatives ps p107 pe and p103.","label":0}
{"pair_id":"AIMed.d104.s878.p4","sentence":"This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (ps pRB pe) or its relatives p107 and ps p103 pe.","label":0}
{"pair_id":"AIMed.d104.s878.p5","sentence":"This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein (pRB) or its relatives ps p107 pe and ps p103 pe.","label":0}
{"pair_id":"AIMed.d49.s434.p0","sentence":"The sequences that confer on ps FGF-7 pe its specific binding to ps KGFR pe have not been identified.","label":1}
{"pair_id":"AIMed.d12.s105.p0","sentence":"In TEN we also found significantly higher levels of ps sIL-2R pe in the blister fluid compared with serum samples, pointing to a predominantly local production contrasting with the low concentration of ps sIL-2R pe in the blister fluid of burned patients.","label":0}
{"pair_id":"BioInfer.d791.s0.p0","sentence":"Vascular endothelial cadherin (ps VE-cadherin pe) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional ps actin pe.","label":0}
{"pair_id":"BioInfer.d791.s0.p1","sentence":"ps Vascular endothelial cadherin pe (ps VE-cadherin pe) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.","label":0}
{"pair_id":"BioInfer.d791.s0.p2","sentence":"Vascular endothelial cadherin (ps VE-cadherin pe) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with ps alpha-catenin pe, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p3","sentence":"Vascular endothelial cadherin (ps VE-cadherin pe) clusters were co-localized with ps beta-catenin pe, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p4","sentence":"ps Vascular endothelial cadherin pe (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional ps actin pe.","label":0}
{"pair_id":"BioInfer.d791.s0.p5","sentence":"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with ps alpha-catenin pe, which is thought to link the complex to the peri-junctional ps actin pe.","label":1}
{"pair_id":"BioInfer.d791.s0.p6","sentence":"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with ps beta-catenin pe, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional ps actin pe.","label":0}
{"pair_id":"BioInfer.d791.s0.p7","sentence":"ps Vascular endothelial cadherin pe (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with ps alpha-catenin pe, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p8","sentence":"ps Vascular endothelial cadherin pe (VE-cadherin) clusters were co-localized with ps beta-catenin pe, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.","label":1}
{"pair_id":"BioInfer.d791.s0.p9","sentence":"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with ps beta-catenin pe, an important signal transduction ligand, and with ps alpha-catenin pe, which is thought to link the complex to the peri-junctional actin.","label":0}
{"pair_id":"BioInfer.d360.s0.p0","sentence":"Interaction of ps Munc-18-2 pe with ps syntaxin 3 pe controls the association of apical SNAREs in epithelial cells.","label":1}
{"pair_id":"BioInfer.d360.s0.p1","sentence":"Interaction of ps Munc-18-2 pe with syntaxin 3 controls the association of apical ps SNAREs pe in epithelial cells.","label":1}
{"pair_id":"BioInfer.d360.s0.p2","sentence":"Interaction of Munc-18-2 with ps syntaxin 3 pe controls the association of apical ps SNAREs pe in epithelial cells.","label":1}
{"pair_id":"BioInfer.d48.s1.p0","sentence":"The viscoelasticity of entangled ps actin pe networks: the influence of defects and modulation by ps talin pe and vinculin.","label":1}
{"pair_id":"BioInfer.d48.s1.p1","sentence":"The viscoelasticity of entangled ps actin pe networks: the influence of defects and modulation by talin and ps vinculin pe.","label":1}
{"pair_id":"BioInfer.d48.s1.p2","sentence":"The viscoelasticity of entangled actin networks: the influence of defects and modulation by ps talin pe and ps vinculin pe.","label":0}
{"pair_id":"BioInfer.d391.s0.p0","sentence":"Isolation of ps profilin pe from embryonic chicken skeletal muscle and evaluation of its interaction with different ps actin pe isoforms.","label":1}
{"pair_id":"AIMed.d69.s590.p0","sentence":"Phosphorylation of recombinant human ps c-Jun pe proteins in vitro by ps GSK-3 pe decreases their DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d151.s0.p0","sentence":"CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by ps cofilin pe and ps Aip1 pe.","label":1}
{"pair_id":"BioInfer.d151.s0.p1","sentence":"CONCLUSIONS: These results suggest the cooperative modulation of the ps actin pe cytoskeleton by cofilin and ps Aip1 pe.","label":1}
{"pair_id":"BioInfer.d151.s0.p2","sentence":"CONCLUSIONS: These results suggest the cooperative modulation of the ps actin pe cytoskeleton by ps cofilin pe and Aip1.","label":1}
{"pair_id":"BioInfer.d300.s0.p0","sentence":"Immunoprecipitation with an ps E-cadherin pe mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and ps beta-alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p1","sentence":"Immunoprecipitation with an ps E-cadherin pe mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate ps alpha-catenin pe, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"BioInfer.d300.s0.p2","sentence":"Immunoprecipitation with an ps E-cadherin pe mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both ps alpha- pe and beta-ps alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p3","sentence":"Immunoprecipitation with an ps E-cadherin pe mAb, which is known to co-precipitate the ps catenins pe, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":1}
{"pair_id":"BioInfer.d300.s0.p4","sentence":"Immunoprecipitation with an ps E-cadherin pe mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing ps E-cadherin pe did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"BioInfer.d300.s0.p5","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate ps alpha-catenin pe, although all of the moderately-well differentiated cell lines expressed both alpha- and ps beta-alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p6","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both ps alpha- pe and ps beta-alpha-  peps alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p7","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the ps catenins pe, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and ps beta-alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p8","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing ps E-cadherin pe did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and ps beta-alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p9","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate ps alpha-catenin pe, although all of the moderately-well differentiated cell lines expressed both ps alpha- pe and beta-ps alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p10","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the ps catenins pe, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate ps alpha-catenin pe, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"BioInfer.d300.s0.p11","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing ps E-cadherin pe did not co-precipitate ps alpha-catenin pe, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":1}
{"pair_id":"BioInfer.d300.s0.p12","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the ps catenins pe, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both ps alpha- pe and beta-ps alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p13","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing ps E-cadherin pe did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both ps alpha- pe and beta-ps alpha-  pe.","label":0}
{"pair_id":"BioInfer.d300.s0.p14","sentence":"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the ps catenins pe, demonstrated that the three poorly differentiated cell lines expressing ps E-cadherin pe did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-alpha- .","label":0}
{"pair_id":"AIMed.d98.s832.p0","sentence":"ps Raf-1 pe, which is known to bind 14-3-3 proteins, has recently been shown to associate with ps cdc25A pe and to stimulate its phosphatase activity.","label":1}
{"pair_id":"AIMed.d59.s518.p0","sentence":"Analysis of the oligomerization of ps myogenin pe and ps E2A pe products in vivo using a two-hybrid assay system.","label":0}
{"pair_id":"BioInfer.d741.s0.p0","sentence":"This is the first report describing the coexistence of profilin with ps actin pe filaments in the division furrow, implying the possible involvement of ps profilin pe in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.","label":0}
{"pair_id":"BioInfer.d741.s0.p1","sentence":"This is the first report describing the coexistence of ps profilin pe with ps actin pe filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.","label":1}
{"pair_id":"BioInfer.d741.s0.p2","sentence":"This is the first report describing the coexistence of ps profilin pe with actin filaments in the division furrow, implying the possible involvement of ps profilin pe in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.","label":0}
{"pair_id":"AIMed.d173.s1456.p0","sentence":"The kinetics of amyloid fibril formation by ps beta-amyloid peptide pe (ps Abeta pe) are typical of a nucleation-dependent polymerization mechanism.","label":0}
{"pair_id":"BioInfer.d61.s2.p0","sentence":"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with ps beta-catenin pe and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d61.s2.p1","sentence":"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in ps alpha-catenin pe required for molecular interaction with ps beta-catenin pe and plakoglobin.","label":1}
{"pair_id":"BioInfer.d61.s2.p2","sentence":"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in ps alpha-catenin pe required for molecular interaction with beta-catenin and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d280.s0.p0","sentence":"However, when all of the four proteins (ps E-cadherin pe, alpha-catenin, ps beta-catenin pe, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p1","sentence":"However, when all of the four proteins (E-cadherin, alpha-catenin, ps beta-catenin pe, and ps gamma-catenin pe) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p2","sentence":"However, when all of the four proteins (E-cadherin, ps alpha-catenin pe, ps beta-catenin pe, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p3","sentence":"However, when all of the four proteins (ps E-cadherin pe, alpha-catenin, beta-catenin, and ps gamma-catenin pe) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p4","sentence":"However, when all of the four proteins (ps E-cadherin pe, ps alpha-catenin pe, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"BioInfer.d280.s0.p5","sentence":"However, when all of the four proteins (E-cadherin, ps alpha-catenin pe, beta-catenin, and ps gamma-catenin pe) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.","label":0}
{"pair_id":"AIMed.d121.s1033.p0","sentence":"These very same hydrophobic residues contact the ps hdm-2 pe and Ad5 ps E1B pe 55-kD oncogene products.","label":0}
{"pair_id":"AIMed.d127.s1090.p0","sentence":"Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal ps Jak3 pe activation, suggesting that mutations of ps Jak3 pe may result in an XSCID-like phenotype.","label":0}
{"pair_id":"AIMed.d185.s1573.p0","sentence":"ps IL-10 pe also activated ps Stat5 pe in Ba\/F3 cells that stably expressed the murine IL-10 receptor.","label":1}
{"pair_id":"AIMed.d185.s1573.p1","sentence":"ps IL-10 pe also activated Stat5 in Ba\/F3 cells that stably expressed the murine ps IL-10 pe receptor.","label":0}
{"pair_id":"AIMed.d185.s1573.p2","sentence":"ps IL-10 pe also activated Stat5 in Ba\/F3 cells that stably expressed the murine ps IL-10 receptor pe.","label":0}
{"pair_id":"AIMed.d185.s1573.p3","sentence":"IL-10 also activated ps Stat5 pe in Ba\/F3 cells that stably expressed the murine ps IL-10 pe receptor.","label":0}
{"pair_id":"AIMed.d185.s1573.p4","sentence":"IL-10 also activated ps Stat5 pe in Ba\/F3 cells that stably expressed the murine ps IL-10 receptor pe.","label":0}
{"pair_id":"AIMed.d185.s1573.p5","sentence":"IL-10 also activated Stat5 in Ba\/F3 cells that stably expressed the murine ps IL-10 peps IL-10 receptor pe.","label":0}
{"pair_id":"AIMed.d192.s1638.p0","sentence":"Lipopolysaccharide-activated ps ICE pe-deficient (ICE-\/-) Kupffer cells synthesized the ps IGIF pe precursor but failed to process it into the active form.","label":0}
{"pair_id":"AIMed.d137.s1158.p0","sentence":"By using several different experimental systems we show that ps TBP pe efficiently associates with ps Oct1 pe and Oct2.","label":1}
{"pair_id":"AIMed.d137.s1158.p1","sentence":"By using several different experimental systems we show that ps TBP pe efficiently associates with Oct1 and ps Oct2 pe.","label":1}
{"pair_id":"AIMed.d137.s1158.p2","sentence":"By using several different experimental systems we show that TBP efficiently associates with ps Oct1 pe and ps Oct2 pe.","label":0}
{"pair_id":"AIMed.d35.s294.p0","sentence":"Although numerous studies revealed predominant localization of ps PS1 pe to endoplasmic reticulum and Golgi, there are conflicting reports on the localization of ps PS1 pe to the cell surface.","label":0}
{"pair_id":"AIMed.d206.s1782.p0","sentence":"ps CD9 pe was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of ps CD44 pe and syndecan, but not of cadherins.","label":0}
{"pair_id":"AIMed.d206.s1782.p1","sentence":"ps CD9 pe was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of CD44 and ps syndecan pe, but not of cadherins.","label":0}
{"pair_id":"AIMed.d206.s1782.p2","sentence":"CD9 was detected in beta 1 integrin immunoprecipitates and also in immunoprecipitates of ps CD44 pe and ps syndecan pe, but not of cadherins.","label":0}
{"pair_id":"AIMed.d192.s1635.p0","sentence":"Activation of ps interferon-gamma peps interferon-gamma inducing factor pe mediated by interleukin-1beta converting enzyme.","label":0}
{"pair_id":"AIMed.d192.s1635.p1","sentence":"Activation of ps interferon-gamma pe inducing factor mediated by ps interleukin-1beta pe converting enzyme.","label":0}
{"pair_id":"AIMed.d192.s1635.p2","sentence":"Activation of ps interferon-gamma pe inducing factor mediated by ps interleukin-1beta converting enzyme pe.","label":0}
{"pair_id":"AIMed.d192.s1635.p3","sentence":"Activation of ps interferon-gamma inducing factor pe mediated by ps interleukin-1beta pe converting enzyme.","label":0}
{"pair_id":"AIMed.d192.s1635.p4","sentence":"Activation of ps interferon-gamma inducing factor pe mediated by ps interleukin-1beta converting enzyme pe.","label":1}
{"pair_id":"AIMed.d192.s1635.p5","sentence":"Activation of interferon-gamma inducing factor mediated by ps interleukin-1beta peps interleukin-1beta converting enzyme pe.","label":0}
{"pair_id":"BioInfer.d207.s0.p0","sentence":"Features studied were ps actin pe, microtubules, vinculin, and ps talin pe, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.","label":0}
{"pair_id":"BioInfer.d207.s0.p1","sentence":"Features studied were actin, microtubules, ps vinculin pe, and ps talin pe, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.","label":0}
{"pair_id":"BioInfer.d207.s0.p2","sentence":"Features studied were ps actin pe, microtubules, ps vinculin pe, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.","label":0}
{"pair_id":"BioInfer.d168.s0.p0","sentence":"Demembranated stereociliary cores consisted primarily of protein bands corresponding to ps actin pe and ps fimbrin pe and several proteins ranging from 43 to 63 kDa.","label":1}
{"pair_id":"BioInfer.d685.s0.p0","sentence":"The resulting ps beta-catenin pe product is unable to bind ps alpha-catenin pe that is responsible for actin filament binding and organization.","label":1}
{"pair_id":"BioInfer.d685.s0.p1","sentence":"The resulting ps beta-catenin pe product is unable to bind alpha-catenin that is responsible for ps actin pe filament binding and organization.","label":0}
{"pair_id":"BioInfer.d685.s0.p2","sentence":"The resulting beta-catenin product is unable to bind ps alpha-catenin pe that is responsible for ps actin pe filament binding and organization.","label":1}
{"pair_id":"BioInfer.d821.s0.p0","sentence":"We show that the HSV-1 UL5, UL8, ps UL29 pe, ps UL30 pe, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p1","sentence":"We show that the HSV-1 UL5, ps UL8 pe, UL29, ps UL30 pe, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p2","sentence":"We show that the HSV-1 ps UL5 pe, UL8, UL29, ps UL30 pe, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p3","sentence":"We show that the HSV-1 UL5, UL8, UL29, ps UL30 pe, UL42, and UL52 gene products along with the AAV ps Rep68 pe protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p4","sentence":"We show that the HSV-1 UL5, UL8, UL29, ps UL30 pe, UL42, and ps UL52 pe gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p5","sentence":"We show that the HSV-1 UL5, UL8, UL29, ps UL30 pe, ps UL42 pe, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p6","sentence":"We show that the HSV-1 UL5, ps UL8 pe, ps UL29 pe, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p7","sentence":"We show that the HSV-1 ps UL5 pe, UL8, ps UL29 pe, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p8","sentence":"We show that the HSV-1 UL5, UL8, ps UL29 pe, UL30, UL42, and UL52 gene products along with the AAV ps Rep68 pe protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p9","sentence":"We show that the HSV-1 UL5, UL8, ps UL29 pe, UL30, UL42, and ps UL52 pe gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p10","sentence":"We show that the HSV-1 UL5, UL8, ps UL29 pe, UL30, ps UL42 pe, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p11","sentence":"We show that the HSV-1 ps UL5 pe, ps UL8 pe, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p12","sentence":"We show that the HSV-1 UL5, ps UL8 pe, UL29, UL30, UL42, and UL52 gene products along with the AAV ps Rep68 pe protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p13","sentence":"We show that the HSV-1 UL5, ps UL8 pe, UL29, UL30, UL42, and ps UL52 pe gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p14","sentence":"We show that the HSV-1 UL5, ps UL8 pe, UL29, UL30, ps UL42 pe, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p15","sentence":"We show that the HSV-1 ps UL5 pe, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV ps Rep68 pe protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p16","sentence":"We show that the HSV-1 ps UL5 pe, UL8, UL29, UL30, UL42, and ps UL52 pe gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p17","sentence":"We show that the HSV-1 ps UL5 pe, UL8, UL29, UL30, ps UL42 pe, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p18","sentence":"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and ps UL52 pe gene products along with the AAV ps Rep68 pe protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p19","sentence":"We show that the HSV-1 UL5, UL8, UL29, UL30, ps UL42 pe, and UL52 gene products along with the AAV ps Rep68 pe protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"BioInfer.d821.s0.p20","sentence":"We show that the HSV-1 UL5, UL8, UL29, UL30, ps UL42 pe, and ps UL52 pe gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.","label":0}
{"pair_id":"AIMed.d137.s1162.p0","sentence":"The ps Oct1 pe POU domain, which is highly homologous to the ps Oct2 pe POU domain, likewise mediates interaction with TBP.","label":0}
{"pair_id":"AIMed.d137.s1162.p1","sentence":"The ps Oct1 pe POU domain, which is highly homologous to the Oct2 POU domain, likewise mediates interaction with ps TBP pe.","label":1}
{"pair_id":"AIMed.d137.s1162.p2","sentence":"The Oct1 POU domain, which is highly homologous to the ps Oct2 pe POU domain, likewise mediates interaction with ps TBP pe.","label":0}
{"pair_id":"BioInfer.d247.s2.p0","sentence":"These findings provide the first evidence that ps profilin pe is a key molecule linking a signaling network to rapid ps actin pe polymerization in microspike formation.","label":1}
{"pair_id":"AIMed.d110.s927.p0","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (ps TAFII230 pe) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p1","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (TAFII230) of human ps TFIID pe through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p2","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including ps Sp1 pe, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p3","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, ps YY1 pe, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p4","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, ps USF pe, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p5","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, ps CTF pe, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p6","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":1}
{"pair_id":"AIMed.d110.s927.p7","sentence":"ps TAFII55 pe is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p8","sentence":"TAFII55 is shown to interact with the largest subunit (ps TAFII230 pe) of human ps TFIID pe through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p9","sentence":"TAFII55 is shown to interact with the largest subunit (ps TAFII230 pe) of human TFIID through its central region and with multiple activators--including ps Sp1 pe, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p10","sentence":"TAFII55 is shown to interact with the largest subunit (ps TAFII230 pe) of human TFIID through its central region and with multiple activators--including Sp1, ps YY1 pe, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p11","sentence":"TAFII55 is shown to interact with the largest subunit (ps TAFII230 pe) of human TFIID through its central region and with multiple activators--including Sp1, YY1, ps USF pe, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p12","sentence":"TAFII55 is shown to interact with the largest subunit (ps TAFII230 pe) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, ps CTF pe, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p13","sentence":"TAFII55 is shown to interact with the largest subunit (ps TAFII230 pe) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p14","sentence":"TAFII55 is shown to interact with the largest subunit (ps TAFII230 pe) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p15","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human ps TFIID pe through its central region and with multiple activators--including ps Sp1 pe, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p16","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human ps TFIID pe through its central region and with multiple activators--including Sp1, ps YY1 pe, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p17","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human ps TFIID pe through its central region and with multiple activators--including Sp1, YY1, ps USF pe, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p18","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human ps TFIID pe through its central region and with multiple activators--including Sp1, YY1, USF, ps CTF pe, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p19","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human ps TFIID pe through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p20","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human ps TFIID pe through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p21","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including ps Sp1 pe, ps YY1 pe, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p22","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including ps Sp1 pe, YY1, ps USF pe, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p23","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including ps Sp1 pe, YY1, USF, ps CTF pe, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p24","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including ps Sp1 pe, YY1, USF, CTF, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p25","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including ps Sp1 pe, YY1, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p26","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, ps YY1 pe, ps USF pe, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p27","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, ps YY1 pe, USF, ps CTF pe, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p28","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, ps YY1 pe, USF, CTF, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p29","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, ps YY1 pe, USF, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p30","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, ps USF pe, ps CTF pe, adenoviral E1A, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p31","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, ps USF pe, CTF, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p32","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, ps USF pe, CTF, adenoviral E1A, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p33","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, ps CTF pe, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 Tat proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p34","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, ps CTF pe, adenoviral E1A, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"AIMed.d110.s927.p35","sentence":"TAFII55 is shown to interact with the largest subunit (TAFII230) of human TFIID through its central region and with multiple activators--including Sp1, YY1, USF, CTF, adenoviral ps E1A pe, and human immunodeficiency virus-type 1 ps Tat pe proteins--through a distinct amino-terminal domain.","label":0}
{"pair_id":"BioInfer.d208.s1.p0","sentence":"Thus, both DR5 and ps DR4 pe use FADD, TRADD, and ps RIP pe in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p1","sentence":"Thus, both DR5 and ps DR4 pe use FADD, ps TRADD pe, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p2","sentence":"Thus, both ps DR5 pe and ps DR4 pe use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p3","sentence":"Thus, both DR5 and ps DR4 pe use ps FADD pe, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p4","sentence":"Thus, both DR5 and ps DR4 pe use FADD, TRADD, and RIP in their signal transduction pathways, and ps FADD pe is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p5","sentence":"Thus, both DR5 and DR4 use FADD, ps TRADD pe, and ps RIP pe in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p6","sentence":"Thus, both ps DR5 pe and DR4 use FADD, TRADD, and ps RIP pe in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p7","sentence":"Thus, both DR5 and DR4 use ps FADD pe, TRADD, and ps RIP pe in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p8","sentence":"Thus, both DR5 and DR4 use FADD, TRADD, and ps RIP pe in their signal transduction pathways, and ps FADD pe is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p9","sentence":"Thus, both ps DR5 pe and DR4 use FADD, ps TRADD pe, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p10","sentence":"Thus, both DR5 and DR4 use ps FADD pe, ps TRADD pe, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p11","sentence":"Thus, both DR5 and DR4 use FADD, ps TRADD pe, and RIP in their signal transduction pathways, and ps FADD pe is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p12","sentence":"Thus, both ps DR5 pe and DR4 use ps FADD pe, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.","label":1}
{"pair_id":"BioInfer.d208.s1.p13","sentence":"Thus, both ps DR5 pe and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and ps FADD pe is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"BioInfer.d208.s1.p14","sentence":"Thus, both DR5 and DR4 use ps FADD pe, TRADD, and RIP in their signal transduction pathways, and ps FADD pe is the common mediator of apoptosis by all known death domain-containing receptors.","label":0}
{"pair_id":"AIMed.d163.s1372.p0","sentence":"Enhanced degradation of ps EGF pe receptors by a sorting ps nexin pe, SNX1.","label":0}
{"pair_id":"AIMed.d163.s1372.p1","sentence":"Enhanced degradation of ps EGF pe receptors by a sorting nexin, ps SNX1 pe.","label":0}
{"pair_id":"AIMed.d163.s1372.p2","sentence":"Enhanced degradation of EGF receptors by a sorting ps nexin pe, ps SNX1 pe.","label":0}
{"pair_id":"AIMed.d142.s1202.p0","sentence":"In addition, we identified domains within ps YY1 pe and ps Sp1 pe that mediate their interactions with each other.","label":1}
{"pair_id":"BioInfer.d237.s0.p0","sentence":"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with ps RAD51 pe and ps RAD52 pe recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p1","sentence":"Here, specific interactions between human RAD51 and ps RAD52 pe proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and ps RAD52 pe recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p2","sentence":"Here, specific interactions between human ps RAD51 pe and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and ps RAD52 pe recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p3","sentence":"Here, specific interactions between human RAD51 and ps RAD52 pe proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with ps RAD51 pe and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p4","sentence":"Here, specific interactions between human ps RAD51 pe and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with ps RAD51 pe and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":0}
{"pair_id":"BioInfer.d237.s0.p5","sentence":"Here, specific interactions between human ps RAD51 pe and ps RAD52 pe proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.","label":1}
{"pair_id":"BioInfer.d122.s0.p0","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (ps eIF3-p33 pe) which is part of the ps eIF3 pe complex and has an RNA binding domain.","label":1}
{"pair_id":"BioInfer.d122.s0.p1","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized ps eIF3 pe subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the ps eIF3 pe complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p2","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: ps PRT1 pe, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the ps eIF3 pe complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p3","sentence":"By two-hybrid screening we have identified two partners that directly associate with ps TIF34 pe: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the ps eIF3 pe complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p4","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized ps eIF3 pe subunit, and a novel protein of 33 kDa (ps eIF3-p33 pe) which is part of the eIF3 complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p5","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: ps PRT1 pe, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (ps eIF3-p33 pe) which is part of the eIF3 complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p6","sentence":"By two-hybrid screening we have identified two partners that directly associate with ps TIF34 pe: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (ps eIF3-p33 pe) which is part of the eIF3 complex and has an RNA binding domain.","label":1}
{"pair_id":"BioInfer.d122.s0.p7","sentence":"By two-hybrid screening we have identified two partners that directly associate with TIF34: ps PRT1 pe, a previously characterized ps eIF3 pe subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.","label":1}
{"pair_id":"BioInfer.d122.s0.p8","sentence":"By two-hybrid screening we have identified two partners that directly associate with ps TIF34 pe: PRT1, a previously characterized ps eIF3 pe subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.","label":0}
{"pair_id":"BioInfer.d122.s0.p9","sentence":"By two-hybrid screening we have identified two partners that directly associate with ps TIF34 pe: ps PRT1 pe, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.","label":1}
{"pair_id":"AIMed.d90.s770.p0","sentence":"We found that deletion of the carboxyl-terminal 28 amino acids of ps PU.1 pe disrupted ps PU.1 pe-NF-IL6 beta physical interaction.","label":0}
{"pair_id":"AIMed.d90.s770.p1","sentence":"We found that deletion of the carboxyl-terminal 28 amino acids of ps PU.1 pe disrupted PU.1-ps NF-IL6 beta pe physical interaction.","label":0}
{"pair_id":"AIMed.d90.s770.p2","sentence":"We found that deletion of the carboxyl-terminal 28 amino acids of PU.1 disrupted ps PU.1 pe-ps NF-IL6 beta pe physical interaction.","label":1}
{"pair_id":"BioInfer.d622.s0.p0","sentence":"The herpes simplex virus type-1 ps UL5 pe, ps UL8 pe, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":0}
{"pair_id":"BioInfer.d622.s0.p1","sentence":"The herpes simplex virus type-1 UL5, ps UL8 pe, and ps UL52 pe genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":0}
{"pair_id":"BioInfer.d622.s0.p2","sentence":"The herpes simplex virus type-1 UL5, ps UL8 pe, and UL52 genes encode an essential heterotrimeric ps DNA helicase-primase pe that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":1}
{"pair_id":"BioInfer.d622.s0.p3","sentence":"The herpes simplex virus type-1 ps UL5 pe, UL8, and ps UL52 pe genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":0}
{"pair_id":"BioInfer.d622.s0.p4","sentence":"The herpes simplex virus type-1 ps UL5 pe, UL8, and UL52 genes encode an essential heterotrimeric ps DNA helicase-primase pe that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":1}
{"pair_id":"BioInfer.d622.s0.p5","sentence":"The herpes simplex virus type-1 UL5, UL8, and ps UL52 pe genes encode an essential heterotrimeric ps DNA helicase-primase pe that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.","label":1}
{"pair_id":"AIMed.d37.s318.p0","sentence":"Chemokines that could compete with high affinity for ps MIP-1beta pe binding could also compete for monomeric ps gp120 pe binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p1","sentence":"Chemokines that could compete with high affinity for ps MIP-1beta pe binding could also compete for monomeric gp120 binding, although with variable potencies; maximal ps gp120 pe binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p2","sentence":"Chemokines that could compete with high affinity for ps MIP-1beta pe binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for ps MCP-2 pe, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p3","sentence":"Chemokines that could compete with high affinity for ps MIP-1beta pe binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for ps MIP-1beta pe.","label":0}
{"pair_id":"AIMed.d37.s318.p4","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric ps gp120 pe binding, although with variable potencies; maximal ps gp120 pe binding inhibition was 80% for MCP-2, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p5","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric ps gp120 pe binding, although with variable potencies; maximal gp120 binding inhibition was 80% for ps MCP-2 pe, but only 30% for MIP-1beta.","label":0}
{"pair_id":"AIMed.d37.s318.p6","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric ps gp120 pe binding, although with variable potencies; maximal gp120 binding inhibition was 80% for MCP-2, but only 30% for ps MIP-1beta pe.","label":0}
{"pair_id":"AIMed.d37.s318.p7","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal ps gp120 pe binding inhibition was 80% for ps MCP-2 pe, but only 30% for MIP-1beta.","label":1}
{"pair_id":"AIMed.d37.s318.p8","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal ps gp120 pe binding inhibition was 80% for MCP-2, but only 30% for ps MIP-1beta pe.","label":1}
{"pair_id":"AIMed.d37.s318.p9","sentence":"Chemokines that could compete with high affinity for MIP-1beta binding could also compete for monomeric gp120 binding, although with variable potencies; maximal gp120 binding inhibition was 80% for ps MCP-2 pe, but only 30% for ps MIP-1beta pe.","label":0}
{"pair_id":"BioInfer.d258.s1.p0","sentence":"The interactions of the UL52 protein with the ps UL8 pe and ps UL5 pe proteins were analysed by using the yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d258.s1.p1","sentence":"The interactions of the ps UL52 pe protein with the UL8 and ps UL5 pe proteins were analysed by using the yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d258.s1.p2","sentence":"The interactions of the ps UL52 pe protein with the ps UL8 pe and UL5 proteins were analysed by using the yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d281.s0.p0","sentence":"Human ps profilins pe are multifunctional, single-domain proteins which directly link the ps actin pe microfilament system to a variety of signalling pathways via two spatially distinct binding sites.","label":1}
{"pair_id":"BioInfer.d546.s0.p0","sentence":"Specific antibodies to myosin heavy chain isoforms (ps SM1 pe, SM2, SMemb), caldesmon, and ps alpha-smooth muscle actin pe and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p1","sentence":"Specific antibodies to myosin heavy chain isoforms (ps SM1 pe, SM2, SMemb), ps caldesmon pe, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p2","sentence":"Specific antibodies to myosin heavy chain isoforms (ps SM1 pe, ps SM2 pe, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p3","sentence":"Specific antibodies to myosin heavy chain isoforms (ps SM1 pe, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for ps SMemb pe were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p4","sentence":"Specific antibodies to myosin heavy chain isoforms (ps SM1 pe, SM2, ps SMemb pe), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p5","sentence":"Specific antibodies to ps myosin heavy chain pe isoforms (ps SM1 pe, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":1}
{"pair_id":"BioInfer.d546.s0.p6","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), ps caldesmon pe, and ps alpha-smooth muscle actin pe and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p7","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, ps SM2 pe, SMemb), caldesmon, and ps alpha-smooth muscle actin pe and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p8","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and ps alpha-smooth muscle actin pe and cDNAs for ps SMemb pe were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p9","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, ps SMemb pe), caldesmon, and ps alpha-smooth muscle actin pe and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p10","sentence":"Specific antibodies to ps myosin heavy chain pe isoforms (SM1, SM2, SMemb), caldesmon, and ps alpha-smooth muscle actin pe and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p11","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, ps SM2 pe, SMemb), ps caldesmon pe, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p12","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), ps caldesmon pe, and alpha-smooth muscle actin and cDNAs for ps SMemb pe were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p13","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, ps SMemb pe), ps caldesmon pe, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p14","sentence":"Specific antibodies to ps myosin heavy chain pe isoforms (SM1, SM2, SMemb), ps caldesmon pe, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p15","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, ps SM2 pe, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for ps SMemb pe were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p16","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, ps SM2 pe, ps SMemb pe), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p17","sentence":"Specific antibodies to ps myosin heavy chain pe isoforms (SM1, ps SM2 pe, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":1}
{"pair_id":"BioInfer.d546.s0.p18","sentence":"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, ps SMemb pe), caldesmon, and alpha-smooth muscle actin and cDNAs for ps SMemb pe were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p19","sentence":"Specific antibodies to ps myosin heavy chain pe isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for ps SMemb pe were used.","label":0}
{"pair_id":"BioInfer.d546.s0.p20","sentence":"Specific antibodies to ps myosin heavy chain pe isoforms (SM1, SM2, ps SMemb pe), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.","label":1}
{"pair_id":"BioInfer.d412.s0.p0","sentence":"Mammalian LIM-kinases (ps LIMKs pe) phosphorylate cofilin and induce ps actin pe cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d412.s0.p1","sentence":"Mammalian ps LIM-kinases pe (LIMKs) phosphorylate cofilin and induce ps actin pe cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d412.s0.p2","sentence":"Mammalian LIM-kinases (LIMKs) phosphorylate ps cofilin pe and induce ps actin pe cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d412.s0.p3","sentence":"Mammalian ps LIM-kinases pe (ps LIMKs pe) phosphorylate cofilin and induce actin cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d412.s0.p4","sentence":"Mammalian LIM-kinases (ps LIMKs pe) phosphorylate ps cofilin pe and induce actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d412.s0.p5","sentence":"Mammalian ps LIM-kinases pe (LIMKs) phosphorylate ps cofilin pe and induce actin cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d62.s0.p0","sentence":"An assembly of the ps UL5 pe and ps UL52 pe subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.","label":1}
{"pair_id":"BioInfer.d62.s0.p1","sentence":"An assembly of the UL5 and ps UL52 pe subunits retains both enzymic activities, and the ps UL8 pe protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.","label":1}
{"pair_id":"BioInfer.d62.s0.p2","sentence":"An assembly of the ps UL5 pe and UL52 subunits retains both enzymic activities, and the ps UL8 pe protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.","label":1}
{"pair_id":"AIMed.d190.s1615.p0","sentence":"In vitro experiments showed that the stable ps Grb2 pe\/ps c-Cbl pe complex interacts, through the Grb2 SH2 domain, with the SCF-activated c-Kit.","label":1}
{"pair_id":"AIMed.d190.s1615.p1","sentence":"In vitro experiments showed that the stable ps Grb2 pe\/c-Cbl complex interacts, through the ps Grb2 pe SH2 domain, with the SCF-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p2","sentence":"In vitro experiments showed that the stable ps Grb2 pe\/c-Cbl complex interacts, through the Grb2 SH2 domain, with the ps SCF pe-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p3","sentence":"In vitro experiments showed that the stable ps Grb2 pe\/c-Cbl complex interacts, through the Grb2 SH2 domain, with the SCF-activated ps c-Kit pe.","label":0}
{"pair_id":"AIMed.d190.s1615.p4","sentence":"In vitro experiments showed that the stable Grb2\/ps c-Cbl pe complex interacts, through the ps Grb2 pe SH2 domain, with the SCF-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p5","sentence":"In vitro experiments showed that the stable Grb2\/ps c-Cbl pe complex interacts, through the Grb2 SH2 domain, with the ps SCF pe-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p6","sentence":"In vitro experiments showed that the stable Grb2\/ps c-Cbl pe complex interacts, through the Grb2 SH2 domain, with the SCF-activated ps c-Kit pe.","label":0}
{"pair_id":"AIMed.d190.s1615.p7","sentence":"In vitro experiments showed that the stable Grb2\/c-Cbl complex interacts, through the ps Grb2 pe SH2 domain, with the ps SCF pe-activated c-Kit.","label":0}
{"pair_id":"AIMed.d190.s1615.p8","sentence":"In vitro experiments showed that the stable Grb2\/c-Cbl complex interacts, through the ps Grb2 pe SH2 domain, with the SCF-activated ps c-Kit pe.","label":1}
{"pair_id":"AIMed.d190.s1615.p9","sentence":"In vitro experiments showed that the stable Grb2\/c-Cbl complex interacts, through the Grb2 SH2 domain, with the ps SCF pe-activated ps c-Kit pe.","label":1}
{"pair_id":"BioInfer.d450.s0.p0","sentence":"Neither can ps profilin I pe, in the presence of the peptide, promote ps actin pe polymerization during its early phase consistent with a lower affinity.","label":1}
{"pair_id":"BioInfer.d190.s0.p0","sentence":"END5 encodes a proline-rich protein (ps End5p pe or ps verprolin pe) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].","label":0}
{"pair_id":"BioInfer.d190.s0.p1","sentence":"ps END5 pe encodes a proline-rich protein (ps End5p pe or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p2","sentence":"END5 encodes a proline-rich protein (ps End5p pe or verprolin) required for a polarised cortical ps actin pe cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p3","sentence":"ps END5 pe encodes a proline-rich protein (End5p or ps verprolin pe) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p4","sentence":"END5 encodes a proline-rich protein (End5p or ps verprolin pe) required for a polarised cortical ps actin pe cytoskeleton and endocytosis [2,3].","label":1}
{"pair_id":"BioInfer.d190.s0.p5","sentence":"ps END5 pe encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical ps actin pe cytoskeleton and endocytosis [2,3].","label":0}
{"pair_id":"AIMed.d76.s639.p0","sentence":"ps CD5 pe associates with the ps T-cell receptor zeta chain pe (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p1","sentence":"ps CD5 pe associates with the T-cell receptor zeta chain (ps TcR zeta pe)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p2","sentence":"ps CD5 pe associates with the T-cell receptor zeta chain (TcR zeta)\/ps CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p3","sentence":"ps CD5 pe associates with the ps T-cell receptor zeta chain (TcR zeta)\/CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":1}
{"pair_id":"AIMed.d76.s639.p4","sentence":"ps CD5 pe associates with the T-cell receptor zeta chain (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of ps TcR zeta pe\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p5","sentence":"ps CD5 pe associates with the T-cell receptor zeta chain (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/ps CD3 pe ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p6","sentence":"CD5 associates with the ps T-cell receptor zeta chain pe (ps TcR zeta pe)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p7","sentence":"CD5 associates with the ps T-cell receptor zeta chain pe (TcR zeta)\/ps CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":1}
{"pair_id":"AIMed.d76.s639.p8","sentence":"CD5 associates with the ps T-cell receptor zeta chain peps T-cell receptor zeta chain (TcR zeta)\/CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p9","sentence":"CD5 associates with the ps T-cell receptor zeta chain pe (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of ps TcR zeta pe\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p10","sentence":"CD5 associates with the ps T-cell receptor zeta chain pe (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/ps CD3 pe ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p11","sentence":"CD5 associates with the T-cell receptor zeta chain (ps TcR zeta pe)\/ps CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":1}
{"pair_id":"AIMed.d76.s639.p12","sentence":"CD5 associates with the ps T-cell receptor zeta chain (TcR zeta)\/CD3 peps TcR zeta pe)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p13","sentence":"CD5 associates with the T-cell receptor zeta chain (ps TcR zeta pe)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of ps TcR zeta pe\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p14","sentence":"CD5 associates with the T-cell receptor zeta chain (ps TcR zeta pe)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/ps CD3 pe ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p15","sentence":"CD5 associates with the ps T-cell receptor zeta chain (TcR zeta)\/CD3 peps CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p16","sentence":"CD5 associates with the T-cell receptor zeta chain (TcR zeta)\/ps CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of ps TcR zeta pe\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p17","sentence":"CD5 associates with the T-cell receptor zeta chain (TcR zeta)\/ps CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/ps CD3 pe ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p18","sentence":"CD5 associates with the ps T-cell receptor zeta chain (TcR zeta)\/CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of ps TcR zeta pe\/CD3 ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p19","sentence":"CD5 associates with the ps T-cell receptor zeta chain (TcR zeta)\/CD3 pe complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta\/ps CD3 pe ligation.","label":0}
{"pair_id":"AIMed.d76.s639.p20","sentence":"CD5 associates with the T-cell receptor zeta chain (TcR zeta)\/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of ps TcR zeta pe\/ps CD3 pe ligation.","label":0}
{"pair_id":"AIMed.d70.s594.p0","sentence":"The ps type II cAMP-dependent protein kinase pe is localized to specific subcellular environments through the binding of the regulatory subunit (ps RII pe) dimer to RII-anchoring proteins.","label":0}
{"pair_id":"AIMed.d70.s594.p1","sentence":"The ps type II cAMP-dependent protein kinase pe is localized to specific subcellular environments through the binding of the regulatory subunit (RII) dimer to ps RII pe-anchoring proteins.","label":0}
{"pair_id":"AIMed.d70.s594.p2","sentence":"The type II cAMP-dependent protein kinase is localized to specific subcellular environments through the binding of the regulatory subunit (ps RII pe) dimer to ps RII pe-anchoring proteins.","label":0}
{"pair_id":"BioInfer.d136.s0.p0","sentence":"Characterization of a mutant ps profilin pe with reduced ps actin pe-binding capacity: effects in vitro and in vivo.","label":1}
{"pair_id":"BioInfer.d347.s0.p0","sentence":"In localization studies with mammalian cells, all fusion proteins showed the localization expected for ps profilin pe in areas of high actin dynamics, such as leading lamellae and ruffles induced by ps epidermal growth factor pe.","label":0}
{"pair_id":"BioInfer.d347.s0.p1","sentence":"In localization studies with mammalian cells, all fusion proteins showed the localization expected for ps profilin pe in areas of high ps actin pe dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.","label":0}
{"pair_id":"BioInfer.d347.s0.p2","sentence":"In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high ps actin pe dynamics, such as leading lamellae and ruffles induced by ps epidermal growth factor pe.","label":0}
{"pair_id":"AIMed.d77.s655.p0","sentence":"We have engineered and purified recombinant ps K5 pe head and ps DPI pe tail, and we demonstrate direct interaction in vitro by solution-binding assays and by ligand blot assays.","label":1}
{"pair_id":"AIMed.d82.s695.p0","sentence":"Identification of an 11-kDa ps FKBP12 pe-rapamycin-binding domain within the 289-kDa ps FKBP12-rapamycin-associated protein pe and characterization of a critical serine residue.","label":0}
{"pair_id":"AIMed.d116.s977.p0","sentence":"Activity of RNA polymerase I transcription factor ps UBF pe blocked by ps Rb pe gene product.","label":1}
{"pair_id":"AIMed.d205.s1775.p0","sentence":"A ps 120-kDa phosphoprotein pe (ps pp120 pe) associated with CD5 and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.","label":0}
{"pair_id":"AIMed.d205.s1775.p1","sentence":"A ps 120-kDa phosphoprotein pe (pp120) associated with ps CD5 pe and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.","label":1}
{"pair_id":"AIMed.d205.s1775.p2","sentence":"A 120-kDa phosphoprotein (ps pp120 pe) associated with ps CD5 pe and specifically with the Y429-Y441 phosphopeptide in stimulated thymocytes.","label":1}
{"pair_id":"BioInfer.d258.s0.p0","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral ps UL5 pe, ps UL8 pe and UL52 genes.","label":0}
{"pair_id":"BioInfer.d258.s0.p1","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric ps helicase-primase pe, the subunits of which are encoded by the viral UL5, ps UL8 pe and UL52 genes.","label":1}
{"pair_id":"BioInfer.d258.s0.p2","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, ps UL8 pe and ps UL52 pe genes.","label":0}
{"pair_id":"BioInfer.d258.s0.p3","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric ps helicase-primase pe, the subunits of which are encoded by the viral ps UL5 pe, UL8 and UL52 genes.","label":1}
{"pair_id":"BioInfer.d258.s0.p4","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral ps UL5 pe, UL8 and ps UL52 pe genes.","label":0}
{"pair_id":"BioInfer.d258.s0.p5","sentence":"Herpes simplex virus type 1 expresses a heterotrimeric ps helicase-primase pe, the subunits of which are encoded by the viral UL5, UL8 and ps UL52 pe genes.","label":1}
{"pair_id":"BioInfer.d41.s2.p0","sentence":"We examined the role of the ps actin pe monomer sequestering protein, ps profilin pe, in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.","label":1}
{"pair_id":"BioInfer.d41.s2.p1","sentence":"We examined the role of the actin monomer sequestering protein, ps profilin pe, in the regulation of ps PMN actin pe filament assembly during chemoattractant stimulation using a Triton extraction method.","label":1}
{"pair_id":"BioInfer.d41.s2.p2","sentence":"We examined the role of the ps actin pe monomer sequestering protein, profilin, in the regulation of ps PMN actin pe filament assembly during chemoattractant stimulation using a Triton extraction method.","label":0}
{"pair_id":"AIMed.d179.s1528.p0","sentence":"We report here that ps Grb2 pe also interacts with tyrosine-phosphorylated ps IRS-1 pe in response to gastrin.","label":1}
{"pair_id":"AIMed.d179.s1528.p1","sentence":"We report here that ps Grb2 pe also interacts with tyrosine-phosphorylated IRS-1 in response to ps gastrin pe.","label":0}
{"pair_id":"AIMed.d179.s1528.p2","sentence":"We report here that Grb2 also interacts with tyrosine-phosphorylated ps IRS-1 pe in response to ps gastrin pe.","label":0}
{"pair_id":"AIMed.d100.s851.p0","sentence":"This largest TAF may therefore play a central role in ps TFIID pe assembly by interacting with both ps TBP pe and other TAFs, as well as serving to link the control of transcription to the cell cycle.","label":0}
{"pair_id":"AIMed.d198.s1691.p0","sentence":"In addition, selected mutant proteins were expressed as full-length ps EPOR pe on the surface of COS cells and analyzed for 125I-ps EPO pe binding in receptor binding assays.","label":0}
{"pair_id":"AIMed.d48.s424.p0","sentence":"The molar concentration of ps LEC pe required to induce maximum cell migration is 20- to 200-fold greater than that required for ps RANTES pe or I309, respectively.","label":0}
{"pair_id":"AIMed.d48.s424.p1","sentence":"The molar concentration of ps LEC pe required to induce maximum cell migration is 20- to 200-fold greater than that required for RANTES or ps I309 pe, respectively.","label":0}
{"pair_id":"AIMed.d48.s424.p2","sentence":"The molar concentration of LEC required to induce maximum cell migration is 20- to 200-fold greater than that required for ps RANTES pe or ps I309 pe, respectively.","label":0}
{"pair_id":"AIMed.d174.s1466.p0","sentence":"Influence of ps interleukin-6 pe (ps IL-6 pe) dimerization on formation of the high affinity hexameric IL-6.receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p1","sentence":"Influence of ps interleukin-6 pe (IL-6) dimerization on formation of the high affinity hexameric ps IL-6 pe.receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p2","sentence":"Influence of ps interleukin-6 pe (IL-6) dimerization on formation of the high affinity hexameric ps IL-6.receptor pe complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p3","sentence":"Influence of interleukin-6 (ps IL-6 pe) dimerization on formation of the high affinity hexameric ps IL-6 pe.receptor complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p4","sentence":"Influence of interleukin-6 (ps IL-6 pe) dimerization on formation of the high affinity hexameric ps IL-6.receptor pe complex.","label":0}
{"pair_id":"AIMed.d174.s1466.p5","sentence":"Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric ps IL-6 peps IL-6.receptor pe complex.","label":0}
{"pair_id":"AIMed.d102.s860.p0","sentence":"ps RB pe, the protein product of the ps retinoblastoma pe tumor-suppressor gene, regulates the activity of specific transcription factors.","label":0}
{"pair_id":"AIMed.d146.s1238.p0","sentence":"Deglycosylation studies showed that the ps p90 pe and ps p76 pe IL-7R are not simply differently glycosylated isoforms of a single receptor.","label":0}
{"pair_id":"AIMed.d146.s1238.p1","sentence":"Deglycosylation studies showed that the ps p90 pe and p76 ps IL-7R pe are not simply differently glycosylated isoforms of a single receptor.","label":0}
{"pair_id":"AIMed.d146.s1238.p2","sentence":"Deglycosylation studies showed that the p90 and ps p76 pe ps IL-7R pe are not simply differently glycosylated isoforms of a single receptor.","label":0}
{"pair_id":"BioInfer.d61.s1.p0","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of ps alpha-catenin pe, beta-catenin competed with the binding of plakoglobin to ps alpha-catenin pe and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p1","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of ps alpha-catenin pe, ps beta-catenin pe competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p2","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of ps alpha-catenin pe, beta-catenin competed with the binding of ps plakoglobin pe to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p3","sentence":"Consistent with the observation that beta-catenin and ps plakoglobin pe bind to the same region of ps alpha-catenin pe, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p4","sentence":"Consistent with the observation that ps beta-catenin pe and plakoglobin bind to the same region of ps alpha-catenin pe, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p5","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, ps beta-catenin pe competed with the binding of plakoglobin to ps alpha-catenin pe and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p6","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of ps plakoglobin pe to ps alpha-catenin pe and vice versa.","label":1}
{"pair_id":"BioInfer.d61.s1.p7","sentence":"Consistent with the observation that beta-catenin and ps plakoglobin pe bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to ps alpha-catenin pe and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p8","sentence":"Consistent with the observation that ps beta-catenin pe and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to ps alpha-catenin pe and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p9","sentence":"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, ps beta-catenin pe competed with the binding of ps plakoglobin pe to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p10","sentence":"Consistent with the observation that beta-catenin and ps plakoglobin pe bind to the same region of alpha-catenin, ps beta-catenin pe competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p11","sentence":"Consistent with the observation that ps beta-catenin pe and plakoglobin bind to the same region of alpha-catenin, ps beta-catenin pe competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p12","sentence":"Consistent with the observation that beta-catenin and ps plakoglobin pe bind to the same region of alpha-catenin, beta-catenin competed with the binding of ps plakoglobin pe to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p13","sentence":"Consistent with the observation that ps beta-catenin pe and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of ps plakoglobin pe to alpha-catenin and vice versa.","label":0}
{"pair_id":"BioInfer.d61.s1.p14","sentence":"Consistent with the observation that ps beta-catenin pe and ps plakoglobin pe bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.","label":0}
{"pair_id":"AIMed.d171.s1441.p0","sentence":"Crystal structure of the ps p27Kip1 pe cyclin-dependent-kinase inhibitor bound to the ps cyclin A pe-Cdk2 complex.","label":1}
{"pair_id":"AIMed.d171.s1441.p1","sentence":"Crystal structure of the ps p27Kip1 pe cyclin-dependent-kinase inhibitor bound to the cyclin A-ps Cdk2 pe complex.","label":1}
{"pair_id":"AIMed.d171.s1441.p2","sentence":"Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the ps cyclin A pe-ps Cdk2 pe complex.","label":1}
{"pair_id":"BioInfer.d135.s0.p0","sentence":"Characterization of ps actin pe and poly-L-proline binding sites of Acanthamoeba ps profilin pe with monoclonal antibodies and by mutagenesis.","label":1}
{"pair_id":"AIMed.d87.s736.p0","sentence":"The results of his3 activation indicated that ps p85 pe, N + C-SH2 and C-SH2 interact with both ps IR pe beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p1","sentence":"The results of his3 activation indicated that ps p85 pe, N + C-SH2 and C-SH2 interact with both ps IR beta pe and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":1}
{"pair_id":"AIMed.d87.s736.p2","sentence":"The results of his3 activation indicated that ps p85 pe, N + C-SH2 and C-SH2 interact with both IR beta and ps IGF-1R pe beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p3","sentence":"The results of his3 activation indicated that ps p85 pe, N + C-SH2 and C-SH2 interact with both IR beta and ps IGF-1R beta pe, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":1}
{"pair_id":"AIMed.d87.s736.p4","sentence":"The results of his3 activation indicated that ps p85 pe, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR pe beta.","label":0}
{"pair_id":"AIMed.d87.s736.p5","sentence":"The results of his3 activation indicated that ps p85 pe, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR beta pe.","label":0}
{"pair_id":"AIMed.d87.s736.p6","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR peps IR beta pe and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p7","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR pe beta and ps IGF-1R pe beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p8","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR pe beta and ps IGF-1R beta pe, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p9","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR pe beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR pe beta.","label":0}
{"pair_id":"AIMed.d87.s736.p10","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR pe beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR beta pe.","label":0}
{"pair_id":"AIMed.d87.s736.p11","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR beta pe and ps IGF-1R pe beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p12","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR beta pe and ps IGF-1R beta pe, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p13","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR beta pe and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR pe beta.","label":0}
{"pair_id":"AIMed.d87.s736.p14","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both ps IR beta pe and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR beta pe.","label":0}
{"pair_id":"AIMed.d87.s736.p15","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and ps IGF-1R peps IGF-1R beta pe, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.","label":0}
{"pair_id":"AIMed.d87.s736.p16","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and ps IGF-1R pe beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR pe beta.","label":0}
{"pair_id":"AIMed.d87.s736.p17","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and ps IGF-1R pe beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR beta pe.","label":0}
{"pair_id":"AIMed.d87.s736.p18","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and ps IGF-1R beta pe, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR pe beta.","label":0}
{"pair_id":"AIMed.d87.s736.p19","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and ps IGF-1R beta pe, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR beta pe.","label":0}
{"pair_id":"AIMed.d87.s736.p20","sentence":"The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with ps IR peps IR beta pe.","label":0}
{"pair_id":"BioInfer.d532.s0.p0","sentence":"Ser-133 phosphorylation enhances ps CREB pe activity by promoting interaction with a 265-kDa CREB binding protein referred to as ps CBP pe (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).","label":1}
{"pair_id":"BioInfer.d532.s0.p1","sentence":"Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa ps CREB binding protein pe referred to as ps CBP pe (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).","label":0}
{"pair_id":"BioInfer.d532.s0.p2","sentence":"Ser-133 phosphorylation enhances ps CREB pe activity by promoting interaction with a 265-kDa ps CREB binding protein pe referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).","label":1}
{"pair_id":"BioInfer.d425.s0.p0","sentence":"Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of ps E-cadherin pe and alpha-catenin and relocalization of ps beta-catenin pe to the cytoplasm and nucleus.","label":0}
{"pair_id":"BioInfer.d425.s0.p1","sentence":"Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and ps alpha-catenin pe and relocalization of ps beta-catenin pe to the cytoplasm and nucleus.","label":0}
{"pair_id":"BioInfer.d425.s0.p2","sentence":"Microinjection or stable expression of ps V12Ras pe into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of ps beta-catenin pe to the cytoplasm and nucleus.","label":1}
{"pair_id":"BioInfer.d425.s0.p3","sentence":"Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of ps E-cadherin pe and ps alpha-catenin pe and relocalization of beta-catenin to the cytoplasm and nucleus.","label":0}
{"pair_id":"BioInfer.d425.s0.p4","sentence":"Microinjection or stable expression of ps V12Ras pe into keratinocytes promotes the loss of ps E-cadherin pe and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.","label":1}
{"pair_id":"BioInfer.d425.s0.p5","sentence":"Microinjection or stable expression of ps V12Ras pe into keratinocytes promotes the loss of E-cadherin and ps alpha-catenin pe and relocalization of beta-catenin to the cytoplasm and nucleus.","label":1}
{"pair_id":"BioInfer.d356.s0.p0","sentence":"Integrating the ps actin pe and ps vimentin pe cytoskeletons.","label":1}
{"pair_id":"BioInfer.d28.s0.p0","sentence":"After 24 or 48 hours of shear, staining for ps VE-cadherin pe, alpha-catenin, and ps beta-catenin pe was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.","label":0}
{"pair_id":"BioInfer.d28.s0.p1","sentence":"After 24 or 48 hours of shear, staining for VE-cadherin, ps alpha-catenin pe, and ps beta-catenin pe was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.","label":0}
{"pair_id":"BioInfer.d28.s0.p2","sentence":"After 24 or 48 hours of shear, staining for ps VE-cadherin pe, ps alpha-catenin pe, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.","label":0}
{"pair_id":"AIMed.d33.s277.p0","sentence":"Native ps C8 pe and ps C9 pe formed a heterodimer in solution of physiological ionic strength with a free-energy change DeltaG degrees of -8.3 kcal\/mol and a dissociation constant Kd of 0.6 microM (at 20 degrees C) that was ionic strength- and temperature-dependent.","label":1}
{"pair_id":"AIMed.d219.s1902.p0","sentence":"The ps Raf-CRD pe is located in the NH2-terminal negative regulatory domain of ps Raf-1 pe and is highly homologous to cysteine-rich domains found in protein kinase C family members.","label":0}
{"pair_id":"AIMed.d206.s1785.p0","sentence":"Like antibodies to the ps beta 1 integrin pe subunit, anti-ps CD9 pe inhibited suspension-induced terminal differentiation.","label":0}
{"pair_id":"BioInfer.d704.s0.p0","sentence":"These proteins each have a ps verprolin pe-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the ps Arp2 pe\/A complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p1","sentence":"These proteins each have a ps verprolin pe-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2\/A complex, leading to rapid ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p2","sentence":"These proteins each have a ps verprolin pe-homology (V) domain, ps cofilin pe-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2\/A complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p3","sentence":"These proteins each have a ps verprolin pe-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the ps Arp pe2\/ps A pe complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p4","sentence":"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the ps Arp2 pe\/A complex, leading to rapid ps actin pe polymerization.","label":1}
{"pair_id":"BioInfer.d704.s0.p5","sentence":"These proteins each have a verprolin-homology (V) domain, ps cofilin pe-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the ps Arp2 pe\/A complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p6","sentence":"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the ps Arp2 peps Arp pe2\/ps A pe complex, leading to rapid actin polymerization.","label":1}
{"pair_id":"BioInfer.d704.s0.p7","sentence":"These proteins each have a verprolin-homology (V) domain, ps cofilin pe-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2\/A complex, leading to rapid ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d704.s0.p8","sentence":"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the ps Arp pe2\/ps A pe complex, leading to rapid ps actin pe polymerization.","label":1}
{"pair_id":"BioInfer.d704.s0.p9","sentence":"These proteins each have a verprolin-homology (V) domain, ps cofilin pe-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the ps Arp pe2\/ps A pe complex, leading to rapid actin polymerization.","label":0}
{"pair_id":"BioInfer.d208.s0.p0","sentence":"Finally, both receptors can interact with FADD, ps TRADD pe, and ps RIP pe.","label":0}
{"pair_id":"BioInfer.d208.s0.p1","sentence":"Finally, both receptors can interact with ps FADD pe, ps TRADD pe, and RIP.","label":0}
{"pair_id":"BioInfer.d208.s0.p2","sentence":"Finally, both receptors can interact with ps FADD pe, TRADD, and ps RIP pe.","label":0}
{"pair_id":"BioInfer.d35.s4.p0","sentence":"We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of ps cofilin pe and restricts cofilin localization to cortical ps actin pe patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p1","sentence":"We conclude that ps Aip1p pe is a cofilin-associated protein that enhances the filament disassembly activity of ps cofilin pe and restricts cofilin localization to cortical actin patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p2","sentence":"We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of ps cofilin pe and restricts ps cofilin pe localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p3","sentence":"We conclude that Aip1p is a ps cofilin pe-associated protein that enhances the filament disassembly activity of ps cofilin pe and restricts cofilin localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p4","sentence":"We conclude that ps Aip1p pe is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical ps actin pe patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p5","sentence":"We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts ps cofilin pe localization to cortical ps actin pe patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p6","sentence":"We conclude that Aip1p is a ps cofilin pe-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical ps actin pe patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p7","sentence":"We conclude that ps Aip1p pe is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts ps cofilin pe localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d35.s4.p8","sentence":"We conclude that ps Aip1p pe is a ps cofilin pe-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.","label":1}
{"pair_id":"BioInfer.d35.s4.p9","sentence":"We conclude that Aip1p is a ps cofilin pe-associated protein that enhances the filament disassembly activity of cofilin and restricts ps cofilin pe localization to cortical actin patches.","label":0}
{"pair_id":"BioInfer.d135.s2.p0","sentence":"The results provide two independent lines of evidence about the binding sites for ps actin pe and poly-L-proline on the ps profilin pe molecule.","label":1}
{"pair_id":"AIMed.d79.s671.p0","sentence":"The ps retinoblastoma pe protein binds to ps RIZ pe, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.","label":1}
{"pair_id":"AIMed.d79.s671.p1","sentence":"The ps retinoblastoma pe protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus ps E1A pe protein.","label":0}
{"pair_id":"AIMed.d79.s671.p2","sentence":"The retinoblastoma protein binds to ps RIZ pe, a zinc-finger protein that shares an epitope with the adenovirus ps E1A pe protein.","label":0}
{"pair_id":"AIMed.d168.s1415.p0","sentence":"Mutant proteins were expressed in bacteria as soluble ps EPO pe binding proteins (ps EBP pe) and characterized for EPO binding activity in a number of different assays.","label":1}
{"pair_id":"AIMed.d168.s1415.p1","sentence":"Mutant proteins were expressed in bacteria as soluble ps EPO pe binding proteins (EBP) and characterized for ps EPO pe binding activity in a number of different assays.","label":0}
{"pair_id":"AIMed.d168.s1415.p2","sentence":"Mutant proteins were expressed in bacteria as soluble EPO binding proteins (ps EBP pe) and characterized for ps EPO pe binding activity in a number of different assays.","label":0}
{"pair_id":"AIMed.d46.s402.p0","sentence":"ps BMP-2 pe antagonists emerge from alterations in the low-affinity binding epitope for receptor ps BMPR-II pe.","label":0}
{"pair_id":"AIMed.d184.s1562.p0","sentence":"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, ps CCR-5 pe and ps CXCR-4 pe, respectively, as well as the primary receptor CD4 (refs 1-6).","label":0}
{"pair_id":"AIMed.d184.s1562.p1","sentence":"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, ps CCR-5 pe and CXCR-4, respectively, as well as the primary receptor ps CD4 pe (refs 1-6).","label":0}
{"pair_id":"AIMed.d184.s1562.p2","sentence":"For efficient entry into target cells, primary macrophage-tropic and laboratory-adapted human immunodeficiency viruses type 1 (HIV-1) require particular chemokine receptors, CCR-5 and ps CXCR-4 pe, respectively, as well as the primary receptor ps CD4 pe (refs 1-6).","label":0}
{"pair_id":"BioInfer.d55.s1.p0","sentence":"Molecular packing in ps profilin pe: ps actin pe crystals and its implications.","label":0}
{"pair_id":"AIMed.d215.s1871.p0","sentence":"Cleavage of ps Ln-5 pe by ps MMP2 pe and the resulting activation of the Ln-5 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.","label":1}
{"pair_id":"AIMed.d215.s1871.p1","sentence":"Cleavage of ps Ln-5 pe by MMP2 and the resulting activation of the ps Ln-5 pe cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.","label":0}
{"pair_id":"AIMed.d215.s1871.p2","sentence":"Cleavage of Ln-5 by ps MMP2 pe and the resulting activation of the ps Ln-5 pe cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.","label":0}
{"pair_id":"AIMed.d92.s788.p0","sentence":"Although multimeric complexes of ps trkA pe and ps p75 pe were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p1","sentence":"Although multimeric complexes of ps trkA pe and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF pe-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p2","sentence":"Although multimeric complexes of ps trkA pe and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF-receptor pe complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p3","sentence":"Although multimeric complexes of ps trkA pe and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with ps trk pe-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p4","sentence":"Although multimeric complexes of ps trkA pe and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked ps p75 pe.","label":0}
{"pair_id":"AIMed.d92.s788.p5","sentence":"Although multimeric complexes of trkA and ps p75 pe were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF pe-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p6","sentence":"Although multimeric complexes of trkA and ps p75 pe were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF-receptor pe complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p7","sentence":"Although multimeric complexes of trkA and ps p75 pe were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with ps trk pe-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p8","sentence":"Although multimeric complexes of trkA and ps p75 pe were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked ps p75 pe.","label":0}
{"pair_id":"AIMed.d92.s788.p9","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF peps NGF-receptor pe complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p10","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF pe-receptor complexes with ps trk pe-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p11","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF pe-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked ps p75 pe.","label":0}
{"pair_id":"AIMed.d92.s788.p12","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF-receptor pe complexes with ps trk pe-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.","label":0}
{"pair_id":"AIMed.d92.s788.p13","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked ps NGF-receptor pe complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked ps p75 pe.","label":0}
{"pair_id":"AIMed.d92.s788.p14","sentence":"Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with ps trk pe-specific antibodies resulted in selective immunoprecipitation of crosslinked ps p75 pe.","label":0}
{"pair_id":"BioInfer.d776.s0.p0","sentence":"Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while ps beta catenin pe levels were reduced, and ps gamma catenin pe expression was unchanged.","label":0}
{"pair_id":"BioInfer.d776.s0.p1","sentence":"Treatment of cells with gamma linolenic acid (GLA) increased ps alpha catenin pe expression in most cell lines, while ps beta catenin pe levels were reduced, and gamma catenin expression was unchanged.","label":0}
{"pair_id":"BioInfer.d776.s0.p2","sentence":"Treatment of cells with gamma linolenic acid (GLA) increased ps alpha catenin pe expression in most cell lines, while beta catenin levels were reduced, and ps gamma catenin pe expression was unchanged.","label":0}
{"pair_id":"BioInfer.d521.s0.p0","sentence":"Resonance energy transfer determination of the following distances, using a hybrid ps myosin pe: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten ps myosin heavy chain pe, and Cys-374 of actin.","label":0}
{"pair_id":"BioInfer.d521.s0.p1","sentence":"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten ps myosin heavy chain pe, and Cys-374 of ps actin pe.","label":0}
{"pair_id":"BioInfer.d521.s0.p2","sentence":"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria ps regulatory light chain pe, SH-1 on the Aequipecten ps myosin heavy chain pe, and Cys-374 of actin.","label":0}
{"pair_id":"BioInfer.d521.s0.p3","sentence":"Resonance energy transfer determination of the following distances, using a hybrid ps myosin pe: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of ps actin pe.","label":0}
{"pair_id":"BioInfer.d521.s0.p4","sentence":"Resonance energy transfer determination of the following distances, using a hybrid ps myosin pe: those between Cys-55 on the Mercenaria ps regulatory light chain pe, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.","label":0}
{"pair_id":"BioInfer.d521.s0.p5","sentence":"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria ps regulatory light chain pe, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of ps actin pe.","label":0}
{"pair_id":"AIMed.d190.s1619.p0","sentence":"By contrast the ps Ras pe exchanger factor (ps Sos1 pe) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":1}
{"pair_id":"AIMed.d190.s1619.p1","sentence":"By contrast the ps Ras pe exchanger factor (Sos1) was not detected in anti-ps c-Cbl pe immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p2","sentence":"By contrast the ps Ras pe exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that ps Grb2 pe\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p3","sentence":"By contrast the ps Ras pe exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/ps Sos1 pe and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p4","sentence":"By contrast the ps Ras pe exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and ps Grb2 pe\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p5","sentence":"By contrast the ps Ras pe exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/ps c-Cbl pe are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p6","sentence":"By contrast the Ras exchanger factor (ps Sos1 pe) was not detected in anti-ps c-Cbl pe immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p7","sentence":"By contrast the Ras exchanger factor (ps Sos1 pe) was not detected in anti-c-Cbl immunoprecipitates suggesting that ps Grb2 pe\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p8","sentence":"By contrast the Ras exchanger factor (ps Sos1 pe) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/ps Sos1 pe and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p9","sentence":"By contrast the Ras exchanger factor (ps Sos1 pe) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and ps Grb2 pe\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p10","sentence":"By contrast the Ras exchanger factor (ps Sos1 pe) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/ps c-Cbl pe are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p11","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-ps c-Cbl pe immunoprecipitates suggesting that ps Grb2 pe\/Sos1 and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p12","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-ps c-Cbl pe immunoprecipitates suggesting that Grb2\/ps Sos1 pe and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p13","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-ps c-Cbl pe immunoprecipitates suggesting that Grb2\/Sos1 and ps Grb2 pe\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p14","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-ps c-Cbl pe immunoprecipitates suggesting that Grb2\/Sos1 and Grb2\/ps c-Cbl pe are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p15","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that ps Grb2 pe\/ps Sos1 pe and Grb2\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p16","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that ps Grb2 pe\/Sos1 and ps Grb2 pe\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p17","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that ps Grb2 pe\/Sos1 and Grb2\/ps c-Cbl pe are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p18","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/ps Sos1 pe and ps Grb2 pe\/c-Cbl are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p19","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/ps Sos1 pe and Grb2\/ps c-Cbl pe are present in different complexes.","label":0}
{"pair_id":"AIMed.d190.s1619.p20","sentence":"By contrast the Ras exchanger factor (Sos1) was not detected in anti-c-Cbl immunoprecipitates suggesting that Grb2\/Sos1 and ps Grb2 pe\/ps c-Cbl pe are present in different complexes.","label":0}
{"pair_id":"AIMed.d42.s361.p0","sentence":"The BMP receptors belong to the family of serine\/threonine kinase receptors, whose activation has been investigated intensively for the ps transforming growth factor-beta pe (ps TGF-beta pe) receptor subfamily.","label":0}
{"pair_id":"AIMed.d180.s1537.p0","sentence":"These results, along with other recent findings, suggest a novel role for the interaction between ps GAP-43 pe and ps CaM pe.","label":1}
{"pair_id":"AIMed.d56.s494.p0","sentence":"Cloning of ps TRAP pe, a ligand for ps CD40 pe on human T cells.","label":1}
{"pair_id":"AIMed.d112.s951.p0","sentence":"Several phosphoproteins, including one of 72 kDa and one of 120 kDa, coprecipitated with ps phospholipase C-gamma 1 pe (ps PLC gamma 1 pe).","label":0}
{"pair_id":"AIMed.d184.s1566.p0","sentence":"A ps gp120 pe fragment retaining the ps CD4 pe-binding site and overlapping epitopes was able to interact with CCR-5 only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.","label":1}
{"pair_id":"AIMed.d184.s1566.p1","sentence":"A ps gp120 pe fragment retaining the CD4-binding site and overlapping epitopes was able to interact with ps CCR-5 pe only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.","label":1}
{"pair_id":"AIMed.d184.s1566.p2","sentence":"A gp120 fragment retaining the ps CD4 pe-binding site and overlapping epitopes was able to interact with ps CCR-5 pe only if the V3 loop, which can specify HIV-1 tropism and chemokine receptor choice, was also present on the molecule.","label":0}
{"pair_id":"AIMed.d192.s1636.p0","sentence":"The ps interleukin-1beta pe (ps IL-1beta pe) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p1","sentence":"The ps interleukin-1beta peps interleukin-1beta (IL-1beta) converting enzyme pe (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p2","sentence":"The ps interleukin-1beta pe (IL-1beta) converting enzyme (ps ICE pe) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":1}
{"pair_id":"AIMed.d192.s1636.p3","sentence":"The ps interleukin-1beta pe (IL-1beta) converting enzyme (ICE) processes the inactive ps IL-1beta pe precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p4","sentence":"The ps interleukin-1beta (IL-1beta) converting enzyme peps IL-1beta pe) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p5","sentence":"The interleukin-1beta (ps IL-1beta pe) converting enzyme (ps ICE pe) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":1}
{"pair_id":"AIMed.d192.s1636.p6","sentence":"The interleukin-1beta (ps IL-1beta pe) converting enzyme (ICE) processes the inactive ps IL-1beta pe precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p7","sentence":"The ps interleukin-1beta (IL-1beta) converting enzyme pe (ps ICE pe) processes the inactive IL-1beta precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p8","sentence":"The ps interleukin-1beta (IL-1beta) converting enzyme pe (ICE) processes the inactive ps IL-1beta pe precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d192.s1636.p9","sentence":"The interleukin-1beta (IL-1beta) converting enzyme (ps ICE pe) processes the inactive ps IL-1beta pe precursor to the proinflammatory cytokine.","label":0}
{"pair_id":"AIMed.d119.s1012.p0","sentence":"Consistent with its role as a coactivator, ps CBP pe augments the activity of phosphorylated ps CREB pe to activate transcription of cAMP-responsive genes.","label":1}
{"pair_id":"AIMed.d208.s1803.p0","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (ps TRADD pe, ps FADD pe\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p1","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (ps TRADD pe, FADD\/ps MORT pe, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p2","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (ps TRADD pe, FADD\/MORT, ps RIP pe, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p3","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (ps TRADD pe, FADD\/MORT, RIP, ps FLICE pe\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p4","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (ps TRADD pe, FADD\/MORT, RIP, FLICE\/ps MACH pe, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p5","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (ps TRADD pe, FADD\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the ps p60 pe and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p6","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (ps TRADD pe, FADD\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and ps p80 pe forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p7","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, ps FADD pe\/ps MORT pe, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p8","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, ps FADD pe\/MORT, ps RIP pe, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p9","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, ps FADD pe\/MORT, RIP, ps FLICE pe\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p10","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, ps FADD pe\/MORT, RIP, FLICE\/ps MACH pe, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p11","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, ps FADD pe\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the ps p60 pe and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p12","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, ps FADD pe\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and ps p80 pe forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p13","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/ps MORT pe, ps RIP pe, FLICE\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p14","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/ps MORT pe, RIP, ps FLICE pe\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p15","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/ps MORT pe, RIP, FLICE\/ps MACH pe, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p16","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/ps MORT pe, RIP, FLICE\/MACH, and TRAFs) associated with both of the ps p60 pe and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p17","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/ps MORT pe, RIP, FLICE\/MACH, and TRAFs) associated with both of the p60 and ps p80 pe forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p18","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, ps RIP pe, ps FLICE pe\/MACH, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p19","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, ps RIP pe, FLICE\/ps MACH pe, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p20","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, ps RIP pe, FLICE\/MACH, and TRAFs) associated with both of the ps p60 pe and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p21","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, ps RIP pe, FLICE\/MACH, and TRAFs) associated with both of the p60 and ps p80 pe forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p22","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, ps FLICE pe\/ps MACH pe, and TRAFs) associated with both of the p60 and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"AIMed.d208.s1803.p23","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, ps FLICE pe\/MACH, and TRAFs) associated with both of the ps p60 pe and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p24","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, ps FLICE pe\/MACH, and TRAFs) associated with both of the p60 and ps p80 pe forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p25","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, FLICE\/ps MACH pe, and TRAFs) associated with both of the ps p60 pe and p80 forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p26","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, FLICE\/ps MACH pe, and TRAFs) associated with both of the p60 and ps p80 pe forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":1}
{"pair_id":"AIMed.d208.s1803.p27","sentence":"The cloning of members of these gene families and the identification of the protein-interaction motifs found within their gene products has initiated the molecular identity of factors (TRADD, FADD\/MORT, RIP, FLICE\/MACH, and TRAFs) associated with both of the ps p60 pe and ps p80 pe forms of the TNF receptor and with other members of the TNF receptor superfamily.","label":0}
{"pair_id":"BioInfer.d336.s0.p0","sentence":"In growth cones, ps myosin heavy chain B pe was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, ps actin pe-rich peripheral region.","label":0}
{"pair_id":"AIMed.d27.s226.p0","sentence":"ps Activin A pe, a member of the ps TGFbeta pe superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.","label":0}
{"pair_id":"BioInfer.d43.s1.p0","sentence":"A portion of ps glucokinase pe appeared to be co-localized with ps actin pe filaments in the cytoplasm of cultured rat hepatocytes incubated with 25 mM glucose.","label":1}
{"pair_id":"AIMed.d206.s1779.p0","sentence":"As ps CD9 pe forms complexes with beta 1 integrins and the integrins are known to regulate keratinocyte behaviour, we investigated ps CD9 pe expression and function in human epidermal keratinocytes.","label":0}
{"pair_id":"BioInfer.d79.s0.p0","sentence":"A series of truncations was carried out at the C terminus of ps profilin pe, a region that has been implicated in ps actin pe binding.","label":1}
{"pair_id":"BioInfer.d338.s0.p0","sentence":"Inhibition of ps actin pe polymerization by a synthetic dodecapeptide patterned on the sequence around the ps actin pe-binding site of cofilin.","label":0}
{"pair_id":"BioInfer.d338.s0.p1","sentence":"Inhibition of ps actin pe polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d338.s0.p2","sentence":"Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the ps actin pe-binding site of ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d100.s2.p0","sentence":"Here, we show that ps PRP5 pe (a DEAD box helicase-like protein), ps PRP9 pe, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p1","sentence":"Here, we show that PRP5 (a DEAD box helicase-like protein), ps PRP9 pe, and ps PRP11 pe are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p2","sentence":"Here, we show that PRP5 (a DEAD box helicase-like protein), ps PRP9 pe, and PRP11 are each required for the ps U2 snRNP pe to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p3","sentence":"Here, we show that PRP5 (a ps DEAD box helicase pe-like protein), ps PRP9 pe, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p4","sentence":"Here, we show that ps PRP5 pe (a DEAD box helicase-like protein), PRP9, and ps PRP11 pe are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p5","sentence":"Here, we show that ps PRP5 pe (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the ps U2 snRNP pe to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p6","sentence":"Here, we show that ps PRP5 pe (a ps DEAD box helicase pe-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p7","sentence":"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and ps PRP11 pe are each required for the ps U2 snRNP pe to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":1}
{"pair_id":"BioInfer.d100.s2.p8","sentence":"Here, we show that PRP5 (a ps DEAD box helicase pe-like protein), PRP9, and ps PRP11 pe are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d100.s2.p9","sentence":"Here, we show that PRP5 (a ps DEAD box helicase pe-like protein), PRP9, and PRP11 are each required for the ps U2 snRNP pe to bind to the pre-spliceosome during spliceosome assembly in vitro.","label":0}
{"pair_id":"BioInfer.d823.s0.p0","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-ps nucleosome pe complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone ps H3 pe.","label":1}
{"pair_id":"BioInfer.d823.s0.p1","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated ps histone pe ps H3 pe.","label":1}
{"pair_id":"BioInfer.d823.s0.p2","sentence":"Western analysis of gel-purified USF-ps nucleosome pe and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone ps H3 pe.","label":1}
{"pair_id":"BioInfer.d823.s0.p3","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-ps AH pe-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone ps H3 pe.","label":1}
{"pair_id":"BioInfer.d823.s0.p4","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated ps histone pe H4 relative to acetylated histone ps H3 pe.","label":0}
{"pair_id":"BioInfer.d823.s0.p5","sentence":"Western analysis of gel-purified ps USF pe-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone ps H3 pe.","label":1}
{"pair_id":"BioInfer.d823.s0.p6","sentence":"Western analysis of gel-purified USF-nucleosome and ps GAL4 pe-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone ps H3 pe.","label":1}
{"pair_id":"BioInfer.d823.s0.p7","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone ps H4 pe relative to acetylated histone ps H3 pe.","label":1}
{"pair_id":"BioInfer.d823.s0.p8","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-ps nucleosome pe complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated ps histone pe H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p9","sentence":"Western analysis of gel-purified USF-ps nucleosome pe and GAL4-AH-ps nucleosome pe complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p10","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-ps AH pe-ps nucleosome pe complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p11","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-ps nucleosome pe complexes demonstrated the predominant presence of acetylated ps histone pe H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p12","sentence":"Western analysis of gel-purified ps USF pe-nucleosome and GAL4-AH-ps nucleosome pe complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p13","sentence":"Western analysis of gel-purified USF-nucleosome and ps GAL4 pe-AH-ps nucleosome pe complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p14","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-ps nucleosome pe complexes demonstrated the predominant presence of acetylated histone ps H4 pe relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p15","sentence":"Western analysis of gel-purified USF-ps nucleosome pe and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated ps histone pe H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p16","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-ps AH pe-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated ps histone pe H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p17","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated ps histone pe H4 relative to acetylated ps histone pe H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p18","sentence":"Western analysis of gel-purified ps USF pe-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated ps histone pe H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p19","sentence":"Western analysis of gel-purified USF-nucleosome and ps GAL4 pe-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated ps histone pe H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p20","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone ps H4 pe relative to acetylated ps histone pe H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p21","sentence":"Western analysis of gel-purified USF-ps nucleosome pe and GAL4-ps AH pe-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p22","sentence":"Western analysis of gel-purified USF-ps nucleosome pe and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated ps histone pe H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p23","sentence":"Western analysis of gel-purified ps USF pe-ps nucleosome pe and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p24","sentence":"Western analysis of gel-purified USF-ps nucleosome pe and ps GAL4 pe-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p25","sentence":"Western analysis of gel-purified USF-ps nucleosome pe and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone ps H4 pe relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p26","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-ps AH pe-nucleosome complexes demonstrated the predominant presence of acetylated ps histone pe H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p27","sentence":"Western analysis of gel-purified ps USF pe-nucleosome and GAL4-ps AH pe-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p28","sentence":"Western analysis of gel-purified USF-nucleosome and ps GAL4 pe-ps AH pe-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p29","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-ps AH pe-nucleosome complexes demonstrated the predominant presence of acetylated histone ps H4 pe relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p30","sentence":"Western analysis of gel-purified ps USF pe-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated ps histone pe H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p31","sentence":"Western analysis of gel-purified USF-nucleosome and ps GAL4 pe-AH-nucleosome complexes demonstrated the predominant presence of acetylated ps histone pe H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p32","sentence":"Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated ps histone pe ps H4 pe relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p33","sentence":"Western analysis of gel-purified ps USF pe-nucleosome and ps GAL4 pe-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.","label":0}
{"pair_id":"BioInfer.d823.s0.p34","sentence":"Western analysis of gel-purified ps USF pe-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone ps H4 pe relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d823.s0.p35","sentence":"Western analysis of gel-purified USF-nucleosome and ps GAL4 pe-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone ps H4 pe relative to acetylated histone H3.","label":1}
{"pair_id":"BioInfer.d705.s0.p0","sentence":"The sequence of the inhibitory region is similar to that of a beta-hairpin region of the ps actin-binding protein pe ps profilin pe.","label":1}
{"pair_id":"BioInfer.d37.s0.p0","sentence":"All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between ps profilin pe and monomeric ps actin pe with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.","label":1}
{"pair_id":"AIMed.d217.s1886.p0","sentence":"Although the cytotoxic activity of mutant Y218D was unaltered, mutant Y218R was inactive, correlating with the prediction that Tyr-218 of ps FasL pe interacts with a cluster of three basic amino acid side chains of ps Fas pe.","label":1}
{"pair_id":"AIMed.d0.s6.p0","sentence":"Levels of ps IFN-gamma pe were slightly increased following ps IFN-alpha pe treatment (P = 0.09).","label":0}
{"pair_id":"AIMed.d101.s856.p0","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both ps c-Fos pe and ps c-Jun pe bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p1","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both ps c-Fos pe and c-Jun bind specifically and stably to ps TBP pe.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.","label":1}
{"pair_id":"AIMed.d101.s856.p2","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both ps c-Fos pe and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of ps c-Fos pe and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p3","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both ps c-Fos pe and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and ps c-Jun pe are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p4","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both ps c-Fos pe and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with ps TBP pe.","label":0}
{"pair_id":"AIMed.d101.s856.p5","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and ps c-Jun pe bind specifically and stably to ps TBP pe.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with TBP.","label":1}
{"pair_id":"AIMed.d101.s856.p6","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and ps c-Jun pe bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of ps c-Fos pe and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p7","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and ps c-Jun pe bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and ps c-Jun pe are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p8","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and ps c-Jun pe bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with ps TBP pe.","label":0}
{"pair_id":"AIMed.d101.s856.p9","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to ps TBP pe.Mutational analysis demonstrates that both the basic region and leucine zipper domains of ps c-Fos pe and c-Jun are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p10","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to ps TBP pe.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and ps c-Jun pe are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p11","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to ps TBP pe.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and c-Jun are necessary and sufficient for stable association with ps TBP pe.","label":0}
{"pair_id":"AIMed.d101.s856.p12","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of ps c-Fos pe and ps c-Jun pe are necessary and sufficient for stable association with TBP.","label":0}
{"pair_id":"AIMed.d101.s856.p13","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of ps c-Fos pe and c-Jun are necessary and sufficient for stable association with ps TBP pe.","label":1}
{"pair_id":"AIMed.d101.s856.p14","sentence":"Using co-immunoprecipitation and protein-protein association assays, we show that both c-Fos and c-Jun bind specifically and stably to TBP.Mutational analysis demonstrates that both the basic region and leucine zipper domains of c-Fos and ps c-Jun pe are necessary and sufficient for stable association with ps TBP pe.","label":1}
{"pair_id":"AIMed.d136.s1153.p0","sentence":"The cytokine, designated ps interleukin-15 pe (ps IL-15 pe), is produced by a wide variety of cells and tissues and shares many biological properties with IL-2.","label":0}
{"pair_id":"AIMed.d136.s1153.p1","sentence":"The cytokine, designated ps interleukin-15 pe (IL-15), is produced by a wide variety of cells and tissues and shares many biological properties with ps IL-2 pe.","label":0}
{"pair_id":"AIMed.d136.s1153.p2","sentence":"The cytokine, designated interleukin-15 (ps IL-15 pe), is produced by a wide variety of cells and tissues and shares many biological properties with ps IL-2 pe.","label":0}
{"pair_id":"AIMed.d105.s890.p0","sentence":"The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that ps gp130 pe dimer is formed through direct binding at two independent and differently oriented sites on ps IL-6 pe.","label":0}
{"pair_id":"AIMed.d218.s1898.p0","sentence":"These results suggest that ps TPO pe has two distinct receptor-binding sites that function to dimerize ps TPO pe receptors in a sequential fashion.","label":0}
{"pair_id":"AIMed.d118.s1004.p0","sentence":"Thus, during ps p53 pe-mediated suppression of cell proliferation, ps p21 pe and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.","label":0}
{"pair_id":"AIMed.d118.s1004.p1","sentence":"Thus, during ps p53 pe-mediated suppression of cell proliferation, p21 and ps PCNA pe may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.","label":0}
{"pair_id":"AIMed.d118.s1004.p2","sentence":"Thus, during p53-mediated suppression of cell proliferation, ps p21 pe and ps PCNA pe may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.","label":0}
{"pair_id":"BioInfer.d81.s1.p0","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the ps actin binding proteins pe Abp1p and ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d81.s1.p1","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins ps Abp1p pe and ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d81.s1.p2","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to ps actin pe together with antibodies to the actin binding proteins Abp1p and ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d81.s1.p3","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the ps actin binding proteins pe ps Abp1p pe and cofilin.","label":1}
{"pair_id":"BioInfer.d81.s1.p4","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to ps actin pe together with antibodies to the ps actin binding proteins pe Abp1p and cofilin.","label":0}
{"pair_id":"BioInfer.d81.s1.p5","sentence":"Immuno-EM double-labeling experiments were conducted with antibodies to ps actin pe together with antibodies to the actin binding proteins ps Abp1p pe and cofilin.","label":0}
{"pair_id":"BioInfer.d237.s2.p0","sentence":"Specific interactions between the human ps RAD51 pe and ps RAD52 pe proteins.","label":1}
{"pair_id":"BioInfer.d831.s0.p0","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor ps p21 pe Cip1\/ps WAF1 pe is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p1","sentence":"While levels of most of these proteins decrease, accumulation of ps cyclin D1 pe and the cyclin-dependent kinase inhibitor p21 Cip1\/ps WAF1 pe is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p2","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the ps cyclin-dependent kinase inhibitor pe p21 Cip1\/ps WAF1 pe is observed.","label":1}
{"pair_id":"BioInfer.d831.s0.p3","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 ps Cip1 pe\/ps WAF1 pe is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p4","sentence":"While levels of most of these proteins decrease, accumulation of ps cyclin D1 pe and the cyclin-dependent kinase inhibitor ps p21 pe Cip1\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p5","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the ps cyclin-dependent kinase inhibitor pe ps p21 pe Cip1\/WAF1 is observed.","label":1}
{"pair_id":"BioInfer.d831.s0.p6","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor ps p21 pe ps Cip1 pe\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p7","sentence":"While levels of most of these proteins decrease, accumulation of ps cyclin D1 pe and the ps cyclin-dependent kinase inhibitor pe p21 Cip1\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p8","sentence":"While levels of most of these proteins decrease, accumulation of ps cyclin D1 pe and the cyclin-dependent kinase inhibitor p21 ps Cip1 pe\/WAF1 is observed.","label":0}
{"pair_id":"BioInfer.d831.s0.p9","sentence":"While levels of most of these proteins decrease, accumulation of cyclin D1 and the ps cyclin-dependent kinase inhibitor pe p21 ps Cip1 pe\/WAF1 is observed.","label":1}
{"pair_id":"AIMed.d148.s1257.p0","sentence":"Moreover, ps cyclin D1 pe was found to be phosphorylated on tyrosine residues in vivo and, like ps cyclin A pe, was readily phosphorylated by pp60c-src in vitro.","label":0}
{"pair_id":"AIMed.d148.s1257.p1","sentence":"Moreover, ps cyclin D1 pe was found to be phosphorylated on tyrosine residues in vivo and, like cyclin A, was readily phosphorylated by ps pp60c-src pe in vitro.","label":1}
{"pair_id":"AIMed.d148.s1257.p2","sentence":"Moreover, cyclin D1 was found to be phosphorylated on tyrosine residues in vivo and, like ps cyclin A pe, was readily phosphorylated by ps pp60c-src pe in vitro.","label":1}
{"pair_id":"BioInfer.d573.s0.p0","sentence":"The amount of unassembled ps actin pe (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and ps profilin pe (5 microM), the barbed ends being capped.","label":1}
{"pair_id":"BioInfer.d573.s0.p1","sentence":"The amount of unassembled actin (12 microM) is accounted for by the sequestering functions of ps T beta 4Xen pe (20 microM) and ps profilin pe (5 microM), the barbed ends being capped.","label":0}
{"pair_id":"BioInfer.d573.s0.p2","sentence":"The amount of unassembled ps actin pe (12 microM) is accounted for by the sequestering functions of ps T beta 4Xen pe (20 microM) and profilin (5 microM), the barbed ends being capped.","label":1}
{"pair_id":"BioInfer.d680.s0.p0","sentence":"There are only 14 non-conservative substitutions in the two ps myosin heavy chains pe, three of which are located in the secondary ps actin pe-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.","label":1}
{"pair_id":"BioInfer.d280.s1.p0","sentence":"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for ps beta-catenin pe, and in 50 (55.6 per cent) for ps gamma-catenin pe.","label":0}
{"pair_id":"BioInfer.d280.s1.p1","sentence":"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for ps alpha-catenin pe, in 50 (55.6 per cent) for ps beta-catenin pe, and in 50 (55.6 per cent) for gamma-catenin.","label":0}
{"pair_id":"BioInfer.d280.s1.p2","sentence":"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for ps alpha-catenin pe, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for ps gamma-catenin pe.","label":0}
{"pair_id":"BioInfer.d830.s0.p0","sentence":"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ps ADF pe and actin are down-regulated compared with ps cofilin pe and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p1","sentence":"When the ps actin pe monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ps ADF pe and actin are down-regulated compared with cofilin and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p2","sentence":"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ps ADF pe and ps actin pe are down-regulated compared with cofilin and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p3","sentence":"When the ps actin pe monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with ps cofilin pe and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p4","sentence":"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and ps actin pe are down-regulated compared with ps cofilin pe and 19 other proteins selected at random.","label":0}
{"pair_id":"BioInfer.d830.s0.p5","sentence":"When the ps actin pe monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and ps actin pe are down-regulated compared with cofilin and 19 other proteins selected at random.","label":0}
{"pair_id":"AIMed.d15.s128.p0","sentence":"MATERIALS AND METHODS: We measured levels of ps IL-8 pe, ps interferon-gamma pe, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p1","sentence":"MATERIALS AND METHODS: We measured levels of ps IL-8 pe, interferon-gamma, ps IL-2 pe and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p2","sentence":"MATERIALS AND METHODS: We measured levels of ps IL-8 pe, interferon-gamma, IL-2 and ps IL-10 pe in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p3","sentence":"MATERIALS AND METHODS: We measured levels of IL-8, ps interferon-gamma pe, ps IL-2 pe and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p4","sentence":"MATERIALS AND METHODS: We measured levels of IL-8, ps interferon-gamma pe, IL-2 and ps IL-10 pe in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"AIMed.d15.s128.p5","sentence":"MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, ps IL-2 pe and ps IL-10 pe in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.","label":0}
{"pair_id":"BioInfer.d95.s0.p0","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, ps RAD51 pe on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD 54 pe, RA and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p1","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, ps RAD51 pe on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD pe 54, RA and ps RA pe did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p2","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, ps RAD51 pe on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD pe 54, ps RA pe and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p3","sentence":"Because other researchers have shown that the ps RAD51 pe and RAD52 proteins interact, ps RAD51 pe on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p4","sentence":"Because other researchers have shown that the RAD51 and ps RAD52 pe proteins interact, ps RAD51 pe on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p5","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, ps RAD51 pe on a high copy number plasmid was tested and found to suppress the ps rad52-20 pe allele, but RAD 54, RA and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p6","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD 54 peps RAD pe 54, RA and ps RA pe did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p7","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD 54 peps RAD pe 54, ps RA pe and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p8","sentence":"Because other researchers have shown that the ps RAD51 pe and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD 54 pe, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p9","sentence":"Because other researchers have shown that the RAD51 and ps RAD52 pe proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD 54 pe, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p10","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the ps rad52-20 pe allele, but ps RAD 54 pe, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p11","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD peps RAD pe 54, ps RA pe and ps RA pe did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p12","sentence":"Because other researchers have shown that the ps RAD51 pe and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD pe 54, RA and ps RA pe did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p13","sentence":"Because other researchers have shown that the RAD51 and ps RAD52 pe proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD pe 54, RA and ps RA pe did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p14","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the ps rad52-20 pe allele, but ps RAD pe 54, RA and ps RA pe did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p15","sentence":"Because other researchers have shown that the ps RAD51 pe and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD pe 54, ps RA pe and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p16","sentence":"Because other researchers have shown that the RAD51 and ps RAD52 pe proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but ps RAD pe 54, ps RA pe and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p17","sentence":"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the ps rad52-20 pe allele, but ps RAD pe 54, ps RA pe and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p18","sentence":"Because other researchers have shown that the ps RAD51 pe and ps RAD52 pe proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, RA and RA did not suppress.","label":1}
{"pair_id":"BioInfer.d95.s0.p19","sentence":"Because other researchers have shown that the ps RAD51 pe and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the ps rad52-20 pe allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"BioInfer.d95.s0.p20","sentence":"Because other researchers have shown that the RAD51 and ps RAD52 pe proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the ps rad52-20 pe allele, but RAD 54, RA and RA did not suppress.","label":0}
{"pair_id":"AIMed.d184.s1563.p0","sentence":"Here we show that a complex of ps gp120 pe, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble ps CD4 pe interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":1}
{"pair_id":"AIMed.d184.s1563.p1","sentence":"Here we show that a complex of ps gp120 pe, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with ps CCR-5 pe and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":1}
{"pair_id":"AIMed.d184.s1563.p2","sentence":"Here we show that a complex of ps gp120 pe, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural ps CCR-5 pe ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p3","sentence":"Here we show that a complex of ps gp120 pe, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, ps macrophage inflammatory protein (MIP)-1alpha pe and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p4","sentence":"Here we show that a complex of ps gp120 pe, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and ps MIP-1beta pe (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p5","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble ps CD4 pe interacts specifically with ps CCR-5 pe and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":1}
{"pair_id":"AIMed.d184.s1563.p6","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble ps CD4 pe interacts specifically with CCR-5 and inhibits the binding of the natural ps CCR-5 pe ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p7","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble ps CD4 pe interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, ps macrophage inflammatory protein (MIP)-1alpha pe and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p8","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble ps CD4 pe interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and ps MIP-1beta pe (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p9","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with ps CCR-5 pe and inhibits the binding of the natural ps CCR-5 pe ligands, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p10","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with ps CCR-5 pe and inhibits the binding of the natural CCR-5 ligands, ps macrophage inflammatory protein (MIP)-1alpha pe and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p11","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with ps CCR-5 pe and inhibits the binding of the natural CCR-5 ligands, macrophage inflammatory protein (MIP)-1alpha and ps MIP-1beta pe (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p12","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural ps CCR-5 pe ligands, ps macrophage inflammatory protein (MIP)-1alpha pe and MIP-1beta (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p13","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural ps CCR-5 pe ligands, macrophage inflammatory protein (MIP)-1alpha and ps MIP-1beta pe (refs 7, 8).","label":0}
{"pair_id":"AIMed.d184.s1563.p14","sentence":"Here we show that a complex of gp120, the exterior envelope glycoprotein, of macrophage-tropic primary HIV-1 and soluble CD4 interacts specifically with CCR-5 and inhibits the binding of the natural CCR-5 ligands, ps macrophage inflammatory protein (MIP)-1alpha pe and ps MIP-1beta pe (refs 7, 8).","label":0}
{"pair_id":"BioInfer.d701.s0.p0","sentence":"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the ps skeletal actin pe gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the ps actin pe and myosin heavy chain families are independently regulated in human heart.","label":0}
{"pair_id":"BioInfer.d701.s0.p1","sentence":"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the ps skeletal actin pe gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and ps myosin heavy chain pe families are independently regulated in human heart.","label":0}
{"pair_id":"BioInfer.d701.s0.p2","sentence":"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the ps actin pe and ps myosin heavy chain pe families are independently regulated in human heart.","label":1}
{"pair_id":"AIMed.d68.s578.p0","sentence":"Two previously unidentified human ps cdc25 pe genes have been isolated, ps cdc25A pe and cdc25B.","label":0}
{"pair_id":"AIMed.d68.s578.p1","sentence":"Two previously unidentified human ps cdc25 pe genes have been isolated, cdc25A and ps cdc25B pe.","label":0}
{"pair_id":"AIMed.d68.s578.p2","sentence":"Two previously unidentified human cdc25 genes have been isolated, ps cdc25A pe and ps cdc25B pe.","label":0}
{"pair_id":"AIMed.d124.s1058.p0","sentence":"These proteins, ps 14-3-3 zeta pe (ps PLA2 pe) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p1","sentence":"These proteins, ps 14-3-3 zeta pe (PLA2) and ps 14-3-3 beta pe (HS1), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p2","sentence":"These proteins, ps 14-3-3 zeta pe (PLA2) and 14-3-3 beta (ps HS1 pe), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p3","sentence":"These proteins, 14-3-3 zeta (ps PLA2 pe) and ps 14-3-3 beta pe (HS1), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p4","sentence":"These proteins, 14-3-3 zeta (ps PLA2 pe) and 14-3-3 beta (ps HS1 pe), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d124.s1058.p5","sentence":"These proteins, 14-3-3 zeta (PLA2) and ps 14-3-3 beta pe (ps HS1 pe), are members of the 14-3-3 family of proteins.","label":0}
{"pair_id":"AIMed.d101.s853.p0","sentence":"ps Fos pe and ps Jun pe oncoproteins form a complex that regulates transcription from promoters containing AP-1 binding sites.","label":1}
{"pair_id":"AIMed.d183.s1557.p0","sentence":"In contrast, in the absence of ps p21ras pe, coexpression of ps JAK2 pe and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p1","sentence":"In contrast, in the absence of ps p21ras pe, coexpression of JAK2 and ps Raf-1 pe resulted in an overall decrease in the Raf-1 kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p2","sentence":"In contrast, in the absence of ps p21ras pe, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the ps Raf-1 pe kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p3","sentence":"In contrast, in the absence of p21ras, coexpression of ps JAK2 pe and ps Raf-1 pe resulted in an overall decrease in the Raf-1 kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p4","sentence":"In contrast, in the absence of p21ras, coexpression of ps JAK2 pe and Raf-1 resulted in an overall decrease in the ps Raf-1 pe kinase activity.","label":0}
{"pair_id":"AIMed.d183.s1557.p5","sentence":"In contrast, in the absence of p21ras, coexpression of JAK2 and ps Raf-1 pe resulted in an overall decrease in the ps Raf-1 pe kinase activity.","label":0}
{"pair_id":"AIMed.d147.s1250.p0","sentence":"In addition we have been able to identify complexes of ps pRB pe and ps RBP1 pe in vivo that are dissociated in the presence of purified human papillomavirus E7 protein.","label":1}
{"pair_id":"AIMed.d147.s1250.p1","sentence":"In addition we have been able to identify complexes of ps pRB pe and RBP1 in vivo that are dissociated in the presence of purified human papillomavirus ps E7 pe protein.","label":0}
{"pair_id":"AIMed.d147.s1250.p2","sentence":"In addition we have been able to identify complexes of pRB and ps RBP1 pe in vivo that are dissociated in the presence of purified human papillomavirus ps E7 pe protein.","label":0}
{"pair_id":"AIMed.d117.s989.p0","sentence":"Here we show that beta:ps beta activin pe binds to the ps activin type II receptor kinase pe (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.","label":1}
{"pair_id":"AIMed.d117.s989.p1","sentence":"Here we show that beta:ps beta activin pe binds to the activin type II receptor kinase (ps ActRII pe) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.","label":1}
{"pair_id":"AIMed.d117.s989.p2","sentence":"Here we show that beta:ps beta activin pe binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase ps SKR2 pe to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p3","sentence":"Here we show that beta:ps beta activin pe binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ps ActRII pe.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p4","sentence":"Here we show that beta:beta activin binds to the ps activin type II receptor kinase pe (ps ActRII pe) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p5","sentence":"Here we show that beta:beta activin binds to the ps activin type II receptor kinase pe (ActRII) which induces activin binding to the type I receptor kinase ps SKR2 pe to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p6","sentence":"Here we show that beta:beta activin binds to the ps activin type II receptor kinase pe (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ps ActRII pe.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p7","sentence":"Here we show that beta:beta activin binds to the activin type II receptor kinase (ps ActRII pe) which induces activin binding to the type I receptor kinase ps SKR2 pe to form ActRII.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p8","sentence":"Here we show that beta:beta activin binds to the activin type II receptor kinase (ps ActRII pe) which induces activin binding to the type I receptor kinase SKR2 to form ps ActRII pe.beta:beta.","label":0}
{"pair_id":"AIMed.d117.s989.p9","sentence":"Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase ps SKR2 pe to form ps ActRII pe.beta:beta.","label":0}
{"pair_id":"AIMed.d179.s1527.p0","sentence":"We have previously reported that tyrosine phosphorylation of ps Shc pe and its association with the ps Grb2 pe-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.","label":1}
{"pair_id":"AIMed.d179.s1527.p1","sentence":"We have previously reported that tyrosine phosphorylation of ps Shc pe and its association with the Grb2-ps Sos pe complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.","label":1}
{"pair_id":"AIMed.d179.s1527.p2","sentence":"We have previously reported that tyrosine phosphorylation of ps Shc pe and its association with the Grb2-Sos complex may contribute to the activation of the ps mitogen-activated protein kinase pe pathway by gastrin.","label":0}
{"pair_id":"AIMed.d179.s1527.p3","sentence":"We have previously reported that tyrosine phosphorylation of ps Shc pe and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by ps gastrin pe.","label":0}
{"pair_id":"AIMed.d179.s1527.p4","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the ps Grb2 pe-ps Sos pe complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.","label":1}
{"pair_id":"AIMed.d179.s1527.p5","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the ps Grb2 pe-Sos complex may contribute to the activation of the ps mitogen-activated protein kinase pe pathway by gastrin.","label":0}
{"pair_id":"AIMed.d179.s1527.p6","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the ps Grb2 pe-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by ps gastrin pe.","label":0}
{"pair_id":"AIMed.d179.s1527.p7","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-ps Sos pe complex may contribute to the activation of the ps mitogen-activated protein kinase pe pathway by gastrin.","label":0}
{"pair_id":"AIMed.d179.s1527.p8","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-ps Sos pe complex may contribute to the activation of the mitogen-activated protein kinase pathway by ps gastrin pe.","label":0}
{"pair_id":"AIMed.d179.s1527.p9","sentence":"We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the ps mitogen-activated protein kinase pe pathway by ps gastrin pe.","label":0}
{"pair_id":"AIMed.d206.s1783.p0","sentence":"ps CD9 pe was associated with alpha 3 beta 1 but not alpha 5 beta 1; small amounts of ps CD9 pe also co-immunoprecipitated with antibodies to alpha 2 beta 1 and alpha 6 beta 4.","label":0}
{"pair_id":"BioInfer.d586.s0.p0","sentence":"The ps RAD54 pe and ps RAD51 pe genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.","label":0}
{"pair_id":"AIMed.d95.s802.p0","sentence":"Mechanism of CDK activation revealed by the structure of a ps cyclinA pe-ps CDK2 pe complex.","label":1}
{"pair_id":"BioInfer.d612.s0.p0","sentence":"The expression of ps APC pe, alpha-catenin and ps beta-catenin pe also was decreased in HT29 cells, with a translocation of APC into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p1","sentence":"The expression of ps APC pe, ps alpha-catenin pe and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p2","sentence":"The expression of ps APC pe, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of ps APC pe into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p3","sentence":"The expression of APC, ps alpha-catenin pe and ps beta-catenin pe also was decreased in HT29 cells, with a translocation of APC into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p4","sentence":"The expression of APC, alpha-catenin and ps beta-catenin pe also was decreased in HT29 cells, with a translocation of ps APC pe into the nucleus.","label":0}
{"pair_id":"BioInfer.d612.s0.p5","sentence":"The expression of APC, ps alpha-catenin pe and beta-catenin also was decreased in HT29 cells, with a translocation of ps APC pe into the nucleus.","label":0}
{"pair_id":"BioInfer.d6.s1.p0","sentence":"In contrast, ps profilin pe had little effect on the rigidity and viscosity of ps actin pe filaments.","label":1}
{"pair_id":"AIMed.d64.s551.p0","sentence":"Crosslinking of iodinated ps acidic FGF pe (ps aFGF pe) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p1","sentence":"Crosslinking of iodinated ps acidic FGF pe (aFGF) and ps basic FGF pe (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p2","sentence":"Crosslinking of iodinated ps acidic FGF pe (aFGF) and basic FGF (ps bFGF pe) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p3","sentence":"Crosslinking of iodinated ps acidic FGF pe (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both ps aFGF pe and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p4","sentence":"Crosslinking of iodinated ps acidic FGF pe (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and ps bFGF pe.","label":0}
{"pair_id":"AIMed.d64.s551.p5","sentence":"Crosslinking of iodinated acidic FGF (ps aFGF pe) and ps basic FGF pe (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p6","sentence":"Crosslinking of iodinated acidic FGF (ps aFGF pe) and basic FGF (ps bFGF pe) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p7","sentence":"Crosslinking of iodinated acidic FGF (ps aFGF pe) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both ps aFGF pe and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p8","sentence":"Crosslinking of iodinated acidic FGF (ps aFGF pe) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and ps bFGF pe.","label":0}
{"pair_id":"AIMed.d64.s551.p9","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and ps basic FGF pe (ps bFGF pe) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p10","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and ps basic FGF pe (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both ps aFGF pe and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p11","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and ps basic FGF pe (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and ps bFGF pe.","label":0}
{"pair_id":"AIMed.d64.s551.p12","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (ps bFGF pe) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both ps aFGF pe and bFGF.","label":0}
{"pair_id":"AIMed.d64.s551.p13","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (ps bFGF pe) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both aFGF and ps bFGF pe.","label":0}
{"pair_id":"AIMed.d64.s551.p14","sentence":"Crosslinking of iodinated acidic FGF (aFGF) and basic FGF (bFGF) to transiently expressing COS-1 cells revealed a major band of 95 kDa, which was competed for by both ps aFGF pe and ps bFGF pe.","label":0}
{"pair_id":"BioInfer.d247.s1.p0","sentence":"The essential role of ps profilin pe in the assembly of ps actin pe for microspike formation.","label":1}
{"pair_id":"AIMed.d79.s677.p0","sentence":"A domain is conserved between ps RIZ pe and the ps PRDI-BF1 pe\/Blimp-1 differentiation factor.","label":0}
{"pair_id":"AIMed.d79.s677.p1","sentence":"A domain is conserved between ps RIZ pe and the PRDI-BF1\/ps Blimp-1 pe differentiation factor.","label":0}
{"pair_id":"AIMed.d79.s677.p2","sentence":"A domain is conserved between RIZ and the ps PRDI-BF1 pe\/ps Blimp-1 pe differentiation factor.","label":0}
{"pair_id":"AIMed.d172.s1446.p0","sentence":"ps Vascular endothelial growth factor peps Vascular endothelial growth factor-related protein pe: a ligand and specific activator of the tyrosine kinase receptor Flt4.","label":0}
{"pair_id":"AIMed.d172.s1446.p1","sentence":"ps Vascular endothelial growth factor pe-related protein: a ligand and specific activator of the tyrosine kinase receptor ps Flt4 pe.","label":0}
{"pair_id":"AIMed.d172.s1446.p2","sentence":"ps Vascular endothelial growth factor-related protein pe: a ligand and specific activator of the tyrosine kinase receptor ps Flt4 pe.","label":1}
{"pair_id":"AIMed.d185.s1571.p0","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the ps interleukin 10 pe (ps IL-10 pe) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p1","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the ps interleukin 10 peps interleukin 10 (IL-10) receptor pe, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p2","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the ps interleukin 10 pe (IL-10) receptor, the STAT proteins activated by ps IL-10 pe in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p3","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the ps interleukin 10 (IL-10) receptor peps IL-10 pe) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p4","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 (ps IL-10 pe) receptor, the STAT proteins activated by ps IL-10 pe in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d185.s1571.p5","sentence":"To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the ps interleukin 10 (IL-10) receptor pe, the STAT proteins activated by ps IL-10 pe in different cell populations were first defined using electrophoretic mobility shift assays.","label":0}
{"pair_id":"AIMed.d183.s1552.p0","sentence":"The cytokine-activated tyrosine kinase ps JAK2 pe activates ps Raf-1 pe in a p21ras-dependent manner.","label":1}
{"pair_id":"AIMed.d183.s1552.p1","sentence":"The cytokine-activated tyrosine kinase ps JAK2 pe activates Raf-1 in a ps p21ras pe-dependent manner.","label":0}
{"pair_id":"AIMed.d183.s1552.p2","sentence":"The cytokine-activated tyrosine kinase JAK2 activates ps Raf-1 pe in a ps p21ras pe-dependent manner.","label":0}
{"pair_id":"BioInfer.d729.s0.p0","sentence":"The two proteins were found to differ in their interaction with actin, like ps destrin pe and ps cofilin pe isolated from porcine brain.","label":1}
{"pair_id":"BioInfer.d729.s0.p1","sentence":"The two proteins were found to differ in their interaction with ps actin pe, like destrin and ps cofilin pe isolated from porcine brain.","label":1}
{"pair_id":"BioInfer.d729.s0.p2","sentence":"The two proteins were found to differ in their interaction with ps actin pe, like ps destrin pe and cofilin isolated from porcine brain.","label":1}
{"pair_id":"AIMed.d215.s1866.p0","sentence":"Induction of cell migration by ps matrix metalloprotease-2 pe cleavage of ps laminin-5 pe.","label":1}
{"pair_id":"AIMed.d81.s690.p0","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of ps Fas pe: ps Fas pe itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.","label":1}
{"pair_id":"AIMed.d81.s690.p1","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of ps Fas pe: Fas itself, and a novel 74 kDa protein we have named ps RIP pe, for receptor interacting protein.","label":1}
{"pair_id":"AIMed.d81.s690.p2","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of ps Fas pe: Fas itself, and a novel 74 kDa protein we have named RIP, for ps receptor interacting protein pe.","label":1}
{"pair_id":"AIMed.d81.s690.p3","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: ps Fas pe itself, and a novel 74 kDa protein we have named ps RIP pe, for receptor interacting protein.","label":0}
{"pair_id":"AIMed.d81.s690.p4","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: ps Fas pe itself, and a novel 74 kDa protein we have named RIP, for ps receptor interacting protein pe.","label":0}
{"pair_id":"AIMed.d81.s690.p5","sentence":"Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named ps RIP pe, for ps receptor interacting protein pe.","label":0}
{"pair_id":"AIMed.d150.s1280.p0","sentence":"Overexpression of a phosphorylation-defective form of ps Rb pe inhibited ps Elf-1 pe-dependent transcription during T cell activation.","label":0}
{"pair_id":"BioInfer.d497.s0.p0","sentence":"ps Profilin pe is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and ps actin pe raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p1","sentence":"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of ps profilin pe and ps actin pe raised the possibility that profilin might also regulate lipid metabolism.","label":1}
{"pair_id":"BioInfer.d497.s0.p2","sentence":"Profilin is generally thought to regulate ps actin pe polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and ps actin pe raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p3","sentence":"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and ps actin pe raised the possibility that ps profilin pe might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p4","sentence":"ps Profilin pe is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of ps profilin pe and actin raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p5","sentence":"ps Profilin pe is generally thought to regulate ps actin pe polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.","label":1}
{"pair_id":"BioInfer.d497.s0.p6","sentence":"ps Profilin pe is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that ps profilin pe might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p7","sentence":"Profilin is generally thought to regulate ps actin pe polymerization, but the observation that acidic phospholipids dissociate the complex of ps profilin pe and actin raised the possibility that profilin might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p8","sentence":"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of ps profilin pe and actin raised the possibility that ps profilin pe might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d497.s0.p9","sentence":"Profilin is generally thought to regulate ps actin pe polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that ps profilin pe might also regulate lipid metabolism.","label":0}
{"pair_id":"BioInfer.d747.s0.p0","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of ps cortexillin I pe or co, two isoforms of the actin-bundling protein ps cortexillin pe.","label":1}
{"pair_id":"BioInfer.d747.s0.p1","sentence":"This technique was employed to quantify changes caused by the lack of ps talin pe, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the actin-bundling protein ps cortexillin pe.","label":0}
{"pair_id":"BioInfer.d747.s0.p2","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of ps cortexillin pe I or ps co pe, two isoforms of the actin-bundling protein ps cortexillin pe.","label":1}
{"pair_id":"BioInfer.d747.s0.p3","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the ps actin pe-bundling protein ps cortexillin pe.","label":1}
{"pair_id":"BioInfer.d747.s0.p4","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the ps actin pe network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the actin-bundling protein ps cortexillin pe.","label":0}
{"pair_id":"BioInfer.d747.s0.p5","sentence":"This technique was employed to quantify changes caused by the lack of ps talin pe, a protein that couples the actin network to the plasma membrane, or by the lack of ps cortexillin I pe or co, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p6","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of ps cortexillin I peps cortexillin pe I or ps co pe, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p7","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of ps cortexillin I pe or co, two isoforms of the ps actin pe-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p8","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the ps actin pe network to the plasma membrane, or by the lack of ps cortexillin I pe or co, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p9","sentence":"This technique was employed to quantify changes caused by the lack of ps talin pe, a protein that couples the actin network to the plasma membrane, or by the lack of ps cortexillin pe I or ps co pe, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p10","sentence":"This technique was employed to quantify changes caused by the lack of ps talin pe, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the ps actin pe-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p11","sentence":"This technique was employed to quantify changes caused by the lack of ps talin pe, a protein that couples the ps actin pe network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the actin-bundling protein cortexillin.","label":1}
{"pair_id":"BioInfer.d747.s0.p12","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of ps cortexillin pe I or ps co pe, two isoforms of the ps actin pe-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p13","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the ps actin pe network to the plasma membrane, or by the lack of ps cortexillin pe I or ps co pe, two isoforms of the actin-bundling protein cortexillin.","label":0}
{"pair_id":"BioInfer.d747.s0.p14","sentence":"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the ps actin pe network to the plasma membrane, or by the lack of cortexillin I or co, two isoforms of the ps actin pe-bundling protein cortexillin.","label":0}
{"pair_id":"AIMed.d22.s181.p0","sentence":"Present data concerning the ps renin pe-ps angiotensin pe system of extrarenal origin.","label":0}
{"pair_id":"BioInfer.d143.s0.p0","sentence":"Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric ps actin pe than did ps class I profilins pe.","label":1}
{"pair_id":"BioInfer.d143.s0.p1","sentence":"ps Class II profilins pe had higher affinity for poly-l-proline and sequestered more monomeric actin than did ps class I profilins pe.","label":0}
{"pair_id":"BioInfer.d143.s0.p2","sentence":"ps Class II profilins pe had higher affinity for poly-l-proline and sequestered more monomeric ps actin pe than did class I profilins.","label":1}
{"pair_id":"BioInfer.d471.s1.p0","sentence":"Our results show that the major pool of polymerizable ps actin pe monomers is complexed with ps profilin pe and spread throughout the cytoplasm.","label":1}
{"pair_id":"AIMed.d183.s1554.p0","sentence":"ps Interferon-gamma pe and several other cytokines that are known to activate ps JAK2 pe kinase were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p1","sentence":"ps Interferon-gamma pe and several other cytokines that are known to activate ps JAK2 kinase pe were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.","label":1}
{"pair_id":"AIMed.d183.s1554.p2","sentence":"ps Interferon-gamma pe and several other cytokines that are known to activate JAK2 kinase were also found to stimulate ps Raf-1 pe kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p3","sentence":"ps Interferon-gamma pe and several other cytokines that are known to activate JAK2 kinase were also found to stimulate ps Raf-1 kinase pe activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p4","sentence":"ps Interferon-gamma pe and several other cytokines that are known to activate JAK2 kinase were also found to stimulate Raf-1 kinase activity toward ps MEK-1 pe in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p5","sentence":"Interferon-gamma and several other cytokines that are known to activate ps JAK2 peps JAK2 kinase pe were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p6","sentence":"Interferon-gamma and several other cytokines that are known to activate ps JAK2 pe kinase were also found to stimulate ps Raf-1 pe kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p7","sentence":"Interferon-gamma and several other cytokines that are known to activate ps JAK2 pe kinase were also found to stimulate ps Raf-1 kinase pe activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p8","sentence":"Interferon-gamma and several other cytokines that are known to activate ps JAK2 pe kinase were also found to stimulate Raf-1 kinase activity toward ps MEK-1 pe in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p9","sentence":"Interferon-gamma and several other cytokines that are known to activate ps JAK2 kinase pe were also found to stimulate ps Raf-1 pe kinase activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p10","sentence":"Interferon-gamma and several other cytokines that are known to activate ps JAK2 kinase pe were also found to stimulate ps Raf-1 kinase pe activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p11","sentence":"Interferon-gamma and several other cytokines that are known to activate ps JAK2 kinase pe were also found to stimulate Raf-1 kinase activity toward ps MEK-1 pe in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p12","sentence":"Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate ps Raf-1 peps Raf-1 kinase pe activity toward MEK-1 in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p13","sentence":"Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate ps Raf-1 pe kinase activity toward ps MEK-1 pe in mammalian cells.","label":0}
{"pair_id":"AIMed.d183.s1554.p14","sentence":"Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate ps Raf-1 kinase pe activity toward ps MEK-1 pe in mammalian cells.","label":1}
{"pair_id":"BioInfer.d59.s0.p0","sentence":"Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that ps cofilin pe was cross-linked with the N-terminal segment of ps actin pe containing residues 1-12.","label":1}
{"pair_id":"BioInfer.d459.s0.p0","sentence":"Once the actin monomer is bound to the filament, the ps profilin pe is released, and is available to bind to additional ps actin pe monomers.","label":1}
{"pair_id":"BioInfer.d459.s0.p1","sentence":"Once the ps actin pe monomer is bound to the filament, the profilin is released, and is available to bind to additional ps actin pe monomers.","label":0}
{"pair_id":"BioInfer.d459.s0.p2","sentence":"Once the ps actin pe monomer is bound to the filament, the ps profilin pe is released, and is available to bind to additional actin monomers.","label":0}
{"pair_id":"AIMed.d167.s1408.p0","sentence":"Both the ps GT155 pe-ps calnexin pe and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":1}
{"pair_id":"AIMed.d167.s1408.p1","sentence":"Both the ps GT155 pe-calnexin and the ps GT155 pe-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p2","sentence":"Both the ps GT155 pe-calnexin and the GT155-ps CAP-60 pe interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p3","sentence":"Both the ps GT155 pe-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on ps GT155 pe, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p4","sentence":"Both the ps GT155 pe-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many ps calnexin pe interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p5","sentence":"Both the GT155-ps calnexin pe and the ps GT155 pe-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p6","sentence":"Both the GT155-ps calnexin pe and the GT155-ps CAP-60 pe interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p7","sentence":"Both the GT155-ps calnexin pe and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on ps GT155 pe, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p8","sentence":"Both the GT155-ps calnexin pe and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many ps calnexin pe interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p9","sentence":"Both the GT155-calnexin and the ps GT155 pe-ps CAP-60 pe interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.","label":1}
{"pair_id":"AIMed.d167.s1408.p10","sentence":"Both the GT155-calnexin and the ps GT155 pe-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on ps GT155 pe, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p11","sentence":"Both the GT155-calnexin and the ps GT155 pe-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many ps calnexin pe interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p12","sentence":"Both the GT155-calnexin and the GT155-ps CAP-60 pe interactions were dependent on the presence of a correctly modified oligosaccharide group on ps GT155 pe, a characteristic of many calnexin interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p13","sentence":"Both the GT155-calnexin and the GT155-ps CAP-60 pe interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many ps calnexin pe interactions.","label":0}
{"pair_id":"AIMed.d167.s1408.p14","sentence":"Both the GT155-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on ps GT155 pe, a characteristic of many ps calnexin pe interactions.","label":0}
{"pair_id":"AIMed.d48.s423.p0","sentence":"ps LEC pe induced maximal migration of ps CCR1 pe and CCR8 transfected cells at 89.3 nmol\/L and cell adhesion at 5.6 nmol\/L.","label":0}
{"pair_id":"AIMed.d48.s423.p1","sentence":"ps LEC pe induced maximal migration of CCR1 and ps CCR8 pe transfected cells at 89.3 nmol\/L and cell adhesion at 5.6 nmol\/L.","label":0}
{"pair_id":"AIMed.d48.s423.p2","sentence":"LEC induced maximal migration of ps CCR1 pe and ps CCR8 pe transfected cells at 89.3 nmol\/L and cell adhesion at 5.6 nmol\/L.","label":0}
{"pair_id":"BioInfer.d6.s0.p0","sentence":"Acanthamoeba ps profilin pe affects the mechanical properties of nonfilamentous ps actin pe.","label":1}
{"pair_id":"BioInfer.d14.s1.p0","sentence":"These studies suggest that ps profilin pe and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d14.s1.p1","sentence":"These studies suggest that ps profilin pe and ps gelsolin pe may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.","label":0}
{"pair_id":"BioInfer.d14.s1.p2","sentence":"These studies suggest that profilin and ps gelsolin pe may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d779.s0.p0","sentence":"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick ps actin-depolymerizing factor pe (ps ADF pe), two structurally and functionally related proteins.","label":0}
{"pair_id":"BioInfer.d779.s0.p1","sentence":"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick ps cofilin pe and 66% identical to chick ps actin-depolymerizing factor pe (ADF), two structurally and functionally related proteins.","label":1}
{"pair_id":"BioInfer.d779.s0.p2","sentence":"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick ps cofilin pe and 66% identical to chick actin-depolymerizing factor (ps ADF pe), two structurally and functionally related proteins.","label":1}
{"pair_id":"AIMed.d152.s1294.p0","sentence":"Here we show that ps TRADD pe directly interacts with ps TRAF2 pe and FADD, signal transducers that activate NF-kappa B and induce apoptosis, respectively.","label":1}
{"pair_id":"AIMed.d152.s1294.p1","sentence":"Here we show that ps TRADD pe directly interacts with TRAF2 and ps FADD pe, signal transducers that activate NF-kappa B and induce apoptosis, respectively.","label":1}
{"pair_id":"AIMed.d152.s1294.p2","sentence":"Here we show that ps TRADD pe directly interacts with TRAF2 and FADD, signal transducers that activate ps NF-kappa B pe and induce apoptosis, respectively.","label":0}
{"pair_id":"AIMed.d152.s1294.p3","sentence":"Here we show that TRADD directly interacts with ps TRAF2 pe and ps FADD pe, signal transducers that activate NF-kappa B and induce apoptosis, respectively.","label":0}
{"pair_id":"AIMed.d152.s1294.p4","sentence":"Here we show that TRADD directly interacts with ps TRAF2 pe and FADD, signal transducers that activate ps NF-kappa B pe and induce apoptosis, respectively.","label":1}
{"pair_id":"AIMed.d152.s1294.p5","sentence":"Here we show that TRADD directly interacts with TRAF2 and ps FADD pe, signal transducers that activate ps NF-kappa B pe and induce apoptosis, respectively.","label":1}
{"pair_id":"BioInfer.d3.s0.p0","sentence":"Absence of ps alpha-syntrophin pe leads to structurally aberrant neuromuscular synapses deficient in ps utrophin pe.","label":1}
{"pair_id":"BioInfer.d608.s0.p0","sentence":"The E-cadherin-associated proteins ps alpha-catenin pe and ps beta-catenin pe were not significantly affected by treatment with TPA.","label":0}
{"pair_id":"BioInfer.d608.s0.p1","sentence":"The E-cadherin-associated proteins ps alpha-catenin pe and beta-catenin were not significantly affected by treatment with ps TPA pe.","label":0}
{"pair_id":"BioInfer.d608.s0.p2","sentence":"The ps E-cadherin pe-associated proteins ps alpha-catenin pe and beta-catenin were not significantly affected by treatment with TPA.","label":1}
{"pair_id":"BioInfer.d608.s0.p3","sentence":"The E-cadherin-associated proteins alpha-catenin and ps beta-catenin pe were not significantly affected by treatment with ps TPA pe.","label":0}
{"pair_id":"BioInfer.d608.s0.p4","sentence":"The ps E-cadherin pe-associated proteins alpha-catenin and ps beta-catenin pe were not significantly affected by treatment with TPA.","label":1}
{"pair_id":"BioInfer.d608.s0.p5","sentence":"The ps E-cadherin pe-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with ps TPA pe.","label":0}
{"pair_id":"AIMed.d99.s842.p0","sentence":"These observations suggest that the products of the ps CSA pe and ps CSB pe genes are involved in transcription.","label":0}
{"pair_id":"AIMed.d76.s647.p0","sentence":"In vivo labelling with 32P(i) also showed a four- to fivefold increase in Y-394 occupancy in ps p56lck pe when associated with ps CD5 pe.","label":1}
{"pair_id":"AIMed.d39.s342.p0","sentence":"ps PS1 pe suppressed ps c-jun pe-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.","label":0}
{"pair_id":"AIMed.d39.s342.p1","sentence":"ps PS1 pe suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in ps PS1 pe.","label":0}
{"pair_id":"AIMed.d39.s342.p2","sentence":"PS1 suppressed ps c-jun pe-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in ps PS1 pe.","label":0}
{"pair_id":"AIMed.d173.s1459.p0","sentence":"Fusion proteins were created by linking the ps Abeta pe fragment to a ps LexA pe DNA-binding domain (bait) and also to a B42 transactivation domain (prey).","label":0}
{"pair_id":"AIMed.d173.s1459.p1","sentence":"Fusion proteins were created by linking the ps Abeta pe fragment to a LexA DNA-binding domain (bait) and also to a ps B42 pe transactivation domain (prey).","label":0}
{"pair_id":"AIMed.d173.s1459.p2","sentence":"Fusion proteins were created by linking the Abeta fragment to a ps LexA pe DNA-binding domain (bait) and also to a ps B42 pe transactivation domain (prey).","label":0}
{"pair_id":"AIMed.d97.s823.p0","sentence":"Binding of ps OP-1 pe\/ps BMP-7 pe to BMPR-II was also observed in nontransfected cell lines.","label":0}
{"pair_id":"AIMed.d97.s823.p1","sentence":"Binding of ps OP-1 pe\/BMP-7 to ps BMPR-II pe was also observed in nontransfected cell lines.","label":1}
{"pair_id":"AIMed.d97.s823.p2","sentence":"Binding of OP-1\/ps BMP-7 pe to ps BMPR-II pe was also observed in nontransfected cell lines.","label":1}
{"pair_id":"BioInfer.d388.s3.p0","sentence":"To study ps profilin pe function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and ps actin pe organization.","label":0}
{"pair_id":"BioInfer.d388.s3.p1","sentence":"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae ps profilin pe gene (PFY1) and examined the consequences of specific point mutations on growth and ps actin pe organization.","label":1}
{"pair_id":"BioInfer.d388.s3.p2","sentence":"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (ps PFY1 pe) and examined the consequences of specific point mutations on growth and ps actin pe organization.","label":1}
{"pair_id":"BioInfer.d388.s3.p3","sentence":"To study ps profilin pe function, we extensively mutagenized the Saccharomyces cerevisiae ps profilin pe gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.","label":0}
{"pair_id":"BioInfer.d388.s3.p4","sentence":"To study ps profilin pe function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (ps PFY1 pe) and examined the consequences of specific point mutations on growth and actin organization.","label":0}
{"pair_id":"BioInfer.d388.s3.p5","sentence":"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae ps profilin pe gene (ps PFY1 pe) and examined the consequences of specific point mutations on growth and actin organization.","label":0}
{"pair_id":"BioInfer.d9.s0.p0","sentence":"A chimera consisting of the alpha-catenin-binding region of ps beta-catenin pe linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since ps beta-catenin pe binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p1","sentence":"A chimera consisting of the alpha-catenin-binding region of ps beta-catenin pe linked to the amino terminus of ps alpha-catenin 57-264 pe behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.","label":1}
{"pair_id":"BioInfer.d9.s0.p2","sentence":"A chimera consisting of the alpha-catenin-binding region of ps beta-catenin pe linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the ps alpha-catenin pe dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p3","sentence":"A chimera consisting of the ps alpha-catenin pe-binding region of ps beta-catenin pe linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.","label":1}
{"pair_id":"BioInfer.d9.s0.p4","sentence":"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of ps alpha-catenin 57-264 pe behaves as a monomer in solution, as expected, since ps beta-catenin pe binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p5","sentence":"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since ps beta-catenin pe binding disrupts the ps alpha-catenin pe dimer.","label":1}
{"pair_id":"BioInfer.d9.s0.p6","sentence":"A chimera consisting of the ps alpha-catenin pe-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since ps beta-catenin pe binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p7","sentence":"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of ps alpha-catenin 57-264 pe behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the ps alpha-catenin pe dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p8","sentence":"A chimera consisting of the ps alpha-catenin pe-binding region of beta-catenin linked to the amino terminus of ps alpha-catenin 57-264 pe behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.","label":0}
{"pair_id":"BioInfer.d9.s0.p9","sentence":"A chimera consisting of the ps alpha-catenin pe-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the ps alpha-catenin pe dimer.","label":0}
{"pair_id":"BioInfer.d455.s0.p0","sentence":"Notably, the two pro-apoptotic adapter proteins ps TRADD pe and ps FADD pe are also involved in the activation of A-SMase.","label":0}
{"pair_id":"BioInfer.d455.s0.p1","sentence":"Notably, the two pro-apoptotic adapter proteins TRADD and ps FADD pe are also involved in the activation of ps A-SMase pe.","label":1}
{"pair_id":"BioInfer.d455.s0.p2","sentence":"Notably, the two pro-apoptotic adapter proteins ps TRADD pe and FADD are also involved in the activation of ps A-SMase pe.","label":1}
{"pair_id":"AIMed.d18.s151.p0","sentence":"Cytokines ps IL-1alpha pe, ps IL-1beta pe, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p1","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p2","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p3","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p4","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p5","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p6","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p7","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p8","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p9","sentence":"Cytokines ps IL-1alpha pe, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p10","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p11","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p12","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p13","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p14","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p15","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p16","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p17","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p18","sentence":"Cytokines IL-1alpha, ps IL-1beta pe, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p19","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p20","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p21","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p22","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p23","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p24","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p25","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p26","sentence":"Cytokines IL-1alpha, IL-1beta, ps IL-6 pe, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p27","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, ps IL-8 pe, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p28","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p29","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p30","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p31","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p32","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p33","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, ps IL-8 pe, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p34","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, ps IL-10 pe (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p35","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p36","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p37","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p38","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p39","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, ps IL-10 pe (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p40","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p41","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p42","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p43","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p44","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), ps endothelin-1 pe, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p45","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (ps sCAM pe) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p46","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p47","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p48","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and ps soluble cell adhesion molecules pe (sCAM) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p49","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and ps sE-selectin pe, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p50","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p51","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (ps sCAM pe) sP- and sE-selectin, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p52","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, ps sICAM-1 pe, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p53","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and ps sE-selectin pe, sICAM-1, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d18.s151.p54","sentence":"Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, ps sICAM-1 pe, and ps sVCAM-1 pe (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).","label":0}
{"pair_id":"AIMed.d153.s1304.p0","sentence":"More importantly, adenosine in the absence of cell surface ps ADA pe inhibited T cell proliferation and ps IL-2 pe production induced by various stimuli.","label":0}
{"pair_id":"BioInfer.d781.s0.p0","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ps ABP pe) but lost greater than 80% of talin and ps myosin pe to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p1","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their ps actin-binding protein pe (ABP) but lost greater than 80% of talin and ps myosin pe to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p2","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of ps talin pe and ps myosin pe to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p3","sentence":"Under all conditions, platelets retained 40-50% of their total ps actin pe and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and ps myosin pe to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p4","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their ps actin-binding protein pe (ps ABP pe) but lost greater than 80% of talin and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p5","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ps ABP pe) but lost greater than 80% of ps talin pe and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p6","sentence":"Under all conditions, platelets retained 40-50% of their total ps actin pe and greater than 70% of their actin-binding protein (ps ABP pe) but lost greater than 80% of talin and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p7","sentence":"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their ps actin-binding protein pe (ABP) but lost greater than 80% of ps talin pe and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p8","sentence":"Under all conditions, platelets retained 40-50% of their total ps actin pe and greater than 70% of their ps actin-binding protein pe (ABP) but lost greater than 80% of talin and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d781.s0.p9","sentence":"Under all conditions, platelets retained 40-50% of their total ps actin pe and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of ps talin pe and myosin to the supernatant.","label":0}
{"pair_id":"BioInfer.d393.s0.p0","sentence":"Isolation of human ps skeletal muscle myosin heavy chain pe and ps actin pe for measurement of fractional synthesis rates.","label":0}
{"pair_id":"AIMed.d92.s789.p0","sentence":"Our results indicate that the ps trkA pe and ps p75 pe receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.","label":0}
{"pair_id":"AIMed.d92.s789.p1","sentence":"Our results indicate that the ps trkA pe and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity ps NGF pe binding sites.","label":0}
{"pair_id":"AIMed.d92.s789.p2","sentence":"Our results indicate that the trkA and ps p75 pe receptors can potentially interact, and that such an association may be responsible for the generation of high affinity ps NGF pe binding sites.","label":0}
{"pair_id":"AIMed.d166.s1397.p0","sentence":"The two residues of ps hLIF pe that contribute the majority of free energy for ps hLIF-R pe binding, Phe-156 and Lys-159 are surrounded by other residues which have only a moderate impact.","label":1}
{"pair_id":"BioInfer.d252.s0.p0","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a ps profilin pe-like fashion, and ps Arp2 pe\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p1","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a ps profilin pe-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp2 pe\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p2","sentence":"Here we show that the N-terminal domain of ActA binds one ps actin pe monomer, in a ps profilin pe-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p3","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a ps profilin pe-like fashion, and ps Arp pe2\/ps A pe complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p4","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a ps profilin pe-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp pe2\/ps A pe complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p5","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a ps profilin pe-like fashion, and Arp2\/A complex and mimics the C-terminal domain of ps WASp pe family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p6","sentence":"Here we show that the N-terminal domain of ps ActA pe binds one actin monomer, in a ps profilin pe-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p7","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and ps Arp2 pe\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp2 pe\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p8","sentence":"Here we show that the N-terminal domain of ActA binds one ps actin pe monomer, in a profilin-like fashion, and ps Arp2 pe\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p9","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and ps Arp2 peps Arp pe2\/ps A pe complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p10","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and ps Arp2 pe\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp pe2\/ps A pe complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p11","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and ps Arp2 pe\/A complex and mimics the C-terminal domain of ps WASp pe family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p12","sentence":"Here we show that the N-terminal domain of ps ActA pe binds one actin monomer, in a profilin-like fashion, and ps Arp2 pe\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p13","sentence":"Here we show that the N-terminal domain of ActA binds one ps actin pe monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp2 pe\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p14","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and ps Arp pe2\/ps A pe complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp2 pe\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p15","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp2 peps Arp pe2\/ps A pe complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p16","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of ps WASp pe family proteins in catalyzing filament barbed end branching by ps Arp2 pe\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p17","sentence":"Here we show that the N-terminal domain of ps ActA pe binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp2 pe\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p18","sentence":"Here we show that the N-terminal domain of ActA binds one ps actin pe monomer, in a profilin-like fashion, and ps Arp pe2\/ps A pe complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p19","sentence":"Here we show that the N-terminal domain of ActA binds one ps actin pe monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp pe2\/ps A pe complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p20","sentence":"Here we show that the N-terminal domain of ActA binds one ps actin pe monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of ps WASp pe family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p21","sentence":"Here we show that the N-terminal domain of ps ActA pe binds one ps actin pe monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p22","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and ps Arp pe2\/ps A pe complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp pe2\/ps A pe complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p23","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and ps Arp pe2\/ps A pe complex and mimics the C-terminal domain of ps WASp pe family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p24","sentence":"Here we show that the N-terminal domain of ps ActA pe binds one actin monomer, in a profilin-like fashion, and ps Arp pe2\/ps A pe complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":1}
{"pair_id":"BioInfer.d252.s0.p25","sentence":"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of ps WASp pe family proteins in catalyzing filament barbed end branching by ps Arp pe2\/ps A pe complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p26","sentence":"Here we show that the N-terminal domain of ps ActA pe binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by ps Arp pe2\/ps A pe complex.","label":0}
{"pair_id":"BioInfer.d252.s0.p27","sentence":"Here we show that the N-terminal domain of ps ActA pe binds one actin monomer, in a profilin-like fashion, and Arp2\/A complex and mimics the C-terminal domain of ps WASp pe family proteins in catalyzing filament barbed end branching by Arp2\/A complex.","label":0}
{"pair_id":"AIMed.d190.s1614.p0","sentence":"In these cells the adaptor protein ps Grb2 pe constitutively binds a substantial fraction of ps c-Cbl pe through the N-terminal SH3 domain.","label":1}
{"pair_id":"AIMed.d199.s1705.p0","sentence":"Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of ps FGFR3 pe, suggesting that the 66-kDa protein may play an important role in ps FGFR3 pe-specific signaling.","label":0}
{"pair_id":"BioInfer.d649.s0.p0","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p1","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p2","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p3","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p4","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p5","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p6","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p7","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p8","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p9","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p10","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, ps calcium vector protein pe, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p11","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p12","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p13","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p14","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p15","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p16","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p17","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p18","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p19","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p20","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, ps myosin heavy chain pe, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p21","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p22","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p23","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p24","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p25","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p26","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p27","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p28","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p29","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, ps calmodulin pe, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p30","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p31","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p32","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p33","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p34","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p35","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p36","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p37","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, ps myosin regulatory light chain pe, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p38","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p39","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p40","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p41","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p42","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p43","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p44","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, ps myosin light chain kinase pe, myosin heavy chain, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p45","sentence":"The muscle-related genes included actin, ps tropomyosin pe, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p46","sentence":"The muscle-related genes included ps actin pe, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p47","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p48","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p49","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p50","sentence":"The muscle-related genes included actin, ps tropomyosin pe, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p51","sentence":"The muscle-related genes included ps actin pe, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p52","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p53","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p54","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p55","sentence":"The muscle-related genes included actin, tropomyosin, ps troponin I pe, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p56","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p57","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p58","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p59","sentence":"The muscle-related genes included ps actin pe, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p60","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p61","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, ps muscle LIM pe protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p62","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, ps muscle LIM pe protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p63","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, creatine kinase, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p64","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, ps calponin pe, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d649.s0.p65","sentence":"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, ps creatine kinase pe, muscle LIM protein, and ps SH3-binding glutamate-rich protein pe, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.","label":0}
{"pair_id":"BioInfer.d672.s0.p0","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p1","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p2","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p3","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p4","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p5","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p6","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p7","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p8","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p9","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":1}
{"pair_id":"BioInfer.d672.s0.p10","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p11","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p12","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p13","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p14","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p15","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p16","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and ps 4b pe are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p17","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p18","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p19","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p20","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p21","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p22","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p23","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p24","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p25","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p26","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p27","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p28","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p29","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p30","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p31","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p32","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-ps G pe-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p33","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p34","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p35","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p36","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p37","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p38","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p39","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p40","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p41","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p42","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p43","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p44","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p45","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p46","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p47","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-ps L pe-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p48","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p49","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p50","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p51","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p52","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p53","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p54","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p55","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p56","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p57","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p58","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p59","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p60","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p61","sentence":"The proposed LNYV genomic map is 3'-N-4a-ps 4b pe-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p62","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p63","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p64","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p65","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p66","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p67","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p68","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p69","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p70","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p71","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p72","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p73","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p74","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-ps M pe-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p75","sentence":"The proposed LNYV genomic map is 3'-ps N pe-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p76","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p77","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p78","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p79","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p80","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p81","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p82","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p83","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p84","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p85","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p86","sentence":"The proposed LNYV genomic map is 3'-ps N pe-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p87","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p88","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p89","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p90","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p91","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p92","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p93","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p94","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p95","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p96","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p97","sentence":"The proposed LNYV genomic map is 3'-N-ps 4a pe-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p98","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p99","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p100","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p101","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p102","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p103","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p104","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p105","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p106","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p107","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; ps G pe is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p108","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p109","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p110","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p111","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p112","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p113","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p114","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p115","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p116","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and ps L pe is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p117","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p118","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p119","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p120","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p121","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p122","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p123","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p124","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where ps N pe is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p125","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p126","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p127","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p128","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p129","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":1}
{"pair_id":"BioInfer.d672.s0.p130","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":1}
{"pair_id":"BioInfer.d672.s0.p131","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein ps P pe and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p132","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p133","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p134","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p135","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p136","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p137","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; ps M pe is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p138","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p139","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p140","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p141","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p142","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed ps transcriptase pe gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p143","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p144","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p145","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p146","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed ps glycoprotein pe gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p147","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p148","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p149","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the ps nucleocapsid protein pe gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p150","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p151","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed ps phosphoprotein pe P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"BioInfer.d672.s0.p152","sentence":"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; ps 4a pe and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed ps matrix protein pe gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.","label":0}
{"pair_id":"AIMed.d197.s1682.p0","sentence":"We studied the capacity of these mutants to form an ps IL-6 pe\/ps IL-6R pe complex and their ability to transduce the signal.","label":1}
{"pair_id":"AIMed.d146.s1242.p0","sentence":"These data demonstrate that the ps p90 pe ps IL-7R pe is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p1","sentence":"These data demonstrate that the ps p90 pe IL-7R is the T-cell homologue of the cloned ps IL-7R pe, and imply that the p90 and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p2","sentence":"These data demonstrate that the ps p90 pe IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the ps p90 pe and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p3","sentence":"These data demonstrate that the ps p90 pe IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and ps p76 pe IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p4","sentence":"These data demonstrate that the ps p90 pe IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 ps IL-7R pe have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p5","sentence":"These data demonstrate that the p90 ps IL-7R pe is the T-cell homologue of the cloned ps IL-7R pe, and imply that the p90 and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p6","sentence":"These data demonstrate that the p90 ps IL-7R pe is the T-cell homologue of the cloned IL-7R, and imply that the ps p90 pe and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p7","sentence":"These data demonstrate that the p90 ps IL-7R pe is the T-cell homologue of the cloned IL-7R, and imply that the p90 and ps p76 pe IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p8","sentence":"These data demonstrate that the p90 ps IL-7R pe is the T-cell homologue of the cloned IL-7R, and imply that the p90 and p76 ps IL-7R pe have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p9","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned ps IL-7R pe, and imply that the ps p90 pe and p76 IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p10","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned ps IL-7R pe, and imply that the p90 and ps p76 pe IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p11","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned ps IL-7R pe, and imply that the p90 and p76 ps IL-7R pe have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p12","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the ps p90 pe and ps p76 pe IL-7R have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p13","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the ps p90 pe and p76 ps IL-7R pe have different extracellular domains.","label":0}
{"pair_id":"AIMed.d146.s1242.p14","sentence":"These data demonstrate that the p90 IL-7R is the T-cell homologue of the cloned IL-7R, and imply that the p90 and ps p76 pe ps IL-7R pe have different extracellular domains.","label":0}
{"pair_id":"BioInfer.d296.s2.p0","sentence":"In normal livers, E-cad, alpha-catenin and ps beta-catenin pe, but not ps CD44s pe, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p1","sentence":"In normal livers, E-cad, alpha-catenin and ps beta-catenin pe, but not CD44s, CD44v5, CD44v6, CD44v7-8, and ps CD44v10 pe, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p2","sentence":"In normal livers, E-cad, alpha-catenin and ps beta-catenin pe, but not CD44s, CD44v5, ps CD44v6 pe, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p3","sentence":"In normal livers, ps E-cad pe, alpha-catenin and ps beta-catenin pe, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p4","sentence":"In normal livers, E-cad, alpha-catenin and ps beta-catenin pe, but not CD44s, ps CD44v5 pe, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p5","sentence":"In normal livers, E-cad, ps alpha-catenin pe and ps beta-catenin pe, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p6","sentence":"In normal livers, E-cad, alpha-catenin and ps beta-catenin pe, but not CD44s, CD44v5, CD44v6, ps CD44v7-8 pe, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p7","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not ps CD44s pe, CD44v5, CD44v6, CD44v7-8, and ps CD44v10 pe, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p8","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not ps CD44s pe, CD44v5, ps CD44v6 pe, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p9","sentence":"In normal livers, ps E-cad pe, alpha-catenin and beta-catenin, but not ps CD44s pe, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p10","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not ps CD44s pe, ps CD44v5 pe, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p11","sentence":"In normal livers, E-cad, ps alpha-catenin pe and beta-catenin, but not ps CD44s pe, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p12","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not ps CD44s pe, CD44v5, CD44v6, ps CD44v7-8 pe, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p13","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, ps CD44v6 pe, CD44v7-8, and ps CD44v10 pe, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p14","sentence":"In normal livers, ps E-cad pe, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and ps CD44v10 pe, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p15","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, ps CD44v5 pe, CD44v6, CD44v7-8, and ps CD44v10 pe, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p16","sentence":"In normal livers, E-cad, ps alpha-catenin pe and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and ps CD44v10 pe, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p17","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, ps CD44v7-8 pe, and ps CD44v10 pe, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p18","sentence":"In normal livers, ps E-cad pe, alpha-catenin and beta-catenin, but not CD44s, CD44v5, ps CD44v6 pe, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p19","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, ps CD44v5 pe, ps CD44v6 pe, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p20","sentence":"In normal livers, E-cad, ps alpha-catenin pe and beta-catenin, but not CD44s, CD44v5, ps CD44v6 pe, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p21","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, ps CD44v6 pe, ps CD44v7-8 pe, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p22","sentence":"In normal livers, ps E-cad pe, alpha-catenin and beta-catenin, but not CD44s, ps CD44v5 pe, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p23","sentence":"In normal livers, ps E-cad pe, ps alpha-catenin pe and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p24","sentence":"In normal livers, ps E-cad pe, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, ps CD44v7-8 pe, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p25","sentence":"In normal livers, E-cad, ps alpha-catenin pe and beta-catenin, but not CD44s, ps CD44v5 pe, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"BioInfer.d296.s2.p26","sentence":"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, ps CD44v5 pe, CD44v6, ps CD44v7-8 pe, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":0}
{"pair_id":"BioInfer.d296.s2.p27","sentence":"In normal livers, E-cad, ps alpha-catenin pe and beta-catenin, but not CD44s, CD44v5, CD44v6, ps CD44v7-8 pe, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.","label":1}
{"pair_id":"AIMed.d29.s244.p0","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in ps IL-8 pe reduced up to 77-fold the binding affinity to ps IL-8 pe receptor subtypes A (CXCR1) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p1","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in ps IL-8 pe reduced up to 77-fold the binding affinity to ps IL-8 receptor subtypes A pe (CXCR1) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p2","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in ps IL-8 pe reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (ps CXCR1 pe) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p3","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in ps IL-8 pe reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (ps CXCR2 pe) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p4","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in ps IL-8 pe reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (CXCR2) and to the ps Duffy antigen pe.","label":0}
{"pair_id":"AIMed.d29.s244.p5","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to ps IL-8 peps IL-8 receptor subtypes A pe (CXCR1) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p6","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to ps IL-8 pe receptor subtypes A (ps CXCR1 pe) and B (CXCR2) and to the Duffy antigen.","label":1}
{"pair_id":"AIMed.d29.s244.p7","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to ps IL-8 pe receptor subtypes A (CXCR1) and B (ps CXCR2 pe) and to the Duffy antigen.","label":1}
{"pair_id":"AIMed.d29.s244.p8","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to ps IL-8 pe receptor subtypes A (CXCR1) and B (CXCR2) and to the ps Duffy antigen pe.","label":1}
{"pair_id":"AIMed.d29.s244.p9","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to ps IL-8 receptor subtypes A pe (ps CXCR1 pe) and B (CXCR2) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p10","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to ps IL-8 receptor subtypes A pe (CXCR1) and B (ps CXCR2 pe) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p11","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to ps IL-8 receptor subtypes A pe (CXCR1) and B (CXCR2) and to the ps Duffy antigen pe.","label":0}
{"pair_id":"AIMed.d29.s244.p12","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (ps CXCR1 pe) and B (ps CXCR2 pe) and to the Duffy antigen.","label":0}
{"pair_id":"AIMed.d29.s244.p13","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (ps CXCR1 pe) and B (CXCR2) and to the ps Duffy antigen pe.","label":0}
{"pair_id":"AIMed.d29.s244.p14","sentence":"This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (ps CXCR2 pe) and to the ps Duffy antigen pe.","label":0}
{"pair_id":"AIMed.d50.s445.p0","sentence":"Interestingly, the ps ifnar2 pe binding site overlaps the largest continuous hydrophobic patch on ps IFNalpha2 pe.","label":1}
{"pair_id":"AIMed.d39.s338.p0","sentence":"The binding of ps QM pe\/ps Jif-1 pe to full-length PS1 was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.","label":0}
{"pair_id":"AIMed.d39.s338.p1","sentence":"The binding of ps QM pe\/Jif-1 to full-length ps PS1 pe was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.","label":1}
{"pair_id":"AIMed.d39.s338.p2","sentence":"The binding of QM\/ps Jif-1 pe to full-length ps PS1 pe was confirmed in vitro by pull-down assay, and in vivo by immunoprecipitation assays with human samples, including AD brains.","label":1}
{"pair_id":"BioInfer.d610.s0.p0","sentence":"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting myosin heavy chain, ps actin pe and ps tropomyosin pe.","label":0}
{"pair_id":"BioInfer.d610.s0.p1","sentence":"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting ps myosin heavy chain pe, ps actin pe and tropomyosin.","label":0}
{"pair_id":"BioInfer.d610.s0.p2","sentence":"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting ps myosin heavy chain pe, actin and ps tropomyosin pe.","label":0}
{"pair_id":"BioInfer.d213.s1.p0","sentence":"Three-dimensional fluorescence microscopy of the fluorescent analog of ps actin pe with a high affinity for ps profilin pe revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.","label":1}
{"pair_id":"BioInfer.d213.s1.p1","sentence":"Three-dimensional fluorescence microscopy of the fluorescent analog of ps actin pe with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of ps actin pe assembly near the surface of the cell.","label":0}
{"pair_id":"BioInfer.d213.s1.p2","sentence":"Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for ps profilin pe revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of ps actin pe assembly near the surface of the cell.","label":0}
{"pair_id":"BioInfer.d654.s0.p0","sentence":"The observed in vivo expression patterns of ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.","label":0}
{"pair_id":"BioInfer.d654.s0.p1","sentence":"The observed in vivo expression patterns of alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.","label":0}
{"pair_id":"BioInfer.d654.s0.p2","sentence":"The observed in vivo expression patterns of ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.","label":0}
{"pair_id":"AIMed.d26.s215.p0","sentence":"ps Granulysin pe has been identified as an effector molecule co-localized with ps perforin pe in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells.","label":0}
{"pair_id":"AIMed.d26.s215.p1","sentence":"ps Granulysin pe has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of ps perforin pe and to induce a cytotoxic effect against tumor cells.","label":0}
{"pair_id":"AIMed.d26.s215.p2","sentence":"Granulysin has been identified as an effector molecule co-localized with ps perforin pe in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of ps perforin pe and to induce a cytotoxic effect against tumor cells.","label":0}
{"pair_id":"AIMed.d187.s1594.p0","sentence":"We propose that ps A beta pe binding proteins play a key role in the modulation of ps A beta pe aggregation and normally prevent amyloid formation in biological fluids and in the brain.","label":0}
{"pair_id":"AIMed.d132.s1130.p0","sentence":"Studies with monoclonal antibodies specific for the ps IL-2 pe receptor gamma chain showed that the gamma chain participates in the functional high-affinity receptor complexes for ps IL-7 pe that are involved in the differentiation of T and B cells.","label":0}
{"pair_id":"BioInfer.d686.s0.p0","sentence":"The results clearly showed that the mutated ps cofilin pe possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant ps cofilin pe with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.","label":0}
{"pair_id":"BioInfer.d686.s0.p1","sentence":"The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant ps cofilin pe with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with ps actin pe.","label":1}
{"pair_id":"BioInfer.d686.s0.p2","sentence":"The results clearly showed that the mutated ps cofilin pe possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with ps actin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p0","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, ps MyoD pe and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p1","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, ps sarcomeric actin pe, Myf-5, ps MyoD pe and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p2","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, ps Myf-5 pe, ps MyoD pe and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p3","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, ps nestin pe, myosin heavy chain, sarcomeric actin, Myf-5, ps MyoD pe and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p4","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, ps myosin heavy chain pe, sarcomeric actin, Myf-5, ps MyoD pe and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p5","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and ps MyoD pe mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, ps MyoD pe and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p6","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with ps desmin pe, nestin, myosin heavy chain, sarcomeric actin, Myf-5, ps MyoD pe and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p7","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, ps MyoD pe and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p8","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, ps sarcomeric actin pe, Myf-5, MyoD and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p9","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, ps Myf-5 pe, MyoD and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p10","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, ps nestin pe, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p11","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, ps myosin heavy chain pe, sarcomeric actin, Myf-5, MyoD and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p12","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and ps MyoD pe mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p13","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with ps desmin pe, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p14","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and ps myogenin pe.","label":0}
{"pair_id":"BioInfer.d316.s0.p15","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, ps sarcomeric actin pe, ps Myf-5 pe, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p16","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, ps nestin pe, myosin heavy chain, ps sarcomeric actin pe, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p17","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, ps myosin heavy chain pe, ps sarcomeric actin pe, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p18","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and ps MyoD pe mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, ps sarcomeric actin pe, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p19","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with ps desmin pe, nestin, myosin heavy chain, ps sarcomeric actin pe, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p20","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, ps sarcomeric actin pe, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p21","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, ps nestin pe, myosin heavy chain, sarcomeric actin, ps Myf-5 pe, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p22","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, ps myosin heavy chain pe, sarcomeric actin, ps Myf-5 pe, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p23","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and ps MyoD pe mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, ps Myf-5 pe, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p24","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with ps desmin pe, nestin, myosin heavy chain, sarcomeric actin, ps Myf-5 pe, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p25","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, ps Myf-5 pe, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p26","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, ps nestin pe, ps myosin heavy chain pe, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p27","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and ps MyoD pe mutant embryos with antibodies reactive with desmin, ps nestin pe, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p28","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with ps desmin pe, ps nestin pe, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p29","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and MyoD mutant embryos with antibodies reactive with desmin, ps nestin pe, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p30","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and ps MyoD pe mutant embryos with antibodies reactive with desmin, nestin, ps myosin heavy chain pe, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p31","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with ps desmin pe, nestin, ps myosin heavy chain pe, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p32","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and MyoD mutant embryos with antibodies reactive with desmin, nestin, ps myosin heavy chain pe, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p33","sentence":"In addition, we performed immunohistochemistry on sectioned Myf-5 and ps MyoD pe mutant embryos with antibodies reactive with ps desmin pe, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p34","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and ps MyoD pe mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"BioInfer.d316.s0.p35","sentence":"In addition, we performed immunohistochemistry on sectioned ps Myf-5 pe and MyoD mutant embryos with antibodies reactive with ps desmin pe, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.","label":0}
{"pair_id":"AIMed.d85.s720.p0","sentence":"Studies in vivo and in vitro demonstrated a highly specific interaction between the SH3 domains of ps p47nck pe and ps Wiskott-Aldrich syndrome protein pe.","label":1}
{"pair_id":"BioInfer.d324.s0.p0","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a ps tropomyosin pe mutant, and the loss of cytoplasmic cables seen in fimbrin, ps Mdm20p pe, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p1","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a ps tropomyosin pe mutant, and the loss of cytoplasmic cables seen in ps fimbrin pe, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p2","sentence":"In contrast, ps act1-159 pe partially suppresses the temperature sensitivity of a ps tropomyosin pe mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p3","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a ps tropomyosin pe mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these ps actin pe-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p4","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a ps tropomyosin pe mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and ps tropomyosin pe null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p5","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in ps fimbrin pe, ps Mdm20p pe, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p6","sentence":"In contrast, ps act1-159 pe partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, ps Mdm20p pe, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p7","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, ps Mdm20p pe, and tropomyosin null mutants, suggesting filament stabilizing functions for these ps actin pe-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p8","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, ps Mdm20p pe, and ps tropomyosin pe null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p9","sentence":"In contrast, ps act1-159 pe partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in ps fimbrin pe, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p10","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in ps fimbrin pe, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these ps actin pe-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p11","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in ps fimbrin pe, Mdm20p, and ps tropomyosin pe null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p12","sentence":"In contrast, ps act1-159 pe partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these ps actin pe-binding proteins.","label":0}
{"pair_id":"BioInfer.d324.s0.p13","sentence":"In contrast, ps act1-159 pe partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and ps tropomyosin pe null mutants, suggesting filament stabilizing functions for these actin-binding proteins.","label":1}
{"pair_id":"BioInfer.d324.s0.p14","sentence":"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and ps tropomyosin pe null mutants, suggesting filament stabilizing functions for these ps actin pe-binding proteins.","label":1}
{"pair_id":"AIMed.d87.s739.p0","sentence":"Activation of lacZ upon interaction of ps p85 pe with ps IR beta pe(delta C-43) was 4-fold less as compared to IR beta.","label":1}
{"pair_id":"AIMed.d87.s739.p1","sentence":"Activation of lacZ upon interaction of ps p85 pe with IR beta(ps delta C-43 pe) was 4-fold less as compared to IR beta.","label":0}
{"pair_id":"AIMed.d87.s739.p2","sentence":"Activation of lacZ upon interaction of ps p85 pe with IR beta(delta C-43) was 4-fold less as compared to ps IR beta pe.","label":1}
{"pair_id":"AIMed.d87.s739.p3","sentence":"Activation of lacZ upon interaction of p85 with ps IR beta pe(ps delta C-43 pe) was 4-fold less as compared to IR beta.","label":0}
{"pair_id":"AIMed.d87.s739.p4","sentence":"Activation of lacZ upon interaction of p85 with ps IR beta pe(delta C-43) was 4-fold less as compared to ps IR beta pe.","label":0}
{"pair_id":"AIMed.d87.s739.p5","sentence":"Activation of lacZ upon interaction of p85 with IR beta(ps delta C-43 pe) was 4-fold less as compared to ps IR beta pe.","label":0}
{"pair_id":"AIMed.d173.s1460.p0","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring ps lacZ pe (ps beta-galactosidase pe) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p1","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring ps lacZ pe (beta-galactosidase) and ps LEU2 pe (leucine utilization) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p2","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring ps lacZ pe (beta-galactosidase) and LEU2 (ps leucine utilization pe) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p3","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (ps beta-galactosidase pe) and ps LEU2 pe (leucine utilization) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p4","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (ps beta-galactosidase pe) and LEU2 (ps leucine utilization pe) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d173.s1460.p5","sentence":"Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and ps LEU2 pe (ps leucine utilization pe) genes under the control of LexA-dependent operators.","label":0}
{"pair_id":"AIMed.d90.s773.p0","sentence":"In transient expression assays, we found that ps PU.1 pe and ps NF-IL6 beta pe can functionally cooperate to synergistically activate transcription.","label":0}
{"pair_id":"AIMed.d12.s102.p0","sentence":"MAIN OUTCOME MEASURES: Measurement of soluble ps interleukin (IL) 2 receptor pe (ps sIL-2R pe) and IL-1alpha in serum samples and fluid of recent blisters.","label":0}
{"pair_id":"AIMed.d12.s102.p1","sentence":"MAIN OUTCOME MEASURES: Measurement of soluble ps interleukin (IL) 2 receptor pe (sIL-2R) and ps IL-1alpha pe in serum samples and fluid of recent blisters.","label":0}
{"pair_id":"AIMed.d12.s102.p2","sentence":"MAIN OUTCOME MEASURES: Measurement of soluble interleukin (IL) 2 receptor (ps sIL-2R pe) and ps IL-1alpha pe in serum samples and fluid of recent blisters.","label":0}
{"pair_id":"BioInfer.d238.s0.p0","sentence":"Here we demonstrate that accessory receptor triggering induces the transient association of ps cofilin pe with the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d346.s0.p0","sentence":"In isolated hearts, PD 81,723 alone produced only a small stimulus to His bundle (S-H) interval prolongation of 1.5 to 4 msec, which was completely reversed by the ps A1 adenosine receptor pe antagonist 8-cyclopentyltheophylline and ps adenosine deaminase pe.","label":0}
{"pair_id":"AIMed.d26.s223.p0","sentence":"In conclusion, impaired expression of ps granulysin pe by NK cells correlates with progression of cancer, and determination of ps granulysin pe expression might prove informative for assessing the immunological condition of cancer patients.","label":0}
{"pair_id":"BioInfer.d376.s0.p0","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (ps DRP pe or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p1","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (ps DRP pe or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p2","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (ps DRP pe or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p3","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (ps DRP pe or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"BioInfer.d376.s0.p4","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (ps DRP pe or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p5","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (DRP or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p6","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (DRP or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p7","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"BioInfer.d376.s0.p8","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human ps dystrophin related protein pe (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p9","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or ps utrophin pe) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"BioInfer.d376.s0.p10","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"BioInfer.d376.s0.p11","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (DRP or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p12","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"BioInfer.d376.s0.p13","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (DRP or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":1}
{"pair_id":"BioInfer.d376.s0.p14","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":0}
{"pair_id":"BioInfer.d522.s1.p0","sentence":"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and ps profilin pe, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to ps actin pe with sufficient affinity to withstand dilution (high-affinity complexes).","label":1}
{"pair_id":"BioInfer.d522.s1.p1","sentence":"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract ps gelsolin pe and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to ps actin pe with sufficient affinity to withstand dilution (high-affinity complexes).","label":1}
{"pair_id":"BioInfer.d522.s1.p2","sentence":"Sepharose beads coupled to either monoclonal anti-ps gelsolin pe antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to ps actin pe with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d522.s1.p3","sentence":"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract ps gelsolin pe and ps profilin pe, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d522.s1.p4","sentence":"Sepharose beads coupled to either monoclonal anti-ps gelsolin pe antibodies or to polyproline were used to extract gelsolin and ps profilin pe, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d522.s1.p5","sentence":"Sepharose beads coupled to either monoclonal anti-ps gelsolin pe antibodies or to polyproline were used to extract ps gelsolin pe and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).","label":0}
{"pair_id":"BioInfer.d124.s0.p0","sentence":"ps Cadherins pe are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate ps beta-catenin pe signaling.","label":1}
{"pair_id":"AIMed.d76.s646.p0","sentence":"The binding of ps p56lck pe to ps CD5 pe induced a 10- to 15-fold increase in p56lck catalytic activity, as measured by in vitro kinase analysis.","label":1}
{"pair_id":"AIMed.d76.s646.p1","sentence":"The binding of ps p56lck pe to CD5 induced a 10- to 15-fold increase in ps p56lck pe catalytic activity, as measured by in vitro kinase analysis.","label":0}
{"pair_id":"AIMed.d76.s646.p2","sentence":"The binding of p56lck to ps CD5 pe induced a 10- to 15-fold increase in ps p56lck pe catalytic activity, as measured by in vitro kinase analysis.","label":0}
{"pair_id":"AIMed.d32.s268.p0","sentence":"Shared and unique determinants of the ps erythropoietin pe (ps EPO pe) receptor are important for binding EPO and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p1","sentence":"Shared and unique determinants of the ps erythropoietin peps erythropoietin (EPO) receptor pe are important for binding EPO and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p2","sentence":"Shared and unique determinants of the ps erythropoietin pe (EPO) receptor are important for binding ps EPO pe and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p3","sentence":"Shared and unique determinants of the ps erythropoietin pe (EPO) receptor are important for binding EPO and ps EPO pe mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p4","sentence":"Shared and unique determinants of the ps erythropoietin pe (EPO) receptor are important for binding EPO and ps EPO mimetic peptide pe.","label":0}
{"pair_id":"AIMed.d32.s268.p5","sentence":"Shared and unique determinants of the ps erythropoietin (EPO) receptor peps EPO pe) receptor are important for binding EPO and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p6","sentence":"Shared and unique determinants of the erythropoietin (ps EPO pe) receptor are important for binding ps EPO pe and EPO mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p7","sentence":"Shared and unique determinants of the erythropoietin (ps EPO pe) receptor are important for binding EPO and ps EPO pe mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p8","sentence":"Shared and unique determinants of the erythropoietin (ps EPO pe) receptor are important for binding EPO and ps EPO mimetic peptide pe.","label":0}
{"pair_id":"AIMed.d32.s268.p9","sentence":"Shared and unique determinants of the ps erythropoietin (EPO) receptor pe are important for binding ps EPO pe and EPO mimetic peptide.","label":1}
{"pair_id":"AIMed.d32.s268.p10","sentence":"Shared and unique determinants of the ps erythropoietin (EPO) receptor pe are important for binding EPO and ps EPO pe mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p11","sentence":"Shared and unique determinants of the ps erythropoietin (EPO) receptor pe are important for binding EPO and ps EPO mimetic peptide pe.","label":0}
{"pair_id":"AIMed.d32.s268.p12","sentence":"Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding ps EPO pe and ps EPO pe mimetic peptide.","label":0}
{"pair_id":"AIMed.d32.s268.p13","sentence":"Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding ps EPO pe and ps EPO mimetic peptide pe.","label":0}
{"pair_id":"AIMed.d32.s268.p14","sentence":"Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and ps EPO peps EPO mimetic peptide pe.","label":0}
{"pair_id":"BioInfer.d441.s1.p0","sentence":"The colocalization of gelsolin and ps profilin pe in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the ps actin pe dynamics that underlie neurite growth.","label":1}
{"pair_id":"BioInfer.d441.s1.p1","sentence":"The colocalization of ps gelsolin pe and ps profilin pe in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.","label":1}
{"pair_id":"BioInfer.d441.s1.p2","sentence":"The colocalization of ps gelsolin pe and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the ps actin pe dynamics that underlie neurite growth.","label":1}
{"pair_id":"BioInfer.d587.s0.p0","sentence":"The ps verprolin pe-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2\/A complex-dependent ps actin pe nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p1","sentence":"The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces ps Arp pe2\/ps A pe complex-dependent ps actin pe nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p2","sentence":"The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces ps Arp2 pe\/A complex-dependent ps actin pe nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p3","sentence":"The verprolin-like central (vc) region of ps Wiskott-Aldrich syndrome protein pe induces Arp2\/A complex-dependent ps actin pe nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p4","sentence":"The ps verprolin pe-like central (vc) region of Wiskott-Aldrich syndrome protein induces ps Arp pe2\/ps A pe complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p5","sentence":"The ps verprolin pe-like central (vc) region of Wiskott-Aldrich syndrome protein induces ps Arp2 pe\/A complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p6","sentence":"The ps verprolin pe-like central (vc) region of ps Wiskott-Aldrich syndrome protein pe induces Arp2\/A complex-dependent actin nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p7","sentence":"The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces ps Arp peps Arp2 pe\/ps A pe complex-dependent actin nucleation.","label":1}
{"pair_id":"BioInfer.d587.s0.p8","sentence":"The verprolin-like central (vc) region of ps Wiskott-Aldrich syndrome protein pe induces ps Arp pe2\/ps A pe complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d587.s0.p9","sentence":"The verprolin-like central (vc) region of ps Wiskott-Aldrich syndrome protein pe induces ps Arp2 pe\/A complex-dependent actin nucleation.","label":0}
{"pair_id":"BioInfer.d393.s1.p0","sentence":"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate ps myosin heavy chain pe (MHC) and ps actin pe from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.","label":0}
{"pair_id":"BioInfer.d393.s1.p1","sentence":"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (ps MHC pe) and ps actin pe from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.","label":0}
{"pair_id":"BioInfer.d393.s1.p2","sentence":"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate ps myosin heavy chain pe (ps MHC pe) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.","label":0}
{"pair_id":"AIMed.d128.s1097.p0","sentence":"In the case of ps hGH pe, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. ps hPRL pe does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p1","sentence":"In the case of ps hGH pe, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the ps hGH pe receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p2","sentence":"In the case of ps hGH pe, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but ps hGH pe binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p3","sentence":"In the case of ps hGH pe, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the ps hGHR pe and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p4","sentence":"In the case of ps hGH pe, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and ps hPRLR pe, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p5","sentence":"In the case of ps hGH pe, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on ps hGH pe overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p6","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. ps hPRL pe does not bind to the ps hGH pe receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p7","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. ps hPRL pe does not bind to the hGH receptor, but ps hGH pe binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p8","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. ps hPRL pe does not bind to the hGH receptor, but hGH binds to both the ps hGHR pe and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p9","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. ps hPRL pe does not bind to the hGH receptor, but hGH binds to both the hGHR and ps hPRLR pe, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p10","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. ps hPRL pe does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on ps hGH pe overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p11","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the ps hGH pe receptor, but ps hGH pe binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p12","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the ps hGH pe receptor, but hGH binds to both the ps hGHR pe and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p13","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the ps hGH pe receptor, but hGH binds to both the hGHR and ps hPRLR pe, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p14","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the ps hGH pe receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on ps hGH pe overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p15","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but ps hGH pe binds to both the ps hGHR pe and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":1}
{"pair_id":"AIMed.d128.s1097.p16","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but ps hGH pe binds to both the hGHR and ps hPRLR pe, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":1}
{"pair_id":"AIMed.d128.s1097.p17","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but ps hGH pe binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on ps hGH pe overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p18","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the ps hGHR pe and ps hPRLR pe, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p19","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the ps hGHR pe and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on ps hGH pe overlap.","label":0}
{"pair_id":"AIMed.d128.s1097.p20","sentence":"In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and ps hPRLR pe, and mutagenesis studies have shown that the receptor-binding sites on ps hGH pe overlap.","label":0}
{"pair_id":"BioInfer.d77.s2.p0","sentence":"Here we show that the ps Arp2 pe subunit of the complex can be chemically cross-linked to the ps actin pe-binding site of profilin.","label":0}
{"pair_id":"BioInfer.d77.s2.p1","sentence":"Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the ps actin pe-binding site of ps profilin pe.","label":1}
{"pair_id":"BioInfer.d77.s2.p2","sentence":"Here we show that the ps Arp2 pe subunit of the complex can be chemically cross-linked to the actin-binding site of ps profilin pe.","label":1}
{"pair_id":"AIMed.d116.s982.p0","sentence":"These results indicate that there is an additional mechanism by which ps Rb pe suppresses cell growth, namely that ps Rb pe directly represses transcription of the rRNA genes.","label":0}
{"pair_id":"BioInfer.d423.s0.p0","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (ps MLC pe), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p1","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (ps MLC pe), troponin I (TnI) isoforms, connexin 43 (ps Cx43 pe), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p2","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (ps MLC pe), troponin I (TnI) isoforms, ps connexin 43 pe (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p3","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (ps MLC pe), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p4","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (ps MLC pe), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p5","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (ps MLC pe), troponin I (ps TnI pe) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p6","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (ps MLC pe), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p7","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (ps MLC pe), ps troponin I pe (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p8","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (ps MLC pe), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p9","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (ps MLC pe), troponin I (TnI) isoforms, connexin 43 (Cx43), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p10","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (ps Cx43 pe), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p11","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, ps connexin 43 pe (Cx43), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p12","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p13","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and ps alpha-smooth muscle actin pe (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p14","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (ps TnI pe) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p15","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p16","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), ps troponin I pe (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p17","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p18","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), ps desmin pe and alpha-smooth muscle actin (ps alpha-SMA pe), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p19","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, ps connexin 43 pe (ps Cx43 pe), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p20","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (ps Cx43 pe), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p21","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (ps Cx43 pe), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p22","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (ps TnI pe) isoforms, connexin 43 (ps Cx43 pe), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p23","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (ps Cx43 pe), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p24","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), ps troponin I pe (TnI) isoforms, connexin 43 (ps Cx43 pe), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p25","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (MLC), troponin I (TnI) isoforms, connexin 43 (ps Cx43 pe), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p26","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (ps Cx43 pe), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p27","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (MLC), troponin I (TnI) isoforms, ps connexin 43 pe (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p28","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, ps connexin 43 pe (Cx43), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p29","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (ps TnI pe) isoforms, ps connexin 43 pe (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p30","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, ps connexin 43 pe (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p31","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), ps troponin I pe (TnI) isoforms, ps connexin 43 pe (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p32","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (MLC), troponin I (TnI) isoforms, ps connexin 43 pe (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p33","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, ps connexin 43 pe (Cx43), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p34","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p35","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (MLC), troponin I (ps TnI pe) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p36","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (ps MHC pe), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p37","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (MLC), ps troponin I pe (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p38","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), ps myosin light chain pe (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p39","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (ps MHC pe), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p40","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (ps TnI pe) isoforms, connexin 43 (Cx43), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p41","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p42","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), ps troponin I pe (TnI) isoforms, connexin 43 (Cx43), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p43","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p44","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), ps desmin pe and ps alpha-smooth muscle actin pe (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p45","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (MLC), troponin I (ps TnI pe) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p46","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), ps troponin I pe (ps TnI pe) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p47","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (MLC), troponin I (ps TnI pe) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p48","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (ps TnI pe) isoforms, connexin 43 (Cx43), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p49","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (MLC), ps troponin I pe (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p50","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), ps myosin light chain pe (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p51","sentence":"METHODS: We have performed a detailed study of the pattern of expression of ps myosin heavy chain pe (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p52","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (MLC), ps troponin I pe (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p53","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), ps troponin I pe (TnI) isoforms, connexin 43 (Cx43), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"BioInfer.d423.s0.p54","sentence":"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), ps myosin light chain pe (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), ps desmin pe and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.","label":0}
{"pair_id":"AIMed.d101.s852.p0","sentence":"The bZIP domains of ps Fos pe and ps Jun pe mediate a physical association with the TATA box-binding protein.","label":0}
{"pair_id":"AIMed.d101.s852.p1","sentence":"The bZIP domains of ps Fos pe and Jun mediate a physical association with the ps TATA box-binding protein pe.","label":1}
{"pair_id":"AIMed.d101.s852.p2","sentence":"The bZIP domains of Fos and ps Jun pe mediate a physical association with the ps TATA box-binding protein pe.","label":1}
{"pair_id":"BioInfer.d693.s0.p0","sentence":"These cells have both ps alpha-catenin pe and ps beta-catenin pe, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.","label":0}
{"pair_id":"BioInfer.d693.s0.p1","sentence":"These cells have both alpha-catenin and ps beta-catenin pe, display unusual expression of ps N-cadherin pe, and have the typical fibroblastic phenotype of transformed cells.","label":0}
{"pair_id":"BioInfer.d693.s0.p2","sentence":"These cells have both ps alpha-catenin pe and beta-catenin, display unusual expression of ps N-cadherin pe, and have the typical fibroblastic phenotype of transformed cells.","label":0}
{"pair_id":"AIMed.d138.s1165.p0","sentence":"Interaction of mammalian splicing factor ps SF3a pe with ps U2 snRNP pe and relation of its 60-kD subunit to yeast PRP9.","label":1}
{"pair_id":"AIMed.d138.s1165.p1","sentence":"Interaction of mammalian splicing factor ps SF3a pe with U2 snRNP and relation of its 60-kD subunit to yeast ps PRP9 pe.","label":0}
{"pair_id":"AIMed.d138.s1165.p2","sentence":"Interaction of mammalian splicing factor SF3a with ps U2 snRNP pe and relation of its 60-kD subunit to yeast ps PRP9 pe.","label":0}
{"pair_id":"BioInfer.d766.s0.p0","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, ps myosin pe heavy chain, ps actin pe, myosin light , and ps myosin light  pe were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p1","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, ps myosin peps myosin pe heavy chain, actin, ps myosin light  pe, and ps myosin light  pe were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p2","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, ps myosin peps myosin heavy chain pe, actin, myosin light , and ps myosin light  pe were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p3","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, ps myosin pe heavy chain, ps actin pe, ps myosin light  pe, and myosin light  were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p4","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, ps myosin heavy chain pe, ps actin pe, myosin light , and myosin light  were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"BioInfer.d766.s0.p5","sentence":"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, ps myosin peps myosin heavy chain pe, actin, ps myosin light  pe, and myosin light  were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.","label":0}
{"pair_id":"AIMed.d64.s553.p0","sentence":"Thus, ps phFGFR pe encodes a human FGF receptor with high affinity for both ps aFGF pe and bFGF.","label":1}
{"pair_id":"AIMed.d64.s553.p1","sentence":"Thus, ps phFGFR pe encodes a human FGF receptor with high affinity for both aFGF and ps bFGF pe.","label":1}
{"pair_id":"AIMed.d64.s553.p2","sentence":"Thus, phFGFR encodes a human FGF receptor with high affinity for both ps aFGF pe and ps bFGF pe.","label":0}
{"pair_id":"AIMed.d8.s61.p0","sentence":"The ps K-ras pe, ps p53 pe, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p1","sentence":"The ps K-ras pe, p53, ps p16 pe and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p2","sentence":"The ps K-ras pe, p53, p16 and ps DPC4 pe genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p3","sentence":"The K-ras, ps p53 pe, ps p16 pe and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p4","sentence":"The K-ras, ps p53 pe, p16 and ps DPC4 pe genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d8.s61.p5","sentence":"The K-ras, p53, ps p16 pe and ps DPC4 pe genes are among those most frequently altered in pancreatic ductal carcinoma.","label":0}
{"pair_id":"AIMed.d1.s12.p0","sentence":"This study describes the distributions of ps bone morphogenetic protein (BMP)-2 pe as well as mRNAs for ps BMP receptor type IB pe (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p1","sentence":"This study describes the distributions of ps bone morphogenetic protein (BMP)-2 pe as well as mRNAs for BMP receptor type IB (ps BMPRIB pe). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p2","sentence":"This study describes the distributions of ps bone morphogenetic protein (BMP)-2 pe as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (ps Col II pe) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p3","sentence":"This study describes the distributions of ps bone morphogenetic protein (BMP)-2 pe as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (ps Col III pe) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p4","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for ps BMP receptor type IB pe (ps BMPRIB pe). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p5","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for ps BMP receptor type IB pe (BMPRIB). collagen types II (ps Col II pe) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p6","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for ps BMP receptor type IB pe (BMPRIB). collagen types II (Col II) and III (ps Col III pe) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p7","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (ps BMPRIB pe). collagen types II (ps Col II pe) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p8","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (ps BMPRIB pe). collagen types II (Col II) and III (ps Col III pe) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d1.s12.p9","sentence":"This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (ps Col II pe) and III (ps Col III pe) in a growing \"cartilage cap\" of osteochondroma.","label":0}
{"pair_id":"AIMed.d108.s913.p0","sentence":"A double point mutation in the activation domain of ps p53 pe impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both ps TAFII40 pe and TAFII60.","label":1}
{"pair_id":"AIMed.d108.s913.p1","sentence":"A double point mutation in the activation domain of ps p53 pe impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both TAFII40 and ps TAFII60 pe.","label":1}
{"pair_id":"AIMed.d108.s913.p2","sentence":"A double point mutation in the activation domain of p53 impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both ps TAFII40 pe and ps TAFII60 pe.","label":0}
{"pair_id":"BioInfer.d398.s0.p0","sentence":"Kinetic measurements indicate that ps profilin pe binding to actin weakens the affinity of ps actin pe for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.","label":1}
{"pair_id":"BioInfer.d398.s0.p1","sentence":"Kinetic measurements indicate that profilin binding to ps actin pe weakens the affinity of ps actin pe for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.","label":1}
{"pair_id":"BioInfer.d398.s0.p2","sentence":"Kinetic measurements indicate that ps profilin pe binding to ps actin pe weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.","label":1}
{"pair_id":"AIMed.d163.s1375.p0","sentence":"ps SNX1 pe contains a region of homology to a yeast vacuolar sorting protein, and overexpression of ps SNX1 pe decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.","label":0}
{"pair_id":"AIMed.d163.s1375.p1","sentence":"ps SNX1 pe contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of ps EGFR pe on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.","label":0}
{"pair_id":"AIMed.d163.s1375.p2","sentence":"SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of ps SNX1 pe decreased the amount of ps EGFR pe on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.","label":0}
{"pair_id":"AIMed.d60.s527.p0","sentence":"ps MAP kinase pe and the protein kinase that activates it (ps MAP kinase kinase pe) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the c-Raf-1 protein kinase.","label":1}
{"pair_id":"AIMed.d60.s527.p1","sentence":"ps MAP kinase pe and the protein kinase that activates it (MAP kinase kinase) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the ps c-Raf-1 pe protein kinase.","label":1}
{"pair_id":"AIMed.d60.s527.p2","sentence":"MAP kinase and the protein kinase that activates it (ps MAP kinase kinase pe) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35EC12, p3722W) of the ps c-Raf-1 pe protein kinase.","label":1}
{"pair_id":"BioInfer.d364.s0.p0","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, ps SIR1 pe and ps SIR4 pe.","label":0}
{"pair_id":"BioInfer.d364.s0.p1","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the ps SIR pe genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and ps SIR4 pe.","label":0}
{"pair_id":"BioInfer.d364.s0.p2","sentence":"In the ps ADE2 pe assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and ps SIR4 pe.","label":0}
{"pair_id":"BioInfer.d364.s0.p3","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two ps SIR pe genes, SIR1 and ps SIR4 pe.","label":1}
{"pair_id":"BioInfer.d364.s0.p4","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the ps SIR pe genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, ps SIR1 pe and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p5","sentence":"In the ps ADE2 pe assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, ps SIR1 pe and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p6","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two ps SIR pe genes, ps SIR1 pe and SIR4.","label":1}
{"pair_id":"BioInfer.d364.s0.p7","sentence":"In the ps ADE2 pe assay system, silencing depends completely upon the function of the ps SIR pe genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p8","sentence":"In the ADE2 assay system, silencing depends completely upon the function of the ps SIR pe genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two ps SIR pe genes, SIR1 and SIR4.","label":0}
{"pair_id":"BioInfer.d364.s0.p9","sentence":"In the ps ADE2 pe assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two ps SIR pe genes, SIR1 and SIR4.","label":0}
{"pair_id":"AIMed.d57.s503.p0","sentence":"Reconstitution of the multiprotein complex of ps pp60src pe, ps hsp90 pe, and p50 in a cell-free system.","label":1}
{"pair_id":"AIMed.d57.s503.p1","sentence":"Reconstitution of the multiprotein complex of ps pp60src pe, hsp90, and ps p50 pe in a cell-free system.","label":0}
{"pair_id":"AIMed.d57.s503.p2","sentence":"Reconstitution of the multiprotein complex of pp60src, ps hsp90 pe, and ps p50 pe in a cell-free system.","label":0}
{"pair_id":"BioInfer.d429.s1.p0","sentence":"ps beta-Catenin pe may also function in signalling pathways, given its homology to the gene product of the Drosophila segment polarity gene ps armadillo pe, which is known to be involved in the wingless signalling cascade.","label":1}
{"pair_id":"BioInfer.d556.s0.p0","sentence":"Suppression of cell transformation by the cyclin-dependent kinase inhibitor ps p57KIP2 pe requires binding to ps proliferating cell nuclear antigen pe.","label":1}
{"pair_id":"BioInfer.d556.s0.p1","sentence":"Suppression of cell transformation by the ps cyclin-dependent kinase inhibitor pe p57KIP2 requires binding to ps proliferating cell nuclear antigen pe.","label":0}
{"pair_id":"BioInfer.d556.s0.p2","sentence":"Suppression of cell transformation by the ps cyclin-dependent kinase inhibitor pe ps p57KIP2 pe requires binding to proliferating cell nuclear antigen.","label":1}
{"pair_id":"AIMed.d105.s884.p0","sentence":"Two distinct and independent sites on ps IL-6 pe trigger ps gp 130 pe dimer formation and signalling.","label":1}
{"pair_id":"BioInfer.d52.s2.p0","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the ps Munc18-2 pe variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from ps syntaxin 3 pe complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p1","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the ps Munc18-2 pe variants with syntaxin 3 correlated well with their ability to displace ps SNAP-23 pe from syntaxin 3 complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p2","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the ps Munc18-2 pe variants with ps syntaxin 3 pe correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p3","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace ps SNAP-23 pe from ps syntaxin 3 pe complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p4","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with ps syntaxin 3 pe correlated well with their ability to displace SNAP-23 from ps syntaxin 3 pe complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"BioInfer.d52.s2.p5","sentence":"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with ps syntaxin 3 pe correlated well with their ability to displace ps SNAP-23 pe from syntaxin 3 complexes when overexpressed in Caco-2 cells.","label":1}
{"pair_id":"AIMed.d2.s24.p0","sentence":"RESULTS: After 7 days hospitalisation, molar ps RBP pe:ps TTR pe ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p1","sentence":"RESULTS: After 7 days hospitalisation, molar ps RBP pe:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in ps RBP pe:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p2","sentence":"RESULTS: After 7 days hospitalisation, molar ps RBP pe:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:ps TTR pe ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p3","sentence":"RESULTS: After 7 days hospitalisation, molar ps RBP pe:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar ps RBP pe:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p4","sentence":"RESULTS: After 7 days hospitalisation, molar ps RBP pe:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:ps TTR pe ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p5","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:ps TTR pe ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in ps RBP pe:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p6","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:ps TTR pe ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:ps TTR pe ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p7","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:ps TTR pe ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar ps RBP pe:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p8","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:ps TTR pe ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:ps TTR pe ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p9","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in ps RBP pe:ps TTR pe ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p10","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in ps RBP pe:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar ps RBP pe:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p11","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in ps RBP pe:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:ps TTR pe ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p12","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:ps TTR pe ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar ps RBP pe:TTR ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p13","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:ps TTR pe ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar RBP:ps TTR pe ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"AIMed.d2.s24.p14","sentence":"RESULTS: After 7 days hospitalisation, molar RBP:TTR ratio (mean+\/-s.d.) of infected children (C-reactive proteins>10 mg\/l) was 0.67+\/-0.31 in the high-dose group (n=81), 0.74+\/-0.44 in the low dose group (n=71) and 0.73+\/-0.39 in the placebo group (n=81). These values did not differ significantly (one-way ANOVA P=0.472). In patients with baseline serum retinol concentrations<0.70 micromol\/l, changes in RBP:TTR ratio between admission and day 7 were not statistically different in the three groups (one-way ANOVA P=0.548). CONCLUSIONS: In this population of malnourished hospitalised children, molar ps RBP pe:ps TTR pe ratio does not appear to be useful to assess VA status during infection. SPONSORSHIP: Our research was partially supported by a grant from the Fonds de la Recherche Scientifique et Medicale (contract 3.4505.94) and the David and Alice Van Buuren Foundation.","label":0}
{"pair_id":"BioInfer.d158.s0.p0","sentence":"Crystallization and preliminary crystallographic analysis of the N-terminal ps actin pe binding domain of human ps fimbrin pe.","label":1}
{"pair_id":"AIMed.d125.s1068.p0","sentence":"Use of deletion mutants of ps Bcl-2 pe suggested that ps Bcl-2 pe homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p1","sentence":"Use of deletion mutants of ps Bcl-2 pe suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the ps Bcl-2 pe protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p2","sentence":"Use of deletion mutants of ps Bcl-2 pe suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing ps Bcl-2 pe amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p3","sentence":"Use of deletion mutants of ps Bcl-2 pe suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing ps Bcl-2 pe amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p4","sentence":"Use of deletion mutants of ps Bcl-2 pe suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing ps Bcl-2 pe amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p5","sentence":"Use of deletion mutants of Bcl-2 suggested that ps Bcl-2 pe homodimerization involves interactions between two distinct regions within the ps Bcl-2 pe protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p6","sentence":"Use of deletion mutants of Bcl-2 suggested that ps Bcl-2 pe homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing ps Bcl-2 pe amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p7","sentence":"Use of deletion mutants of Bcl-2 suggested that ps Bcl-2 pe homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing ps Bcl-2 pe amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p8","sentence":"Use of deletion mutants of Bcl-2 suggested that ps Bcl-2 pe homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing ps Bcl-2 pe amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p9","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the ps Bcl-2 pe protein, since a LexA protein containing ps Bcl-2 pe amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p10","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the ps Bcl-2 pe protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing ps Bcl-2 pe amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p11","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the ps Bcl-2 pe protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing ps Bcl-2 pe amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p12","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing ps Bcl-2 pe amino acids 83-218 mediated functional interactions with a B42 fusion protein containing ps Bcl-2 pe amino acids 1-81 but did not complement a B42 fusion protein containing Bcl-2 amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p13","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing ps Bcl-2 pe amino acids 83-218 mediated functional interactions with a B42 fusion protein containing Bcl-2 amino acids 1-81 but did not complement a B42 fusion protein containing ps Bcl-2 pe amino acids 83-218.","label":0}
{"pair_id":"AIMed.d125.s1068.p14","sentence":"Use of deletion mutants of Bcl-2 suggested that Bcl-2 homodimerization involves interactions between two distinct regions within the Bcl-2 protein, since a LexA protein containing Bcl-2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing ps Bcl-2 pe amino acids 1-81 but did not complement a B42 fusion protein containing ps Bcl-2 pe amino acids 83-218.","label":0}
{"pair_id":"AIMed.d119.s1011.p0","sentence":"The activation domain of ps CBP pe interacts with the basal transcription factor ps TFIIB pe through a domain that is conserved in the yeast coactivator ADA-1 (ref. 8).","label":0}
{"pair_id":"AIMed.d119.s1011.p1","sentence":"The activation domain of ps CBP pe interacts with the basal transcription factor TFIIB through a domain that is conserved in the yeast coactivator ps ADA-1 pe (ref. 8).","label":1}
{"pair_id":"AIMed.d119.s1011.p2","sentence":"The activation domain of CBP interacts with the basal transcription factor ps TFIIB pe through a domain that is conserved in the yeast coactivator ps ADA-1 pe (ref. 8).","label":0}
{"pair_id":"BioInfer.d487.s0.p0","sentence":"Phosphorylation of the headpiece domain could regulate the ps actin pe binding and bundling properties of ps fimbrin pe, or it could regulate the interaction of fimbrin with other proteins.","label":1}
{"pair_id":"BioInfer.d487.s0.p1","sentence":"Phosphorylation of the headpiece domain could regulate the ps actin pe binding and bundling properties of fimbrin, or it could regulate the interaction of ps fimbrin pe with other proteins.","label":0}
{"pair_id":"BioInfer.d487.s0.p2","sentence":"Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of ps fimbrin pe, or it could regulate the interaction of ps fimbrin pe with other proteins.","label":1}
{"pair_id":"AIMed.d123.s1052.p0","sentence":"Lastly, in agreement with our findings for yeast cells, we show that the ps insulin receptor pe is unable to phosphorylate an ps IRS-1 pe protein containing a deletion of amino acids 45 to 516 when expressed in COS cells.","label":0}
{"pair_id":"BioInfer.d337.s0.p0","sentence":"Inhibition of 12P-CRE binding was also observed in the presence of an antibody to ps CREB-binding protein pe (265-kDa ps CBP pe), an integrator and coactivator of cAMP-responsive genes.","label":0}
{"pair_id":"BioInfer.d707.s0.p0","sentence":"These regions also interact with the physiologically relevant ligands of ps profilin pe, ps actin pe and proline-rich peptides.","label":1}
{"pair_id":"BioInfer.d375.s2.p0","sentence":"The current view of the mechanism of action of Acanthamoeba ps profilin pe is that it binds to ps actin pe monomers, forming a complex that cannot polymerize [Tobacman, L. S., & Korn, E. D. (1982) J. Biol. Chem. 257, 4166-4170; Tseng, P., & Pollard, T. D. (1982) J. Cell Biol. 94, 213-218; Tobacman, L. S., Brenner, S. L., & Korn, E. D. (1983) J. Biol. Chem. 258, 8806-8812].","label":1}
{"pair_id":"BioInfer.d758.s0.p0","sentence":"ps TNF pe also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and ps myosin heavy chain pe.","label":0}
{"pair_id":"BioInfer.d758.s0.p1","sentence":"ps TNF pe also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as ps alpha-skeletal actin pe and myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d758.s0.p2","sentence":"TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as ps alpha-skeletal actin pe and ps myosin heavy chain pe.","label":0}
{"pair_id":"AIMed.d218.s1897.p0","sentence":"In contrast, the other three monoclonal antibodies, which were effective at blocking ps TPO pe activity but did not block initial binding of ps TPO pe to its receptor, had epitopes predominantly on helix or 3.","label":0}
{"pair_id":"BioInfer.d335.s0.p0","sentence":"In flattened cells under starvation stress, ps cofilin pe localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid ps actin pe meshwork in focal adhesion plaques.","label":1}
{"pair_id":"BioInfer.d335.s0.p1","sentence":"In flattened cells under starvation stress, cofilin localized at dramatically reorganizing ps actin pe-cytoskeletons in ruffling membranes of the leading edge, but not at rigid ps actin pe meshwork in focal adhesion plaques.","label":0}
{"pair_id":"BioInfer.d335.s0.p2","sentence":"In flattened cells under starvation stress, ps cofilin pe localized at dramatically reorganizing ps actin pe-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.","label":1}
{"pair_id":"AIMed.d129.s1111.p0","sentence":"These antibodies specifically immunoprecipitate ps p23 pe in complex with ps hsp90 pe in all tissues tested and can be used to immunoaffinity isolate progesterone receptor complexes from chicken oviduct cytosol.","label":1}
{"pair_id":"BioInfer.d566.s0.p0","sentence":"The ability of WIP to replace verprolin is dependent on its WH2 ps actin pe binding domain and a putative ps profilin pe binding domain.","label":0}
{"pair_id":"BioInfer.d566.s0.p1","sentence":"The ability of ps WIP pe to replace verprolin is dependent on its WH2 actin binding domain and a putative ps profilin pe binding domain.","label":1}
{"pair_id":"BioInfer.d566.s0.p2","sentence":"The ability of WIP to replace ps verprolin pe is dependent on its WH2 actin binding domain and a putative ps profilin pe binding domain.","label":0}
{"pair_id":"BioInfer.d566.s0.p3","sentence":"The ability of ps WIP pe to replace verprolin is dependent on its WH2 ps actin pe binding domain and a putative profilin binding domain.","label":1}
{"pair_id":"BioInfer.d566.s0.p4","sentence":"The ability of WIP to replace ps verprolin pe is dependent on its WH2 ps actin pe binding domain and a putative profilin binding domain.","label":0}
{"pair_id":"BioInfer.d566.s0.p5","sentence":"The ability of ps WIP pe to replace ps verprolin pe is dependent on its WH2 actin binding domain and a putative profilin binding domain.","label":1}
{"pair_id":"AIMed.d179.s1529.p0","sentence":"Taken together, our results suggest that ps IRS-1 pe may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the ps gastrin pe\/CCKB G protein-coupled receptor and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p1","sentence":"Taken together, our results suggest that ps IRS-1 pe may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/ps CCKB pe G protein-coupled receptor and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p2","sentence":"Taken together, our results suggest that ps IRS-1 pe may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/ps CCKB G protein-coupled receptor pe and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p3","sentence":"Taken together, our results suggest that ps IRS-1 pe may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/CCKB G protein-coupled receptor and the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p4","sentence":"Taken together, our results suggest that ps IRS-1 pe may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/CCKB G protein-coupled receptor and the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1529.p5","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the ps gastrin pe\/ps CCKB pe G protein-coupled receptor and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p6","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the ps gastrin pe\/ps CCKB G protein-coupled receptor pe and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p7","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the ps gastrin pe\/CCKB G protein-coupled receptor and the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p8","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the ps gastrin pe\/CCKB G protein-coupled receptor and the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1529.p9","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/ps CCKB peps CCKB G protein-coupled receptor pe and the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p10","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/ps CCKB pe G protein-coupled receptor and the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p11","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/ps CCKB pe G protein-coupled receptor and the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1529.p12","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/ps CCKB G protein-coupled receptor pe and the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1529.p13","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/ps CCKB G protein-coupled receptor pe and the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1529.p14","sentence":"Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin\/CCKB G protein-coupled receptor and the ps insulin peps insulin receptor pe.","label":0}
{"pair_id":"BioInfer.d144.s0.p0","sentence":"Coexpression of the ps A8R pe and ps A23R pe genes in Escherichia coli was required for in vitro activity.","label":1}
{"pair_id":"BioInfer.d497.s2.p0","sentence":"The cellular concentrations and binding characteristics of these molecules are consistent with ps profilin pe being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of ps actin pe polymerization.","label":1}
{"pair_id":"BioInfer.d263.s2.p0","sentence":"Interestingly, profilin overproduction can compensate for the deleterious effects of too much ps actin pe in a ps profilin pe concentration-dependent manner.","label":1}
{"pair_id":"BioInfer.d263.s2.p1","sentence":"Interestingly, ps profilin pe overproduction can compensate for the deleterious effects of too much ps actin pe in a profilin concentration-dependent manner.","label":1}
{"pair_id":"BioInfer.d263.s2.p2","sentence":"Interestingly, ps profilin pe overproduction can compensate for the deleterious effects of too much actin in a ps profilin pe concentration-dependent manner.","label":0}
{"pair_id":"AIMed.d89.s763.p0","sentence":"The present study has shown that cell surface ps calreticulin pe binds to the ps B beta chain of fibrinogen pe mediating its mitogenic activity.","label":1}
{"pair_id":"BioInfer.d410.s1.p0","sentence":"There was a trend towards an association between advanced tumour stage and loss of membranous expression of ps alpha-catenin pe or ps beta-catenin pe, although these associations were not statistically significant.","label":0}
{"pair_id":"AIMed.d76.s644.p0","sentence":"Anti-ps CD5 pe also precipitated the kinase from various T cells irrespective of the expression of ps TcR zeta pe\/CD3 or CD4.","label":0}
{"pair_id":"AIMed.d76.s644.p1","sentence":"Anti-ps CD5 pe also precipitated the kinase from various T cells irrespective of the expression of TcR zeta\/ps CD3 pe or CD4.","label":0}
{"pair_id":"AIMed.d76.s644.p2","sentence":"Anti-ps CD5 pe also precipitated the kinase from various T cells irrespective of the expression of TcR zeta\/CD3 or ps CD4 pe.","label":0}
{"pair_id":"AIMed.d76.s644.p3","sentence":"Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of ps TcR zeta pe\/ps CD3 pe or CD4.","label":0}
{"pair_id":"AIMed.d76.s644.p4","sentence":"Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of ps TcR zeta pe\/CD3 or ps CD4 pe.","label":0}
{"pair_id":"AIMed.d76.s644.p5","sentence":"Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta\/ps CD3 pe or ps CD4 pe.","label":0}
{"pair_id":"AIMed.d192.s1639.p0","sentence":"ps Interferon-gamma pe and ps IGIF pe were diminished in the sera of ICE-\/- mice exposed to Propionibacterium acnes and lipopolysaccharide.","label":0}
{"pair_id":"AIMed.d192.s1639.p1","sentence":"ps Interferon-gamma pe and IGIF were diminished in the sera of ps ICE pe-\/- mice exposed to Propionibacterium acnes and lipopolysaccharide.","label":0}
{"pair_id":"AIMed.d192.s1639.p2","sentence":"Interferon-gamma and ps IGIF pe were diminished in the sera of ps ICE pe-\/- mice exposed to Propionibacterium acnes and lipopolysaccharide.","label":0}
{"pair_id":"BioInfer.d699.s0.p0","sentence":"These genes were designated ps UL5 pe, UL8, ps UL9 pe, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p1","sentence":"These genes were designated ps UL5 pe, ps UL8 pe, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p2","sentence":"These genes were designated ps UL5 pe, UL8, UL9, UL42, and ps UL52 pe and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p3","sentence":"These genes were designated ps UL5 pe, UL8, UL9, ps UL42 pe, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p4","sentence":"These genes were designated UL5, ps UL8 pe, ps UL9 pe, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p5","sentence":"These genes were designated UL5, UL8, ps UL9 pe, UL42, and ps UL52 pe and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p6","sentence":"These genes were designated UL5, UL8, ps UL9 pe, ps UL42 pe, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p7","sentence":"These genes were designated UL5, ps UL8 pe, UL9, UL42, and ps UL52 pe and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p8","sentence":"These genes were designated UL5, ps UL8 pe, UL9, ps UL42 pe, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d699.s0.p9","sentence":"These genes were designated UL5, UL8, UL9, ps UL42 pe, and ps UL52 pe and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.","label":0}
{"pair_id":"BioInfer.d238.s1.p0","sentence":"Recently, we have shown that the small ps actin pe-depolymerizing protein ps cofilin pe represents a component of a co-stimulatory signaling pathway in human T cells.","label":1}
{"pair_id":"BioInfer.d247.s0.p0","sentence":"Here, we prepared a ps profilin pe mutant (ps profi pe) defective in ps actin pe binding, but retaining the ability to bind to other proteins.","label":1}
{"pair_id":"AIMed.d96.s815.p0","sentence":"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including ps PTPmu pe, the cadherins associated with ps PTPmu pe are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for PTPmu.","label":0}
{"pair_id":"AIMed.d96.s815.p1","sentence":"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including ps PTPmu pe, the cadherins associated with PTPmu are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for ps PTPmu pe.","label":0}
{"pair_id":"AIMed.d96.s815.p2","sentence":"After pervanadate treatment of MvLu cells, which inhibits cellular tyrosine phosphatase activity including PTPmu, the cadherins associated with ps PTPmu pe are now found in a tyrosine-phosphorylated form, indicating that the cadherins may be an endogenous substrate for ps PTPmu pe.","label":0}
{"pair_id":"AIMed.d44.s387.p0","sentence":"Finally, we demonstrate that the anti-ps CD30L pe MAb M81 also completely inhibits ps CD30 pe\/CD30L interaction.","label":0}
{"pair_id":"AIMed.d44.s387.p1","sentence":"Finally, we demonstrate that the anti-ps CD30L pe MAb M81 also completely inhibits CD30\/ps CD30L pe interaction.","label":0}
{"pair_id":"AIMed.d44.s387.p2","sentence":"Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits ps CD30 pe\/ps CD30L pe interaction.","label":1}
{"pair_id":"AIMed.d113.s958.p0","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of ps BAG-1 pe and ps Bcl-2 pe provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or Bcl-2 protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p1","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of ps BAG-1 pe and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either ps BAG-1 pe or Bcl-2 protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p2","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of ps BAG-1 pe and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or ps Bcl-2 pe protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p3","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and ps Bcl-2 pe provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either ps BAG-1 pe or Bcl-2 protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p4","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and ps Bcl-2 pe provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either BAG-1 or ps Bcl-2 pe protein alone.","label":0}
{"pair_id":"AIMed.d113.s958.p5","sentence":"In gene transfer experiments using a human lymphoid cell line, Jurkat, coexpression of BAG-1 and Bcl-2 provided markedly increased protection from cell death induced by several stimuli, including staurosporine, anti-Fas antibody, and cytolytic T cells, relative to cells that contained gene transfer-mediated elevations in either ps BAG-1 pe or ps Bcl-2 pe protein alone.","label":0}
{"pair_id":"AIMed.d33.s279.p0","sentence":"Native ps C8 pe also formed a heterodimer with ps C5 pe,and low concentrations of polyionic ligands such as protamine and suramin inhibited the interaction.","label":1}
{"pair_id":"BioInfer.d68.s0.p0","sentence":"ps ORC1 pe, ps ORC4 pe and Cdc6 were stable (T1\/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.","label":1}
{"pair_id":"BioInfer.d68.s0.p1","sentence":"ORC1, ps ORC4 pe and ps Cdc6 pe were stable (T1\/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.","label":1}
{"pair_id":"BioInfer.d68.s0.p2","sentence":"ps ORC1 pe, ORC4 and ps Cdc6 pe were stable (T1\/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.","label":1}
{"pair_id":"AIMed.d216.s1876.p0","sentence":"The switch II region of ps Ras pe is stabilized by ps GAP-334 pe, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.","label":1}
{"pair_id":"AIMed.d216.s1876.p1","sentence":"The switch II region of ps Ras pe is stabilized by GAP-334, thus allowing glutamine-61 of ps Ras pe, mutation of which activates the oncogenic potential, to participate in catalysis.","label":0}
{"pair_id":"AIMed.d216.s1876.p2","sentence":"The switch II region of Ras is stabilized by ps GAP-334 pe, thus allowing glutamine-61 of ps Ras pe, mutation of which activates the oncogenic potential, to participate in catalysis.","label":0}
{"pair_id":"BioInfer.d288.s0.p0","sentence":"Immunofluorescence experiments showed that, like ps Abp1p pe, cofilin is associated with the membrane ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d288.s0.p1","sentence":"Immunofluorescence experiments showed that, like ps Abp1p pe, ps cofilin pe is associated with the membrane actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d288.s0.p2","sentence":"Immunofluorescence experiments showed that, like Abp1p, ps cofilin pe is associated with the membrane ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d204.s0.p0","sentence":"Expression of c-Myc or ps cyclin D1 pe was sufficient to activate cyclin E-ps Cdk2 pe by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p1","sentence":"Expression of c-Myc or ps cyclin D1 pe was sufficient to activate ps cyclin E pe-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p2","sentence":"Expression of c-Myc or ps cyclin D1 pe was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the ps cyclin-dependent kinase inhibitor pe p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p3","sentence":"Expression of ps c-Myc pe or ps cyclin D1 pe was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p4","sentence":"Expression of c-Myc or ps cyclin D1 pe was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor ps p21 pe, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p5","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate ps cyclin E pe-ps Cdk2 pe by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p6","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-ps Cdk2 pe by promoting the formation of high-molecular-weight complexes lacking the ps cyclin-dependent kinase inhibitor pe p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p7","sentence":"Expression of ps c-Myc pe or cyclin D1 was sufficient to activate cyclin E-ps Cdk2 pe by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p8","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-ps Cdk2 pe by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor ps p21 pe, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p9","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate ps cyclin E pe-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the ps cyclin-dependent kinase inhibitor pe p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p10","sentence":"Expression of ps c-Myc pe or cyclin D1 was sufficient to activate ps cyclin E pe-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p11","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate ps cyclin E pe-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor ps p21 pe, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p12","sentence":"Expression of ps c-Myc pe or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the ps cyclin-dependent kinase inhibitor pe p21, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d204.s0.p13","sentence":"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the ps cyclin-dependent kinase inhibitor pe ps p21 pe, as has been described, following estrogen treatment.","label":1}
{"pair_id":"BioInfer.d204.s0.p14","sentence":"Expression of ps c-Myc pe or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor ps p21 pe, as has been described, following estrogen treatment.","label":0}
{"pair_id":"BioInfer.d17.s0.p0","sentence":"ps Actin pe expression was reduced by 25-50%, relative to that of myosin heavy chain, in smooth muscle of KO mice, without any change in the relative distribution of the ps actin pe isoforms.","label":0}
{"pair_id":"BioInfer.d17.s0.p1","sentence":"ps Actin pe expression was reduced by 25-50%, relative to that of ps myosin heavy chain pe, in smooth muscle of KO mice, without any change in the relative distribution of the actin isoforms.","label":0}
{"pair_id":"BioInfer.d17.s0.p2","sentence":"Actin expression was reduced by 25-50%, relative to that of ps myosin heavy chain pe, in smooth muscle of KO mice, without any change in the relative distribution of the ps actin pe isoforms.","label":0}
{"pair_id":"BioInfer.d696.s0.p0","sentence":"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of ps myosin heavy chain pe, actin and ps tropomyosin pe.","label":0}
{"pair_id":"BioInfer.d696.s0.p1","sentence":"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, ps actin pe and ps tropomyosin pe.","label":0}
{"pair_id":"BioInfer.d696.s0.p2","sentence":"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of ps myosin heavy chain pe, ps actin pe and tropomyosin.","label":0}
{"pair_id":"AIMed.d150.s1275.p0","sentence":"ps Elf-1 pe is a lymphoid-specific ps Ets pe transcription factor that regulates inducible gene expression during T cell activation.","label":0}
{"pair_id":"AIMed.d25.s203.p0","sentence":"Assaying of ps tumor necrosis factor alpha pe, complement factors, and ps alpha-1-antitrypsin pe in the diagnosis of malignant serous effusions.","label":0}
{"pair_id":"AIMed.d169.s1425.p0","sentence":"ps Interleukin-13 pe (ps IL-13 pe) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.","label":0}
{"pair_id":"AIMed.d169.s1425.p1","sentence":"ps Interleukin-13 pe (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with ps IL-4 pe.","label":0}
{"pair_id":"AIMed.d169.s1425.p2","sentence":"Interleukin-13 (ps IL-13 pe) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with ps IL-4 pe.","label":0}
{"pair_id":"AIMed.d162.s1369.p0","sentence":"In transfected cells, wild-type ps p53 pe repressed the hormone-dependent transcriptional activation of ps h-TR beta 1 pe.","label":1}
{"pair_id":"BioInfer.d721.s0.p0","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p1","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p2","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p3","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p4","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p5","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p6","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p7","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p8","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p9","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p10","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p11","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p12","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (ps L pe; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p13","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p14","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p15","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p16","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p17","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p18","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p19","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p20","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p21","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p22","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p23","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p24","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (ps F0 pe; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p25","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p26","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p27","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p28","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p29","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p30","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p31","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p32","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p33","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p34","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p35","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), ps fusion pe (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p36","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p37","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p38","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p39","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p40","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p41","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p42","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p43","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (ps V pe; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p44","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p45","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and ps non-structural pe (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p46","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p47","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p48","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p49","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p50","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p51","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p52","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (ps V pe; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p53","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p54","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), ps matrix pe (ps M pe; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p55","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p56","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p57","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p58","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p59","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p60","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p61","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p62","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (ps HN pe; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p63","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p64","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p65","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p66","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p67","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p68","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p69","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the ps large pe (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p70","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p71","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p72","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p73","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p74","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p75","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), ps nucleocapsid pe (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p76","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop peps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p77","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p78","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p79","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p80","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), ps haemagglutinin neuraminidase pe (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p81","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p82","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p83","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p84","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), ps phosphoprotein pe (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) ps phosphop pe.","label":0}
{"pair_id":"BioInfer.d721.s0.p85","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p86","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p87","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (ps P pe; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p88","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (ps V pe; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p89","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (ps V pe; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d721.s0.p90","sentence":"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (ps N pe; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (ps M pe; 43 kDa) and non-structural (V; 35 kDa) phosphop.","label":0}
{"pair_id":"BioInfer.d191.s0.p0","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, ps myogenin pe, desmin, and ps muscle-specific actin pe over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p1","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, ps desmin pe, and ps muscle-specific actin pe over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p2","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of ps myosin heavy chain pe, myogenin, desmin, and ps muscle-specific actin pe over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p3","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, ps myogenin pe, ps desmin pe, and muscle-specific actin over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p4","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of ps myosin heavy chain pe, ps myogenin pe, desmin, and muscle-specific actin over a 240 h period in culture.","label":0}
{"pair_id":"BioInfer.d191.s0.p5","sentence":"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of ps myosin heavy chain pe, myogenin, ps desmin pe, and muscle-specific actin over a 240 h period in culture.","label":0}
{"pair_id":"AIMed.d204.s1762.p0","sentence":"Only the activated and not the latent forms of wild-type and C-terminal mutant des-(248-450)-ps MMP-1 pe proteins are able to form complexes with ps TIMP pe.","label":1}
{"pair_id":"BioInfer.d440.s0.p0","sentence":"Most previous studies have focused on ps profilin pe itself rather than its complex with ps actin pe.","label":1}
{"pair_id":"AIMed.d30.s251.p0","sentence":"We screened proteins for interaction with ps presenilin (PS) 1 pe, and cloned the full-length cDNA of human ps delta-catenin pe, which encoded 1225 amino acids.","label":1}
{"pair_id":"AIMed.d112.s947.p0","sentence":"ps Syk pe and ps Lyn pe coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and Lyn reassociated in vitro, demonstrating their direct interaction.","label":1}
{"pair_id":"AIMed.d112.s947.p1","sentence":"ps Syk pe and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified ps Syk pe and Lyn reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p2","sentence":"ps Syk pe and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and ps Lyn pe reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p3","sentence":"Syk and ps Lyn pe coimmunoprecipitated from mature and activated B-cell lines, and gel-purified ps Syk pe and Lyn reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p4","sentence":"Syk and ps Lyn pe coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and ps Lyn pe reassociated in vitro, demonstrating their direct interaction.","label":0}
{"pair_id":"AIMed.d112.s947.p5","sentence":"Syk and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified ps Syk pe and ps Lyn pe reassociated in vitro, demonstrating their direct interaction.","label":1}
{"pair_id":"BioInfer.d410.s0.p0","sentence":"Loss of memberanous expression of ps E-cadherin pe, alpha-catenin and ps beta-catenin pe was demonstrated in 52%, 85% and 40% of tumours respectively.","label":0}
{"pair_id":"BioInfer.d410.s0.p1","sentence":"Loss of memberanous expression of ps E-cadherin pe, ps alpha-catenin pe and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.","label":0}
{"pair_id":"BioInfer.d410.s0.p2","sentence":"Loss of memberanous expression of E-cadherin, ps alpha-catenin pe and ps beta-catenin pe was demonstrated in 52%, 85% and 40% of tumours respectively.","label":0}
{"pair_id":"AIMed.d214.s1863.p0","sentence":"The interaction between ps Vav pe and ps c-Cbl pe is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.","label":1}
{"pair_id":"AIMed.d214.s1863.p1","sentence":"The interaction between ps Vav pe and c-Cbl is directly mediated via the SH2 domain of ps Vav pe and is dependent on tyrosine phosphorylation of c-Cbl.","label":0}
{"pair_id":"AIMed.d214.s1863.p2","sentence":"The interaction between ps Vav pe and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of ps c-Cbl pe.","label":0}
{"pair_id":"AIMed.d214.s1863.p3","sentence":"The interaction between Vav and ps c-Cbl pe is directly mediated via the SH2 domain of ps Vav pe and is dependent on tyrosine phosphorylation of c-Cbl.","label":0}
{"pair_id":"AIMed.d214.s1863.p4","sentence":"The interaction between Vav and ps c-Cbl pe is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of ps c-Cbl pe.","label":0}
{"pair_id":"AIMed.d214.s1863.p5","sentence":"The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of ps Vav pe and is dependent on tyrosine phosphorylation of ps c-Cbl pe.","label":0}
{"pair_id":"AIMed.d213.s1854.p0","sentence":"In contrast, physical interaction is not necessary for ps YY1 pe to repress ps Sp1 pe- and CREB-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1854.p1","sentence":"In contrast, physical interaction is not necessary for ps YY1 pe to repress Sp1- and ps CREB pe-mediated transcription.","label":0}
{"pair_id":"AIMed.d213.s1854.p2","sentence":"In contrast, physical interaction is not necessary for YY1 to repress ps Sp1 pe- and ps CREB pe-mediated transcription.","label":0}
{"pair_id":"BioInfer.d59.s1.p0","sentence":"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the ps cofilin pe-binding site in the ps actin pe sequence.","label":1}
{"pair_id":"BioInfer.d59.s1.p1","sentence":"Purification of cofilin, a 21,000 molecular weight ps actin-binding protein pe, from porcine kidney and identification of the cofilin-binding site in the ps actin pe sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p2","sentence":"Purification of ps cofilin pe, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the ps actin pe sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p3","sentence":"Purification of cofilin, a 21,000 molecular weight ps actin-binding protein pe, from porcine kidney and identification of the ps cofilin pe-binding site in the actin sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p4","sentence":"Purification of ps cofilin pe, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the ps cofilin pe-binding site in the actin sequence.","label":0}
{"pair_id":"BioInfer.d59.s1.p5","sentence":"Purification of ps cofilin pe, a 21,000 molecular weight ps actin-binding protein pe, from porcine kidney and identification of the cofilin-binding site in the actin sequence.","label":1}
{"pair_id":"AIMed.d175.s1482.p0","sentence":"Association of ps CDK4 pe with both ps CDC37 pe and HSP90 may also imply a mechanistic link between the functions of CDC37 and HSP90.","label":1}
{"pair_id":"AIMed.d175.s1482.p1","sentence":"Association of ps CDK4 pe with both CDC37 and ps HSP90 pe may also imply a mechanistic link between the functions of CDC37 and HSP90.","label":1}
{"pair_id":"AIMed.d175.s1482.p2","sentence":"Association of ps CDK4 pe with both CDC37 and HSP90 may also imply a mechanistic link between the functions of ps CDC37 pe and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p3","sentence":"Association of ps CDK4 pe with both CDC37 and HSP90 may also imply a mechanistic link between the functions of CDC37 and ps HSP90 pe.","label":0}
{"pair_id":"AIMed.d175.s1482.p4","sentence":"Association of CDK4 with both ps CDC37 pe and ps HSP90 pe may also imply a mechanistic link between the functions of CDC37 and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p5","sentence":"Association of CDK4 with both ps CDC37 pe and HSP90 may also imply a mechanistic link between the functions of ps CDC37 pe and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p6","sentence":"Association of CDK4 with both ps CDC37 pe and HSP90 may also imply a mechanistic link between the functions of CDC37 and ps HSP90 pe.","label":0}
{"pair_id":"AIMed.d175.s1482.p7","sentence":"Association of CDK4 with both CDC37 and ps HSP90 pe may also imply a mechanistic link between the functions of ps CDC37 pe and HSP90.","label":0}
{"pair_id":"AIMed.d175.s1482.p8","sentence":"Association of CDK4 with both CDC37 and ps HSP90 pe may also imply a mechanistic link between the functions of CDC37 and ps HSP90 pe.","label":0}
{"pair_id":"AIMed.d175.s1482.p9","sentence":"Association of CDK4 with both CDC37 and HSP90 may also imply a mechanistic link between the functions of ps CDC37 pe and ps HSP90 pe.","label":0}
{"pair_id":"BioInfer.d366.s0.p0","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, ps RAD17 pe, RAD24, MEC1, ps MEC2 pe and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p1","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, ps RAD24 pe, MEC1, ps MEC2 pe and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p2","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes ps RAD9 pe, RAD17, RAD24, MEC1, ps MEC2 pe and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p3","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, ps MEC2 pe and ps MEC3 pe.","label":0}
{"pair_id":"BioInfer.d366.s0.p4","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, ps MEC1 pe, ps MEC2 pe and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p5","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, ps RAD17 pe, ps RAD24 pe, MEC1, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p6","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes ps RAD9 pe, ps RAD17 pe, RAD24, MEC1, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p7","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, ps RAD17 pe, RAD24, MEC1, MEC2 and ps MEC3 pe.","label":0}
{"pair_id":"BioInfer.d366.s0.p8","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, ps RAD17 pe, RAD24, ps MEC1 pe, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p9","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes ps RAD9 pe, RAD17, ps RAD24 pe, MEC1, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p10","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, ps RAD24 pe, MEC1, MEC2 and ps MEC3 pe.","label":0}
{"pair_id":"BioInfer.d366.s0.p11","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, ps RAD24 pe, ps MEC1 pe, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p12","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes ps RAD9 pe, RAD17, RAD24, MEC1, MEC2 and ps MEC3 pe.","label":0}
{"pair_id":"BioInfer.d366.s0.p13","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes ps RAD9 pe, RAD17, RAD24, ps MEC1 pe, MEC2 and MEC3.","label":0}
{"pair_id":"BioInfer.d366.s0.p14","sentence":"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, ps MEC1 pe, MEC2 and ps MEC3 pe.","label":0}
{"pair_id":"BioInfer.d433.s2.p0","sentence":"To investigate the possibility that ps TD77 pe disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional ps talin pe fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p1","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal ps actin pe binding site, additional ps talin pe fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p2","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional ps talin pe fusion proteins were generated and analyzed for TD77 and ps actin pe binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p3","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional ps talin pe fusion proteins were generated and analyzed for ps TD77 pe and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p4","sentence":"To investigate the possibility that TD77 disrupts ps actin pe stress fibers by binding directly to the C-terminal actin binding site, additional ps talin pe fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p5","sentence":"To investigate the possibility that ps TD77 pe disrupts actin stress fibers by binding directly to the C-terminal ps actin pe binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p6","sentence":"To investigate the possibility that ps TD77 pe disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and ps actin pe binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p7","sentence":"To investigate the possibility that ps TD77 pe disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for ps TD77 pe and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p8","sentence":"To investigate the possibility that ps TD77 pe disrupts ps actin pe stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.","label":1}
{"pair_id":"BioInfer.d433.s2.p9","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal ps actin pe binding site, additional talin fusion proteins were generated and analyzed for TD77 and ps actin pe binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p10","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal ps actin pe binding site, additional talin fusion proteins were generated and analyzed for ps TD77 pe and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p11","sentence":"To investigate the possibility that TD77 disrupts ps actin pe stress fibers by binding directly to the C-terminal ps actin pe binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p12","sentence":"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for ps TD77 pe and ps actin pe binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p13","sentence":"To investigate the possibility that TD77 disrupts ps actin pe stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and ps actin pe binding.","label":0}
{"pair_id":"BioInfer.d433.s2.p14","sentence":"To investigate the possibility that TD77 disrupts ps actin pe stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for ps TD77 pe and actin binding.","label":0}
{"pair_id":"BioInfer.d505.s1.p0","sentence":"Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of ps profilin pe for ps actin pe.","label":1}
{"pair_id":"BioInfer.d580.s1.p0","sentence":"The herpes simplex virus type 1 (HSV) UL5, ps UL8 pe, and ps UL52 pe proteins form a helicase-primase complex in infected cells.","label":1}
{"pair_id":"BioInfer.d580.s1.p1","sentence":"The herpes simplex virus type 1 (HSV) ps UL5 pe, UL8, and ps UL52 pe proteins form a helicase-primase complex in infected cells.","label":1}
{"pair_id":"BioInfer.d580.s1.p2","sentence":"The herpes simplex virus type 1 (HSV) ps UL5 pe, ps UL8 pe, and UL52 proteins form a helicase-primase complex in infected cells.","label":1}
{"pair_id":"BioInfer.d4.s0.p0","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and ps alpha-catenin pe is not affected by the differential ps calreticulin pe expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p1","sentence":"Abundance of ps actin pe, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and ps alpha-catenin pe is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p2","sentence":"Abundance of actin, talin, ps alpha 5 pe and beta 1 ps integrins pe, pp125 focal adhesion kinase, and ps alpha-catenin pe is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p3","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, ps pp125 pe focal adhesion kinase, and ps alpha-catenin pe is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p4","sentence":"Abundance of actin, talin, alpha 5 and ps beta 1 integrins pe, pp125 focal adhesion kinase, and ps alpha-catenin pe is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p5","sentence":"Abundance of actin, ps talin pe, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and ps alpha-catenin pe is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p6","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 ps focal adhesion kinase pe, and ps alpha-catenin pe is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p7","sentence":"Abundance of ps actin pe, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential ps calreticulin pe expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p8","sentence":"Abundance of actin, talin, ps alpha 5 pe and beta 1 ps integrins pe, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential ps calreticulin pe expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p9","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, ps pp125 pe focal adhesion kinase, and alpha-catenin is not affected by the differential ps calreticulin pe expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p10","sentence":"Abundance of actin, talin, alpha 5 and ps beta 1 integrins pe, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential ps calreticulin pe expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p11","sentence":"Abundance of actin, ps talin pe, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential ps calreticulin pe expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p12","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 ps focal adhesion kinase pe, and alpha-catenin is not affected by the differential ps calreticulin pe expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p13","sentence":"Abundance of ps actin pe, talin, ps alpha 5 pe and beta 1 ps integrins pe, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p14","sentence":"Abundance of ps actin pe, talin, alpha 5 and beta 1 integrins, ps pp125 pe focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p15","sentence":"Abundance of ps actin pe, talin, alpha 5 and ps beta 1 integrins pe, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p16","sentence":"Abundance of ps actin pe, ps talin pe, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p17","sentence":"Abundance of ps actin pe, talin, alpha 5 and beta 1 integrins, pp125 ps focal adhesion kinase pe, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p18","sentence":"Abundance of actin, talin, ps alpha 5 pe and beta 1 ps integrins pe, ps pp125 pe focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p19","sentence":"Abundance of actin, talin, ps alpha 5 pe and ps beta 1 integrins peps integrins pe, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p20","sentence":"Abundance of actin, ps talin pe, ps alpha 5 pe and beta 1 ps integrins pe, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p21","sentence":"Abundance of actin, talin, ps alpha 5 pe and beta 1 ps integrins pe, pp125 ps focal adhesion kinase pe, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p22","sentence":"Abundance of actin, talin, alpha 5 and ps beta 1 integrins pe, ps pp125 pe focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p23","sentence":"Abundance of actin, ps talin pe, alpha 5 and beta 1 integrins, ps pp125 pe focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p24","sentence":"Abundance of actin, talin, alpha 5 and beta 1 integrins, ps pp125 pe ps focal adhesion kinase pe, and alpha-catenin is not affected by the differential calreticulin expression.","label":1}
{"pair_id":"BioInfer.d4.s0.p25","sentence":"Abundance of actin, ps talin pe, alpha 5 and ps beta 1 integrins pe, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p26","sentence":"Abundance of actin, talin, alpha 5 and ps beta 1 integrins pe, pp125 ps focal adhesion kinase pe, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d4.s0.p27","sentence":"Abundance of actin, ps talin pe, alpha 5 and beta 1 integrins, pp125 ps focal adhesion kinase pe, and alpha-catenin is not affected by the differential calreticulin expression.","label":0}
{"pair_id":"BioInfer.d460.s0.p0","sentence":"One involves ps talin pe, which has recently been shown to bind ps actin pe directly.","label":1}
{"pair_id":"AIMed.d167.s1411.p0","sentence":"Thus, our data show that both ps calnexin pe and ps calreticulin pe interact with Glut 1 in a glycosylation-dependent manner.","label":0}
{"pair_id":"AIMed.d167.s1411.p1","sentence":"Thus, our data show that both ps calnexin pe and calreticulin interact with ps Glut 1 pe in a glycosylation-dependent manner.","label":1}
{"pair_id":"AIMed.d167.s1411.p2","sentence":"Thus, our data show that both calnexin and ps calreticulin pe interact with ps Glut 1 pe in a glycosylation-dependent manner.","label":1}
{"pair_id":"BioInfer.d49.s3.p0","sentence":"The role of ps profilin pe in the regulation of ps actin pe assembly has been reexamined.","label":1}
{"pair_id":"AIMed.d89.s762.p0","sentence":"Further, polyclonal antibodies to human ps calreticulin pe significantly inhibited the mitogenic activity of ps fibrinogen B beta chain pe on human fibroblasts.","label":0}
{"pair_id":"AIMed.d53.s470.p0","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral ps IL-6 pe and human ps gp130 pe, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation.","label":1}
{"pair_id":"AIMed.d53.s470.p1","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral ps IL-6 pe and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of ps gp130 pe and site III of viral IL-6, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p2","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral ps IL-6 pe and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral ps IL-6 pe, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p3","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human ps gp130 pe, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of ps gp130 pe and site III of viral IL-6, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p4","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human ps gp130 pe, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral ps IL-6 pe, which is necessary for receptor activation.","label":0}
{"pair_id":"AIMed.d53.s470.p5","sentence":"In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of ps gp130 pe and site III of viral ps IL-6 pe, which is necessary for receptor activation.","label":1}
{"pair_id":"BioInfer.d73.s1.p0","sentence":"ps RAD51 pe, RAD54, ps RAD55 pe and RAD57 are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p1","sentence":"RAD51, RAD54, ps RAD55 pe and ps RAD57 pe are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p2","sentence":"RAD51, ps RAD54 pe, ps RAD55 pe and RAD57 are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p3","sentence":"ps RAD51 pe, RAD54, RAD55 and ps RAD57 pe are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p4","sentence":"ps RAD51 pe, ps RAD54 pe, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"BioInfer.d73.s1.p5","sentence":"RAD51, ps RAD54 pe, RAD55 and ps RAD57 pe are still required when the same transcribed donor is on the chromosome.","label":0}
{"pair_id":"AIMed.d198.s1687.p0","sentence":"Mutagenesis of the ps erythropoietin peps erythropoietin receptor pe (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p1","sentence":"Mutagenesis of the ps erythropoietin pe receptor (ps EPOR pe) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.","label":1}
{"pair_id":"AIMed.d198.s1687.p2","sentence":"Mutagenesis of the ps erythropoietin pe receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to ps erythropoietin pe (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p3","sentence":"Mutagenesis of the ps erythropoietin pe receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (ps EPO pe) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p4","sentence":"Mutagenesis of the ps erythropoietin receptor pe (ps EPOR pe) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p5","sentence":"Mutagenesis of the ps erythropoietin receptor pe (EPOR) permits analysis of the contribution that individual amino acid residues make to ps erythropoietin pe (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p6","sentence":"Mutagenesis of the ps erythropoietin receptor pe (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (ps EPO pe) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p7","sentence":"Mutagenesis of the erythropoietin receptor (ps EPOR pe) permits analysis of the contribution that individual amino acid residues make to ps erythropoietin pe (EPO) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p8","sentence":"Mutagenesis of the erythropoietin receptor (ps EPOR pe) permits analysis of the contribution that individual amino acid residues make to erythropoietin (ps EPO pe) binding.","label":0}
{"pair_id":"AIMed.d198.s1687.p9","sentence":"Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to ps erythropoietin pe (ps EPO pe) binding.","label":0}
{"pair_id":"AIMed.d148.s1253.p0","sentence":"Other recent studies have identified human ps cyclin D1 pe (ps PRAD1 pe) as a putative G1 cyclin and candidate proto-oncogene.","label":0}
{"pair_id":"BioInfer.d48.s0.p0","sentence":"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and ps vinculin pe on the structure, chain dynamics, elasticity and viscoelasticity of ps actin pe filaments with time.","label":1}
{"pair_id":"BioInfer.d48.s0.p1","sentence":"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of ps talin pe and ps vinculin pe on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.","label":0}
{"pair_id":"BioInfer.d48.s0.p2","sentence":"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of ps talin pe and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of ps actin pe filaments with time.","label":1}
{"pair_id":"BioInfer.d537.s0.p0","sentence":"Signaling pathways involved in dephosphorylation and localization of the ps actin-binding protein pe ps cofilin pe in stimulated human neutrophils.","label":1}
{"pair_id":"BioInfer.d793.s0.p0","sentence":"Villin and ps fimbrin pe are two actin-binding proteins that bundle ps actin pe filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"BioInfer.d793.s0.p1","sentence":"ps Villin pe and fimbrin are two actin-binding proteins that bundle ps actin pe filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"BioInfer.d793.s0.p2","sentence":"Villin and fimbrin are two ps actin-binding proteins pe that bundle ps actin pe filaments in the intestine and kidney brush border epithelium.","label":0}
{"pair_id":"BioInfer.d793.s0.p3","sentence":"ps Villin pe and ps fimbrin pe are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.","label":0}
{"pair_id":"BioInfer.d793.s0.p4","sentence":"Villin and ps fimbrin pe are two ps actin-binding proteins pe that bundle actin filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"BioInfer.d793.s0.p5","sentence":"ps Villin pe and fimbrin are two ps actin-binding proteins pe that bundle actin filaments in the intestine and kidney brush border epithelium.","label":1}
{"pair_id":"AIMed.d64.s552.p0","sentence":"From Scatchard analyses, the Kd:s for binding of ps aFGF pe and ps bFGF pe to hFGFR-1 were estimated to 25 pM and 41 pM, respectively.","label":0}
{"pair_id":"AIMed.d64.s552.p1","sentence":"From Scatchard analyses, the Kd:s for binding of ps aFGF pe and bFGF to ps hFGFR-1 pe were estimated to 25 pM and 41 pM, respectively.","label":1}
{"pair_id":"AIMed.d64.s552.p2","sentence":"From Scatchard analyses, the Kd:s for binding of aFGF and ps bFGF pe to ps hFGFR-1 pe were estimated to 25 pM and 41 pM, respectively.","label":1}
{"pair_id":"AIMed.d8.s60.p0","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of ps K-ras pe, ps p53 pe, p16 and DPC4\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p1","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of ps K-ras pe, p53, ps p16 pe and DPC4\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p2","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of ps K-ras pe, p53, p16 and ps DPC4 pe\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p3","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of ps K-ras pe, p53, p16 and DPC4\/ps Smad4 pe.","label":0}
{"pair_id":"AIMed.d8.s60.p4","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, ps p53 pe, ps p16 pe and DPC4\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p5","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, ps p53 pe, p16 and ps DPC4 pe\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p6","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, ps p53 pe, p16 and DPC4\/ps Smad4 pe.","label":0}
{"pair_id":"AIMed.d8.s60.p7","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, ps p16 pe and ps DPC4 pe\/Smad4.","label":0}
{"pair_id":"AIMed.d8.s60.p8","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, ps p16 pe and DPC4\/ps Smad4 pe.","label":0}
{"pair_id":"AIMed.d8.s60.p9","sentence":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and ps DPC4 pe\/ps Smad4 pe.","label":0}
{"pair_id":"BioInfer.d27.s1.p0","sentence":"In contrast, ADP-ribosylation of actin at Arg95\/Arg372 induced by turkey ps erythrocyte transferase pe decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the ps profilin pe-induced stimulation of nucleotide exchange.","label":0}
{"pair_id":"BioInfer.d27.s1.p1","sentence":"In contrast, ADP-ribosylation of ps actin pe at Arg95\/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the ps profilin pe-induced stimulation of nucleotide exchange.","label":0}
{"pair_id":"BioInfer.d27.s1.p2","sentence":"In contrast, ADP-ribosylation of ps actin pe at Arg95\/Arg372 induced by turkey ps erythrocyte transferase pe decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.","label":1}
{"pair_id":"AIMed.d87.s741.p0","sentence":"Thus, the C-terminal domain in ps IGF-1R pe appears to exert a negative control on binding of ps p85 pe thereby providing a possible regulatory mechanism for direct activation of the PI 3-kinase pathway.","label":1}
{"pair_id":"AIMed.d87.s741.p1","sentence":"Thus, the C-terminal domain in ps IGF-1R pe appears to exert a negative control on binding of p85 thereby providing a possible regulatory mechanism for direct activation of the ps PI 3-kinase pe pathway.","label":0}
{"pair_id":"AIMed.d87.s741.p2","sentence":"Thus, the C-terminal domain in IGF-1R appears to exert a negative control on binding of ps p85 pe thereby providing a possible regulatory mechanism for direct activation of the ps PI 3-kinase pe pathway.","label":0}
{"pair_id":"AIMed.d218.s1889.p0","sentence":"ps Thrombopoietin pe (ps TPO pe) is a hematopoietin important for megakaryocyte proliferation and production of blood platelets.","label":0}
{"pair_id":"AIMed.d167.s1410.p0","sentence":"ps Calreticulin pe, the soluble homologue of ps calnexin pe, was also shown to interact with GT155 only when the protein bore a correctly modified oligosaccharide group.","label":0}
{"pair_id":"AIMed.d167.s1410.p1","sentence":"ps Calreticulin pe, the soluble homologue of calnexin, was also shown to interact with ps GT155 pe only when the protein bore a correctly modified oligosaccharide group.","label":1}
{"pair_id":"AIMed.d167.s1410.p2","sentence":"Calreticulin, the soluble homologue of ps calnexin pe, was also shown to interact with ps GT155 pe only when the protein bore a correctly modified oligosaccharide group.","label":0}
{"pair_id":"BioInfer.d274.s1.p0","sentence":"Identification of ps alpha-syntrophin pe binding to syntrophin triplet, ps dystrophin pe, and utrophin.","label":1}
{"pair_id":"BioInfer.d274.s1.p1","sentence":"Identification of ps alpha-syntrophin pe binding to ps syntrophin triplet pe, dystrophin, and utrophin.","label":1}
{"pair_id":"BioInfer.d274.s1.p2","sentence":"Identification of ps alpha-syntrophin pe binding to syntrophin triplet, dystrophin, and ps utrophin pe.","label":1}
{"pair_id":"BioInfer.d274.s1.p3","sentence":"Identification of alpha-syntrophin binding to ps syntrophin triplet pe, ps dystrophin pe, and utrophin.","label":0}
{"pair_id":"BioInfer.d274.s1.p4","sentence":"Identification of alpha-syntrophin binding to syntrophin triplet, ps dystrophin pe, and ps utrophin pe.","label":0}
{"pair_id":"BioInfer.d274.s1.p5","sentence":"Identification of alpha-syntrophin binding to ps syntrophin triplet pe, dystrophin, and ps utrophin pe.","label":0}
{"pair_id":"BioInfer.d550.s0.p0","sentence":"Stable transfection of mutant plakoglobin molecules showed that deletion of the ps N-cadherin pe binding domain, but not the ps alpha-catenin pe binding domain, abolished beta-catenin downregulation.","label":0}
{"pair_id":"BioInfer.d550.s0.p1","sentence":"Stable transfection of mutant plakoglobin molecules showed that deletion of the ps N-cadherin pe binding domain, but not the alpha-catenin binding domain, abolished ps beta-catenin pe downregulation.","label":0}
{"pair_id":"BioInfer.d550.s0.p2","sentence":"Stable transfection of mutant ps plakoglobin pe molecules showed that deletion of the ps N-cadherin pe binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.","label":1}
{"pair_id":"BioInfer.d550.s0.p3","sentence":"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the ps alpha-catenin pe binding domain, abolished ps beta-catenin pe downregulation.","label":0}
{"pair_id":"BioInfer.d550.s0.p4","sentence":"Stable transfection of mutant ps plakoglobin pe molecules showed that deletion of the N-cadherin binding domain, but not the ps alpha-catenin pe binding domain, abolished beta-catenin downregulation.","label":1}
{"pair_id":"BioInfer.d550.s0.p5","sentence":"Stable transfection of mutant ps plakoglobin pe molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished ps beta-catenin pe downregulation.","label":1}
{"pair_id":"AIMed.d154.s1311.p0","sentence":"The deduced amino acid sequences of human alpha 1- and ps beta 2-syntrophin pe are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like ps beta 1-syntrophin pe, human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.","label":0}
{"pair_id":"AIMed.d154.s1311.p1","sentence":"The deduced amino acid sequences of human alpha 1- and ps beta 2-syntrophin pe are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human ps beta 2-syntrophin pe has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.","label":0}
{"pair_id":"AIMed.d154.s1311.p2","sentence":"The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like ps beta 1-syntrophin pe, human ps beta 2-syntrophin pe has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.","label":0}
{"pair_id":"AIMed.d118.s1001.p0","sentence":"Here we use simian virus 40 DNA replication in vitro to show than ps p21 pe directly inhibits ps PCNA pe-dependent DNA replication in the absence of a cyclin\/CDK.","label":1}
{"pair_id":"BioInfer.d595.s0.p0","sentence":"The common denominator is impaired ps beta-catenin pe association with either ps E-cadherin pe (PaTuII) or alpha-catenin (BxPc3 and T3M4).","label":1}
{"pair_id":"BioInfer.d595.s0.p1","sentence":"The common denominator is impaired ps beta-catenin pe association with either E-cadherin (PaTuII) or ps alpha-catenin pe (BxPc3 and T3M4).","label":1}
{"pair_id":"BioInfer.d595.s0.p2","sentence":"The common denominator is impaired beta-catenin association with either ps E-cadherin pe (PaTuII) or ps alpha-catenin pe (BxPc3 and T3M4).","label":0}
{"pair_id":"AIMed.d76.s637.p0","sentence":"The T-cell antigen ps CD5 pe acts as a receptor and substrate for the protein-tyrosine kinase ps p56lck pe.","label":1}
{"pair_id":"AIMed.d76.s642.p0","sentence":"Coexpression of ps CD5 pe with ps p56lck pe in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.","label":0}
{"pair_id":"AIMed.d76.s642.p1","sentence":"Coexpression of ps CD5 pe with p56lck in the baculovirus expression system resulted in the phosphorylation of ps CD5 pe on tyrosine residues.","label":0}
{"pair_id":"AIMed.d76.s642.p2","sentence":"Coexpression of CD5 with ps p56lck pe in the baculovirus expression system resulted in the phosphorylation of ps CD5 pe on tyrosine residues.","label":0}
{"pair_id":"AIMed.d151.s1285.p0","sentence":"We previously have shown that ps PTF pe purified from human HeLa cells is a multisubunit complex of four polypeptides designated ps PTF pe alpha, -beta, -gamma, and -delta.","label":0}
{"pair_id":"AIMed.d151.s1285.p1","sentence":"We previously have shown that ps PTF pe purified from human HeLa cells is a multisubunit complex of four polypeptides designated ps PTF alpha pe, -beta, -gamma, and -delta.","label":0}
{"pair_id":"AIMed.d151.s1285.p2","sentence":"We previously have shown that PTF purified from human HeLa cells is a multisubunit complex of four polypeptides designated ps PTF peps PTF alpha pe, -beta, -gamma, and -delta.","label":0}
{"pair_id":"BioInfer.d236.s1.p0","sentence":"The ps talin pe dimer, which is crucial for ps actin pe and lipid binding, is built of a backbone containing the 200 kDa rod portions, at both ends of which a 47 kDa globular domain is attached.","label":1}
{"pair_id":"BioInfer.d438.s0.p0","sentence":"Moreover, the virus-encoded ps profilin pe homolog was not required for ps actin pe-associated events, including intracellular virus movement to the periphery of the cell, formation of specialized microvilli, or release of mature virions, as shown by electron microscopy and yields of infectious intra- and extracellular virus.","label":0}
{"pair_id":"AIMed.d179.s1520.p0","sentence":"The growth-promoting effects of ps gastrin pe on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the ps gastrin pe\/CCKB receptor, which belongs to the family of G protein-coupled receptors.","label":0}
{"pair_id":"AIMed.d179.s1520.p1","sentence":"The growth-promoting effects of ps gastrin pe on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the gastrin\/ps CCKB receptor pe, which belongs to the family of G protein-coupled receptors.","label":0}
{"pair_id":"AIMed.d179.s1520.p2","sentence":"The growth-promoting effects of gastrin on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the ps gastrin pe\/ps CCKB receptor pe, which belongs to the family of G protein-coupled receptors.","label":0}
{"pair_id":"BioInfer.d323.s0.p0","sentence":"In cells lacking the ps myosin-II heavy chain pe, the bundles, which were induced by an over-expression of ps cofilin pe, shortened and became straight following hyperosmotic stress, forming a polygonal structure.","label":0}
{"pair_id":"BioInfer.d580.s0.p0","sentence":"The UL8 component of the herpes simplex virus ps helicase-primase pe complex stimulates primer synthesis by a subassembly of the UL5 and ps UL52 pe components.","label":0}
{"pair_id":"BioInfer.d580.s0.p1","sentence":"The ps UL8 pe component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and ps UL52 pe components.","label":1}
{"pair_id":"BioInfer.d580.s0.p2","sentence":"The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the ps UL5 pe and ps UL52 pe components.","label":1}
{"pair_id":"BioInfer.d580.s0.p3","sentence":"The ps UL8 pe component of the herpes simplex virus ps helicase-primase pe complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.","label":1}
{"pair_id":"BioInfer.d580.s0.p4","sentence":"The UL8 component of the herpes simplex virus ps helicase-primase pe complex stimulates primer synthesis by a subassembly of the ps UL5 pe and UL52 components.","label":0}
{"pair_id":"BioInfer.d580.s0.p5","sentence":"The ps UL8 pe component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the ps UL5 pe and UL52 components.","label":1}
{"pair_id":"BioInfer.d357.s0.p0","sentence":"ps Integrin pe (ps Inte pe) ps Integr pe, for example, interact with ps actin-binding proteins pe (e.g. talin and filamin), which form mechanical links to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d357.s0.p1","sentence":"ps Integrin pe (ps Inte pe) ps Integr pe, for example, interact with actin-binding proteins (e.g. ps talin pe and filamin), which form mechanical links to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d357.s0.p2","sentence":"ps Integrin pe (ps Inte pe) ps Integr pe, for example, interact with actin-binding proteins (e.g. talin and ps filamin pe), which form mechanical links to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d357.s0.p3","sentence":"Integrin (Inte) Integr, for example, interact with ps actin-binding proteins pe (e.g. ps talin pe and filamin), which form mechanical links to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d357.s0.p4","sentence":"Integrin (Inte) Integr, for example, interact with ps actin-binding proteins pe (e.g. talin and ps filamin pe), which form mechanical links to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d357.s0.p5","sentence":"Integrin (Inte) Integr, for example, interact with actin-binding proteins (e.g. ps talin pe and ps filamin pe), which form mechanical links to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d154.s0.p0","sentence":"Conversely, inhibition of ps LIMK pe's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of ps actin pe filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p1","sentence":"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A ps cofilin pe mutant induces loss of ps actin pe filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p2","sentence":"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, ps LIMK1- pe, or expression of the constitutively active S3A cofilin mutant induces loss of ps actin pe filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p3","sentence":"Conversely, inhibition of ps LIMK pe's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A ps cofilin pe mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.","label":0}
{"pair_id":"BioInfer.d154.s0.p4","sentence":"Conversely, inhibition of ps LIMK pe's activity by expressing a dominant negative construct, ps LIMK1- pe, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.","label":1}
{"pair_id":"BioInfer.d154.s0.p5","sentence":"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, ps LIMK1- pe, or expression of the constitutively active S3A ps cofilin pe mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.","label":0}
{"pair_id":"AIMed.d207.s1795.p0","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-ps MyoD pe (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p1","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-MyoD (ps ER pe-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p2","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-MyoD (ER-ps MyoD pe) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p3","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-MyoD (ER-MyoD) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p4","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of ps cyclinA pe\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p5","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/ps cdk2 pe to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p6","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p7","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing ps Estrogen Receptor pe-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p8","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-ps MyoD pe (ps ER pe-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p9","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-ps MyoD pe (ER-ps MyoD pe) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p10","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-ps MyoD pe (ER-MyoD) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p11","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-ps MyoD pe (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of ps cyclinA pe\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p12","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-ps MyoD pe (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/ps cdk2 pe to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p13","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-ps MyoD pe (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p14","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-ps MyoD pe (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p15","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ps ER pe-ps MyoD pe) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p16","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ps ER pe-MyoD) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p17","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ps ER pe-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of ps cyclinA pe\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p18","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ps ER pe-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/ps cdk2 pe to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p19","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ps ER pe-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p20","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ps ER pe-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p21","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-ps MyoD pe) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p22","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-ps MyoD pe) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of ps cyclinA pe\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p23","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-ps MyoD pe) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/ps cdk2 pe to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p24","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-ps MyoD pe) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p25","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-ps MyoD pe) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p26","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of ps cyclinA pe\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p27","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of cyclinA\/ps cdk2 pe to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p28","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of cyclinA\/cdk2 to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p29","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed ps MyoD pe activation prevents the reassociation of cyclinA\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p30","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of ps cyclinA pe\/ps cdk2 pe to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":1}
{"pair_id":"AIMed.d207.s1795.p31","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of ps cyclinA pe\/cdk2 to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p32","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of ps cyclinA pe\/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p33","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/ps cdk2 pe to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p34","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/ps cdk2 pe to the E2F4 containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d207.s1795.p35","sentence":"Using a subclone of C3H10T1\/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA\/cdk2 to the ps E2F4 pe containing complex following serum stimulation and this correlates with suppression of ps E2F pe activity and the inability of cells to re-enter the cell cycle.","label":0}
{"pair_id":"AIMed.d43.s377.p0","sentence":"The resulting Trk variant recruited binding of ps NGF pe equivalent to ps TrkA pe, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":1}
{"pair_id":"AIMed.d43.s377.p1","sentence":"The resulting Trk variant recruited binding of ps NGF pe equivalent to TrkA, maintained ps neurotrophin-3 pe binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p2","sentence":"The resulting Trk variant recruited binding of ps NGF pe equivalent to TrkA, maintained neurotrophin-3 binding equivalent to ps TrkC pe, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p3","sentence":"The resulting Trk variant recruited binding of ps NGF pe equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound ps brain-derived neurotrophin pe, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p4","sentence":"The resulting Trk variant recruited binding of ps NGF pe equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with ps TrkB pe.","label":0}
{"pair_id":"AIMed.d43.s377.p5","sentence":"The resulting Trk variant recruited binding of NGF equivalent to ps TrkA pe, maintained ps neurotrophin-3 pe binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p6","sentence":"The resulting Trk variant recruited binding of NGF equivalent to ps TrkA pe, maintained neurotrophin-3 binding equivalent to ps TrkC pe, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p7","sentence":"The resulting Trk variant recruited binding of NGF equivalent to ps TrkA pe, maintained neurotrophin-3 binding equivalent to TrkC, and also bound ps brain-derived neurotrophin pe, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p8","sentence":"The resulting Trk variant recruited binding of NGF equivalent to ps TrkA pe, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with ps TrkB pe.","label":0}
{"pair_id":"AIMed.d43.s377.p9","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained ps neurotrophin-3 pe binding equivalent to ps TrkC pe, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.","label":1}
{"pair_id":"AIMed.d43.s377.p10","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained ps neurotrophin-3 pe binding equivalent to TrkC, and also bound ps brain-derived neurotrophin pe, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p11","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained ps neurotrophin-3 pe binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with ps TrkB pe.","label":0}
{"pair_id":"AIMed.d43.s377.p12","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to ps TrkC pe, and also bound ps brain-derived neurotrophin pe, although with lower affinity compared with TrkB.","label":0}
{"pair_id":"AIMed.d43.s377.p13","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to ps TrkC pe, and also bound brain-derived neurotrophin, although with lower affinity compared with ps TrkB pe.","label":0}
{"pair_id":"AIMed.d43.s377.p14","sentence":"The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound ps brain-derived neurotrophin pe, although with lower affinity compared with ps TrkB pe.","label":1}
{"pair_id":"BioInfer.d520.s0.p0","sentence":"Requirement of yeast ps fimbrin pe for ps actin pe organization and morphogenesis in vivo.","label":1}
{"pair_id":"BioInfer.d197.s0.p0","sentence":"Exclusion of ps cardiac myosin heavy chain pe and ps actin pe gene involvement in hypertrophic cardiomyopathy of several French families.","label":0}
{"pair_id":"AIMed.d204.s1763.p0","sentence":"Neither mutation of His199, nor deletion mutants des-(161-228)-ps MMP-1 pe and des-(161-228\/248-450)-ps MMP-1 pe, interact with TIMP.","label":0}
{"pair_id":"AIMed.d204.s1763.p1","sentence":"Neither mutation of His199, nor deletion mutants des-(161-228)-ps MMP-1 pe and des-(161-228\/248-450)-MMP-1, interact with ps TIMP pe.","label":0}
{"pair_id":"AIMed.d204.s1763.p2","sentence":"Neither mutation of His199, nor deletion mutants des-(161-228)-MMP-1 and des-(161-228\/248-450)-ps MMP-1 pe, interact with ps TIMP pe.","label":0}
{"pair_id":"BioInfer.d796.s0.p0","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae ps RAD51 pe and ps RAD54 pe, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p1","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in ps rhp51 pe and rhp54 (homologues of S.cerevisiae ps RAD51 pe and RAD54, respectively) are not affected.","label":1}
{"pair_id":"BioInfer.d796.s0.p2","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and ps rhp54 pe (homologues of S.cerevisiae ps RAD51 pe and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p3","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant ps rad3 pe-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae ps RAD51 pe and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p4","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in ps rhp51 pe and rhp54 (homologues of S.cerevisiae RAD51 and ps RAD54 pe, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p5","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and ps rhp54 pe (homologues of S.cerevisiae RAD51 and ps RAD54 pe, respectively) are not affected.","label":1}
{"pair_id":"BioInfer.d796.s0.p6","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant ps rad3 pe-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and ps RAD54 pe, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p7","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in ps rhp51 pe and ps rhp54 pe (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p8","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant ps rad3 pe-d and two recombination mutants defective in ps rhp51 pe and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d796.s0.p9","sentence":"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant ps rad3 pe-d and two recombination mutants defective in rhp51 and ps rhp54 pe (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.","label":0}
{"pair_id":"BioInfer.d118.s0.p0","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes ps actin pe tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and ps filamin pe.","label":0}
{"pair_id":"BioInfer.d118.s0.p1","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes ps actin pe tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, ps vinculin pe, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p2","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes ps actin pe tails were shown to contain the cytoskeletal proteins ps vasodilator-stimulated phosphoprotein pe profilin, vinculin, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p3","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes ps actin pe tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein ps profilin pe, vinculin, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p4","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, ps vinculin pe, and ps filamin pe.","label":0}
{"pair_id":"BioInfer.d118.s0.p5","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins ps vasodilator-stimulated phosphoprotein pe profilin, vinculin, and ps filamin pe.","label":0}
{"pair_id":"BioInfer.d118.s0.p6","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein ps profilin pe, vinculin, and ps filamin pe.","label":0}
{"pair_id":"BioInfer.d118.s0.p7","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins ps vasodilator-stimulated phosphoprotein pe profilin, ps vinculin pe, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p8","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein ps profilin pe, ps vinculin pe, and filamin.","label":0}
{"pair_id":"BioInfer.d118.s0.p9","sentence":"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins ps vasodilator-stimulated phosphoprotein pe ps profilin pe, vinculin, and filamin.","label":0}
{"pair_id":"AIMed.d112.s954.p0","sentence":"Thus, ps pp120 pe may serve as a link between ps Syk pe and PLC gamma 1, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.","label":1}
{"pair_id":"AIMed.d112.s954.p1","sentence":"Thus, ps pp120 pe may serve as a link between Syk and ps PLC gamma 1 pe, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.","label":1}
{"pair_id":"AIMed.d112.s954.p2","sentence":"Thus, pp120 may serve as a link between ps Syk pe and ps PLC gamma 1 pe, coupling the B-cell antigen receptor to the phosphatidylinositol pathway.","label":1}
{"pair_id":"BioInfer.d671.s0.p0","sentence":"The prominent 125 A transverse stripping pattern characteristic of the ps actin pe cross-bridges in a bundle is also absent in hair borders suggesting ps fimbrin pe as the component that gives rise to the transverse stripes.","label":0}
{"pair_id":"BioInfer.d177.s0.p0","sentence":"Disruption of the RVS167 gene, which is homologous to ps END6 pe\/RVS161 and which is also required for correct ps actin pe localization, also blocks endocytosis.","label":0}
{"pair_id":"BioInfer.d177.s0.p1","sentence":"Disruption of the RVS167 gene, which is homologous to END6\/ps RVS161 pe and which is also required for correct ps actin pe localization, also blocks endocytosis.","label":0}
{"pair_id":"BioInfer.d177.s0.p2","sentence":"Disruption of the ps RVS167 pe gene, which is homologous to END6\/RVS161 and which is also required for correct ps actin pe localization, also blocks endocytosis.","label":1}
{"pair_id":"BioInfer.d177.s0.p3","sentence":"Disruption of the RVS167 gene, which is homologous to ps END6 pe\/ps RVS161 pe and which is also required for correct actin localization, also blocks endocytosis.","label":0}
{"pair_id":"BioInfer.d177.s0.p4","sentence":"Disruption of the ps RVS167 pe gene, which is homologous to ps END6 pe\/RVS161 and which is also required for correct actin localization, also blocks endocytosis.","label":1}
{"pair_id":"BioInfer.d177.s0.p5","sentence":"Disruption of the ps RVS167 pe gene, which is homologous to END6\/ps RVS161 pe and which is also required for correct actin localization, also blocks endocytosis.","label":1}
{"pair_id":"BioInfer.d782.s0.p0","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins ps tropomyosin pe and ps profilin pe also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p1","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and ps profilin pe also did not exhibit medial GFP-ps Cdc42p pe staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p2","sentence":"Unexpectedly, treatment with the ps actin pe-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and ps profilin pe also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p3","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and ps profilin pe also did not exhibit medial ps GFP pe-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p4","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the ps actin-binding proteins pe tropomyosin and ps profilin pe also did not exhibit medial GFP-Cdc42p staining.","label":1}
{"pair_id":"BioInfer.d782.s0.p5","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins ps tropomyosin pe and profilin also did not exhibit medial GFP-ps Cdc42p pe staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p6","sentence":"Unexpectedly, treatment with the ps actin pe-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins ps tropomyosin pe and profilin also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p7","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins ps tropomyosin pe and profilin also did not exhibit medial ps GFP pe-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p8","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the ps actin-binding proteins pe ps tropomyosin pe and profilin also did not exhibit medial GFP-Cdc42p staining.","label":1}
{"pair_id":"BioInfer.d782.s0.p9","sentence":"Unexpectedly, treatment with the ps actin pe-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-ps Cdc42p pe staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p10","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial ps GFP pe-ps Cdc42p pe staining.","label":1}
{"pair_id":"BioInfer.d782.s0.p11","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the ps actin-binding proteins pe tropomyosin and profilin also did not exhibit medial GFP-ps Cdc42p pe staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p12","sentence":"Unexpectedly, treatment with the ps actin pe-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial ps GFP pe-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p13","sentence":"Unexpectedly, treatment with the ps actin pe-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the ps actin-binding proteins pe tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.","label":0}
{"pair_id":"BioInfer.d782.s0.p14","sentence":"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the ps actin-binding proteins pe tropomyosin and profilin also did not exhibit medial ps GFP pe-Cdc42p staining.","label":0}
{"pair_id":"AIMed.d143.s1215.p0","sentence":"These results demonstrate that ps IL-11 pe and ps IL-6 pe utilize different ligand binding proteins, but share common signal transducer, gp130, in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1215.p1","sentence":"These results demonstrate that ps IL-11 pe and IL-6 utilize different ligand binding proteins, but share common signal transducer, ps gp130 pe, in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1215.p2","sentence":"These results demonstrate that IL-11 and ps IL-6 pe utilize different ligand binding proteins, but share common signal transducer, ps gp130 pe, in TF-1 cells.","label":0}
{"pair_id":"AIMed.d51.s458.p0","sentence":"The structure of the ps FGF1 pe-ps FGFR2 pe-heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling.","label":1}
{"pair_id":"BioInfer.d226.s1.p0","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and ps vinculin pe at the ends of ps actin pe stress fibers at presumptive focal contacts in melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s1.p1","sentence":"Immunofluorescence microscopy of cells grown on ps fibronectin pe confirmed the presence of paxillin, talin, and vinculin at the ends of ps actin pe stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p2","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of ps paxillin pe, talin, and vinculin at the ends of ps actin pe stress fibers at presumptive focal contacts in melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s1.p3","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, ps talin pe, and vinculin at the ends of ps actin pe stress fibers at presumptive focal contacts in melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s1.p4","sentence":"Immunofluorescence microscopy of cells grown on ps fibronectin pe confirmed the presence of paxillin, talin, and ps vinculin pe at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p5","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of ps paxillin pe, talin, and ps vinculin pe at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p6","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, ps talin pe, and ps vinculin pe at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p7","sentence":"Immunofluorescence microscopy of cells grown on ps fibronectin pe confirmed the presence of ps paxillin pe, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p8","sentence":"Immunofluorescence microscopy of cells grown on ps fibronectin pe confirmed the presence of paxillin, ps talin pe, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d226.s1.p9","sentence":"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of ps paxillin pe, ps talin pe, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.","label":0}
{"pair_id":"BioInfer.d302.s0.p0","sentence":"Immunoreactivity for ps pan-cadherin pe, E-cadherin, ps alpha-catenin pe, beta-catenin, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p1","sentence":"Immunoreactivity for pan-cadherin, E-cadherin, ps alpha-catenin pe, beta-catenin, and ps p120 pe was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p2","sentence":"Immunoreactivity for pan-cadherin, ps E-cadherin pe, ps alpha-catenin pe, beta-catenin, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p3","sentence":"Immunoreactivity for pan-cadherin, E-cadherin, ps alpha-catenin pe, ps beta-catenin pe, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p4","sentence":"Immunoreactivity for ps pan-cadherin pe, E-cadherin, alpha-catenin, beta-catenin, and ps p120 pe was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p5","sentence":"Immunoreactivity for ps pan-cadherin pe, ps E-cadherin pe, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p6","sentence":"Immunoreactivity for ps pan-cadherin pe, E-cadherin, alpha-catenin, ps beta-catenin pe, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p7","sentence":"Immunoreactivity for pan-cadherin, ps E-cadherin pe, alpha-catenin, beta-catenin, and ps p120 pe was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p8","sentence":"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, ps beta-catenin pe, and ps p120 pe was observed in all 15 specimens.","label":0}
{"pair_id":"BioInfer.d302.s0.p9","sentence":"Immunoreactivity for pan-cadherin, ps E-cadherin pe, alpha-catenin, ps beta-catenin pe, and p120 was observed in all 15 specimens.","label":0}
{"pair_id":"AIMed.d41.s352.p0","sentence":"Crystal structure of the hereditary haemochromatosis protein ps HFE pe complexed with ps transferrin pe receptor.","label":0}
{"pair_id":"AIMed.d41.s352.p1","sentence":"Crystal structure of the hereditary haemochromatosis protein ps HFE pe complexed with ps transferrin receptor pe.","label":1}
{"pair_id":"AIMed.d41.s352.p2","sentence":"Crystal structure of the hereditary haemochromatosis protein HFE complexed with ps transferrin peps transferrin receptor pe.","label":0}
{"pair_id":"AIMed.d91.s779.p0","sentence":"Here we report the cloning, expression, and biochemical characterization of the 32-kDa subunit of human (h) ps TFIID pe, termed ps hTAFII32 pe.","label":0}
{"pair_id":"AIMed.d177.s1503.p0","sentence":"We have selected such mutations in the transcription factor ps E2F1 pe that affect its ability to heterodimerize with ps DP1 pe.","label":1}
{"pair_id":"BioInfer.d379.s0.p0","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the ps MSH2 pe protein and the MSH3 and ps MSH6 pe proteins.","label":1}
{"pair_id":"BioInfer.d379.s0.p1","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the ps MSH2 pe protein and the ps MSH3 pe and MSH6 proteins.","label":1}
{"pair_id":"BioInfer.d379.s0.p2","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, ps msh3 pe, and msh6 mutations and by studying the physical interaction between the ps MSH2 pe protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p3","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, msh3, and msh6 mutations and by studying the physical interaction between the ps MSH2 pe protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p4","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and ps msh6 pe mutations and by studying the physical interaction between the ps MSH2 pe protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p5","sentence":"In this study the role of ps MSH2 pe, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the ps MSH2 pe protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p6","sentence":"In this study the role of MSH2, MSH3, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the ps MSH2 pe protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p7","sentence":"In this study the role of MSH2, ps MSH3 pe, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the ps MSH2 pe protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p8","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the ps MSH3 pe and ps MSH6 pe proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p9","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, ps msh3 pe, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and ps MSH6 pe proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p10","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and ps MSH6 pe proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p11","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and ps msh6 pe mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and ps MSH6 pe proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p12","sentence":"In this study the role of ps MSH2 pe, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and ps MSH6 pe proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p13","sentence":"In this study the role of MSH2, MSH3, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and ps MSH6 pe proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p14","sentence":"In this study the role of MSH2, ps MSH3 pe, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and ps MSH6 pe proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p15","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, ps msh3 pe, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the ps MSH3 pe and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p16","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the ps MSH3 pe and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p17","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and ps msh6 pe mutations and by studying the physical interaction between the MSH2 protein and the ps MSH3 pe and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p18","sentence":"In this study the role of ps MSH2 pe, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the ps MSH3 pe and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p19","sentence":"In this study the role of MSH2, MSH3, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the ps MSH3 pe and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p20","sentence":"In this study the role of MSH2, ps MSH3 pe, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the ps MSH3 pe and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p21","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, ps msh3 pe, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p22","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, ps msh3 pe, and ps msh6 pe mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p23","sentence":"In this study the role of ps MSH2 pe, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, ps msh3 pe, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p24","sentence":"In this study the role of MSH2, MSH3, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, ps msh3 pe, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p25","sentence":"In this study the role of MSH2, ps MSH3 pe, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, ps msh3 pe, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p26","sentence":"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, msh3, and ps msh6 pe mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p27","sentence":"In this study the role of ps MSH2 pe, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p28","sentence":"In this study the role of MSH2, MSH3, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p29","sentence":"In this study the role of MSH2, ps MSH3 pe, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of ps msh2 pe, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p30","sentence":"In this study the role of ps MSH2 pe, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and ps msh6 pe mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p31","sentence":"In this study the role of MSH2, MSH3, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and ps msh6 pe mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p32","sentence":"In this study the role of MSH2, ps MSH3 pe, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and ps msh6 pe mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p33","sentence":"In this study the role of ps MSH2 pe, MSH3, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p34","sentence":"In this study the role of ps MSH2 pe, ps MSH3 pe, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d379.s0.p35","sentence":"In this study the role of MSH2, ps MSH3 pe, and ps MSH6 pe in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.","label":0}
{"pair_id":"BioInfer.d390.s0.p0","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/ps MORT-1 pe, RIP) and ps TRAF pe domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p1","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, ps FADD pe\/MORT-1, RIP) and ps TRAF pe domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p2","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and ps TRAF pe domain-containing proteins (TRAF-1, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p3","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and ps TRAF pe domain-containing proteins (ps TRAF-1 pe, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p4","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and ps TRAF pe domain-containing proteins (TRAF-1, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p5","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, TRADD, FADD\/MORT-1, RIP) and ps TRAF pe domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p6","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, ps TRADD pe, FADD\/MORT-1, RIP) and ps TRAF pe domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p7","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, TRADD, FADD\/MORT-1, RIP) and ps TRAF pe domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p8","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, ps RIP pe) and ps TRAF pe domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p9","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, ps FADD pe\/ps MORT-1 pe, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p10","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/ps MORT-1 pe, RIP) and TRAF domain-containing proteins (TRAF-1, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p11","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/ps MORT-1 pe, RIP) and TRAF domain-containing proteins (ps TRAF-1 pe, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p12","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/ps MORT-1 pe, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p13","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, TRADD, FADD\/ps MORT-1 pe, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p14","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, ps TRADD pe, FADD\/ps MORT-1 pe, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p15","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, TRADD, FADD\/ps MORT-1 pe, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p16","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/ps MORT-1 pe, ps RIP pe) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p17","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, ps FADD pe\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p18","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, ps FADD pe\/MORT-1, RIP) and TRAF domain-containing proteins (ps TRAF-1 pe, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p19","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, ps FADD pe\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p20","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, TRADD, ps FADD pe\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p21","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, ps TRADD pe, ps FADD pe\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p22","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, TRADD, ps FADD pe\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p23","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, ps FADD pe\/MORT-1, ps RIP pe) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p24","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (ps TRAF-1 pe, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p25","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, ps TRAF-2 pe, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p26","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p27","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, ps TRADD pe, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p28","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p29","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, ps RIP pe) and TRAF domain-containing proteins (TRAF-1, ps TRAF-2 pe, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p30","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (ps TRAF-1 pe, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p31","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (ps TRAF-1 pe, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p32","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, ps TRADD pe, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (ps TRAF-1 pe, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p33","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (ps TRAF-1 pe, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p34","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, ps RIP pe) and TRAF domain-containing proteins (ps TRAF-1 pe, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p35","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p36","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, ps TRADD pe, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p37","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p38","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD\/MORT-1, ps RIP pe) and TRAF domain-containing proteins (TRAF-1, TRAF-2, ps TRAF-3 pe) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p39","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, ps TRADD pe, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p40","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, ps Fas pe, TRADD, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p41","sentence":"Isolation and characterization of death domain (ps TNF-RI pe, Fas, TRADD, FADD\/MORT-1, ps RIP pe) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p42","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, ps TRADD pe, FADD\/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p43","sentence":"Isolation and characterization of death domain (TNF-RI, Fas, ps TRADD pe, FADD\/MORT-1, ps RIP pe) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d390.s0.p44","sentence":"Isolation and characterization of death domain (TNF-RI, ps Fas pe, TRADD, FADD\/MORT-1, ps RIP pe) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.","label":0}
{"pair_id":"BioInfer.d317.s0.p0","sentence":"In addition, we report that radiation induced transient activation of ps c-Jun N-terminal kinase pe\/ps stress-activated protein kinase pe (JNK\/SAPK) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p1","sentence":"In addition, we report that radiation induced transient activation of ps c-Jun N-terminal kinase pe\/stress-activated protein kinase (JNK\/SAPK) activation and the transcription factor, ps AP-1 pe.","label":0}
{"pair_id":"BioInfer.d317.s0.p2","sentence":"In addition, we report that radiation induced transient activation of ps c-Jun N-terminal kinase pe\/stress-activated protein kinase (ps JNK pe\/SAPK) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p3","sentence":"In addition, we report that radiation induced transient activation of ps c-Jun N-terminal kinase pe\/stress-activated protein kinase (JNK\/ps SAPK pe) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p4","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/ps stress-activated protein kinase pe (JNK\/SAPK) activation and the transcription factor, ps AP-1 pe.","label":0}
{"pair_id":"BioInfer.d317.s0.p5","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/ps stress-activated protein kinase pe (ps JNK pe\/SAPK) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p6","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/ps stress-activated protein kinase pe (JNK\/ps SAPK pe) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d317.s0.p7","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/stress-activated protein kinase (ps JNK pe\/SAPK) activation and the transcription factor, ps AP-1 pe.","label":0}
{"pair_id":"BioInfer.d317.s0.p8","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/stress-activated protein kinase (JNK\/ps SAPK pe) activation and the transcription factor, ps AP-1 pe.","label":0}
{"pair_id":"BioInfer.d317.s0.p9","sentence":"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase\/stress-activated protein kinase (ps JNK pe\/ps SAPK pe) activation and the transcription factor, AP-1.","label":0}
{"pair_id":"BioInfer.d259.s0.p0","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, ps UL8 pe, and ps UL52 pe genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p1","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a ps helicase-primase pe that consists of the products of the UL5, ps UL8 pe, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p2","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the ps UL5 pe, ps UL8 pe, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p3","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a ps helicase-primase pe that consists of the products of the UL5, UL8, and ps UL52 pe genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p4","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the ps UL5 pe, UL8, and ps UL52 pe genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"BioInfer.d259.s0.p5","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a ps helicase-primase pe that consists of the products of the ps UL5 pe, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).","label":1}
{"pair_id":"AIMed.d137.s1163.p0","sentence":"The interaction can also be observed in vivo, as ps TBP pe can be co-precipitated with ps Oct2 pe from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous Oct1 from HeLa cells.","label":1}
{"pair_id":"AIMed.d137.s1163.p1","sentence":"The interaction can also be observed in vivo, as ps TBP pe can be co-precipitated with Oct2 from co-transfected Cos1 cells and ps TBP pe co-immunoprecipitates with the endogenous Oct1 from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p2","sentence":"The interaction can also be observed in vivo, as ps TBP pe can be co-precipitated with Oct2 from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous ps Oct1 pe from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p3","sentence":"The interaction can also be observed in vivo, as TBP can be co-precipitated with ps Oct2 pe from co-transfected Cos1 cells and ps TBP pe co-immunoprecipitates with the endogenous Oct1 from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p4","sentence":"The interaction can also be observed in vivo, as TBP can be co-precipitated with ps Oct2 pe from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous ps Oct1 pe from HeLa cells.","label":0}
{"pair_id":"AIMed.d137.s1163.p5","sentence":"The interaction can also be observed in vivo, as TBP can be co-precipitated with Oct2 from co-transfected Cos1 cells and ps TBP pe co-immunoprecipitates with the endogenous ps Oct1 pe from HeLa cells.","label":1}
{"pair_id":"BioInfer.d225.s0.p0","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and ps BTG pe secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and ps myosin pe into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p1","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in ps TXB2 pe and ps BTG pe secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p2","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and ps BTG pe secretion as measured by RIA and an increased incorporation of actin binding protein, ps talin pe, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p3","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and ps BTG pe secretion as measured by RIA and an increased incorporation of ps actin binding protein pe, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p4","sentence":"Further, PRP incubated with ps IL-6 pe showed a dose dependent increase in TXB2 and ps BTG pe secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p5","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in ps TXB2 pe and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and ps myosin pe into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p6","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, ps talin pe, and ps myosin pe into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p7","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of ps actin binding protein pe, talin, and ps myosin pe into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p8","sentence":"Further, PRP incubated with ps IL-6 pe showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and ps myosin pe into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p9","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in ps TXB2 pe and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, ps talin pe, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p10","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in ps TXB2 pe and BTG secretion as measured by RIA and an increased incorporation of ps actin binding protein pe, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p11","sentence":"Further, PRP incubated with ps IL-6 pe showed a dose dependent increase in ps TXB2 pe and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p12","sentence":"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of ps actin binding protein pe, ps talin pe, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":1}
{"pair_id":"BioInfer.d225.s0.p13","sentence":"Further, PRP incubated with ps IL-6 pe showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, ps talin pe, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d225.s0.p14","sentence":"Further, PRP incubated with ps IL-6 pe showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of ps actin binding protein pe, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.","label":0}
{"pair_id":"BioInfer.d810.s0.p0","sentence":"We have cloned a Saccharomyces cerevisiae gene (ps COF1 pe) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast ps cofilin pe; Cof); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p1","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast ps cofilin pe; ps Cof pe); its aa sequence is 35% identical to porcine Cof.","label":0}
{"pair_id":"BioInfer.d810.s0.p2","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) ps actin-binding protein pe of 143 amino acid (aa) residues (yeast ps cofilin pe; Cof); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p3","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast ps cofilin pe; Cof); its aa sequence is 35% identical to porcine ps Cof pe.","label":1}
{"pair_id":"BioInfer.d810.s0.p4","sentence":"We have cloned a Saccharomyces cerevisiae gene (ps COF1 pe) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; ps Cof pe); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p5","sentence":"We have cloned a Saccharomyces cerevisiae gene (ps COF1 pe) encoding a low-M(r) ps actin-binding protein pe of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.","label":0}
{"pair_id":"BioInfer.d810.s0.p6","sentence":"We have cloned a Saccharomyces cerevisiae gene (ps COF1 pe) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine ps Cof pe.","label":0}
{"pair_id":"BioInfer.d810.s0.p7","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) ps actin-binding protein pe of 143 amino acid (aa) residues (yeast cofilin; ps Cof pe); its aa sequence is 35% identical to porcine Cof.","label":1}
{"pair_id":"BioInfer.d810.s0.p8","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; ps Cof pe); its aa sequence is 35% identical to porcine ps Cof pe.","label":1}
{"pair_id":"BioInfer.d810.s0.p9","sentence":"We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) ps actin-binding protein pe of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine ps Cof pe.","label":0}
{"pair_id":"AIMed.d50.s442.p0","sentence":"Here, we quantitatively mapped the complete binding region of ps ifnar2 pe on ps interferon (IFN)alpha2 pe by 35 individual mutations to alanine and isosteric residues.","label":1}
{"pair_id":"AIMed.d98.s834.p0","sentence":"Instead, 14-3-3 may facilitate the association of ps cdc25 pe with ps Raf-1 pe in vivo, participating in the linkage between mitogenic signaling and the cell cycle machinery.","label":1}
{"pair_id":"AIMed.d108.s911.p0","sentence":"The multisubunit ps transcription factor IID pe (ps TFIID pe) is thought to be a primary target for site-specific activators of transcription.","label":0}
{"pair_id":"AIMed.d56.s500.p0","sentence":"Expressed in a murine myeloma, ps TRAP pe was identified as a ligand for ps CD40 pe by binding to a soluble CD40 construct.","label":1}
{"pair_id":"AIMed.d56.s500.p1","sentence":"Expressed in a murine myeloma, ps TRAP pe was identified as a ligand for CD40 by binding to a soluble ps CD40 pe construct.","label":1}
{"pair_id":"AIMed.d56.s500.p2","sentence":"Expressed in a murine myeloma, TRAP was identified as a ligand for ps CD40 pe by binding to a soluble ps CD40 pe construct.","label":0}
{"pair_id":"BioInfer.d834.s0.p0","sentence":"Within the sieve-tube exudate, ps profilin pe was present in 15-fold molar excess to ps actin pe.","label":0}
{"pair_id":"BioInfer.d127.s0.p0","sentence":"Calpain activity in vivo was determined by observing proteolysis of ps actin-binding protein pe and ps talin pe, two known substrates of calpain.","label":0}
{"pair_id":"BioInfer.d127.s0.p1","sentence":"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and ps talin pe, two known substrates of ps calpain pe.","label":1}
{"pair_id":"BioInfer.d127.s0.p2","sentence":"ps Calpain pe activity in vivo was determined by observing proteolysis of actin-binding protein and ps talin pe, two known substrates of calpain.","label":0}
{"pair_id":"BioInfer.d127.s0.p3","sentence":"Calpain activity in vivo was determined by observing proteolysis of ps actin-binding protein pe and talin, two known substrates of ps calpain pe.","label":1}
{"pair_id":"BioInfer.d127.s0.p4","sentence":"ps Calpain pe activity in vivo was determined by observing proteolysis of ps actin-binding protein pe and talin, two known substrates of calpain.","label":0}
{"pair_id":"BioInfer.d127.s0.p5","sentence":"ps Calpain pe activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of ps calpain pe.","label":0}
{"pair_id":"BioInfer.d726.s0.p0","sentence":"The Tetrahymena ps fimbrin pe has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links ps actin pe filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"BioInfer.d726.s0.p1","sentence":"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena ps fimbrin pe probably cross-links ps actin pe filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":1}
{"pair_id":"BioInfer.d726.s0.p2","sentence":"The Tetrahymena fimbrin has two ps actin pe-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links ps actin pe filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"BioInfer.d726.s0.p3","sentence":"The Tetrahymena ps fimbrin pe has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena ps fimbrin pe probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"BioInfer.d726.s0.p4","sentence":"The Tetrahymena ps fimbrin pe has two ps actin pe-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":1}
{"pair_id":"BioInfer.d726.s0.p5","sentence":"The Tetrahymena fimbrin has two ps actin pe-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena ps fimbrin pe probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.","label":0}
{"pair_id":"AIMed.d224.s1951.p0","sentence":"In addition, ps HLA-E pe dissociates from ps TAP pe upon binding of MHC class I leader sequence peptides.","label":1}
{"pair_id":"AIMed.d108.s915.p0","sentence":"Together, these results suggest that ps TAFII40 pe and ps TAFII60 pe are important targets for transmitting activation signals between p53 and the initiation complex.","label":0}
{"pair_id":"AIMed.d108.s915.p1","sentence":"Together, these results suggest that ps TAFII40 pe and TAFII60 are important targets for transmitting activation signals between ps p53 pe and the initiation complex.","label":1}
{"pair_id":"AIMed.d108.s915.p2","sentence":"Together, these results suggest that TAFII40 and ps TAFII60 pe are important targets for transmitting activation signals between ps p53 pe and the initiation complex.","label":1}
{"pair_id":"BioInfer.d387.s0.p0","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK pe1\/ps M pe) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p1","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p2","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ps ERK pe) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p3","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ps ERK pe1\/ps E pe, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p4","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK1 pe\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p5","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d387.s0.p6","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ps ERK1 pe\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p7","sentence":"In vitro studies indicated that suramin completely blocked ps PDGF receptor pe activation or phosphorylation stimulated by PDGF-AB, inhibited activation of ps mitogen-activated protein kinase pe (ERK) ps mitogen pe (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p8","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK pe1\/ps M pe) and ERK1\/E, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p9","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ps ERK pe) mitogen (ps MEK pe1\/ps M pe) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p10","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK pe1\/ps M pe) and ps ERK pe1\/ps E pe, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p11","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK peps MEK1 pe\/ps M pe) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p12","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK pe1\/ps M pe) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p13","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK pe1\/ps M pe) and ps ERK1 pe\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p14","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of ps mitogen-activated protein kinase pe (ERK) ps mitogen pe (ps MEK pe1\/ps M pe) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d387.s0.p15","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ps ERK pe) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p16","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ps ERK pe1\/ps E pe, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p17","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK1 pe\/M) and ERK1\/E, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p18","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p19","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ps ERK1 pe\/E, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p20","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of ps mitogen-activated protein kinase pe (ERK) ps mitogen pe (MEK1\/M) and ERK1\/E, and abrogated transcription factor ps AP-1 pe DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p21","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ps ERK pe) mitogen (MEK1\/M) and ps ERK pe1\/ps E pe, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p22","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ps ERK pe) mitogen (ps MEK1 pe\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p23","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of mitogen-activated protein kinase (ps ERK pe) mitogen (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p24","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ps ERK pe) mitogen (MEK1\/M) and ps ERK1 pe\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p25","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of ps mitogen-activated protein kinase pe (ps ERK pe) ps mitogen pe (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p26","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK1 pe\/M) and ps ERK pe1\/ps E pe, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p27","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ps ERK pe1\/ps E pe, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p28","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ps ERK peps ERK1 pe\/ps E pe, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p29","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of ps mitogen-activated protein kinase pe (ERK) ps mitogen pe (MEK1\/M) and ps ERK pe1\/ps E pe, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p30","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK1 pe\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p31","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (ps MEK1 pe\/M) and ps ERK1 pe\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p32","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of ps mitogen-activated protein kinase pe (ERK) ps mitogen pe (ps MEK1 pe\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":1}
{"pair_id":"BioInfer.d387.s0.p33","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of mitogen-activated protein kinase (ERK) mitogen (MEK1\/M) and ps ERK1 pe\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p34","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by ps PDGF-AB pe, inhibited activation of ps mitogen-activated protein kinase pe (ERK) ps mitogen pe (MEK1\/M) and ERK1\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"BioInfer.d387.s0.p35","sentence":"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of ps mitogen-activated protein kinase pe (ERK) ps mitogen pe (MEK1\/M) and ps ERK1 pe\/E, and abrogated transcription factor AP-1 DNA-binding activity.","label":0}
{"pair_id":"AIMed.d175.s1476.p0","sentence":"Physical interaction of mammalian ps CDC37 pe with ps CDK4 pe","label":1}
{"pair_id":"BioInfer.d102.s1.p0","sentence":"In this study, ps profilin pe is identified as an ps actin-binding protein pe in higher plants which is present in monocot and dicot angiosperms.","label":1}
{"pair_id":"AIMed.d150.s1276.p0","sentence":"In this report, it is demonstrated that ps Elf-1 pe contains a sequence motif that is highly related to the ps Rb pe binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.","label":0}
{"pair_id":"AIMed.d150.s1276.p1","sentence":"In this report, it is demonstrated that ps Elf-1 pe contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of ps Rb pe both in vitro and in vivo.","label":1}
{"pair_id":"AIMed.d150.s1276.p2","sentence":"In this report, it is demonstrated that Elf-1 contains a sequence motif that is highly related to the ps Rb pe binding sites of several viral oncoproteins and binds to the pocket region of ps Rb pe both in vitro and in vivo.","label":0}
{"pair_id":"BioInfer.d144.s2.p0","sentence":"We found that the 34- and 45-kDa polypeptides encoded by vaccinia virus ORFs ps A8R pe and ps A23R pe, respectively, were necessary to reconstitute transcription of a template with an intermediate stage promoter.","label":0}
{"pair_id":"AIMed.d126.s1081.p0","sentence":"This suggests that ps rhodanese pe must interact with ps groEL pe throughout most of its folding reaction before it acquires a folding competent (groE independent) state.","label":1}
{"pair_id":"BioInfer.d285.s1.p0","sentence":"alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of ps alpha-catenin pe joined the complex at a time coincident with the arrival of ps E-cadherin pe at the plasma membrane.","label":1}
{"pair_id":"BioInfer.d285.s1.p1","sentence":"ps alpha-Catenin pe was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of ps E-cadherin pe at the plasma membrane.","label":0}
{"pair_id":"BioInfer.d285.s1.p2","sentence":"ps alpha-Catenin pe was not associated with these complexes after synthesis, but a subpopulation of ps alpha-catenin pe joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.","label":0}
{"pair_id":"BioInfer.d496.s0.p0","sentence":"ps Profilin II pe binds actin with a similar affinity to that of ps profilin I pe, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p1","sentence":"Profilin II binds actin with a similar affinity to that of ps profilin I pe, although it inhibits actin polymerization more strongly than ps profilin I pe under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p2","sentence":"Profilin II binds ps actin pe with a similar affinity to that of ps profilin I pe, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p3","sentence":"Profilin II binds actin with a similar affinity to that of ps profilin I pe, although it inhibits ps actin pe polymerization more strongly than profilin I under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p4","sentence":"ps Profilin II pe binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than ps profilin I pe under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p5","sentence":"ps Profilin II pe binds ps actin pe with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p6","sentence":"ps Profilin II pe binds actin with a similar affinity to that of profilin I, although it inhibits ps actin pe polymerization more strongly than profilin I under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p7","sentence":"Profilin II binds ps actin pe with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than ps profilin I pe under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d496.s0.p8","sentence":"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits ps actin pe polymerization more strongly than ps profilin I pe under non-equilibrium conditions.","label":1}
{"pair_id":"BioInfer.d496.s0.p9","sentence":"Profilin II binds ps actin pe with a similar affinity to that of profilin I, although it inhibits ps actin pe polymerization more strongly than profilin I under non-equilibrium conditions.","label":0}
{"pair_id":"BioInfer.d63.s0.p0","sentence":"An association was seen between E-cadherin and ps alpha-catenin pe expression, in both effusions and solid tumours, and for ps beta-catenin pe in solid tumours (range p<0. 001 to p=0.014).","label":0}
{"pair_id":"BioInfer.d63.s0.p1","sentence":"An association was seen between ps E-cadherin pe and alpha-catenin expression, in both effusions and solid tumours, and for ps beta-catenin pe in solid tumours (range p<0. 001 to p=0.014).","label":0}
{"pair_id":"BioInfer.d63.s0.p2","sentence":"An association was seen between ps E-cadherin pe and ps alpha-catenin pe expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).","label":1}
{"pair_id":"AIMed.d102.s865.p0","sentence":"Furthermore, we demonstrate that ps RB pe binds directly to ps hTAFII250 pe in vitro and in vivo.","label":1}
{"pair_id":"BioInfer.d160.s0.p0","sentence":"Cytoplasmic staining included stress fibers that colocalized with ps actin pe, probably as a consequence of the ps myosin heavy chain pe component of the fusion protein.","label":1}
{"pair_id":"BioInfer.d399.s0.p0","sentence":"Kinetic studies on the effect of yeast ps cofilin pe on yeast ps actin pe polymerization.","label":1}
{"pair_id":"BioInfer.d56.s0.p0","sentence":"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas ps SIR2 pe, SIR3, and ps SIR4 pe are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p1","sentence":"Analysis of changes in state suggests that ps SIR1 pe protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas ps SIR2 pe, SIR3, and SIR4 are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p2","sentence":"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas ps SIR2 pe, ps SIR3 pe, and SIR4 are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p3","sentence":"Analysis of changes in state suggests that ps SIR1 pe protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and ps SIR4 pe are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p4","sentence":"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, ps SIR3 pe, and ps SIR4 pe are required for maintenance.","label":0}
{"pair_id":"BioInfer.d56.s0.p5","sentence":"Analysis of changes in state suggests that ps SIR1 pe protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, ps SIR3 pe, and SIR4 are required for maintenance.","label":0}
{"pair_id":"BioInfer.d116.s0.p0","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: ps BUD1 pe\/RSR1, BUD2, ps BUD3 pe, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p1","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: ps BUD1 pe\/RSR1, ps BUD2 pe, BUD3, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p2","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: ps BUD1 pe\/RSR1, BUD2, BUD3, BUD4 and ps BUD5 pe.","label":0}
{"pair_id":"BioInfer.d116.s0.p3","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: ps BUD1 pe\/RSR1, BUD2, BUD3, ps BUD4 pe and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p4","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: ps BUD1 pe\/ps RSR1 pe, BUD2, BUD3, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p5","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, ps BUD2 pe, ps BUD3 pe, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p6","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, BUD2, ps BUD3 pe, BUD4 and ps BUD5 pe.","label":0}
{"pair_id":"BioInfer.d116.s0.p7","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, BUD2, ps BUD3 pe, ps BUD4 pe and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p8","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/ps RSR1 pe, BUD2, ps BUD3 pe, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p9","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, ps BUD2 pe, BUD3, BUD4 and ps BUD5 pe.","label":0}
{"pair_id":"BioInfer.d116.s0.p10","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, ps BUD2 pe, BUD3, ps BUD4 pe and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p11","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/ps RSR1 pe, ps BUD2 pe, BUD3, BUD4 and BUD5.","label":0}
{"pair_id":"BioInfer.d116.s0.p12","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/RSR1, BUD2, BUD3, ps BUD4 pe and ps BUD5 pe.","label":0}
{"pair_id":"BioInfer.d116.s0.p13","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/ps RSR1 pe, BUD2, BUD3, BUD4 and ps BUD5 pe.","label":0}
{"pair_id":"BioInfer.d116.s0.p14","sentence":"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1\/ps RSR1 pe, BUD2, BUD3, ps BUD4 pe and BUD5.","label":0}
{"pair_id":"AIMed.d64.s549.p0","sentence":"We have isolated and characterized a cDNA clone, ps phFGFR pe, encoding a human fibroblast growth factor (FGF) receptor. ps phFGFR pe contains an open reading frame which encodes an 820 amino acid polypeptide with three immunoglobulin-like domains in the extracellular part and an intracellular split tyrosine kinase domain.","label":0}
{"pair_id":"BioInfer.d278.s0.p0","sentence":"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of ps actin pe microfilaments but not with the nuclear transport of ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d278.s0.p1","sentence":"However, these rod structures were not observed in response to ps TSH pe, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of ps actin pe microfilaments but not with the nuclear transport of cofilin.","label":0}
{"pair_id":"BioInfer.d278.s0.p2","sentence":"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of ps cofilin pe correlates with the reorganization of ps actin pe microfilaments but not with the nuclear transport of cofilin.","label":1}
{"pair_id":"BioInfer.d278.s0.p3","sentence":"However, these rod structures were not observed in response to ps TSH pe, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d278.s0.p4","sentence":"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of ps cofilin pe correlates with the reorganization of actin microfilaments but not with the nuclear transport of ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d278.s0.p5","sentence":"However, these rod structures were not observed in response to ps TSH pe, forskolin, or TPA, suggesting that dephosphorylation of ps cofilin pe correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.","label":0}
{"pair_id":"AIMed.d2.s18.p0","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum ps retinol-binding protein pe (ps RBP pe) to transthyretin (TTR) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p1","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum ps retinol-binding protein pe (RBP) to ps transthyretin pe (TTR) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p2","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum ps retinol-binding protein pe (RBP) to transthyretin (ps TTR pe) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p3","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (ps RBP pe) to ps transthyretin pe (TTR) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p4","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (ps RBP pe) to transthyretin (ps TTR pe) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d2.s18.p5","sentence":"OBJECTIVE: To assess the usefulness of the molar ratio of serum retinol-binding protein (RBP) to ps transthyretin pe (ps TTR pe) to determine vitamin A (VA) status during infection.","label":0}
{"pair_id":"AIMed.d91.s777.p0","sentence":"Transcription factor ps TFIID pe consists of ps TATA binding protein pe (TBP) and at least eight TBP-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p1","sentence":"Transcription factor ps TFIID pe consists of TATA binding protein (ps TBP pe) and at least eight TBP-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p2","sentence":"Transcription factor ps TFIID pe consists of TATA binding protein (TBP) and at least eight ps TBP pe-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p3","sentence":"Transcription factor TFIID consists of ps TATA binding protein pe (ps TBP pe) and at least eight TBP-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p4","sentence":"Transcription factor TFIID consists of ps TATA binding protein pe (TBP) and at least eight ps TBP pe-associated factors (TAFs).","label":0}
{"pair_id":"AIMed.d91.s777.p5","sentence":"Transcription factor TFIID consists of TATA binding protein (ps TBP pe) and at least eight ps TBP pe-associated factors (TAFs).","label":0}
{"pair_id":"BioInfer.d298.s0.p0","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal ps beta-catenin pe, indicating truncated ps beta-catenin pe.","label":0}
{"pair_id":"BioInfer.d298.s0.p1","sentence":"Immunoprecipitation of metabolically labeled proteins with ps HECD-1 pe revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated ps beta-catenin pe.","label":1}
{"pair_id":"BioInfer.d298.s0.p2","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to ps E-cadherin pe, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated ps beta-catenin pe.","label":0}
{"pair_id":"BioInfer.d298.s0.p3","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, ps alpha-catenin pe, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated ps beta-catenin pe.","label":0}
{"pair_id":"BioInfer.d298.s0.p4","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and ps gamma-catenin pe and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated ps beta-catenin pe.","label":0}
{"pair_id":"BioInfer.d298.s0.p5","sentence":"Immunoprecipitation of metabolically labeled proteins with ps HECD-1 pe revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal ps beta-catenin pe, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p6","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to ps E-cadherin pe, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal ps beta-catenin pe, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p7","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, ps alpha-catenin pe, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal ps beta-catenin pe, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p8","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and ps gamma-catenin pe and a 79-kDa band which was apparently smaller than that of normal ps beta-catenin pe, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p9","sentence":"Immunoprecipitation of metabolically labeled proteins with ps HECD-1 pe revealed three bands corresponding to ps E-cadherin pe, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":1}
{"pair_id":"BioInfer.d298.s0.p10","sentence":"Immunoprecipitation of metabolically labeled proteins with ps HECD-1 pe revealed three bands corresponding to E-cadherin, ps alpha-catenin pe, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":1}
{"pair_id":"BioInfer.d298.s0.p11","sentence":"Immunoprecipitation of metabolically labeled proteins with ps HECD-1 pe revealed three bands corresponding to E-cadherin, alpha-catenin, and ps gamma-catenin pe and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":1}
{"pair_id":"BioInfer.d298.s0.p12","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to ps E-cadherin pe, ps alpha-catenin pe, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p13","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to ps E-cadherin pe, alpha-catenin, and ps gamma-catenin pe and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":0}
{"pair_id":"BioInfer.d298.s0.p14","sentence":"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, ps alpha-catenin pe, and ps gamma-catenin pe and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.","label":0}
{"pair_id":"AIMed.d207.s1794.p0","sentence":"Thus, during myogenic differentiation, formation of ps E2F4 pe and ps pRb2 pe\/p130 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.","label":1}
{"pair_id":"AIMed.d207.s1794.p1","sentence":"Thus, during myogenic differentiation, formation of ps E2F4 pe and pRb2\/ps p130 pe containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.","label":1}
{"pair_id":"AIMed.d207.s1794.p2","sentence":"Thus, during myogenic differentiation, formation of E2F4 and ps pRb2 pe\/ps p130 pe containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.","label":0}
{"pair_id":"BioInfer.d178.s1.p0","sentence":"We attribute these effects to potential sequestration of ps actin pe monomers by ps profilin pe, when present in excess.","label":1}
{"pair_id":"BioInfer.d639.s0.p0","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (ps CDKI pe), arises from its binding with the cyclin E\/ps cyclin-dependent kinase 2 pe (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p1","sentence":"The main inhibitory action of ps p27 pe, a cyclin-dependent kinase inhibitor (ps CDKI pe), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p2","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (ps CDKI pe), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (ps Cdk2 pe) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p3","sentence":"The main inhibitory action of p27, a ps cyclin-dependent kinase inhibitor pe (ps CDKI pe), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p4","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (ps CDKI pe), arises from its binding with the ps cyclin E pe\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p5","sentence":"The main inhibitory action of ps p27 pe, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E\/ps cyclin-dependent kinase 2 pe (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p6","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E\/ps cyclin-dependent kinase 2 pe (ps Cdk2 pe) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p7","sentence":"The main inhibitory action of p27, a ps cyclin-dependent kinase inhibitor pe (CDKI), arises from its binding with the cyclin E\/ps cyclin-dependent kinase 2 pe (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p8","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the ps cyclin E pe\/ps cyclin-dependent kinase 2 pe (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p9","sentence":"The main inhibitory action of ps p27 pe, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (ps Cdk2 pe) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p10","sentence":"The main inhibitory action of ps p27 pe, a ps cyclin-dependent kinase inhibitor pe (CDKI), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p11","sentence":"The main inhibitory action of ps p27 pe, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the ps cyclin E pe\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p12","sentence":"The main inhibitory action of p27, a ps cyclin-dependent kinase inhibitor pe (CDKI), arises from its binding with the cyclin E\/cyclin-dependent kinase 2 (ps Cdk2 pe) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d639.s0.p13","sentence":"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the ps cyclin E pe\/cyclin-dependent kinase 2 (ps Cdk2 pe) complex that results in G(1)-S arrest.","label":1}
{"pair_id":"BioInfer.d639.s0.p14","sentence":"The main inhibitory action of p27, a ps cyclin-dependent kinase inhibitor pe (CDKI), arises from its binding with the ps cyclin E pe\/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.","label":0}
{"pair_id":"BioInfer.d0.s0.p0","sentence":"ps alpha-catenin pe inhibits beta-catenin signaling by preventing formation of a beta-catenin*ps T-cell factor pe*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p1","sentence":"alpha-catenin inhibits ps beta-catenin pe signaling by preventing formation of a beta-catenin*ps T-cell factor pe*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p2","sentence":"alpha-catenin inhibits beta-catenin signaling by preventing formation of a ps beta-catenin pe*ps T-cell factor pe*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p3","sentence":"ps alpha-catenin pe inhibits ps beta-catenin pe signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p4","sentence":"ps alpha-catenin pe inhibits beta-catenin signaling by preventing formation of a ps beta-catenin pe*T-cell factor*DNA complex.","label":1}
{"pair_id":"BioInfer.d0.s0.p5","sentence":"alpha-catenin inhibits ps beta-catenin pe signaling by preventing formation of a ps beta-catenin pe*T-cell factor*DNA complex.","label":1}
{"pair_id":"BioInfer.d767.s0.p0","sentence":"To determine whether alpha 1-adrenergic stimulation produced similar effects on the turnover of myofibrillar proteins, rates of synthesis and degradation were estimated for a myofibrillar-enriched protein fraction and for ps myosin heavy chain pe and ps actin pe.","label":0}
{"pair_id":"AIMed.d61.s535.p0","sentence":"Immunoprecipitation of ps TNF-R2 pe from 32P-labeled 293\/ps TNF-R2 pe cells demonstrated that the receptor is phosphorylated.","label":0}
{"pair_id":"AIMed.d193.s1644.p0","sentence":"As expected, overexpression of either ps Id3 pe\/ps HLH462 pe or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p1","sentence":"As expected, overexpression of either ps Id3 pe\/HLH462 or ps ITF-2b pe effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p2","sentence":"As expected, overexpression of either ps Id3 pe\/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific ps creatine kinase pe promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p3","sentence":"As expected, overexpression of either ps Id3 pe\/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor ps MyoD pe.","label":0}
{"pair_id":"AIMed.d193.s1644.p4","sentence":"As expected, overexpression of either Id3\/ps HLH462 pe or ps ITF-2b pe effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p5","sentence":"As expected, overexpression of either Id3\/ps HLH462 pe or ITF-2b effectively inhibited the activation of the muscle-specific ps creatine kinase pe promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p6","sentence":"As expected, overexpression of either Id3\/ps HLH462 pe or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor ps MyoD pe.","label":0}
{"pair_id":"AIMed.d193.s1644.p7","sentence":"As expected, overexpression of either Id3\/HLH462 or ps ITF-2b pe effectively inhibited the activation of the muscle-specific ps creatine kinase pe promoter by the myogenic transcription factor MyoD.","label":0}
{"pair_id":"AIMed.d193.s1644.p8","sentence":"As expected, overexpression of either Id3\/HLH462 or ps ITF-2b pe effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor ps MyoD pe.","label":0}
{"pair_id":"AIMed.d193.s1644.p9","sentence":"As expected, overexpression of either Id3\/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific ps creatine kinase pe promoter by the myogenic transcription factor ps MyoD pe.","label":0}
{"pair_id":"BioInfer.d161.s0.p0","sentence":"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, ps thymosin beta(4) pe, and ps actin pe form a ternary complex.","label":1}
{"pair_id":"BioInfer.d161.s0.p1","sentence":"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that ps profilin pe, ps thymosin beta(4) pe, and actin form a ternary complex.","label":1}
{"pair_id":"BioInfer.d161.s0.p2","sentence":"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that ps profilin pe, thymosin beta(4), and ps actin pe form a ternary complex.","label":1}
{"pair_id":"AIMed.d187.s1591.p0","sentence":"Endogenous ps TTR pe-ps A beta pe complexes were detected in human CSF by immunoprecipitation.","label":1}
{"pair_id":"AIMed.d146.s1241.p0","sentence":"In addition, PCR analysis of ps p76 pe-expressing cells could not detect splicing of the extracellular domain of the cloned ps IL-7R pe, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p1","sentence":"In addition, PCR analysis of ps p76 pe-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the ps p76 pe IL-7R is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p2","sentence":"In addition, PCR analysis of ps p76 pe-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 ps IL-7R pe is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p3","sentence":"In addition, PCR analysis of ps p76 pe-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1241.p4","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned ps IL-7R pe, thereby excluding the possibility that the ps p76 pe IL-7R is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p5","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned ps IL-7R pe, thereby excluding the possibility that the p76 ps IL-7R pe is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p6","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned ps IL-7R pe, thereby excluding the possibility that the p76 IL-7R is a previously undescribed splice variant of the cloned ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1241.p7","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the ps p76 pe ps IL-7R pe is a previously undescribed splice variant of the cloned IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1241.p8","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the ps p76 pe IL-7R is a previously undescribed splice variant of the cloned ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1241.p9","sentence":"In addition, PCR analysis of p76-expressing cells could not detect splicing of the extracellular domain of the cloned IL-7R, thereby excluding the possibility that the p76 ps IL-7R pe is a previously undescribed splice variant of the cloned ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1236.p0","sentence":"These analyses showed that the ability of PBMC to proliferate to ps IL-7 pe correlated with expression of the ps p76 pe IL-7R, and not with expression of the p90 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p1","sentence":"These analyses showed that the ability of PBMC to proliferate to ps IL-7 pe correlated with expression of the p76 ps IL-7R pe, and not with expression of the p90 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p2","sentence":"These analyses showed that the ability of PBMC to proliferate to ps IL-7 pe correlated with expression of the p76 IL-7R, and not with expression of the ps p90 pe IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p3","sentence":"These analyses showed that the ability of PBMC to proliferate to ps IL-7 pe correlated with expression of the p76 IL-7R, and not with expression of the p90 ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1236.p4","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the ps p76 pe ps IL-7R pe, and not with expression of the p90 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p5","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the ps p76 pe IL-7R, and not with expression of the ps p90 pe IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p6","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the ps p76 pe IL-7R, and not with expression of the p90 ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1236.p7","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 ps IL-7R pe, and not with expression of the ps p90 pe IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1236.p8","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 ps IL-7R pe, and not with expression of the p90 ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1236.p9","sentence":"These analyses showed that the ability of PBMC to proliferate to IL-7 correlated with expression of the p76 IL-7R, and not with expression of the ps p90 pe ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d183.s1556.p0","sentence":"Under these conditions, a ternary complex of ps p21ras pe, ps JAK2 pe, and Raf-1 was observed.","label":1}
{"pair_id":"AIMed.d183.s1556.p1","sentence":"Under these conditions, a ternary complex of ps p21ras pe, JAK2, and ps Raf-1 pe was observed.","label":0}
{"pair_id":"AIMed.d183.s1556.p2","sentence":"Under these conditions, a ternary complex of p21ras, ps JAK2 pe, and ps Raf-1 pe was observed.","label":0}
{"pair_id":"BioInfer.d67.s0.p0","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (ps SAC6 pe), Abp1p (ABP1), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p1","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (SAC6), Abp1p (ABP1), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p2","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p3","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p4","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (ps CAP1 pe and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p5","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), ps Abp1p pe (ABP1), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p6","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and ps capping protein pe (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":1}
{"pair_id":"BioInfer.d67.s0.p7","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ps ABP1 pe), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p8","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p9","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and ps CAP2 pe) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p10","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (ps SAC6 pe), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p11","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (ps SAC6 pe), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p12","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (ps SAC6 pe), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p13","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (ps SAC6 pe), Abp1p (ABP1), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p14","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (ps SAC6 pe), ps Abp1p pe (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p15","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (ps SAC6 pe), Abp1p (ABP1), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p16","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (ps SAC6 pe), Abp1p (ps ABP1 pe), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p17","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (ps SAC6 pe), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p18","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (ps SAC6 pe), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p19","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), ps fimbrin pe (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p20","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p21","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (SAC6), Abp1p (ABP1), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p22","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (SAC6), ps Abp1p pe (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p23","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (SAC6), Abp1p (ABP1), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p24","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (SAC6), Abp1p (ps ABP1 pe), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p25","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), ps fimbrin pe (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p26","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), ps fimbrin pe (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p27","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p28","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p29","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (SAC6), ps Abp1p pe (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p30","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (SAC6), Abp1p (ABP1), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p31","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (SAC6), Abp1p (ps ABP1 pe), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p32","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the ps tropomyosin pe (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p33","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the ps tropomyosin pe (ps TPM1 pe), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p34","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p35","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), ps Abp1p pe (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p36","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p37","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ps ABP1 pe), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p38","sentence":"A null mutation of the ps actin pe gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p39","sentence":"A null mutation of the ps actin pe gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p40","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), ps Abp1p pe (ABP1), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p41","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and ps capping protein pe (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":1}
{"pair_id":"BioInfer.d67.s0.p42","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ps ABP1 pe), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p43","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p44","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (SAC6), Abp1p (ABP1), and capping protein (ps CAP1 pe and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p45","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), ps Abp1p pe (ABP1), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p46","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), ps Abp1p pe (ps ABP1 pe), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p47","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), ps Abp1p pe (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p48","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (SAC6), ps Abp1p pe (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p49","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ps ABP1 pe), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p50","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p51","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (SAC6), Abp1p (ABP1), and ps capping protein pe (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p52","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ps ABP1 pe), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p53","sentence":"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (SAC6), Abp1p (ps ABP1 pe), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"BioInfer.d67.s0.p54","sentence":"A null mutation of the actin gene (ps ACT1 pe) is lethal, but null mutations in the tropomyosin (ps TPM1 pe), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.","label":0}
{"pair_id":"AIMed.d224.s1950.p0","sentence":"Further studies on the interaction of ps HLA-E pe with molecules in the endoplasmic reticulum revealed that ps HLA-E pe associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p1","sentence":"Further studies on the interaction of ps HLA-E pe with molecules in the endoplasmic reticulum revealed that HLA-E associates with the ps transporter associated with antigen processing pe (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p2","sentence":"Further studies on the interaction of ps HLA-E pe with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (ps TAP pe) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p3","sentence":"Further studies on the interaction of ps HLA-E pe with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and ps calreticulin pe, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p4","sentence":"Further studies on the interaction of ps HLA-E pe with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that ps HLA-E pe expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p5","sentence":"Further studies on the interaction of ps HLA-E pe with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is ps TAP pe-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p6","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that ps HLA-E pe associates with the ps transporter associated with antigen processing pe (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":1}
{"pair_id":"AIMed.d224.s1950.p7","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that ps HLA-E pe associates with the transporter associated with antigen processing (ps TAP pe) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":1}
{"pair_id":"AIMed.d224.s1950.p8","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that ps HLA-E pe associates with the transporter associated with antigen processing (TAP) and ps calreticulin pe, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":1}
{"pair_id":"AIMed.d224.s1950.p9","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that ps HLA-E pe associates with the transporter associated with antigen processing (TAP) and calreticulin, and that ps HLA-E pe expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p10","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that ps HLA-E pe associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is ps TAP pe-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p11","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the ps transporter associated with antigen processing pe (ps TAP pe) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p12","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the ps transporter associated with antigen processing pe (TAP) and ps calreticulin pe, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p13","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the ps transporter associated with antigen processing pe (TAP) and calreticulin, and that ps HLA-E pe expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p14","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the ps transporter associated with antigen processing pe (TAP) and calreticulin, and that HLA-E expression is ps TAP pe-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p15","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (ps TAP pe) and ps calreticulin pe, and that HLA-E expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p16","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (ps TAP pe) and calreticulin, and that ps HLA-E pe expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p17","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (ps TAP pe) and calreticulin, and that HLA-E expression is ps TAP pe-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p18","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and ps calreticulin pe, and that ps HLA-E pe expression is TAP-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p19","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and ps calreticulin pe, and that HLA-E expression is ps TAP pe-dependent and tapasin-dependent.","label":0}
{"pair_id":"AIMed.d224.s1950.p20","sentence":"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that ps HLA-E pe expression is ps TAP pe-dependent and tapasin-dependent.","label":0}
{"pair_id":"BioInfer.d342.s0.p0","sentence":"Inhibition of the interactions of ps cofilin pe, destrin, and ps deoxyribonuclease I pe with actin by phosphoinositides.","label":0}
{"pair_id":"BioInfer.d342.s0.p1","sentence":"Inhibition of the interactions of ps cofilin pe, destrin, and deoxyribonuclease I with ps actin pe by phosphoinositides.","label":1}
{"pair_id":"BioInfer.d342.s0.p2","sentence":"Inhibition of the interactions of ps cofilin pe, ps destrin pe, and deoxyribonuclease I with actin by phosphoinositides.","label":0}
{"pair_id":"BioInfer.d342.s0.p3","sentence":"Inhibition of the interactions of cofilin, destrin, and ps deoxyribonuclease I pe with ps actin pe by phosphoinositides.","label":1}
{"pair_id":"BioInfer.d342.s0.p4","sentence":"Inhibition of the interactions of cofilin, ps destrin pe, and ps deoxyribonuclease I pe with actin by phosphoinositides.","label":0}
{"pair_id":"BioInfer.d342.s0.p5","sentence":"Inhibition of the interactions of cofilin, ps destrin pe, and deoxyribonuclease I with ps actin pe by phosphoinositides.","label":1}
{"pair_id":"AIMed.d98.s833.p0","sentence":"14-3-3 protein, however, has no effect on the ps cdc25A pe-kinase activity of ps Raf-1 pe.","label":0}
{"pair_id":"BioInfer.d87.s0.p0","sentence":"A truncated ps beta-catenin pe disrupts the interaction between ps E-cadherin pe and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.","label":1}
{"pair_id":"BioInfer.d87.s0.p1","sentence":"A truncated beta-catenin disrupts the interaction between ps E-cadherin pe and ps alpha-catenin pe: a cause of loss of intercellular adhesiveness in human cancer cell lines.","label":1}
{"pair_id":"BioInfer.d87.s0.p2","sentence":"A truncated ps beta-catenin pe disrupts the interaction between E-cadherin and ps alpha-catenin pe: a cause of loss of intercellular adhesiveness in human cancer cell lines.","label":1}
{"pair_id":"AIMed.d151.s1289.p0","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and ps PTF pe delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p1","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and PTF delta with ps TBP pe, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p2","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and PTF delta with TBP, consistent either with the natural association of ps TBP pe with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p3","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and PTF delta with TBP, consistent either with the natural association of TBP with ps PTF pe in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p4","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable ps TBP pe-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p5","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p6","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p7","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant ps PTF pe gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p8","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and ps PTF pe delta with ps TBP pe, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p9","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and ps PTF pe delta with TBP, consistent either with the natural association of ps TBP pe with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p10","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and ps PTF pe delta with TBP, consistent either with the natural association of TBP with ps PTF pe in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p11","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and ps PTF pe delta with TBP, consistent either with the natural association of TBP with PTF in a semistable ps TBP pe-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p12","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and ps PTF pe delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p13","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and ps PTF pe delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p14","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and ps PTF pe delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p15","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with ps TBP pe, consistent either with the natural association of ps TBP pe with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p16","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with ps TBP pe, consistent either with the natural association of TBP with ps PTF pe in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p17","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with ps TBP pe, consistent either with the natural association of TBP with PTF in a semistable ps TBP pe-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p18","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with ps TBP pe, consistent either with the natural association of TBP with PTF in a semistable TBP-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p19","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with ps TBP pe, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p20","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with ps TBP pe, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p21","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of ps TBP pe with ps PTF pe in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p22","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of ps TBP pe with PTF in a semistable ps TBP pe-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p23","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of ps TBP pe with PTF in a semistable TBP-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p24","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of ps TBP pe with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p25","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of ps TBP pe with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p26","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with ps PTF pe in a semistable ps TBP pe-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p27","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with ps PTF pe in a semistable TBP-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p28","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with ps PTF pe in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p29","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with ps PTF pe in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p30","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable ps TBP pe-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p31","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable ps TBP pe-TBP-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p32","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable ps TBP pe-TBP-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p33","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound TBP during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p34","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-ps TBP pe-associated factor complex or with possible functional interactions between PSE-bound PTF and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"AIMed.d151.s1289.p35","sentence":"Glutathione S-transferase pulldown assays further indicate relatively strong direct interactions of both recombinant PTF gamma and PTF delta with TBP, consistent either with the natural association of TBP with PTF in a semistable TBP-TBP-associated factor complex or with possible functional interactions between PSE-bound ps PTF pe and TATA-bound ps TBP pe during promoter activation.","label":0}
{"pair_id":"BioInfer.d400.s0.p0","sentence":"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of ps actin pe, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein ps talin pe.","label":0}
{"pair_id":"BioInfer.d400.s0.p1","sentence":"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is ps actin pe with perhaps smaller quantities of a 240-kd component, identified by others as the protein ps talin pe.","label":0}
{"pair_id":"BioInfer.d400.s0.p2","sentence":"Lack of detection in these preparations of a constituent that binds RBC ps alpha-spectrin pe antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein ps talin pe.","label":0}
{"pair_id":"BioInfer.d400.s0.p3","sentence":"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of ps actin pe, further suggests that the principal membrane skeletal element is ps actin pe with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.","label":0}
{"pair_id":"BioInfer.d400.s0.p4","sentence":"Lack of detection in these preparations of a constituent that binds RBC ps alpha-spectrin pe antibody plus the presence of significant quantities of ps actin pe, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.","label":0}
{"pair_id":"BioInfer.d400.s0.p5","sentence":"Lack of detection in these preparations of a constituent that binds RBC ps alpha-spectrin pe antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is ps actin pe with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.","label":0}
{"pair_id":"BioInfer.d29.s0.p0","sentence":"After digestion of the 60 kDa fragment with cyanogen bromide, the N-terminal 21-amino acid sequence of one of the resulting peptides was found to show sequence similarity to a region near the ps actin pe-binding site (amino acid residues 260-281) of yeast ps fimbrin pe.","label":1}
{"pair_id":"BioInfer.d276.s0.p0","sentence":"However, some proteins (e.g., ps profilin pe) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making ps actin pe intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"BioInfer.d276.s0.p1","sentence":"However, some proteins (e.g., ps profilin pe) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled ps actin pe.","label":0}
{"pair_id":"BioInfer.d276.s0.p2","sentence":"However, some proteins (e.g., ps profilin pe) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with ps actin pe, and in validating data obtained using labeled actin.","label":1}
{"pair_id":"BioInfer.d276.s0.p3","sentence":"However, some proteins (e.g., ps profilin pe) and other agents (e.g., cytochalasin D) that bind to ps actin pe are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.","label":1}
{"pair_id":"BioInfer.d276.s0.p4","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making ps actin pe intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled ps actin pe.","label":0}
{"pair_id":"BioInfer.d276.s0.p5","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making ps actin pe intrinsic fluorescence potentially useful in investigating the interaction of these agents with ps actin pe, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"BioInfer.d276.s0.p6","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to ps actin pe are affected by the presence of fluorescent labels, making ps actin pe intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"BioInfer.d276.s0.p7","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with ps actin pe, and in validating data obtained using labeled ps actin pe.","label":0}
{"pair_id":"BioInfer.d276.s0.p8","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to ps actin pe are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled ps actin pe.","label":0}
{"pair_id":"BioInfer.d276.s0.p9","sentence":"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to ps actin pe are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with ps actin pe, and in validating data obtained using labeled actin.","label":0}
{"pair_id":"AIMed.d179.s1526.p0","sentence":"In addition, activation of ps PI 3-kinase pe was detected in anti-ps IRS-1 pe immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p1","sentence":"In addition, activation of ps PI 3-kinase pe was detected in anti-IRS-1 immunoprecipitates from ps gastrin pe-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p2","sentence":"In addition, activation of ps PI 3-kinase pe was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of ps IRS-1 pe, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p3","sentence":"In addition, activation of ps PI 3-kinase pe was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of ps p85 pe, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p4","sentence":"In addition, activation of ps PI 3-kinase pe was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by ps gastrin pe to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p5","sentence":"In addition, activation of ps PI 3-kinase pe was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate ps PI 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1526.p6","sentence":"In addition, activation of PI 3-kinase was detected in anti-ps IRS-1 pe immunoprecipitates from ps gastrin pe-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p7","sentence":"In addition, activation of PI 3-kinase was detected in anti-ps IRS-1 pe immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of ps IRS-1 pe, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p8","sentence":"In addition, activation of PI 3-kinase was detected in anti-ps IRS-1 pe immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of ps p85 pe, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p9","sentence":"In addition, activation of PI 3-kinase was detected in anti-ps IRS-1 pe immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by ps gastrin pe to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p10","sentence":"In addition, activation of PI 3-kinase was detected in anti-ps IRS-1 pe immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate ps PI 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1526.p11","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from ps gastrin pe-treated cells, suggesting that tyrosine phosphorylation of ps IRS-1 pe, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p12","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from ps gastrin pe-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of ps p85 pe, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p13","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from ps gastrin pe-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by ps gastrin pe to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p14","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from ps gastrin pe-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate ps PI 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1526.p15","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of ps IRS-1 pe, which leads to the rapid recruitment of ps p85 pe, might be one mechanism used by gastrin to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p16","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of ps IRS-1 pe, which leads to the rapid recruitment of p85, might be one mechanism used by ps gastrin pe to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p17","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of ps IRS-1 pe, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate ps PI 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1526.p18","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of ps p85 pe, might be one mechanism used by ps gastrin pe to activate PI 3-kinase.","label":0}
{"pair_id":"AIMed.d179.s1526.p19","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of ps p85 pe, might be one mechanism used by gastrin to activate ps PI 3-kinase pe.","label":0}
{"pair_id":"AIMed.d179.s1526.p20","sentence":"In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by ps gastrin pe to activate ps PI 3-kinase pe.","label":0}
{"pair_id":"BioInfer.d777.s0.p0","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ps ERK1 pe and ps ERK2 pe, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p1","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ps ERK1 pe and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor ps AP-1 pe DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p2","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ps ERK1 pe and ERK2, induction of c-fos and ps c-jun pe protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p3","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ps ERK1 pe and ERK2, induction of ps c-fos pe and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p4","sentence":"Treatment with HNE resulted in activation of ps extracellular signal-regulated protein kinases pe ps ERK1 pe and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":1}
{"pair_id":"BioInfer.d777.s0.p5","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ps ERK2 pe, induction of c-fos and c-jun protein expression, and an increase in transcription factor ps AP-1 pe DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p6","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ps ERK2 pe, induction of c-fos and ps c-jun pe protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p7","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ps ERK2 pe, induction of ps c-fos pe and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p8","sentence":"Treatment with HNE resulted in activation of ps extracellular signal-regulated protein kinases pe ERK1 and ps ERK2 pe, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":1}
{"pair_id":"BioInfer.d777.s0.p9","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and ps c-jun pe protein expression, and an increase in transcription factor ps AP-1 pe DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p10","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of ps c-fos pe and c-jun protein expression, and an increase in transcription factor ps AP-1 pe DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p11","sentence":"Treatment with HNE resulted in activation of ps extracellular signal-regulated protein kinases pe ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor ps AP-1 pe DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p12","sentence":"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of ps c-fos pe and ps c-jun pe protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p13","sentence":"Treatment with HNE resulted in activation of ps extracellular signal-regulated protein kinases pe ERK1 and ERK2, induction of c-fos and ps c-jun pe protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d777.s0.p14","sentence":"Treatment with HNE resulted in activation of ps extracellular signal-regulated protein kinases pe ERK1 and ERK2, induction of ps c-fos pe and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.","label":0}
{"pair_id":"BioInfer.d73.s2.p0","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, ps RAD52 pe, RAD54, ps RAD55 pe or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p1","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, ps RAD55 pe or ps RAD57 pe.","label":0}
{"pair_id":"BioInfer.d73.s2.p2","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes ps RAD51 pe, RAD52, RAD54, ps RAD55 pe or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p3","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, ps RAD54 pe, ps RAD55 pe or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p4","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, ps RAD52 pe, RAD54, RAD55 or ps RAD57 pe.","label":0}
{"pair_id":"BioInfer.d73.s2.p5","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes ps RAD51 pe, ps RAD52 pe, RAD54, RAD55 or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p6","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, ps RAD52 pe, ps RAD54 pe, RAD55 or RAD57.","label":0}
{"pair_id":"BioInfer.d73.s2.p7","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes ps RAD51 pe, RAD52, RAD54, RAD55 or ps RAD57 pe.","label":0}
{"pair_id":"BioInfer.d73.s2.p8","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, ps RAD54 pe, RAD55 or ps RAD57 pe.","label":0}
{"pair_id":"BioInfer.d73.s2.p9","sentence":"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes ps RAD51 pe, RAD52, ps RAD54 pe, RAD55 or RAD57.","label":0}
{"pair_id":"AIMed.d65.s558.p0","sentence":"Although ps Fos pe\/ps Jun pe and ATF\/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p1","sentence":"Although ps Fos pe\/Jun and ps ATF pe\/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p2","sentence":"Although ps Fos pe\/Jun and ATF\/ps CREB pe were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p3","sentence":"Although Fos\/ps Jun pe and ps ATF pe\/CREB were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p4","sentence":"Although Fos\/ps Jun pe and ATF\/ps CREB pe were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"AIMed.d65.s558.p5","sentence":"Although Fos\/Jun and ps ATF pe\/ps CREB pe were previously thought to interact preferentially with different DNA regulatory elements (the AP-1\/TRE and ATF\/CRE sites, respectively), we find that members of these two families form selective cross-family heterodimers.","label":0}
{"pair_id":"BioInfer.d632.s0.p0","sentence":"The interactions of ps actin pe with thymosin beta 4, ps actobindin pe and profilin are compared.","label":1}
{"pair_id":"BioInfer.d632.s0.p1","sentence":"The interactions of ps actin pe with ps thymosin beta 4 pe, actobindin and profilin are compared.","label":1}
{"pair_id":"BioInfer.d632.s0.p2","sentence":"The interactions of ps actin pe with thymosin beta 4, actobindin and ps profilin pe are compared.","label":1}
{"pair_id":"BioInfer.d632.s0.p3","sentence":"The interactions of actin with ps thymosin beta 4 pe, ps actobindin pe and profilin are compared.","label":0}
{"pair_id":"BioInfer.d632.s0.p4","sentence":"The interactions of actin with thymosin beta 4, ps actobindin pe and ps profilin pe are compared.","label":0}
{"pair_id":"BioInfer.d632.s0.p5","sentence":"The interactions of actin with ps thymosin beta 4 pe, actobindin and ps profilin pe are compared.","label":0}
{"pair_id":"BioInfer.d809.s1.p0","sentence":"Yeast ps profilin pe can sequester yeast ps actin pe monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.","label":1}
{"pair_id":"BioInfer.d809.s1.p1","sentence":"Yeast ps profilin pe can sequester yeast actin monomers and thereby reduce the ability of yeast ps actin pe to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.","label":1}
{"pair_id":"BioInfer.d809.s1.p2","sentence":"Yeast ps profilin pe can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit ps skeletal muscle actin pe.","label":1}
{"pair_id":"BioInfer.d809.s1.p3","sentence":"Yeast profilin can sequester yeast ps actin pe monomers and thereby reduce the ability of yeast ps actin pe to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.","label":0}
{"pair_id":"BioInfer.d809.s1.p4","sentence":"Yeast profilin can sequester yeast ps actin pe monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit ps skeletal muscle actin pe.","label":0}
{"pair_id":"BioInfer.d809.s1.p5","sentence":"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast ps actin pe to polymerize, whereas it has little effect on the degree of polymerization of rabbit ps skeletal muscle actin pe.","label":0}
{"pair_id":"AIMed.d185.s1575.p0","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated ps Stat3 pe but not ps Stat1 pe and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p1","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated ps Stat3 pe but not Stat1 and blocked ps IL-10 pe-induced Stat3 phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p2","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated ps Stat3 pe but not Stat1 and blocked IL-10-induced ps Stat3 pe phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p3","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not ps Stat1 pe and blocked ps IL-10 pe-induced Stat3 phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p4","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not ps Stat1 pe and blocked IL-10-induced ps Stat3 pe phosphorylation in a cell-free system.","label":0}
{"pair_id":"AIMed.d185.s1575.p5","sentence":"Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked ps IL-10 pe-induced ps Stat3 pe phosphorylation in a cell-free system.","label":0}
{"pair_id":"BioInfer.d223.s0.p0","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of ps sac6 pe, a mutant in yeast fimbrin, supporting a role for ps synaptojanin pe family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p1","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for ps synaptojanin pe family members in ps actin pe function.","label":1}
{"pair_id":"BioInfer.d223.s0.p2","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast ps fimbrin pe, supporting a role for ps synaptojanin pe family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p3","sentence":"Furthermore, the deletion of ps SJL1 pe suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for ps synaptojanin pe family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p4","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of ps sac6 pe, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in ps actin pe function.","label":0}
{"pair_id":"BioInfer.d223.s0.p5","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of ps sac6 pe, a mutant in yeast ps fimbrin pe, supporting a role for synaptojanin family members in actin function.","label":0}
{"pair_id":"BioInfer.d223.s0.p6","sentence":"Furthermore, the deletion of ps SJL1 pe suppresses the temperature-sensitive growth defect of ps sac6 pe, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.","label":1}
{"pair_id":"BioInfer.d223.s0.p7","sentence":"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast ps fimbrin pe, supporting a role for synaptojanin family members in ps actin pe function.","label":0}
{"pair_id":"BioInfer.d223.s0.p8","sentence":"Furthermore, the deletion of ps SJL1 pe suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in ps actin pe function.","label":0}
{"pair_id":"BioInfer.d223.s0.p9","sentence":"Furthermore, the deletion of ps SJL1 pe suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast ps fimbrin pe, supporting a role for synaptojanin family members in actin function.","label":0}
{"pair_id":"AIMed.d213.s1853.p0","sentence":"Repression of ps CTF-1 pe-directed transcription may be accomplished through direct physical interaction between ps YY1 pe and this activator.","label":0}
{"pair_id":"AIMed.d182.s1548.p0","sentence":"The crystal structure of the 109-residue amino-terminal domain of ps MDM2 pe bound to a 15-residue transactivation domain peptide of ps p53 pe revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.","label":1}
{"pair_id":"AIMed.d182.s1548.p1","sentence":"The crystal structure of the 109-residue amino-terminal domain of ps MDM2 pe bound to a 15-residue transactivation domain peptide of p53 revealed that ps MDM2 pe has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p2","sentence":"The crystal structure of the 109-residue amino-terminal domain of ps MDM2 pe bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the ps p53 pe peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p3","sentence":"The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of ps p53 pe revealed that ps MDM2 pe has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p4","sentence":"The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of ps p53 pe revealed that MDM2 has a deep hydrophobic cleft on which the ps p53 pe peptide binds as an amphipathic alpha helix.","label":0}
{"pair_id":"AIMed.d182.s1548.p5","sentence":"The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that ps MDM2 pe has a deep hydrophobic cleft on which the ps p53 pe peptide binds as an amphipathic alpha helix.","label":1}
{"pair_id":"BioInfer.d171.s1.p0","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the ps RAD52 pe region in 16%, in RAD54 in 20% and in the BRCA1 and ps BRCA2 pe regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p1","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in ps RAD54 pe in 20% and in the BRCA1 and ps BRCA2 pe regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p2","sentence":"LOH was found in the ps RAD51 pe region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and ps BRCA2 pe regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p3","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the ps BRCA1 pe and ps BRCA2 pe regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p4","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the ps RAD52 pe region in 16%, in ps RAD54 pe in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p5","sentence":"LOH was found in the ps RAD51 pe region in 32% of tumours, in the ps RAD52 pe region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p6","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the ps RAD52 pe region in 16%, in RAD54 in 20% and in the ps BRCA1 pe and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p7","sentence":"LOH was found in the ps RAD51 pe region in 32% of tumours, in the RAD52 region in 16%, in ps RAD54 pe in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p8","sentence":"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in ps RAD54 pe in 20% and in the ps BRCA1 pe and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d171.s1.p9","sentence":"LOH was found in the ps RAD51 pe region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the ps BRCA1 pe and BRCA2 regions in 49% and 44% respectively.","label":0}
{"pair_id":"BioInfer.d26.s0.p0","sentence":"A distinct modulating domain in ps glucocorticoid receptor pe monomers in the repression of activity of the transcription factor ps AP-1 pe.","label":1}
{"pair_id":"AIMed.d160.s1346.p0","sentence":"Alanine-scanning mutagenesis was used to identify a positively charged surface in ps VEGF pe that mediates binding to ps KDR pe\/Flk-1.","label":0}
{"pair_id":"AIMed.d160.s1346.p1","sentence":"Alanine-scanning mutagenesis was used to identify a positively charged surface in ps VEGF pe that mediates binding to KDR\/ps Flk-1 pe.","label":0}
{"pair_id":"AIMed.d160.s1346.p2","sentence":"Alanine-scanning mutagenesis was used to identify a positively charged surface in VEGF that mediates binding to ps KDR pe\/ps Flk-1 pe.","label":0}
{"pair_id":"BioInfer.d675.s0.p0","sentence":"The proteins encoded by ps MRS5 pe and ps MRS11 pe, which display 35%, sequence identity are both located in the mitochondrial intermembrane space.","label":1}
{"pair_id":"AIMed.d33.s280.p0","sentence":"Suramin induced high-affinity trimerization of ps C8 pe (Kd = 0.10 microM at 20 degrees C) and dimerization of ps C9 pe (Kd = 0.86 microM at 20 degrees C).","label":0}
{"pair_id":"BioInfer.d24.s0.p0","sentence":"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of ps actin-binding protein pe, talin, and ps pp60src pe in response to A23187 (1 microM).","label":0}
{"pair_id":"BioInfer.d24.s0.p1","sentence":"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, ps talin pe, and ps pp60src pe in response to A23187 (1 microM).","label":0}
{"pair_id":"BioInfer.d24.s0.p2","sentence":"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of ps actin-binding protein pe, ps talin pe, and pp60src in response to A23187 (1 microM).","label":0}
{"pair_id":"BioInfer.d650.s1.p0","sentence":"The role of ps profilin pe in ps actin pe polymerization and nucleotide exchange.","label":1}
{"pair_id":"AIMed.d40.s347.p0","sentence":"We have crystallized a complex between human ps FGF1 pe and a two-domain extracellular fragment of human ps FGFR2 pe.","label":1}
{"pair_id":"AIMed.d39.s341.p0","sentence":"By monitoring fluorescent recombinant protein and by gel mobility shift assays, ps PS1 pe was shown to accelerate the translocation of ps QM pe from the cytoplasm to the nucleus and to thereby suppress the binding of c-Jun homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).","label":0}
{"pair_id":"AIMed.d39.s341.p1","sentence":"By monitoring fluorescent recombinant protein and by gel mobility shift assays, ps PS1 pe was shown to accelerate the translocation of QM from the cytoplasm to the nucleus and to thereby suppress the binding of ps c-Jun pe homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).","label":0}
{"pair_id":"AIMed.d39.s341.p2","sentence":"By monitoring fluorescent recombinant protein and by gel mobility shift assays, PS1 was shown to accelerate the translocation of ps QM pe from the cytoplasm to the nucleus and to thereby suppress the binding of ps c-Jun pe homodimer to 12-O-tetradecanoylphorbol-13- acetate (TPA)-responsive element (TRE).","label":0}
{"pair_id":"BioInfer.d111.s0.p0","sentence":"Both pathway cells and superior tarsal smooth muscle cells expressed ps alpha-smooth muscle actin pe and ps smooth muscle myosin heavy chain pe throughout development.","label":0}
{"pair_id":"BioInfer.d569.s0.p0","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, ps desmin pe, and SM myosin heavy chain isoforms, but not ps smoothelin pe.","label":0}
{"pair_id":"BioInfer.d569.s0.p1","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and ps SM myosin heavy chain pe isoforms, but not ps smoothelin pe.","label":0}
{"pair_id":"BioInfer.d569.s0.p2","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed ps alpha-SM actin pe, desmin, and SM myosin heavy chain isoforms, but not ps smoothelin pe.","label":0}
{"pair_id":"BioInfer.d569.s0.p3","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, ps desmin pe, and ps SM myosin heavy chain pe isoforms, but not smoothelin.","label":0}
{"pair_id":"BioInfer.d569.s0.p4","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed ps alpha-SM actin pe, ps desmin pe, and SM myosin heavy chain isoforms, but not smoothelin.","label":0}
{"pair_id":"BioInfer.d569.s0.p5","sentence":"The adventitial tissue underlying PTCA-induced lesions temporarily expressed ps alpha-SM actin pe, desmin, and ps SM myosin heavy chain pe isoforms, but not smoothelin.","label":0}
{"pair_id":"BioInfer.d175.s0.p0","sentence":"Discrete segments (70-150 amino acids) of ps PRT1 pe and TIF35 were found to be responsible for their binding to ps TIF34 pe.","label":1}
{"pair_id":"BioInfer.d175.s0.p1","sentence":"Discrete segments (70-150 amino acids) of ps PRT1 pe and ps TIF35 pe were found to be responsible for their binding to TIF34.","label":0}
{"pair_id":"BioInfer.d175.s0.p2","sentence":"Discrete segments (70-150 amino acids) of PRT1 and ps TIF35 pe were found to be responsible for their binding to ps TIF34 pe.","label":1}
{"pair_id":"AIMed.d49.s436.p0","sentence":"Replacement of this loop with the homologous loop from ps FGF-2 pe dramatically reduced both the affinity of ps FGF-7 pe for KGFR and its biological potency but did not result in the ability to bind FGFR1.","label":0}
{"pair_id":"AIMed.d49.s436.p1","sentence":"Replacement of this loop with the homologous loop from ps FGF-2 pe dramatically reduced both the affinity of FGF-7 for ps KGFR pe and its biological potency but did not result in the ability to bind FGFR1.","label":0}
{"pair_id":"AIMed.d49.s436.p2","sentence":"Replacement of this loop with the homologous loop from ps FGF-2 pe dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind ps FGFR1 pe.","label":0}
{"pair_id":"AIMed.d49.s436.p3","sentence":"Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of ps FGF-7 pe for ps KGFR pe and its biological potency but did not result in the ability to bind FGFR1.","label":1}
{"pair_id":"AIMed.d49.s436.p4","sentence":"Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of ps FGF-7 pe for KGFR and its biological potency but did not result in the ability to bind ps FGFR1 pe.","label":0}
{"pair_id":"AIMed.d49.s436.p5","sentence":"Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of FGF-7 for ps KGFR pe and its biological potency but did not result in the ability to bind ps FGFR1 pe.","label":0}
{"pair_id":"BioInfer.d417.s0.p0","sentence":"Mechanism of regulation of ps actin pe polymerization by Physarum ps profilin pe.","label":1}
{"pair_id":"BioInfer.d114.s0.p0","sentence":"ps RAD52 pe or ps RAD51 pe recombination-deficient yeast strains stabilize otherwise unstable YACs containing ribosomal DNA or the human color vision locus (Kohno et al., 1994).","label":0}
{"pair_id":"AIMed.d209.s1807.p0","sentence":"We now show that full-length ps RIN1 pe interacts with activated ps RAS pe in mammalian cells and defines a minimum region of 434 aa required for efficient RAS binding.","label":1}
{"pair_id":"AIMed.d209.s1807.p1","sentence":"We now show that full-length ps RIN1 pe interacts with activated RAS in mammalian cells and defines a minimum region of 434 aa required for efficient ps RAS pe binding.","label":0}
{"pair_id":"AIMed.d209.s1807.p2","sentence":"We now show that full-length RIN1 interacts with activated ps RAS pe in mammalian cells and defines a minimum region of 434 aa required for efficient ps RAS pe binding.","label":0}
{"pair_id":"BioInfer.d226.s0.p0","sentence":"Further, we show that talin, a high molecular weight structural protein that links ps integrins pe to the ps actin pe cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s0.p1","sentence":"Further, we show that ps talin pe, a high molecular weight structural protein that links ps integrins pe to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.","label":1}
{"pair_id":"BioInfer.d226.s0.p2","sentence":"Further, we show that ps talin pe, a high molecular weight structural protein that links integrins to the ps actin pe cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.","label":1}
{"pair_id":"AIMed.d193.s1648.p0","sentence":"Additional analysis revealed the presence of transcripts for both the activating (ps ITF-2a pe) and inhibitory (ps ITF-2b pe) isoforms in differentiating C2C12 cultures, suggesting that both isoforms might participate in regulating the differentiation process.","label":0}
{"pair_id":"AIMed.d175.s1477.p0","sentence":"ps .CDC37 pe was originally identified as a Start gene in budding yeast and has been shown to be required for association of ps CDC28 pe with cyclins.","label":0}
{"pair_id":"AIMed.d41.s354.p0","sentence":"ps HFE pe binds to the ps transferrin pe receptor (TfR), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p1","sentence":"ps HFE pe binds to the ps transferrin receptor pe (TfR), a receptor by which cells acquire iron-loaded transferrin.","label":1}
{"pair_id":"AIMed.d41.s354.p2","sentence":"ps HFE pe binds to the transferrin receptor (ps TfR pe), a receptor by which cells acquire iron-loaded transferrin.","label":1}
{"pair_id":"AIMed.d41.s354.p3","sentence":"ps HFE pe binds to the transferrin receptor (TfR), a receptor by which cells acquire iron-loaded ps transferrin pe.","label":0}
{"pair_id":"AIMed.d41.s354.p4","sentence":"HFE binds to the ps transferrin peps transferrin receptor pe (TfR), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p5","sentence":"HFE binds to the ps transferrin pe receptor (ps TfR pe), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p6","sentence":"HFE binds to the ps transferrin pe receptor (TfR), a receptor by which cells acquire iron-loaded ps transferrin pe.","label":0}
{"pair_id":"AIMed.d41.s354.p7","sentence":"HFE binds to the ps transferrin receptor pe (ps TfR pe), a receptor by which cells acquire iron-loaded transferrin.","label":0}
{"pair_id":"AIMed.d41.s354.p8","sentence":"HFE binds to the ps transferrin receptor pe (TfR), a receptor by which cells acquire iron-loaded ps transferrin pe.","label":0}
{"pair_id":"AIMed.d41.s354.p9","sentence":"HFE binds to the transferrin receptor (ps TfR pe), a receptor by which cells acquire iron-loaded ps transferrin pe.","label":0}
{"pair_id":"BioInfer.d607.s0.p0","sentence":"The drastic effects of the exogenous ps cofilin pe on ps actin pe assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).","label":1}
{"pair_id":"BioInfer.d683.s0.p0","sentence":"The recombinant material is similar to authentic human ps platelet profilin pe based on the measured Kd for rabbit ps skeletal muscle actin pe.","label":1}
{"pair_id":"AIMed.d204.s1756.p0","sentence":"The catalytic domain of activated ps collagenase I pe (ps MMP-1 pe) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).","label":0}
{"pair_id":"AIMed.d204.s1756.p1","sentence":"The catalytic domain of activated ps collagenase I pe (MMP-1) is absolutely required for interaction with its specific inhibitor, ps tissue inhibitor of metalloproteinases-1 pe (TIMP-1).","label":0}
{"pair_id":"AIMed.d204.s1756.p2","sentence":"The catalytic domain of activated ps collagenase I pe (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (ps TIMP-1 pe).","label":0}
{"pair_id":"AIMed.d204.s1756.p3","sentence":"The catalytic domain of activated collagenase I (ps MMP-1 pe) is absolutely required for interaction with its specific inhibitor, ps tissue inhibitor of metalloproteinases-1 pe (TIMP-1).","label":1}
{"pair_id":"AIMed.d204.s1756.p4","sentence":"The catalytic domain of activated collagenase I (ps MMP-1 pe) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (ps TIMP-1 pe).","label":1}
{"pair_id":"AIMed.d204.s1756.p5","sentence":"The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, ps tissue inhibitor of metalloproteinases-1 pe (ps TIMP-1 pe).","label":0}
{"pair_id":"BioInfer.d295.s0.p0","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to ps alpha-smooth muscle actin pe, smooth muscle myosin heavy chain and ps vimentin pe (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p1","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to ps alpha-smooth muscle actin pe, ps smooth muscle myosin heavy chain pe and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p2","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to ps alpha-smooth muscle actin pe, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to ps desmin pe ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p3","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, ps smooth muscle myosin heavy chain pe and ps vimentin pe (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p4","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and ps vimentin pe (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to ps desmin pe ('-' and '+').","label":0}
{"pair_id":"BioInfer.d295.s0.p5","sentence":"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, ps smooth muscle myosin heavy chain pe and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to ps desmin pe ('-' and '+').","label":0}
{"pair_id":"AIMed.d128.s1098.p0","sentence":"We present here the crystal structure of the 1:1 complex of ps hGH pe bound to the extracellular domain of the ps hPRLR pe.","label":1}
{"pair_id":"AIMed.d131.s1119.p0","sentence":"Expression cloning and characterization of a human ps IL-10 peps IL-10 receptor pe.","label":0}
{"pair_id":"BioInfer.d268.s1.p0","sentence":"Using the two-hybrid system, we show that ps verprolin pe binds ps actin pe.","label":1}
{"pair_id":"BioInfer.d537.s1.p0","sentence":"These findings suggest a role of ps cofilin pe in stimulus-dependent ps actin pe remodeling in motile neutrophils.","label":1}
{"pair_id":"AIMed.d37.s314.p0","sentence":"All CC-chemokines currently available were tested for their ability to compete with [(125)I]-ps MIP-1beta pe binding on a stable cell line expressing recombinant ps CCR5 pe, and\/or to induce a functional response in these cells.","label":0}
{"pair_id":"BioInfer.d787.s0.p0","sentence":"Using ITP (a substrate for myosin II ps ATPase pe) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [ps MHCK pe]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p1","sentence":"Using ITP (a substrate for ps myosin II pe ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [ps MHCK pe]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p2","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [ps MHCK pe]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that ps MHCK pe was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p3","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for ps myosin II heavy-chain kinase pe [ps MHCK pe]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p4","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [ps MHCK pe]), we demonstrated that phosphorylation of ps myosin heavy chains pe occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p5","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [ps MHCK pe]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the ps actin pe network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p6","sentence":"Using ITP (a substrate for ps myosin II pe ps ATPase pe) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":1}
{"pair_id":"BioInfer.d787.s0.p7","sentence":"Using ITP (a substrate for myosin II ps ATPase pe) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that ps MHCK pe was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p8","sentence":"Using ITP (a substrate for myosin II ps ATPase pe) and\/or ATP gamma S (a substrate for ps myosin II heavy-chain kinase pe [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p9","sentence":"Using ITP (a substrate for myosin II ps ATPase pe) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of ps myosin heavy chains pe occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p10","sentence":"Using ITP (a substrate for myosin II ps ATPase pe) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the ps actin pe network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p11","sentence":"Using ITP (a substrate for ps myosin II pe ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that ps MHCK pe was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p12","sentence":"Using ITP (a substrate for ps myosin II pe ATPase) and\/or ATP gamma S (a substrate for ps myosin II heavy-chain kinase pe [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p13","sentence":"Using ITP (a substrate for ps myosin II pe ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of ps myosin heavy chains pe occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p14","sentence":"Using ITP (a substrate for ps myosin II pe ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the ps actin pe network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p15","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for ps myosin II heavy-chain kinase pe [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that ps MHCK pe was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p16","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of ps myosin heavy chains pe occurred at the foci within the actin network, a result that suggests that ps MHCK pe was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p17","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the ps actin pe network, a result that suggests that ps MHCK pe was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p18","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for ps myosin II heavy-chain kinase pe [MHCK]), we demonstrated that phosphorylation of ps myosin heavy chains pe occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p19","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for ps myosin II heavy-chain kinase pe [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the ps actin pe network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"BioInfer.d787.s0.p20","sentence":"Using ITP (a substrate for myosin II ATPase) and\/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of ps myosin heavy chains pe occurred at the foci within the ps actin pe network, a result that suggests that MHCK was localized at the foci.","label":0}
{"pair_id":"AIMed.d220.s1909.p0","sentence":"Interactions between ps brain-derived neurotrophic factor pe and the ps TRKB pe receptor. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p1","sentence":"Interactions between ps brain-derived neurotrophic factor pe and the ps TRKB receptor pe. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking.","label":1}
{"pair_id":"AIMed.d220.s1909.p2","sentence":"Interactions between ps brain-derived neurotrophic factor pe and the TRKB receptor. Identification of two ligand binding domains in soluble ps TRKB pe by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p3","sentence":"Interactions between brain-derived neurotrophic factor and the ps TRKB peps TRKB receptor pe. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p4","sentence":"Interactions between brain-derived neurotrophic factor and the ps TRKB pe receptor. Identification of two ligand binding domains in soluble ps TRKB pe by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"AIMed.d220.s1909.p5","sentence":"Interactions between brain-derived neurotrophic factor and the ps TRKB receptor pe. Identification of two ligand binding domains in soluble ps TRKB pe by affinity separation and chemical cross-linking.","label":0}
{"pair_id":"BioInfer.d49.s2.p0","sentence":"How profilin promotes ps actin pe filament assembly in the presence of ps thymosin beta 4 pe.","label":0}
{"pair_id":"BioInfer.d49.s2.p1","sentence":"How ps profilin pe promotes ps actin pe filament assembly in the presence of thymosin beta 4.","label":1}
{"pair_id":"BioInfer.d49.s2.p2","sentence":"How ps profilin pe promotes actin filament assembly in the presence of ps thymosin beta 4 pe.","label":0}
{"pair_id":"BioInfer.d274.s0.p0","sentence":"However, similar to utrophin, ps alpha-syntrophin pe is only present at the neuromuscular junction in mdx mouse muscle in which ps dystrophin pe is absent.","label":0}
{"pair_id":"BioInfer.d274.s0.p1","sentence":"However, similar to ps utrophin pe, ps alpha-syntrophin pe is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.","label":1}
{"pair_id":"BioInfer.d274.s0.p2","sentence":"However, similar to ps utrophin pe, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which ps dystrophin pe is absent.","label":0}
{"pair_id":"BioInfer.d174.s1.p0","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (ps WASP pe) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of ps verprolin pe.","label":1}
{"pair_id":"BioInfer.d174.s1.p1","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (ps WASP pe) and its homolog expressed in neurons (ps N-WASP pe), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p2","sentence":"Recently, two mammalian proteins previously shown to regulate the ps actin pe cytoskeleton, Wiskott-Aldrich Syndrome Protein (ps WASP pe) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p3","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, ps Wiskott-Aldrich Syndrome Protein pe (ps WASP pe) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.","label":0}
{"pair_id":"BioInfer.d174.s1.p4","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (ps N-WASP pe), were found to possess short peptide motifs homologous to one part of ps verprolin pe.","label":1}
{"pair_id":"BioInfer.d174.s1.p5","sentence":"Recently, two mammalian proteins previously shown to regulate the ps actin pe cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of ps verprolin pe.","label":0}
{"pair_id":"BioInfer.d174.s1.p6","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, ps Wiskott-Aldrich Syndrome Protein pe (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of ps verprolin pe.","label":1}
{"pair_id":"BioInfer.d174.s1.p7","sentence":"Recently, two mammalian proteins previously shown to regulate the ps actin pe cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (ps N-WASP pe), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p8","sentence":"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, ps Wiskott-Aldrich Syndrome Protein pe (WASP) and its homolog expressed in neurons (ps N-WASP pe), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d174.s1.p9","sentence":"Recently, two mammalian proteins previously shown to regulate the ps actin pe cytoskeleton, ps Wiskott-Aldrich Syndrome Protein pe (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.","label":1}
{"pair_id":"BioInfer.d737.s0.p0","sentence":"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in ps sgs1 pe ps srs2 pe mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p1","sentence":"This arrest can be suppressed by mutations in RAD51, ps RAD52 pe, and RAD57, suggesting that the cell cycle defect in ps sgs1 pe srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p2","sentence":"This arrest can be suppressed by mutations in RAD51, RAD52, and ps RAD57 pe, suggesting that the cell cycle defect in ps sgs1 pe srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p3","sentence":"This arrest can be suppressed by mutations in ps RAD51 pe, RAD52, and RAD57, suggesting that the cell cycle defect in ps sgs1 pe srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p4","sentence":"This arrest can be suppressed by mutations in RAD51, ps RAD52 pe, and RAD57, suggesting that the cell cycle defect in sgs1 ps srs2 pe mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p5","sentence":"This arrest can be suppressed by mutations in RAD51, RAD52, and ps RAD57 pe, suggesting that the cell cycle defect in sgs1 ps srs2 pe mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p6","sentence":"This arrest can be suppressed by mutations in ps RAD51 pe, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 ps srs2 pe mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p7","sentence":"This arrest can be suppressed by mutations in RAD51, ps RAD52 pe, and ps RAD57 pe, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p8","sentence":"This arrest can be suppressed by mutations in ps RAD51 pe, ps RAD52 pe, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d737.s0.p9","sentence":"This arrest can be suppressed by mutations in ps RAD51 pe, RAD52, and ps RAD57 pe, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.","label":0}
{"pair_id":"BioInfer.d471.s3.p0","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much ps profilin pe is bound to its known ligands: actin, membrane PIP(2), ps Arp2 pe\/A complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p1","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: ps actin pe, membrane PIP(2), ps Arp2 pe\/A complex and polyproline sequences.","label":0}
{"pair_id":"BioInfer.d471.s3.p2","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), ps Arp2 peps Arp pe2\/ps A pe complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p3","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much ps profilin pe is bound to its known ligands: ps actin pe, membrane PIP(2), Arp2\/A complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p4","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much ps profilin pe is bound to its known ligands: actin, membrane PIP(2), ps Arp pe2\/ps A pe complex and polyproline sequences.","label":1}
{"pair_id":"BioInfer.d471.s3.p5","sentence":"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: ps actin pe, membrane PIP(2), ps Arp pe2\/ps A pe complex and polyproline sequences.","label":0}
{"pair_id":"BioInfer.d35.s3.p0","sentence":"Here, we report that Aip1p also interacts with the ubiquitous ps actin depolymerizing factor pe ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d35.s3.p1","sentence":"Here, we report that ps Aip1p pe also interacts with the ubiquitous ps actin depolymerizing factor pe cofilin.","label":0}
{"pair_id":"BioInfer.d35.s3.p2","sentence":"Here, we report that ps Aip1p pe also interacts with the ubiquitous actin depolymerizing factor ps cofilin pe.","label":1}
{"pair_id":"AIMed.d103.s872.p0","sentence":"Deletion analysis indicates that ps TBP pe and ps hTAFII18 pe bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p1","sentence":"Deletion analysis indicates that ps TBP pe and hTAFII18 bind to distinct domains of ps hTAFII28 pe. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p2","sentence":"Deletion analysis indicates that ps TBP pe and hTAFII18 bind to distinct domains of hTAFII28. ps hTAFII18 pe also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p3","sentence":"Deletion analysis indicates that ps TBP pe and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with ps TBP pe, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p4","sentence":"Deletion analysis indicates that ps TBP pe and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with ps hTAFII28 pe and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p5","sentence":"Deletion analysis indicates that ps TBP pe and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and ps hTAFII30 pe.","label":0}
{"pair_id":"AIMed.d103.s872.p6","sentence":"Deletion analysis indicates that TBP and ps hTAFII18 pe bind to distinct domains of ps hTAFII28 pe. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p7","sentence":"Deletion analysis indicates that TBP and ps hTAFII18 pe bind to distinct domains of hTAFII28. ps hTAFII18 pe also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p8","sentence":"Deletion analysis indicates that TBP and ps hTAFII18 pe bind to distinct domains of hTAFII28. hTAFII18 also interacts with ps TBP pe, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p9","sentence":"Deletion analysis indicates that TBP and ps hTAFII18 pe bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with ps hTAFII28 pe and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p10","sentence":"Deletion analysis indicates that TBP and ps hTAFII18 pe bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and ps hTAFII30 pe.","label":0}
{"pair_id":"AIMed.d103.s872.p11","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of ps hTAFII28 pe. ps hTAFII18 pe also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p12","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of ps hTAFII28 pe. hTAFII18 also interacts with ps TBP pe, but it interacts more strongly with hTAFII28 and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p13","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of ps hTAFII28 pe. hTAFII18 also interacts with TBP, but it interacts more strongly with ps hTAFII28 pe and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p14","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of ps hTAFII28 pe. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and ps hTAFII30 pe.","label":0}
{"pair_id":"AIMed.d103.s872.p15","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. ps hTAFII18 pe also interacts with ps TBP pe, but it interacts more strongly with hTAFII28 and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p16","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. ps hTAFII18 pe also interacts with TBP, but it interacts more strongly with ps hTAFII28 pe and hTAFII30.","label":1}
{"pair_id":"AIMed.d103.s872.p17","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. ps hTAFII18 pe also interacts with TBP, but it interacts more strongly with hTAFII28 and ps hTAFII30 pe.","label":1}
{"pair_id":"AIMed.d103.s872.p18","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with ps TBP pe, but it interacts more strongly with ps hTAFII28 pe and hTAFII30.","label":0}
{"pair_id":"AIMed.d103.s872.p19","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with ps TBP pe, but it interacts more strongly with hTAFII28 and ps hTAFII30 pe.","label":0}
{"pair_id":"AIMed.d103.s872.p20","sentence":"Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with ps hTAFII28 pe and ps hTAFII30 pe.","label":0}
{"pair_id":"BioInfer.d575.s2.p0","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p1","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p2","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, ps beta-catenin pe, and plakoglobin which are independent from the ps cadherin pe-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p3","sentence":"Thus, ps APC pe forms distinct heteromeric complexes containing combinations of alpha-catenin, ps beta-catenin pe, and plakoglobin which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p4","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, ps beta-catenin pe, and plakoglobin which are independent from the cadherin-ps catenin pe complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p5","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p6","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of ps alpha-catenin pe, beta-catenin, and plakoglobin which are independent from the ps cadherin pe-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p7","sentence":"Thus, ps APC pe forms distinct heteromeric complexes containing combinations of ps alpha-catenin pe, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p8","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of ps alpha-catenin pe, beta-catenin, and plakoglobin which are independent from the cadherin-ps catenin pe complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p9","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and ps plakoglobin pe which are independent from the ps cadherin pe-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p10","sentence":"Thus, ps APC pe forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and ps plakoglobin pe which are independent from the cadherin-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p11","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and ps plakoglobin pe which are independent from the cadherin-ps catenin pe complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p12","sentence":"Thus, ps APC pe forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the ps cadherin pe-catenin complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p13","sentence":"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the ps cadherin pe-ps catenin pe complexes.","label":1}
{"pair_id":"BioInfer.d575.s2.p14","sentence":"Thus, ps APC pe forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-ps catenin pe complexes.","label":1}
{"pair_id":"AIMed.d49.s438.p0","sentence":"The reciprocal loop replacement mutant (ps FGF2 pe-L4\/7) retained ps FGF-2 pe like affinity for FGFR1 and for KGFR.","label":0}
{"pair_id":"AIMed.d49.s438.p1","sentence":"The reciprocal loop replacement mutant (ps FGF2 pe-L4\/7) retained FGF-2 like affinity for ps FGFR1 pe and for KGFR.","label":0}
{"pair_id":"AIMed.d49.s438.p2","sentence":"The reciprocal loop replacement mutant (ps FGF2 pe-L4\/7) retained FGF-2 like affinity for FGFR1 and for ps KGFR pe.","label":0}
{"pair_id":"AIMed.d49.s438.p3","sentence":"The reciprocal loop replacement mutant (FGF2-L4\/7) retained ps FGF-2 pe like affinity for ps FGFR1 pe and for KGFR.","label":1}
{"pair_id":"AIMed.d49.s438.p4","sentence":"The reciprocal loop replacement mutant (FGF2-L4\/7) retained ps FGF-2 pe like affinity for FGFR1 and for ps KGFR pe.","label":1}
{"pair_id":"AIMed.d49.s438.p5","sentence":"The reciprocal loop replacement mutant (FGF2-L4\/7) retained FGF-2 like affinity for ps FGFR1 pe and for ps KGFR pe.","label":0}
{"pair_id":"BioInfer.d166.s0.p0","sentence":"Deletion of both RAD50 and ps RAD51 pe produces a phenotype similar to that produced by deletion of ps RAD52 pe.","label":0}
{"pair_id":"BioInfer.d166.s0.p1","sentence":"Deletion of both ps RAD50 pe and ps RAD51 pe produces a phenotype similar to that produced by deletion of RAD52.","label":0}
{"pair_id":"BioInfer.d166.s0.p2","sentence":"Deletion of both ps RAD50 pe and RAD51 produces a phenotype similar to that produced by deletion of ps RAD52 pe.","label":0}
{"pair_id":"BioInfer.d171.s0.p0","sentence":"Detection of loss of heterozygosity at RAD51, ps RAD52 pe, RAD54 and BRCA1 and ps BRCA2 pe loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p1","sentence":"Detection of loss of heterozygosity at RAD51, RAD52, ps RAD54 pe and BRCA1 and ps BRCA2 pe loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p2","sentence":"Detection of loss of heterozygosity at ps RAD51 pe, RAD52, RAD54 and BRCA1 and ps BRCA2 pe loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p3","sentence":"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and ps BRCA1 pe and ps BRCA2 pe loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p4","sentence":"Detection of loss of heterozygosity at RAD51, ps RAD52 pe, ps RAD54 pe and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p5","sentence":"Detection of loss of heterozygosity at ps RAD51 pe, ps RAD52 pe, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p6","sentence":"Detection of loss of heterozygosity at RAD51, ps RAD52 pe, RAD54 and ps BRCA1 pe and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p7","sentence":"Detection of loss of heterozygosity at ps RAD51 pe, RAD52, ps RAD54 pe and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p8","sentence":"Detection of loss of heterozygosity at RAD51, RAD52, ps RAD54 pe and ps BRCA1 pe and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d171.s0.p9","sentence":"Detection of loss of heterozygosity at ps RAD51 pe, RAD52, RAD54 and ps BRCA1 pe and BRCA2 loci in breast cancer: pathological correlations.","label":0}
{"pair_id":"BioInfer.d119.s0.p0","sentence":"By site-directed mutagenesis of ps profilin II pe from Dictyostelium discoideum the point mutations K114E and W3N were generated by PCR thus changing ps actin pe and poly-(L)-proline-binding activity respectively.","label":1}
{"pair_id":"AIMed.d36.s303.p0","sentence":"We further demonstrated that ps apolipoprotein E2 pe and E3 but not ps apolipoprotein E4 pe can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.","label":0}
{"pair_id":"AIMed.d36.s303.p1","sentence":"We further demonstrated that ps apolipoprotein E2 pe and E3 but not apolipoprotein E4 can decrease the fusogenic activity of ps Abeta pe(29-42) via a direct interaction.","label":1}
{"pair_id":"AIMed.d36.s303.p2","sentence":"We further demonstrated that apolipoprotein E2 and E3 but not ps apolipoprotein E4 pe can decrease the fusogenic activity of ps Abeta pe(29-42) via a direct interaction.","label":0}
{"pair_id":"BioInfer.d404.s0.p0","sentence":"Like the ps spectrin alpha-chain pe, the major central part of the ps spectrin beta-chain pe is made up of repeat units of 106 amino-acids.","label":0}
{"pair_id":"AIMed.d214.s1865.p0","sentence":"These data imply that ps c-Cbl pe is a molecular adapter that regulates the function of ps Vav pe in thymocytes and peripheral T cells.","label":0}
{"pair_id":"AIMed.d90.s764.p0","sentence":"Multiple proteins physically interact with ps PU.1 pe. Transcriptional synergy with ps NF-IL6 beta pe (C\/EBP delta, CRP3).","label":0}
{"pair_id":"AIMed.d90.s764.p1","sentence":"Multiple proteins physically interact with ps PU.1 pe. Transcriptional synergy with NF-IL6 beta (C\/ps EBP delta pe, CRP3).","label":0}
{"pair_id":"AIMed.d90.s764.p2","sentence":"Multiple proteins physically interact with ps PU.1 pe. Transcriptional synergy with NF-IL6 beta (C\/EBP delta, ps CRP3 pe).","label":0}
{"pair_id":"AIMed.d90.s764.p3","sentence":"Multiple proteins physically interact with PU.1. Transcriptional synergy with ps NF-IL6 beta pe (C\/ps EBP delta pe, CRP3).","label":0}
{"pair_id":"AIMed.d90.s764.p4","sentence":"Multiple proteins physically interact with PU.1. Transcriptional synergy with ps NF-IL6 beta pe (C\/EBP delta, ps CRP3 pe).","label":0}
{"pair_id":"AIMed.d90.s764.p5","sentence":"Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C\/ps EBP delta pe, ps CRP3 pe).","label":0}
{"pair_id":"AIMed.d74.s631.p0","sentence":"When transfected into COS cells the cloned cDNA directed the expression of a ps GM-CSF-R pe showing a single class of affinity (KD = 2(-8) nM) and specificity for human ps GM-CSF pe but not interleukin-3.","label":1}
{"pair_id":"AIMed.d74.s631.p1","sentence":"When transfected into COS cells the cloned cDNA directed the expression of a ps GM-CSF-R pe showing a single class of affinity (KD = 2(-8) nM) and specificity for human GM-CSF but not ps interleukin-3 pe.","label":0}
{"pair_id":"AIMed.d74.s631.p2","sentence":"When transfected into COS cells the cloned cDNA directed the expression of a GM-CSF-R showing a single class of affinity (KD = 2(-8) nM) and specificity for human ps GM-CSF pe but not ps interleukin-3 pe.","label":0}
{"pair_id":"AIMed.d103.s868.p0","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p1","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p2","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p3","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p4","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p5","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p6","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p7","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p8","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p9","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p10","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p11","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p12","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p13","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p14","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p15","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p16","sentence":"We have cloned cDNAs encoding three novel TAFIIs [ps TATA-binding protein pe (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p17","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p18","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p19","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p20","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p21","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p22","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p23","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p24","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p25","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p26","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p27","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p28","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p29","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p30","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p31","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p32","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (ps TBP pe)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p33","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p34","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p35","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p36","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p37","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p38","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p39","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p40","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p41","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p42","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p43","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p44","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p45","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p46","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p47","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell ps TFIID pe complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p48","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p49","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p50","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p51","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p52","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p53","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p54","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p55","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p56","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p57","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p58","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p59","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p60","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p61","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes ps hTAFII28 pe, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p62","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p63","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p64","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p65","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p66","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p67","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p68","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p69","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p70","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p71","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p72","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p73","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p74","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, ps hTAFII20 pe and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p75","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p76","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p77","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p78","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p79","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p80","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p81","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p82","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p83","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p84","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p85","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p86","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and ps hTAFII18 pe. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p87","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p88","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p89","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p90","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p91","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p92","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p93","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p94","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p95","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p96","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p97","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. ps hTAFII28 pe is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p98","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p99","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p100","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p101","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p102","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p103","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p104","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p105","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p106","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p107","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core ps hTAFII pe present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p108","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p109","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p110","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p111","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p112","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p113","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p114","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p115","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p116","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described ps hTFIID pe species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p117","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p118","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p119","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p120","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p121","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p122","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p123","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p124","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain ps hTAFII30 pe (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p125","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID peps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p126","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p127","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p128","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p129","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p130","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p131","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID pe alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p132","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p133","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p134","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p135","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p136","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p137","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (ps hTFIID alpha pe and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p138","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID peps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p139","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p140","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p141","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p142","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID pe beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p143","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p144","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p145","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p146","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and ps hTFIID beta pe respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p147","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p148","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p149","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)ps TAFII30 beta pe. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p150","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p151","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. ps hTAFII18 pe is a novel hTAFII which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"AIMed.d103.s868.p152","sentence":"We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel ps hTAFII pe which shows homology to the N-terminal region of the yeast ps TAFIISPT3 pe, but has no known Drosophila counterpart.","label":0}
{"pair_id":"BioInfer.d528.s0.p0","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as ps actin pe (43 kDa Mr), myosin heavy chain (195 kDa Mr), ps spectrin pe (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p1","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), ps spectrin pe (235 and 240 kDa Mr), and ps tubulin pe (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p2","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), ps myosin heavy chain pe (195 kDa Mr), ps spectrin pe (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p3","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as ps actin pe (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and ps tubulin pe (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p4","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as ps actin pe (43 kDa Mr), ps myosin heavy chain pe (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d528.s0.p5","sentence":"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), ps myosin heavy chain pe (195 kDa Mr), spectrin (235 and 240 kDa Mr), and ps tubulin pe (51-54 kDa Mr).","label":0}
{"pair_id":"BioInfer.d815.s0.p0","sentence":"We have shown that these proteins are indeed ps nuclear basic proteins pe: the 14 kd is the histone H4, the 19 kd is the ps histone pe H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p1","sentence":"We have shown that these proteins are indeed ps nuclear basic proteins pe: the 14 kd is the ps histone pe H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p2","sentence":"We have shown that these proteins are indeed ps nuclear basic proteins pe: the 14 kd is the histone ps H4 pe, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p3","sentence":"We have shown that these proteins are indeed ps nuclear basic proteins pe: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein ps SP2 pe.","label":1}
{"pair_id":"BioInfer.d815.s0.p4","sentence":"We have shown that these proteins are indeed ps nuclear basic proteins pe: the 14 kd is the histone H4, the 19 kd is the histone ps H3 pe, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p5","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the ps histone pe H4, the 19 kd is the ps histone pe H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p6","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone ps H4 pe, the 19 kd is the ps histone pe H3, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p7","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the ps histone pe H3, and the 25 kd is the sperm-specific protein ps SP2 pe.","label":0}
{"pair_id":"BioInfer.d815.s0.p8","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the ps histone pe ps H3 pe, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p9","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the ps histone pe ps H4 pe, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.","label":1}
{"pair_id":"BioInfer.d815.s0.p10","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the ps histone pe H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein ps SP2 pe.","label":0}
{"pair_id":"BioInfer.d815.s0.p11","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the ps histone pe H4, the 19 kd is the histone ps H3 pe, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p12","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone ps H4 pe, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein ps SP2 pe.","label":0}
{"pair_id":"BioInfer.d815.s0.p13","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone ps H4 pe, the 19 kd is the histone ps H3 pe, and the 25 kd is the sperm-specific protein SP2.","label":0}
{"pair_id":"BioInfer.d815.s0.p14","sentence":"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone ps H3 pe, and the 25 kd is the sperm-specific protein ps SP2 pe.","label":0}
{"pair_id":"AIMed.d30.s255.p0","sentence":"We also found another ps armadillo-protein pe, ps p0071 pe, interacted with PS1.","label":0}
{"pair_id":"AIMed.d30.s255.p1","sentence":"We also found another ps armadillo-protein pe, p0071, interacted with ps PS1 pe.","label":0}
{"pair_id":"AIMed.d30.s255.p2","sentence":"We also found another armadillo-protein, ps p0071 pe, interacted with ps PS1 pe.","label":1}
{"pair_id":"BioInfer.d474.s0.p0","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that ps Stat1 pe could directly interact with TNFR1 and ps TRADD pe but not with FADD.","label":1}
{"pair_id":"BioInfer.d474.s0.p1","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that ps Stat1 pe could directly interact with ps TNFR1 pe and TRADD but not with FADD.","label":1}
{"pair_id":"BioInfer.d474.s0.p2","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that ps Stat1 pe could directly interact with TNFR1 and TRADD but not with ps FADD pe.","label":1}
{"pair_id":"BioInfer.d474.s0.p3","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with ps TNFR1 pe and ps TRADD pe but not with FADD.","label":0}
{"pair_id":"BioInfer.d474.s0.p4","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and ps TRADD pe but not with ps FADD pe.","label":0}
{"pair_id":"BioInfer.d474.s0.p5","sentence":"Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with ps TNFR1 pe and TRADD but not with ps FADD pe.","label":0}
{"pair_id":"BioInfer.d451.s0.p0","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the ps Rho pe and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p1","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the ps Rho pe and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p2","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the ps Rho pe and Rac families, the translational regulator ps RAFT1 pe, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p3","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the ps Rho pe and Rac families, the translational regulator RAFT1, and actin-binding proteins like ps profilin pe might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p4","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the ps Rho pe and Rac families, the translational regulator RAFT1, and ps actin-binding proteins pe like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p5","sentence":"Newly disclosed interactions between ps gephyrin pe, exchange factors for G proteins of the ps Rho pe and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p6","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the ps Rho pe and ps Rac pe families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p7","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins peps G proteins pe of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p8","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator ps RAFT1 pe, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p9","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like ps profilin pe might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p10","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator RAFT1, and ps actin-binding proteins pe like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p11","sentence":"Newly disclosed interactions between ps gephyrin pe, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p12","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and ps Rac pe families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p13","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator ps RAFT1 pe, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p14","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like ps profilin pe might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p15","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator RAFT1, and ps actin-binding proteins pe like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p16","sentence":"Newly disclosed interactions between ps gephyrin pe, exchange factors for ps G proteins pe of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p17","sentence":"Newly disclosed interactions between gephyrin, exchange factors for ps G proteins pe of the Rho and ps Rac pe families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p18","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator ps RAFT1 pe, and actin-binding proteins like ps profilin pe might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p19","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator ps RAFT1 pe, and ps actin-binding proteins pe like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p20","sentence":"Newly disclosed interactions between ps gephyrin pe, exchange factors for G proteins of the Rho and Rac families, the translational regulator ps RAFT1 pe, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p21","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and ps Rac pe families, the translational regulator ps RAFT1 pe, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p22","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and ps actin-binding proteins pe like ps profilin pe might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p23","sentence":"Newly disclosed interactions between ps gephyrin pe, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like ps profilin pe might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p24","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and ps Rac pe families, the translational regulator RAFT1, and actin-binding proteins like ps profilin pe might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p25","sentence":"Newly disclosed interactions between ps gephyrin pe, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and ps actin-binding proteins pe like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":1}
{"pair_id":"BioInfer.d451.s0.p26","sentence":"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and ps Rac pe families, the translational regulator RAFT1, and ps actin-binding proteins pe like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d451.s0.p27","sentence":"Newly disclosed interactions between ps gephyrin pe, exchange factors for G proteins of the Rho and ps Rac pe families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.","label":0}
{"pair_id":"BioInfer.d596.s0.p0","sentence":"The comparison of ps E-CD pe proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d596.s0.p1","sentence":"The comparison of ps E-CD pe proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, ps beta-catenin pe, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d596.s0.p2","sentence":"The comparison of ps E-CD pe proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with ps alpha-catenin pe, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d596.s0.p3","sentence":"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d596.s0.p4","sentence":"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d596.s0.p5","sentence":"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin.","label":0}
{"pair_id":"AIMed.d118.s997.p0","sentence":"The ps p53 pe tumour-suppressor protein controls the expression of a gene encoding the ps p21 pe cyclin-dependent protein kinase (CDK) regulator.","label":0}
{"pair_id":"AIMed.d70.s601.p0","sentence":"These data suggest that anchoring proteins interact with ps RII peps RII alpha pe via an amphipathic helix binding motif.","label":0}
{"pair_id":"AIMed.d44.s383.p0","sentence":"Using a soluble ps CD30L pe\/ps CD8alpha pe chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p1","sentence":"Using a soluble ps CD30L pe\/CD8alpha chimeric protein, we assessed the ability of anti-ps CD30 pe MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p2","sentence":"Using a soluble ps CD30L pe\/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of ps CD30L pe to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p3","sentence":"Using a soluble ps CD30L pe\/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to ps CD30 pe expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p4","sentence":"Using a soluble CD30L\/ps CD8alpha pe chimeric protein, we assessed the ability of anti-ps CD30 pe MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p5","sentence":"Using a soluble CD30L\/ps CD8alpha pe chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of ps CD30L pe to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p6","sentence":"Using a soluble CD30L\/ps CD8alpha pe chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to ps CD30 pe expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p7","sentence":"Using a soluble CD30L\/CD8alpha chimeric protein, we assessed the ability of anti-ps CD30 pe MAb to inhibit the binding of ps CD30L pe to CD30 expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p8","sentence":"Using a soluble CD30L\/CD8alpha chimeric protein, we assessed the ability of anti-ps CD30 pe MAb to inhibit the binding of CD30L to ps CD30 pe expressed by the CD30+ Karpas 299 cell line.","label":0}
{"pair_id":"AIMed.d44.s383.p9","sentence":"Using a soluble CD30L\/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of ps CD30L pe to ps CD30 pe expressed by the CD30+ Karpas 299 cell line.","label":1}
{"pair_id":"AIMed.d161.s1355.p0","sentence":"ps SHPTP2 pe associates with the ps platelet-derived growth factor pe (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p1","sentence":"ps SHPTP2 pe associates with the platelet-derived growth factor (ps PDGF pe) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p2","sentence":"ps SHPTP2 pe associates with the ps platelet-derived growth factor (PDGF) receptor pe after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":1}
{"pair_id":"AIMed.d161.s1355.p3","sentence":"ps SHPTP2 pe associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of ps SHPTP2 pe to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p4","sentence":"ps SHPTP2 pe associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of ps SHPTP2 pe.","label":0}
{"pair_id":"AIMed.d161.s1355.p5","sentence":"SHPTP2 associates with the ps platelet-derived growth factor pe (ps PDGF pe) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p6","sentence":"SHPTP2 associates with the ps platelet-derived growth factor peps platelet-derived growth factor (PDGF) receptor pe after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p7","sentence":"SHPTP2 associates with the ps platelet-derived growth factor pe (PDGF) receptor after ligand stimulation, and binding of ps SHPTP2 pe to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p8","sentence":"SHPTP2 associates with the ps platelet-derived growth factor pe (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of ps SHPTP2 pe.","label":0}
{"pair_id":"AIMed.d161.s1355.p9","sentence":"SHPTP2 associates with the ps platelet-derived growth factor (PDGF) receptor peps PDGF pe) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p10","sentence":"SHPTP2 associates with the platelet-derived growth factor (ps PDGF pe) receptor after ligand stimulation, and binding of ps SHPTP2 pe to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p11","sentence":"SHPTP2 associates with the platelet-derived growth factor (ps PDGF pe) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of ps SHPTP2 pe.","label":0}
{"pair_id":"AIMed.d161.s1355.p12","sentence":"SHPTP2 associates with the ps platelet-derived growth factor (PDGF) receptor pe after ligand stimulation, and binding of ps SHPTP2 pe to this receptor promotes tyrosine phosphorylation of SHPTP2.","label":0}
{"pair_id":"AIMed.d161.s1355.p13","sentence":"SHPTP2 associates with the ps platelet-derived growth factor (PDGF) receptor pe after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of ps SHPTP2 pe.","label":0}
{"pair_id":"AIMed.d161.s1355.p14","sentence":"SHPTP2 associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of ps SHPTP2 pe to this receptor promotes tyrosine phosphorylation of ps SHPTP2 pe.","label":0}
{"pair_id":"AIMed.d60.s525.p0","sentence":"Activation of ps mitogen-activated protein kinase peps mitogen-activated protein kinase kinase pe by v-Raf in NIH 3T3 cells and in vitro.","label":0}
{"pair_id":"AIMed.d60.s525.p1","sentence":"Activation of ps mitogen-activated protein kinase pe kinase by ps v-Raf pe in NIH 3T3 cells and in vitro.","label":0}
{"pair_id":"AIMed.d60.s525.p2","sentence":"Activation of ps mitogen-activated protein kinase kinase pe by ps v-Raf pe in NIH 3T3 cells and in vitro.","label":1}
{"pair_id":"BioInfer.d256.s0.p0","sentence":"Here, we sought to determine the spatial distributions of ps E-cadherin pe, alpha-catenin, ps beta-catenin pe, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p1","sentence":"Here, we sought to determine the spatial distributions of E-cadherin, ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p2","sentence":"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p3","sentence":"Here, we sought to determine the spatial distributions of ps E-cadherin pe, ps alpha-catenin pe, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p4","sentence":"Here, we sought to determine the spatial distributions of ps E-cadherin pe, alpha-catenin, beta-catenin, and ps plakoglobin pe, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"BioInfer.d256.s0.p5","sentence":"Here, we sought to determine the spatial distributions of E-cadherin, ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.","label":0}
{"pair_id":"AIMed.d69.s587.p0","sentence":"In resting human epithelial and fibroblastic cells, ps c-Jun pe is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by ps glycogen synthase kinase 3 pe (GSK-3).","label":1}
{"pair_id":"AIMed.d69.s587.p1","sentence":"In resting human epithelial and fibroblastic cells, ps c-Jun pe is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by glycogen synthase kinase 3 (ps GSK-3 pe).","label":1}
{"pair_id":"AIMed.d69.s587.p2","sentence":"In resting human epithelial and fibroblastic cells, c-Jun is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by ps glycogen synthase kinase 3 pe (ps GSK-3 pe).","label":0}
{"pair_id":"BioInfer.d43.s2.p0","sentence":"Co-localization of ps glucokinase pe with ps actin pe filaments.","label":1}
{"pair_id":"AIMed.d224.s1954.p0","sentence":"Our results also show that, although these ps HLA-E pe binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the ps TAP pe complex and loaded onto HLA-E molecules.","label":0}
{"pair_id":"AIMed.d224.s1954.p1","sentence":"Our results also show that, although these ps HLA-E pe binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto ps HLA-E pe molecules.","label":0}
{"pair_id":"AIMed.d224.s1954.p2","sentence":"Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the ps TAP pe complex and loaded onto ps HLA-E pe molecules.","label":0}
{"pair_id":"BioInfer.d285.s0.p0","sentence":"Immediately after synthesis, E-cadherin, ps beta-catenin pe, and ps plakoglobin pe cosedimented as complexes.","label":1}
{"pair_id":"BioInfer.d285.s0.p1","sentence":"Immediately after synthesis, ps E-cadherin pe, ps beta-catenin pe, and plakoglobin cosedimented as complexes.","label":1}
{"pair_id":"BioInfer.d285.s0.p2","sentence":"Immediately after synthesis, ps E-cadherin pe, beta-catenin, and ps plakoglobin pe cosedimented as complexes.","label":1}
{"pair_id":"AIMed.d142.s1203.p0","sentence":"The physical interaction between ps YY1 pe and ps Sp1 pe may thus form the basis for the functional interplay observed previously.","label":1}
{"pair_id":"BioInfer.d153.s0.p0","sentence":"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in ps actin pe cytoarchitecture and the distribution of focal contact proteins vinculin and ps talin pe.","label":0}
{"pair_id":"BioInfer.d153.s0.p1","sentence":"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in ps actin pe cytoarchitecture and the distribution of focal contact proteins ps vinculin pe and talin.","label":0}
{"pair_id":"BioInfer.d153.s0.p2","sentence":"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins ps vinculin pe and ps talin pe.","label":0}
{"pair_id":"AIMed.d205.s1771.p0","sentence":"We investigated whether ps phosphatidylinositol (PI) 3-kinase pe, which binds to tyrosine-phosphorylated ps ITAM pe, interacts with CD5 following T cell activation.","label":1}
{"pair_id":"AIMed.d205.s1771.p1","sentence":"We investigated whether ps phosphatidylinositol (PI) 3-kinase pe, which binds to tyrosine-phosphorylated ITAM, interacts with ps CD5 pe following T cell activation.","label":0}
{"pair_id":"AIMed.d205.s1771.p2","sentence":"We investigated whether phosphatidylinositol (PI) 3-kinase, which binds to tyrosine-phosphorylated ps ITAM pe, interacts with ps CD5 pe following T cell activation.","label":0}
{"pair_id":"AIMed.d198.s1688.p0","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as ps EPO peps EPO binding protein pe, EBP) of the EPOR.","label":0}
{"pair_id":"AIMed.d198.s1688.p1","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as ps EPO pe binding protein, ps EBP pe) of the EPOR.","label":1}
{"pair_id":"AIMed.d198.s1688.p2","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as ps EPO pe binding protein, EBP) of the ps EPOR pe.","label":0}
{"pair_id":"AIMed.d198.s1688.p3","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as ps EPO binding protein pe, ps EBP pe) of the EPOR.","label":0}
{"pair_id":"AIMed.d198.s1688.p4","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as ps EPO binding protein pe, EBP) of the ps EPOR pe.","label":0}
{"pair_id":"AIMed.d198.s1688.p5","sentence":"We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as EPO binding protein, ps EBP pe) of the ps EPOR pe.","label":0}
{"pair_id":"AIMed.d25.s212.p0","sentence":"Determination of ps TNFalpha pe, complement factors ps C3 pe and C4, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p1","sentence":"Determination of ps TNFalpha pe, complement factors C3 and ps C4 pe, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p2","sentence":"Determination of ps TNFalpha pe, complement factors C3 and C4, and ps alpha1AT pe may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p3","sentence":"Determination of TNFalpha, complement factors ps C3 pe and ps C4 pe, and alpha1AT may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p4","sentence":"Determination of TNFalpha, complement factors ps C3 pe and C4, and ps alpha1AT pe may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d25.s212.p5","sentence":"Determination of TNFalpha, complement factors C3 and ps C4 pe, and ps alpha1AT pe may be a significant parameter in the differential diagnosis of serous effusions, particularly in those patients with malignant disease.","label":0}
{"pair_id":"AIMed.d217.s1882.p0","sentence":"Based on the structure of the closely related ps lymphotoxin alpha pe-ps tumor necrosis factor receptor I pe complex, a molecular model of the FasL homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.","label":1}
{"pair_id":"AIMed.d217.s1882.p1","sentence":"Based on the structure of the closely related ps lymphotoxin alpha pe-tumor necrosis factor receptor I complex, a molecular model of the ps FasL pe homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p2","sentence":"Based on the structure of the closely related ps lymphotoxin alpha pe-tumor necrosis factor receptor I complex, a molecular model of the FasL homotrimer bound to three ps Fas pe molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p3","sentence":"Based on the structure of the closely related lymphotoxin alpha-ps tumor necrosis factor receptor I pe complex, a molecular model of the ps FasL pe homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p4","sentence":"Based on the structure of the closely related lymphotoxin alpha-ps tumor necrosis factor receptor I pe complex, a molecular model of the FasL homotrimer bound to three ps Fas pe molecules was generated using knowledge-based protein modeling methods.","label":0}
{"pair_id":"AIMed.d217.s1882.p5","sentence":"Based on the structure of the closely related lymphotoxin alpha-tumor necrosis factor receptor I complex, a molecular model of the ps FasL pe homotrimer bound to three ps Fas pe molecules was generated using knowledge-based protein modeling methods.","label":1}
{"pair_id":"AIMed.d120.s1020.p0","sentence":"Immunoblotting studies were used to confirm the binding of ps FXIII pe from fresh platelet lysates to the ps HSP27 pe fusion protein.","label":1}
{"pair_id":"BioInfer.d85.s0.p0","sentence":"Associations of UBE2I with RAD52, ps UBL1 pe, p53, and ps RAD51 pe proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p1","sentence":"Associations of UBE2I with ps RAD52 pe, ps UBL1 pe, p53, and RAD51 proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p2","sentence":"Associations of ps UBE2I pe with RAD52, ps UBL1 pe, p53, and RAD51 proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d85.s0.p3","sentence":"Associations of UBE2I with RAD52, ps UBL1 pe, ps p53 pe, and RAD51 proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p4","sentence":"Associations of UBE2I with ps RAD52 pe, UBL1, p53, and ps RAD51 pe proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p5","sentence":"Associations of ps UBE2I pe with RAD52, UBL1, p53, and ps RAD51 pe proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d85.s0.p6","sentence":"Associations of UBE2I with RAD52, UBL1, ps p53 pe, and ps RAD51 pe proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p7","sentence":"Associations of ps UBE2I pe with ps RAD52 pe, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"BioInfer.d85.s0.p8","sentence":"Associations of UBE2I with ps RAD52 pe, UBL1, ps p53 pe, and RAD51 proteins in a yeast two-hybrid system.","label":0}
{"pair_id":"BioInfer.d85.s0.p9","sentence":"Associations of ps UBE2I pe with RAD52, UBL1, ps p53 pe, and RAD51 proteins in a yeast two-hybrid system.","label":1}
{"pair_id":"AIMed.d180.s1532.p0","sentence":"ps GAP-43 pe (ps neuromodulin pe, B-50, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p1","sentence":"ps GAP-43 pe (neuromodulin, ps B-50 pe, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p2","sentence":"ps GAP-43 pe (neuromodulin, B-50, ps F1 pe), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p3","sentence":"ps GAP-43 pe (neuromodulin, B-50, F1), a ps protein kinase C pe (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p4","sentence":"ps GAP-43 pe (neuromodulin, B-50, F1), a protein kinase C (ps PKC pe) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p5","sentence":"GAP-43 (ps neuromodulin pe, ps B-50 pe, F1), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p6","sentence":"GAP-43 (ps neuromodulin pe, B-50, ps F1 pe), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p7","sentence":"GAP-43 (ps neuromodulin pe, B-50, F1), a ps protein kinase C pe (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p8","sentence":"GAP-43 (ps neuromodulin pe, B-50, F1), a protein kinase C (ps PKC pe) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p9","sentence":"GAP-43 (neuromodulin, ps B-50 pe, ps F1 pe), a protein kinase C (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"AIMed.d180.s1532.p10","sentence":"GAP-43 (neuromodulin, ps B-50 pe, F1), a ps protein kinase C pe (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p11","sentence":"GAP-43 (neuromodulin, ps B-50 pe, F1), a protein kinase C (ps PKC pe) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p12","sentence":"GAP-43 (neuromodulin, B-50, ps F1 pe), a ps protein kinase C pe (PKC) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p13","sentence":"GAP-43 (neuromodulin, B-50, ps F1 pe), a protein kinase C (ps PKC pe) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":1}
{"pair_id":"AIMed.d180.s1532.p14","sentence":"GAP-43 (neuromodulin, B-50, F1), a ps protein kinase C pe (ps PKC pe) substrate important for the growth and plasticity of neuronal connections, has been implicated in vitro in several signal transduction pathways.","label":0}
{"pair_id":"BioInfer.d77.s0.p0","sentence":"ps Arp2 pe\/A complex from Acanthamoeba binds ps profilin pe and cross-links actin filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p1","sentence":"ps Arp pe2\/ps A pe complex from Acanthamoeba binds ps profilin pe and cross-links actin filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p2","sentence":"Arp2\/A complex from Acanthamoeba binds ps profilin pe and cross-links ps actin pe filaments.","label":0}
{"pair_id":"BioInfer.d77.s0.p3","sentence":"ps Arp2 peps Arp pe2\/ps A pe complex from Acanthamoeba binds profilin and cross-links actin filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p4","sentence":"ps Arp2 pe\/A complex from Acanthamoeba binds profilin and cross-links ps actin pe filaments.","label":1}
{"pair_id":"BioInfer.d77.s0.p5","sentence":"ps Arp pe2\/ps A pe complex from Acanthamoeba binds profilin and cross-links ps actin pe filaments.","label":1}
{"pair_id":"AIMed.d46.s403.p0","sentence":"ps Bone morphogenetic protein-2 pe (ps BMP-2 pe) induces bone formation and regeneration in adult vertebrates and regulates important developmental processes in all animals.","label":0}
{"pair_id":"AIMed.d132.s1128.p0","sentence":"Functional participation of the ps IL-2 peps IL-2 receptor gamma pe chain in IL-7 receptor complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p1","sentence":"Functional participation of the ps IL-2 pe receptor gamma chain in ps IL-7 pe receptor complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p2","sentence":"Functional participation of the ps IL-2 pe receptor gamma chain in ps IL-7 receptor pe complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p3","sentence":"Functional participation of the ps IL-2 receptor gamma pe chain in ps IL-7 pe receptor complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p4","sentence":"Functional participation of the ps IL-2 receptor gamma pe chain in ps IL-7 receptor pe complexes.","label":0}
{"pair_id":"AIMed.d132.s1128.p5","sentence":"Functional participation of the IL-2 receptor gamma chain in ps IL-7 peps IL-7 receptor pe complexes.","label":0}
{"pair_id":"BioInfer.d134.s0.p0","sentence":"Changes in beta-catenin binding to ps cadherin pe or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d134.s0.p1","sentence":"Changes in ps beta-catenin pe binding to ps cadherin pe or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d134.s0.p2","sentence":"Changes in beta-catenin binding to ps cadherin pe or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of ps beta-catenin pe binding to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d134.s0.p3","sentence":"Changes in beta-catenin binding to ps cadherin pe or ps APC pe protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d134.s0.p4","sentence":"Changes in ps beta-catenin pe binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to ps alpha-catenin pe.","label":1}
{"pair_id":"BioInfer.d134.s0.p5","sentence":"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of ps beta-catenin pe binding to ps alpha-catenin pe.","label":1}
{"pair_id":"BioInfer.d134.s0.p6","sentence":"Changes in beta-catenin binding to cadherin or ps APC pe protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d134.s0.p7","sentence":"Changes in ps beta-catenin pe binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of ps beta-catenin pe binding to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d134.s0.p8","sentence":"Changes in ps beta-catenin pe binding to cadherin or ps APC pe protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.","label":1}
{"pair_id":"BioInfer.d134.s0.p9","sentence":"Changes in beta-catenin binding to cadherin or ps APC pe protein, and the ensuing effects on cell morphology and adhesion, are independent of ps beta-catenin pe binding to alpha-catenin.","label":0}
{"pair_id":"BioInfer.d245.s0.p0","sentence":"Here we have now identified the reciprocal complementary binding site in ps alpha-catenin pe which mediates its interaction with ps beta-catenin pe and plakoglobin.","label":1}
{"pair_id":"BioInfer.d245.s0.p1","sentence":"Here we have now identified the reciprocal complementary binding site in ps alpha-catenin pe which mediates its interaction with beta-catenin and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d245.s0.p2","sentence":"Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with ps beta-catenin pe and ps plakoglobin pe.","label":0}
{"pair_id":"AIMed.d116.s981.p0","sentence":"This last observation was confirmed by affinity chromatography and immunoprecipitation, which demonstrated an interaction between ps Rb pe and ps UBF pe.","label":1}
{"pair_id":"BioInfer.d807.s0.p0","sentence":"We have analyzed the expression levels of the genes encoding ps alpha-catenin pe, beta-catenin and ps plakoglobin pe in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p1","sentence":"We have analyzed the expression levels of the genes encoding ps alpha-catenin pe, ps beta-catenin pe and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p2","sentence":"We have analyzed the expression levels of the genes encoding ps alpha-catenin pe, beta-catenin and plakoglobin in correlation to the ps E-cadherin pe expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p3","sentence":"We have analyzed the expression levels of the genes encoding alpha-catenin, ps beta-catenin pe and ps plakoglobin pe in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p4","sentence":"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and ps plakoglobin pe in correlation to the ps E-cadherin pe expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"BioInfer.d807.s0.p5","sentence":"We have analyzed the expression levels of the genes encoding alpha-catenin, ps beta-catenin pe and plakoglobin in correlation to the ps E-cadherin pe expression levels in cell lines derived from human cervical carcinomas.","label":0}
{"pair_id":"AIMed.d206.s1781.p0","sentence":"There was extensive co-localisation of ps CD9 pe and beta 1 integrins on microvilli and at cell-cell borders of basal keratinocytes; however, in contrast to the integrins, ps CD9 pe was not found in focal adhesions.","label":0}
{"pair_id":"BioInfer.d183.s0.p0","sentence":"Dynamic ps actin pe structures stabilized by ps profilin pe.","label":1}
{"pair_id":"AIMed.d176.s1483.p0","sentence":"Interactions of ps p60 pe, a mediator of ps progesterone receptor pe assembly, with heat shock proteins hsp90 and hsp70.","label":0}
{"pair_id":"AIMed.d176.s1483.p1","sentence":"Interactions of ps p60 pe, a mediator of progesterone receptor assembly, with heat shock proteins ps hsp90 pe and hsp70.","label":1}
{"pair_id":"AIMed.d176.s1483.p2","sentence":"Interactions of ps p60 pe, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and ps hsp70 pe.","label":1}
{"pair_id":"AIMed.d176.s1483.p3","sentence":"Interactions of p60, a mediator of ps progesterone receptor pe assembly, with heat shock proteins ps hsp90 pe and hsp70.","label":0}
{"pair_id":"AIMed.d176.s1483.p4","sentence":"Interactions of p60, a mediator of ps progesterone receptor pe assembly, with heat shock proteins hsp90 and ps hsp70 pe.","label":0}
{"pair_id":"AIMed.d176.s1483.p5","sentence":"Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins ps hsp90 pe and ps hsp70 pe.","label":0}
{"pair_id":"BioInfer.d764.s0.p0","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, ps HHF35 pe and CGA7, and two anti-SMC myosin heavy chain markers, anti-ps SM1 pe and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p1","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, ps HHF35 pe and CGA7, and two anti-ps SMC myosin heavy chain pe markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p2","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, ps HHF35 pe and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-ps SM2 pe antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p3","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, ps HHF35 pe and ps CGA7 pe, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p4","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antips muscle actin pe antibodies, ps HHF35 pe and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":1}
{"pair_id":"BioInfer.d764.s0.p5","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-ps SMC myosin heavy chain pe markers, anti-ps SM1 pe and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p6","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-ps SM1 pe and anti-ps SM2 pe antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p7","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and ps CGA7 pe, and two anti-SMC myosin heavy chain markers, anti-ps SM1 pe and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p8","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antips muscle actin pe antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-ps SM1 pe and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p9","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-ps SMC myosin heavy chain pe markers, anti-SM1 and anti-ps SM2 pe antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p10","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and ps CGA7 pe, and two anti-ps SMC myosin heavy chain pe markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p11","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antips muscle actin pe antibodies, HHF35 and CGA7, and two anti-ps SMC myosin heavy chain pe markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p12","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and ps CGA7 pe, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-ps SM2 pe antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p13","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antips muscle actin pe antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-ps SM2 pe antibodies and related antibodies.","label":0}
{"pair_id":"BioInfer.d764.s0.p14","sentence":"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antips muscle actin pe antibodies, HHF35 and ps CGA7 pe, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.","label":1}
{"pair_id":"AIMed.d171.s1442.p0","sentence":"The crystal structure of the human ps p27Kip1 kinase pe inhibitory domain bound to the phosphorylated ps cyclin A pe-cyclin-dependent kinase 2 (Cdk2) complex has been determined at 2.3 angstrom.","label":1}
{"pair_id":"AIMed.d171.s1442.p1","sentence":"The crystal structure of the human ps p27Kip1 kinase pe inhibitory domain bound to the phosphorylated cyclin A-ps cyclin-dependent kinase 2 pe (Cdk2) complex has been determined at 2.3 angstrom.","label":0}
{"pair_id":"AIMed.d171.s1442.p2","sentence":"The crystal structure of the human ps p27Kip1 kinase pe inhibitory domain bound to the phosphorylated cyclin A-cyclin-dependent kinase 2 (ps Cdk2 pe) complex has been determined at 2.3 angstrom.","label":1}
{"pair_id":"AIMed.d171.s1442.p3","sentence":"The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated ps cyclin A pe-ps cyclin-dependent kinase 2 pe (Cdk2) complex has been determined at 2.3 angstrom.","label":0}
{"pair_id":"AIMed.d171.s1442.p4","sentence":"The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated ps cyclin A pe-cyclin-dependent kinase 2 (ps Cdk2 pe) complex has been determined at 2.3 angstrom.","label":1}
{"pair_id":"AIMed.d171.s1442.p5","sentence":"The crystal structure of the human p27Kip1 kinase inhibitory domain bound to the phosphorylated cyclin A-ps cyclin-dependent kinase 2 pe (ps Cdk2 pe) complex has been determined at 2.3 angstrom.","label":0}
{"pair_id":"BioInfer.d674.s0.p0","sentence":"The protein has the two conserved domains identified as ps actin pe and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the ps cofilin pe family.","label":1}
{"pair_id":"BioInfer.d195.s0.p0","sentence":"Evidence for a conformational change in actin induced by ps fimbrin pe (ps N375 pe) binding.","label":1}
{"pair_id":"BioInfer.d195.s0.p1","sentence":"Evidence for a conformational change in ps actin pe induced by ps fimbrin pe (N375) binding.","label":0}
{"pair_id":"BioInfer.d195.s0.p2","sentence":"Evidence for a conformational change in ps actin pe induced by fimbrin (ps N375 pe) binding.","label":1}
{"pair_id":"AIMed.d153.s1306.p0","sentence":"These data suggest that ps ADA pe on the cell surface is involved in an important immunoregulatory mechanism by which released ps ADA pe binds to cell surface CD26, and this complex is capable of reducing the local concentration of adenosine.","label":0}
{"pair_id":"AIMed.d153.s1306.p1","sentence":"These data suggest that ps ADA pe on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface ps CD26 pe, and this complex is capable of reducing the local concentration of adenosine.","label":0}
{"pair_id":"AIMed.d153.s1306.p2","sentence":"These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released ps ADA pe binds to cell surface ps CD26 pe, and this complex is capable of reducing the local concentration of adenosine.","label":1}
{"pair_id":"AIMed.d143.s1211.p0","sentence":"We next tested whether ps IL-11 pe induced signaling can be inhibited by anti-ps gp130 pe antibodies which blocked IL-6-mediated functions.","label":0}
{"pair_id":"AIMed.d143.s1211.p1","sentence":"We next tested whether ps IL-11 pe induced signaling can be inhibited by anti-gp130 antibodies which blocked ps IL-6 pe-mediated functions.","label":0}
{"pair_id":"AIMed.d143.s1211.p2","sentence":"We next tested whether IL-11 induced signaling can be inhibited by anti-ps gp130 pe antibodies which blocked ps IL-6 pe-mediated functions.","label":0}
{"pair_id":"BioInfer.d157.s0.p0","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV ps helicase-primase pe complex (UL5, UL8, UL52) and the major DNA-binding protein (ps UL29 pe), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p1","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV ps helicase-primase pe complex (UL5, UL8, ps UL52 pe) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p2","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV ps helicase-primase pe complex (UL5, UL8, UL52) and the ps major DNA-binding protein pe (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p3","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV ps helicase-primase pe complex (ps UL5 pe, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p4","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV ps helicase-primase pe complex (UL5, ps UL8 pe, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p5","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, ps UL52 pe) and the major DNA-binding protein (ps UL29 pe), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p6","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the ps major DNA-binding protein pe (ps UL29 pe), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p7","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (ps UL5 pe, UL8, UL52) and the major DNA-binding protein (ps UL29 pe), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p8","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, ps UL8 pe, UL52) and the major DNA-binding protein (ps UL29 pe), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p9","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, ps UL52 pe) and the ps major DNA-binding protein pe (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p10","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (ps UL5 pe, UL8, ps UL52 pe) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p11","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, ps UL8 pe, ps UL52 pe) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"BioInfer.d157.s0.p12","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (ps UL5 pe, UL8, UL52) and the ps major DNA-binding protein pe (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p13","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, ps UL8 pe, UL52) and the ps major DNA-binding protein pe (UL29), was already sufficient to mediate the helper effect.","label":0}
{"pair_id":"BioInfer.d157.s0.p14","sentence":"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (ps UL5 pe, ps UL8 pe, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.","label":1}
{"pair_id":"AIMed.d65.s554.p0","sentence":"Cross-family dimerization of transcription factors ps Fos pe\/ps Jun pe and ATF\/CREB alters DNA binding specificity.","label":1}
{"pair_id":"AIMed.d65.s554.p1","sentence":"Cross-family dimerization of transcription factors ps Fos pe\/Jun and ps ATF pe\/CREB alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p2","sentence":"Cross-family dimerization of transcription factors ps Fos pe\/Jun and ATF\/ps CREB pe alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p3","sentence":"Cross-family dimerization of transcription factors Fos\/ps Jun pe and ps ATF pe\/CREB alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p4","sentence":"Cross-family dimerization of transcription factors Fos\/ps Jun pe and ATF\/ps CREB pe alters DNA binding specificity.","label":0}
{"pair_id":"AIMed.d65.s554.p5","sentence":"Cross-family dimerization of transcription factors Fos\/Jun and ps ATF pe\/ps CREB pe alters DNA binding specificity.","label":1}
{"pair_id":"AIMed.d135.s1150.p0","sentence":"A receptor specific for human ps LT-beta pe was identified, which suggests that cell surface LT may have functions that are distinct from those of secreted ps LT-alpha pe.","label":0}
{"pair_id":"AIMed.d54.s479.p0","sentence":"Analysis of ps PDGF-CC pe in vivo in a diabetic mouse model of delayed wound healing showed that ps PDGF-CC pe significantly enhanced repair of a full-thickness skin excision.","label":0}
{"pair_id":"BioInfer.d722.s0.p0","sentence":"The Src homology domain 3 (SH3) of a yeast type I myosin, ps Myo5p pe, binds to ps verprolin pe and is required for targeting to sites of actin polarization.","label":1}
{"pair_id":"BioInfer.d722.s0.p1","sentence":"The Src homology domain 3 (SH3) of a yeast ps type I myosin pe, Myo5p, binds to ps verprolin pe and is required for targeting to sites of actin polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p2","sentence":"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to ps verprolin pe and is required for targeting to sites of ps actin pe polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p3","sentence":"The ps Src pe homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to ps verprolin pe and is required for targeting to sites of actin polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p4","sentence":"The Src homology domain 3 (SH3) of a yeast ps type I myosin pe, ps Myo5p pe, binds to verprolin and is required for targeting to sites of actin polarization.","label":1}
{"pair_id":"BioInfer.d722.s0.p5","sentence":"The Src homology domain 3 (SH3) of a yeast type I myosin, ps Myo5p pe, binds to verprolin and is required for targeting to sites of ps actin pe polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p6","sentence":"The ps Src pe homology domain 3 (SH3) of a yeast type I myosin, ps Myo5p pe, binds to verprolin and is required for targeting to sites of actin polarization.","label":1}
{"pair_id":"BioInfer.d722.s0.p7","sentence":"The Src homology domain 3 (SH3) of a yeast ps type I myosin pe, Myo5p, binds to verprolin and is required for targeting to sites of ps actin pe polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p8","sentence":"The ps Src pe homology domain 3 (SH3) of a yeast ps type I myosin pe, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.","label":0}
{"pair_id":"BioInfer.d722.s0.p9","sentence":"The ps Src pe homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of ps actin pe polarization.","label":0}
{"pair_id":"BioInfer.d498.s0.p0","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the ps profilin pe-ps actin pe complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.","label":1}
{"pair_id":"BioInfer.d498.s0.p1","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the profilin-ps actin pe complex, and proline-rich ligands which localize profilin to sites requiring extensive ps actin pe filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p2","sentence":"ps Profilins pe also bind polyphosphoinositides, which can disrupt the profilin-ps actin pe complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.","label":1}
{"pair_id":"BioInfer.d498.s0.p3","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the profilin-ps actin pe complex, and proline-rich ligands which localize ps profilin pe to sites requiring extensive actin filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p4","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the ps profilin pe-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive ps actin pe filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p5","sentence":"ps Profilins pe also bind polyphosphoinositides, which can disrupt the ps profilin pe-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.","label":1}
{"pair_id":"BioInfer.d498.s0.p6","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the ps profilin pe-actin complex, and proline-rich ligands which localize ps profilin pe to sites requiring extensive actin filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p7","sentence":"ps Profilins pe also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive ps actin pe filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p8","sentence":"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize ps profilin pe to sites requiring extensive ps actin pe filament accumulation.","label":0}
{"pair_id":"BioInfer.d498.s0.p9","sentence":"ps Profilins pe also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize ps profilin pe to sites requiring extensive actin filament accumulation.","label":0}
{"pair_id":"AIMed.d105.s889.p0","sentence":"We demonstrate here that both the site 2 and site 3 ps IL-6 pe variants complexed with ps IL-6R alpha pe bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with gp130.","label":1}
{"pair_id":"AIMed.d105.s889.p1","sentence":"We demonstrate here that both the site 2 and site 3 ps IL-6 pe variants complexed with IL-6R alpha bind a single ps gp130 pe molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with gp130.","label":1}
{"pair_id":"AIMed.d105.s889.p2","sentence":"We demonstrate here that both the site 2 and site 3 ps IL-6 pe variants complexed with IL-6R alpha bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with ps gp130 pe.","label":0}
{"pair_id":"AIMed.d105.s889.p3","sentence":"We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with ps IL-6R alpha pe bind a single ps gp130 pe molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with gp130.","label":1}
{"pair_id":"AIMed.d105.s889.p4","sentence":"We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with ps IL-6R alpha pe bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with ps gp130 pe.","label":0}
{"pair_id":"AIMed.d105.s889.p5","sentence":"We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6R alpha bind a single ps gp130 pe molecule but are unable to dimerize it, whereas the combined site 2\/3 variants lose the ability to interact with ps gp130 pe.","label":0}
{"pair_id":"BioInfer.d542.s0.p0","sentence":"Since ps RAD54 pe is a recombinational protein associated with ps RAD51 pe, this is the first genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.","label":1}
{"pair_id":"AIMed.d163.s1374.p0","sentence":"A protein, ps sorting nexin-1 pe (ps SNX1 pe), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (EGFR) containing the lysosomal targeting code.","label":0}
{"pair_id":"AIMed.d163.s1374.p1","sentence":"A protein, ps sorting nexin-1 pe (SNX1), was identified in a human cell line that bound to a region of the ps epidermal growth factor receptor pe (EGFR) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p2","sentence":"A protein, ps sorting nexin-1 pe (SNX1), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (ps EGFR pe) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p3","sentence":"A protein, sorting nexin-1 (ps SNX1 pe), was identified in a human cell line that bound to a region of the ps epidermal growth factor receptor pe (EGFR) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p4","sentence":"A protein, sorting nexin-1 (ps SNX1 pe), was identified in a human cell line that bound to a region of the epidermal growth factor receptor (ps EGFR pe) containing the lysosomal targeting code.","label":1}
{"pair_id":"AIMed.d163.s1374.p5","sentence":"A protein, sorting nexin-1 (SNX1), was identified in a human cell line that bound to a region of the ps epidermal growth factor receptor pe (ps EGFR pe) containing the lysosomal targeting code.","label":0}
{"pair_id":"AIMed.d174.s1467.p0","sentence":"The high affinity ps interleukin-6 pe (ps IL-6 pe) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p1","sentence":"The high affinity ps interleukin-6 pe (IL-6) signaling complex consists of ps IL-6 pe and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p2","sentence":"The high affinity ps interleukin-6 pe (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific ps IL-6 pe receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p3","sentence":"The high affinity ps interleukin-6 pe (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific ps IL-6 receptor pe and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p4","sentence":"The high affinity ps interleukin-6 pe (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein ps gp130 pe.","label":0}
{"pair_id":"AIMed.d174.s1467.p5","sentence":"The high affinity interleukin-6 (ps IL-6 pe) signaling complex consists of ps IL-6 pe and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p6","sentence":"The high affinity interleukin-6 (ps IL-6 pe) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific ps IL-6 pe receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p7","sentence":"The high affinity interleukin-6 (ps IL-6 pe) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific ps IL-6 receptor pe and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p8","sentence":"The high affinity interleukin-6 (ps IL-6 pe) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein ps gp130 pe.","label":0}
{"pair_id":"AIMed.d174.s1467.p9","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of ps IL-6 pe and two membrane-associated receptor components: a low affinity but specific ps IL-6 pe receptor and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p10","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of ps IL-6 pe and two membrane-associated receptor components: a low affinity but specific ps IL-6 receptor pe and the affinity converter\/signal transducing protein gp130.","label":1}
{"pair_id":"AIMed.d174.s1467.p11","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of ps IL-6 pe and two membrane-associated receptor components: a low affinity but specific IL-6 receptor and the affinity converter\/signal transducing protein ps gp130 pe.","label":0}
{"pair_id":"AIMed.d174.s1467.p12","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific ps IL-6 peps IL-6 receptor pe and the affinity converter\/signal transducing protein gp130.","label":0}
{"pair_id":"AIMed.d174.s1467.p13","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific ps IL-6 pe receptor and the affinity converter\/signal transducing protein ps gp130 pe.","label":0}
{"pair_id":"AIMed.d174.s1467.p14","sentence":"The high affinity interleukin-6 (IL-6) signaling complex consists of IL-6 and two membrane-associated receptor components: a low affinity but specific ps IL-6 receptor pe and the affinity converter\/signal transducing protein ps gp130 pe.","label":0}
{"pair_id":"BioInfer.d575.s1.p0","sentence":"The ps APC pe protein and ps E-cadherin pe form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p1","sentence":"The APC protein and ps E-cadherin pe form similar but independent complexes with alpha-catenin, beta-catenin, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d575.s1.p2","sentence":"The APC protein and ps E-cadherin pe form similar but independent complexes with ps alpha-catenin pe, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p3","sentence":"The APC protein and ps E-cadherin pe form similar but independent complexes with alpha-catenin, ps beta-catenin pe, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p4","sentence":"The ps APC pe protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d575.s1.p5","sentence":"The ps APC pe protein and E-cadherin form similar but independent complexes with ps alpha-catenin pe, beta-catenin, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p6","sentence":"The ps APC pe protein and E-cadherin form similar but independent complexes with alpha-catenin, ps beta-catenin pe, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d575.s1.p7","sentence":"The APC protein and E-cadherin form similar but independent complexes with ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d575.s1.p8","sentence":"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d575.s1.p9","sentence":"The APC protein and E-cadherin form similar but independent complexes with ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin.","label":1}
{"pair_id":"BioInfer.d287.s0.p0","sentence":"Immunocytochemical localisation of ps actin pe and ps profilin pe in the generative cell of angiosperm pollen: TEM studies on high-pressure frozen and freeze-substituted Ledebouria socialis Roth (Hyacinthaceae).","label":0}
{"pair_id":"BioInfer.d279.s0.p0","sentence":"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing ps cofilin pe and actin were apparently larger and thicker in cells overexpressing ps cofilin pe than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p1","sentence":"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and ps actin pe were apparently larger and thicker in cells overexpressing ps cofilin pe than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p2","sentence":"However, upon treatment with DMSO, cytoplasmic ps actin pe filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing ps cofilin pe than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p3","sentence":"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing ps cofilin pe and ps actin pe were apparently larger and thicker in cells overexpressing cofilin than in normal cells.","label":1}
{"pair_id":"BioInfer.d279.s0.p4","sentence":"However, upon treatment with DMSO, cytoplasmic ps actin pe filaments were disrupted and intranuclear rod structures containing ps cofilin pe and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.","label":0}
{"pair_id":"BioInfer.d279.s0.p5","sentence":"However, upon treatment with DMSO, cytoplasmic ps actin pe filaments were disrupted and intranuclear rod structures containing cofilin and ps actin pe were apparently larger and thicker in cells overexpressing cofilin than in normal cells.","label":0}
{"pair_id":"BioInfer.d456.s0.p0","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of ps oncostatin M pe (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p1","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding ps cytokines pe can mimic the effects of ps oncostatin M pe (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p2","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of ps oncostatin M pe (OSM) in acting synergistically with ps interleukin-1alpha pe (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p3","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of ps oncostatin M pe (OSM) in acting synergistically with interleukin-1alpha (ps IL-1alpha pe) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p4","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of ps oncostatin M pe (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage ps collagen pe breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p5","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (gp130) binding cytokines can mimic the effects of ps oncostatin M pe (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p6","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of ps oncostatin M pe (ps OSM pe) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p7","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (ps gp130 pe) binding cytokines can mimic the effects of ps oncostatin M pe (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p8","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding ps cytokines pe can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p9","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with ps interleukin-1alpha pe (IL-1alpha) to induce cartilage collagen breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p10","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (ps IL-1alpha pe) to induce cartilage collagen breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p11","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage ps collagen pe breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p12","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p13","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (ps OSM pe) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p14","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (ps gp130 pe) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and ps collagenase pe expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p15","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding ps cytokines pe can mimic the effects of oncostatin M (OSM) in acting synergistically with ps interleukin-1alpha pe (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p16","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding ps cytokines pe can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (ps IL-1alpha pe) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p17","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding ps cytokines pe can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage ps collagen pe breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p18","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (gp130) binding ps cytokines pe can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p19","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding ps cytokines pe can mimic the effects of oncostatin M (ps OSM pe) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p20","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (ps gp130 pe) binding ps cytokines pe can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p21","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with ps interleukin-1alpha pe (ps IL-1alpha pe) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p22","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with ps interleukin-1alpha pe (IL-1alpha) to induce cartilage ps collagen pe breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p23","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with ps interleukin-1alpha pe (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p24","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (ps OSM pe) in acting synergistically with ps interleukin-1alpha pe (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p25","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (ps gp130 pe) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with ps interleukin-1alpha pe (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p26","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (ps IL-1alpha pe) to induce cartilage ps collagen pe breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p27","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (ps IL-1alpha pe) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p28","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (ps OSM pe) in acting synergistically with interleukin-1alpha (ps IL-1alpha pe) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p29","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (ps gp130 pe) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (ps IL-1alpha pe) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p30","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage ps collagen pe breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p31","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (ps OSM pe) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage ps collagen pe breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":1}
{"pair_id":"BioInfer.d456.s0.p32","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (ps gp130 pe) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage ps collagen pe breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p33","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (gp130) binding cytokines can mimic the effects of oncostatin M (ps OSM pe) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p34","sentence":"OBJECTIVE: To determine whether other ps glycoprotein 130 pe (ps gp130 pe) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"BioInfer.d456.s0.p35","sentence":"OBJECTIVE: To determine whether other glycoprotein 130 (ps gp130 pe) binding cytokines can mimic the effects of oncostatin M (ps OSM pe) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.","label":0}
{"pair_id":"AIMed.d142.s1201.p0","sentence":"We found that ps YY1 pe and ps Sp1 pe can form a physical complex.","label":1}
{"pair_id":"BioInfer.d218.s0.p0","sentence":"From these observations it is concluded that (i) ps RAD52 pe is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that ps RAD51 pe and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p1","sentence":"From these observations it is concluded that (i) ps RAD52 pe is required for high levels of both gene conversions and reciprocal crossovers, (ii) that ps RAD51 pe is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p2","sentence":"From these observations it is concluded that (i) ps RAD52 pe is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and ps RAD52 pe have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p3","sentence":"From these observations it is concluded that (i) ps RAD52 pe is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/ps Rad52 pe protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p4","sentence":"From these observations it is concluded that (i) ps RAD52 pe is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that ps RAD52 pe has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p5","sentence":"From these observations it is concluded that (i) ps RAD52 pe is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the ps Rad51 pe\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p6","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that ps RAD51 pe is not required for intrachromosomal crossovers, and (iii) that ps RAD51 pe and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p7","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that ps RAD51 pe and ps RAD52 pe have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":1}
{"pair_id":"BioInfer.d218.s0.p8","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that ps RAD51 pe and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/ps Rad52 pe protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p9","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that ps RAD51 pe and RAD52 have different functions, or that ps RAD52 pe has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p10","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that ps RAD51 pe and RAD52 have different functions, or that RAD52 has functions in addition to those of the ps Rad51 pe\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p11","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that ps RAD51 pe is not required for intrachromosomal crossovers, and (iii) that RAD51 and ps RAD52 pe have different functions, or that RAD52 has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p12","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that ps RAD51 pe is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51\/ps Rad52 pe protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p13","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that ps RAD51 pe is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that ps RAD52 pe has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p14","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that ps RAD51 pe is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the ps Rad51 pe\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p15","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and ps RAD52 pe have different functions, or that RAD52 has functions in addition to those of the Rad51\/ps Rad52 pe protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p16","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and ps RAD52 pe have different functions, or that ps RAD52 pe has functions in addition to those of the Rad51\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p17","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and ps RAD52 pe have different functions, or that RAD52 has functions in addition to those of the ps Rad51 pe\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p18","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that ps RAD52 pe has functions in addition to those of the Rad51\/ps Rad52 pe protein complex.","label":0}
{"pair_id":"BioInfer.d218.s0.p19","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the ps Rad51 pe\/ps Rad52 pe protein complex.","label":1}
{"pair_id":"BioInfer.d218.s0.p20","sentence":"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that ps RAD52 pe has functions in addition to those of the ps Rad51 pe\/Rad52 protein complex.","label":0}
{"pair_id":"BioInfer.d576.s0.p0","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, ps p18 pe, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p1","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p2","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p3","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, ps p35 pe, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p4","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, p35, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p5","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, p35, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p6","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p7","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p8","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, ps p19 pe, ps p18 pe, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p9","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, p35, p19, ps p18 pe, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p10","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p11","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p12","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, ps p35 pe, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p13","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, p35, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p14","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, p35, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p15","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p16","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p17","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, ps p19 pe, p18, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p18","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and ps p14 pe (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p19","sentence":"The ps Arp2 peps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p20","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, ps p35 pe, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p21","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p22","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p23","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p24","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p25","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p26","sentence":"The ps Arp2 pe\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p27","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, ps p35 pe, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p28","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p29","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p30","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p31","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p32","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p33","sentence":"The ps Arp pe2\/ps A pe complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p34","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, ps p35 pe, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p35","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, ps p35 pe, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p36","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, ps p35 pe, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p37","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, ps p35 pe, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p38","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, ps p35 pe, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p39","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, ps p35 pe, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p40","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, ps p40 pe, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p41","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p42","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p43","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and ps Arp3 pe; and five apparently novel proteins, p40, p35, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p44","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and ps Arp3 pe; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p45","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p46","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p47","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, ps p40 pe, p35, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p48","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, ps p40 pe, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p49","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p50","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p51","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two ps actin pe-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"BioInfer.d576.s0.p52","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p53","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on ps profilin pe, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).","label":0}
{"pair_id":"BioInfer.d576.s0.p54","sentence":"The Arp2\/A complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, ps Arp2 pe and Arp3; and five apparently novel proteins, p40, p35, ps p19 pe, p18, and p14 (Machesky et al., 1994).","label":1}
{"pair_id":"AIMed.d146.s1243.p0","sentence":"Taken together these data suggest that the 76-kDa receptor is a novel high affinity ps IL-7R pe that may be necessary for ps IL-7 pe driven proliferation in human T cells.","label":0}
{"pair_id":"AIMed.d80.s685.p0","sentence":"A point mutation in ps FADD pe, analogous to the lpr mutation of ps Fas pe, abolishes its ability to bind Fas, suggesting a death domain to death domain interaction.","label":0}
{"pair_id":"AIMed.d80.s685.p1","sentence":"A point mutation in ps FADD pe, analogous to the lpr mutation of Fas, abolishes its ability to bind ps Fas pe, suggesting a death domain to death domain interaction.","label":1}
{"pair_id":"AIMed.d80.s685.p2","sentence":"A point mutation in FADD, analogous to the lpr mutation of ps Fas pe, abolishes its ability to bind ps Fas pe, suggesting a death domain to death domain interaction.","label":0}
{"pair_id":"AIMed.d73.s623.p0","sentence":"Unlabeled ps TNF-alpha pe and ps TNF-beta pe were equally effective at displacing the binding of labeled TNF-alpha to TNF-R expressing cells.","label":0}
{"pair_id":"AIMed.d73.s623.p1","sentence":"Unlabeled ps TNF-alpha pe and TNF-beta were equally effective at displacing the binding of labeled ps TNF-alpha pe to TNF-R expressing cells.","label":0}
{"pair_id":"AIMed.d73.s623.p2","sentence":"Unlabeled TNF-alpha and ps TNF-beta pe were equally effective at displacing the binding of labeled ps TNF-alpha pe to TNF-R expressing cells.","label":0}
{"pair_id":"AIMed.d146.s1239.p0","sentence":"In agreement, mAb to the previously cloned ps IL-7R pe were found to stain unstimulated T cells that express only the ps p90 pe IL-7R but not T-cell clones that express predominantly the p76 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p1","sentence":"In agreement, mAb to the previously cloned ps IL-7R pe were found to stain unstimulated T cells that express only the p90 ps IL-7R pe but not T-cell clones that express predominantly the p76 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p2","sentence":"In agreement, mAb to the previously cloned ps IL-7R pe were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the ps p76 pe IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p3","sentence":"In agreement, mAb to the previously cloned ps IL-7R pe were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the p76 ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1239.p4","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the ps p90 pe ps IL-7R pe but not T-cell clones that express predominantly the p76 IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p5","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the ps p90 pe IL-7R but not T-cell clones that express predominantly the ps p76 pe IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p6","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the ps p90 pe IL-7R but not T-cell clones that express predominantly the p76 ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1239.p7","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 ps IL-7R pe but not T-cell clones that express predominantly the ps p76 pe IL-7R.","label":0}
{"pair_id":"AIMed.d146.s1239.p8","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 ps IL-7R pe but not T-cell clones that express predominantly the p76 ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d146.s1239.p9","sentence":"In agreement, mAb to the previously cloned IL-7R were found to stain unstimulated T cells that express only the p90 IL-7R but not T-cell clones that express predominantly the ps p76 pe ps IL-7R pe.","label":0}
{"pair_id":"AIMed.d154.s1309.p0","sentence":"We have cloned and characterized human ps acidic (alpha 1-) syntrophin pe and a second isoform of human ps basic (beta 2-) syntrophin pe.","label":0}
{"pair_id":"AIMed.d141.s1193.p0","sentence":"Cotransfection experiments indicate that ps CIP1 pe and ps SV40 T antigen pe function in a mutually antagonistic manner to control cell cycle progression.","label":0}
{"pair_id":"BioInfer.d545.s0.p0","sentence":"ps Smooth muscle talin pe prepared from chicken gizzard binds to ps skeletal muscle actin pe in vitro.","label":1}
{"pair_id":"BioInfer.d553.s0.p0","sentence":"Studies on the interaction between ps actin pe and ps cofilin pe purified by a new method.","label":1}
{"pair_id":"BioInfer.d182.s0.p0","sentence":"During incubation of whole myofibrils at 37 degrees C, ps myosin heavy chain pe, alpha actinin, ps actin pe and troponin T suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p1","sentence":"During incubation of whole myofibrils at 37 degrees C, ps myosin heavy chain pe, ps alpha actinin pe, actin and troponin T suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p2","sentence":"During incubation of whole myofibrils at 37 degrees C, ps myosin heavy chain pe, alpha actinin, actin and ps troponin T pe suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p3","sentence":"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, ps alpha actinin pe, ps actin pe and troponin T suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p4","sentence":"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, ps actin pe and ps troponin T pe suffered degradation.","label":0}
{"pair_id":"BioInfer.d182.s0.p5","sentence":"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, ps alpha actinin pe, actin and ps troponin T pe suffered degradation.","label":0}
{"pair_id":"AIMed.d174.s1469.p0","sentence":"Although ps IL-6D pe has a higher binding affinity for immobilized ps sIL-6R pe, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than IL-6D in a STAT3 phosphorylation assay.","label":1}
{"pair_id":"AIMed.d174.s1469.p1","sentence":"Although ps IL-6D pe has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, ps IL-6M pe is more potent than IL-6D in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p2","sentence":"Although ps IL-6D pe has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than ps IL-6D pe in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p3","sentence":"Although IL-6D has a higher binding affinity for immobilized ps sIL-6R pe, as determined by biosensor analysis employing surface plasmon resonance detection, ps IL-6M pe is more potent than IL-6D in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p4","sentence":"Although IL-6D has a higher binding affinity for immobilized ps sIL-6R pe, as determined by biosensor analysis employing surface plasmon resonance detection, IL-6M is more potent than ps IL-6D pe in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d174.s1469.p5","sentence":"Although IL-6D has a higher binding affinity for immobilized sIL-6R, as determined by biosensor analysis employing surface plasmon resonance detection, ps IL-6M pe is more potent than ps IL-6D pe in a STAT3 phosphorylation assay.","label":0}
{"pair_id":"AIMed.d137.s1155.p0","sentence":"The POU domains of the ps Oct1 pe and ps Oct2 pe transcription factors mediate specific interaction with TBP.","label":0}
{"pair_id":"AIMed.d137.s1155.p1","sentence":"The POU domains of the ps Oct1 pe and Oct2 transcription factors mediate specific interaction with ps TBP pe.","label":1}
{"pair_id":"AIMed.d137.s1155.p2","sentence":"The POU domains of the Oct1 and ps Oct2 pe transcription factors mediate specific interaction with ps TBP pe.","label":1}
{"pair_id":"AIMed.d58.s511.p0","sentence":"A cDNA clone encoding a novel, widely expressed protein (called ps growth factor receptor-bound protein 2 pe or ps GRB2 pe) containing one src homology 2 (SH2) domain and two SH3 domains was isolated.","label":0}
{"pair_id":"AIMed.d128.s1091.p0","sentence":"The X-ray structure of a ps growth hormone pe-ps prolactin pe receptor complex.","label":0}
{"pair_id":"BioInfer.d749.s0.p0","sentence":"Three actin-associated proteins, ps actin-binding protein pe, ps gelsolin pe, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p1","sentence":"Three ps actin pe-associated proteins, actin-binding protein, ps gelsolin pe, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":1}
{"pair_id":"BioInfer.d749.s0.p2","sentence":"Three actin-associated proteins, actin-binding protein, ps gelsolin pe, and profilin, influence gelation, solation, and polymerization, respectively, of ps actin pe in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p3","sentence":"Three actin-associated proteins, actin-binding protein, ps gelsolin pe, and ps profilin pe, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p4","sentence":"Three ps actin pe-associated proteins, ps actin-binding protein pe, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":1}
{"pair_id":"BioInfer.d749.s0.p5","sentence":"Three actin-associated proteins, ps actin-binding protein pe, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of ps actin pe in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p6","sentence":"Three actin-associated proteins, ps actin-binding protein pe, gelsolin, and ps profilin pe, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p7","sentence":"Three ps actin pe-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of ps actin pe in vitro.","label":0}
{"pair_id":"BioInfer.d749.s0.p8","sentence":"Three ps actin pe-associated proteins, actin-binding protein, gelsolin, and ps profilin pe, influence gelation, solation, and polymerization, respectively, of actin in vitro.","label":1}
{"pair_id":"BioInfer.d749.s0.p9","sentence":"Three actin-associated proteins, actin-binding protein, gelsolin, and ps profilin pe, influence gelation, solation, and polymerization, respectively, of ps actin pe in vitro.","label":1}
{"pair_id":"BioInfer.d87.s2.p0","sentence":"These results suggest that the dysfunction of ps E-cadherin pe in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in ps beta-catenin pe.","label":1}
{"pair_id":"BioInfer.d87.s2.p1","sentence":"These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with ps alpha-catenin pe, and that this defect results from the mutation in ps beta-catenin pe.","label":1}
{"pair_id":"BioInfer.d87.s2.p2","sentence":"These results suggest that the dysfunction of ps E-cadherin pe in these cell lines is due primarily to its failure to interact with ps alpha-catenin pe, and that this defect results from the mutation in beta-catenin.","label":1}
{"pair_id":"AIMed.d168.s1414.p0","sentence":"We have used site-specific mutagenesis within the extracellular domain of the ps EPOR pe to search for amino acid residues involved in ps erythropoietin pe (EPO) binding.","label":1}
{"pair_id":"AIMed.d168.s1414.p1","sentence":"We have used site-specific mutagenesis within the extracellular domain of the ps EPOR pe to search for amino acid residues involved in erythropoietin (ps EPO pe) binding.","label":1}
{"pair_id":"AIMed.d168.s1414.p2","sentence":"We have used site-specific mutagenesis within the extracellular domain of the EPOR to search for amino acid residues involved in ps erythropoietin pe (ps EPO pe) binding.","label":0}
{"pair_id":"BioInfer.d1.s0.p0","sentence":"A binary complex of birch ps profilin pe and ps skeletal muscle actin pe could be isolated by gel chromatography.","label":1}
{"pair_id":"AIMed.d222.s1928.p0","sentence":"The protein product of ps c-cbl pe proto-oncogene is known to interact with several proteins, including ps Grb2 pe, Crk and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.","label":1}
{"pair_id":"AIMed.d222.s1928.p1","sentence":"The protein product of ps c-cbl pe proto-oncogene is known to interact with several proteins, including Grb2, ps Crk pe and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.","label":1}
{"pair_id":"AIMed.d222.s1928.p2","sentence":"The protein product of ps c-cbl pe proto-oncogene is known to interact with several proteins, including Grb2, Crk and ps PI3 kinase pe, and is thought to regulate signalling by many cell surface receptors.","label":1}
{"pair_id":"AIMed.d222.s1928.p3","sentence":"The protein product of c-cbl proto-oncogene is known to interact with several proteins, including ps Grb2 pe, ps Crk pe and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.","label":0}
{"pair_id":"AIMed.d222.s1928.p4","sentence":"The protein product of c-cbl proto-oncogene is known to interact with several proteins, including ps Grb2 pe, Crk and ps PI3 kinase pe, and is thought to regulate signalling by many cell surface receptors.","label":0}
{"pair_id":"AIMed.d222.s1928.p5","sentence":"The protein product of c-cbl proto-oncogene is known to interact with several proteins, including Grb2, ps Crk pe and ps PI3 kinase pe, and is thought to regulate signalling by many cell surface receptors.","label":0}
{"pair_id":"AIMed.d131.s1127.p0","sentence":"Because ps IL-10 pe inhibits macrophage activation by ps IFN-gamma pe, this relationship suggests possible shared receptor or signal transduction pathway components.","label":0}
{"pair_id":"BioInfer.d688.s0.p0","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with ps LEF-1 pe and vinculin; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p1","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p2","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of ps beta-catenin pe, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p3","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and ps vinculin pe; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p4","sentence":"The results indicate that (a) ps plakoglobin pe and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p5","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, ps cadherin pe and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p6","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p7","sentence":"The results indicate that (a) plakoglobin and ps beta-catenin pe differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) ps LEF-1 pe-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p8","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with ps LEF-1 pe and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p9","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with ps LEF-1 pe and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of ps beta-catenin pe, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p10","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with ps LEF-1 pe and ps vinculin pe; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p11","sentence":"The results indicate that (a) ps plakoglobin pe and beta-catenin differ in their nuclear translocation and complexing with ps LEF-1 pe and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p12","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with ps LEF-1 pe and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, ps cadherin pe and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p13","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with ps LEF-1 pe and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p14","sentence":"The results indicate that (a) plakoglobin and ps beta-catenin pe differ in their nuclear translocation and complexing with ps LEF-1 pe and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p15","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of ps beta-catenin pe, cadherin and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p16","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and ps vinculin pe; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p17","sentence":"The results indicate that (a) ps plakoglobin pe and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p18","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, ps cadherin pe and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p19","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of beta-catenin, cadherin and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p20","sentence":"The results indicate that (a) plakoglobin and ps beta-catenin pe differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and ps alpha-catenin pe, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p21","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and ps vinculin pe; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of ps beta-catenin pe, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p22","sentence":"The results indicate that (a) ps plakoglobin pe and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of ps beta-catenin pe, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p23","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of ps beta-catenin pe, ps cadherin pe and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p24","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of ps beta-catenin pe, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p25","sentence":"The results indicate that (a) plakoglobin and ps beta-catenin pe differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of ps beta-catenin pe, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p26","sentence":"The results indicate that (a) ps plakoglobin pe and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and ps vinculin pe; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p27","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and ps vinculin pe; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, ps cadherin pe and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p28","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and ps vinculin pe; (b) LEF-1-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p29","sentence":"The results indicate that (a) plakoglobin and ps beta-catenin pe differ in their nuclear translocation and complexing with LEF-1 and ps vinculin pe; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p30","sentence":"The results indicate that (a) ps plakoglobin pe and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, ps cadherin pe and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p31","sentence":"The results indicate that (a) ps plakoglobin pe and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p32","sentence":"The results indicate that (a) ps plakoglobin pe and ps beta-catenin pe differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":1}
{"pair_id":"BioInfer.d688.s0.p33","sentence":"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of beta-catenin, ps cadherin pe and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p34","sentence":"The results indicate that (a) plakoglobin and ps beta-catenin pe differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, ps cadherin pe and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d688.s0.p35","sentence":"The results indicate that (a) plakoglobin and ps beta-catenin pe differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by ps beta-catenin pe; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.","label":0}
{"pair_id":"BioInfer.d784.s0.p0","sentence":"Unmasking of this site serves as a molecular switch that initiates assembly of an ps actin pe-based motility complex containing ps VASP pe and profilin.","label":1}
{"pair_id":"BioInfer.d784.s0.p1","sentence":"Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing ps VASP pe and ps profilin pe.","label":1}
{"pair_id":"BioInfer.d784.s0.p2","sentence":"Unmasking of this site serves as a molecular switch that initiates assembly of an ps actin pe-based motility complex containing VASP and ps profilin pe.","label":1}
{"pair_id":"AIMed.d157.s1328.p0","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (ps PKA pe) and ps phosphatase 2B pe [calcineurin (CaN)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p1","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (ps PKA pe) and phosphatase 2B [ps calcineurin pe (CaN)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p2","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (ps PKA pe) and phosphatase 2B [calcineurin (ps CaN pe)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p3","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (ps PKA pe) and phosphatase 2B [calcineurin (CaN)] are complexed by an ps A kinase anchoring protein pe, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p4","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (ps PKA pe) and phosphatase 2B [calcineurin (CaN)] are complexed by an A kinase anchoring protein, ps AKAP79 pe.","label":0}
{"pair_id":"AIMed.d157.s1328.p5","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and ps phosphatase 2B pe [ps calcineurin pe (CaN)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p6","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and ps phosphatase 2B pe [calcineurin (ps CaN pe)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p7","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and ps phosphatase 2B pe [calcineurin (CaN)] are complexed by an ps A kinase anchoring protein pe, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p8","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and ps phosphatase 2B pe [calcineurin (CaN)] are complexed by an A kinase anchoring protein, ps AKAP79 pe.","label":0}
{"pair_id":"AIMed.d157.s1328.p9","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [ps calcineurin pe (ps CaN pe)] are complexed by an A kinase anchoring protein, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p10","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [ps calcineurin pe (CaN)] are complexed by an ps A kinase anchoring protein pe, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p11","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [ps calcineurin pe (CaN)] are complexed by an A kinase anchoring protein, ps AKAP79 pe.","label":0}
{"pair_id":"AIMed.d157.s1328.p12","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [calcineurin (ps CaN pe)] are complexed by an ps A kinase anchoring protein pe, AKAP79.","label":0}
{"pair_id":"AIMed.d157.s1328.p13","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [calcineurin (ps CaN pe)] are complexed by an A kinase anchoring protein, ps AKAP79 pe.","label":0}
{"pair_id":"AIMed.d157.s1328.p14","sentence":"Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase (PKA) and phosphatase 2B [calcineurin (CaN)] are complexed by an ps A kinase anchoring protein pe, ps AKAP79 pe.","label":0}
{"pair_id":"AIMed.d118.s999.p0","sentence":"In normal human cells, but not in many tumour cells, ps p21 pe exists in a quaternary complex with a cyclin, a CDK, and the ps proliferating-cell nuclear antigen pe (PCNA).","label":1}
{"pair_id":"AIMed.d118.s999.p1","sentence":"In normal human cells, but not in many tumour cells, ps p21 pe exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (ps PCNA pe).","label":1}
{"pair_id":"AIMed.d118.s999.p2","sentence":"In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the ps proliferating-cell nuclear antigen pe (ps PCNA pe).","label":0}
{"pair_id":"BioInfer.d623.s1.p0","sentence":"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate ps profilins pe, purified the recombinant viral ps profilin pe, and characterized its interactions with actin and polyphosphoinositides.","label":0}
{"pair_id":"BioInfer.d623.s1.p1","sentence":"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral ps profilin pe, and characterized its interactions with ps actin pe and polyphosphoinositides.","label":1}
{"pair_id":"BioInfer.d623.s1.p2","sentence":"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate ps profilins pe, purified the recombinant viral profilin, and characterized its interactions with ps actin pe and polyphosphoinositides.","label":0}
{"pair_id":"BioInfer.d192.s0.p0","sentence":"Essential domains of the ps PRP21 pe splicing factor are implicated in the binding to ps PRP9 pe and PRP11 proteins and are conserved through evolution.","label":1}
{"pair_id":"BioInfer.d192.s0.p1","sentence":"Essential domains of the ps PRP21 pe splicing factor are implicated in the binding to PRP9 and ps PRP11 pe proteins and are conserved through evolution.","label":1}
{"pair_id":"BioInfer.d192.s0.p2","sentence":"Essential domains of the PRP21 splicing factor are implicated in the binding to ps PRP9 pe and ps PRP11 pe proteins and are conserved through evolution.","label":0}
{"pair_id":"BioInfer.d534.s0.p0","sentence":"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and ps plakoglobin pe, are tightly associated with these ps cadherins pe and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p1","sentence":"Several intracellular proteins termed ps catenins pe, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these ps cadherins pe and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p2","sentence":"Several intracellular proteins termed catenins, including ps alpha-catenin pe, beta-catenin, and plakoglobin, are tightly associated with these ps cadherins pe and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p3","sentence":"Several intracellular proteins termed catenins, including alpha-catenin, ps beta-catenin pe, and plakoglobin, are tightly associated with these ps cadherins pe and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p4","sentence":"Several intracellular proteins termed ps catenins pe, including alpha-catenin, beta-catenin, and ps plakoglobin pe, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p5","sentence":"Several intracellular proteins termed catenins, including ps alpha-catenin pe, beta-catenin, and ps plakoglobin pe, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p6","sentence":"Several intracellular proteins termed catenins, including alpha-catenin, ps beta-catenin pe, and ps plakoglobin pe, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d534.s0.p7","sentence":"Several intracellular proteins termed ps catenins pe, including ps alpha-catenin pe, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p8","sentence":"Several intracellular proteins termed ps catenins pe, including alpha-catenin, ps beta-catenin pe, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":1}
{"pair_id":"BioInfer.d534.s0.p9","sentence":"Several intracellular proteins termed catenins, including ps alpha-catenin pe, ps beta-catenin pe, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.","label":0}
{"pair_id":"BioInfer.d325.s0.p0","sentence":"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human ps platelet pe and ps lymphocyte plate peps plate pe.","label":0}
{"pair_id":"BioInfer.d325.s0.p1","sentence":"In contrast, ps talin pe, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and ps lymphocyte plate pe.","label":0}
{"pair_id":"BioInfer.d325.s0.p2","sentence":"In contrast, talin, another putative ps actin pe-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and ps lymphocyte plate pe.","label":0}
{"pair_id":"BioInfer.d325.s0.p3","sentence":"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken ps gizzard talin pe, which reacted with human platelet and ps lymphocyte plate pe.","label":0}
{"pair_id":"BioInfer.d325.s0.p4","sentence":"In contrast, ps talin pe, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human ps platelet pe and lymphocyte ps plate pe.","label":0}
{"pair_id":"BioInfer.d325.s0.p5","sentence":"In contrast, talin, another putative ps actin pe-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human ps platelet pe and lymphocyte ps plate pe.","label":0}
{"pair_id":"BioInfer.d325.s0.p6","sentence":"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken ps gizzard talin pe, which reacted with human ps platelet pe and lymphocyte ps plate pe.","label":0}
{"pair_id":"BioInfer.d325.s0.p7","sentence":"In contrast, ps talin pe, another putative ps actin pe-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte plate.","label":1}
{"pair_id":"BioInfer.d325.s0.p8","sentence":"In contrast, ps talin pe, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken ps gizzard talin pe, which reacted with human platelet and lymphocyte plate.","label":0}
{"pair_id":"BioInfer.d325.s0.p9","sentence":"In contrast, talin, another putative ps actin pe-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken ps gizzard talin pe, which reacted with human platelet and lymphocyte plate.","label":0}
{"pair_id":"AIMed.d102.s862.p0","sentence":"Here we report that stimulation of ps Sp1 pe-mediated transcription by ps RB pe is partially abrogated at the nonpermissive temperature in ts13 cells.","label":0}
{"pair_id":"BioInfer.d407.s0.p0","sentence":"Live dynamics of Dictyostelium ps cofilin pe suggests a role in remodeling ps actin pe latticework into bundles.","label":1}
{"pair_id":"AIMed.d114.s964.p0","sentence":"We expressed the cDNA of human ps beta 1-syntrophin pe and the COOH terminus of human ps dystrophin pe in reticulocyte lysates using an in vitro transcription\/translation system.","label":0}
{"pair_id":"BioInfer.d709.s0.p0","sentence":"These results indicate that phosphorylation of ps LIM-kinase pe by ROCK and consequently increased phosphorylation of cofilin by ps LIM-kinase pe contribute to Rho-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p1","sentence":"These results indicate that phosphorylation of ps LIM-kinase pe by ROCK and consequently increased phosphorylation of ps cofilin pe by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p2","sentence":"These results indicate that phosphorylation of ps LIM-kinase pe by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p3","sentence":"These results indicate that phosphorylation of ps LIM-kinase pe by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to ps Rho pe-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p4","sentence":"These results indicate that phosphorylation of ps LIM-kinase pe by ps ROCK pe and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p5","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of ps cofilin pe by ps LIM-kinase pe contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p6","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by ps LIM-kinase pe contribute to Rho-induced reorganization of the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p7","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by ps LIM-kinase pe contribute to ps Rho pe-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p8","sentence":"These results indicate that phosphorylation of LIM-kinase by ps ROCK pe and consequently increased phosphorylation of cofilin by ps LIM-kinase pe contribute to Rho-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p9","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of ps cofilin pe by LIM-kinase contribute to Rho-induced reorganization of the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p10","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of ps cofilin pe by LIM-kinase contribute to ps Rho pe-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d709.s0.p11","sentence":"These results indicate that phosphorylation of LIM-kinase by ps ROCK pe and consequently increased phosphorylation of ps cofilin pe by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p12","sentence":"These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to ps Rho pe-induced reorganization of the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p13","sentence":"These results indicate that phosphorylation of LIM-kinase by ps ROCK pe and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d709.s0.p14","sentence":"These results indicate that phosphorylation of LIM-kinase by ps ROCK pe and consequently increased phosphorylation of cofilin by LIM-kinase contribute to ps Rho pe-induced reorganization of the actin cytoskeleton.","label":0}
{"pair_id":"AIMed.d114.s968.p0","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human ps dystrophin pe related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p1","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human ps dystrophin related protein pe (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p2","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (ps DRP pe or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p3","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (DRP or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p4","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (DRP or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p5","sentence":"In this recombinant expression system, the ps dystrophin pe relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":0}
{"pair_id":"AIMed.d114.s968.p6","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin peps dystrophin related protein pe (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p7","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin pe related protein (ps DRP pe or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p8","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin pe related protein (DRP or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p9","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin pe related protein (DRP or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p10","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin pe related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":0}
{"pair_id":"AIMed.d114.s968.p11","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (ps DRP pe or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p12","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (DRP or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p13","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (DRP or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p14","sentence":"In this recombinant expression system, the dystrophin relatives, human ps dystrophin related protein pe (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"AIMed.d114.s968.p15","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (ps DRP pe or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p16","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (ps DRP pe or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p17","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (ps DRP pe or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"AIMed.d114.s968.p18","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or ps utrophin pe) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated beta 1-syntrophin.","label":0}
{"pair_id":"AIMed.d114.s968.p19","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or ps utrophin pe) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"AIMed.d114.s968.p20","sentence":"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the ps 87K postsynaptic protein pe from Torpedo electric organ, also bind to translated ps beta 1-syntrophin pe.","label":1}
{"pair_id":"BioInfer.d523.s0.p0","sentence":"RIPc, one of the cleavage products, enhanced interaction between TRADD and ps FADD pe\/MORT1 and increased cells' sensitivity to ps TNF pe.","label":0}
{"pair_id":"BioInfer.d523.s0.p1","sentence":"ps RIPc pe, one of the cleavage products, enhanced interaction between TRADD and FADD\/MORT1 and increased cells' sensitivity to ps TNF pe.","label":1}
{"pair_id":"BioInfer.d523.s0.p2","sentence":"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD\/ps MORT1 pe and increased cells' sensitivity to ps TNF pe.","label":0}
{"pair_id":"BioInfer.d523.s0.p3","sentence":"RIPc, one of the cleavage products, enhanced interaction between ps TRADD pe and FADD\/MORT1 and increased cells' sensitivity to ps TNF pe.","label":0}
{"pair_id":"BioInfer.d523.s0.p4","sentence":"ps RIPc pe, one of the cleavage products, enhanced interaction between TRADD and ps FADD pe\/MORT1 and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p5","sentence":"RIPc, one of the cleavage products, enhanced interaction between TRADD and ps FADD pe\/ps MORT1 pe and increased cells' sensitivity to TNF.","label":0}
{"pair_id":"BioInfer.d523.s0.p6","sentence":"RIPc, one of the cleavage products, enhanced interaction between ps TRADD pe and ps FADD pe\/MORT1 and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p7","sentence":"ps RIPc pe, one of the cleavage products, enhanced interaction between TRADD and FADD\/ps MORT1 pe and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p8","sentence":"ps RIPc pe, one of the cleavage products, enhanced interaction between ps TRADD pe and FADD\/MORT1 and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d523.s0.p9","sentence":"RIPc, one of the cleavage products, enhanced interaction between ps TRADD pe and FADD\/ps MORT1 pe and increased cells' sensitivity to TNF.","label":1}
{"pair_id":"BioInfer.d640.s0.p0","sentence":"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for ps E-CD pe; 86 per cent for ps alpha-catenin pe; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.","label":0}
{"pair_id":"BioInfer.d640.s0.p1","sentence":"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for ps alpha-catenin pe; 91 per cent for ps beta-catenin pe) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.","label":0}
{"pair_id":"BioInfer.d640.s0.p2","sentence":"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for ps E-CD pe; 86 per cent for alpha-catenin; 91 per cent for ps beta-catenin pe) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.","label":0}
{"pair_id":"BioInfer.d1.s4.p0","sentence":"These data indicate that the ps actin pe-binding domains in plant and animal ps profilins pe are functionally highly conserved, although the overall sequence similarity is less than 25%.","label":1}
{"pair_id":"BioInfer.d169.s1.p0","sentence":"In the presence of magnesium ions birch profilin promoted the polymerization of ps actin pe from ps A pe:Tbeta4.","label":1}
{"pair_id":"BioInfer.d169.s1.p1","sentence":"In the presence of magnesium ions birch ps profilin pe promoted the polymerization of actin from ps A pe:Tbeta4.","label":0}
{"pair_id":"BioInfer.d169.s1.p2","sentence":"In the presence of magnesium ions birch profilin promoted the polymerization of actin from ps A pe:ps Tbeta4 pe.","label":1}
{"pair_id":"BioInfer.d169.s1.p3","sentence":"In the presence of magnesium ions birch ps profilin pe promoted the polymerization of ps actin pe from A:Tbeta4.","label":1}
{"pair_id":"BioInfer.d169.s1.p4","sentence":"In the presence of magnesium ions birch profilin promoted the polymerization of ps actin pe from A:ps Tbeta4 pe.","label":1}
{"pair_id":"BioInfer.d169.s1.p5","sentence":"In the presence of magnesium ions birch ps profilin pe promoted the polymerization of actin from A:ps Tbeta4 pe.","label":0}
{"pair_id":"BioInfer.d307.s0.p0","sentence":"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to ps actin pe monomers, and by ps capping protein pe, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":0}
{"pair_id":"BioInfer.d307.s0.p1","sentence":"In Acanthamoeba actin polymerization is regulated, at least in part, by ps profilin pe, which binds to actin monomers, and by ps capping protein pe, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":0}
{"pair_id":"BioInfer.d307.s0.p2","sentence":"In Acanthamoeba ps actin pe polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by ps capping protein pe, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":1}
{"pair_id":"BioInfer.d307.s0.p3","sentence":"In Acanthamoeba actin polymerization is regulated, at least in part, by ps profilin pe, which binds to ps actin pe monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":1}
{"pair_id":"BioInfer.d307.s0.p4","sentence":"In Acanthamoeba ps actin pe polymerization is regulated, at least in part, by profilin, which binds to ps actin pe monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":0}
{"pair_id":"BioInfer.d307.s0.p5","sentence":"In Acanthamoeba ps actin pe polymerization is regulated, at least in part, by ps profilin pe, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.","label":1}
{"pair_id":"BioInfer.d653.s0.p0","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p1","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p2","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p3","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p4","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p5","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p6","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p7","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p8","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p9","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p10","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p11","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p12","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p13","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, ps F pe: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p14","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p15","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p16","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p17","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p18","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p19","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p20","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p21","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p22","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p23","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p24","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p25","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p26","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, ps P pe: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p27","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p28","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p29","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p30","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p31","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p32","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p33","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p34","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p35","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p36","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p37","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p38","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, ps L pe: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p39","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p40","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein pe (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p41","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p42","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p43","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p44","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (F), and large ps protein pe (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p45","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein pe (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p46","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein pe (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p47","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and ps large protein pe (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p48","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p49","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (ps L pe) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p50","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p51","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p52","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p53","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p54","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p55","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p56","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p57","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p58","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p59","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, ps M pe: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p60","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p61","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p62","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (ps F pe), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p63","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p64","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), ps fusion pe (F), and large ps protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p65","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), ps fusion pe (F), and large ps protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p66","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and ps large protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p67","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p68","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), ps fusion pe (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p69","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (ps P pe), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p70","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p71","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p72","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), ps matrix pe (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p73","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (ps P pe), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p74","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p75","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (ps M pe), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p76","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (ps P pe), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p77","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p78","sentence":"The nucleotide sequences of ps nucleocapsid pe (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p79","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p80","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p81","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p82","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (ps M pe), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p83","sentence":"The nucleotide sequences of nucleocapsid (ps N pe), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p84","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p85","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (ps F pe), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p86","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (ps F pe), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p87","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p88","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p89","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (ps F pe), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p90","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p91","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p92","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (F), and ps large protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p93","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p94","sentence":"The nucleotide sequences of ps nucleocapsid pe (N), phosphoprotein (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p95","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), ps matrix pe (M), fusion (F), and large ps protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p96","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and ps large protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p97","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (ps M pe), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p98","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), ps matrix pe (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p99","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and ps large protein peps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p100","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (ps M pe), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p101","sentence":"The nucleotide sequences of nucleocapsid (N), ps phosphoprotein pe (P), matrix (M), fusion (F), and large ps protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p102","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p103","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and ps large protein pe (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"BioInfer.d653.s0.p104","sentence":"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (ps M pe), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position ps N pe: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.","label":0}
{"pair_id":"AIMed.d83.s704.p0","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ps ciliary neurotrophic factor pe (ps CNTF pe) with CNTFR alpha and not with the beta-components, gp130 and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p1","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ps ciliary neurotrophic factor pe (CNTF) with ps CNTFR alpha pe and not with the beta-components, gp130 and LIFR.","label":1}
{"pair_id":"AIMed.d83.s704.p2","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ps ciliary neurotrophic factor pe (CNTF) with CNTFR alpha and not with the beta-components, ps gp130 pe and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p3","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ps ciliary neurotrophic factor pe (CNTF) with CNTFR alpha and not with the beta-components, gp130 and ps LIFR pe.","label":0}
{"pair_id":"AIMed.d83.s704.p4","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (ps CNTF pe) with ps CNTFR alpha pe and not with the beta-components, gp130 and LIFR.","label":1}
{"pair_id":"AIMed.d83.s704.p5","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (ps CNTF pe) with CNTFR alpha and not with the beta-components, ps gp130 pe and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p6","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (ps CNTF pe) with CNTFR alpha and not with the beta-components, gp130 and ps LIFR pe.","label":0}
{"pair_id":"AIMed.d83.s704.p7","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (CNTF) with ps CNTFR alpha pe and not with the beta-components, ps gp130 pe and LIFR.","label":0}
{"pair_id":"AIMed.d83.s704.p8","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (CNTF) with ps CNTFR alpha pe and not with the beta-components, gp130 and ps LIFR pe.","label":0}
{"pair_id":"AIMed.d83.s704.p9","sentence":"By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (CNTF) with CNTFR alpha and not with the beta-components, ps gp130 pe and ps LIFR pe.","label":0}
{"pair_id":"BioInfer.d564.s0.p0","sentence":"The alpha-catenin molecule links E-cadherin\/ ps beta-catenin pe or ps E-cadherin pe\/plakoglobin complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p1","sentence":"The alpha-catenin molecule links ps E-cadherin pe\/ beta-catenin or ps E-cadherin pe\/plakoglobin complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p2","sentence":"The alpha-catenin molecule links E-cadherin\/ beta-catenin or ps E-cadherin pe\/ps plakoglobin pe complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p3","sentence":"The ps alpha-catenin pe molecule links E-cadherin\/ beta-catenin or ps E-cadherin pe\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p4","sentence":"The alpha-catenin molecule links E-cadherin\/ beta-catenin or ps E-cadherin pe\/plakoglobin complexes to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p5","sentence":"The alpha-catenin molecule links ps E-cadherin pe\/ ps beta-catenin pe or E-cadherin\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p6","sentence":"The alpha-catenin molecule links E-cadherin\/ ps beta-catenin pe or E-cadherin\/ps plakoglobin pe complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p7","sentence":"The ps alpha-catenin pe molecule links E-cadherin\/ ps beta-catenin pe or E-cadherin\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p8","sentence":"The alpha-catenin molecule links E-cadherin\/ ps beta-catenin pe or E-cadherin\/plakoglobin complexes to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p9","sentence":"The alpha-catenin molecule links ps E-cadherin pe\/ beta-catenin or E-cadherin\/ps plakoglobin pe complexes to the actin cytoskeleton.","label":0}
{"pair_id":"BioInfer.d564.s0.p10","sentence":"The ps alpha-catenin pe molecule links ps E-cadherin pe\/ beta-catenin or E-cadherin\/plakoglobin complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p11","sentence":"The alpha-catenin molecule links ps E-cadherin pe\/ beta-catenin or E-cadherin\/plakoglobin complexes to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p12","sentence":"The ps alpha-catenin pe molecule links E-cadherin\/ beta-catenin or E-cadherin\/ps plakoglobin pe complexes to the actin cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p13","sentence":"The alpha-catenin molecule links E-cadherin\/ beta-catenin or E-cadherin\/ps plakoglobin pe complexes to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d564.s0.p14","sentence":"The ps alpha-catenin pe molecule links E-cadherin\/ beta-catenin or E-cadherin\/plakoglobin complexes to the ps actin pe cytoskeleton.","label":1}
{"pair_id":"AIMed.d36.s306.p0","sentence":"In this study, we simulated interactions of all amphipathic helices of ps apolipoproteins E pe and A-I with ps Abeta pe and simian immunodeficiency virus (SIV) fusogenic fragments by molecular modeling.","label":0}
{"pair_id":"BioInfer.d129.s0.p0","sentence":"ps CD26 pe, a T cell activation Ag, also known as ps dipeptidyl peptidase IV pe, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"BioInfer.d129.s0.p1","sentence":"ps CD26 pe, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ps ADA pe) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p2","sentence":"ps CD26 pe, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with ps adenosine deaminase pe (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p3","sentence":"CD26, a T cell activation Ag, also known as ps dipeptidyl peptidase IV pe, is directly associated with adenosine deaminase (ps ADA pe) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p4","sentence":"CD26, a T cell activation Ag, also known as ps dipeptidyl peptidase IV pe, is directly associated with ps adenosine deaminase pe (ADA) on the surface of T cells and T cell lines.","label":1}
{"pair_id":"BioInfer.d129.s0.p5","sentence":"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with ps adenosine deaminase pe (ps ADA pe) on the surface of T cells and T cell lines.","label":0}
{"pair_id":"AIMed.d105.s891.p0","sentence":"Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two ps IL-6 pe, two ps IL-6R alpha pe and two gp130 molecules.","label":1}
{"pair_id":"AIMed.d105.s891.p1","sentence":"Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two ps IL-6 pe, two IL-6R alpha and two ps gp130 pe molecules.","label":1}
{"pair_id":"AIMed.d105.s891.p2","sentence":"Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two ps IL-6R alpha pe and two ps gp130 pe molecules.","label":1}
{"pair_id":"AIMed.d77.s654.p0","sentence":"We show that the carboxy terminal \"tail\" of ps DPI pe associates directly with the amino terminal \"head\" of type II epidermal keratins, including ps K1 pe, K2, K5, and K6.","label":1}
{"pair_id":"AIMed.d77.s654.p1","sentence":"We show that the carboxy terminal \"tail\" of ps DPI pe associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, ps K2 pe, K5, and K6.","label":1}
{"pair_id":"AIMed.d77.s654.p2","sentence":"We show that the carboxy terminal \"tail\" of ps DPI pe associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, ps K5 pe, and K6.","label":1}
{"pair_id":"AIMed.d77.s654.p3","sentence":"We show that the carboxy terminal \"tail\" of ps DPI pe associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, K5, and ps K6 pe.","label":1}
{"pair_id":"AIMed.d77.s654.p4","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including ps K1 pe, ps K2 pe, K5, and K6.","label":0}
{"pair_id":"AIMed.d77.s654.p5","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including ps K1 pe, K2, ps K5 pe, and K6.","label":0}
{"pair_id":"AIMed.d77.s654.p6","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including ps K1 pe, K2, K5, and ps K6 pe.","label":0}
{"pair_id":"AIMed.d77.s654.p7","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, ps K2 pe, ps K5 pe, and K6.","label":0}
{"pair_id":"AIMed.d77.s654.p8","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, ps K2 pe, K5, and ps K6 pe.","label":0}
{"pair_id":"AIMed.d77.s654.p9","sentence":"We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, ps K5 pe, and ps K6 pe.","label":0}
{"pair_id":"AIMed.d197.s1675.p0","sentence":"Analysis of the human ps interleukin-6 pe\/human ps interleukin-6 pe receptor binding interface at the amino acid level: proposed mechanism of interaction.","label":0}
{"pair_id":"AIMed.d197.s1675.p1","sentence":"Analysis of the human ps interleukin-6 pe\/human ps interleukin-6 receptor pe binding interface at the amino acid level: proposed mechanism of interaction.","label":1}
{"pair_id":"AIMed.d197.s1675.p2","sentence":"Analysis of the human interleukin-6\/human ps interleukin-6 peps interleukin-6 receptor pe binding interface at the amino acid level: proposed mechanism of interaction.","label":0}
{"pair_id":"BioInfer.d384.s0.p0","sentence":"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with ps alpha-catenin pe and ps APC pe were detectable.","label":0}
{"pair_id":"BioInfer.d384.s0.p1","sentence":"In three of the cell lines with CTNNB1 mutations, complexes of ps beta-catenin pe with alpha-catenin and ps APC pe were detectable.","label":1}
{"pair_id":"BioInfer.d384.s0.p2","sentence":"In three of the cell lines with ps CTNNB1 pe mutations, complexes of beta-catenin with alpha-catenin and ps APC pe were detectable.","label":0}
{"pair_id":"BioInfer.d384.s0.p3","sentence":"In three of the cell lines with CTNNB1 mutations, complexes of ps beta-catenin pe with ps alpha-catenin pe and APC were detectable.","label":1}
{"pair_id":"BioInfer.d384.s0.p4","sentence":"In three of the cell lines with ps CTNNB1 pe mutations, complexes of beta-catenin with ps alpha-catenin pe and APC were detectable.","label":0}
{"pair_id":"BioInfer.d384.s0.p5","sentence":"In three of the cell lines with ps CTNNB1 pe mutations, complexes of ps beta-catenin pe with alpha-catenin and APC were detectable.","label":0}
{"pair_id":"BioInfer.d730.s0.p0","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p1","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p2","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p3","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p4","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p5","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p6","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p7","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p8","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p9","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p10","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p11","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or ps actin pe stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p12","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p13","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p14","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p15","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p16","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p17","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p18","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p19","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p20","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p21","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p22","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble ps talin pe-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p23","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p24","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p25","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p26","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p27","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p28","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p29","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p30","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p31","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p32","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas ps vinculin pe (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p33","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p34","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p35","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p36","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p37","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p38","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p39","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p40","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p41","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble ps vinculin pe or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p42","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p43","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p44","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p45","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p46","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p47","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p48","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p49","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on ps fibronectin pe, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p50","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p51","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p52","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p53","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p54","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p55","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p56","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or ps laminin pe and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p57","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p58","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p59","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p60","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p61","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p62","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not ps fibronectin pe (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p63","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p64","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p65","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p66","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p67","sentence":"The undifferentiated cells (a) were unable to spread on ps gelatin pe or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p68","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p69","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p70","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p71","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on ps fibronectin pe (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p72","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p73","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p74","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of ps beta1 integrin pe, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p75","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p76","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or ps paxillin pe-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d730.s0.p77","sentence":"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to ps laminin pe, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a ps vinculin pe (-\/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-\/-) ES cells were able to assemble talin-containing focal adhesions.","label":0}
{"pair_id":"BioInfer.d652.s1.p0","sentence":"The Pro1176 to Thr substitution found in ps talin pe from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind ps actin pe or vinculin.","label":1}
{"pair_id":"BioInfer.d652.s1.p1","sentence":"The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind ps actin pe or ps vinculin pe.","label":0}
{"pair_id":"BioInfer.d652.s1.p2","sentence":"The Pro1176 to Thr substitution found in ps talin pe from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or ps vinculin pe.","label":1}
{"pair_id":"BioInfer.d407.s1.p0","sentence":"These results demonstrate that ps cofilin pe plays a crucial role in vivo in rapid remodeling of the cortical ps actin pe meshwork into bundles.","label":1}
{"pair_id":"AIMed.d70.s595.p0","sentence":"Computer-aided analysis of secondary structure, performed on four ps RII pe-anchoring protein sequences (the ps microtubule-associated protein 2 pe, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p1","sentence":"Computer-aided analysis of secondary structure, performed on four ps RII pe-anchoring protein sequences (the microtubule-associated protein 2, ps P150 pe, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p2","sentence":"Computer-aided analysis of secondary structure, performed on four ps RII pe-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins ps Ht 21 pe and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p3","sentence":"Computer-aided analysis of secondary structure, performed on four ps RII pe-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and ps Ht 31 pe), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p4","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the ps microtubule-associated protein 2 pe, ps P150 pe, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p5","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the ps microtubule-associated protein 2 pe, P150, and two thyroid proteins ps Ht 21 pe and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p6","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the ps microtubule-associated protein 2 pe, P150, and two thyroid proteins Ht 21 and ps Ht 31 pe), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p7","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, ps P150 pe, and two thyroid proteins ps Ht 21 pe and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p8","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, ps P150 pe, and two thyroid proteins Ht 21 and ps Ht 31 pe), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"AIMed.d70.s595.p9","sentence":"Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins ps Ht 21 pe and ps Ht 31 pe), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.","label":0}
{"pair_id":"BioInfer.d291.s0.p0","sentence":"Immunohistochemical identification and localization of ps actin pe and ps fimbrin pe in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.","label":0}
{"pair_id":"AIMed.d165.s1390.p0","sentence":"Additionally we have examined interactions between ps TFIIH pe components, the human NER protein ps XPG pe, and the CSB protein which is implicated in Cockayne syndrome (CS).","label":0}
{"pair_id":"AIMed.d165.s1390.p1","sentence":"Additionally we have examined interactions between ps TFIIH pe components, the human NER protein XPG, and the ps CSB pe protein which is implicated in Cockayne syndrome (CS).","label":0}
{"pair_id":"AIMed.d165.s1390.p2","sentence":"Additionally we have examined interactions between TFIIH components, the human NER protein ps XPG pe, and the ps CSB pe protein which is implicated in Cockayne syndrome (CS).","label":0}
{"pair_id":"BioInfer.d773.s0.p0","sentence":"Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, ps GAL4 pe, and a negative regulatory protein, ps GAL80 pe.","label":1}
{"pair_id":"AIMed.d68.s581.p0","sentence":"Association between ps cdc25A pe and ps cyclin B1 pe\/cdc2 was detected in the HeLa cells.","label":1}
{"pair_id":"AIMed.d68.s581.p1","sentence":"Association between ps cdc25A pe and cyclin B1\/ps cdc2 pe was detected in the HeLa cells.","label":1}
{"pair_id":"AIMed.d68.s581.p2","sentence":"Association between cdc25A and ps cyclin B1 pe\/ps cdc2 pe was detected in the HeLa cells.","label":0}
{"pair_id":"BioInfer.d351.s0.p0","sentence":"In reconstitution experiments, ps actin pe filaments incubated in EGTA with purified ps fimbrin pe and villin form smooth-sided bundles containing an apparently random number of filaments.","label":1}
{"pair_id":"BioInfer.d351.s0.p1","sentence":"In reconstitution experiments, actin filaments incubated in EGTA with purified ps fimbrin pe and ps villin pe form smooth-sided bundles containing an apparently random number of filaments.","label":0}
{"pair_id":"BioInfer.d351.s0.p2","sentence":"In reconstitution experiments, ps actin pe filaments incubated in EGTA with purified fimbrin and ps villin pe form smooth-sided bundles containing an apparently random number of filaments.","label":1}
{"pair_id":"BioInfer.d237.s1.p0","sentence":"Interaction of the yeast ps RAD51 pe and ps RAD52 pe proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.","label":1}
{"pair_id":"AIMed.d141.s1189.p0","sentence":"The cyclin-dependent kinase ps Cdk2 pe associates with ps cyclins A pe, D, and E and has been implicated in the control of the G1 to S phase transition in mammals.","label":0}
{"pair_id":"BioInfer.d750.s0.p0","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: ps Armadillo pe (homolog of beta-catenin), Drosophila ps E-cadherin pe (DE-cadherin), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p1","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila ps E-cadherin pe (DE-cadherin), and ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d750.s0.p2","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of ps beta-catenin pe), Drosophila ps E-cadherin pe (DE-cadherin), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p3","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila ps E-cadherin pe (ps DE-cadherin pe), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p4","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: ps Armadillo pe (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d750.s0.p5","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: ps Armadillo pe (homolog of ps beta-catenin pe), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.","label":1}
{"pair_id":"BioInfer.d750.s0.p6","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: ps Armadillo pe (homolog of beta-catenin), Drosophila E-cadherin (ps DE-cadherin pe), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d750.s0.p7","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of ps beta-catenin pe), Drosophila E-cadherin (DE-cadherin), and ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d750.s0.p8","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (ps DE-cadherin pe), and ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d750.s0.p9","sentence":"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of ps beta-catenin pe), Drosophila E-cadherin (ps DE-cadherin pe), and alpha-catenin.","label":0}
{"pair_id":"BioInfer.d694.s0.p0","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of ps class II myosins pe, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium ps myosin II pe requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p1","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of ps class II myosins pe, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated ps actin pe-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p2","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of ps class II myosins pe, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent ps MgATPase pe activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p3","sentence":"These data strongly suggest that the head, neck, and tail domains of all ps myosin heavy chains pe, and light chains at least of ps class II myosins pe, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p4","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated ps actin pe-dependent MgATPase activity of Dictyostelium ps myosin II pe requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p5","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent ps MgATPase pe activity of Dictyostelium ps myosin II pe requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p6","sentence":"These data strongly suggest that the head, neck, and tail domains of all ps myosin heavy chains pe, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium ps myosin II pe requires isoform specific interactions between the heavy chain head and tail and light chains.","label":1}
{"pair_id":"BioInfer.d694.s0.p7","sentence":"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated ps actin pe-dependent ps MgATPase pe activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p8","sentence":"These data strongly suggest that the head, neck, and tail domains of all ps myosin heavy chains pe, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated ps actin pe-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d694.s0.p9","sentence":"These data strongly suggest that the head, neck, and tail domains of all ps myosin heavy chains pe, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent ps MgATPase pe activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.","label":0}
{"pair_id":"BioInfer.d299.s0.p0","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- ps catenin pe complexes, one composed of E-cadherin, alpha-catenin and ps beta-catenin pe, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p1","sentence":"Immunoprecipitations showed in both cell lines the presence of two different ps E-cadherin pe- catenin complexes, one composed of E-cadherin, alpha-catenin and ps beta-catenin pe, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p2","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and ps beta-catenin pe, and the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p3","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and ps beta-catenin pe, and the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d299.s0.p4","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and ps beta-catenin pe, and the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p5","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of ps E-cadherin pe, alpha-catenin and ps beta-catenin pe, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p6","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, ps alpha-catenin pe and ps beta-catenin pe, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p7","sentence":"Immunoprecipitations showed in both cell lines the presence of two different ps E-cadherin pe- ps catenin pe complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p8","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- ps catenin pe complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p9","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- ps catenin pe complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d299.s0.p10","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- ps catenin pe complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p11","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- ps catenin pe complexes, one composed of ps E-cadherin pe, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p12","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- ps catenin pe complexes, one composed of E-cadherin, ps alpha-catenin pe and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p13","sentence":"Immunoprecipitations showed in both cell lines the presence of two different ps E-cadherin pe- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p14","sentence":"Immunoprecipitations showed in both cell lines the presence of two different ps E-cadherin pe- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d299.s0.p15","sentence":"Immunoprecipitations showed in both cell lines the presence of two different ps E-cadherin pe- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p16","sentence":"Immunoprecipitations showed in both cell lines the presence of two different ps E-cadherin pe- catenin complexes, one composed of ps E-cadherin pe, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p17","sentence":"Immunoprecipitations showed in both cell lines the presence of two different ps E-cadherin pe- catenin complexes, one composed of E-cadherin, ps alpha-catenin pe and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p18","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of ps E-cadherin pe, alpha-catenin and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d299.s0.p19","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of ps E-cadherin pe, ps alpha-catenin pe and plakoglobin.","label":1}
{"pair_id":"BioInfer.d299.s0.p20","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of ps E-cadherin pe, alpha-catenin and beta-catenin, and the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p21","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, ps alpha-catenin pe and beta-catenin, and the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p22","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, ps alpha-catenin pe and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d299.s0.p23","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of ps E-cadherin pe, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d299.s0.p24","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, ps alpha-catenin pe and beta-catenin, and the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d299.s0.p25","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of ps E-cadherin pe, alpha-catenin and beta-catenin, and the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p26","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, ps alpha-catenin pe and beta-catenin, and the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d299.s0.p27","sentence":"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of ps E-cadherin pe, ps alpha-catenin pe and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"AIMed.d183.s1559.p0","sentence":"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of ps Raf-1 pe coimmunoprecipitated with ps JAK2 pe in lysates of cells in which JAK2 was activated as judged by its state of tyrosine phosphorylation.","label":1}
{"pair_id":"AIMed.d183.s1559.p1","sentence":"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of ps Raf-1 pe coimmunoprecipitated with JAK2 in lysates of cells in which ps JAK2 pe was activated as judged by its state of tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d183.s1559.p2","sentence":"In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of Raf-1 coimmunoprecipitated with ps JAK2 pe in lysates of cells in which ps JAK2 pe was activated as judged by its state of tyrosine phosphorylation.","label":0}
{"pair_id":"AIMed.d37.s316.p0","sentence":"Among these ligands, ps MCP-3 pe had the remarkable property of binding ps CCR5 pe with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":1}
{"pair_id":"AIMed.d37.s316.p1","sentence":"Among these ligands, ps MCP-3 pe had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, ps MCP-3 pe could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p2","sentence":"Among these ligands, ps MCP-3 pe had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of ps CCR5 pe by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p3","sentence":"Among these ligands, ps MCP-3 pe had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by ps MIP-1beta pe and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p4","sentence":"Among these ligands, ps MCP-3 pe had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for ps CCR5 pe.","label":0}
{"pair_id":"AIMed.d37.s316.p5","sentence":"Among these ligands, MCP-3 had the remarkable property of binding ps CCR5 pe with high affinity without eliciting a functional response, ps MCP-3 pe could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p6","sentence":"Among these ligands, MCP-3 had the remarkable property of binding ps CCR5 pe with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of ps CCR5 pe by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p7","sentence":"Among these ligands, MCP-3 had the remarkable property of binding ps CCR5 pe with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by ps MIP-1beta pe and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p8","sentence":"Among these ligands, MCP-3 had the remarkable property of binding ps CCR5 pe with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for ps CCR5 pe.","label":0}
{"pair_id":"AIMed.d37.s316.p9","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, ps MCP-3 pe could also inhibit the activation of ps CCR5 pe by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p10","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, ps MCP-3 pe could also inhibit the activation of CCR5 by ps MIP-1beta pe and may therefore be considered as a natural antagonist for CCR5.","label":0}
{"pair_id":"AIMed.d37.s316.p11","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, ps MCP-3 pe could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for ps CCR5 pe.","label":1}
{"pair_id":"AIMed.d37.s316.p12","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of ps CCR5 pe by ps MIP-1beta pe and may therefore be considered as a natural antagonist for CCR5.","label":1}
{"pair_id":"AIMed.d37.s316.p13","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of ps CCR5 pe by MIP-1beta and may therefore be considered as a natural antagonist for ps CCR5 pe.","label":0}
{"pair_id":"AIMed.d37.s316.p14","sentence":"Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by ps MIP-1beta pe and may therefore be considered as a natural antagonist for ps CCR5 pe.","label":0}
{"pair_id":"AIMed.d207.s1788.p0","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the ps myogenic basic helix-loop-helix pe (ps bHLH pe) protein MyoD and the pocket proteins pRb, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p1","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the ps myogenic basic helix-loop-helix pe (bHLH) protein ps MyoD pe and the pocket proteins pRb, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p2","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the ps myogenic basic helix-loop-helix pe (bHLH) protein MyoD and the pocket proteins ps pRb pe, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p3","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the ps myogenic basic helix-loop-helix pe (bHLH) protein MyoD and the pocket proteins pRb, ps p107 pe and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p4","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the ps myogenic basic helix-loop-helix pe (bHLH) protein MyoD and the pocket proteins pRb, p107 and ps pRb2 pe\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p5","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the ps myogenic basic helix-loop-helix pe (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2\/ps p130 pe.","label":0}
{"pair_id":"AIMed.d207.s1788.p6","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (ps bHLH pe) protein ps MyoD pe and the pocket proteins pRb, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p7","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (ps bHLH pe) protein MyoD and the pocket proteins ps pRb pe, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p8","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (ps bHLH pe) protein MyoD and the pocket proteins pRb, ps p107 pe and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p9","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (ps bHLH pe) protein MyoD and the pocket proteins pRb, p107 and ps pRb2 pe\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p10","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (ps bHLH pe) protein MyoD and the pocket proteins pRb, p107 and pRb2\/ps p130 pe.","label":0}
{"pair_id":"AIMed.d207.s1788.p11","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein ps MyoD pe and the pocket proteins ps pRb pe, p107 and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p12","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein ps MyoD pe and the pocket proteins pRb, ps p107 pe and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p13","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein ps MyoD pe and the pocket proteins pRb, p107 and ps pRb2 pe\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p14","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein ps MyoD pe and the pocket proteins pRb, p107 and pRb2\/ps p130 pe.","label":0}
{"pair_id":"AIMed.d207.s1788.p15","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins ps pRb pe, ps p107 pe and pRb2\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p16","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins ps pRb pe, p107 and ps pRb2 pe\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p17","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins ps pRb pe, p107 and pRb2\/ps p130 pe.","label":0}
{"pair_id":"AIMed.d207.s1788.p18","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, ps p107 pe and ps pRb2 pe\/p130.","label":0}
{"pair_id":"AIMed.d207.s1788.p19","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, ps p107 pe and pRb2\/ps p130 pe.","label":0}
{"pair_id":"AIMed.d207.s1788.p20","sentence":"Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and ps pRb2 pe\/ps p130 pe.","label":0}
{"pair_id":"AIMed.d81.s688.p0","sentence":"ps RIP pe: a novel protein containing a death domain that interacts with ps Fas pe\/APO-1 (CD95) in yeast and causes cell death.","label":1}
{"pair_id":"AIMed.d81.s688.p1","sentence":"ps RIP pe: a novel protein containing a death domain that interacts with Fas\/ps APO-1 pe (CD95) in yeast and causes cell death.","label":1}
{"pair_id":"AIMed.d81.s688.p2","sentence":"ps RIP pe: a novel protein containing a death domain that interacts with Fas\/APO-1 (ps CD95 pe) in yeast and causes cell death.","label":1}
{"pair_id":"AIMed.d81.s688.p3","sentence":"RIP: a novel protein containing a death domain that interacts with ps Fas pe\/ps APO-1 pe (CD95) in yeast and causes cell death.","label":0}
{"pair_id":"AIMed.d81.s688.p4","sentence":"RIP: a novel protein containing a death domain that interacts with ps Fas pe\/APO-1 (ps CD95 pe) in yeast and causes cell death.","label":0}
{"pair_id":"AIMed.d81.s688.p5","sentence":"RIP: a novel protein containing a death domain that interacts with Fas\/ps APO-1 pe (ps CD95 pe) in yeast and causes cell death.","label":0}
{"pair_id":"AIMed.d103.s869.p0","sentence":"In contrast to ps hTAFII28 pe, ps hTAFII18 pe is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p1","sentence":"In contrast to ps hTAFII28 pe, hTAFII18 is a ps TFIID pe beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p2","sentence":"In contrast to ps hTAFII28 pe, hTAFII18 is a ps TFIID beta pe-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p3","sentence":"In contrast to ps hTAFII28 pe, hTAFII18 is a TFIID beta-specific ps hTAFII pe. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p4","sentence":"In contrast to ps hTAFII28 pe, hTAFII18 is a TFIID beta-specific hTAFII. ps hTAFII20 pe is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p5","sentence":"In contrast to ps hTAFII28 pe, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of ps p22 pe, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p6","sentence":"In contrast to ps hTAFII28 pe, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dps TAFII30 alpha pe (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p7","sentence":"In contrast to ps hTAFII28 pe, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (ps p32 pe).","label":0}
{"pair_id":"AIMed.d103.s869.p8","sentence":"In contrast to hTAFII28, ps hTAFII18 pe is a ps TFIID pe beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p9","sentence":"In contrast to hTAFII28, ps hTAFII18 pe is a ps TFIID beta pe-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p10","sentence":"In contrast to hTAFII28, ps hTAFII18 pe is a TFIID beta-specific ps hTAFII pe. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p11","sentence":"In contrast to hTAFII28, ps hTAFII18 pe is a TFIID beta-specific hTAFII. ps hTAFII20 pe is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p12","sentence":"In contrast to hTAFII28, ps hTAFII18 pe is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of ps p22 pe, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p13","sentence":"In contrast to hTAFII28, ps hTAFII18 pe is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dps TAFII30 alpha pe (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p14","sentence":"In contrast to hTAFII28, ps hTAFII18 pe is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (ps p32 pe).","label":0}
{"pair_id":"AIMed.d103.s869.p15","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID peps TFIID beta pe-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p16","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID pe beta-specific ps hTAFII pe. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p17","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID pe beta-specific hTAFII. ps hTAFII20 pe is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p18","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID pe beta-specific hTAFII. hTAFII20 is the homologue of ps p22 pe, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p19","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID pe beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dps TAFII30 alpha pe (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p20","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID pe beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (ps p32 pe).","label":0}
{"pair_id":"AIMed.d103.s869.p21","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID beta pe-specific ps hTAFII pe. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p22","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID beta pe-specific hTAFII. ps hTAFII20 pe is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p23","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID beta pe-specific hTAFII. hTAFII20 is the homologue of ps p22 pe, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p24","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID beta pe-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dps TAFII30 alpha pe (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p25","sentence":"In contrast to hTAFII28, hTAFII18 is a ps TFIID beta pe-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (ps p32 pe).","label":0}
{"pair_id":"AIMed.d103.s869.p26","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific ps hTAFII pe. ps hTAFII20 pe is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p27","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific ps hTAFII pe. hTAFII20 is the homologue of ps p22 pe, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p28","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific ps hTAFII pe. hTAFII20 is the homologue of p22, an alternatively spliced form of dps TAFII30 alpha pe (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p29","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific ps hTAFII pe. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (ps p32 pe).","label":0}
{"pair_id":"AIMed.d103.s869.p30","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. ps hTAFII20 pe is the homologue of ps p22 pe, an alternatively spliced form of dTAFII30 alpha (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p31","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. ps hTAFII20 pe is the homologue of p22, an alternatively spliced form of dps TAFII30 alpha pe (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p32","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. ps hTAFII20 pe is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (ps p32 pe).","label":0}
{"pair_id":"AIMed.d103.s869.p33","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of ps p22 pe, an alternatively spliced form of dps TAFII30 alpha pe (p32).","label":0}
{"pair_id":"AIMed.d103.s869.p34","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of ps p22 pe, an alternatively spliced form of dTAFII30 alpha (ps p32 pe).","label":0}
{"pair_id":"AIMed.d103.s869.p35","sentence":"In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dps TAFII30 alpha pe (ps p32 pe).","label":0}
{"pair_id":"AIMed.d41.s358.p0","sentence":"The ps HFE pe-ps TfR pe complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.","label":1}
{"pair_id":"AIMed.d41.s358.p1","sentence":"The ps HFE pe-TfR complex suggests a binding site for transferrin on ps TfR pe and sheds light upon the function of HFE in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p2","sentence":"The ps HFE pe-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of ps HFE pe in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p3","sentence":"The HFE-ps TfR pe complex suggests a binding site for transferrin on ps TfR pe and sheds light upon the function of HFE in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p4","sentence":"The HFE-ps TfR pe complex suggests a binding site for transferrin on TfR and sheds light upon the function of ps HFE pe in regulating iron homeostasis.","label":0}
{"pair_id":"AIMed.d41.s358.p5","sentence":"The HFE-TfR complex suggests a binding site for transferrin on ps TfR pe and sheds light upon the function of ps HFE pe in regulating iron homeostasis.","label":0}
{"pair_id":"BioInfer.d519.s0.p0","sentence":"Requirement of the yeast MSH3 and ps MSH6 pe genes for ps MSH2 pe-dependent genomic stability.","label":1}
{"pair_id":"BioInfer.d519.s0.p1","sentence":"Requirement of the yeast ps MSH3 pe and MSH6 genes for ps MSH2 pe-dependent genomic stability.","label":1}
{"pair_id":"BioInfer.d519.s0.p2","sentence":"Requirement of the yeast ps MSH3 pe and ps MSH6 pe genes for MSH2-dependent genomic stability.","label":0}
{"pair_id":"AIMed.d46.s405.p0","sentence":"The binding epitopes of ps BMP-2 pe for ps BMPR-IA pe (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":1}
{"pair_id":"AIMed.d46.s405.p1","sentence":"The binding epitopes of ps BMP-2 pe for BMPR-IA (type I) and ps BMPR-II pe or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":1}
{"pair_id":"AIMed.d46.s405.p2","sentence":"The binding epitopes of ps BMP-2 pe for BMPR-IA (type I) and BMPR-II or ps ActR-II pe (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":1}
{"pair_id":"AIMed.d46.s405.p3","sentence":"The binding epitopes of ps BMP-2 pe for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using ps BMP-2 pe mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p4","sentence":"The binding epitopes of BMP-2 for ps BMPR-IA pe (type I) and ps BMPR-II pe or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p5","sentence":"The binding epitopes of BMP-2 for ps BMPR-IA pe (type I) and BMPR-II or ps ActR-II pe (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p6","sentence":"The binding epitopes of BMP-2 for ps BMPR-IA pe (type I) and BMPR-II or ActR-II (type II) were characterized using ps BMP-2 pe mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p7","sentence":"The binding epitopes of BMP-2 for BMPR-IA (type I) and ps BMPR-II pe or ps ActR-II pe (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p8","sentence":"The binding epitopes of BMP-2 for BMPR-IA (type I) and ps BMPR-II pe or ActR-II (type II) were characterized using ps BMP-2 pe mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"AIMed.d46.s405.p9","sentence":"The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or ps ActR-II pe (type II) were characterized using ps BMP-2 pe mutant proteins for analysis of interactions with receptor ectodomains.","label":0}
{"pair_id":"BioInfer.d7.s4.p0","sentence":"MgCl2 strongly inhibits these effects of ps profilin pe, most likely by binding to the high-affinity divalent cation site on the ps actin pe.","label":1}
{"pair_id":"AIMed.d32.s274.p0","sentence":"Thus, Phe93 and Phe205 are important binding determinants for both ps EPO pe and ps EMP1 pe, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the EPOR for productive ligand binding.","label":0}
{"pair_id":"AIMed.d32.s274.p1","sentence":"Thus, Phe93 and Phe205 are important binding determinants for both ps EPO pe and EMP1, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the ps EPOR pe for productive ligand binding.","label":1}
{"pair_id":"AIMed.d32.s274.p2","sentence":"Thus, Phe93 and Phe205 are important binding determinants for both EPO and ps EMP1 pe, even though these ligands share no sequence or structural homology, suggesting that these residues may represent a minimum epitope on the ps EPOR pe for productive ligand binding.","label":1}
{"pair_id":"AIMed.d209.s1808.p0","sentence":"ps RIN1 pe interacts with the \"effector domain\" of ps RAS pe and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.","label":1}
{"pair_id":"AIMed.d209.s1808.p1","sentence":"ps RIN1 pe interacts with the \"effector domain\" of RAS and employs some ps RAS pe determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p2","sentence":"ps RIN1 pe interacts with the \"effector domain\" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of ps RAF1 pe, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p3","sentence":"ps RIN1 pe interacts with the \"effector domain\" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known ps RAS pe effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p4","sentence":"RIN1 interacts with the \"effector domain\" of ps RAS pe and employs some ps RAS pe determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p5","sentence":"RIN1 interacts with the \"effector domain\" of ps RAS pe and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of ps RAF1 pe, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p6","sentence":"RIN1 interacts with the \"effector domain\" of ps RAS pe and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known ps RAS pe effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p7","sentence":"RIN1 interacts with the \"effector domain\" of RAS and employs some ps RAS pe determinants that are common to, and others that are distinct from, those required for the binding of ps RAF1 pe, a known RAS effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p8","sentence":"RIN1 interacts with the \"effector domain\" of RAS and employs some ps RAS pe determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known ps RAS pe effector.","label":0}
{"pair_id":"AIMed.d209.s1808.p9","sentence":"RIN1 interacts with the \"effector domain\" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of ps RAF1 pe, a known ps RAS pe effector.","label":1}
{"pair_id":"AIMed.d199.s1699.p0","sentence":"ps FGFR3 pe utilizes two different pools of adapter protein ps GRB2 pe to link to Ras.","label":0}
{"pair_id":"AIMed.d199.s1699.p1","sentence":"ps FGFR3 pe utilizes two different pools of adapter protein GRB2 to link to ps Ras pe.","label":0}
{"pair_id":"AIMed.d199.s1699.p2","sentence":"FGFR3 utilizes two different pools of adapter protein ps GRB2 pe to link to ps Ras pe.","label":0}
{"pair_id":"AIMed.d94.s799.p0","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, ps (MIP)-1 alpha pe ps MIP pe and RANTES were both potent agonists for CC CKR3 and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p1","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, ps (MIP)-1 alpha pe MIP and ps RANTES pe were both potent agonists for CC CKR3 and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p2","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, ps (MIP)-1 alpha pe MIP and RANTES were both potent agonists for ps CC CKR3 pe and CC CKR1.","label":1}
{"pair_id":"AIMed.d94.s799.p3","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, ps (MIP)-1 alpha pe MIP and RANTES were both potent agonists for CC CKR3 and ps CC CKR1 pe.","label":1}
{"pair_id":"AIMed.d94.s799.p4","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha ps MIP pe and ps RANTES pe were both potent agonists for CC CKR3 and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p5","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha ps MIP pe and RANTES were both potent agonists for ps CC CKR3 pe and CC CKR1.","label":0}
{"pair_id":"AIMed.d94.s799.p6","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha ps MIP pe and RANTES were both potent agonists for CC CKR3 and ps CC CKR1 pe.","label":0}
{"pair_id":"AIMed.d94.s799.p7","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and ps RANTES pe were both potent agonists for ps CC CKR3 pe and CC CKR1.","label":1}
{"pair_id":"AIMed.d94.s799.p8","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and ps RANTES pe were both potent agonists for CC CKR3 and ps CC CKR1 pe.","label":1}
{"pair_id":"AIMed.d94.s799.p9","sentence":"When [Ca2+]i changes were monitored in stably transfected human embryonic kidney 293 cells, (MIP)-1 alpha MIP and RANTES were both potent agonists for ps CC CKR3 pe and ps CC CKR1 pe.","label":0}
{"pair_id":"AIMed.d199.s1700.p0","sentence":"Activated ps FGFR3 pe predominantly interacts with ps GRB2 pe.","label":1}
{"pair_id":"BioInfer.d5.s1.p0","sentence":"Acanthamoeba ps profilin pe was cross-linked to ps actin pe via a zero-length isopeptide bond using carbodiimide.","label":1}
{"pair_id":"BioInfer.d723.s0.p0","sentence":"The structural homology between cofilin and ps gelsolin pe segment-1 binding to ps actin pe was confirmed experimentally by two types of competitive binding assays.","label":1}
{"pair_id":"BioInfer.d723.s0.p1","sentence":"The structural homology between ps cofilin pe and gelsolin segment-1 binding to ps actin pe was confirmed experimentally by two types of competitive binding assays.","label":1}
{"pair_id":"BioInfer.d723.s0.p2","sentence":"The structural homology between ps cofilin pe and ps gelsolin pe segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.","label":1}
{"pair_id":"BioInfer.d241.s0.p0","sentence":"Here, we describe proline-rich proteins involved in regulating ps actin pe polymerization and classify them according to their role in recruiting ps profilin pe to the membrane.","label":0}
{"pair_id":"BioInfer.d261.s0.p0","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric ps helicase-primase pe composed of the products of the three DNA replication-specific genes UL5, ps UL8 pe, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p1","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes ps UL5 pe, ps UL8 pe, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p2","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, ps UL8 pe, and ps UL52 pe (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p3","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric ps helicase-primase pe composed of the products of the three DNA replication-specific genes ps UL5 pe, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p4","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric ps helicase-primase pe composed of the products of the three DNA replication-specific genes UL5, UL8, and ps UL52 pe (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"BioInfer.d261.s0.p5","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes ps UL5 pe, UL8, and ps UL52 pe (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).","label":1}
{"pair_id":"AIMed.d199.s1715.p0","sentence":"Finally, activated ps FGFR3 pe was also found to result in phosphorylation of ps phospholipase C-gamma pe but reduced phosphorylation of c-Src.","label":0}
{"pair_id":"AIMed.d199.s1715.p1","sentence":"Finally, activated ps FGFR3 pe was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of ps c-Src pe.","label":0}
{"pair_id":"AIMed.d199.s1715.p2","sentence":"Finally, activated FGFR3 was also found to result in phosphorylation of ps phospholipase C-gamma pe but reduced phosphorylation of ps c-Src pe.","label":0}
{"pair_id":"AIMed.d161.s1353.p0","sentence":"Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, ps SHPTP2 pe, with another SH2-containing protein, ps Grb7 pe.","label":1}
{"pair_id":"AIMed.d92.s785.p0","sentence":"ps Nerve growth factor pe binds independently to two transmembrane receptors, the ps p75 pe neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p1","sentence":"ps Nerve growth factor pe binds independently to two transmembrane receptors, the ps p75 neurotrophin receptor pe and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":1}
{"pair_id":"AIMed.d92.s785.p2","sentence":"ps Nerve growth factor pe binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the ps p140trk pe (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p3","sentence":"ps Nerve growth factor pe binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (ps trkA pe) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p4","sentence":"ps Nerve growth factor pe binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the ps p140trk (trkA) tyrosine kinase receptor pe, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":1}
{"pair_id":"AIMed.d92.s785.p5","sentence":"ps Nerve growth factor pe binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to ps NGF pe.","label":0}
{"pair_id":"AIMed.d92.s785.p6","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 peps p75 neurotrophin receptor pe and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p7","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 pe neurotrophin receptor and the ps p140trk pe (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p8","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 pe neurotrophin receptor and the p140trk (ps trkA pe) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p9","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 pe neurotrophin receptor and the ps p140trk (trkA) tyrosine kinase receptor pe, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p10","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 pe neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to ps NGF pe.","label":0}
{"pair_id":"AIMed.d92.s785.p11","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 neurotrophin receptor pe and the ps p140trk pe (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p12","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 neurotrophin receptor pe and the p140trk (ps trkA pe) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p13","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 neurotrophin receptor pe and the ps p140trk (trkA) tyrosine kinase receptor pe, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p14","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the ps p75 neurotrophin receptor pe and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to ps NGF pe.","label":0}
{"pair_id":"AIMed.d92.s785.p15","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the ps p140trk pe (ps trkA pe) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p16","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the ps p140trk peps p140trk (trkA) tyrosine kinase receptor pe, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p17","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the ps p140trk pe (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to ps NGF pe.","label":0}
{"pair_id":"AIMed.d92.s785.p18","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the ps p140trk (trkA) tyrosine kinase receptor peps trkA pe) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.","label":0}
{"pair_id":"AIMed.d92.s785.p19","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (ps trkA pe) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to ps NGF pe.","label":0}
{"pair_id":"AIMed.d92.s785.p20","sentence":"Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the ps p140trk (trkA) tyrosine kinase receptor pe, which are both co-expressed in the majority of neuronal cells that respond to ps NGF pe.","label":0}
{"pair_id":"AIMed.d44.s380.p0","sentence":"ps CD30 pe and its counter-receptor ps CD30 pe ligand (CD30L) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p1","sentence":"ps CD30 pe and its counter-receptor ps CD30 ligand pe (CD30L) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":1}
{"pair_id":"AIMed.d44.s380.p2","sentence":"ps CD30 pe and its counter-receptor CD30 ligand (ps CD30L pe) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":1}
{"pair_id":"AIMed.d44.s380.p3","sentence":"ps CD30 pe and its counter-receptor CD30 ligand (CD30L) are members of the TNF-receptor\/ps TNFalpha pe superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p4","sentence":"CD30 and its counter-receptor ps CD30 peps CD30 ligand pe (CD30L) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p5","sentence":"CD30 and its counter-receptor ps CD30 pe ligand (ps CD30L pe) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p6","sentence":"CD30 and its counter-receptor ps CD30 pe ligand (CD30L) are members of the TNF-receptor\/ps TNFalpha pe superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p7","sentence":"CD30 and its counter-receptor ps CD30 ligand pe (ps CD30L pe) are members of the TNF-receptor\/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p8","sentence":"CD30 and its counter-receptor ps CD30 ligand pe (CD30L) are members of the TNF-receptor\/ps TNFalpha pe superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"AIMed.d44.s380.p9","sentence":"CD30 and its counter-receptor CD30 ligand (ps CD30L pe) are members of the TNF-receptor\/ps TNFalpha pe superfamily and function to regulate lymphocyte survival and differentiation.","label":0}
{"pair_id":"BioInfer.d232.s1.p0","sentence":"We find that heterozygotes for actin (Act88F) or myosin heavy chain (ps Mhc36B pe) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; ps Act88F pe-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p1","sentence":"We find that heterozygotes for actin (Act88F) or ps myosin heavy chain pe (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; ps Act88F pe-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p2","sentence":"We find that heterozygotes for actin (ps Act88F pe) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; ps Act88F pe-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p3","sentence":"We find that heterozygotes for ps actin pe (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; ps Act88F pe-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p4","sentence":"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas ps Mhc36B pe-\/+; ps Act88F pe-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p5","sentence":"We find that heterozygotes for actin (Act88F) or ps myosin heavy chain pe (ps Mhc36B pe) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p6","sentence":"We find that heterozygotes for actin (ps Act88F pe) or myosin heavy chain (ps Mhc36B pe) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p7","sentence":"We find that heterozygotes for ps actin pe (Act88F) or myosin heavy chain (ps Mhc36B pe) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p8","sentence":"We find that heterozygotes for actin (Act88F) or myosin heavy chain (ps Mhc36B pe) null alleles have complex myofibrillar defects, whereas ps Mhc36B pe-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p9","sentence":"We find that heterozygotes for actin (ps Act88F pe) or ps myosin heavy chain pe (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p10","sentence":"We find that heterozygotes for ps actin pe (Act88F) or ps myosin heavy chain pe (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p11","sentence":"We find that heterozygotes for actin (Act88F) or ps myosin heavy chain pe (Mhc36B) null alleles have complex myofibrillar defects, whereas ps Mhc36B pe-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p12","sentence":"We find that heterozygotes for ps actin pe (ps Act88F pe) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p13","sentence":"We find that heterozygotes for actin (ps Act88F pe) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas ps Mhc36B pe-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d232.s1.p14","sentence":"We find that heterozygotes for ps actin pe (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas ps Mhc36B pe-\/+; Act88F-\/+ double heterozygotes have nearly normal myofibrils.","label":0}
{"pair_id":"BioInfer.d43.s3.p0","sentence":"When liver- or ps islet-liver- type gluc pe was transiently expressed in COS-7 cells, the expressed ps glucokinase pe was also co-localized with actin filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p1","sentence":"When ps liver- pe or ps islet-liver- type gluc peps liver- type gluc pe was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p2","sentence":"When liver- or ps islet-liver- type gluc pe was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with ps actin pe filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p3","sentence":"When ps liver- pe or islet-ps liver- type gluc pe was transiently expressed in COS-7 cells, the expressed ps glucokinase pe was also co-localized with actin filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d43.s3.p4","sentence":"When liver- or islet-liver- type gluc was transiently expressed in COS-7 cells, the expressed ps glucokinase pe was also co-localized with ps actin pe filaments in the cytoplasm of these transfected cells.","label":1}
{"pair_id":"BioInfer.d43.s3.p5","sentence":"When ps liver- pe or islet-ps liver- type gluc pe was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with ps actin pe filaments in the cytoplasm of these transfected cells.","label":0}
{"pair_id":"BioInfer.d789.s0.p0","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects ps actin pe filaments in these cells from Z. mays ps profilin pe (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":1}
{"pair_id":"BioInfer.d789.s0.p1","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that ps AtFim1 pe protects actin filaments in these cells from Z. mays ps profilin pe (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p2","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays ps profilin pe (ps ZmPRO5 pe)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p3","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the ps actin pe cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays ps profilin pe (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p4","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that ps AtFim1 pe protects ps actin pe filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":1}
{"pair_id":"BioInfer.d789.s0.p5","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects ps actin pe filaments in these cells from Z. mays profilin (ps ZmPRO5 pe)-induced depolymerization, in a dose-dependent manner.","label":1}
{"pair_id":"BioInfer.d789.s0.p6","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the ps actin pe cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects ps actin pe filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p7","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that ps AtFim1 pe protects actin filaments in these cells from Z. mays profilin (ps ZmPRO5 pe)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p8","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the ps actin pe cytoskeleton in living stamen hair cells, we demonstrated that ps AtFim1 pe protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"BioInfer.d789.s0.p9","sentence":"Using the 'nuclear displacement assay' as a measure of the integrity of the ps actin pe cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ps ZmPRO5 pe)-induced depolymerization, in a dose-dependent manner.","label":0}
{"pair_id":"AIMed.d145.s1229.p0","sentence":"The novel fold of the TNF receptor structure is likely to be representative of the ps nerve growth factor pe (ps NGF pe)\/TNF receptor family as a whole.","label":0}
{"pair_id":"BioInfer.d79.s1.p0","sentence":"Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and ps actin pe binding may be important for ps profilin pe function.","label":1}
{"pair_id":"BioInfer.d79.s1.p1","sentence":"Since our earlier studies of Acanthamoeba ps profilins pe suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for ps profilin pe function.","label":0}
{"pair_id":"BioInfer.d79.s1.p2","sentence":"Since our earlier studies of Acanthamoeba ps profilins pe suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and ps actin pe binding may be important for profilin function.","label":0}
{"pair_id":"AIMed.d120.s1022.p0","sentence":"The data thus demonstrate specific binding of platelet ps FXIII pe to ps HSP27 pe and suggest that HSP27 may participate in the cellular localization and\/or enzymatic regulation of platelet FXIII.","label":1}
{"pair_id":"AIMed.d120.s1022.p1","sentence":"The data thus demonstrate specific binding of platelet ps FXIII pe to HSP27 and suggest that ps HSP27 pe may participate in the cellular localization and\/or enzymatic regulation of platelet FXIII.","label":0}
{"pair_id":"AIMed.d120.s1022.p2","sentence":"The data thus demonstrate specific binding of platelet ps FXIII pe to HSP27 and suggest that HSP27 may participate in the cellular localization and\/or enzymatic regulation of platelet ps FXIII pe.","label":0}
{"pair_id":"AIMed.d120.s1022.p3","sentence":"The data thus demonstrate specific binding of platelet FXIII to ps HSP27 pe and suggest that ps HSP27 pe may participate in the cellular localization and\/or enzymatic regulation of platelet FXIII.","label":0}
{"pair_id":"AIMed.d120.s1022.p4","sentence":"The data thus demonstrate specific binding of platelet FXIII to ps HSP27 pe and suggest that HSP27 may participate in the cellular localization and\/or enzymatic regulation of platelet ps FXIII pe.","label":0}
{"pair_id":"AIMed.d120.s1022.p5","sentence":"The data thus demonstrate specific binding of platelet FXIII to HSP27 and suggest that ps HSP27 pe may participate in the cellular localization and\/or enzymatic regulation of platelet ps FXIII pe.","label":1}
{"pair_id":"AIMed.d104.s883.p0","sentence":"However, the various ps E2F pe\/DP complexes display strong differences in the ability to bind to either ps pRB pe or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p1","sentence":"However, the various ps E2F pe\/DP complexes display strong differences in the ability to bind to either pRB or ps p107 pe in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p2","sentence":"However, the various ps E2F pe\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of ps pRB pe or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p3","sentence":"However, the various ps E2F pe\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or ps p107 pe binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p4","sentence":"However, the various ps E2F pe\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the ps E2F pe subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p5","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either ps pRB pe or ps p107 pe in vivo, and the specificity of pRB or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p6","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either ps pRB pe or p107 in vivo, and the specificity of ps pRB pe or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p7","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either ps pRB pe or p107 in vivo, and the specificity of pRB or ps p107 pe binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p8","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either ps pRB pe or p107 in vivo, and the specificity of pRB or p107 binding is mediated by the ps E2F pe subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p9","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or ps p107 pe in vivo, and the specificity of ps pRB pe or p107 binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p10","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or ps p107 pe in vivo, and the specificity of pRB or ps p107 pe binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p11","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or ps p107 pe in vivo, and the specificity of pRB or p107 binding is mediated by the ps E2F pe subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p12","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of ps pRB pe or ps p107 pe binding is mediated by the E2F subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p13","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of ps pRB pe or p107 binding is mediated by the ps E2F pe subunit.","label":0}
{"pair_id":"AIMed.d104.s883.p14","sentence":"However, the various E2F\/DP complexes display strong differences in the ability to bind to either pRB or p107 in vivo, and the specificity of pRB or ps p107 pe binding is mediated by the ps E2F pe subunit.","label":0}
{"pair_id":"AIMed.d146.s1233.p0","sentence":"We have previously demonstrated such changes by affinity cross-linking studies, and have shown that unstimulated human T cells express a single ps IL-7R pe of 90 kDa, whereas activated T cells express an additional 76-kDa ps IL-7 pe binding protein.","label":0}
{"pair_id":"AIMed.d29.s245.p0","sentence":"These Ala mutants triggered neutrophil degranulation and induced calcium responses mediated by ps CXCR1 pe and ps CXCR2 pe.","label":0}
{"pair_id":"AIMed.d166.s1395.p0","sentence":"The region of ps hLIF pe most important for binding to the ps hLIF-R pe is composed of residues from the amino terminus of the D-helix, carboxyl terminus of the B-helix, and C-D loop.","label":1}
{"pair_id":"BioInfer.d210.s0.p0","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor ps p53 pe, and have determined that histone ps H3 pe is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p1","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor ps p53 pe, and have determined that histone H3 is significantly preferred over the histone ps H4 pe and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p2","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor ps p53 pe, and have determined that ps histone pe H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p3","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and ps H4 pe and the transcription factor ps p53 pe, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p4","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones H3 and H4 and the transcription factor ps p53 pe, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p5","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones ps H3 pe and H4 and the transcription factor ps p53 pe, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p6","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe H3 and H4 and the transcription factor ps p53 pe, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p7","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor ps p53 pe, and have determined that histone H3 is significantly preferred over the ps histone pe H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p8","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor ps p53 pe, and have determined that histone H3 is significantly preferred over the histone H4 and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p9","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone ps H3 pe is significantly preferred over the histone ps H4 pe and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p10","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that ps histone pe ps H3 pe is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p11","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and ps H4 pe and the transcription factor p53, and have determined that histone ps H3 pe is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p12","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone ps H3 pe is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p13","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones ps H3 pe and H4 and the transcription factor p53, and have determined that histone ps H3 pe is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p14","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe H3 and H4 and the transcription factor p53, and have determined that histone ps H3 pe is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p15","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone ps H3 pe is significantly preferred over the ps histone pe H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p16","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone ps H3 pe is significantly preferred over the histone H4 and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p17","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that ps histone pe H3 is significantly preferred over the histone ps H4 pe and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p18","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and ps H4 pe and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone ps H4 pe and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p19","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone ps H4 pe and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p20","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones ps H3 pe and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone ps H4 pe and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p21","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone ps H4 pe and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p22","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the ps histone pe ps H4 pe and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p23","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone ps H4 pe and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p24","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and ps H4 pe and the transcription factor p53, and have determined that ps histone pe H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p25","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones H3 and H4 and the transcription factor p53, and have determined that ps histone pe H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p26","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones ps H3 pe and H4 and the transcription factor p53, and have determined that ps histone pe H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p27","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe H3 and H4 and the transcription factor p53, and have determined that ps histone pe H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p28","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that ps histone pe H3 is significantly preferred over the ps histone pe H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p29","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that ps histone pe H3 is significantly preferred over the histone H4 and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p30","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones H3 and ps H4 pe and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p31","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones ps H3 pe and ps H4 pe and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p32","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe H3 and ps H4 pe and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p33","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and ps H4 pe and the transcription factor p53, and have determined that histone H3 is significantly preferred over the ps histone pe H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p34","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and ps H4 pe and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p35","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones ps H3 pe and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p36","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, ps histones pe H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p37","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the ps histone pe H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p38","sentence":"Finally, we evaluated the acetylation of three putative ps PCAF pe substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p39","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe ps H3 pe and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.","label":1}
{"pair_id":"BioInfer.d210.s0.p40","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones ps H3 pe and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the ps histone pe H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p41","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones ps H3 pe and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p42","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the ps histone pe H4 and p53 substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p43","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, ps histones pe H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and ps p53 pe substrates.","label":0}
{"pair_id":"BioInfer.d210.s0.p44","sentence":"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the ps histone pe H4 and ps p53 pe substrates.","label":0}
{"pair_id":"AIMed.d142.s1197.p0","sentence":"The recently cloned ps YY1 pe is such an ps Inr-binding protein pe.","label":0}
{"pair_id":"BioInfer.d833.s0.p0","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, ps alpha-catenin pe, ps beta-catenin pe, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p1","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, ps beta-catenin pe, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p2","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, ps beta-catenin pe, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p3","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, ps beta-catenin pe, ps plakoglobin pe, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p4","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, ps beta-catenin pe, plakoglobin, vinculin and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p5","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, ps beta-catenin pe, plakoglobin, ps vinculin pe and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p6","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, ps cadherins pe, alpha-catenin, ps beta-catenin pe, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p7","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, cadherins, alpha-catenin, ps beta-catenin pe, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p8","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, ps alpha-catenin pe, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p9","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, ps alpha-catenin pe, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p10","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, ps alpha-catenin pe, beta-catenin, ps plakoglobin pe, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p11","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, ps alpha-catenin pe, beta-catenin, plakoglobin, vinculin and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p12","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, ps alpha-catenin pe, beta-catenin, plakoglobin, ps vinculin pe and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p13","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, ps cadherins pe, ps alpha-catenin pe, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p14","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, cadherins, ps alpha-catenin pe, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p15","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p16","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, ps plakoglobin pe, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p17","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p18","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, ps vinculin pe and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p19","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, ps cadherins pe, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p20","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, ps paxillin pe and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p21","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, ps plakoglobin pe, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p22","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p23","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, ps vinculin pe and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p24","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, ps cadherins pe, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p25","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and ps talin pe, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p26","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, ps plakoglobin pe, vinculin and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p27","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, ps plakoglobin pe, ps vinculin pe and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p28","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, ps cadherins pe, alpha-catenin, beta-catenin, ps plakoglobin pe, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p29","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, cadherins, alpha-catenin, beta-catenin, ps plakoglobin pe, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p30","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, ps vinculin pe and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p31","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, ps cadherins pe, alpha-catenin, beta-catenin, plakoglobin, vinculin and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p32","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and ps alpha-actinin pe appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p33","sentence":"Within 1 hour of raising the concentration of calcium ions, integrins, ps cadherins pe, alpha-catenin, beta-catenin, plakoglobin, ps vinculin pe and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p34","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, cadherins, alpha-catenin, beta-catenin, plakoglobin, ps vinculin pe and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"BioInfer.d833.s0.p35","sentence":"Within 1 hour of raising the concentration of calcium ions, ps integrins pe, ps cadherins pe, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.","label":1}
{"pair_id":"AIMed.d185.s1577.p0","sentence":"These data demonstrate that ps Stat3 pe but not ps Stat1 pe or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p1","sentence":"These data demonstrate that ps Stat3 pe but not Stat1 or ps Stat5 pe is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p2","sentence":"These data demonstrate that ps Stat3 pe but not Stat1 or Stat5 is directly recruited to the ligand-activated ps IL-10 pe receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p3","sentence":"These data demonstrate that ps Stat3 pe but not Stat1 or Stat5 is directly recruited to the ligand-activated ps IL-10 receptor pe by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":1}
{"pair_id":"AIMed.d185.s1577.p4","sentence":"These data demonstrate that Stat3 but not ps Stat1 pe or ps Stat5 pe is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p5","sentence":"These data demonstrate that Stat3 but not ps Stat1 pe or Stat5 is directly recruited to the ligand-activated ps IL-10 pe receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p6","sentence":"These data demonstrate that Stat3 but not ps Stat1 pe or Stat5 is directly recruited to the ligand-activated ps IL-10 receptor pe by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p7","sentence":"These data demonstrate that Stat3 but not Stat1 or ps Stat5 pe is directly recruited to the ligand-activated ps IL-10 pe receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p8","sentence":"These data demonstrate that Stat3 but not Stat1 or ps Stat5 pe is directly recruited to the ligand-activated ps IL-10 receptor pe by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d185.s1577.p9","sentence":"These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated ps IL-10 peps IL-10 receptor pe by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.","label":0}
{"pair_id":"AIMed.d202.s1739.p0","sentence":"The ps IL-1 pe family currently consists of two agonists, ps IL-1alpha pe and IL-1beta, and one antagonist, IL-1ra.","label":0}
{"pair_id":"AIMed.d202.s1739.p1","sentence":"The ps IL-1 pe family currently consists of two agonists, IL-1alpha and ps IL-1beta pe, and one antagonist, IL-1ra.","label":0}
{"pair_id":"AIMed.d202.s1739.p2","sentence":"The ps IL-1 pe family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, ps IL-1ra pe.","label":0}
{"pair_id":"AIMed.d202.s1739.p3","sentence":"The IL-1 family currently consists of two agonists, ps IL-1alpha pe and ps IL-1beta pe, and one antagonist, IL-1ra.","label":0}
{"pair_id":"AIMed.d202.s1739.p4","sentence":"The IL-1 family currently consists of two agonists, ps IL-1alpha pe and IL-1beta, and one antagonist, ps IL-1ra pe.","label":0}
{"pair_id":"AIMed.d202.s1739.p5","sentence":"The IL-1 family currently consists of two agonists, IL-1alpha and ps IL-1beta pe, and one antagonist, ps IL-1ra pe.","label":0}
{"pair_id":"AIMed.d124.s1059.p0","sentence":"Expression of 14-3-3 proteins in Xenopus oocytes enhanced ps Raf-1 pe activity and promoted ps Raf-1 pe-dependent oocyte maturation.","label":0}
{"pair_id":"BioInfer.d539.s0.p0","sentence":"Silencing mediated by ps GBD pe-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, ps SIR4 pe, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p1","sentence":"Silencing mediated by GBD-ps SIR1 pe requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, ps SIR4 pe, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p2","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, ps SIR3 pe, ps SIR4 pe, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p3","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, ps SIR4 pe, and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d539.s0.p4","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, ps SIR2 pe, SIR3, ps SIR4 pe, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p5","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, ps SIR4 pe, and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p6","sentence":"Silencing mediated by ps GBD pe-ps SIR1 pe requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.","label":1}
{"pair_id":"BioInfer.d539.s0.p7","sentence":"Silencing mediated by ps GBD pe-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, ps SIR3 pe, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p8","sentence":"Silencing mediated by ps GBD pe-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d539.s0.p9","sentence":"Silencing mediated by ps GBD pe-SIR1 requires the trans-acting factors that normally participate in repression, namely, ps SIR2 pe, SIR3, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p10","sentence":"Silencing mediated by ps GBD pe-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p11","sentence":"Silencing mediated by GBD-ps SIR1 pe requires the trans-acting factors that normally participate in repression, namely, SIR2, ps SIR3 pe, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p12","sentence":"Silencing mediated by GBD-ps SIR1 pe requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d539.s0.p13","sentence":"Silencing mediated by GBD-ps SIR1 pe requires the trans-acting factors that normally participate in repression, namely, ps SIR2 pe, SIR3, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p14","sentence":"Silencing mediated by GBD-ps SIR1 pe requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p15","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, ps SIR3 pe, SIR4, and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d539.s0.p16","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, ps SIR2 pe, ps SIR3 pe, SIR4, and histone H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p17","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, ps SIR3 pe, SIR4, and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d539.s0.p18","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, ps SIR2 pe, SIR3, SIR4, and histone ps H4 pe.","label":0}
{"pair_id":"BioInfer.d539.s0.p19","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and ps histone pe ps H4 pe.","label":1}
{"pair_id":"BioInfer.d539.s0.p20","sentence":"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, ps SIR2 pe, SIR3, SIR4, and ps histone pe H4.","label":0}
{"pair_id":"BioInfer.d468.s0.p0","sentence":"Opposite effects of cofilin and ps profilin pe from porcine brain on rate of exchange of ps actin pe-bound adenosine 5'-triphosphate.","label":0}
{"pair_id":"BioInfer.d468.s0.p1","sentence":"Opposite effects of ps cofilin pe and ps profilin pe from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.","label":0}
{"pair_id":"BioInfer.d468.s0.p2","sentence":"Opposite effects of ps cofilin pe and profilin from porcine brain on rate of exchange of ps actin pe-bound adenosine 5'-triphosphate.","label":0}
{"pair_id":"BioInfer.d78.s0.p0","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in ps actin pe, ADF and\/or ps cofilin pe may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p1","sentence":"As a nuclear transport signal sequence exists in ps cofilin pe and ADF but not in actin, ADF and\/or ps cofilin pe may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p2","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and\/or ps cofilin pe may be responsible for the nuclear import of ps actin pe in myogenic cells under certain conditions.","label":1}
{"pair_id":"BioInfer.d78.s0.p3","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ps ADF pe and\/or ps cofilin pe may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p4","sentence":"As a nuclear transport signal sequence exists in cofilin and ps ADF pe but not in actin, ADF and\/or ps cofilin pe may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p5","sentence":"As a nuclear transport signal sequence exists in ps cofilin pe and ADF but not in ps actin pe, ADF and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p6","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in ps actin pe, ADF and\/or cofilin may be responsible for the nuclear import of ps actin pe in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p7","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in ps actin pe, ps ADF pe and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p8","sentence":"As a nuclear transport signal sequence exists in cofilin and ps ADF pe but not in ps actin pe, ADF and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p9","sentence":"As a nuclear transport signal sequence exists in ps cofilin pe and ADF but not in actin, ADF and\/or cofilin may be responsible for the nuclear import of ps actin pe in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p10","sentence":"As a nuclear transport signal sequence exists in ps cofilin pe and ADF but not in actin, ps ADF pe and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p11","sentence":"As a nuclear transport signal sequence exists in ps cofilin pe and ps ADF pe but not in actin, ADF and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p12","sentence":"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ps ADF pe and\/or cofilin may be responsible for the nuclear import of ps actin pe in myogenic cells under certain conditions.","label":1}
{"pair_id":"BioInfer.d78.s0.p13","sentence":"As a nuclear transport signal sequence exists in cofilin and ps ADF pe but not in actin, ADF and\/or cofilin may be responsible for the nuclear import of ps actin pe in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d78.s0.p14","sentence":"As a nuclear transport signal sequence exists in cofilin and ps ADF pe but not in actin, ps ADF pe and\/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.","label":0}
{"pair_id":"BioInfer.d417.s1.p0","sentence":"The apparent critical concentration for polymerization of ps actin pe is increased by the addition of ps profilin pe.","label":1}
{"pair_id":"BioInfer.d334.s2.p0","sentence":"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing ps actin pe and ps clathrin pe assembly to distinct membrane domains.","label":0}
{"pair_id":"BioInfer.d334.s2.p1","sentence":"Our findings strongly suggest that in brain profilin I and profilin II complexes link the ps actin pe cytoskeleton and endocytic membrane flow, directing ps actin pe and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p2","sentence":"Our findings strongly suggest that in brain profilin I and ps profilin II pe complexes link the actin cytoskeleton and endocytic membrane flow, directing ps actin pe and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p3","sentence":"Our findings strongly suggest that in brain ps profilin I pe and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing ps actin pe and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p4","sentence":"Our findings strongly suggest that in brain profilin I and profilin II complexes link the ps actin pe cytoskeleton and endocytic membrane flow, directing actin and ps clathrin pe assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p5","sentence":"Our findings strongly suggest that in brain profilin I and ps profilin II pe complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and ps clathrin pe assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p6","sentence":"Our findings strongly suggest that in brain ps profilin I pe and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and ps clathrin pe assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p7","sentence":"Our findings strongly suggest that in brain profilin I and ps profilin II pe complexes link the ps actin pe cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p8","sentence":"Our findings strongly suggest that in brain ps profilin I pe and profilin II complexes link the ps actin pe cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.","label":1}
{"pair_id":"BioInfer.d334.s2.p9","sentence":"Our findings strongly suggest that in brain ps profilin I pe and ps profilin II pe complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.","label":0}
{"pair_id":"BioInfer.d30.s0.p0","sentence":"After elution of the three actin-binding proteins, ps actin pe and profilin were recovered from the ps DNase I pe column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p1","sentence":"After elution of the three ps actin-binding proteins pe, ps actin pe and profilin were recovered from the DNase I column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p2","sentence":"After elution of the three actin-binding proteins, ps actin pe and ps profilin pe were recovered from the DNase I column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p3","sentence":"After elution of the three ps actin-binding proteins pe, actin and profilin were recovered from the ps DNase I pe column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p4","sentence":"After elution of the three actin-binding proteins, actin and ps profilin pe were recovered from the ps DNase I pe column with 2 M urea solution.","label":0}
{"pair_id":"BioInfer.d30.s0.p5","sentence":"After elution of the three ps actin-binding proteins pe, actin and ps profilin pe were recovered from the DNase I column with 2 M urea solution.","label":0}
{"pair_id":"AIMed.d80.s684.p0","sentence":"ps FADD pe contains a death domain homologous to the death domains of ps Fas pe and TNFR-1.","label":0}
{"pair_id":"AIMed.d80.s684.p1","sentence":"ps FADD pe contains a death domain homologous to the death domains of Fas and ps TNFR-1 pe.","label":0}
{"pair_id":"AIMed.d80.s684.p2","sentence":"FADD contains a death domain homologous to the death domains of ps Fas pe and ps TNFR-1 pe.","label":0}
{"pair_id":"AIMed.d108.s914.p0","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila ps TATA binding protein pe (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p1","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila TATA binding protein (ps dTBP pe), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p2","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila TATA binding protein (dTBP), human ps TAFII250 pe, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p3","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila TATA binding protein (dTBP), human TAFII250, ps dTAFII60 pe, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p4","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p5","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p6","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking ps TAFII40 pe and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p7","sentence":"Furthermore, a partial ps TFIID pe complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d108.s914.p8","sentence":"Furthermore, a partial TFIID complex containing Drosophila ps TATA binding protein pe (ps dTBP pe), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p9","sentence":"Furthermore, a partial TFIID complex containing Drosophila ps TATA binding protein pe (dTBP), human ps TAFII250 pe, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p10","sentence":"Furthermore, a partial TFIID complex containing Drosophila ps TATA binding protein pe (dTBP), human TAFII250, ps dTAFII60 pe, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p11","sentence":"Furthermore, a partial TFIID complex containing Drosophila ps TATA binding protein pe (dTBP), human TAFII250, dTAFII60, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p12","sentence":"Furthermore, a partial TFIID complex containing Drosophila ps TATA binding protein pe (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p13","sentence":"Furthermore, a partial TFIID complex containing Drosophila ps TATA binding protein pe (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking ps TAFII40 pe and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p14","sentence":"Furthermore, a partial TFIID complex containing Drosophila ps TATA binding protein pe (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d108.s914.p15","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (ps dTBP pe), human ps TAFII250 pe, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p16","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (ps dTBP pe), human TAFII250, ps dTAFII60 pe, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p17","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (ps dTBP pe), human TAFII250, dTAFII60, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p18","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (ps dTBP pe), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p19","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (ps dTBP pe), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking ps TAFII40 pe and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p20","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (ps dTBP pe), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d108.s914.p21","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human ps TAFII250 pe, ps dTAFII60 pe, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p22","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human ps TAFII250 pe, dTAFII60, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p23","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human ps TAFII250 pe, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p24","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human ps TAFII250 pe, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking ps TAFII40 pe and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p25","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human ps TAFII250 pe, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d108.s914.p26","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, ps dTAFII60 pe, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p27","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, ps dTAFII60 pe, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p28","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, ps dTAFII60 pe, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking ps TAFII40 pe and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p29","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, ps dTAFII60 pe, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d108.s914.p30","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking TAFII40 and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p31","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking ps TAFII40 pe and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p32","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and ps dTAFII40 pe supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d108.s914.p33","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking ps TAFII40 pe and TAFII60 did not.","label":0}
{"pair_id":"AIMed.d108.s914.p34","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas ps TBP pe or a subcomplex lacking TAFII40 and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d108.s914.p35","sentence":"Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking ps TAFII40 pe and ps TAFII60 pe did not.","label":0}
{"pair_id":"AIMed.d109.s916.p0","sentence":"Crystal structure of the heterodimeric bZIP transcription factor ps c-Fos pe-ps c-Jun pe bound to DNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p0","sentence":"Four yeast spliceosomal proteins (ps PRP5 pe, PRP9, PRP11, and PRP21) interact to promote ps U2 snRNP pe binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p1","sentence":"Four yeast spliceosomal proteins (ps PRP5 pe, PRP9, PRP11, and ps PRP21 pe) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p2","sentence":"Four yeast spliceosomal proteins (ps PRP5 pe, ps PRP9 pe, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p3","sentence":"Four yeast spliceosomal proteins (ps PRP5 pe, PRP9, ps PRP11 pe, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p4","sentence":"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and ps PRP21 pe) interact to promote ps U2 snRNP pe binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p5","sentence":"Four yeast spliceosomal proteins (PRP5, ps PRP9 pe, PRP11, and PRP21) interact to promote ps U2 snRNP pe binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p6","sentence":"Four yeast spliceosomal proteins (PRP5, PRP9, ps PRP11 pe, and PRP21) interact to promote ps U2 snRNP pe binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p7","sentence":"Four yeast spliceosomal proteins (PRP5, ps PRP9 pe, PRP11, and ps PRP21 pe) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p8","sentence":"Four yeast spliceosomal proteins (PRP5, PRP9, ps PRP11 pe, and ps PRP21 pe) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"BioInfer.d100.s1.p9","sentence":"Four yeast spliceosomal proteins (PRP5, ps PRP9 pe, ps PRP11 pe, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.","label":1}
{"pair_id":"AIMed.d219.s1900.p0","sentence":"Although ps Raf-1 pe is a critical effector of ps Ras pe signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p1","sentence":"Although ps Raf-1 pe is a critical effector of Ras signaling and transformation, the mechanism by which ps Ras pe promotes Raf-1 activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p2","sentence":"Although ps Raf-1 pe is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes ps Raf-1 pe activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p3","sentence":"Although Raf-1 is a critical effector of ps Ras pe signaling and transformation, the mechanism by which ps Ras pe promotes Raf-1 activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p4","sentence":"Although Raf-1 is a critical effector of ps Ras pe signaling and transformation, the mechanism by which Ras promotes ps Raf-1 pe activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d219.s1900.p5","sentence":"Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which ps Ras pe promotes ps Raf-1 pe activation is complex and remains poorly understood.","label":0}
{"pair_id":"AIMed.d198.s1686.p0","sentence":"Mutagenesis studies of the human ps erythropoietin peps erythropoietin receptor pe. Establishment of structure-function relationships.","label":0}
{"pair_id":"BioInfer.d309.s0.p0","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(ps INK4A pe) and\/or up-regulation of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d309.s0.p1","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the ps cyclin-dependent kinase inhibitor pe p16(ps INK4A pe) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"BioInfer.d309.s0.p2","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor ps p16 pe(ps INK4A pe) and\/or up-regulation of cyclin D1.","label":0}
{"pair_id":"BioInfer.d309.s0.p3","sentence":"Inactivation of the ps Rb pe pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(ps INK4A pe) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"BioInfer.d309.s0.p4","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the ps cyclin-dependent kinase inhibitor pe p16(INK4A) and\/or up-regulation of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d309.s0.p5","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor ps p16 pe(INK4A) and\/or up-regulation of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d309.s0.p6","sentence":"Inactivation of the ps Rb pe pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and\/or up-regulation of ps cyclin D1 pe.","label":1}
{"pair_id":"BioInfer.d309.s0.p7","sentence":"Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the ps cyclin-dependent kinase inhibitor pe ps p16 pe(INK4A) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"BioInfer.d309.s0.p8","sentence":"Inactivation of the ps Rb pe pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the ps cyclin-dependent kinase inhibitor pe p16(INK4A) and\/or up-regulation of cyclin D1.","label":0}
{"pair_id":"BioInfer.d309.s0.p9","sentence":"Inactivation of the ps Rb pe pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor ps p16 pe(INK4A) and\/or up-regulation of cyclin D1.","label":1}
{"pair_id":"AIMed.d137.s1157.p0","sentence":"We have therefore investigated whether the octamer binding proteins might physically interact with ps TBP pe, the ps TATA box binding protein pe component of the TFIID factor.","label":0}
{"pair_id":"AIMed.d137.s1157.p1","sentence":"We have therefore investigated whether the octamer binding proteins might physically interact with ps TBP pe, the TATA box binding protein component of the ps TFIID pe factor.","label":0}
{"pair_id":"AIMed.d137.s1157.p2","sentence":"We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the ps TATA box binding protein pe component of the ps TFIID pe factor.","label":0}
{"pair_id":"BioInfer.d244.s0.p0","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by ps myosin heavy chain pe antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with ps non-muscle myosin heavy chain pe; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p1","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional ps non-muscle myosin heavy chain pe: it comigrates in SDS-PAGE with ps non-muscle myosin heavy chain pe; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p2","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with ps non-muscle myosin heavy chain pe; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified ps actin pe filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p3","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by ps myosin heavy chain pe antibodies and was found to possess other characteristics of conventional ps non-muscle myosin heavy chain pe: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p4","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by ps myosin heavy chain pe antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified ps actin pe filaments in the absence of ATP.","label":0}
{"pair_id":"BioInfer.d244.s0.p5","sentence":"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional ps non-muscle myosin heavy chain pe: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified ps actin pe filaments in the absence of ATP.","label":1}
{"pair_id":"AIMed.d44.s386.p0","sentence":"The pattern of ps CD30L pe binding inhibition shows only limited correspondence to the functional capacity of some anti-ps CD30 pe MAb to trigger CD30 signaling.","label":0}
{"pair_id":"AIMed.d44.s386.p1","sentence":"The pattern of ps CD30L pe binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger ps CD30 pe signaling.","label":0}
{"pair_id":"AIMed.d44.s386.p2","sentence":"The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-ps CD30 pe MAb to trigger ps CD30 pe signaling.","label":0}
{"pair_id":"AIMed.d117.s987.p0","sentence":"Activin type I receptors, ps SKR1 pe and ps SKR2 pe, were first cloned from well differentiated human hepatoma cells (HepG2).","label":0}
{"pair_id":"AIMed.d184.s1567.p0","sentence":"Neutralizing antibodies directed against either ps CD4 pe-induced or V3 epitopes on ps gp120 pe blocked the interaction of gp12O-CD4 complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p1","sentence":"Neutralizing antibodies directed against either ps CD4 pe-induced or V3 epitopes on gp120 blocked the interaction of ps gp12O pe-CD4 complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p2","sentence":"Neutralizing antibodies directed against either ps CD4 pe-induced or V3 epitopes on gp120 blocked the interaction of gp12O-ps CD4 pe complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p3","sentence":"Neutralizing antibodies directed against either ps CD4 pe-induced or V3 epitopes on gp120 blocked the interaction of gp12O-CD4 complexes with ps CCR-5 pe.","label":0}
{"pair_id":"AIMed.d184.s1567.p4","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on ps gp120 pe blocked the interaction of ps gp12O pe-CD4 complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p5","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on ps gp120 pe blocked the interaction of gp12O-ps CD4 pe complexes with CCR-5.","label":0}
{"pair_id":"AIMed.d184.s1567.p6","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on ps gp120 pe blocked the interaction of gp12O-CD4 complexes with ps CCR-5 pe.","label":0}
{"pair_id":"AIMed.d184.s1567.p7","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of ps gp12O pe-ps CD4 pe complexes with CCR-5.","label":1}
{"pair_id":"AIMed.d184.s1567.p8","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of ps gp12O pe-CD4 complexes with ps CCR-5 pe.","label":1}
{"pair_id":"AIMed.d184.s1567.p9","sentence":"Neutralizing antibodies directed against either CD4-induced or V3 epitopes on gp120 blocked the interaction of gp12O-ps CD4 pe complexes with ps CCR-5 pe.","label":1}
{"pair_id":"AIMed.d105.s886.p0","sentence":"We expressed differently tagged forms of ps gp130 pe and used them in solution-phase binding assays to show that the soluble extracellular domains of ps gp130 pe undergo dimerization in the absence of membranes.","label":0}
{"pair_id":"BioInfer.d11.s0.p0","sentence":"A common feature of these ps talin pe-positive domains is the deep membrane infoldings, where bundles of ps actin pe filaments are inserted into the membrane.","label":0}
{"pair_id":"AIMed.d23.s189.p0","sentence":"In the present study, we examined the presence of glucocorticoid receptors (GRs) and ps cyclooxygenase-2 pe (ps COX-2 pe) in the nasal polyps of nonallergic patients as compared with normal controls.","label":0}
{"pair_id":"AIMed.d104.s882.p0","sentence":"Both ps hDP-1 pe and ps hDP-2 pe bind to all E2F family members in vivo, and each complex is capable of activating transcription.","label":0}
{"pair_id":"AIMed.d104.s882.p1","sentence":"Both ps hDP-1 pe and hDP-2 bind to all ps E2F pe family members in vivo, and each complex is capable of activating transcription.","label":0}
{"pair_id":"AIMed.d104.s882.p2","sentence":"Both hDP-1 and ps hDP-2 pe bind to all ps E2F pe family members in vivo, and each complex is capable of activating transcription.","label":0}
{"pair_id":"BioInfer.d305.s0.p0","sentence":"In 50 mM KCl, high concentrations of Acanthamoeba ps profilin pe inhibit the elongation rate of ps muscle actin pe filaments measured directly by electron microscopy, but the effect is minimal in KCl with 2 MgCl2.","label":1}
{"pair_id":"AIMed.d198.s1692.p0","sentence":"Using these methods, we have identified residues that appear to be involved in ps EPO pe binding as well as other residues, most of which are conserved in receptors of the cytokine receptor family, that appear to be necessary for the proper folding and\/or stability of the ps EPOR pe.","label":0}
{"pair_id":"AIMed.d179.s1525.p0","sentence":"Following ps gastrin pe stimulation, we observed a time- and dose-dependent association of ps IRS-1 pe with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p1","sentence":"Following ps gastrin pe stimulation, we observed a time- and dose-dependent association of IRS-1 with the ps p85 pe regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p2","sentence":"Following ps gastrin pe stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of ps phosphatidylinositol 3-kinase pe (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p3","sentence":"Following ps gastrin pe stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (ps PI 3-kinase pe).","label":0}
{"pair_id":"AIMed.d179.s1525.p4","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of ps IRS-1 pe with the ps p85 pe regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p5","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of ps IRS-1 pe with the p85 regulatory subunit of ps phosphatidylinositol 3-kinase pe (PI 3-kinase).","label":1}
{"pair_id":"AIMed.d179.s1525.p6","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of ps IRS-1 pe with the p85 regulatory subunit of phosphatidylinositol 3-kinase (ps PI 3-kinase pe).","label":1}
{"pair_id":"AIMed.d179.s1525.p7","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the ps p85 pe regulatory subunit of ps phosphatidylinositol 3-kinase pe (PI 3-kinase).","label":0}
{"pair_id":"AIMed.d179.s1525.p8","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the ps p85 pe regulatory subunit of phosphatidylinositol 3-kinase (ps PI 3-kinase pe).","label":0}
{"pair_id":"AIMed.d179.s1525.p9","sentence":"Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of ps phosphatidylinositol 3-kinase pe (ps PI 3-kinase pe).","label":0}
{"pair_id":"BioInfer.d437.s0.p0","sentence":"Moreover, in the presence of ps cofilin pe, rapid interconversion of monomeric and polymeric forms of ps actin pe can be induced by simply changing the pH of the medium.","label":0}
{"pair_id":"AIMed.d143.s1214.p0","sentence":"Finally, anti-ps IL-6R pe antibody inhibited the ability of ps IL-6 pe, but not IL-11, to transduce early signals in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1214.p1","sentence":"Finally, anti-ps IL-6R pe antibody inhibited the ability of IL-6, but not ps IL-11 pe, to transduce early signals in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1214.p2","sentence":"Finally, anti-IL-6R antibody inhibited the ability of ps IL-6 pe, but not ps IL-11 pe, to transduce early signals in TF-1 cells.","label":0}
{"pair_id":"AIMed.d176.s1491.p0","sentence":"Mutational analysis of ps p60 pe indicates that the N terminus is required for ps hsp70 pe binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.","label":1}
{"pair_id":"AIMed.d176.s1491.p1","sentence":"Mutational analysis of ps p60 pe indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding ps hsp90 pe and hsp70.","label":1}
{"pair_id":"AIMed.d176.s1491.p2","sentence":"Mutational analysis of ps p60 pe indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and ps hsp70 pe.","label":1}
{"pair_id":"AIMed.d176.s1491.p3","sentence":"Mutational analysis of p60 indicates that the N terminus is required for ps hsp70 pe binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding ps hsp90 pe and hsp70.","label":0}
{"pair_id":"AIMed.d176.s1491.p4","sentence":"Mutational analysis of p60 indicates that the N terminus is required for ps hsp70 pe binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and ps hsp70 pe.","label":0}
{"pair_id":"AIMed.d176.s1491.p5","sentence":"Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding ps hsp90 pe and ps hsp70 pe.","label":0}
{"pair_id":"AIMed.d90.s768.p0","sentence":"Three of these clones encode DNA binding proteins (ps NF-IL6 beta pe, ps HMG I\/Y pe, and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.","label":0}
{"pair_id":"AIMed.d90.s768.p1","sentence":"Three of these clones encode DNA binding proteins (ps NF-IL6 beta pe, HMG I\/Y, and ps SSRP pe), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.","label":0}
{"pair_id":"AIMed.d90.s768.p2","sentence":"Three of these clones encode DNA binding proteins (NF-IL6 beta, ps HMG I\/Y pe, and ps SSRP pe), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.","label":0}
{"pair_id":"AIMed.d209.s1806.p0","sentence":"Human ps RIN1 pe was first characterized as a ps RAS pe binding protein based on the properties of its carboxyl-terminal domain.","label":1}
{"pair_id":"AIMed.d209.s1806.p1","sentence":"Human ps RIN1 pe was first characterized as a ps RAS binding protein pe based on the properties of its carboxyl-terminal domain.","label":0}
{"pair_id":"AIMed.d209.s1806.p2","sentence":"Human RIN1 was first characterized as a ps RAS peps RAS binding protein pe based on the properties of its carboxyl-terminal domain.","label":0}
{"pair_id":"AIMed.d141.s1191.p0","sentence":"ps CIP1 pe encodes a novel 21 kd protein that is found in ps cyclin A pe, cyclin D1, cyclin E, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p1","sentence":"ps CIP1 pe encodes a novel 21 kd protein that is found in cyclin A, ps cyclin D1 pe, cyclin E, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p2","sentence":"ps CIP1 pe encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, ps cyclin E pe, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p3","sentence":"ps CIP1 pe encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, cyclin E, and ps Cdk2 pe immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p4","sentence":"CIP1 encodes a novel 21 kd protein that is found in ps cyclin A pe, ps cyclin D1 pe, cyclin E, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p5","sentence":"CIP1 encodes a novel 21 kd protein that is found in ps cyclin A pe, cyclin D1, ps cyclin E pe, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p6","sentence":"CIP1 encodes a novel 21 kd protein that is found in ps cyclin A pe, cyclin D1, cyclin E, and ps Cdk2 pe immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p7","sentence":"CIP1 encodes a novel 21 kd protein that is found in cyclin A, ps cyclin D1 pe, ps cyclin E pe, and Cdk2 immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p8","sentence":"CIP1 encodes a novel 21 kd protein that is found in cyclin A, ps cyclin D1 pe, cyclin E, and ps Cdk2 pe immunoprecipitates.","label":0}
{"pair_id":"AIMed.d141.s1191.p9","sentence":"CIP1 encodes a novel 21 kd protein that is found in cyclin A, cyclin D1, ps cyclin E pe, and ps Cdk2 pe immunoprecipitates.","label":0}
{"pair_id":"AIMed.d160.s1349.p0","sentence":"Mutations within the ps KDR pe site had minimal effect on ps FLT-1 pe binding, and mutants deficient in FLT-1 binding did not affect KDR binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p1","sentence":"Mutations within the ps KDR pe site had minimal effect on FLT-1 binding, and mutants deficient in ps FLT-1 pe binding did not affect KDR binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p2","sentence":"Mutations within the ps KDR pe site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect ps KDR pe binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p3","sentence":"Mutations within the KDR site had minimal effect on ps FLT-1 pe binding, and mutants deficient in ps FLT-1 pe binding did not affect KDR binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p4","sentence":"Mutations within the KDR site had minimal effect on ps FLT-1 pe binding, and mutants deficient in FLT-1 binding did not affect ps KDR pe binding.","label":0}
{"pair_id":"AIMed.d160.s1349.p5","sentence":"Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in ps FLT-1 pe binding did not affect ps KDR pe binding.","label":0}
{"pair_id":"BioInfer.d522.s0.p0","sentence":"Reversible binding of ps actin pe to gelsolin and ps profilin pe in human platelet extracts.","label":1}
{"pair_id":"BioInfer.d522.s0.p1","sentence":"Reversible binding of actin to ps gelsolin pe and ps profilin pe in human platelet extracts.","label":0}
{"pair_id":"BioInfer.d522.s0.p2","sentence":"Reversible binding of ps actin pe to ps gelsolin pe and profilin in human platelet extracts.","label":1}
{"pair_id":"BioInfer.d186.s0.p0","sentence":"Effects of mutations of ps RAD50 pe, RAD51, ps RAD52 pe, and related genes on illegitimate recombination in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d186.s0.p1","sentence":"Effects of mutations of ps RAD50 pe, ps RAD51 pe, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.","label":0}
{"pair_id":"BioInfer.d186.s0.p2","sentence":"Effects of mutations of RAD50, ps RAD51 pe, ps RAD52 pe, and related genes on illegitimate recombination in Saccharomyces cerevisiae.","label":0}
{"pair_id":"AIMed.d173.s1463.p0","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing ps LexA pe-ps Abeta pe bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p1","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing ps LexA pe-Abeta bait when the ps B42 pe transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p2","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing ps LexA pe-Abeta bait when the B42 transactivation domain was fused to an ps Abeta pe fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p3","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-ps Abeta pe bait when the ps B42 pe transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p4","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-ps Abeta pe bait when the B42 transactivation domain was fused to an ps Abeta pe fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"AIMed.d173.s1463.p5","sentence":"Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the ps B42 pe transactivation domain was fused to an ps Abeta pe fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.","label":0}
{"pair_id":"BioInfer.d78.s1.p0","sentence":"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ps ADF pe and ps cofilin pe, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.","label":0}
{"pair_id":"BioInfer.d78.s1.p1","sentence":"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and ps cofilin pe, are transported into nuclei of cultured myogenic cells to form rod structures there together with ps actin pe, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p2","sentence":"Immunofluorescence microscopy revealed that two ps actin-binding proteins pe of low molecular weight with different functional activity, ADF and ps cofilin pe, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p3","sentence":"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ps ADF pe and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with ps actin pe, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p4","sentence":"Immunofluorescence microscopy revealed that two ps actin-binding proteins pe of low molecular weight with different functional activity, ps ADF pe and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.","label":1}
{"pair_id":"BioInfer.d78.s1.p5","sentence":"Immunofluorescence microscopy revealed that two ps actin-binding proteins pe of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with ps actin pe, when the cells were incubated in medium containing dimethylsulfoxide.","label":0}
{"pair_id":"AIMed.d68.s585.p0","sentence":"The motif may represent an activating domain that has to be provided to ps cdc25 pe by intermolecular interaction with ps cyclin B pe.","label":0}
{"pair_id":"AIMed.d122.s1041.p0","sentence":"Measurement of ps RII alpha pe I3A,I5A interaction with the human ps thyroid AKAP pe, Ht 31, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.","label":1}
{"pair_id":"AIMed.d122.s1041.p1","sentence":"Measurement of ps RII alpha pe I3A,I5A interaction with the human thyroid AKAP, ps Ht 31 pe, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.","label":1}
{"pair_id":"AIMed.d122.s1041.p2","sentence":"Measurement of RII alpha I3A,I5A interaction with the human ps thyroid AKAP pe, ps Ht 31 pe, by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold.","label":0}
{"pair_id":"AIMed.d113.s957.p0","sentence":"The ps BAG-1 pe protein shares no significant homology with ps Bcl-2 pe or other Bcl-2 family proteins, which can form homo- and heterodimers.","label":0}
{"pair_id":"AIMed.d113.s957.p1","sentence":"The ps BAG-1 pe protein shares no significant homology with Bcl-2 or other ps Bcl-2 pe family proteins, which can form homo- and heterodimers.","label":0}
{"pair_id":"AIMed.d113.s957.p2","sentence":"The BAG-1 protein shares no significant homology with ps Bcl-2 pe or other ps Bcl-2 pe family proteins, which can form homo- and heterodimers.","label":0}
{"pair_id":"AIMed.d101.s858.p0","sentence":"We propose that ps c-Fos pe and ps c-Jun pe proteins function as transcriptional activators, in part by recruiting TBP to form complexes to initiate RNA synthesis.","label":0}
{"pair_id":"AIMed.d101.s858.p1","sentence":"We propose that ps c-Fos pe and c-Jun proteins function as transcriptional activators, in part by recruiting ps TBP pe to form complexes to initiate RNA synthesis.","label":1}
{"pair_id":"AIMed.d101.s858.p2","sentence":"We propose that c-Fos and ps c-Jun pe proteins function as transcriptional activators, in part by recruiting ps TBP pe to form complexes to initiate RNA synthesis.","label":1}
{"pair_id":"BioInfer.d331.s0.p0","sentence":"Increased interaction of ps beta1D integrin pe with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to ps talin pe.","label":1}
{"pair_id":"BioInfer.d331.s0.p1","sentence":"Increased interaction of beta1D integrin with the ps actin pe cytoskeleton is consistent with and might be mediated by its enhanced binding to ps talin pe.","label":1}
{"pair_id":"BioInfer.d331.s0.p2","sentence":"Increased interaction of ps beta1D integrin pe with the ps actin pe cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.","label":1}
{"pair_id":"AIMed.d158.s1336.p0","sentence":"Overexpression of the intact ps RIP pe protein induces both ps NF-kappa B pe activation and apoptosis.","label":0}
{"pair_id":"BioInfer.d397.s2.p0","sentence":"The ps cardiac ventricular myosin heavy chain pe phenotype is developmentally and hormonally regulated, but less is known concerning the ps actin pe phenotype.","label":0}
{"pair_id":"AIMed.d118.s998.p0","sentence":"Levels of ps p21 pe protein are increased in senescent cells and ps p21 pe overexpression blocks the growth of tumour cells.","label":0}
{"pair_id":"AIMed.d112.s944.p0","sentence":"Human spleen tyrosine kinase ps p72Syk pe associates with the Src-family kinase ps p53 pe\/56Lyn and a 120-kDa phosphoprotein.","label":1}
{"pair_id":"AIMed.d112.s944.p1","sentence":"Human spleen tyrosine kinase ps p72Syk pe associates with the Src-family kinase p53\/ps 56Lyn pe and a 120-kDa phosphoprotein.","label":1}
{"pair_id":"AIMed.d112.s944.p2","sentence":"Human spleen tyrosine kinase ps p72Syk pe associates with the Src-family kinase p53\/56Lyn and a ps 120-kDa phosphoprotein pe.","label":1}
{"pair_id":"AIMed.d112.s944.p3","sentence":"Human spleen tyrosine kinase p72Syk associates with the Src-family kinase ps p53 pe\/ps 56Lyn pe and a 120-kDa phosphoprotein.","label":0}
{"pair_id":"AIMed.d112.s944.p4","sentence":"Human spleen tyrosine kinase p72Syk associates with the Src-family kinase ps p53 pe\/56Lyn and a ps 120-kDa phosphoprotein pe.","label":0}
{"pair_id":"AIMed.d112.s944.p5","sentence":"Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53\/ps 56Lyn pe and a ps 120-kDa phosphoprotein pe.","label":0}
{"pair_id":"AIMed.d184.s1565.p0","sentence":"Additionally, in the absence of ps gp120 pe, an interaction between a two-domain ps CD4 pe fragment and CCR-5 was observed.","label":0}
{"pair_id":"AIMed.d184.s1565.p1","sentence":"Additionally, in the absence of ps gp120 pe, an interaction between a two-domain CD4 fragment and ps CCR-5 pe was observed.","label":0}
{"pair_id":"AIMed.d184.s1565.p2","sentence":"Additionally, in the absence of gp120, an interaction between a two-domain ps CD4 pe fragment and ps CCR-5 pe was observed.","label":1}
{"pair_id":"AIMed.d209.s1813.p0","sentence":"Moreover, the amino-terminal domain of ps RIN1 pe directly associates with, and is tyrosine phosphorylated by, ps c-ABL pe.","label":1}
{"pair_id":"BioInfer.d769.s0.p0","sentence":"To improve our ability to study these proteins, we have expressed ps UL5 pe, UL8, ps UL9 pe, and UL52 in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p1","sentence":"To improve our ability to study these proteins, we have expressed ps UL5 pe, ps UL8 pe, UL9, and UL52 in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p2","sentence":"To improve our ability to study these proteins, we have expressed ps UL5 pe, UL8, UL9, and ps UL52 pe in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p3","sentence":"To improve our ability to study these proteins, we have expressed UL5, ps UL8 pe, ps UL9 pe, and UL52 in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p4","sentence":"To improve our ability to study these proteins, we have expressed UL5, UL8, ps UL9 pe, and ps UL52 pe in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d769.s0.p5","sentence":"To improve our ability to study these proteins, we have expressed UL5, ps UL8 pe, UL9, and ps UL52 pe in insect cells by using the baculovirus expression system.","label":0}
{"pair_id":"BioInfer.d667.s0.p0","sentence":"The primary purpose of this study was to determine the relationship between myosin heavy chain (ps MHC pe) and ps actin pe contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.","label":0}
{"pair_id":"BioInfer.d667.s0.p1","sentence":"The primary purpose of this study was to determine the relationship between ps myosin heavy chain pe (MHC) and ps actin pe contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.","label":0}
{"pair_id":"BioInfer.d667.s0.p2","sentence":"The primary purpose of this study was to determine the relationship between ps myosin heavy chain pe (ps MHC pe) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.","label":0}
{"pair_id":"AIMed.d71.s607.p0","sentence":"The ps MAP kinase pe enzymes ps pp54 pe and pp42\/44 are regulated by tyrosine as well as serine\/threonine phosphorylation.","label":0}
{"pair_id":"AIMed.d71.s607.p1","sentence":"The ps MAP kinase pe enzymes pp54 and ps pp42 pe\/44 are regulated by tyrosine as well as serine\/threonine phosphorylation.","label":0}
{"pair_id":"AIMed.d71.s607.p2","sentence":"The MAP kinase enzymes ps pp54 pe and ps pp42 pe\/44 are regulated by tyrosine as well as serine\/threonine phosphorylation.","label":0}
{"pair_id":"AIMed.d199.s1714.p0","sentence":"ps Sos pe; these two complexes may alternatively link ps FGFG3 pe to mitogen-activated protein kinase.","label":0}
{"pair_id":"AIMed.d199.s1714.p1","sentence":"ps Sos pe; these two complexes may alternatively link FGFG3 to ps mitogen-activated protein kinase pe.","label":0}
{"pair_id":"AIMed.d199.s1714.p2","sentence":"Sos; these two complexes may alternatively link ps FGFG3 pe to ps mitogen-activated protein kinase pe.","label":0}
{"pair_id":"BioInfer.d611.s0.p0","sentence":"The existence of this pathway helps to explain some of the effects of ps LIM kinase pe and ps cofilin pe in the control of actin dynamics.","label":0}
{"pair_id":"BioInfer.d611.s0.p1","sentence":"The existence of this pathway helps to explain some of the effects of ps LIM kinase pe and cofilin in the control of ps actin pe dynamics.","label":1}
{"pair_id":"BioInfer.d611.s0.p2","sentence":"The existence of this pathway helps to explain some of the effects of LIM kinase and ps cofilin pe in the control of ps actin pe dynamics.","label":1}
{"pair_id":"AIMed.d174.s1472.p0","sentence":"Studies of the ps IL-6 pe ternary complex formation demonstrated that the reduced biological potency of ps IL-6D pe resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p1","sentence":"Studies of the ps IL-6 pe ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the ps IL-6D pe (sIL-6R)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p2","sentence":"Studies of the ps IL-6 pe ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (ps sIL-6R pe)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p3","sentence":"Studies of the ps IL-6 pe ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of ps gp130 pe.","label":0}
{"pair_id":"AIMed.d174.s1472.p4","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of ps IL-6D pe resulted from a decreased ability of the ps IL-6D pe (sIL-6R)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p5","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of ps IL-6D pe resulted from a decreased ability of the IL-6D (ps sIL-6R pe)2 complex to couple with the soluble portion of gp130.","label":0}
{"pair_id":"AIMed.d174.s1472.p6","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of ps IL-6D pe resulted from a decreased ability of the IL-6D (sIL-6R)2 complex to couple with the soluble portion of ps gp130 pe.","label":0}
{"pair_id":"AIMed.d174.s1472.p7","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the ps IL-6D pe (ps sIL-6R pe)2 complex to couple with the soluble portion of gp130.","label":1}
{"pair_id":"AIMed.d174.s1472.p8","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the ps IL-6D pe (sIL-6R)2 complex to couple with the soluble portion of ps gp130 pe.","label":0}
{"pair_id":"AIMed.d174.s1472.p9","sentence":"Studies of the IL-6 ternary complex formation demonstrated that the reduced biological potency of IL-6D resulted from a decreased ability of the IL-6D (ps sIL-6R pe)2 complex to couple with the soluble portion of ps gp130 pe.","label":0}
{"pair_id":"BioInfer.d123.s0.p0","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p1","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p2","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p3","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p4","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p5","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p6","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p7","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p8","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p9","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p10","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe ps H4 pe, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p11","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p12","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p13","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p14","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p15","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p16","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p17","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p18","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p19","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p20","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous ps p21 pe\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p21","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p22","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p23","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p24","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p25","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p26","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p27","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p28","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p29","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone ps H3 pe, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p30","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p31","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p32","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p33","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p34","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p35","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p36","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p37","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that ps CBP pe\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p38","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p39","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p40","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p41","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p42","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p43","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p44","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the ps SAGA pe complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p45","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p46","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p47","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p48","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p49","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p50","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/ps p300 pe, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p51","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p52","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p53","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p54","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p55","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous p21\/ps waf1 pe promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p56","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p57","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p58","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p59","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/ps waf1 pe in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p60","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p61","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":1}
{"pair_id":"BioInfer.d123.s0.p62","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of ps p21 pe\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p63","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p64","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not ps histone pe H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d123.s0.p65","sentence":"By using a chromatin immunoprecipitation (ChIP) assay, we observed that ps histone pe H4, and not histone H3, was acetylated from the endogenous p21\/waf1 promoter in vivo, implying that CBP\/p300, and not the SAGA complex, was critical in complexing with ps E2A pe in up-regulation of p21\/waf1 in HTLV-1-infected cells.","label":0}
{"pair_id":"BioInfer.d790.s0.p0","sentence":"Using these methods, we confirm previous reports that intact ps talin pe induces cross-linking as well as filament shortening on ps actin pe networks.","label":1}
{"pair_id":"BioInfer.d84.s0.p0","sentence":"As shown by in situ hybridization with cloned probes and analysis of in vitro translation products, M. occulta embryos do not accumulate high levels of ps alpha actin pe or ps myosin heavy chain pe mRNA.","label":0}
{"pair_id":"AIMed.d182.s1550.p0","sentence":"These same ps p53 pe residues are also involved in transactivation, supporting the hypothesis that ps MDM2 pe inactivates p53 by concealing its transactivation domain.","label":0}
{"pair_id":"AIMed.d182.s1550.p1","sentence":"These same ps p53 pe residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates ps p53 pe by concealing its transactivation domain.","label":0}
{"pair_id":"AIMed.d182.s1550.p2","sentence":"These same p53 residues are also involved in transactivation, supporting the hypothesis that ps MDM2 pe inactivates ps p53 pe by concealing its transactivation domain.","label":1}
{"pair_id":"AIMed.d68.s582.p0","sentence":"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the ps cdc2 pe protein kinase, but also activate the ps cdc25 pe tyrosine phosphatase, of which cdc2 is the physiological substrate.","label":0}
{"pair_id":"AIMed.d68.s582.p1","sentence":"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the ps cdc2 pe protein kinase, but also activate the cdc25 tyrosine phosphatase, of which ps cdc2 pe is the physiological substrate.","label":0}
{"pair_id":"AIMed.d68.s582.p2","sentence":"These findings indicate that B-type cyclins are multifunctional proteins that not only act as M phase regulatory subunits of the cdc2 protein kinase, but also activate the ps cdc25 pe tyrosine phosphatase, of which ps cdc2 pe is the physiological substrate.","label":0}
{"pair_id":"AIMed.d23.s195.p0","sentence":"Therefore, 1) the presence of GRs and ps COX-2 pe in nasal polyps from nonallergic patients, as well as upregulation of ps COX-2 pe expression, suggests that inflammation may play an important role in the pathophysiology of nasal polyps; and 2) glucocorticoid could be a potential treatment method for suppressing inflammatory processes.","label":0}
{"pair_id":"AIMed.d116.s978.p0","sentence":"The protein encoded by the ps retinoblastoma susceptibility gene pe (ps Rb pe) functions as a tumour suppressor and negative growth regulator.","label":0}
{"pair_id":"BioInfer.d494.s0.p0","sentence":"Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of ps gelsolin pe and profilin with ps actin pe.","label":1}
{"pair_id":"BioInfer.d494.s0.p1","sentence":"Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and ps profilin pe with ps actin pe.","label":1}
{"pair_id":"BioInfer.d494.s0.p2","sentence":"Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of ps gelsolin pe and ps profilin pe with actin.","label":0}
{"pair_id":"AIMed.d65.s560.p0","sentence":"These findings indicate that the ps Fos pe\/ps Jun pe and ATF\/CREB families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p1","sentence":"These findings indicate that the ps Fos pe\/Jun and ps ATF pe\/CREB families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p2","sentence":"These findings indicate that the ps Fos pe\/Jun and ATF\/ps CREB pe families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p3","sentence":"These findings indicate that the Fos\/ps Jun pe and ps ATF pe\/CREB families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p4","sentence":"These findings indicate that the Fos\/ps Jun pe and ATF\/ps CREB pe families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d65.s560.p5","sentence":"These findings indicate that the Fos\/Jun and ps ATF pe\/ps CREB pe families of transcription factors are not as distinct as was previously thought.","label":0}
{"pair_id":"AIMed.d41.s356.p0","sentence":"On a cell membrane containing both proteins, ps HFE pe would 'lie down' parallel to the membrane, such that the ps HFE pe helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the TfR dimerization domain.","label":0}
{"pair_id":"AIMed.d41.s356.p1","sentence":"On a cell membrane containing both proteins, ps HFE pe would 'lie down' parallel to the membrane, such that the HFE helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the ps TfR pe dimerization domain.","label":0}
{"pair_id":"AIMed.d41.s356.p2","sentence":"On a cell membrane containing both proteins, HFE would 'lie down' parallel to the membrane, such that the ps HFE pe helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the ps TfR pe dimerization domain.","label":1}
{"pair_id":"BioInfer.d161.s1.p0","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why ps thymosin beta(4) pe and profilin can bind simultaneously to ps actin pe.","label":1}
{"pair_id":"BioInfer.d161.s1.p1","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between ps actin pe and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to ps actin pe.","label":0}
{"pair_id":"BioInfer.d161.s1.p2","sentence":"Experiments using a peptide that corresponds to the N-terminus of ps thymosin beta(4) pe (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to ps actin pe.","label":0}
{"pair_id":"BioInfer.d161.s1.p3","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and ps thymosin beta(4) pe, and explain why thymosin beta(4) and profilin can bind simultaneously to ps actin pe.","label":0}
{"pair_id":"BioInfer.d161.s1.p4","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and ps profilin pe can bind simultaneously to ps actin pe.","label":1}
{"pair_id":"BioInfer.d161.s1.p5","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between ps actin pe and thymosin beta(4), and explain why ps thymosin beta(4) pe and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p6","sentence":"Experiments using a peptide that corresponds to the N-terminus of ps thymosin beta(4) pe (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why ps thymosin beta(4) pe and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p7","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and ps thymosin beta(4) pe, and explain why ps thymosin beta(4) pe and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p8","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why ps thymosin beta(4) pe and ps profilin pe can bind simultaneously to actin.","label":1}
{"pair_id":"BioInfer.d161.s1.p9","sentence":"Experiments using a peptide that corresponds to the N-terminus of ps thymosin beta(4) pe (residues 6-22) confirm the presence of an extensive binding surface between ps actin pe and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p10","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between ps actin pe and ps thymosin beta(4) pe, and explain why thymosin beta(4) and profilin can bind simultaneously to actin.","label":1}
{"pair_id":"BioInfer.d161.s1.p11","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between ps actin pe and thymosin beta(4), and explain why thymosin beta(4) and ps profilin pe can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p12","sentence":"Experiments using a peptide that corresponds to the N-terminus of ps thymosin beta(4) pe (residues 6-22) confirm the presence of an extensive binding surface between actin and ps thymosin beta(4) pe, and explain why thymosin beta(4) and profilin can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p13","sentence":"Experiments using a peptide that corresponds to the N-terminus of ps thymosin beta(4) pe (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and ps profilin pe can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d161.s1.p14","sentence":"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and ps thymosin beta(4) pe, and explain why thymosin beta(4) and ps profilin pe can bind simultaneously to actin.","label":0}
{"pair_id":"BioInfer.d340.s0.p0","sentence":"Inhibition of ps actomyosin pe subfragment 1 ATPase activity by analog peptides of the ps actin pe-binding site around the Cys(SH1) of myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d340.s0.p1","sentence":"Inhibition of ps actomyosin pe subfragment 1 ps ATPase pe activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.","label":1}
{"pair_id":"BioInfer.d340.s0.p2","sentence":"Inhibition of ps actomyosin pe subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of ps myosin heavy chain pe.","label":1}
{"pair_id":"BioInfer.d340.s0.p3","sentence":"Inhibition of actomyosin subfragment 1 ps ATPase pe activity by analog peptides of the ps actin pe-binding site around the Cys(SH1) of myosin heavy chain.","label":0}
{"pair_id":"BioInfer.d340.s0.p4","sentence":"Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the ps actin pe-binding site around the Cys(SH1) of ps myosin heavy chain pe.","label":1}
{"pair_id":"BioInfer.d340.s0.p5","sentence":"Inhibition of actomyosin subfragment 1 ps ATPase pe activity by analog peptides of the actin-binding site around the Cys(SH1) of ps myosin heavy chain pe.","label":0}
{"pair_id":"BioInfer.d121.s0.p0","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p1","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p2","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p3","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p4","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p5","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p6","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p7","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p8","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p9","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p10","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p11","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, ps P pe and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p12","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p13","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p14","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p15","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p16","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p17","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p18","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p19","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p20","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p21","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p22","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains ps nucleocapsid protein pe (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p23","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p24","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p25","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p26","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p27","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p28","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p29","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p30","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p31","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p32","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, ps M pe and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p33","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p34","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p35","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p36","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p37","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p38","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p39","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p40","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p41","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and ps phosphoprotein pe (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p42","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p43","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p44","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p45","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p46","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p47","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p48","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p49","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (ps NP pe) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p50","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p51","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p52","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p53","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p54","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p55","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p56","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, ps F0 pe and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p57","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p58","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p59","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p60","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p61","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p62","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (ps M pe) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p63","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p64","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p65","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p66","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p67","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (ps P pe) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p68","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p69","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p70","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p71","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and ps membrane protein pe (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p72","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p73","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p74","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (ps F0 pe) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p75","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p76","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and ps fusion protein pe (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (HN) gene sequences.","label":0}
{"pair_id":"BioInfer.d121.s0.p77","sentence":"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and ps hemagglutinin-neuraminidase protein pe (ps HN pe) gene sequences.","label":0}
{"pair_id":"BioInfer.d156.s0.p0","sentence":"Coprecipitations revealed that transfected cadherin molecules are complexed with ps alpha-catenin pe and ps beta-catenin pe at plasma membranes.","label":1}
{"pair_id":"BioInfer.d156.s0.p1","sentence":"Coprecipitations revealed that transfected ps cadherin pe molecules are complexed with alpha-catenin and ps beta-catenin pe at plasma membranes.","label":1}
{"pair_id":"BioInfer.d156.s0.p2","sentence":"Coprecipitations revealed that transfected ps cadherin pe molecules are complexed with ps alpha-catenin pe and beta-catenin at plasma membranes.","label":1}
{"pair_id":"BioInfer.d62.s1.p0","sentence":"Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the ps UL5 pe and ps UL52 pe proteins.","label":0}
{"pair_id":"BioInfer.d62.s1.p1","sentence":"Deletion mutants of the herpes simplex virus type 1 ps UL8 pe protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and ps UL52 pe proteins.","label":1}
{"pair_id":"BioInfer.d62.s1.p2","sentence":"Deletion mutants of the herpes simplex virus type 1 ps UL8 pe protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the ps UL5 pe and UL52 proteins.","label":1}
{"pair_id":"BioInfer.d501.s0.p0","sentence":"ps PS1 pe fragments form complexes with E-cadherin, ps beta-catenin pe, and alpha-catenin, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p1","sentence":"ps PS1 pe fragments form complexes with ps E-cadherin pe, beta-catenin, and alpha-catenin, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p2","sentence":"ps PS1 pe fragments form complexes with E-cadherin, beta-catenin, and ps alpha-catenin pe, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p3","sentence":"PS1 fragments form complexes with ps E-cadherin pe, ps beta-catenin pe, and alpha-catenin, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p4","sentence":"PS1 fragments form complexes with E-cadherin, ps beta-catenin pe, and ps alpha-catenin pe, all components of adherens junctions.","label":1}
{"pair_id":"BioInfer.d501.s0.p5","sentence":"PS1 fragments form complexes with ps E-cadherin pe, beta-catenin, and ps alpha-catenin pe, all components of adherens junctions.","label":1}
{"pair_id":"AIMed.d174.s1475.p0","sentence":"Due to its increased affinity for the ps IL-6R pe but its decreased ability to couple with ps gp130 pe, we suggest that a stable IL-6 dimer may be an efficient IL-6 antagonist.","label":0}
{"pair_id":"AIMed.d174.s1475.p1","sentence":"Due to its increased affinity for the ps IL-6R pe but its decreased ability to couple with gp130, we suggest that a stable ps IL-6 pe dimer may be an efficient IL-6 antagonist.","label":1}
{"pair_id":"AIMed.d174.s1475.p2","sentence":"Due to its increased affinity for the ps IL-6R pe but its decreased ability to couple with gp130, we suggest that a stable IL-6 dimer may be an efficient ps IL-6 pe antagonist.","label":0}
{"pair_id":"AIMed.d174.s1475.p3","sentence":"Due to its increased affinity for the IL-6R but its decreased ability to couple with ps gp130 pe, we suggest that a stable ps IL-6 pe dimer may be an efficient IL-6 antagonist.","label":1}
{"pair_id":"AIMed.d174.s1475.p4","sentence":"Due to its increased affinity for the IL-6R but its decreased ability to couple with ps gp130 pe, we suggest that a stable IL-6 dimer may be an efficient ps IL-6 pe antagonist.","label":0}
{"pair_id":"AIMed.d174.s1475.p5","sentence":"Due to its increased affinity for the IL-6R but its decreased ability to couple with gp130, we suggest that a stable ps IL-6 pe dimer may be an efficient ps IL-6 pe antagonist.","label":0}
{"pair_id":"BioInfer.d714.s0.p0","sentence":"These results suggest that the heptapeptide sequence is specific for the interaction with ps actin pe and, therefore, may constitute part of the actin-binding domain of ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d714.s0.p1","sentence":"These results suggest that the heptapeptide sequence is specific for the interaction with ps actin pe and, therefore, may constitute part of the ps actin pe-binding domain of cofilin.","label":0}
{"pair_id":"BioInfer.d714.s0.p2","sentence":"These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the ps actin pe-binding domain of ps cofilin pe.","label":1}
{"pair_id":"AIMed.d147.s1249.p0","sentence":"The products of the ps RBP1 pe and ps RBP2 pe genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p1","sentence":"The products of the ps RBP1 pe and RBP2 genes are ubiquitously expressed, large (200 kDa for ps RBP1 pe and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p2","sentence":"The products of the ps RBP1 pe and RBP2 genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for ps RBP2 pe) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p3","sentence":"The products of the RBP1 and ps RBP2 pe genes are ubiquitously expressed, large (200 kDa for ps RBP1 pe and 195 kDa for RBP2) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p4","sentence":"The products of the RBP1 and ps RBP2 pe genes are ubiquitously expressed, large (200 kDa for RBP1 and 195 kDa for ps RBP2 pe) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d147.s1249.p5","sentence":"The products of the RBP1 and RBP2 genes are ubiquitously expressed, large (200 kDa for ps RBP1 pe and 195 kDa for ps RBP2 pe) nuclear phosphoproteins with structural motifs that suggest a role in transcriptional regulation.","label":0}
{"pair_id":"AIMed.d49.s435.p0","sentence":"By utilizing domain swapping and site-directed mutagenesis we have found that the loop connecting the beta4-beta5 strands of ps FGF-7 pe contributes to high affinity receptor binding and is critical for ps KGFR pe recognition.","label":1}
{"pair_id":"BioInfer.d804.s0.p0","sentence":"We find that ps profilin pe contributes in several ways to Cdc42-induced nucleation of ps actin pe filaments in high speed supernatant of lysed neutrophils.","label":1}
{"pair_id":"BioInfer.d804.s0.p1","sentence":"We find that ps profilin pe contributes in several ways to ps Cdc42 pe-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.","label":0}
{"pair_id":"BioInfer.d804.s0.p2","sentence":"We find that profilin contributes in several ways to ps Cdc42 pe-induced nucleation of ps actin pe filaments in high speed supernatant of lysed neutrophils.","label":1}
{"pair_id":"BioInfer.d174.s0.p0","sentence":"Direct binding of the ps verprolin pe-homology domain in N-WASP to ps actin pe is essential for cytoskeletal reorganization.","label":0}
{"pair_id":"BioInfer.d174.s0.p1","sentence":"Direct binding of the ps verprolin pe-homology domain in ps N-WASP pe to actin is essential for cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d174.s0.p2","sentence":"Direct binding of the verprolin-homology domain in ps N-WASP pe to ps actin pe is essential for cytoskeletal reorganization.","label":1}
{"pair_id":"BioInfer.d106.s0.p0","sentence":"ps Neuropilin-1 pe is expressed by endothelial and tumor cells as an isoform-specific receptor for ps vascular endothelial growth factor pe.","label":1}
{"pair_id":"BioInfer.d493.s0.p0","sentence":"Previous studies have yielded conflicting results concerning the physiological role of ps profilin pe, a 12-15-kD ps actin pe- and phosphoinositide-binding protein, as a regulator of actin polymerization.","label":1}
{"pair_id":"BioInfer.d493.s0.p1","sentence":"Previous studies have yielded conflicting results concerning the physiological role of ps profilin pe, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of ps actin pe polymerization.","label":1}
{"pair_id":"BioInfer.d493.s0.p2","sentence":"Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD ps actin pe- and phosphoinositide-binding protein, as a regulator of ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d237.s3.p0","sentence":"The RAD51-interacting region (amino acids 291-330) of the human ps RAD52 pe protein shows no homology with the yeast ps RAD52 pe protein, indicating that the interaction between RAD51 and RAD52 is species-specific.","label":1}
{"pair_id":"BioInfer.d237.s3.p1","sentence":"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast ps RAD52 pe protein, indicating that the interaction between ps RAD51 pe and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p2","sentence":"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast ps RAD52 pe protein, indicating that the interaction between RAD51 and ps RAD52 pe is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p3","sentence":"The ps RAD51 pe-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast ps RAD52 pe protein, indicating that the interaction between RAD51 and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p4","sentence":"The RAD51-interacting region (amino acids 291-330) of the human ps RAD52 pe protein shows no homology with the yeast RAD52 protein, indicating that the interaction between ps RAD51 pe and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p5","sentence":"The RAD51-interacting region (amino acids 291-330) of the human ps RAD52 pe protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and ps RAD52 pe is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p6","sentence":"The ps RAD51 pe-interacting region (amino acids 291-330) of the human ps RAD52 pe protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.","label":1}
{"pair_id":"BioInfer.d237.s3.p7","sentence":"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between ps RAD51 pe and ps RAD52 pe is species-specific.","label":1}
{"pair_id":"BioInfer.d237.s3.p8","sentence":"The ps RAD51 pe-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between ps RAD51 pe and RAD52 is species-specific.","label":0}
{"pair_id":"BioInfer.d237.s3.p9","sentence":"The ps RAD51 pe-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and ps RAD52 pe is species-specific.","label":0}
{"pair_id":"BioInfer.d115.s1.p0","sentence":"SNF11 interacts with ps SNF2 pe in vitro and copurifies with the SNF-ps SWI pe complex from yeast cells.","label":0}
{"pair_id":"BioInfer.d115.s1.p1","sentence":"ps SNF11 pe interacts with SNF2 in vitro and copurifies with the SNF-ps SWI pe complex from yeast cells.","label":1}
{"pair_id":"BioInfer.d115.s1.p2","sentence":"SNF11 interacts with SNF2 in vitro and copurifies with the ps SNF pe-ps SWI pe complex from yeast cells.","label":1}
{"pair_id":"BioInfer.d115.s1.p3","sentence":"ps SNF11 pe interacts with ps SNF2 pe in vitro and copurifies with the SNF-SWI complex from yeast cells.","label":1}
{"pair_id":"BioInfer.d115.s1.p4","sentence":"SNF11 interacts with ps SNF2 pe in vitro and copurifies with the ps SNF pe-SWI complex from yeast cells.","label":0}
{"pair_id":"BioInfer.d115.s1.p5","sentence":"ps SNF11 pe interacts with SNF2 in vitro and copurifies with the ps SNF pe-SWI complex from yeast cells.","label":1}
{"pair_id":"AIMed.d219.s1906.p0","sentence":"Moreover, mutation of ps Raf-1 pe residues 143-145 impairs binding of 14-3-3, but not ps Ras pe, to the Raf-CRD.","label":1}
{"pair_id":"AIMed.d219.s1906.p1","sentence":"Moreover, mutation of ps Raf-1 pe residues 143-145 impairs binding of 14-3-3, but not Ras, to the ps Raf-CRD pe.","label":1}
{"pair_id":"AIMed.d219.s1906.p2","sentence":"Moreover, mutation of Raf-1 residues 143-145 impairs binding of 14-3-3, but not ps Ras pe, to the ps Raf-CRD pe.","label":0}
{"pair_id":"AIMed.d102.s866.p0","sentence":"These results suggest that ps RB pe can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with ps TFIID pe, in particular with TAFII250.","label":0}
{"pair_id":"AIMed.d102.s866.p1","sentence":"These results suggest that ps RB pe can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with TFIID, in particular with ps TAFII250 pe.","label":1}
{"pair_id":"AIMed.d102.s866.p2","sentence":"These results suggest that RB can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with ps TFIID pe, in particular with ps TAFII250 pe.","label":0}
{"pair_id":"AIMed.d214.s1864.p0","sentence":"In addition, we show that the conserved motif Y699 MTP present in ps c-Cbl pe is the binding site for the ps Vav pe SH2 domain in vitro.","label":1}
{"pair_id":"BioInfer.d164.s0.p0","sentence":"ps Death receptors pe belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as ps Caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d164.s0.p1","sentence":"ps Death receptors pe belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as ps TRADD pe and FADD and cysteine proteases such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p2","sentence":"ps Death receptors pe belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and ps FADD pe and cysteine proteases such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p3","sentence":"ps Death receptors pe belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and ps cysteine proteases pe such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p4","sentence":"ps Death receptors pe belong to the ps TNF receptor pe family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.","label":1}
{"pair_id":"BioInfer.d164.s0.p5","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as ps TRADD pe and FADD and cysteine proteases such as ps Caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d164.s0.p6","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and ps FADD pe and cysteine proteases such as ps Caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d164.s0.p7","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and ps cysteine proteases pe such as ps Caspase-8 pe.","label":1}
{"pair_id":"BioInfer.d164.s0.p8","sentence":"Death receptors belong to the ps TNF receptor pe family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as ps Caspase-8 pe.","label":0}
{"pair_id":"BioInfer.d164.s0.p9","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as ps TRADD pe and ps FADD pe and cysteine proteases such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p10","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as ps TRADD pe and FADD and ps cysteine proteases pe such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p11","sentence":"Death receptors belong to the ps TNF receptor pe family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as ps TRADD pe and FADD and cysteine proteases such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p12","sentence":"Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and ps FADD pe and ps cysteine proteases pe such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p13","sentence":"Death receptors belong to the ps TNF receptor pe family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and ps FADD pe and cysteine proteases such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d164.s0.p14","sentence":"Death receptors belong to the ps TNF receptor pe family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and ps cysteine proteases pe such as Caspase-8.","label":0}
{"pair_id":"BioInfer.d617.s0.p0","sentence":"The head domain of ps talin pe thus binds to ps integrins pe to form a link to the actin cytoskeleton and can thus regulate integrin function.","label":1}
{"pair_id":"BioInfer.d617.s0.p1","sentence":"The head domain of talin thus binds to ps integrins pe to form a link to the actin cytoskeleton and can thus regulate ps integrin pe function.","label":0}
{"pair_id":"BioInfer.d617.s0.p2","sentence":"The head domain of talin thus binds to ps integrins pe to form a link to the ps actin pe cytoskeleton and can thus regulate integrin function.","label":1}
{"pair_id":"BioInfer.d617.s0.p3","sentence":"The head domain of ps talin pe thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate ps integrin pe function.","label":1}
{"pair_id":"BioInfer.d617.s0.p4","sentence":"The head domain of ps talin pe thus binds to integrins to form a link to the ps actin pe cytoskeleton and can thus regulate integrin function.","label":1}
{"pair_id":"BioInfer.d617.s0.p5","sentence":"The head domain of talin thus binds to integrins to form a link to the ps actin pe cytoskeleton and can thus regulate ps integrin pe function.","label":0}
{"pair_id":"AIMed.d143.s1212.p0","sentence":"It was observed that anti-ps gp130 pe antibodies abolished cell proliferation, protein tyrosine phosphorylation, and ps junB pe gene expression elicited by IL-11 or IL-6 in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p1","sentence":"It was observed that anti-ps gp130 pe antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by ps IL-11 pe or IL-6 in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p2","sentence":"It was observed that anti-ps gp130 pe antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or ps IL-6 pe in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p3","sentence":"It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and ps junB pe gene expression elicited by ps IL-11 pe or IL-6 in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p4","sentence":"It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and ps junB pe gene expression elicited by IL-11 or ps IL-6 pe in TF-1 cells.","label":0}
{"pair_id":"AIMed.d143.s1212.p5","sentence":"It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by ps IL-11 pe or ps IL-6 pe in TF-1 cells.","label":0}
{"pair_id":"BioInfer.d113.s0.p0","sentence":"Both tyrosine phosphorylation and association of beta-catenin with ps EGFR pe were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from ps E-cadherin pe was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p1","sentence":"Both tyrosine phosphorylation and association of beta-catenin with ps EGFR pe were inhibited by tyrphostin, a specific inhibitor of the ps EGFR pe tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p2","sentence":"Both tyrosine phosphorylation and association of beta-catenin with ps EGFR pe were inhibited by tyrphostin, a specific inhibitor of the EGFR ps tyrosine kinase pe, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p3","sentence":"Both tyrosine phosphorylation and association of beta-catenin with ps EGFR pe were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of ps alpha-catenin pe from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p4","sentence":"Both tyrosine phosphorylation and association of ps beta-catenin pe with ps EGFR pe were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.","label":1}
{"pair_id":"BioInfer.d113.s0.p5","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the ps EGFR pe tyrosine kinase, whereas dissociation of alpha-catenin from ps E-cadherin pe was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p6","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR ps tyrosine kinase pe, whereas dissociation of alpha-catenin from ps E-cadherin pe was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p7","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of ps alpha-catenin pe from ps E-cadherin pe was not.","label":1}
{"pair_id":"BioInfer.d113.s0.p8","sentence":"Both tyrosine phosphorylation and association of ps beta-catenin pe with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from ps E-cadherin pe was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p9","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the ps EGFR pe ps tyrosine kinase pe, whereas dissociation of alpha-catenin from E-cadherin was not.","label":1}
{"pair_id":"BioInfer.d113.s0.p10","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the ps EGFR pe tyrosine kinase, whereas dissociation of ps alpha-catenin pe from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p11","sentence":"Both tyrosine phosphorylation and association of ps beta-catenin pe with EGFR were inhibited by tyrphostin, a specific inhibitor of the ps EGFR pe tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p12","sentence":"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR ps tyrosine kinase pe, whereas dissociation of ps alpha-catenin pe from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p13","sentence":"Both tyrosine phosphorylation and association of ps beta-catenin pe with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR ps tyrosine kinase pe, whereas dissociation of alpha-catenin from E-cadherin was not.","label":0}
{"pair_id":"BioInfer.d113.s0.p14","sentence":"Both tyrosine phosphorylation and association of ps beta-catenin pe with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of ps alpha-catenin pe from E-cadherin was not.","label":0}
{"pair_id":"AIMed.d199.s1701.p0","sentence":"ps Sos pe in complex with a previously identified 90-kDa protein and designated protein ps 80K-H pe.","label":0}
{"pair_id":"AIMed.d142.s1194.p0","sentence":"Evidence for physical interaction between the zinc-finger transcription factors ps YY1 pe and ps Sp1 pe.","label":1}
{"pair_id":"BioInfer.d209.s0.p0","sentence":"Finally it was shown that the two isoforms of ps actin pe can be separated from each other in the absence of ps profilin pe also by chromatography on hydroxyapatite.","label":0}
{"pair_id":"BioInfer.d215.s0.p0","sentence":"For example, it is associated with alpha-catenin and ps beta-catenin pe (ps Armadillo pe), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p1","sentence":"For example, it is associated with alpha-catenin and ps beta-catenin pe (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic ps cadherins pe.","label":1}
{"pair_id":"BioInfer.d215.s0.p2","sentence":"For example, it is associated with ps alpha-catenin pe and ps beta-catenin pe (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p3","sentence":"For example, it is associated with alpha-catenin and ps beta-catenin pe (Armadillo), and protected from ps trypsin pe digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p4","sentence":"For example, it is associated with alpha-catenin and beta-catenin (ps Armadillo pe), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic ps cadherins pe.","label":1}
{"pair_id":"BioInfer.d215.s0.p5","sentence":"For example, it is associated with ps alpha-catenin pe and beta-catenin (ps Armadillo pe), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p6","sentence":"For example, it is associated with alpha-catenin and beta-catenin (ps Armadillo pe), and protected from ps trypsin pe digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"BioInfer.d215.s0.p7","sentence":"For example, it is associated with ps alpha-catenin pe and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic ps cadherins pe.","label":1}
{"pair_id":"BioInfer.d215.s0.p8","sentence":"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from ps trypsin pe digestion only in the presence of Ca2+, as is the case for many of classic ps cadherins pe.","label":1}
{"pair_id":"BioInfer.d215.s0.p9","sentence":"For example, it is associated with ps alpha-catenin pe and beta-catenin (Armadillo), and protected from ps trypsin pe digestion only in the presence of Ca2+, as is the case for many of classic cadherins.","label":0}
{"pair_id":"AIMed.d152.s1292.p0","sentence":"Tumor necrosis factor (TNF) can induce apoptosis and activate ps NF-kappa B pe through signaling cascades emanating from ps TNF receptor 1 pe (TNFR1).","label":0}
{"pair_id":"AIMed.d152.s1292.p1","sentence":"Tumor necrosis factor (TNF) can induce apoptosis and activate ps NF-kappa B pe through signaling cascades emanating from TNF receptor 1 (ps TNFR1 pe).","label":0}
{"pair_id":"AIMed.d152.s1292.p2","sentence":"Tumor necrosis factor (TNF) can induce apoptosis and activate NF-kappa B through signaling cascades emanating from ps TNF receptor 1 pe (ps TNFR1 pe).","label":0}
{"pair_id":"AIMed.d73.s621.p0","sentence":"The extracellular cysteine-rich domain of the TNF-R is homologous to the nerve growth factor receptor and the ps B cell activation protein pe ps Bp50 pe.","label":0}
{"pair_id":"BioInfer.d592.s0.p0","sentence":"The cellular transcription co-activators p300 and the ps CREB-binding protein pe ps CBP pe are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).","label":1}
{"pair_id":"BioInfer.d592.s0.p1","sentence":"The cellular transcription co-activators ps p300 pe and the ps CREB-binding protein pe CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).","label":0}
{"pair_id":"BioInfer.d592.s0.p2","sentence":"The cellular transcription co-activators p300 and the ps CREB-binding protein pe CBP are cellular targets for transformation by the ps E1A pe proteins of non-oncogenic adenovirus 5 (Ad5).","label":0}
{"pair_id":"BioInfer.d592.s0.p3","sentence":"The cellular transcription co-activators ps p300 pe and the CREB-binding protein ps CBP pe are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).","label":0}
{"pair_id":"BioInfer.d592.s0.p4","sentence":"The cellular transcription co-activators p300 and the CREB-binding protein ps CBP pe are cellular targets for transformation by the ps E1A pe proteins of non-oncogenic adenovirus 5 (Ad5).","label":1}
{"pair_id":"BioInfer.d592.s0.p5","sentence":"The cellular transcription co-activators ps p300 pe and the CREB-binding protein CBP are cellular targets for transformation by the ps E1A pe proteins of non-oncogenic adenovirus 5 (Ad5).","label":1}
{"pair_id":"BioInfer.d140.s1.p0","sentence":"In this study we have used the yeast two-hybrid system to map the domains on ps alpha-catenin pe that allow it to associate with beta-catenin\/ps plakoglobin pe and with alpha-actinin.","label":1}
{"pair_id":"BioInfer.d140.s1.p1","sentence":"In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with ps beta-catenin pe\/ps plakoglobin pe and with alpha-actinin.","label":0}
{"pair_id":"BioInfer.d140.s1.p2","sentence":"In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin\/ps plakoglobin pe and with ps alpha-actinin pe.","label":0}
{"pair_id":"BioInfer.d140.s1.p3","sentence":"In this study we have used the yeast two-hybrid system to map the domains on ps alpha-catenin pe that allow it to associate with ps beta-catenin pe\/plakoglobin and with alpha-actinin.","label":1}
{"pair_id":"BioInfer.d140.s1.p4","sentence":"In this study we have used the yeast two-hybrid system to map the domains on ps alpha-catenin pe that allow it to associate with beta-catenin\/plakoglobin and with ps alpha-actinin pe.","label":1}
{"pair_id":"BioInfer.d140.s1.p5","sentence":"In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with ps beta-catenin pe\/plakoglobin and with ps alpha-actinin pe.","label":0}
{"pair_id":"BioInfer.d507.s0.p0","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the ps fimbrin\/plastin pe family of ps actin pe filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":1}
{"pair_id":"BioInfer.d507.s0.p1","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana ps fimbrin 1 pe (AtFim1) is a member of the ps fimbrin\/plastin pe family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":1}
{"pair_id":"BioInfer.d507.s0.p2","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (ps AtFim1 pe) is a member of the ps fimbrin\/plastin pe family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":1}
{"pair_id":"BioInfer.d507.s0.p3","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana ps fimbrin 1 pe (AtFim1) is a member of the fimbrin\/plastin family of ps actin pe filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":0}
{"pair_id":"BioInfer.d507.s0.p4","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (ps AtFim1 pe) is a member of the fimbrin\/plastin family of ps actin pe filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":0}
{"pair_id":"BioInfer.d507.s0.p5","sentence":"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana ps fimbrin 1 pe (ps AtFim1 pe) is a member of the fimbrin\/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].","label":0}
{"pair_id":"AIMed.d169.s1431.p0","sentence":"COS-7 cells transfected with the ps IL-13R pe cDNA bind ps IL-13 pe with high affinity but do not bind IL-4.","label":1}
{"pair_id":"AIMed.d169.s1431.p1","sentence":"COS-7 cells transfected with the ps IL-13R pe cDNA bind IL-13 with high affinity but do not bind ps IL-4 pe.","label":0}
{"pair_id":"AIMed.d169.s1431.p2","sentence":"COS-7 cells transfected with the IL-13R cDNA bind ps IL-13 pe with high affinity but do not bind ps IL-4 pe.","label":0}
{"pair_id":"BioInfer.d377.s0.p0","sentence":"In this study, by immunoprecipitation and affinity chromatography it is shown that ps adenosine deaminase pe and ps A1 adenosine receptors pe interact in pig brain cortical membranes.","label":1}
{"pair_id":"BioInfer.d654.s1.p0","sentence":"This study details the expression patterns of ps alpha-catenin pe, beta-catenin, and ps gamma-catenin pe, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.","label":0}
{"pair_id":"BioInfer.d654.s1.p1","sentence":"This study details the expression patterns of ps alpha-catenin pe, ps beta-catenin pe, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.","label":0}
{"pair_id":"BioInfer.d654.s1.p2","sentence":"This study details the expression patterns of alpha-catenin, ps beta-catenin pe, and ps gamma-catenin pe, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.","label":0}
{"pair_id":"AIMed.d26.s214.p0","sentence":"Differential expression of ps granulysin pe and ps perforin pe by NK cells in cancer patients and correlation of impaired granulysin expression withprogression of cancer.","label":0}
{"pair_id":"AIMed.d26.s214.p1","sentence":"Differential expression of ps granulysin pe and perforin by NK cells in cancer patients and correlation of impaired ps granulysin pe expression withprogression of cancer.","label":0}
{"pair_id":"AIMed.d26.s214.p2","sentence":"Differential expression of granulysin and ps perforin pe by NK cells in cancer patients and correlation of impaired ps granulysin pe expression withprogression of cancer.","label":0}
{"pair_id":"AIMed.d162.s1368.p0","sentence":"As a result of this physical interaction, binding of ps h-TR beta 1 pe to its hormone response elements either as homodimer or as a heterodimer with the ps retinoic X receptor pe was inhibited by p53 in a concentration-dependent manner.","label":1}
{"pair_id":"AIMed.d162.s1368.p1","sentence":"As a result of this physical interaction, binding of ps h-TR beta 1 pe to its hormone response elements either as homodimer or as a heterodimer with the retinoic X receptor was inhibited by ps p53 pe in a concentration-dependent manner.","label":0}
{"pair_id":"AIMed.d162.s1368.p2","sentence":"As a result of this physical interaction, binding of h-TR beta 1 to its hormone response elements either as homodimer or as a heterodimer with the ps retinoic X receptor pe was inhibited by ps p53 pe in a concentration-dependent manner.","label":0}
{"pair_id":"AIMed.d193.s1646.p0","sentence":"Moreover, while ps ITF-2b pe inhibited the ps creatine kinase pe promoter, it acted as a weak transactivator on an artificial promoter consisting of three tandem copies of the consensus myogenic factor DNA binding site.","label":0}
{"pair_id":"AIMed.d184.s1561.p0","sentence":"ps CD4 pe-induced interaction of primary HIV-1 ps gp120 pe glycoproteins with the chemokine receptor CCR-5.","label":1}
{"pair_id":"AIMed.d184.s1561.p1","sentence":"ps CD4 pe-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor ps CCR-5 pe.","label":0}
{"pair_id":"AIMed.d184.s1561.p2","sentence":"CD4-induced interaction of primary HIV-1 ps gp120 pe glycoproteins with the chemokine receptor ps CCR-5 pe.","label":0}
{"pair_id":"BioInfer.d37.s1.p0","sentence":"The interaction of Acanthamoeba ps actin pe and Acanthamoeba ps profilin pe was evaluated as a function of ionic conditions.","label":1}
{"pair_id":"AIMed.d18.s157.p0","sentence":"We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of ps IL-1beta pe, ps IL-6 pe, and IL-10, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.","label":0}
{"pair_id":"AIMed.d18.s157.p1","sentence":"We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of ps IL-1beta pe, IL-6, and ps IL-10 pe, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.","label":0}
{"pair_id":"AIMed.d18.s157.p2","sentence":"We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of IL-1beta, ps IL-6 pe, and ps IL-10 pe, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.","label":0}
{"pair_id":"AIMed.d141.s1192.p0","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p1","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p2","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-ps Cdk2 pe, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p3","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, ps cyclin E pe-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p4","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-ps Cdk2 pe, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p5","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, ps cyclin D1 pe-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p6","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-ps Cdk4 pe, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p7","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p8","sentence":"ps p21CIP1 pe is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p9","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by ps cyclin A pe-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p10","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-ps Cdk2 pe, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p11","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-Cdk2, ps cyclin E pe-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p12","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-Cdk2, cyclin E-ps Cdk2 pe, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p13","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-Cdk2, cyclin E-Cdk2, ps cyclin D1 pe-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p14","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-ps Cdk4 pe, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p15","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p16","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of ps Rb pe by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p17","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-ps Cdk2 pe, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":1}
{"pair_id":"AIMed.d141.s1192.p18","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-Cdk2, ps cyclin E pe-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p19","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-Cdk2, cyclin E-ps Cdk2 pe, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p20","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-Cdk2, cyclin E-Cdk2, ps cyclin D1 pe-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p21","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-Cdk2, cyclin E-Cdk2, cyclin D1-ps Cdk4 pe, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p22","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p23","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by ps cyclin A pe-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p24","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-ps Cdk2 pe, ps cyclin E pe-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p25","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-ps Cdk2 pe, cyclin E-ps Cdk2 pe, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p26","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-ps Cdk2 pe, cyclin E-Cdk2, ps cyclin D1 pe-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p27","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-ps Cdk2 pe, cyclin E-Cdk2, cyclin D1-ps Cdk4 pe, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p28","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-ps Cdk2 pe, cyclin E-Cdk2, cyclin D1-Cdk4, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p29","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-ps Cdk2 pe, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p30","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, ps cyclin E pe-ps Cdk2 pe, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.","label":1}
{"pair_id":"AIMed.d141.s1192.p31","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, ps cyclin E pe-Cdk2, ps cyclin D1 pe-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p32","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, ps cyclin E pe-Cdk2, cyclin D1-ps Cdk4 pe, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p33","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, ps cyclin E pe-Cdk2, cyclin D1-Cdk4, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p34","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, ps cyclin E pe-Cdk2, cyclin D1-Cdk4, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p35","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-ps Cdk2 pe, ps cyclin D1 pe-Cdk4, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p36","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-ps Cdk2 pe, cyclin D1-ps Cdk4 pe, and cyclin D2-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p37","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-ps Cdk2 pe, cyclin D1-Cdk4, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p38","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-ps Cdk2 pe, cyclin D1-Cdk4, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p39","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, ps cyclin D1 pe-ps Cdk4 pe, and cyclin D2-Cdk4 complexes.","label":1}
{"pair_id":"AIMed.d141.s1192.p40","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, ps cyclin D1 pe-Cdk4, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p41","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, ps cyclin D1 pe-Cdk4, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p42","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-ps Cdk4 pe, and ps cyclin D2 pe-Cdk4 complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p43","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-ps Cdk4 pe, and cyclin D2-ps Cdk4 pe complexes.","label":0}
{"pair_id":"AIMed.d141.s1192.p44","sentence":"p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and ps cyclin D2 pe-ps Cdk4 pe complexes.","label":1}
{"pair_id":"AIMed.d74.s630.p0","sentence":"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for ps interleukin-6 pe, ps erythropoietin pe and interleukin-2 (beta-chain) and also to the prolactin receptor.","label":0}
{"pair_id":"AIMed.d74.s630.p1","sentence":"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for ps interleukin-6 pe, erythropoietin and ps interleukin-2 pe (beta-chain) and also to the prolactin receptor.","label":0}
{"pair_id":"AIMed.d74.s630.p2","sentence":"It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, ps erythropoietin pe and ps interleukin-2 pe (beta-chain) and also to the prolactin receptor.","label":0}
{"pair_id":"BioInfer.d786.s0.p0","sentence":"Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of ps skeletal myosin heavy chain pe, we recently demonstrated that this segment is an ps actin pe binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].","label":1}
{"pair_id":"AIMed.d220.s1920.p0","sentence":"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the ps TRKB peps TRKB receptor pe in binding BDNF.","label":0}
{"pair_id":"AIMed.d220.s1920.p1","sentence":"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the ps TRKB pe receptor in binding ps BDNF pe.","label":0}
{"pair_id":"AIMed.d220.s1920.p2","sentence":"These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the ps TRKB receptor pe in binding ps BDNF pe.","label":1}
{"pair_id":"AIMed.d167.s1402.p0","sentence":"The ps glut 1 pe glucose transporter interacts with ps calnexin pe and calreticulin.","label":1}
{"pair_id":"AIMed.d167.s1402.p1","sentence":"The ps glut 1 pe glucose transporter interacts with calnexin and ps calreticulin pe.","label":1}
{"pair_id":"AIMed.d167.s1402.p2","sentence":"The glut 1 glucose transporter interacts with ps calnexin pe and ps calreticulin pe.","label":0}
{"pair_id":"AIMed.d71.s608.p0","sentence":"ps MAP kinase pe activation of ps c-jun pe may underlie the common stimulation of this transcription factor by mitogens, growth factors and oncogenes.","label":0}
{"pair_id":"AIMed.d142.s1200.p0","sentence":"To study the mechanism underlying the apparent functional cooperation between ps YY1 pe and ps Sp1 pe, we explored the possibility of protein-protein interactions between these two transcription factors.","label":0}
{"pair_id":"AIMed.d179.s1522.p0","sentence":"In the present study, we demonstrate that ps gastrin pe stimulates tyrosine phosphorylation of ps insulin pe receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p1","sentence":"In the present study, we demonstrate that ps gastrin pe stimulates tyrosine phosphorylation of ps insulin receptor substrate 1 pe (IRS-1), the major cytoplasmic substrate of the insulin receptor.","label":1}
{"pair_id":"AIMed.d179.s1522.p2","sentence":"In the present study, we demonstrate that ps gastrin pe stimulates tyrosine phosphorylation of insulin receptor substrate 1 (ps IRS-1 pe), the major cytoplasmic substrate of the insulin receptor.","label":1}
{"pair_id":"AIMed.d179.s1522.p3","sentence":"In the present study, we demonstrate that ps gastrin pe stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p4","sentence":"In the present study, we demonstrate that ps gastrin pe stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1522.p5","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of ps insulin peps insulin receptor substrate 1 pe (IRS-1), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p6","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of ps insulin pe receptor substrate 1 (ps IRS-1 pe), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p7","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of ps insulin pe receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p8","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of ps insulin pe receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1522.p9","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of ps insulin receptor substrate 1 pe (ps IRS-1 pe), the major cytoplasmic substrate of the insulin receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p10","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of ps insulin receptor substrate 1 pe (IRS-1), the major cytoplasmic substrate of the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p11","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of ps insulin receptor substrate 1 pe (IRS-1), the major cytoplasmic substrate of the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1522.p12","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (ps IRS-1 pe), the major cytoplasmic substrate of the ps insulin pe receptor.","label":0}
{"pair_id":"AIMed.d179.s1522.p13","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (ps IRS-1 pe), the major cytoplasmic substrate of the ps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d179.s1522.p14","sentence":"In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the ps insulin peps insulin receptor pe.","label":0}
{"pair_id":"AIMed.d193.s1641.p0","sentence":"Physical and functional interactions between the transcriptional inhibitors ps Id3 pe and ps ITF-2b pe. Evidence toward a novel mechanism regulating muscle-specific gene expression.","label":1}
{"pair_id":"AIMed.d23.s194.p0","sentence":"In contrast, in normal nasal tissues, ps COX-2 pe labeling was only found in the vascular wall, and the expression was weaker--a finding demonstrating that ps COX-2 pe is upregulated in nasal polyps.","label":0}
{"pair_id":"AIMed.d37.s311.p0","sentence":"ps CCR5 pe was first characterized as a receptor for ps MIP-1alpha pe, MIP-1beta, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":1}
{"pair_id":"AIMed.d37.s311.p1","sentence":"ps CCR5 pe was first characterized as a receptor for MIP-1alpha, ps MIP-1beta pe, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":1}
{"pair_id":"AIMed.d37.s311.p2","sentence":"ps CCR5 pe was first characterized as a receptor for MIP-1alpha, MIP-1beta, and ps RANTES pe, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":1}
{"pair_id":"AIMed.d37.s311.p3","sentence":"CCR5 was first characterized as a receptor for ps MIP-1alpha pe, ps MIP-1beta pe, and RANTES, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":0}
{"pair_id":"AIMed.d37.s311.p4","sentence":"CCR5 was first characterized as a receptor for ps MIP-1alpha pe, MIP-1beta, and ps RANTES pe, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":0}
{"pair_id":"AIMed.d37.s311.p5","sentence":"CCR5 was first characterized as a receptor for MIP-1alpha, ps MIP-1beta pe, and ps RANTES pe, and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus (HIV)-1 strains and simian immunodeficiency virus (SIV).","label":0}
{"pair_id":"BioInfer.d473.s0.p0","sentence":"Our data, which suggest that pollen ps profilin pe can regulate ps actin pe-based cytoskeletal protein assembly and protein kinase or protein pho activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p1","sentence":"Our data, which suggest that pollen profilin can regulate ps actin pe-based cytoskeletal protein assembly and protein kinase or protein pho activity, indicate a possible role for the involvement of ps profilin pe in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p2","sentence":"Our data, which suggest that pollen profilin can regulate ps actin pe-based cytoskeletal protein assembly and ps protein kinase pe or protein pho activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p3","sentence":"Our data, which suggest that pollen profilin can regulate ps actin pe-based cytoskeletal protein assembly and ps protein pe kinase or ps protein pho pe activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p4","sentence":"Our data, which suggest that pollen ps profilin pe can regulate actin-based cytoskeletal protein assembly and protein kinase or protein pho activity, indicate a possible role for the involvement of ps profilin pe in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p5","sentence":"Our data, which suggest that pollen ps profilin pe can regulate actin-based cytoskeletal protein assembly and ps protein kinase pe or protein pho activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":1}
{"pair_id":"BioInfer.d473.s0.p6","sentence":"Our data, which suggest that pollen ps profilin pe can regulate actin-based cytoskeletal protein assembly and ps protein pe kinase or ps protein pho pe activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":1}
{"pair_id":"BioInfer.d473.s0.p7","sentence":"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and ps protein kinase pe or protein pho activity, indicate a possible role for the involvement of ps profilin pe in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p8","sentence":"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and ps protein pe kinase or ps protein pho pe activity, indicate a possible role for the involvement of ps profilin pe in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d473.s0.p9","sentence":"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and ps protein kinase peps protein pe kinase or ps protein pho pe activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.","label":0}
{"pair_id":"BioInfer.d87.s4.p0","sentence":"While ps alpha-catenin pe has been demonstrated to be crucial for ps cadherin pe function, the role of beta-catenin is not yet fully understood.","label":1}
{"pair_id":"BioInfer.d87.s4.p1","sentence":"While alpha-catenin has been demonstrated to be crucial for ps cadherin pe function, the role of ps beta-catenin pe is not yet fully understood.","label":0}
{"pair_id":"BioInfer.d87.s4.p2","sentence":"While ps alpha-catenin pe has been demonstrated to be crucial for cadherin function, the role of ps beta-catenin pe is not yet fully understood.","label":0}
{"pair_id":"BioInfer.d544.s0.p0","sentence":"ps Smooth muscle alpha actin peps Smooth muscle pe alpha actin and ps Smooth muscle myos pe expression in the vascular smooth muscle cells surrounding human endometrial arterioles.","label":0}
{"pair_id":"BioInfer.d628.s0.p0","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the ps cyclin-dependent kinase inhibitor pe p27(kip1) but a striking inhibition of the expression of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d628.s0.p1","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the ps cyclin-dependent kinase inhibitor pe p27(ps kip1 pe) but a striking inhibition of the expression of cyclin D1.","label":1}
{"pair_id":"BioInfer.d628.s0.p2","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the ps cyclin-dependent kinase inhibitor pe ps p27 pe(kip1) but a striking inhibition of the expression of cyclin D1.","label":1}
{"pair_id":"BioInfer.d628.s0.p3","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(ps kip1 pe) but a striking inhibition of the expression of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d628.s0.p4","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor ps p27 pe(kip1) but a striking inhibition of the expression of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d628.s0.p5","sentence":"The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor ps p27 pe(ps kip1 pe) but a striking inhibition of the expression of cyclin D1.","label":0}
{"pair_id":"AIMed.d185.s1574.p0","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine ps IL-10 peps IL-10 receptor pe were found to be redundantly required for receptor function and for activation of Stat3 but not for Stat1 or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p1","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine ps IL-10 pe receptor were found to be redundantly required for receptor function and for activation of ps Stat3 pe but not for Stat1 or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p2","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine ps IL-10 pe receptor were found to be redundantly required for receptor function and for activation of Stat3 but not for ps Stat1 pe or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p3","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine ps IL-10 receptor pe were found to be redundantly required for receptor function and for activation of ps Stat3 pe but not for Stat1 or Stat5.","label":1}
{"pair_id":"AIMed.d185.s1574.p4","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine ps IL-10 receptor pe were found to be redundantly required for receptor function and for activation of Stat3 but not for ps Stat1 pe or Stat5.","label":0}
{"pair_id":"AIMed.d185.s1574.p5","sentence":"Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine IL-10 receptor were found to be redundantly required for receptor function and for activation of ps Stat3 pe but not for ps Stat1 pe or Stat5.","label":0}